data_2jvl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jvl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 110.155 -0.313 . . . . 10.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -129.05 87.59 53.95 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.326 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.44 165.77 31.42 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.697 2.265 . . . . 10.0 111.844 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -88.88 -179.84 6.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.073 0.464 . . . . 10.0 110.927 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -125.09 147.23 49.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.32 165.66 27.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 10.0 111.16 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.63 148.65 20.06 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.514 -0.635 . . . . 10.0 111.514 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.82 162.16 30.67 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.541 -0.838 . . . . 10.0 112.002 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -144.31 94.23 2.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 10.0 110.347 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -112.81 148.54 34.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.633 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.85 -137.26 2.24 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.699 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 61.51 85.62 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.279 0.561 . . . . 10.0 111.268 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.245 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.7 0.286 . . . . 10.0 111.073 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.46 HG23 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -59.35 -42.16 86.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.693 0.257 . . . . 10.0 111.693 -178.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 120.74 148.84 8.1 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.441 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -67.4 -55.05 15.3 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.599 0.199 . . . . 10.0 111.52 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.17 -36.22 81.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.314 -0.625 . . . . 10.0 109.314 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 87' ' ' ILE . 43.2 t -58.57 -50.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.189 -0.914 . . . . 10.0 110.553 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.02 -42.37 99.73 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.712 -0.756 . . . . 10.0 112.235 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.88 -43.36 93.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 10.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.7 68.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.861 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.0 mt -60.32 -46.32 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.394 . . . . 10.0 110.26 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.93 -52.12 18.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.235 0.54 . . . . 10.0 110.196 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 11.9 mt-30 -60.69 -34.09 73.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.131 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.5 -28.19 57.99 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.582 -0.818 . . . . 10.0 112.459 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.6 HH12 ' HG3' ' A' ' 133' ' ' GLU . 2.5 mpt_? -80.36 -27.28 38.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.481 0.657 . . . . 10.0 109.807 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.405 ' HA ' HG21 ' A' ' 97' ' ' THR . 99.1 mt-30 -76.53 -9.32 58.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.239 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 10.0 mmtp -85.73 9.06 17.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.413 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.44 -162.58 0.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.556 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 77.9 mm-40 -122.48 104.64 36.93 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.946 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.2 Cg_endo -87.99 -26.71 5.55 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.941 -1.275 . . . . 10.0 112.523 -0.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.405 HG21 ' HA ' ' A' ' 92' ' ' GLN . 11.4 m -165.22 122.37 1.51 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.706 -1.588 . . . . 10.0 109.762 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.9 tpp -82.76 112.86 19.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.794 -0.447 . . . . 10.0 109.794 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 t -80.82 177.16 9.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.683 0.754 . . . . 10.0 111.971 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.72 -48.84 73.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.241 -1.345 . . . . 10.0 111.352 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.61 96.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.512 -0.313 . . . . 10.0 111.808 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.78 -50.01 66.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 10.0 111.838 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 107' ' ' ILE . 14.3 tp -62.43 -42.02 99.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.62 98.58 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.067 -0.813 . . . . 10.0 111.067 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.412 0.149 . . . . 10.0 111.297 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.442 ' OE1' HG21 ' A' ' 135' ' ' VAL . 12.0 pt-20 -67.58 -34.13 76.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 103' ' ' LEU . 36.7 pt -85.05 -8.32 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.536 -0.465 . . . . 10.0 111.807 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.18 31.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 10.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -123.71 -177.64 3.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.883 0.373 . . . . 10.0 110.662 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.4 170.51 9.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.889 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.8 97.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 10.0 110.783 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.68 72.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.782 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -61.07 -49.91 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.111 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.46 -44.01 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.295 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.28 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.698 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 16.6 m -75.33 -29.42 59.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.829 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.02 -42.62 72.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.702 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.11 -17.79 64.76 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.765 0.316 . . . . 10.0 111.057 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 116' ' ' SER . 13.2 ttp85 -69.75 -21.74 63.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.401 0.619 . . . . 10.0 109.855 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.46 ' C ' HG23 ' A' ' 79' ' ' VAL . . . 97.41 20.53 22.35 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.922 -0.656 . . . . 10.0 111.537 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 121' ' ' THR . 7.5 t -175.14 110.17 0.12 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.939 0.876 . . . . 10.0 110.468 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.19 23.13 0.42 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.083 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m 61.19 91.72 0.07 OUTLIER Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.411 ' HB3' HG11 ' A' ' 79' ' ' VAL . 74.5 Cg_endo -72.4 104.25 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.688 2.259 . . . . 10.0 115.623 -175.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 117.84 25.76 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.056 -2.572 . . . . 10.0 104.056 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 17.1 mm-40 -46.63 -38.67 10.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -64.75 -33.29 75.62 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.813 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.75 ' O ' ' HG3' ' A' ' 132' ' ' MET . 91.7 mt -69.88 -58.73 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.29 -0.256 . . . . 10.0 110.54 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -36.99 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.318 0.58 . . . . 10.0 110.955 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.0 m -54.06 -49.94 67.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.252 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 135' ' ' VAL . 1.5 mppt? -75.9 -38.5 57.74 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.146 0.424 . . . . 10.0 112.146 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.75 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 38.9 mtp -50.04 -58.27 5.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.315 0.579 . . . . 10.0 111.491 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mp0 -78.65 -29.92 46.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 115.165 1.543 . . . . 10.0 115.165 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -68.77 -34.52 75.71 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.43 0.53 . . . . 10.0 112.43 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 131' ' ' LYS . 87.1 t -60.89 -25.39 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.654 0.264 . . . . 10.0 111.117 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -115.13 2.54 14.16 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.13 60.74 2.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.716 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 1.9 m -143.06 155.94 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 30.3 mmmt -129.98 144.57 51.4 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.871 -0.418 . . . . 10.0 109.871 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.435 ' CD1' HG13 ' A' ' 83' ' ' VAL . 10.3 mt -106.49 40.06 1.7 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.462 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -141.03 135.95 31.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.759 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.88 -149.34 16.68 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.016 -0.612 . . . . 10.0 112.384 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.58 -32.21 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 10.0 110.789 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -87.42 57.89 4.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.67 . . . . 10.0 109.986 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.455 HD13 HG23 ' A' ' 145' ' ' ILE . 25.2 mm -65.1 132.68 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.018 -0.992 . . . . 10.0 111.573 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.409 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 88.18 -1.82 84.86 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.691 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -116.31 160.32 36.34 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.555 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.17 115.05 3.09 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.268 1.312 . . . . 10.0 109.231 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? . . . . . 0 C--N 1.315 -0.909 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 110.007 -0.368 . . . . 10.0 110.007 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.57 146.64 62.31 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.679 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.16 163.99 33.92 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.734 2.289 . . . . 10.0 112.08 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 174.01 6.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.824 0.345 . . . . 10.0 111.112 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -153.53 111.55 3.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.856 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.67 155.77 47.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.943 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.91 138.38 10.11 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.082 -0.58 . . . . 10.0 112.164 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.95 126.53 2.8 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 10.0 112.153 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -157.18 131.78 8.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.927 0.394 . . . . 10.0 110.28 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -144.16 143.41 31.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.046 -0.524 . . . . 10.0 109.639 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.32 -159.3 9.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.724 -0.75 . . . . 10.0 111.726 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.39 169.1 17.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.615 0.245 . . . . 10.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 10.0 109.982 179.718 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 110.268 -0.271 . . . . 10.0 110.268 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.484 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 2.3 m -83.1 -33.18 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.4 145.84 8.7 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.321 -0.942 . . . . 10.0 112.302 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -71.59 -28.82 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.892 0.33 . . . . 10.0 111.892 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -38.88 72.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.44 -44.7 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.461 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.04 98.03 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.944 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -62.95 -43.95 97.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.331 . . . . 10.0 110.753 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . . . -70.48 -37.95 74.31 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.649 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.769 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.7 mt -55.35 -48.48 76.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.655 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.08 -42.45 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.046 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -66.35 -30.7 71.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 10.0 109.926 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.663 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -71.06 -39.98 62.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.844 -0.693 . . . . 10.0 113.0 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.769 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 12.8 mmt85 -66.08 -38.32 87.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.141 0.496 . . . . 10.0 110.606 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -83.7 -0.93 52.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -80.1 -11.7 59.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.259 0.552 . . . . 10.0 110.367 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -171.97 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.803 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -131.55 110.87 14.94 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.658 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.77 -32.84 3.79 Favored 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.325 -1.531 . . . . 10.0 112.543 -0.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.6 m -163.95 131.19 3.32 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.413 -1.267 . . . . 10.0 110.204 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 26.1 tpp -82.48 136.31 34.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.707 -0.224 . . . . 10.0 110.422 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.0 p -83.56 156.33 22.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.887 0.375 . . . . 10.0 110.941 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.7 -33.94 73.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.83 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.11 73.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.313 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.89 -33.77 76.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.701 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -37.61 75.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.628 ' CA ' HG23 ' A' ' 114' ' ' VAL . . . -68.49 -46.84 60.67 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.498 -0.774 . . . . 10.0 112.605 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -58.67 -39.86 81.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.862 0.363 . . . . 10.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -64.03 -29.19 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 10.0 112.512 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.5 pt -106.76 3.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.0 32.96 69.65 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 121.296 -0.478 . . . . 10.0 113.402 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -120.18 163.09 18.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.849 0.357 . . . . 10.0 110.815 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.526 ' O ' HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -78.88 150.3 32.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.757 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.4 -44.15 68.46 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.36 93.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.741 -0.209 . . . . 10.0 110.579 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.9 m -59.18 -44.23 92.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.678 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.628 HG23 ' CA ' ' A' ' 104' ' ' GLY . 46.7 t -63.79 -43.21 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.121 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.62 -29.47 63.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 10.0 110.312 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 63.0 m -76.55 -25.8 54.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.749 . . . . 10.0 111.311 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.5 -37.76 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.998 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.61 -17.74 64.99 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.695 0.283 . . . . 10.0 111.693 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.579 ' HB3' ' O ' ' A' ' 116' ' ' SER . 37.3 ttm180 -67.8 -20.52 65.2 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.391 0.615 . . . . 10.0 110.462 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.484 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 93.88 23.66 22.38 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.339 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.553 HG21 ' O ' ' A' ' 121' ' ' THR . 7.3 t -170.25 107.61 0.34 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.282 1.039 . . . . 10.0 110.447 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.94 28.91 0.08 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.496 -1.229 . . . . 10.0 109.339 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m 64.63 103.04 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.416 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 84.1 Cg_endo -75.91 92.9 1.02 Allowed 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 123.058 2.505 . . . . 10.0 116.054 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.656 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.7 t70 -87.92 111.92 21.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 105.319 -2.104 . . . . 10.0 105.319 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -49.08 -38.22 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.132 0.895 . . . . 10.0 112.573 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 60.9 t30 -71.51 -45.31 62.76 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.113 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.2 mt -60.53 -50.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.481 -0.192 . . . . 10.0 110.481 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 11.7 mt -52.75 -45.27 66.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.562 0.696 . . . . 10.0 109.66 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.578 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 74.4 m -62.63 -43.03 99.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.018 -0.992 . . . . 10.0 110.992 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER -71.36 -42.95 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -178.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.544 ' SD ' ' HA ' ' A' ' 129' ' ' LEU . 3.7 ptm -61.59 -49.76 75.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.778 0.323 . . . . 10.0 111.867 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.594 ' O ' HD21 ' A' ' 136' ' ' LEU . 27.9 mm-40 -73.77 -25.78 60.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.938 0.399 . . . . 10.0 111.464 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -56.35 -23.39 37.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 10.0 111.289 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 t -71.92 -33.67 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.996 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -113.97 7.71 16.94 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.517 -0.473 . . . . 10.0 112.241 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 148' ' ' PRO . 56.4 t30 67.31 59.06 0.52 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.644 0.735 . . . . 10.0 111.068 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 t -129.53 144.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.849 -1.068 . . . . 10.0 109.292 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -119.16 132.09 55.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.244 0.545 . . . . 10.0 110.574 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.44 21.54 9.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 10.0 111.034 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -143.89 158.3 43.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.784 0.325 . . . . 10.0 110.918 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.38 -163.48 20.92 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 121.095 -0.574 . . . . 10.0 112.022 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.95 -31.82 14.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.02 0.438 . . . . 10.0 110.627 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.22 56.64 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.073 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 146' ' ' GLY . 25.8 mt -62.03 137.75 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.862 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 89.49 -8.51 79.69 Favored Glycine 0 CA--C 1.509 -0.328 0 C-N-CA 121.15 -0.548 . . . . 10.0 111.775 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.96 156.27 39.38 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.113 -0.544 . . . . 10.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 17.9 Cg_endo -63.12 124.1 13.35 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.276 1.984 . . . . 10.0 110.018 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 10.0 110.349 -178.329 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.804 0.335 . . . . 10.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -132.13 95.87 20.85 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.185 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.25 112.39 2.97 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.434 2.09 . . . . 10.0 112.088 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.66 95.57 6.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.048 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.11 155.84 42.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.395 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.05 128.64 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.814 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.91 162.12 12.49 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.104 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.84 74.65 0.22 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.975 -0.631 . . . . 10.0 112.403 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -119.88 103.43 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.788 -0.242 . . . . 10.0 110.728 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -90.3 158.2 17.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.57 124.44 2.85 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.065 -0.588 . . . . 10.0 112.22 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -158.25 150.96 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.651 0.226 . . . . 10.0 110.477 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 . . . . . 0 C--N 1.328 -0.333 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.426 HG13 ' CG2' ' A' ' 83' ' ' VAL . 2.2 t -85.12 -71.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.815 -0.354 . . . . 10.0 110.511 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.78 157.08 7.58 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -74.89 -53.77 8.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.401 0.601 . . . . 10.0 112.144 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.81 -38.42 88.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.668 -0.242 . . . . 10.0 111.508 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 87' ' ' ILE . 33.2 m -67.13 -35.91 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 120.74 -0.384 . . . . 10.0 110.391 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.81 -41.68 98.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.004 -0.617 . . . . 10.0 111.692 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -41.5 98.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.895 0.379 . . . . 10.0 110.136 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.69 -30.99 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.695 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.452 HG21 HH21 ' A' ' 91' ' ' ARG . 7.2 mt -62.84 -42.39 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 10.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -70.45 -50.33 39.39 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.93 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.64 -40.9 96.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.826 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.55 -30.38 74.9 Favored Glycine 0 C--N 1.328 0.12 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.833 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.479 HH22 ' HB3' ' A' ' 132' ' ' MET . 0.0 OUTLIER -80.35 -42.05 23.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.846 0.355 . . . . 10.0 110.67 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.14 -21.15 63.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.236 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -87.73 19.12 3.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.455 0.539 . . . . 10.0 112.455 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.23 -0.12 56.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 53.14 100.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 123.917 0.761 . . . . 10.0 112.831 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.44 -41.85 0.83 Allowed 'Cis proline' 0 CA--C 1.517 -0.349 0 C-N-CA 123.292 -1.545 . . . . 10.0 112.524 -0.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -168.41 128.69 1.25 Allowed 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.88 -1.054 . . . . 10.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.408 ' HE2' ' HB2' ' A' ' 98' ' ' MET . 19.3 ttm -58.65 137.53 57.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.834 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.7 144.08 39.59 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.631 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -70.09 -41.03 74.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.162 0.506 . . . . 10.0 110.465 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.37 90.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.941 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.8 -43.61 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.698 -0.228 . . . . 10.0 110.978 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 107' ' ' ILE . 56.6 tp -64.49 -39.47 93.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.41 96.06 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.865 -0.894 . . . . 10.0 110.865 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -39.64 91.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.809 0.338 . . . . 10.0 110.213 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.91 -41.54 98.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.161 -0.472 . . . . 10.0 112.049 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 103' ' ' LEU . 29.3 pt -93.24 -7.83 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.615 0.598 . . . . 10.0 112.615 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.77 34.12 22.74 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.549 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -125.99 176.67 6.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.93 0.395 . . . . 10.0 110.576 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.35 161.16 15.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.19 94.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 10.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.79 76.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.464 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.3 m -63.39 -46.34 86.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.157 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.411 ' CG1' HD22 ' A' ' 103' ' ' LEU . 90.0 t -62.28 -43.08 97.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.194 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -66.47 -35.23 79.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.728 -0.669 . . . . 10.0 111.598 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 25.8 p -77.76 -26.27 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.77 0.319 . . . . 10.0 111.496 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.473 ' OH ' ' HA ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -55.07 -40.48 70.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 8.2 pt-20 -63.11 -20.48 65.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.489 ' HB3' ' O ' ' A' ' 116' ' ' SER . 72.9 ttt180 -71.54 -20.34 62.04 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.611 0.719 . . . . 10.0 109.828 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.86 15.91 43.86 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.422 -0.808 . . . . 10.0 112.352 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.9 t -164.15 108.56 0.98 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.285 1.04 . . . . 10.0 109.827 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.09 19.06 0.5 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.724 -1.125 . . . . 10.0 110.999 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m 58.51 83.71 0.21 Allowed Pre-proline 0 C--O 1.235 0.294 0 CA-C-O 121.622 0.725 . . . . 10.0 110.031 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.473 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 27.6 Cg_endo -96.13 178.44 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.409 2.739 . . . . 10.0 114.868 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.601 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.2 t70 -139.94 150.68 44.83 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -58.32 -37.51 75.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 10.0 110.707 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.632 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 9.9 t30 -63.72 -41.66 98.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.466 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.9 mt -63.75 -55.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 110.362 -0.236 . . . . 10.0 110.362 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.1 mt -48.84 -45.88 41.32 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.312 0.577 . . . . 10.0 110.348 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.9 m -55.01 -47.0 75.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.953 -1.021 . . . . 10.0 111.604 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 49.7 mmtt -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.74 0.305 . . . . 10.0 111.014 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.479 ' HB3' HH22 ' A' ' 91' ' ' ARG . 3.5 mtp -51.28 -56.41 13.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.762 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 16.0 mt-10 -72.45 -29.56 63.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.144 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -62.07 -43.96 97.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.099 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 131' ' ' LYS . 48.3 t -62.32 -25.54 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.322 -0.399 . . . . 10.0 112.006 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.425 HD22 HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -107.14 -3.61 19.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 10.0 112.904 -177.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.1 t30 56.57 55.32 6.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.524 0.678 . . . . 10.0 109.706 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 35.5 m -140.99 164.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.736 -1.12 . . . . 10.0 108.754 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -124.19 129.0 50.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.151 0.501 . . . . 10.0 110.261 178.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.66 13.01 21.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.751 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -128.31 139.4 52.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.36 -159.03 16.39 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.095 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.66 -33.29 13.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.926 0.393 . . . . 10.0 110.606 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -86.57 53.14 2.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.095 0.474 . . . . 10.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 61.1 mt -75.03 137.55 22.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 93.13 -1.27 70.0 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.124 -0.79 . . . . 10.0 111.124 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.09 155.41 80.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.035 -0.583 . . . . 10.0 109.857 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.38 120.05 7.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.617 1.545 . . . . 10.0 110.177 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? . . . . . 0 C--N 1.322 -0.627 0 CA-C-O 121.228 0.537 . . . . 10.0 109.606 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.9 ttm . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.971 0.415 . . . . 10.0 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.28 85.94 6.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.102 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.93 177.83 8.39 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.689 2.259 . . . . 10.0 112.219 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.55 131.56 36.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.928 0.394 . . . . 10.0 110.833 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -152.94 126.33 8.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.808 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.79 150.96 38.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.707 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.31 171.08 13.57 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.55 145.65 13.23 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.385 -0.912 . . . . 10.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -142.15 127.16 18.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.767 -0.456 . . . . 10.0 109.767 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.23 148.78 42.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 10.0 111.504 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.78 132.46 2.52 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.16 -0.776 . . . . 10.0 111.16 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -156.94 156.85 33.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.247 0.523 . . . . 10.0 111.743 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.693 . . . . 10.0 109.154 179.17 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 19.2 p . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.551 HG23 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -91.57 -30.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.386 . . . . 10.0 111.751 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.65 141.95 5.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.542 -0.837 . . . . 10.0 112.333 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -66.58 -52.35 46.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 10.0 111.123 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -32.91 74.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.376 0.608 . . . . 10.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.87 -50.39 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 114.88 -1.055 . . . . 10.0 110.269 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.39 98.89 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -60.14 -51.14 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 10.0 110.493 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.15 -30.77 71.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.999 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.827 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.6 mt -57.88 -47.33 86.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -70.9 -47.05 61.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.941 0.4 . . . . 10.0 110.4 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -62.18 -34.14 75.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.428 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.64 -30.29 68.76 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.21 -0.995 . . . . 10.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.6 mmt180 -81.47 -33.81 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 10.0 111.373 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -77.33 -16.56 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.097 0.475 . . . . 10.0 110.536 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -80.44 12.61 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -19.86 23.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 10.0 111.561 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 59.89 110.1 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.904 -1.044 . . . . 10.0 111.777 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.05 -59.11 0.13 OUTLIER 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.279 -1.551 . . . . 10.0 113.026 -0.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.2 m -163.97 135.8 4.79 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.492 -0.776 . . . . 10.0 110.903 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 36.4 tpp -74.57 136.85 42.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.56 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 64.7 p -84.03 160.41 20.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.359 -0.537 . . . . 10.0 111.251 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.56 -26.94 64.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.668 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.02 -57.98 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.408 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.56 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 13.7 pt-20 -62.52 -36.85 83.88 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.914 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.598 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 2.4 tt -61.91 -42.48 99.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.682 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.76 -39.74 90.0 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.463 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -62.3 -39.53 93.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.705 0.288 . . . . 10.0 111.574 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 17.3 pt-20 -73.62 -16.59 61.23 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 103' ' ' LEU . 40.6 pt -113.43 0.08 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.623 -0.431 . . . . 10.0 111.738 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.42 37.61 53.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.593 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -133.19 -168.92 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 10.0 110.52 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -111.95 177.25 4.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.738 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.12 79.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 10.0 110.656 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.89 -47.07 87.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.657 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.9 m -55.74 -45.3 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.55 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.82 -50.54 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -64.92 -32.12 73.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.331 0.586 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.0 m -73.6 -28.19 61.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -75.34 -35.62 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 12.5 pt-20 -67.42 -17.8 64.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 10.0 110.799 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.496 ' HG2' ' CG2' ' A' ' 121' ' ' THR . 0.0 OUTLIER -74.61 -20.93 59.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.21 0.529 . . . . 10.0 109.79 178.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 79' ' ' VAL . . . 93.52 21.49 29.05 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.43 -0.891 . . . . 10.0 112.053 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.537 ' O ' HG22 ' A' ' 121' ' ' THR . 9.9 t -170.07 104.22 0.3 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.437 1.113 . . . . 10.0 110.113 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.33 27.7 0.51 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.747 -1.115 . . . . 10.0 109.212 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 m 61.61 96.98 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.8 -1.091 . . . . 10.0 108.594 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.429 ' HG3' ' O ' ' A' ' 78' ' ' THR . 70.8 Cg_endo -68.18 99.84 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.655 2.236 . . . . 10.0 115.256 -175.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.563 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -85.72 116.12 23.8 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.92 -2.252 . . . . 10.0 104.92 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -48.91 -40.17 28.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.142 -0.481 . . . . 10.0 112.147 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.2 t30 -66.93 -44.06 81.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.675 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.668 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.8 mt -58.62 -55.17 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 119.585 -0.245 . . . . 10.0 110.651 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.0 mt -50.24 -42.24 51.47 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.571 0.7 . . . . 10.0 110.235 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 66.7 m -59.86 -45.72 91.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.983 -1.008 . . . . 10.0 111.497 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 29.2 mmtt -73.75 -40.86 63.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 10.0 111.234 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.668 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -50.65 -59.46 4.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.207 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.737 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 5.8 mt-10 -74.12 -26.84 60.57 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.045 -0.98 . . . . 10.0 112.997 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -54.63 -27.25 38.22 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.91 -25.64 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.81 0.338 . . . . 10.0 111.796 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.0 -16.32 18.76 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 67.84 25.99 7.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.262 0.553 . . . . 10.0 110.527 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.737 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 26.8 m -121.94 142.9 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 23.9 mmmt -119.19 142.97 47.51 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.49 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 8.9 mt -102.71 39.44 1.53 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.658 0.742 . . . . 10.0 109.783 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -129.54 141.32 51.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.089 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.22 -162.19 43.93 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.233 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.34 3.24 55.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.885 0.374 . . . . 10.0 111.399 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -110.31 40.95 1.84 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 10.0 110.672 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 44.9 mt -67.17 136.71 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.727 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.485 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 91.9 0.3 71.91 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.937 -0.865 . . . . 10.0 110.937 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.56 158.45 75.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.546 . . . . 10.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.29 121.68 10.3 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.284 1.989 . . . . 10.0 109.914 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.844 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.8 ptp . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.693 0.759 . . . . 10.0 111.456 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -121.96 88.44 47.73 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.438 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.81 145.9 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.348 2.699 . . . . 10.0 111.897 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -104.03 154.0 20.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.812 0.339 . . . . 10.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -144.68 132.27 21.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.24 166.55 23.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.016 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.61 -177.91 36.01 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.486 -0.864 . . . . 10.0 112.394 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 175.2 147.88 6.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.41 -0.676 . . . . 10.0 111.41 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 t -137.31 128.17 27.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.105 0.479 . . . . 10.0 110.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.81 -42.91 10.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.248 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.22 104.31 2.39 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.569 -0.612 . . . . 10.0 111.569 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -107.32 -16.49 14.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 10.0 111.387 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.503 -179.207 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.531 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 2.8 p . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.904 -0.406 . . . . 10.0 109.904 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -84.48 -34.65 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.651 -0.419 . . . . 10.0 111.157 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.04 136.98 4.33 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.013 -0.613 . . . . 10.0 111.596 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -63.45 -57.04 11.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -25.63 65.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 140' ' ' LEU . 46.0 t -63.36 -46.97 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.497 -1.229 . . . . 10.0 110.052 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.32 -38.42 95.83 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.353 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 40.1 ttmt -59.32 -49.25 78.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 10.0 109.786 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.85 -30.51 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.558 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.747 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.3 mt -59.85 -48.5 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 4.3 tt0 -67.06 -50.38 62.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.022 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 62.4 mm-40 -59.97 -36.41 77.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.23 85.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.967 -0.635 . . . . 10.0 113.281 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.747 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.9 mmt180 -79.22 -29.88 43.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.173 0.511 . . . . 10.0 109.64 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 82.0 mt-30 -78.66 -16.76 56.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.645 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 55.9 mtpt -85.79 22.13 1.72 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.955 0.407 . . . . 10.0 111.261 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.65 -8.88 36.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.883 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 53.4 104.05 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 114.902 -1.045 . . . . 10.0 112.618 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.64 -50.12 0.2 Allowed 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.486 -1.464 . . . . 10.0 113.367 0.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -168.93 132.62 1.4 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.403 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.7 tpp -73.58 134.89 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.291 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.17 145.38 51.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.902 0.382 . . . . 10.0 111.679 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.41 -37.49 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.022 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.07 -36.39 83.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.75 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.79 -39.19 57.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.094 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -61.19 -43.62 98.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.837 . . . . 10.0 108.739 178.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.74 -39.39 95.23 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.504 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -64.32 -38.27 90.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.651 0.262 . . . . 10.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.532 ' OE2' HD22 ' A' ' 103' ' ' LEU . 15.3 pt-20 -78.02 -13.9 59.7 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.119 0.785 . . . . 10.0 113.119 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 103' ' ' LEU . 41.2 pt -109.68 -7.45 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.623 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.83 30.89 19.62 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.815 -0.707 . . . . 10.0 112.807 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.94 -168.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.278 0.231 . . . . 10.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -109.91 177.25 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.528 -0.305 . . . . 10.0 110.254 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.73 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.616 -0.265 . . . . 10.0 111.351 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.29 81.34 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.039 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.45 -50.3 73.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.779 0.323 . . . . 10.0 110.723 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.12 -45.04 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.79 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 10.0 111.115 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.3 m -76.77 -27.46 55.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.943 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.871 0.693 . . . . 10.0 112.871 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -61.53 -18.66 60.13 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.195 0.442 . . . . 10.0 112.195 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 119' ' ' ARG . 0.8 OUTLIER -69.53 -22.93 63.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.197 0.522 . . . . 10.0 110.088 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.99 21.7 15.08 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.607 -0.806 . . . . 10.0 112.086 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.517 HG21 ' O ' ' A' ' 121' ' ' THR . 6.7 t -171.87 111.9 0.3 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.24 1.019 . . . . 10.0 110.396 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.57 34.58 0.27 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.561 -1.2 . . . . 10.0 109.277 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 m 55.77 85.16 0.2 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.266 -0.879 . . . . 10.0 108.839 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.531 ' HG3' ' O ' ' A' ' 78' ' ' THR . 72.8 Cg_endo -72.47 98.04 0.92 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.543 2.828 . . . . 10.0 115.544 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -82.18 128.04 33.76 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 104.638 -2.356 . . . . 10.0 104.638 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -54.17 -31.31 52.34 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.427 0.528 . . . . 10.0 112.427 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -72.12 -32.89 67.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.848 -0.614 . . . . 10.0 111.355 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.791 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.0 mt -71.3 -57.94 6.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.691 -0.403 . . . . 10.0 110.099 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.6 -43.31 46.33 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.489 0.662 . . . . 10.0 110.777 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.583 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 45.0 m -54.51 -48.95 71.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.033 -0.985 . . . . 10.0 111.828 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 135' ' ' VAL . 13.0 mttt -76.79 -37.68 55.36 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.833 0.309 . . . . 10.0 111.833 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.791 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 75.0 mtp -53.97 -58.56 6.85 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.182 0.515 . . . . 10.0 111.863 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.0 mp0 -72.52 -26.18 61.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.787 -0.642 . . . . 10.0 112.266 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.4 ttm-85 -59.3 -27.42 65.84 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.036 0.446 . . . . 10.0 110.034 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 131' ' ' LYS . 61.1 t -63.82 -41.34 92.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.689 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -94.98 -6.35 42.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 121.152 -0.219 . . . . 10.0 110.437 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 t30 64.36 49.65 2.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.494 0.664 . . . . 10.0 109.736 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 34.4 m -132.12 162.88 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.355 -0.839 . . . . 10.0 109.627 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 15.9 mmtt -131.96 140.89 49.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.342 -0.614 . . . . 10.0 109.342 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.452 ' HG ' ' HG2' ' A' ' 133' ' ' GLU . 12.2 mt -108.5 17.71 21.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.26 0.552 . . . . 10.0 110.873 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -124.25 139.63 53.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.63 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.9 -146.65 17.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.729 -0.748 . . . . 10.0 112.336 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.24 -34.99 8.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.985 0.421 . . . . 10.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -82.33 54.82 2.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.929 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 146' ' ' GLY . 52.6 mt -72.9 137.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.474 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 86.36 -0.48 87.12 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.978 -0.849 . . . . 10.0 110.978 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.71 156.87 70.38 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.476 . . . . 10.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.79 122.5 11.09 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 121.897 1.731 . . . . 10.0 110.382 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.375 0.607 . . . . 10.0 110.146 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.031 -0.359 . . . . 10.0 110.031 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -116.97 150.8 46.56 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.374 -0.375 . . . . 10.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.29 170.38 20.33 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.626 2.217 . . . . 10.0 112.379 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -123.78 152.5 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.247 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.14 151.37 49.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.394 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.05 138.05 15.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.78 -160.78 11.78 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.22 25.06 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.86 132.37 52.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.662 0.268 . . . . 10.0 110.846 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -140.14 167.6 21.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.897 -0.409 . . . . 10.0 109.897 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.25 117.92 0.8 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.455 -0.879 . . . . 10.0 112.742 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -102.8 173.43 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.19 -0.3 . . . . 10.0 110.19 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 10.0 110.901 -179.396 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.481 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 5.0 p . . . . . 0 C--O 1.235 0.305 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.51 HG11 ' CG1' ' A' ' 83' ' ' VAL . 1.8 t -82.55 -60.15 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 10.0 110.537 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.07 137.23 4.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.33 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.7 -42.85 99.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.663 0.268 . . . . 10.0 111.269 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 -29.0 64.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.51 ' CG1' HG11 ' A' ' 79' ' ' VAL . 3.8 t -68.47 -49.28 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.338 -0.846 . . . . 10.0 109.864 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.39 97.19 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.999 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -64.03 -39.41 94.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 10.0 110.486 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.43 64.89 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.685 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.785 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.9 mt -59.89 -49.95 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.01 -53.23 58.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.956 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.39 -31.47 72.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.901 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.09 -30.73 69.6 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.731 -0.747 . . . . 10.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.785 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -81.6 -41.94 20.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 10.0 109.57 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -61.4 -36.89 81.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.535 -0.757 . . . . 10.0 111.31 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -81.75 51.21 1.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -3.54 16.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.69 0.281 . . . . 10.0 111.257 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 57.94 100.56 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.926 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.65 -45.1 0.46 Allowed 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.592 -1.42 . . . . 10.0 112.205 -0.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.2 m -161.71 133.56 5.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.541 -1.209 . . . . 10.0 110.004 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.3 127.95 32.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.23 53.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.43 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.94 85.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.692 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -71.07 -44.42 65.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.822 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -63.68 -40.19 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.42 -49.05 73.12 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.261 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -62.69 -34.68 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.4 -26.45 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.934 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 103' ' ' LEU . 25.6 pt -110.14 8.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.796 0.295 . . . . 10.0 111.796 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 20.34 71.77 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.252 -0.499 . . . . 10.0 113.097 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -118.56 -164.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.309 -0.256 . . . . 10.0 110.309 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.3 p -115.05 176.07 5.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.562 0.22 . . . . 10.0 110.589 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.04 89.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 10.0 109.998 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.9 76.12 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.563 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.3 m -62.06 -46.29 89.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 10.0 110.345 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 t -66.17 -43.47 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.071 -0.513 . . . . 10.0 109.91 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.66 -29.54 69.58 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.702 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 m -78.84 -33.77 45.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.898 0.38 . . . . 10.0 111.473 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -65.98 -33.79 76.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.81 -18.27 54.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.821 0.344 . . . . 10.0 111.8 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -71.57 -26.17 62.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.281 0.562 . . . . 10.0 110.51 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.82 12.56 55.37 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.612 -0.722 . . . . 10.0 112.482 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.587 ' O ' HG22 ' A' ' 121' ' ' THR . 8.8 t -153.39 98.68 2.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.715 1.245 . . . . 10.0 109.456 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.06 27.49 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.323 -1.308 . . . . 10.0 109.914 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m 59.37 95.5 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.199 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.481 ' HG3' ' C ' ' A' ' 78' ' ' THR . 74.4 Cg_endo -69.73 99.8 0.77 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.242 2.628 . . . . 10.0 114.646 -176.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.57 117.9 25.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 8.4 mm-40 -48.56 -39.62 24.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.471 0.915 . . . . 10.0 113.471 -174.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.555 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.4 t30 -70.55 -34.0 71.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.86 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.7 mt -68.96 -57.89 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.758 -0.377 . . . . 10.0 111.299 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -39.01 59.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.161 0.505 . . . . 10.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 m -55.02 -49.83 70.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.631 -0.713 . . . . 10.0 111.232 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 35.3 mmtt -75.77 -30.4 59.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.954 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.771 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.7 mtp -56.35 -59.59 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 4.0 mp0 -74.04 -26.49 60.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -53.92 -33.24 56.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.986 0.365 . . . . 10.0 111.986 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.69 -30.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.973 0.416 . . . . 10.0 111.245 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.451 HD11 ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -94.78 -10.73 30.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.565 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.2 t30 62.58 47.11 5.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 10.0 110.749 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.1 m -131.91 158.15 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -130.66 143.69 50.92 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.591 -0.443 . . . . 10.0 110.847 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.42 HD11 ' CG1' ' A' ' 83' ' ' VAL . 11.6 mt -103.53 40.2 1.46 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.728 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -128.26 139.88 52.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.534 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.08 -146.25 23.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.371 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.33 -21.68 14.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.89 0.376 . . . . 10.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -88.06 52.96 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 110.696 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 146' ' ' GLY . 54.5 mt -76.53 141.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.518 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.591 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 85.38 1.16 88.16 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.877 -0.678 . . . . 10.0 112.145 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.0 156.37 76.28 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 110.046 -0.353 . . . . 10.0 110.046 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.96 122.3 11.38 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.957 1.772 . . . . 10.0 109.294 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.483 . . . . 10.0 109.829 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 110.23 -0.285 . . . . 10.0 110.23 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.32 136.73 19.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.508 -0.314 . . . . 10.0 111.061 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.03 142.02 45.66 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.993 2.462 . . . . 10.0 112.104 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.12 143.66 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.911 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -136.2 132.13 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 10.0 109.652 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.55 155.56 37.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.832 0.348 . . . . 10.0 111.125 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.69 -155.07 29.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.121 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -162.72 11.79 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.542 -0.623 . . . . 10.0 111.542 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 m -154.52 108.09 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.082 0.441 . . . . 10.0 110.939 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.28 173.85 6.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.6 173.2 34.36 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.348 -0.93 . . . . 10.0 112.692 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -158.25 151.52 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.664 0.268 . . . . 10.0 110.477 179.218 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.783 0.325 . . . . 10.0 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -76.41 -32.03 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.61 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.34 138.4 5.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.374 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -70.14 -42.65 72.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.987 0.422 . . . . 10.0 110.682 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -75.39 -25.35 57.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.655 0.74 . . . . 10.0 109.234 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 87' ' ' ILE . 37.2 t -69.28 -45.3 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 114.507 -1.224 . . . . 10.0 110.249 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.79 98.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.87 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -62.76 -40.3 96.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 10.0 110.434 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.81 66.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.064 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 83' ' ' VAL . 23.4 mt -59.93 -46.81 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.96 0.41 . . . . 10.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -71.46 -52.95 15.68 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.582 -0.447 . . . . 10.0 110.538 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.431 ' O ' ' HD3' ' A' ' 93' ' ' LYS . 46.8 mt-30 -60.61 -35.05 75.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.239 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.69 -31.9 52.28 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.636 -1.269 . . . . 10.0 112.365 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 1.3 mpt_? -81.72 -34.43 30.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.924 0.392 . . . . 10.0 111.383 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -75.19 -2.12 26.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.995 0.426 . . . . 10.0 110.451 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 89' ' ' GLN . 1.5 tptm -84.9 0.11 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.023 0.44 . . . . 10.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -171.98 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 10.0 111.185 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 52.6 mt-10 -126.46 112.1 23.2 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.54 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 65.8 Cg_endo -78.84 -31.19 5.17 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.358 -1.518 . . . . 10.0 112.558 -0.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.0 m -168.3 130.29 1.4 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.82 -1.536 . . . . 10.0 108.724 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 tpp -73.24 110.36 7.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.521 -0.472 . . . . 10.0 109.958 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -69.53 156.78 38.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.147 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.08 -35.22 76.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.582 -0.735 . . . . 10.0 109.911 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.059 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.68 -49.87 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.701 -0.227 . . . . 10.0 110.794 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.569 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.34 -46.66 85.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.48 0.488 . . . . 10.0 109.887 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.08 -47.18 92.29 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.119 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -64.26 -38.57 91.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.904 0.335 . . . . 10.0 111.904 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.416 ' OE1' HG21 ' A' ' 135' ' ' VAL . 13.5 pt-20 -73.3 -15.18 61.41 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 103' ' ' LEU . 43.4 pt -107.05 3.69 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 10.0 111.006 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.86 25.72 55.31 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.079 -0.582 . . . . 10.0 113.034 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -125.24 -157.47 0.78 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.668 0.271 . . . . 10.0 110.356 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 p -124.92 176.68 6.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.48 91.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.617 0.246 . . . . 10.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.88 76.35 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.76 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 m -60.68 -47.18 87.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.15 -45.16 97.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.246 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.07 -32.35 73.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.806 0.812 . . . . 10.0 109.834 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.633 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 11.6 m -74.66 -24.89 58.88 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.201 -0.909 . . . . 10.0 111.275 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -77.61 -34.36 53.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -66.09 -20.36 66.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.9 ptm180 -70.88 -23.05 62.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.665 0.745 . . . . 10.0 110.738 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.401 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.51 28.43 7.54 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.012 -0.995 . . . . 10.0 112.063 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 121' ' ' THR . 8.8 t -173.8 107.69 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.167 0.984 . . . . 10.0 110.201 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.04 25.95 0.26 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.843 -1.071 . . . . 10.0 109.616 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 m 62.33 99.99 0.04 OUTLIER Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.806 -0.813 . . . . 10.0 108.806 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.76 99.29 0.95 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.855 2.37 . . . . 10.0 114.042 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.635 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 4.5 t0 -87.5 120.41 28.78 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.443 -2.058 . . . . 10.0 105.443 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.6 mm-40 -52.07 -42.33 63.1 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.22 -30.88 70.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.697 ' O ' ' HG3' ' A' ' 132' ' ' MET . 73.2 mt -72.07 -56.2 10.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.0 mt -48.85 -42.78 37.53 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.615 0.572 . . . . 10.0 110.361 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 74.4 m -57.02 -47.3 81.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.152 -0.931 . . . . 10.0 111.765 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 107' ' ' ILE . 2.6 mppt? -74.66 -38.01 62.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.697 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 32.9 mtp -50.42 -55.83 14.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.832 0.825 . . . . 10.0 111.161 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.628 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 53.8 mt-10 -73.24 -27.24 61.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.801 -1.09 . . . . 10.0 113.315 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -68.74 -27.39 65.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.963 1.098 . . . . 10.0 113.963 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.416 HG21 ' OE1' ' A' ' 106' ' ' GLU . 6.0 t -71.0 -22.79 23.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.158 0.429 . . . . 10.0 112.158 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -127.32 -23.85 3.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.816 1.043 . . . . 10.0 113.816 -176.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 2.8 m120 77.91 63.68 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.082 0.944 . . . . 10.0 110.099 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 2.8 t -135.96 139.86 45.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.127 -1.397 . . . . 10.0 108.178 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 12.1 mmtm -112.45 133.14 54.69 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.338 -0.545 . . . . 10.0 112.145 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HG ' ' OE2' ' A' ' 133' ' ' GLU . 1.1 mt -93.24 -20.25 20.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.163 -0.926 . . . . 10.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -120.15 152.04 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 10.0 111.06 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.85 -156.78 15.37 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.184 -0.766 . . . . 10.0 111.184 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.8 -37.1 10.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.821 0.343 . . . . 10.0 110.628 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -89.92 55.65 3.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.646 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 146' ' ' GLY . 19.8 mt -69.84 137.63 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 10.0 110.913 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 82.09 4.66 90.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.093 -0.803 . . . . 10.0 111.093 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.31 147.77 58.68 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.301 -0.449 . . . . 10.0 110.914 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.7 123.65 13.09 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.474 2.116 . . . . 10.0 110.718 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 109.225 -0.658 . . . . 10.0 109.225 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -158.57 130.03 3.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.78 46.03 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.069 2.513 . . . . 10.0 114.209 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.89 130.92 55.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -126.5 123.24 37.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 10.0 111.163 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.76 -174.07 2.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.58 -146.95 8.83 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.678 -0.569 . . . . 10.0 111.678 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.27 91.76 1.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.633 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -123.55 124.35 42.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.612 0.244 . . . . 10.0 110.373 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.86 149.83 50.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.25 -166.76 20.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.086 -0.578 . . . . 10.0 111.94 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -139.92 174.08 10.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.815 0.34 . . . . 10.0 110.777 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.699 -179.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 120' ' ' GLY . 1.9 m -83.17 -23.67 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 10.0 111.663 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.45 139.14 7.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.49 -0.862 . . . . 10.0 112.526 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -68.53 -47.64 66.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.724 0.297 . . . . 10.0 111.426 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -66.32 -33.47 75.79 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.38 0.61 . . . . 10.0 109.512 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.1 -44.52 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.021 -0.991 . . . . 10.0 109.998 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.47 -41.71 98.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.929 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.44 -41.25 98.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 10.0 110.199 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.78 -30.84 65.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.114 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.694 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.3 mt -60.71 -47.38 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.267 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.48 -53.19 46.1 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.434 0.459 . . . . 10.0 110.46 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.74 -33.44 72.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.573 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.04 -31.9 82.28 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.788 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -80.05 -32.34 39.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.483 0.658 . . . . 10.0 109.28 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -74.2 -24.99 59.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.334 -0.848 . . . . 10.0 110.764 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -84.58 54.03 2.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.978 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.94 0.68 8.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.836 0.31 . . . . 10.0 111.836 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 1.6 tt0 56.11 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 124.159 0.912 . . . . 10.0 112.016 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 75.6 Cg_endo -81.81 -37.94 1.43 Allowed 'Cis proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.545 -1.44 . . . . 10.0 113.451 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.3 m -173.88 124.88 0.36 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.395 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 98' ' ' MET . 6.7 ttm -83.57 142.36 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.286 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 75.5 p -74.52 163.55 27.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 10.0 111.142 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.27 -32.59 71.87 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.256 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.07 82.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.548 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.419 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 14.0 mm-40 -60.72 -54.45 45.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.594 -0.276 . . . . 10.0 110.445 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.416 ' HG ' HH11 ' A' ' 91' ' ' ARG . 0.2 OUTLIER -64.76 -36.91 85.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.632 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.63 -47.5 86.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.816 -0.707 . . . . 10.0 111.742 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.96 -40.48 91.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.259 -0.275 . . . . 10.0 110.259 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.4 -31.74 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.352 0.501 . . . . 10.0 112.352 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 103' ' ' LEU . 46.8 pt -90.86 1.8 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 10.0 111.42 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.36 15.24 74.55 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.96 -0.638 . . . . 10.0 113.311 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -116.63 -149.4 0.44 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.65 172.07 9.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.602 0.239 . . . . 10.0 110.988 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.91 78.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.933 0.397 . . . . 10.0 110.505 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.65 77.55 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.637 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.408 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 4.0 m -59.64 -47.5 85.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.36 -44.13 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.25 -34.95 78.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.219 0.533 . . . . 10.0 110.893 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 36.5 m -76.83 -32.51 57.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.426 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.408 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.9 m-85 -67.57 -37.37 82.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.511 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.59 -18.78 65.21 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.721 0.296 . . . . 10.0 111.514 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 116' ' ' SER . 42.8 ttt180 -70.48 -20.39 62.86 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.402 0.62 . . . . 10.0 110.105 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.427 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 93.27 23.14 25.29 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 121' ' ' THR . 4.1 t -170.21 105.18 0.3 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.888 0.851 . . . . 10.0 110.35 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.47 33.59 0.11 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.98 -1.009 . . . . 10.0 109.824 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 m 64.26 104.04 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.774 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.1 83.74 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.508 2.138 . . . . 10.0 113.353 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -84.44 120.33 26.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.412 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 4.0 mm-40 -50.09 -47.36 53.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.74 0.644 . . . . 10.0 112.74 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 26.8 p-10 -61.36 -39.28 90.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.892 -0.14 . . . . 10.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.559 ' O ' ' HG3' ' A' ' 132' ' ' MET . 77.4 mt -69.45 -50.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 12.7 mt -54.4 -41.85 69.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.901 0.381 . . . . 10.0 110.006 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -55.83 -42.47 75.78 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.463 -0.79 . . . . 10.0 111.288 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.56 ' O ' HG21 ' A' ' 135' ' ' VAL . 70.4 mmtt -73.66 -43.34 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 10.0 110.518 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.673 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 4.0 mtt -52.61 -56.13 17.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.161 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.94 -29.61 70.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.544 -0.753 . . . . 10.0 112.45 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.9 mmt180 -75.59 -45.16 39.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.931 0.715 . . . . 10.0 112.931 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 131' ' ' LYS . 17.7 t -65.39 -41.19 90.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 111.898 0.332 . . . . 10.0 111.898 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 132' ' ' MET . 0.0 OUTLIER -89.91 -10.16 46.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.87 -0.332 . . . . 10.0 111.869 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.9 t30 57.51 52.9 7.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.549 0.69 . . . . 10.0 110.481 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.59 140.66 28.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.762 -1.108 . . . . 10.0 108.19 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 1.5 mtpp -96.67 133.46 41.16 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.028 -0.669 . . . . 10.0 110.251 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.6 mt -101.58 14.74 31.05 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.525 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -129.37 145.86 51.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.192 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.52 -155.85 21.86 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.469 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.98 -22.79 14.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.023 0.439 . . . . 10.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.88 51.68 1.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.056 0.455 . . . . 10.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 58.7 mt -71.9 142.65 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.705 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 83.84 4.29 88.83 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.455 -0.658 . . . . 10.0 111.455 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.55 143.49 48.55 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.568 -0.316 . . . . 10.0 110.548 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 124.0 10.68 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.683 1.589 . . . . 10.0 108.061 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.5 ttp85 . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 121.268 0.556 . . . . 10.0 110.058 -178.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.2 ptp . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.864 0.364 . . . . 10.0 110.223 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -150.63 130.37 6.67 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.448 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.76 122.6 7.42 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.776 2.317 . . . . 10.0 112.86 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.87 145.06 34.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.19 167.37 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 10.0 110.77 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.63 158.74 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.099 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.67 31.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.722 -0.752 . . . . 10.0 112.267 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.07 -20.02 10.79 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.704 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -96.9 112.19 24.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.291 -0.263 . . . . 10.0 110.291 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -153.12 179.47 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.807 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.8 20.02 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.378 -0.689 . . . . 10.0 111.378 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -90.51 151.16 21.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.42 . . . . 10.0 111.533 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.787 179.784 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.627 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 3.5 p . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.76 -0.459 . . . . 10.0 109.76 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 124' ' ' PRO . 3.4 t -70.75 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.239 0.542 . . . . 10.0 110.87 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.77 153.35 5.91 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -76.48 -52.28 10.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.581 0.691 . . . . 10.0 112.543 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -30.5 69.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.605 -0.438 . . . . 10.0 111.568 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.9 m -68.01 -35.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 120.735 -0.386 . . . . 10.0 110.39 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.75 -48.66 82.69 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.277 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -63.62 -36.77 84.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 10.0 110.756 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.7 -30.75 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.963 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.824 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.7 mt -61.27 -47.88 91.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 109.381 -0.599 . . . . 10.0 109.381 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.81 -53.34 57.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.872 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.6 -35.09 79.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.676 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.26 80.34 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.925 -0.655 . . . . 10.0 113.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.824 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.8 mmt180 -75.84 -35.56 59.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.233 0.539 . . . . 10.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -78.67 -12.91 60.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.776 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -77.94 -0.79 28.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.676 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -168.56 0.47 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.145 0.498 . . . . 10.0 111.466 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 12.7 tp10 -131.05 109.95 15.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.472 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.0 Cg_endo -79.06 -29.2 6.79 Favored 'Cis proline' 0 CA--C 1.515 -0.45 0 C-N-CA 123.188 -1.588 . . . . 10.0 112.157 -0.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.0 m -168.47 136.21 2.11 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.55 -1.659 . . . . 10.0 109.198 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.9 tpp -87.01 127.57 35.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.3 p -77.25 156.82 31.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.361 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -68.13 -33.68 74.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.192 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.75 71.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.385 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.48 -42.26 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.454 -0.339 . . . . 10.0 111.461 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.542 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tm? -65.46 -44.52 86.93 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.06 96.58 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.769 -0.729 . . . . 10.0 111.394 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.72 -43.92 97.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.987 0.115 . . . . 10.0 111.297 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.91 -16.83 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 103' ' ' LEU . 33.6 pt -103.47 -3.19 9.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.255 -0.578 . . . . 10.0 110.779 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.44 50.09 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.291 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -120.32 -160.17 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.683 0.278 . . . . 10.0 110.481 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 175.09 5.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.453 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.64 -41.65 99.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.758 0.313 . . . . 10.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.82 73.62 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.07 -0.514 . . . . 10.0 110.873 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 m -59.6 -49.54 77.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.878 0.37 . . . . 10.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.36 -42.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.93 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.16 70.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.571 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 67.8 m -78.52 -31.96 47.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.141 0.423 . . . . 10.0 112.141 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -18.77 36.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.373 0.509 . . . . 10.0 112.373 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -69.18 -23.39 63.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.309 0.576 . . . . 10.0 110.339 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.62 13.91 54.23 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.677 -0.773 . . . . 10.0 112.296 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.9 t -158.94 107.32 1.87 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.233 1.016 . . . . 10.0 109.37 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.78 29.17 0.37 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.443 -1.253 . . . . 10.0 110.017 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m 58.58 87.77 0.13 Allowed Pre-proline 0 N--CA 1.463 0.214 0 N-CA-C 108.378 -0.971 . . . . 10.0 108.378 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.627 ' HG3' ' C ' ' A' ' 78' ' ' THR . 87.9 Cg_endo -78.96 110.89 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.717 2.278 . . . . 10.0 115.454 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.442 ' HB3' HG13 ' A' ' 128' ' ' ILE . 6.6 t70 -85.95 124.91 32.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.93 -2.989 . . . . 10.0 102.93 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.44 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 5.0 mm-40 -50.97 -32.04 19.8 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.14 0.793 . . . . 10.0 113.14 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.514 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.5 t30 -75.9 -31.88 59.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.449 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.745 ' O ' ' HG3' ' A' ' 132' ' ' MET . 97.9 mt -64.85 -55.96 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.955 -0.298 . . . . 10.0 110.499 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.94 -38.85 17.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.737 0.779 . . . . 10.0 110.116 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.3 m -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.463 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 67.3 mmtt -75.57 -40.16 57.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.745 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.3 mtp -53.47 -57.73 9.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.227 0.537 . . . . 10.0 111.552 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.779 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mt-10 -72.27 -27.3 62.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.461 -0.79 . . . . 10.0 112.777 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -56.06 -30.22 61.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 10.0 111.362 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.7 -30.85 19.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.443 . . . . 10.0 111.814 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.528 HD13 ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -96.18 -10.57 27.8 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 67.24 19.15 10.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.746 0.418 . . . . 10.0 111.772 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.779 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.9 m -114.03 140.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.1 mmtp -121.11 140.6 51.75 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.801 -0.76 . . . . 10.0 111.204 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.507 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 1.8 mt -102.46 41.26 1.25 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.192 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -131.3 141.21 49.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 10.0 111.092 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.52 -152.49 30.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.291 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.55 15.09 30.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.195 0.522 . . . . 10.0 110.698 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.08 45.25 2.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.251 0.548 . . . . 10.0 110.173 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 49.1 mt -68.8 138.98 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.502 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 82.72 7.03 87.93 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.367 -1.093 . . . . 10.0 110.367 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -131.62 157.63 77.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 114.833 -0.684 . . . . 10.0 109.799 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.33 122.4 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.751 . . . . 10.0 110.23 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.587 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 3.2 tpp180 . . . . . 0 C--N 1.318 -0.776 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.5 mtm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.647 0.261 . . . . 10.0 110.419 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -111.71 151.16 43.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.175 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.66 133.88 44.6 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.584 2.19 . . . . 10.0 112.318 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -76.64 152.99 35.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.365 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.37 151.37 29.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.804 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.3 153.64 27.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.402 -0.363 . . . . 10.0 110.594 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.0 -166.71 11.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.329 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.92 158.78 25.85 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.967 -0.635 . . . . 10.0 111.862 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 m -152.64 131.09 12.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.837 0.351 . . . . 10.0 110.58 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -145.01 -178.37 6.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.437 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.88 119.43 1.51 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.022 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -127.26 162.09 27.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 63' ' ' ARG . 11.6 ptm180 . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.815 0.34 . . . . 10.0 110.71 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.232 0.177 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.3 m -77.21 -31.48 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 10.0 110.789 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.5 132.05 3.88 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.576 -0.821 . . . . 10.0 112.401 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.53 -45.19 88.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.856 0.36 . . . . 10.0 110.819 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -29.7 65.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 87' ' ' ILE . 41.2 t -65.2 -46.2 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.078 -0.965 . . . . 10.0 109.773 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.58 -45.74 95.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.538 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -61.48 -38.59 87.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.005 0.431 . . . . 10.0 110.347 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.502 ' CB ' HD22 ' A' ' 140' ' ' LEU . . . -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.399 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.807 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.9 mt -59.8 -49.17 84.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.65 -51.45 65.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.538 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.42 -32.23 73.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.744 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 93' ' ' LYS . . . -73.65 -29.78 62.98 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.796 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.807 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.6 mmt180 -82.76 -36.29 25.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 10.0 109.812 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -72.92 -15.3 61.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.445 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 13.5 ptmt -84.86 6.69 23.69 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.703 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.88 -20.96 55.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.718 0.294 . . . . 10.0 111.777 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 56.98 102.44 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.052 -0.977 . . . . 10.0 111.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.46 -62.04 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.524 -1.448 . . . . 10.0 113.234 -0.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.0 m -161.38 135.44 6.86 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.139 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 132.59 46.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.45 145.73 54.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -69.14 -36.59 77.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 10.0 109.879 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.49 76.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.254 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -64.19 -39.26 93.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 10.0 110.958 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.448 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -64.77 -43.89 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.35 -43.98 96.07 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.321 -0.712 . . . . 10.0 111.321 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.63 -38.63 81.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.794 0.331 . . . . 10.0 110.56 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.71 -18.78 65.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.114 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 103' ' ' LEU . 4.4 pt -117.0 5.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.676 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.42 26.72 60.82 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.306 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.41 -171.14 2.11 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 p -107.42 173.61 6.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.635 0.255 . . . . 10.0 110.958 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.04 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 10.0 110.069 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.73 84.99 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.637 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -60.78 -46.49 90.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.729 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.71 -37.2 77.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.993 0.425 . . . . 10.0 110.757 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.22 77.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.09 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.4 p -75.99 -29.83 58.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.023 0.439 . . . . 10.0 110.539 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.444 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 1.0 OUTLIER -63.35 -41.78 98.88 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.881 -0.599 . . . . 10.0 112.356 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -63.54 -18.22 63.62 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -74.08 -22.68 59.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.356 0.598 . . . . 10.0 109.864 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.47 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 101.14 21.58 11.62 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.781 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.497 ' O ' HG22 ' A' ' 121' ' ' THR . 7.5 t -170.09 113.19 0.47 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 122.108 0.956 . . . . 10.0 110.611 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.29 27.73 0.09 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.422 -1.263 . . . . 10.0 108.86 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m 65.4 106.33 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.789 -1.096 . . . . 10.0 108.708 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 85.9 Cg_endo -78.15 89.63 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.763 2.309 . . . . 10.0 115.419 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.51 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -83.28 116.49 22.45 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.566 -2.012 . . . . 10.0 105.566 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -50.73 -40.13 53.6 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.647 0.61 . . . . 10.0 112.647 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.71 -32.83 73.74 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.258 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.7 mt -69.76 -55.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 121.026 -0.27 . . . . 10.0 110.348 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -51.58 -40.11 59.17 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.582 0.706 . . . . 10.0 110.46 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.0 m -60.11 -52.96 63.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.513 -0.767 . . . . 10.0 112.032 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 -33.68 48.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.521 0.934 . . . . 10.0 113.521 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.423 ' HE3' ' HB2' ' A' ' 132' ' ' MET . 4.5 ptm -63.11 -45.32 92.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.701 0.286 . . . . 10.0 111.564 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.859 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 21.8 mt-10 -75.66 -27.71 58.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.305 0.574 . . . . 10.0 111.801 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -25.22 67.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.411 -0.813 . . . . 10.0 112.514 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.65 -25.34 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.17 0.51 . . . . 10.0 110.995 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.562 HD23 ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -111.95 -12.74 13.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.302 -178.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 70.7 43.38 0.74 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.217 1.008 . . . . 10.0 108.657 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.859 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.9 t -128.31 141.58 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 113.545 -1.662 . . . . 10.0 107.319 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.6 mmmt -128.55 136.05 50.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.583 0.706 . . . . 10.0 111.259 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.502 HD22 ' CB ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -106.76 30.35 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.794 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -131.22 139.13 49.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.524 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.23 -149.47 18.7 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.429 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.7 -24.16 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 10.0 110.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.66 50.58 1.84 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 10.0 110.555 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.463 HG22 HD12 ' A' ' 145' ' ' ILE . 4.3 mm -65.28 138.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.987 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 85.24 3.48 87.17 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.345 -0.702 . . . . 10.0 111.345 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.04 163.06 52.97 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.938 -0.631 . . . . 10.0 109.846 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.67 123.0 11.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.217 1.945 . . . . 10.0 111.328 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.602 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 22.7 tpt180 . . . . . 0 C--N 1.321 -0.639 0 CA-C-O 120.954 0.406 . . . . 10.0 109.973 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.8 ttt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.389 0.614 . . . . 10.0 110.255 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -136.88 85.43 23.42 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.101 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.41 153.91 12.22 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.467 2.111 . . . . 10.0 112.577 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.68 154.07 18.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.025 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -122.99 93.6 4.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.035 0.445 . . . . 10.0 110.223 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.96 137.54 46.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.105 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.46 -176.16 38.57 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.394 -0.908 . . . . 10.0 112.184 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.72 113.61 2.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.114 -0.565 . . . . 10.0 111.99 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.3 t -159.3 149.36 19.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.684 0.278 . . . . 10.0 110.341 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -125.0 -176.41 3.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.317 -0.402 . . . . 10.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.39 102.66 0.66 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.206 -0.997 . . . . 10.0 112.792 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -142.93 143.8 32.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.835 -0.432 . . . . 10.0 109.835 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.688 179.765 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.569 0.223 . . . . 10.0 110.545 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.454 HG21 ' C ' ' A' ' 120' ' ' GLY . 2.7 m -78.88 -30.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 121.033 -0.267 . . . . 10.0 111.199 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.28 137.6 5.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.65 -52.91 39.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.637 0.256 . . . . 10.0 111.533 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.58 -31.03 71.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.533 HG12 ' CD1' ' A' ' 140' ' ' LEU . 6.0 t -62.36 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.365 -1.289 . . . . 10.0 109.856 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.4 -47.86 88.81 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.784 -0.644 . . . . 10.0 112.991 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -61.12 -38.17 85.41 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.25 0.548 . . . . 10.0 110.065 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.401 ' HB1' HG22 ' A' ' 145' ' ' ILE . . . -69.29 -30.32 68.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.357 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.777 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.5 mt -60.55 -45.81 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.763 -0.458 . . . . 10.0 109.763 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.04 -48.05 63.85 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.698 -0.482 . . . . 10.0 109.698 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.573 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 4.3 mm-40 -62.31 -34.7 77.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.33 -36.82 93.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.626 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.777 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.96 -36.25 31.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.211 0.529 . . . . 10.0 110.004 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -74.49 -24.13 58.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.39 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 12.4 mptt -87.52 23.45 1.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 10.0 111.28 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -16.12 56.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.018 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 58.65 104.23 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.759 -1.11 . . . . 10.0 111.41 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.09 -60.92 0.06 OUTLIER 'Cis proline' 0 CA--C 1.516 -0.392 0 C-N-CA 123.78 -1.342 . . . . 10.0 113.037 0.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.8 m -158.77 125.15 4.61 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.206 -0.907 . . . . 10.0 110.799 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.3 tpp -78.31 135.55 37.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.16 144.97 50.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.775 0.321 . . . . 10.0 111.09 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.35 -36.55 77.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.989 0.423 . . . . 10.0 110.215 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -65.14 -45.35 85.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 10.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -66.72 -39.95 88.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -63.6 -38.03 89.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -47.7 69.15 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.418 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 33.6 mmtp -59.2 -40.82 86.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.749 0.309 . . . . 10.0 110.663 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -33.87 73.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.066 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 103' ' ' LEU . 31.1 pt -95.54 -0.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 10.0 111.293 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.62 14.93 69.4 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.185 -0.531 . . . . 10.0 113.29 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -111.56 -157.97 0.63 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.6 p -119.3 174.7 6.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.493 0.187 . . . . 10.0 110.63 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.51 81.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.036 0.445 . . . . 10.0 109.804 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.54 72.29 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.447 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.0 m -64.78 -48.01 76.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.728 0.299 . . . . 10.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.8 -45.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 10.0 110.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.601 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.18 -31.69 72.68 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.061 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 m -76.64 -34.71 58.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.975 0.417 . . . . 10.0 111.768 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.32 -34.2 77.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.46 -17.6 59.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.819 0.342 . . . . 10.0 111.551 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -69.43 -28.09 65.83 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.226 0.536 . . . . 10.0 111.262 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.454 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 98.1 21.91 16.7 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.593 -0.813 . . . . 10.0 111.956 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 121' ' ' THR . 8.5 t -169.79 105.56 0.34 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.316 1.055 . . . . 10.0 109.438 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.88 25.13 0.09 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.497 -1.229 . . . . 10.0 109.636 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.7 m 67.56 106.7 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.111 -0.95 . . . . 10.0 110.737 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.99 88.66 1.07 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.572 2.181 . . . . 10.0 113.989 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.72 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.7 t70 -81.88 116.74 21.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -49.7 -46.77 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -62.09 -43.4 98.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.544 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.699 ' O ' ' HG3' ' A' ' 132' ' ' MET . 55.7 mt -63.55 -56.84 14.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 13.3 mt -47.44 -45.92 26.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.349 0.595 . . . . 10.0 110.744 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.554 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 71.4 m -56.58 -51.18 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.986 -1.006 . . . . 10.0 112.191 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.429 ' O ' HG22 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -75.17 -30.66 60.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.699 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 31.4 mtp -56.36 -61.4 2.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 10.0 111.929 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.45 ' CD ' HD11 ' A' ' 140' ' ' LEU . 3.5 mp0 -76.37 -26.37 55.59 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' A' ' 130' ' ' SER . 12.3 ptt85 -58.61 -29.66 66.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.924 0.329 . . . . 10.0 111.364 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 131' ' ' LYS . 66.7 t -71.48 -33.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.0 0.429 . . . . 10.0 110.969 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.525 HD11 ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -95.16 -17.45 21.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.488 -178.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.9 t30 62.27 56.03 2.26 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.531 0.682 . . . . 10.0 109.536 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 11.9 m -137.19 159.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.44 -1.254 . . . . 10.0 108.715 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 6.5 mmpt? -127.25 139.77 52.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.533 ' CD1' HG12 ' A' ' 83' ' ' VAL . 11.2 mt -95.13 36.11 1.24 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.39 0.614 . . . . 10.0 110.282 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -135.62 155.72 50.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.627 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.02 -163.23 43.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.057 -0.592 . . . . 10.0 112.571 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.86 -12.49 36.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 10.0 110.854 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -104.86 49.89 0.8 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.11 0.481 . . . . 10.0 110.36 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 146' ' ' GLY . 22.7 mt -70.81 137.63 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.444 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 92.96 1.89 67.05 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.77 -0.932 . . . . 10.0 110.77 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -135.24 159.19 72.79 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -0.738 . . . . 10.0 109.217 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.17 120.99 9.29 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.029 1.819 . . . . 10.0 109.905 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 7.3 tpp85 . . . . . 0 C--N 1.321 -0.666 0 O-C-N 121.899 -0.5 . . . . 10.0 110.629 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.747 0.308 . . . . 10.0 110.318 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.11 136.49 26.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.87 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.94 116.68 3.3 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.171 2.581 . . . . 10.0 112.685 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -83.31 115.11 21.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.156 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.93 141.53 35.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.665 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.85 149.78 22.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.852 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.13 -162.19 37.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.458 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.02 -166.64 23.24 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -154.35 148.94 26.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.907 0.384 . . . . 10.0 110.542 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -157.96 138.73 13.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.259 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.15 174.49 16.16 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.964 -0.636 . . . . 10.0 111.709 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -165.96 135.24 3.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 10.0 110.513 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.212 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 3.1 p . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 109.874 -0.417 . . . . 10.0 109.874 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.4 m -84.31 -30.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.968 -0.293 . . . . 10.0 111.444 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.1 140.27 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.253 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.71 -51.94 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.791 0.329 . . . . 10.0 111.092 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.21 -33.93 76.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.408 HG21 HH21 ' A' ' 141' ' ' ARG . 13.1 t -61.88 -47.12 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.154 -0.93 . . . . 10.0 110.478 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -39.47 95.94 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.699 -0.762 . . . . 10.0 111.827 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.77 -40.32 91.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.38 83.18 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.822 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.456 HG21 ' CZ ' ' A' ' 91' ' ' ARG . 3.4 mt -54.25 -45.28 67.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.054 0.454 . . . . 10.0 110.503 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.87 -48.05 60.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.348 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.2 mt-30 -62.54 -37.65 86.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.147 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.98 -38.76 94.44 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.978 -0.556 . . . . 10.0 113.287 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.619 HH22 ' HB3' ' A' ' 132' ' ' MET . 0.5 OUTLIER -78.98 -38.62 36.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.808 0.337 . . . . 10.0 111.425 -178.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' HA ' HG21 ' A' ' 97' ' ' THR . 2.2 pt20 -72.49 -13.63 61.47 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.492 -0.483 . . . . 10.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 2.0 tttm -81.54 12.12 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -158.42 0.22 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 10.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 24.6 mt-10 -131.66 105.39 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.909 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 72.7 Cg_endo -81.08 -30.41 5.33 Favored 'Cis proline' 0 C--N 1.348 0.504 0 C-N-CA 123.523 -1.449 . . . . 10.0 112.725 -0.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 92' ' ' GLN . 15.2 m -161.33 135.76 7.11 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.862 -1.517 . . . . 10.0 109.445 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.18 127.72 35.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.109 -0.33 . . . . 10.0 110.109 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.578 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 59.0 p -79.99 163.69 24.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 10.0 110.641 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.88 -28.91 67.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.87 -32.59 69.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.281 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.578 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 21.4 mm-40 -66.59 -54.97 17.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.547 0.213 . . . . 10.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -63.91 -40.4 96.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.212 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.38 -46.07 93.48 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 111.352 -0.699 . . . . 10.0 111.352 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -65.48 -44.34 87.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.95 -36.54 77.3 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.611 HD11 ' SD ' ' A' ' 132' ' ' MET . 36.4 pt -87.61 -12.46 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.777 -0.369 . . . . 10.0 111.74 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.86 22.45 30.68 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.888 -0.672 . . . . 10.0 113.476 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -119.89 -154.92 0.6 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 p -115.14 176.96 4.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.568 0.223 . . . . 10.0 110.719 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -34.19 75.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.817 0.342 . . . . 10.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.98 84.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.435 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -58.33 -48.2 81.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.164 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.98 -46.66 90.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.554 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.48 -37.84 87.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.274 0.559 . . . . 10.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 58.2 m -74.23 -26.28 60.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.092 -0.503 . . . . 10.0 110.652 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -43.27 69.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.464 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.72 -18.89 57.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.957 0.408 . . . . 10.0 111.035 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 116' ' ' SER . 45.3 ttp180 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.265 0.555 . . . . 10.0 110.411 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.443 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.06 21.49 22.86 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.868 -0.606 . . . . 10.0 111.783 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 121' ' ' THR . 8.0 t -174.62 114.35 0.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.026 0.917 . . . . 10.0 109.712 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.92 29.83 0.15 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.827 -1.079 . . . . 10.0 109.863 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m 58.88 93.1 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.414 ' HG3' ' O ' ' A' ' 78' ' ' THR . 73.3 Cg_endo -71.45 104.67 1.61 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.926 2.418 . . . . 10.0 115.977 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.581 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 18.3 t70 -90.2 119.57 30.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 104.85 -2.278 . . . . 10.0 104.85 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -49.01 -46.65 44.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -63.3 -36.52 83.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.305 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.37 -55.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.852 -0.158 . . . . 10.0 110.914 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -54.42 -38.76 66.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.979 0.418 . . . . 10.0 110.616 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.661 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.6 m -58.69 -50.37 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.605 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -34.51 61.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.719 0.266 . . . . 10.0 111.719 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.619 ' HB3' HH22 ' A' ' 91' ' ' ARG . 5.3 mmm -52.52 -61.06 2.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.355 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HG3' ' HG ' ' A' ' 140' ' ' LEU . 49.4 mm-40 -76.49 -24.04 53.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.487 -0.779 . . . . 10.0 112.17 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' A' ' 130' ' ' SER . 20.9 ttp180 -52.58 -40.73 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 10.0 111.805 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.98 -24.95 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 10.0 111.197 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.2 OUTLIER -99.57 -16.39 18.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.974 -178.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 6.3 m-20 78.79 52.46 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.57 0.7 . . . . 10.0 109.908 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -133.17 159.49 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.886 -1.052 . . . . 10.0 108.248 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -130.15 -2.19 4.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.566 -0.854 . . . . 10.0 113.103 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.527 ' HG ' ' HG3' ' A' ' 133' ' ' GLU . 22.4 mt 54.61 10.51 0.35 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.792 -1.095 . . . . 10.0 113.699 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.408 HH21 HG21 ' A' ' 83' ' ' VAL . 4.3 mmt85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.297 -0.252 . . . . 10.0 110.47 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.74 -179.78 26.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.769 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.74 -25.05 48.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 10.0 109.9 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -89.37 56.48 3.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.571 -0.74 . . . . 10.0 110.845 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 146' ' ' GLY . 20.2 mm -65.68 139.28 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.054 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.552 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 83.64 19.54 61.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.088 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -150.46 162.0 28.82 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.577 . . . . 10.0 109.462 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.83 122.73 11.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.618 1.545 . . . . 10.0 110.149 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 110.315 -0.254 . . . . 10.0 110.315 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -100.71 147.17 33.27 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.539 -0.3 . . . . 10.0 110.723 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.41 151.79 83.23 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.216 2.61 . . . . 10.0 112.507 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -117.28 156.36 27.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -151.59 154.17 35.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -177.81 6.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.763 0.316 . . . . 10.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.37 -133.96 1.86 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.19 -0.529 . . . . 10.0 111.861 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.99 158.01 7.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.148 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -141.45 170.24 16.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.13 179.65 4.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 10.0 110.71 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -125.66 1.21 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.753 -0.737 . . . . 10.0 111.922 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.02 145.22 53.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.902 0.382 . . . . 10.0 110.687 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.991 179.845 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.659 0.266 . . . . 10.0 110.478 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 3.1 p -71.63 -33.89 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.116 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.06 130.18 3.1 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.438 -0.887 . . . . 10.0 112.192 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.99 -53.02 61.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.313 . . . . 10.0 111.089 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -65.34 -33.02 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.51 -0.552 . . . . 10.0 109.51 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 87' ' ' ILE . 92.9 t -62.69 -46.09 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.096 -0.956 . . . . 10.0 110.18 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -60.14 -42.77 98.7 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.973 -0.558 . . . . 10.0 113.176 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -69.24 -34.16 74.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 10.0 110.447 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.22 -29.68 66.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.707 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 83' ' ' VAL . 39.5 mt -59.27 -44.09 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 10.0 109.99 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.38 -54.63 11.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.245 0.545 . . . . 10.0 110.028 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 47.8 mt-30 -55.2 -38.19 68.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.975 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.46 -34.38 40.39 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.158 -1.02 . . . . 10.0 113.12 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.664 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -81.7 -26.03 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.053 0.454 . . . . 10.0 111.375 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -75.21 -8.8 57.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.187 0.517 . . . . 10.0 109.905 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 8.4 mtpm? -76.63 8.13 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.973 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.62 -13.9 55.7 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.873 -0.331 . . . . 10.0 111.689 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.04 111.1 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 O-C-N 124.32 1.013 . . . . 10.0 112.096 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.0 -37.86 1.99 Allowed 'Cis proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.205 -1.581 . . . . 10.0 112.373 -0.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -170.98 135.85 1.06 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.973 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 33.9 tpp -70.79 127.02 31.21 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -63.18 146.64 52.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.572 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -64.74 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.979 0.419 . . . . 10.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.72 -47.22 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.23 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -68.31 -37.04 80.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.707 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.478 HD12 ' CG ' ' A' ' 91' ' ' ARG . 0.5 OUTLIER -61.83 -44.24 97.24 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.72 97.97 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.346 -0.843 . . . . 10.0 111.513 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -62.9 -36.05 82.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.168 0.509 . . . . 10.0 110.331 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -71.94 -40.87 68.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.193 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.8 pt -82.53 -5.9 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 111.992 0.367 . . . . 10.0 111.992 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.9 28.45 37.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.837 -0.697 . . . . 10.0 112.907 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -130.14 -146.84 0.32 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.216 -0.661 . . . . 10.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.35 175.73 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.615 0.245 . . . . 10.0 111.097 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.24 91.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.726 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.75 76.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.671 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -60.27 -46.45 89.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.398 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.49 -45.91 91.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.354 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.92 -32.87 74.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.86 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -77.2 -28.18 53.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.471 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -70.33 -39.71 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.125 0.417 . . . . 10.0 112.125 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.56 -19.51 57.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.091 0.472 . . . . 10.0 111.469 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' A' ' 119' ' ' ARG . 12.1 ttm180 -72.89 -29.34 63.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.738 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.99 12.21 47.07 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.998 -0.62 . . . . 10.0 113.633 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.1 t -149.38 59.33 1.02 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.795 0.807 . . . . 10.0 111.022 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.2 27.53 9.42 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.613 -0.721 . . . . 10.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.4 m 64.97 109.38 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 123.627 0.58 . . . . 10.0 110.506 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 44.0 Cg_endo -70.37 88.37 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.171 1.914 . . . . 10.0 113.642 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.713 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.0 t70 -87.35 114.43 23.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.7 -1.222 . . . . 10.0 107.7 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -49.75 -45.64 49.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.472 0.483 . . . . 10.0 111.933 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 22.6 t30 -61.25 -44.97 96.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.822 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.573 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.5 mt -63.02 -55.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.181 -0.207 . . . . 10.0 110.648 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 6.3 mt -50.12 -41.38 48.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.356 0.598 . . . . 10.0 110.321 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 73.9 m -58.97 -43.55 91.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.124 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 135' ' ' VAL . 74.2 mmtt -72.98 -43.28 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.909 0.337 . . . . 10.0 111.909 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.573 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 14.3 mtp -49.28 -56.97 7.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.752 0.786 . . . . 10.0 111.841 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 11.8 mt-10 -73.93 -27.28 60.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -1.112 . . . . 10.0 113.083 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.603 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -68.72 -22.65 64.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.261 0.467 . . . . 10.0 112.261 -178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.6 t -66.9 -24.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 10.0 109.957 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.511 HD13 HH11 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -123.53 -96.54 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.151 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 19.0 p-10 173.42 31.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 136' ' ' LEU . 3.2 m -111.55 147.62 15.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 2.9 mmpt? -115.6 132.92 56.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 10.0 110.711 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.408 HD13 HH22 ' A' ' 91' ' ' ARG . 40.8 mt -97.42 40.58 1.15 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -139.33 139.35 37.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.794 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.58 -157.8 19.83 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.651 -0.785 . . . . 10.0 112.802 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.29 -19.24 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.128 0.49 . . . . 10.0 111.16 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -97.75 54.07 1.14 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 146' ' ' GLY . 14.1 mm -63.17 136.54 25.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.389 -0.823 . . . . 10.0 112.127 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.517 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 82.2 4.01 90.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.023 -0.608 . . . . 10.0 112.144 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.76 54.66 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.942 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 12.0 Cg_endo -58.5 121.86 10.68 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.803 2.335 . . . . 10.0 110.594 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 121.556 0.693 . . . . 10.0 109.169 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.1 mtt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.583 0.23 . . . . 10.0 110.81 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.97 90.34 49.75 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.567 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -86.49 154.7 9.15 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.025 2.483 . . . . 10.0 112.994 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.49 141.34 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.209 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -159.89 151.68 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.712 0.291 . . . . 10.0 110.661 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.38 150.26 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.038 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.76 166.16 34.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.61 -0.805 . . . . 10.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.08 170.4 20.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.187 -0.53 . . . . 10.0 112.307 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 162.39 12.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.844 0.354 . . . . 10.0 111.274 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.91 -175.17 4.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.45 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.78 158.83 31.45 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.601 -0.6 . . . . 10.0 111.601 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.26 176.95 7.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.992 0.396 . . . . 10.0 110.975 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.095 179.749 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' C ' ' A' ' 120' ' ' GLY . 1.1 m -88.24 -34.12 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.42 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.41 143.03 7.62 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.581 -0.818 . . . . 10.0 112.489 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -67.28 -55.67 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.641 0.237 . . . . 10.0 111.641 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.15 -35.39 80.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.543 0.687 . . . . 10.0 109.221 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 87' ' ' ILE . 38.9 t -59.51 -45.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.681 -1.145 . . . . 10.0 110.411 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.11 97.76 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.117 -0.564 . . . . 10.0 112.476 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -65.04 -37.0 86.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 10.0 110.561 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.04 -30.63 67.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.176 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.461 HG12 ' NH2' ' A' ' 91' ' ' ARG . 17.8 mt -60.95 -46.28 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.403 0.621 . . . . 10.0 109.643 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.77 -50.88 31.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.048 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.69 -35.78 75.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.565 . . . . 10.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.71 -34.92 37.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.492 -1.337 . . . . 10.0 113.203 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.597 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 1.3 mpt_? -81.24 -44.22 18.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 10.0 111.582 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' THR . 71.9 mt-30 -67.01 -18.33 65.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.656 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -81.16 29.58 0.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.715 0.293 . . . . 10.0 111.55 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.67 -3.84 51.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.835 0.309 . . . . 10.0 111.835 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.13 109.14 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.021 0.826 . . . . 10.0 112.418 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -73.62 -54.39 0.15 OUTLIER 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.816 -1.327 . . . . 10.0 112.788 -0.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 13.1 m -161.62 123.14 2.83 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.134 -0.939 . . . . 10.0 110.582 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.5 ttm -64.59 128.84 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.828 0.346 . . . . 10.0 110.438 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.6 p -76.81 157.3 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -66.97 -28.78 68.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.413 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.66 80.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.194 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 46.7 mm-40 -64.51 -53.88 41.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.747 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.508 ' O ' HG12 ' A' ' 107' ' ' ILE . 22.5 tp -60.47 -40.13 90.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.31 -45.68 95.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.684 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -64.36 -44.18 92.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 10.0 110.402 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 58.0 mm-40 -61.47 -41.0 96.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 10.0 112.113 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 103' ' ' LEU . 43.9 pt -84.59 -14.91 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 111.931 0.345 . . . . 10.0 111.931 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.16 41.34 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.969 -0.634 . . . . 10.0 113.225 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -121.95 -176.13 3.27 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.03 163.59 14.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.655 0.264 . . . . 10.0 110.767 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.81 -35.29 76.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 10.0 110.842 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.31 71.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -66.91 -47.4 71.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.46 -43.5 98.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.637 -0.71 . . . . 10.0 110.503 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.31 80.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.403 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 7.2 t -74.29 -30.77 62.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.183 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.09 -44.71 94.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.171 -0.468 . . . . 10.0 111.536 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.59 -19.08 65.69 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.985 -0.286 . . . . 10.0 111.148 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 116' ' ' SER . 20.7 ttp180 -71.92 -22.78 61.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.417 0.627 . . . . 10.0 109.534 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.419 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 100.45 25.49 8.71 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.522 -0.763 . . . . 10.0 112.132 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.3 t -174.2 111.97 0.17 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.975 0.893 . . . . 10.0 110.467 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.35 33.42 0.09 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.99 -1.005 . . . . 10.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m 60.76 99.99 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.312 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.19 88.82 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.878 2.386 . . . . 10.0 115.06 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.694 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.5 t70 -86.01 117.07 24.62 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 105.856 -1.905 . . . . 10.0 105.856 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -51.51 -41.28 60.88 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.613 0.571 . . . . 10.0 112.178 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 53.4 t30 -65.63 -44.15 87.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.598 ' O ' ' HG3' ' A' ' 132' ' ' MET . 79.4 mt -59.87 -53.93 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.7 mt -48.75 -48.02 41.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.478 0.656 . . . . 10.0 109.736 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.578 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.9 m -55.12 -39.84 69.84 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.803 -1.09 . . . . 10.0 111.189 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 66.8 mmtt -71.72 -48.07 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.598 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 10.1 mtp -52.33 -52.29 54.01 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.86 0.838 . . . . 10.0 111.213 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 32.4 mt-10 -72.56 -29.28 63.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.553 -1.203 . . . . 10.0 113.17 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.2 ttp85 -64.43 -28.92 70.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 131' ' ' LYS . 22.8 t -64.0 -31.97 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.528 HD23 HH11 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -123.16 2.77 9.25 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.539 0.94 . . . . 10.0 113.539 -178.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.51 43.38 16.19 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 31.4 m -131.96 138.47 52.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.434 ' CG ' ' H ' ' A' ' 149' ' ' ARG . 30.4 mmmt -114.06 149.98 34.68 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.466 -0.494 . . . . 10.0 111.364 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.434 HD11 HH22 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -110.6 15.34 22.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.191 -0.913 . . . . 10.0 109.866 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -115.65 140.68 48.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.434 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.46 -162.81 29.59 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.21 -26.58 21.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.978 0.418 . . . . 10.0 111.117 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -87.74 54.91 3.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.004 0.431 . . . . 10.0 111.726 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 73.6 mt -74.41 142.33 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.1 73.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.688 -0.965 . . . . 10.0 110.688 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.0 156.78 76.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.639 -0.78 . . . . 10.0 109.398 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -61.94 123.72 13.13 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.826 1.684 . . . . 10.0 109.667 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.434 ' H ' ' CG ' ' A' ' 139' ' ' LYS . 23.3 tpt180 . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 121.21 0.528 . . . . 10.0 110.931 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mtp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -151.15 145.42 18.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.124 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.06 147.79 34.19 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.71 2.274 . . . . 10.0 112.619 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.77 143.29 57.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.742 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -72.03 150.36 44.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.423 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.68 30.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.1 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.88 157.19 15.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.241 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.36 169.54 32.17 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.828 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -147.49 97.04 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.062 0.458 . . . . 10.0 110.995 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.06 149.71 24.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.623 -0.51 . . . . 10.0 109.623 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.96 -170.34 12.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.585 -0.817 . . . . 10.0 112.779 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -157.81 167.27 30.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.113 -0.328 . . . . 10.0 110.113 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.981 -179.51 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 109.976 -0.379 . . . . 10.0 109.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.411 HG21 ' C ' ' A' ' 120' ' ' GLY . 1.4 m -83.4 -27.61 7.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.759 -0.376 . . . . 10.0 110.69 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.9 139.19 6.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 10.0 111.719 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -65.23 -56.29 13.63 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.709 0.29 . . . . 10.0 111.294 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.56 -32.94 74.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 87' ' ' ILE . 38.5 t -62.15 -43.71 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.224 -0.898 . . . . 10.0 109.857 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.28 99.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.405 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -63.28 -37.81 88.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.622 . . . . 10.0 109.777 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.494 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . . . -73.92 -29.78 62.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.617 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.728 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 12.4 mt -58.39 -52.3 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.99 -48.98 66.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.552 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.501 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -60.6 -29.27 69.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.354 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.565 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -76.28 -37.84 35.66 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.422 -0.894 . . . . 10.0 113.051 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.5 mmt180 -79.65 -43.75 22.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.28 0.54 . . . . 10.0 110.747 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.2 -5.44 27.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.04 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 38.8 tttt -78.91 -10.9 59.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.835 0.35 . . . . 10.0 110.643 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.61 172.35 4.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.38 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -120.31 125.12 27.38 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.507 -0.315 . . . . 10.0 110.387 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.52 -39.51 1.3 Allowed 'Cis proline' 0 CA--C 1.519 -0.258 0 C-N-CA 123.617 -1.409 . . . . 10.0 112.544 -0.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.5 m -170.61 120.95 0.58 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.608 -1.178 . . . . 10.0 109.333 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 35.3 tpp -65.28 122.5 17.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.8 p -74.47 159.27 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.033 0.444 . . . . 10.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -68.91 -37.66 79.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.178 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.1 -41.67 90.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.02 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -66.19 -46.15 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.144 -0.222 . . . . 10.0 110.808 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tp -65.45 -39.56 92.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.15 -47.55 90.24 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.147 -0.933 . . . . 10.0 111.384 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.82 -43.41 98.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -60.65 -41.74 95.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.899 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 103' ' ' LEU . 38.9 pt -82.84 -7.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.895 0.332 . . . . 10.0 111.895 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.22 29.99 29.3 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.648 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.51 -154.0 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.51 172.36 7.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.535 -0.172 . . . . 10.0 110.535 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.42 89.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.02 0.438 . . . . 10.0 110.336 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.77 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.639 -0.71 . . . . 10.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -62.22 -46.64 87.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 10.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.0 t -65.67 -43.76 93.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.451 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -65.96 -35.09 79.64 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.208 0.527 . . . . 10.0 111.085 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.9 m -77.3 -27.71 53.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.459 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -37.92 89.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.5 -17.83 56.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -64.9 -23.84 67.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.305 0.574 . . . . 10.0 110.405 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.411 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 96.42 24.28 14.53 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.678 -0.772 . . . . 10.0 111.647 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 121' ' ' THR . 8.4 t -175.0 115.02 0.15 Allowed 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.829 0.823 . . . . 10.0 109.549 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.58 30.56 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.898 -1.046 . . . . 10.0 109.585 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.7 m 62.32 97.6 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.08 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.97 90.95 0.94 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.85 2.367 . . . . 10.0 114.515 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.6 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -80.87 124.75 29.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.189 -2.152 . . . . 10.0 105.189 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -51.63 -42.69 62.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -63.99 -39.13 93.42 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.678 0.611 . . . . 10.0 110.84 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.749 ' O ' ' HG3' ' A' ' 132' ' ' MET . 96.9 mt -64.3 -57.08 12.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 120.751 -0.379 . . . . 10.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.3 mt -50.47 -45.65 56.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.505 0.503 . . . . 10.0 110.592 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.2 m -55.32 -46.44 76.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.449 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.636 ' O ' HG21 ' A' ' 135' ' ' VAL . 19.1 mtmt -73.55 -40.35 64.03 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.749 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 29.6 mtp -52.06 -55.22 22.02 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.857 0.837 . . . . 10.0 111.011 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.675 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 27.1 mt-10 -72.98 -31.81 64.78 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.463 -1.244 . . . . 10.0 113.361 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -69.88 -23.43 63.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 131' ' ' LYS . 57.4 t -61.51 -38.17 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 10.0 111.805 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -114.53 -5.91 12.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.92 46.41 0.48 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.226 1.013 . . . . 10.0 109.412 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.675 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 47.7 t -122.68 138.91 51.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.648 -1.614 . . . . 10.0 106.943 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 13.4 mmmm -122.79 140.29 53.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 118.842 0.747 . . . . 10.0 111.792 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.57 18.26 19.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.431 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -113.98 140.53 48.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.494 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.39 -156.61 25.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.749 -0.738 . . . . 10.0 111.92 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.04 0.74 41.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.089 0.471 . . . . 10.0 110.96 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -110.36 51.1 0.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.799 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 146' ' ' GLY . 49.0 mt -72.54 136.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.519 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 94.54 4.4 62.28 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.996 -0.841 . . . . 10.0 110.996 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.28 156.87 73.47 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.278 -0.461 . . . . 10.0 110.245 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -64.55 122.31 10.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.897 1.731 . . . . 10.0 109.387 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.63 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 15.7 tpt180 . . . . . 0 C--N 1.319 -0.735 0 CA-C-O 121.094 0.473 . . . . 10.0 110.052 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.8 tpt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.875 0.369 . . . . 10.0 110.909 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.84 143.5 48.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 166.65 28.42 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.638 2.225 . . . . 10.0 113.245 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.63 162.64 16.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.847 -0.615 . . . . 10.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -145.18 157.78 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.2 144.66 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.21 175.51 42.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.247 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.62 148.85 18.68 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.751 -0.738 . . . . 10.0 112.453 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.6 m -91.64 127.88 37.26 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.039 -0.356 . . . . 10.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.73 167.17 15.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.997 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.04 166.77 28.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.714 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -123.06 165.17 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.813 0.306 . . . . 10.0 111.026 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.331 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 110.196 -0.298 . . . . 10.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.407 HG23 ' C ' ' A' ' 120' ' ' GLY . 1.5 m -82.88 -29.94 8.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.831 0.308 . . . . 10.0 111.831 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.31 140.7 8.04 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.111 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.46 -49.84 67.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.882 0.341 . . . . 10.0 111.682 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -59.35 -38.45 80.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.375 0.607 . . . . 10.0 109.742 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.03 -42.93 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.1 -0.955 . . . . 10.0 110.134 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.29 -43.61 96.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.14 -0.552 . . . . 10.0 112.538 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -61.34 -43.06 99.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.188 0.518 . . . . 10.0 109.902 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.83 -29.69 67.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.33 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.792 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.2 mt -58.1 -48.54 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.981 -0.378 . . . . 10.0 109.981 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.69 -48.57 63.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.248 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.26 -33.39 73.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.67 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.73 -30.15 68.72 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.793 -0.639 . . . . 10.0 113.264 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.792 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 13.0 mmt85 -77.37 -29.41 53.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -79.1 -8.06 58.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 10.0 109.717 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -75.14 -8.5 56.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.929 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -168.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -133.21 110.35 12.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.469 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.13 -30.64 5.69 Favored 'Cis proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.225 -1.573 . . . . 10.0 112.522 -0.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.6 m -170.45 134.37 1.13 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.802 -1.544 . . . . 10.0 109.65 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 122.13 22.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.5 p -69.89 158.15 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 10.0 111.102 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -67.41 -36.08 80.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.845 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.58 78.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.358 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.47 -47.17 86.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.362 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.5 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -64.94 -40.71 95.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.574 -0.528 . . . . 10.0 109.574 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -48.38 81.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.214 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -64.02 -38.04 89.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.966 0.412 . . . . 10.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -39.39 92.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.635 -0.711 . . . . 10.0 111.296 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 103' ' ' LEU . 32.6 pt -89.07 -28.63 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.85 6.1 21.35 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.59 -0.814 . . . . 10.0 112.818 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -106.33 -164.39 1.0 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 171.07 7.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.103 -0.239 . . . . 10.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.85 -38.05 80.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 10.0 110.402 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.42 75.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.526 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 9.7 m -66.98 -40.28 87.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.283 0.563 . . . . 10.0 110.271 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.75 -37.23 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.82 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -72.44 -33.03 66.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.38 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 52.3 p -76.58 -29.1 56.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.924 0.392 . . . . 10.0 111.6 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.411 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.3 m-85 -63.18 -36.7 84.49 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -63.61 -18.57 64.05 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 116' ' ' SER . 61.5 ttt180 -68.13 -18.76 64.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.229 0.538 . . . . 10.0 110.657 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 79' ' ' VAL . . . 91.3 28.84 13.6 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.247 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 121' ' ' THR . 5.2 t -175.96 111.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.917 0.865 . . . . 10.0 109.793 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.94 34.34 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.946 -1.025 . . . . 10.0 110.057 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m 63.28 99.23 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.454 -0.793 . . . . 10.0 109.137 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.424 ' HA ' HD22 ' A' ' 129' ' ' LEU . 92.2 Cg_endo -77.16 88.55 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.996 2.464 . . . . 10.0 115.727 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.584 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 5.9 t70 -81.68 116.07 21.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -48.65 -41.11 30.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.6 t30 -68.78 -42.24 77.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.783 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' A' ' 132' ' ' MET . 66.7 mt -60.46 -55.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 121.186 -0.206 . . . . 10.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 7.5 mt -47.65 -47.23 29.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.659 0.599 . . . . 10.0 110.325 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 28.0 m -57.95 -38.65 76.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.211 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 74.6 mmtt -73.66 -36.78 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 10.0 111.464 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.561 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 18.9 mtp -54.22 -57.15 12.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.481 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.588 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -73.36 -26.69 61.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.871 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.7 OUTLIER -52.58 -38.54 60.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 -177.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.43 -26.7 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.881 -0.327 . . . . 10.0 111.234 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -92.33 -21.18 20.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.252 0.464 . . . . 10.0 112.252 -178.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 57.5 m-20 70.45 48.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.601 0.715 . . . . 10.0 110.184 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.06 169.41 21.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.852 -1.067 . . . . 10.0 108.557 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -137.64 133.21 34.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.938 0.399 . . . . 10.0 110.45 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.588 ' HG ' ' OE2' ' A' ' 133' ' ' GLU . 8.2 mt -100.86 12.0 38.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.583 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -125.4 139.86 53.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.94 -153.72 17.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.342 -0.703 . . . . 10.0 111.342 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.99 -33.57 10.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.968 0.413 . . . . 10.0 111.16 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -87.43 55.65 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.263 0.554 . . . . 10.0 110.576 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 146' ' ' GLY . 71.0 mt -69.0 141.17 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.658 . . . . 10.0 111.323 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.578 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 86.94 -5.54 84.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.152 -0.546 . . . . 10.0 111.831 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.64 158.21 62.92 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.304 -0.448 . . . . 10.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.01 122.47 10.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.167 1.912 . . . . 10.0 110.849 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 121.546 0.689 . . . . 10.0 110.046 -179.711 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.5 mtm . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.835 -0.431 . . . . 10.0 109.835 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.18 121.85 6.7 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.612 -0.267 . . . . 10.0 110.366 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.85 122.03 10.39 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.661 2.24 . . . . 10.0 112.425 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.35 137.87 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.596 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -138.44 140.21 39.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.806 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -104.28 -44.64 4.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.032 0.444 . . . . 10.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.61 -119.8 5.06 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.416 -0.674 . . . . 10.0 111.416 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 141.36 117.37 1.34 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.9 m -103.62 142.15 34.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.749 0.309 . . . . 10.0 110.648 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.12 -150.51 0.43 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.267 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.09 -168.05 40.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.013 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -154.17 176.94 11.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 10.0 110.998 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.108 179.738 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.428 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 23.6 p . . . . . 0 CA--C 1.531 0.228 0 CA-C-O 120.702 0.287 . . . . 10.0 110.764 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.509 HG13 ' CG2' ' A' ' 83' ' ' VAL . 3.0 t -82.26 -68.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.628 -0.26 . . . . 10.0 111.299 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 83' ' ' VAL . . . 146.64 161.6 9.4 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 111.574 -0.611 . . . . 10.0 111.574 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -78.87 -55.02 5.47 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 -178.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.1 tp10 -71.97 -28.61 63.54 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.511 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.509 ' CG2' HG13 ' A' ' 79' ' ' VAL . 6.6 m -64.27 -36.4 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.252 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.16 -47.22 90.08 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.496 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.33 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 10.0 110.816 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.78 68.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.414 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.752 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.3 mt -61.23 -49.76 83.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.95 -53.06 60.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.622 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.4 mt-30 -59.22 -39.8 83.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.043 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.47 -35.34 91.59 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.855 -0.688 . . . . 10.0 113.544 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.752 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.4 -39.63 28.01 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.042 0.449 . . . . 10.0 110.509 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -69.91 -25.1 63.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.733 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 39.2 tttm -80.0 54.42 1.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.712 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -126.1 3.38 7.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 54.99 101.24 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.915 0.759 . . . . 10.0 112.817 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.79 -30.56 4.63 Favored 'Cis proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.176 -1.593 . . . . 10.0 112.61 -0.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -174.81 129.78 0.32 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.837 -1.529 . . . . 10.0 110.007 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.6 tpp -76.69 143.1 40.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.929 -0.397 . . . . 10.0 109.929 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 145.39 50.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.631 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.69 -41.89 74.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.062 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.68 83.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.953 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -70.93 -32.01 68.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.492 -0.322 . . . . 10.0 110.339 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -63.81 -43.38 96.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.02 -37.4 91.99 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.157 -0.929 . . . . 10.0 111.357 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -65.47 -35.4 80.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 10.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.71 -40.49 84.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.844 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 29.6 pt -87.81 -22.54 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 34.38 5.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.478 -0.868 . . . . 10.0 112.382 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -129.64 -171.79 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.859 0.362 . . . . 10.0 110.444 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 166.96 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.567 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.4 91.01 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.523 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.71 -32.86 70.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.55 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -60.43 -47.09 87.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.096 -0.502 . . . . 10.0 109.998 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.48 -46.47 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.8 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.32 -35.86 80.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.322 0.582 . . . . 10.0 111.069 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.3 m -75.26 -27.96 59.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.641 ' OH ' ' HA ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -63.74 -38.91 92.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.801 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -65.09 -18.42 65.29 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.053 0.39 . . . . 10.0 112.053 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -78.39 -18.67 54.71 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.62 14.54 46.7 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.431 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 121' ' ' THR . 7.5 t -160.04 106.1 1.58 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.173 0.987 . . . . 10.0 109.802 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.89 24.6 0.5 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.714 -1.13 . . . . 10.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m 59.67 80.63 0.27 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.288 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.641 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 72.9 Cg_endo -75.21 158.8 41.18 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.785 2.323 . . . . 10.0 114.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.697 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.6 t70 -137.48 140.17 41.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.257 -1.338 . . . . 10.0 107.86 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -54.73 -40.2 69.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.582 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.97 -35.45 72.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.548 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.74 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.1 mt -66.78 -57.33 10.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 120.581 -0.448 . . . . 10.0 110.234 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.3 mt -50.13 -39.64 43.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.744 0.783 . . . . 10.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 72.1 m -62.56 -50.32 71.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 10.0 111.488 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 127' ' ' ASN . 1.5 mptp? -74.91 -31.33 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 10.0 112.449 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.74 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 52.9 mtp -60.32 -59.38 5.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.577 0.703 . . . . 10.0 111.403 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.689 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 2.9 mp0 -74.56 -25.49 59.33 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 19.6 ptt180 -56.87 -26.9 59.63 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.358 0.526 . . . . 10.0 111.395 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.09 -25.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.148 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -100.29 -19.23 16.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.795 0.294 . . . . 10.0 111.795 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 68.34 43.16 1.52 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.606 0.717 . . . . 10.0 111.312 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.8 m -136.68 140.1 43.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.342 -1.355 . . . . 10.0 107.342 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 3.4 mmpt? -116.65 135.49 53.75 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.806 -0.758 . . . . 10.0 111.058 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.29 36.05 2.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.125 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -138.21 139.21 39.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.235 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.14 -163.07 21.99 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.309 -0.716 . . . . 10.0 111.309 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.92 23.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.968 0.413 . . . . 10.0 110.399 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -85.93 55.27 3.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.752 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.532 HG21 ' N ' ' A' ' 146' ' ' GLY . 8.2 mm -68.57 138.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.477 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.532 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 82.91 2.5 90.67 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.464 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.32 160.68 56.46 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.815 -0.192 . . . . 10.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -62.52 120.37 7.87 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.451 1.434 . . . . 10.0 109.506 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? . . . . . 0 C--N 1.318 -0.787 0 CA-C-O 120.771 0.32 . . . . 10.0 110.178 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.1 mtm . . . . . 0 CA--C 1.521 -0.157 0 N-CA-C 110.239 -0.282 . . . . 10.0 110.239 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 t70 62.0 99.19 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 123.818 0.699 . . . . 10.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -88.9 164.61 5.98 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.995 2.463 . . . . 10.0 111.797 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.01 139.89 50.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.224 -0.287 . . . . 10.0 110.224 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -121.41 169.91 10.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.364 . . . . 10.0 110.868 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.81 172.5 17.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.901 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.94 121.0 2.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.518 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.5 124.24 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.025 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 t -144.54 139.08 27.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.006 0.432 . . . . 10.0 110.429 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -106.83 -65.79 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.66 175.27 29.63 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.771 -0.65 . . . . 10.0 111.82 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -155.3 138.89 15.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.774 -0.454 . . . . 10.0 109.774 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 179.264 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.587 HG11 ' O ' ' A' ' 121' ' ' THR . 4.9 m -79.87 -35.14 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.822 -0.351 . . . . 10.0 111.063 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.95 147.9 6.85 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.97 -53.05 35.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.068 0.434 . . . . 10.0 111.626 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -69.15 -33.45 73.43 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 140' ' ' LEU . 38.3 t -58.72 -41.28 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.69 -1.141 . . . . 10.0 109.951 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.8 -41.47 97.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.131 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -64.56 -45.11 88.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.946 0.403 . . . . 10.0 109.958 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.05 77.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.733 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.669 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.6 mt -58.73 -46.01 90.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.733 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.12 -49.15 59.65 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.042 0.448 . . . . 10.0 110.401 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -61.4 -36.55 80.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.7 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.56 98.01 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.039 -0.528 . . . . 10.0 114.013 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 17.7 mmt-85 -69.84 -36.58 75.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.383 0.591 . . . . 10.0 110.254 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -82.42 -5.89 58.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.781 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -89.03 14.58 10.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.846 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.87 -17.7 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.876 0.325 . . . . 10.0 111.876 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 60.55 106.95 0.03 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.937 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.98 -59.03 0.14 OUTLIER 'Cis proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.534 -1.444 . . . . 10.0 112.347 0.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.0 m -157.51 124.07 4.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.878 -1.055 . . . . 10.0 110.732 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.6 tpp -72.49 141.66 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 142.75 55.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.995 0.426 . . . . 10.0 111.037 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -70.5 -37.37 74.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.473 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.23 76.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.195 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.06 -41.93 40.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.817 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.417 ' HG ' ' HD2' ' A' ' 91' ' ' ARG . 1.2 tm? -64.11 -38.33 90.67 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.1 -46.24 59.19 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.391 -0.822 . . . . 10.0 111.555 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -58.09 -39.06 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 10.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.08 -39.29 89.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.301 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.404 HG22 HD12 ' A' ' 107' ' ' ILE . 17.6 pt -92.91 4.01 7.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.15 71.88 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.959 -0.638 . . . . 10.0 113.926 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.446 ' OE1' HG21 ' A' ' 113' ' ' THR . 32.0 mm-40 -109.46 -162.8 0.82 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.0 p -125.24 174.7 7.92 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.252 -0.28 . . . . 10.0 111.048 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.84 87.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.321 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.31 77.62 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.347 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.446 HG21 ' OE1' ' A' ' 109' ' ' GLU . 2.6 m -62.4 -50.32 72.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.43 -42.68 91.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 10.0 110.232 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.44 -37.04 82.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.925 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 m -74.84 -27.44 60.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.17 -0.468 . . . . 10.0 111.967 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.33 -32.75 70.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.153 0.427 . . . . 10.0 112.153 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -18.14 41.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.42 ' HG2' ' CG2' ' A' ' 121' ' ' THR . 1.6 ttt85 -61.89 -24.01 66.67 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.02 0.438 . . . . 10.0 111.093 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.424 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.13 23.8 11.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.348 -0.93 . . . . 10.0 113.933 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.587 ' O ' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -154.73 -88.46 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.824 0.312 . . . . 10.0 110.651 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.413 ' H ' ' CG2' ' A' ' 121' ' ' THR . . . 58.78 11.79 1.98 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.527 0.936 . . . . 10.0 113.527 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m 45.64 76.59 0.53 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.544 ' HB2' HD21 ' A' ' 129' ' ' LEU . 42.6 Cg_endo -89.01 147.46 5.58 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.308 2.672 . . . . 10.0 116.962 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.31 129.33 42.48 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 103.994 -2.595 . . . . 10.0 103.994 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.446 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.6 mm-40 -55.84 -29.55 60.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.41 -48.4 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 110.431 -0.211 . . . . 10.0 110.431 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 124' ' ' PRO . 5.4 mt -57.76 -36.47 72.15 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.404 0.621 . . . . 10.0 109.883 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -66.04 -49.52 67.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.142 -0.935 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.525 ' O ' HG21 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -74.48 -38.62 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.751 1.019 . . . . 10.0 113.751 -178.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.1 ptm -61.2 -50.25 73.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.009 0.368 . . . . 10.0 111.543 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.605 ' CD ' HH22 ' A' ' 91' ' ' ARG . 15.5 mm-40 -76.91 -29.03 55.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.253 0.834 . . . . 10.0 113.253 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -62.61 -23.38 67.02 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.133 -0.354 . . . . 10.0 111.478 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 131' ' ' LYS . 59.1 t -63.1 -34.18 65.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.189 0.519 . . . . 10.0 110.311 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.59 HD11 ' OE1' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.12 3.65 28.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.881 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.6 t30 70.18 51.79 0.39 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.579 0.704 . . . . 10.0 110.27 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.421 ' CG2' HD13 ' A' ' 136' ' ' LEU . 22.2 t -132.59 152.32 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.129 -0.941 . . . . 10.0 109.606 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 26.0 mmmt -131.04 145.15 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 10.0 110.512 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.476 ' HG ' ' HG3' ' A' ' 133' ' ' GLU . 27.6 mt -106.86 20.16 19.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.118 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -134.21 139.28 45.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.841 0.353 . . . . 10.0 110.948 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.33 -157.37 15.15 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.543 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.41 -30.59 14.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.075 0.464 . . . . 10.0 110.007 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.83 59.04 5.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.645 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 145' ' ' ILE . 15.5 mm -66.9 137.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 10.0 110.652 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 80.45 10.32 85.46 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.23 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -133.81 157.14 78.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.372 -0.414 . . . . 10.0 110.381 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.12 123.82 13.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.557 2.171 . . . . 10.0 111.235 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.603 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 5.2 tmm_? . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.2 ttm . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.861 0.363 . . . . 10.0 110.916 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.08 146.04 31.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.945 -0.57 . . . . 10.0 109.903 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.9 168.46 24.15 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.402 . . . . 10.0 112.699 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -107.6 160.01 16.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.799 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.89 136.89 25.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.725 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.72 168.32 26.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 10.0 111.122 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.58 170.04 29.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.9 -178.69 25.08 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.398 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -147.72 138.42 23.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.118 -0.327 . . . . 10.0 110.118 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -94.55 -64.66 1.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.988 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.65 -166.89 13.76 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.896 -0.669 . . . . 10.0 111.475 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.54 145.76 9.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.074 0.437 . . . . 10.0 110.802 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.294 179.525 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.1 p . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.424 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.5 m -88.35 -25.37 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.567 -0.453 . . . . 10.0 111.541 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.32 138.57 5.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.906 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -67.65 -39.56 84.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 10.0 111.861 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.99 -31.49 50.7 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 87' ' ' ILE . 42.7 t -66.02 -40.22 86.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.184 -0.916 . . . . 10.0 110.056 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.39 -41.74 95.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.891 -0.671 . . . . 10.0 112.12 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -39.5 74.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.163 0.506 . . . . 10.0 110.051 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.32 70.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.817 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 83' ' ' VAL . 7.9 mt -59.47 -45.53 93.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.081 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.93 -53.87 13.44 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.754 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 35.0 mt-30 -54.05 -34.91 61.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.351 -0.84 . . . . 10.0 111.267 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.4 -34.87 39.04 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.754 -0.736 . . . . 10.0 112.766 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.654 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -80.13 -33.61 38.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.019 0.438 . . . . 10.0 110.357 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -73.33 -2.62 22.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.1 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 48.4 mttm -83.25 -2.68 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.015 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.457 ' CE1' HG11 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -78.0 177.06 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.584 -0.735 . . . . 10.0 110.589 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -120.69 121.27 29.13 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.319 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.98 -29.32 6.82 Favored 'Cis proline' 0 CA--C 1.515 -0.445 0 C-N-CA 123.723 -1.365 . . . . 10.0 112.693 -0.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 m -179.05 122.43 0.08 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 113.754 -1.566 . . . . 10.0 109.324 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.8 ttm -70.46 110.87 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.211 -0.292 . . . . 10.0 110.211 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.567 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.9 p -78.51 172.37 13.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.869 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -62.84 -35.7 80.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.769 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.73 -42.42 81.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.005 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 16.8 mm-40 -68.52 -48.82 63.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.917 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -61.06 -42.22 98.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.34 98.16 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.575 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -65.99 -36.03 82.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.792 0.33 . . . . 10.0 110.659 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.26 -40.99 77.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.792 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 103' ' ' LEU . 35.9 pt -83.48 -17.71 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.884 -0.326 . . . . 10.0 111.689 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.91 27.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 10.0 112.77 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -119.89 -169.71 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.769 0.318 . . . . 10.0 110.225 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.7 p -98.98 168.2 10.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.535 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.05 78.6 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.863 0.364 . . . . 10.0 110.623 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.244 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.221 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.77 -43.2 90.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -64.02 -35.23 80.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.443 0.64 . . . . 10.0 110.463 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 48.9 m -76.13 -27.03 56.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.18 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -43.16 77.39 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.676 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.24 -18.69 59.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.975 0.417 . . . . 10.0 111.729 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 116' ' ' SER . 48.3 ttp180 -67.25 -21.63 65.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.312 0.577 . . . . 10.0 110.636 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.424 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 95.22 20.34 28.02 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.728 -0.749 . . . . 10.0 111.692 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 121' ' ' THR . 5.3 t -172.62 108.36 0.19 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.01 0.91 . . . . 10.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.28 30.29 0.2 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.544 -1.207 . . . . 10.0 109.547 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m 60.63 96.4 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.126 -0.943 . . . . 10.0 110.032 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.42 94.84 0.26 Allowed 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 123.173 2.582 . . . . 10.0 113.952 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.705 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.0 t70 -85.97 120.0 26.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.616 -1.253 . . . . 10.0 107.616 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -52.98 -37.97 61.79 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.466 0.479 . . . . 10.0 111.89 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -68.49 -44.36 74.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.047 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.617 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.9 mt -64.13 -54.11 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.185 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 17.6 mt -50.61 -41.83 55.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.269 0.557 . . . . 10.0 110.189 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.3 m -59.61 -49.72 76.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.274 -0.875 . . . . 10.0 111.096 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.659 ' O ' HG21 ' A' ' 135' ' ' VAL . 1.8 mptp? -67.48 -40.26 85.27 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.377 0.51 . . . . 10.0 112.377 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -49.01 -58.31 5.12 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.441 0.638 . . . . 10.0 111.765 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 24.9 mt-10 -75.38 -28.63 59.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.413 -0.812 . . . . 10.0 112.805 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -64.88 -22.97 67.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.926 0.713 . . . . 10.0 112.926 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 131' ' ' LYS . 21.2 t -67.9 -25.0 31.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.631 . . . . 10.0 110.006 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -122.17 -100.44 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.198 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.5 t30 174.29 64.02 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.407 -0.815 . . . . 10.0 109.251 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.3 OUTLIER -136.23 155.83 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.274 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HA ' ' OE1' ' A' ' 133' ' ' GLU . 4.6 mmtm -130.82 132.36 45.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.044 0.45 . . . . 10.0 110.969 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.49 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 13.5 mt -104.64 17.97 23.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.196 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 141' ' ' ARG . 40.0 mtp-105 -127.96 144.42 51.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.751 -0.658 . . . . 10.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.16 -155.38 19.54 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.443 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.73 15.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.653 0.263 . . . . 10.0 111.523 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.45 52.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.035 0.445 . . . . 10.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.495 HG21 ' N ' ' A' ' 146' ' ' GLY . 54.7 mt -68.69 139.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.737 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.495 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 83.95 12.01 77.86 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.176 -0.77 . . . . 10.0 111.176 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.01 152.37 64.96 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.925 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.1 120.09 7.42 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.779 1.652 . . . . 10.0 108.737 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 . . . . . 0 C--N 1.322 -0.607 0 CA-C-O 121.126 0.489 . . . . 10.0 110.088 -178.338 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.012 0.434 . . . . 10.0 110.328 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.57 84.12 23.63 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.96 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.27 133.66 23.28 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.273 1.982 . . . . 10.0 111.331 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.23 120.98 25.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.729 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -87.61 159.63 18.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.269 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.28 155.18 17.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.614 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.06 -135.65 8.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.919 -0.657 . . . . 10.0 111.809 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.68 171.05 34.21 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.665 -0.778 . . . . 10.0 112.424 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -137.37 136.21 37.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.743 -0.466 . . . . 10.0 109.743 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -135.43 150.54 49.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.566 0.222 . . . . 10.0 110.62 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.96 173.2 22.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 10.0 111.962 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -113.44 -172.26 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.679 0.276 . . . . 10.0 110.811 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.74 0.305 . . . . 10.0 110.832 -179.837 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -84.93 -28.76 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 121.073 -0.251 . . . . 10.0 111.301 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.19 135.63 5.16 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.593 -0.813 . . . . 10.0 112.28 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -65.26 -48.1 74.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.615 0.245 . . . . 10.0 111.364 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.33 -34.91 79.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 140' ' ' LEU . 25.0 t -59.28 -46.99 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.546 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.16 95.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.044 -0.598 . . . . 10.0 112.19 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -64.52 -43.86 92.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 10.0 110.378 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.3 82.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.794 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.78 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.8 mt -56.34 -47.67 80.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -66.16 -49.22 68.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.62 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.16 -37.16 84.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.215 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.96 -34.29 89.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.927 -0.654 . . . . 10.0 112.916 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.78 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.8 mmt180 -76.27 -34.71 59.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.287 0.565 . . . . 10.0 109.689 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.438 ' HA ' HG22 ' A' ' 97' ' ' THR . 96.8 mt-30 -75.36 -14.38 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -98.55 21.69 10.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.438 -0.346 . . . . 10.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -7.08 59.7 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.817 0.302 . . . . 10.0 111.817 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 54.41 101.17 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.662 0 O-C-N 123.984 0.803 . . . . 10.0 112.228 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.4 -50.93 0.17 OUTLIER 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.218 -1.576 . . . . 10.0 113.18 0.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 92' ' ' GLN . 21.5 m -163.49 137.15 5.72 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.891 . . . . 10.0 110.169 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.99 132.21 37.29 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.88 -0.415 . . . . 10.0 109.88 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.494 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.2 p -75.55 163.46 27.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 10.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.21 -29.69 67.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.679 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.14 84.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.127 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.494 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 55.8 mm-40 -62.8 -49.33 75.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.475 -0.329 . . . . 10.0 111.004 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.623 ' O ' HG12 ' A' ' 107' ' ' ILE . 24.5 tp -62.03 -47.08 86.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.04 -46.19 91.69 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.076 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -64.82 -42.16 95.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.754 0.279 . . . . 10.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 15.5 pt-20 -69.65 -23.99 63.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 103' ' ' LEU . 27.6 pt -97.3 -7.04 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.769 -0.582 . . . . 10.0 111.127 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.54 16.34 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.745 -0.74 . . . . 10.0 112.664 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -130.04 -156.64 0.77 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.74 -0.467 . . . . 10.0 109.74 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -126.11 176.35 7.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.521 0.201 . . . . 10.0 110.818 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.43 95.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.785 0.326 . . . . 10.0 111.208 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 116' ' ' SER . . . -61.11 -30.45 70.37 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.922 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.7 m -68.54 -43.79 75.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.135 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 92.8 t -64.44 -46.17 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.372 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.13 73.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.442 0.639 . . . . 10.0 110.064 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -74.69 -31.89 62.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 10.0 110.667 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.41 -41.18 66.53 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.616 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.53 -18.35 64.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.165 0.507 . . . . 10.0 110.439 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 116' ' ' SER . 19.7 tpt180 -73.97 -19.31 60.7 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.18 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.23 26.56 25.58 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.054 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' THR . 5.3 t -175.23 102.6 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.957 0.884 . . . . 10.0 110.507 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.5 33.24 0.51 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.376 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 m 63.42 98.96 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.226 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 96.54 0.59 Allowed 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 123.348 2.698 . . . . 10.0 115.169 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.92 112.39 24.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.562 -2.384 . . . . 10.0 104.562 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.5 mm-40 -46.56 -38.98 10.23 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.549 1.314 . . . . 10.0 114.549 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.26 -33.09 65.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 111.683 0.253 . . . . 10.0 111.683 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.792 ' O ' ' HG3' ' A' ' 132' ' ' MET . 68.6 mt -70.09 -58.91 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.706 -0.398 . . . . 10.0 111.484 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -35.35 71.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.798 0.332 . . . . 10.0 111.558 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 22.7 m -63.31 -44.09 95.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 135' ' ' VAL . 25.2 mtmt -75.14 -34.58 61.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.011 0.375 . . . . 10.0 112.011 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.792 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 44.2 mtp -51.0 -61.34 2.29 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.325 0.584 . . . . 10.0 112.251 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.601 ' OE1' HG23 ' A' ' 138' ' ' VAL . 9.2 mm-40 -74.33 -26.57 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.684 . . . . 10.0 112.074 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 130' ' ' SER . 9.0 ttp85 -55.99 -37.48 69.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.061 0.458 . . . . 10.0 110.719 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 131' ' ' LYS . 29.8 t -63.92 -31.76 54.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.545 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.599 HD22 ' NH1' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -95.51 -2.11 49.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.306 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.5 t30 65.74 45.3 2.65 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.273 0.559 . . . . 10.0 110.136 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.601 HG23 ' OE1' ' A' ' 133' ' ' GLU . 15.4 m -134.85 155.75 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.648 ' HD2' ' O ' ' A' ' 149' ' ' ARG . 32.0 mttp -133.18 136.62 45.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.255 0.55 . . . . 10.0 110.715 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.456 ' HB3' HG23 ' A' ' 83' ' ' VAL . 3.1 mt -89.38 39.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.291 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -131.32 136.96 48.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.811 -0.356 . . . . 10.0 110.176 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.14 -161.18 24.28 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.867 -0.682 . . . . 10.0 112.24 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.71 -24.73 17.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 10.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -81.37 50.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.336 0.589 . . . . 10.0 110.286 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.509 HD13 HG22 ' A' ' 145' ' ' ILE . 9.7 mm -70.1 139.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.551 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 88.49 6.15 74.2 Favored Glycine 0 CA--C 1.509 -0.33 0 C-N-CA 120.761 -0.733 . . . . 10.0 111.762 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.31 156.76 78.69 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.274 -0.269 . . . . 10.0 110.274 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.75 124.83 16.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.186 1.924 . . . . 10.0 110.171 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.648 ' O ' ' HD2' ' A' ' 139' ' ' LYS . 4.7 ttt180 . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 111.793 -0.523 . . . . 10.0 111.793 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.2 160.22 42.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.631 0.253 . . . . 10.0 110.659 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.7 tpt -148.61 128.78 13.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.155 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -129.05 87.59 53.95 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.326 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.44 165.77 31.42 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.697 2.265 . . . . 10.0 111.844 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -88.88 -179.84 6.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.073 0.464 . . . . 10.0 110.927 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -125.09 147.23 49.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.32 165.66 27.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 10.0 111.16 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.63 148.65 20.06 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.514 -0.635 . . . . 10.0 111.514 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.82 162.16 30.67 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.541 -0.838 . . . . 10.0 112.002 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -144.31 94.23 2.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 10.0 110.347 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -112.81 148.54 34.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.633 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.85 -137.26 2.24 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.699 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 61.51 85.62 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.279 0.561 . . . . 10.0 111.268 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.74 140.24 41.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.245 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -127.2 135.99 51.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.469 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.17 148.46 25.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.05 -0.352 . . . . 10.0 110.05 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -132.34 148.04 52.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.851 0.358 . . . . 10.0 110.847 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.3 t -102.71 143.69 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.075 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.92 157.25 28.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.924 0.392 . . . . 10.0 110.403 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -125.61 93.14 3.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.946 0.403 . . . . 10.0 110.454 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 m -122.62 97.88 5.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.588 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -147.07 74.11 1.33 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.251 0.548 . . . . 10.0 109.707 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -132.33 55.22 1.89 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.641 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.0 mt -88.88 90.39 3.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.902 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 mm -87.63 95.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.035 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -126.45 111.49 23.26 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.011 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.42 85.39 1.79 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.743 2.295 . . . . 10.0 111.856 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -140.91 137.74 33.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.955 -0.566 . . . . 10.0 109.837 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.4 p -56.69 165.88 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 10.0 111.073 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.46 HG23 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -59.35 -42.16 86.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.693 0.257 . . . . 10.0 111.693 -178.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 120.74 148.84 8.1 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.441 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -67.4 -55.05 15.3 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.599 0.199 . . . . 10.0 111.52 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.17 -36.22 81.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.314 -0.625 . . . . 10.0 109.314 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 87' ' ' ILE . 43.2 t -58.57 -50.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.189 -0.914 . . . . 10.0 110.553 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.02 -42.37 99.73 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.712 -0.756 . . . . 10.0 112.235 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.88 -43.36 93.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 10.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.7 68.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.861 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.0 mt -60.32 -46.32 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.394 . . . . 10.0 110.26 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.93 -52.12 18.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.235 0.54 . . . . 10.0 110.196 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.556 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 11.9 mt-30 -60.69 -34.09 73.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.131 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.5 -28.19 57.99 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.582 -0.818 . . . . 10.0 112.459 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.6 HH12 ' HG3' ' A' ' 133' ' ' GLU . 2.5 mpt_? -80.36 -27.28 38.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.481 0.657 . . . . 10.0 109.807 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.405 ' HA ' HG21 ' A' ' 97' ' ' THR . 99.1 mt-30 -76.53 -9.32 58.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.239 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 10.0 mmtp -85.73 9.06 17.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.413 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.44 -162.58 0.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.556 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 77.9 mm-40 -122.48 104.64 36.93 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.946 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.2 Cg_endo -87.99 -26.71 5.55 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.941 -1.275 . . . . 10.0 112.523 -0.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.405 HG21 ' HA ' ' A' ' 92' ' ' GLN . 11.4 m -165.22 122.37 1.51 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.706 -1.588 . . . . 10.0 109.762 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.9 tpp -82.76 112.86 19.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.794 -0.447 . . . . 10.0 109.794 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 t -80.82 177.16 9.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.683 0.754 . . . . 10.0 111.971 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -64.72 -48.84 73.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.241 -1.345 . . . . 10.0 111.352 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.61 96.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.512 -0.313 . . . . 10.0 111.808 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.78 -50.01 66.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 10.0 111.838 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 107' ' ' ILE . 14.3 tp -62.43 -42.02 99.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.62 98.58 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.067 -0.813 . . . . 10.0 111.067 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.412 0.149 . . . . 10.0 111.297 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.442 ' OE1' HG21 ' A' ' 135' ' ' VAL . 12.0 pt-20 -67.58 -34.13 76.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 103' ' ' LEU . 36.7 pt -85.05 -8.32 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.536 -0.465 . . . . 10.0 111.807 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.18 31.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 10.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -123.71 -177.64 3.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.883 0.373 . . . . 10.0 110.662 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.4 170.51 9.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.889 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.8 97.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 10.0 110.783 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.68 72.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.782 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -61.07 -49.91 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.111 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.46 -44.01 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.295 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.28 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.698 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 16.6 m -75.33 -29.42 59.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.829 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.02 -42.62 72.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.702 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.11 -17.79 64.76 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.765 0.316 . . . . 10.0 111.057 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 116' ' ' SER . 13.2 ttp85 -69.75 -21.74 63.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.401 0.619 . . . . 10.0 109.855 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.46 ' C ' HG23 ' A' ' 79' ' ' VAL . . . 97.41 20.53 22.35 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.922 -0.656 . . . . 10.0 111.537 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 121' ' ' THR . 7.5 t -175.14 110.17 0.12 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.939 0.876 . . . . 10.0 110.468 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.19 23.13 0.42 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.083 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m 61.19 91.72 0.07 OUTLIER Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.411 ' HB3' HG11 ' A' ' 79' ' ' VAL . 74.5 Cg_endo -72.4 104.25 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.688 2.259 . . . . 10.0 115.623 -175.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 117.84 25.76 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.056 -2.572 . . . . 10.0 104.056 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.408 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 17.1 mm-40 -46.63 -38.67 10.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -64.75 -33.29 75.62 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.813 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.75 ' O ' ' HG3' ' A' ' 132' ' ' MET . 91.7 mt -69.88 -58.73 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.29 -0.256 . . . . 10.0 110.54 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.17 -36.99 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.318 0.58 . . . . 10.0 110.955 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.0 m -54.06 -49.94 67.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.252 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 135' ' ' VAL . 1.5 mppt? -75.9 -38.5 57.74 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.146 0.424 . . . . 10.0 112.146 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.75 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 38.9 mtp -50.04 -58.27 5.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.315 0.579 . . . . 10.0 111.491 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.716 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mp0 -78.65 -29.92 46.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 115.165 1.543 . . . . 10.0 115.165 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -68.77 -34.52 75.71 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.43 0.53 . . . . 10.0 112.43 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 131' ' ' LYS . 87.1 t -60.89 -25.39 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.654 0.264 . . . . 10.0 111.117 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -115.13 2.54 14.16 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.13 60.74 2.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.716 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 1.9 m -143.06 155.94 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 30.3 mmmt -129.98 144.57 51.4 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.871 -0.418 . . . . 10.0 109.871 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.435 ' CD1' HG13 ' A' ' 83' ' ' VAL . 10.3 mt -106.49 40.06 1.7 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.462 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -141.03 135.95 31.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.759 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.88 -149.34 16.68 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.016 -0.612 . . . . 10.0 112.384 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.58 -32.21 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 10.0 110.789 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -87.42 57.89 4.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.67 . . . . 10.0 109.986 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.455 HD13 HG23 ' A' ' 145' ' ' ILE . 25.2 mm -65.1 132.68 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.018 -0.992 . . . . 10.0 111.573 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.409 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 88.18 -1.82 84.86 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.691 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -116.31 160.32 36.34 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.555 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.17 115.05 3.09 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.268 1.312 . . . . 10.0 109.231 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? -137.5 93.91 2.86 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 29.5 mt 63.57 24.57 14.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.837 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.93 -84.02 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.417 -0.81 . . . . 10.0 111.673 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.38 -36.44 66.78 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.099 1.866 . . . . 10.0 110.403 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -136.92 121.21 18.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.293 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 150' ' ' LEU . 19.9 pttp -88.51 50.45 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.486 0.66 . . . . 10.0 110.852 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.489 -0.778 . . . . 10.0 109.818 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.002 -0.439 . . . . 10.0 112.002 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.58 164.66 34.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.353 -0.24 . . . . 10.0 110.353 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -148.58 162.26 40.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.57 146.64 62.31 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.679 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.16 163.99 33.92 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.734 2.289 . . . . 10.0 112.08 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 174.01 6.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.824 0.345 . . . . 10.0 111.112 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -153.53 111.55 3.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.856 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.67 155.77 47.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.943 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.91 138.38 10.11 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.082 -0.58 . . . . 10.0 112.164 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.95 126.53 2.8 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 10.0 112.153 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -157.18 131.78 8.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.927 0.394 . . . . 10.0 110.28 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -144.16 143.41 31.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.046 -0.524 . . . . 10.0 109.639 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.32 -159.3 9.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.724 -0.75 . . . . 10.0 111.726 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.39 169.1 17.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.615 0.245 . . . . 10.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -117.93 120.69 38.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 10.0 109.982 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.9 mt -83.73 84.29 7.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.815 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -76.58 76.45 3.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.44 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -106.97 118.95 38.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.142 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.48 119.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.362 0.601 . . . . 10.0 110.506 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -140.42 102.35 4.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.388 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 11.5 ptm180 -161.03 152.86 19.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.4 -0.818 . . . . 10.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.33 -3.43 22.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.206 0.527 . . . . 10.0 110.115 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 69' ' ' ARG . 13.8 p-10 -101.96 35.7 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.782 -0.645 . . . . 10.0 110.452 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -84.06 52.28 2.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.256 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.4 mt -73.84 -44.96 50.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.289 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.2 pt -96.78 15.13 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.458 0.647 . . . . 10.0 110.814 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -126.28 97.34 34.62 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.575 -0.739 . . . . 10.0 110.458 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.38 80.42 3.04 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.54 2.16 . . . . 10.0 111.992 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -114.44 21.94 14.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.921 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 p -116.77 147.32 42.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.268 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.484 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 2.3 m -83.1 -33.18 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.4 145.84 8.7 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.321 -0.942 . . . . 10.0 112.302 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -71.59 -28.82 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.892 0.33 . . . . 10.0 111.892 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -38.88 72.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.44 -44.7 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.461 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.04 98.03 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.944 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -62.95 -43.95 97.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.331 . . . . 10.0 110.753 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.441 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . . . -70.48 -37.95 74.31 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.649 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.769 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.7 mt -55.35 -48.48 76.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.655 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.08 -42.45 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.046 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.441 ' NE2' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -66.35 -30.7 71.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 10.0 109.926 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.663 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -71.06 -39.98 62.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.844 -0.693 . . . . 10.0 113.0 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.769 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 12.8 mmt85 -66.08 -38.32 87.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.141 0.496 . . . . 10.0 110.606 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -83.7 -0.93 52.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -80.1 -11.7 59.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.259 0.552 . . . . 10.0 110.367 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -171.97 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.803 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -131.55 110.87 14.94 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.658 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.77 -32.84 3.79 Favored 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.325 -1.531 . . . . 10.0 112.543 -0.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.6 m -163.95 131.19 3.32 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.413 -1.267 . . . . 10.0 110.204 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 26.1 tpp -82.48 136.31 34.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.707 -0.224 . . . . 10.0 110.422 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.0 p -83.56 156.33 22.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.887 0.375 . . . . 10.0 110.941 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.7 -33.94 73.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.83 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.11 73.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.313 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.89 -33.77 76.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.701 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -37.61 75.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.628 ' CA ' HG23 ' A' ' 114' ' ' VAL . . . -68.49 -46.84 60.67 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.498 -0.774 . . . . 10.0 112.605 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -58.67 -39.86 81.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.862 0.363 . . . . 10.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -64.03 -29.19 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 10.0 112.512 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.5 pt -106.76 3.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.0 32.96 69.65 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 121.296 -0.478 . . . . 10.0 113.402 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -120.18 163.09 18.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.849 0.357 . . . . 10.0 110.815 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.526 ' O ' HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -78.88 150.3 32.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.757 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.4 -44.15 68.46 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.36 93.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.741 -0.209 . . . . 10.0 110.579 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.9 m -59.18 -44.23 92.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.678 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.628 HG23 ' CA ' ' A' ' 104' ' ' GLY . 46.7 t -63.79 -43.21 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.121 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.62 -29.47 63.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 10.0 110.312 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 63.0 m -76.55 -25.8 54.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.749 . . . . 10.0 111.311 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.5 -37.76 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.998 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.61 -17.74 64.99 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.695 0.283 . . . . 10.0 111.693 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.579 ' HB3' ' O ' ' A' ' 116' ' ' SER . 37.3 ttm180 -67.8 -20.52 65.2 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.391 0.615 . . . . 10.0 110.462 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.484 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 93.88 23.66 22.38 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.339 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.553 HG21 ' O ' ' A' ' 121' ' ' THR . 7.3 t -170.25 107.61 0.34 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.282 1.039 . . . . 10.0 110.447 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.94 28.91 0.08 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.496 -1.229 . . . . 10.0 109.339 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m 64.63 103.04 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.416 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.484 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 84.1 Cg_endo -75.91 92.9 1.02 Allowed 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 123.058 2.505 . . . . 10.0 116.054 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.656 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.7 t70 -87.92 111.92 21.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 105.319 -2.104 . . . . 10.0 105.319 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -49.08 -38.22 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.132 0.895 . . . . 10.0 112.573 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.408 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 60.9 t30 -71.51 -45.31 62.76 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.113 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 59.2 mt -60.53 -50.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.481 -0.192 . . . . 10.0 110.481 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 11.7 mt -52.75 -45.27 66.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.562 0.696 . . . . 10.0 109.66 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.578 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 74.4 m -62.63 -43.03 99.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.018 -0.992 . . . . 10.0 110.992 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 127' ' ' ASN . 0.6 OUTLIER -71.36 -42.95 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -178.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.544 ' SD ' ' HA ' ' A' ' 129' ' ' LEU . 3.7 ptm -61.59 -49.76 75.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.778 0.323 . . . . 10.0 111.867 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.594 ' O ' HD21 ' A' ' 136' ' ' LEU . 27.9 mm-40 -73.77 -25.78 60.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.938 0.399 . . . . 10.0 111.464 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -56.35 -23.39 37.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 10.0 111.289 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 t -71.92 -33.67 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.996 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -113.97 7.71 16.94 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.517 -0.473 . . . . 10.0 112.241 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.417 ' ND2' ' HB3' ' A' ' 148' ' ' PRO . 56.4 t30 67.31 59.06 0.52 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.644 0.735 . . . . 10.0 111.068 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.0 t -129.53 144.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.849 -1.068 . . . . 10.0 109.292 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -119.16 132.09 55.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.244 0.545 . . . . 10.0 110.574 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.44 21.54 9.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 10.0 111.034 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -143.89 158.3 43.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.784 0.325 . . . . 10.0 110.918 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.38 -163.48 20.92 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 121.095 -0.574 . . . . 10.0 112.022 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.95 -31.82 14.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.02 0.438 . . . . 10.0 110.627 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.22 56.64 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.073 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 146' ' ' GLY . 25.8 mt -62.03 137.75 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.862 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 89.49 -8.51 79.69 Favored Glycine 0 CA--C 1.509 -0.328 0 C-N-CA 121.15 -0.548 . . . . 10.0 111.775 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.96 156.27 39.38 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.113 -0.544 . . . . 10.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 17.9 Cg_endo -63.12 124.1 13.35 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.276 1.984 . . . . 10.0 110.018 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -149.69 -159.59 1.05 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 10.0 110.349 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.491 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 31.1 mt -129.31 151.16 50.26 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.376 -0.602 . . . . 10.0 109.376 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -112.52 89.24 0.52 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.62 -0.8 . . . . 10.0 111.717 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 150' ' ' LEU . 1.6 Cg_endo -84.39 97.34 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.028 2.486 . . . . 10.0 111.376 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -141.49 102.02 4.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.308 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -74.26 119.05 17.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.044 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.9 mttp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.278 -0.868 . . . . 10.0 110.495 -179.373 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.963 -0.455 . . . . 10.0 111.963 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.87 110.4 5.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.13 -0.322 . . . . 10.0 110.13 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -120.29 150.31 40.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.792 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -132.13 95.87 20.85 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.185 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.25 112.39 2.97 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.434 2.09 . . . . 10.0 112.088 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.66 95.57 6.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.048 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.11 155.84 42.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.395 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.05 128.64 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.814 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.91 162.12 12.49 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.104 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.84 74.65 0.22 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.975 -0.631 . . . . 10.0 112.403 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -119.88 103.43 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.788 -0.242 . . . . 10.0 110.728 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -90.3 158.2 17.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.57 124.44 2.85 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.065 -0.588 . . . . 10.0 112.22 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -158.25 150.96 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.651 0.226 . . . . 10.0 110.477 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -130.73 137.99 49.77 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.2 mt -84.96 149.39 25.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.538 -0.301 . . . . 10.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m 57.91 41.62 24.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.736 0.779 . . . . 10.0 110.204 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -95.65 2.54 54.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.206 -0.907 . . . . 10.0 110.987 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.0 131.76 32.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.885 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -162.45 135.61 5.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.018 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -178.29 130.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.96 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -132.65 21.11 4.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.84 0.352 . . . . 10.0 111.247 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -138.99 116.17 11.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.462 0.649 . . . . 10.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.91 -19.87 13.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.535 -0.757 . . . . 10.0 109.973 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.3 mt -114.82 138.59 44.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.652 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.1 mt -75.24 106.58 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.946 0.403 . . . . 10.0 110.675 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -124.0 89.59 51.52 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.395 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.74 126.4 18.13 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.892 2.395 . . . . 10.0 111.872 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -138.55 -177.31 4.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.092 0.472 . . . . 10.0 109.81 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -107.68 -179.76 4.0 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.374 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.426 HG13 ' CG2' ' A' ' 83' ' ' VAL . 2.2 t -85.12 -71.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.815 -0.354 . . . . 10.0 110.511 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.78 157.08 7.58 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -74.89 -53.77 8.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.401 0.601 . . . . 10.0 112.144 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.81 -38.42 88.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.668 -0.242 . . . . 10.0 111.508 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 87' ' ' ILE . 33.2 m -67.13 -35.91 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 120.74 -0.384 . . . . 10.0 110.391 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.81 -41.68 98.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.004 -0.617 . . . . 10.0 111.692 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -41.5 98.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.895 0.379 . . . . 10.0 110.136 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.69 -30.99 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.695 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.452 HG21 HH21 ' A' ' 91' ' ' ARG . 7.2 mt -62.84 -42.39 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 10.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -70.45 -50.33 39.39 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.93 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.64 -40.9 96.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.826 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.55 -30.38 74.9 Favored Glycine 0 C--N 1.328 0.12 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.833 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.479 HH22 ' HB3' ' A' ' 132' ' ' MET . 0.0 OUTLIER -80.35 -42.05 23.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.846 0.355 . . . . 10.0 110.67 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.14 -21.15 63.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.236 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -87.73 19.12 3.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.455 0.539 . . . . 10.0 112.455 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.23 -0.12 56.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 53.14 100.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 123.917 0.761 . . . . 10.0 112.831 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.44 -41.85 0.83 Allowed 'Cis proline' 0 CA--C 1.517 -0.349 0 C-N-CA 123.292 -1.545 . . . . 10.0 112.524 -0.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -168.41 128.69 1.25 Allowed 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.88 -1.054 . . . . 10.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.408 ' HE2' ' HB2' ' A' ' 98' ' ' MET . 19.3 ttm -58.65 137.53 57.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.834 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.7 144.08 39.59 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.631 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -70.09 -41.03 74.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.162 0.506 . . . . 10.0 110.465 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.37 90.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.941 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.8 -43.61 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.698 -0.228 . . . . 10.0 110.978 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 107' ' ' ILE . 56.6 tp -64.49 -39.47 93.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.41 96.06 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.865 -0.894 . . . . 10.0 110.865 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -39.64 91.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.809 0.338 . . . . 10.0 110.213 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.91 -41.54 98.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.161 -0.472 . . . . 10.0 112.049 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 103' ' ' LEU . 29.3 pt -93.24 -7.83 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.615 0.598 . . . . 10.0 112.615 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.77 34.12 22.74 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.549 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -125.99 176.67 6.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.93 0.395 . . . . 10.0 110.576 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.35 161.16 15.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.19 94.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 10.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.79 76.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.464 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.3 m -63.39 -46.34 86.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.157 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.411 ' CG1' HD22 ' A' ' 103' ' ' LEU . 90.0 t -62.28 -43.08 97.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.194 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -66.47 -35.23 79.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.728 -0.669 . . . . 10.0 111.598 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 25.8 p -77.76 -26.27 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.77 0.319 . . . . 10.0 111.496 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.473 ' OH ' ' HA ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -55.07 -40.48 70.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 8.2 pt-20 -63.11 -20.48 65.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.489 ' HB3' ' O ' ' A' ' 116' ' ' SER . 72.9 ttt180 -71.54 -20.34 62.04 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.611 0.719 . . . . 10.0 109.828 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.86 15.91 43.86 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.422 -0.808 . . . . 10.0 112.352 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.9 t -164.15 108.56 0.98 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.285 1.04 . . . . 10.0 109.827 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.09 19.06 0.5 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.724 -1.125 . . . . 10.0 110.999 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m 58.51 83.71 0.21 Allowed Pre-proline 0 C--O 1.235 0.294 0 CA-C-O 121.622 0.725 . . . . 10.0 110.031 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.473 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 27.6 Cg_endo -96.13 178.44 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.409 2.739 . . . . 10.0 114.868 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.601 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.2 t70 -139.94 150.68 44.83 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -58.32 -37.51 75.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 10.0 110.707 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.632 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 9.9 t30 -63.72 -41.66 98.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.466 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.475 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.9 mt -63.75 -55.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 110.362 -0.236 . . . . 10.0 110.362 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.1 mt -48.84 -45.88 41.32 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.312 0.577 . . . . 10.0 110.348 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.9 m -55.01 -47.0 75.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.953 -1.021 . . . . 10.0 111.604 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 49.7 mmtt -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.74 0.305 . . . . 10.0 111.014 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.479 ' HB3' HH22 ' A' ' 91' ' ' ARG . 3.5 mtp -51.28 -56.41 13.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.762 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 16.0 mt-10 -72.45 -29.56 63.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.144 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -62.07 -43.96 97.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.099 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 131' ' ' LYS . 48.3 t -62.32 -25.54 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.322 -0.399 . . . . 10.0 112.006 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.425 HD22 HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -107.14 -3.61 19.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 10.0 112.904 -177.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.1 t30 56.57 55.32 6.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.524 0.678 . . . . 10.0 109.706 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.478 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 35.5 m -140.99 164.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.736 -1.12 . . . . 10.0 108.754 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -124.19 129.0 50.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.151 0.501 . . . . 10.0 110.261 178.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.66 13.01 21.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.751 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -128.31 139.4 52.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.36 -159.03 16.39 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.095 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.66 -33.29 13.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.926 0.393 . . . . 10.0 110.606 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -86.57 53.14 2.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.095 0.474 . . . . 10.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 61.1 mt -75.03 137.55 22.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 93.13 -1.27 70.0 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.124 -0.79 . . . . 10.0 111.124 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.09 155.41 80.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.035 -0.583 . . . . 10.0 109.857 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.38 120.05 7.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.617 1.545 . . . . 10.0 110.177 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -137.11 65.96 1.48 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.228 0.537 . . . . 10.0 109.606 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.3 mt -90.23 87.46 6.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.535 -0.757 . . . . 10.0 110.588 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -118.61 150.9 17.95 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.42 -0.809 . . . . 10.0 111.622 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.36 -5.44 17.13 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.698 2.265 . . . . 10.0 112.861 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -78.15 115.51 17.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.039 0.447 . . . . 10.0 111.014 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -133.02 -169.46 2.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.675 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.879 -0.582 . . . . 10.0 110.203 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.431 ' HA3' ' OD2' ' A' ' 52' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 112.08 -0.408 . . . . 10.0 112.08 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.79 74.46 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.105 0.409 . . . . 10.0 112.105 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.9 ttm -147.06 102.53 3.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.971 0.415 . . . . 10.0 111.442 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' OD2' ' HA3' ' A' ' 49' ' ' GLY . 0.3 OUTLIER -148.28 85.94 6.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.102 179.332 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.93 177.83 8.39 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.689 2.259 . . . . 10.0 112.219 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.55 131.56 36.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.928 0.394 . . . . 10.0 110.833 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -152.94 126.33 8.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.808 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.79 150.96 38.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.707 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.31 171.08 13.57 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.55 145.65 13.23 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.385 -0.912 . . . . 10.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -142.15 127.16 18.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.767 -0.456 . . . . 10.0 109.767 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.23 148.78 42.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 10.0 111.504 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.78 132.46 2.52 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.16 -0.776 . . . . 10.0 111.16 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -156.94 156.85 33.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.247 0.523 . . . . 10.0 111.743 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -113.26 141.37 47.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.693 . . . . 10.0 109.154 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.446 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -145.56 167.88 21.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.068 0.461 . . . . 10.0 111.814 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.3 m -153.65 137.92 16.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.076 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.1 159.23 19.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.301 . . . . 10.0 110.354 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 p -158.28 117.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.134 -0.485 . . . . 10.0 110.239 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -69.62 151.57 45.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.473 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HB3' ' H ' ' A' ' 70' ' ' SER . 78.9 mtt180 -147.45 -159.19 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.468 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 0.7 OUTLIER -80.86 178.27 8.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.873 0.368 . . . . 10.0 110.848 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -103.56 8.94 37.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.025 0.44 . . . . 10.0 111.192 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -86.91 53.58 2.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.433 0.635 . . . . 10.0 110.375 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pt -134.62 160.87 41.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.732 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.437 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 43.3 pt -80.93 174.7 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.264 -0.426 . . . . 10.0 110.466 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.57 87.57 17.66 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.296 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 16.4 Cg_endo -90.93 -143.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.713 2.942 . . . . 10.0 111.71 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 28.3 mmmt -88.69 33.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.018 0.437 . . . . 10.0 110.766 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 19.2 p -110.76 158.78 18.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.551 HG23 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -91.57 -30.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.386 . . . . 10.0 111.751 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.65 141.95 5.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.542 -0.837 . . . . 10.0 112.333 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -66.58 -52.35 46.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 10.0 111.123 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -32.91 74.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.376 0.608 . . . . 10.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.87 -50.39 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 114.88 -1.055 . . . . 10.0 110.269 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.39 98.89 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -60.14 -51.14 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 10.0 110.493 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.15 -30.77 71.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.999 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.827 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.6 mt -57.88 -47.33 86.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -70.9 -47.05 61.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.941 0.4 . . . . 10.0 110.4 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -62.18 -34.14 75.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.428 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.64 -30.29 68.76 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.21 -0.995 . . . . 10.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.827 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.6 mmt180 -81.47 -33.81 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 10.0 111.373 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -77.33 -16.56 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.097 0.475 . . . . 10.0 110.536 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -80.44 12.61 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -19.86 23.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 10.0 111.561 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 59.89 110.1 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.904 -1.044 . . . . 10.0 111.777 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.05 -59.11 0.13 OUTLIER 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.279 -1.551 . . . . 10.0 113.026 -0.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.2 m -163.97 135.8 4.79 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.492 -0.776 . . . . 10.0 110.903 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 36.4 tpp -74.57 136.85 42.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.56 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 64.7 p -84.03 160.41 20.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.359 -0.537 . . . . 10.0 111.251 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.56 -26.94 64.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.668 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.02 -57.98 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.408 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.56 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 13.7 pt-20 -62.52 -36.85 83.88 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.914 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.598 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 2.4 tt -61.91 -42.48 99.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.682 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.76 -39.74 90.0 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.463 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -62.3 -39.53 93.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.705 0.288 . . . . 10.0 111.574 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 17.3 pt-20 -73.62 -16.59 61.23 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 103' ' ' LEU . 40.6 pt -113.43 0.08 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.623 -0.431 . . . . 10.0 111.738 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.42 37.61 53.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.593 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -133.19 -168.92 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 10.0 110.52 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -111.95 177.25 4.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.738 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.12 79.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 10.0 110.656 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.89 -47.07 87.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.657 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.9 m -55.74 -45.3 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.55 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.82 -50.54 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -64.92 -32.12 73.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.331 0.586 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.0 m -73.6 -28.19 61.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -75.34 -35.62 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 12.5 pt-20 -67.42 -17.8 64.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 10.0 110.799 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.496 ' HG2' ' CG2' ' A' ' 121' ' ' THR . 0.0 OUTLIER -74.61 -20.93 59.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.21 0.529 . . . . 10.0 109.79 178.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.551 ' C ' HG23 ' A' ' 79' ' ' VAL . . . 93.52 21.49 29.05 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.43 -0.891 . . . . 10.0 112.053 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.537 ' O ' HG22 ' A' ' 121' ' ' THR . 9.9 t -170.07 104.22 0.3 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.437 1.113 . . . . 10.0 110.113 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.33 27.7 0.51 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.747 -1.115 . . . . 10.0 109.212 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 m 61.61 96.98 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.8 -1.091 . . . . 10.0 108.594 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.429 ' HG3' ' O ' ' A' ' 78' ' ' THR . 70.8 Cg_endo -68.18 99.84 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.655 2.236 . . . . 10.0 115.256 -175.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.563 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -85.72 116.12 23.8 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.92 -2.252 . . . . 10.0 104.92 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -48.91 -40.17 28.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.142 -0.481 . . . . 10.0 112.147 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.2 t30 -66.93 -44.06 81.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.675 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.668 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.8 mt -58.62 -55.17 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 119.585 -0.245 . . . . 10.0 110.651 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.0 mt -50.24 -42.24 51.47 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.571 0.7 . . . . 10.0 110.235 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 66.7 m -59.86 -45.72 91.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.983 -1.008 . . . . 10.0 111.497 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 29.2 mmtt -73.75 -40.86 63.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 10.0 111.234 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.668 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -50.65 -59.46 4.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.207 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.737 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 5.8 mt-10 -74.12 -26.84 60.57 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.045 -0.98 . . . . 10.0 112.997 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -54.63 -27.25 38.22 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.91 -25.64 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.81 0.338 . . . . 10.0 111.796 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.0 -16.32 18.76 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 67.84 25.99 7.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.262 0.553 . . . . 10.0 110.527 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.737 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 26.8 m -121.94 142.9 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 23.9 mmmt -119.19 142.97 47.51 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.49 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 8.9 mt -102.71 39.44 1.53 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.658 0.742 . . . . 10.0 109.783 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -129.54 141.32 51.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.089 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.22 -162.19 43.93 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.233 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.34 3.24 55.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.885 0.374 . . . . 10.0 111.399 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -110.31 40.95 1.84 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 10.0 110.672 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 44.9 mt -67.17 136.71 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.727 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.485 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 91.9 0.3 71.91 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.937 -0.865 . . . . 10.0 110.937 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.56 158.45 75.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.546 . . . . 10.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.29 121.68 10.3 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.284 1.989 . . . . 10.0 109.914 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -146.64 100.84 3.39 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.3 tp -77.68 72.44 4.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.274 0.559 . . . . 10.0 110.712 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -126.63 72.96 0.45 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.454 -0.793 . . . . 10.0 111.338 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.66 152.68 29.55 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.772 2.315 . . . . 10.0 112.784 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -103.83 -31.99 9.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.684 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -143.78 145.62 32.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.189 -0.459 . . . . 10.0 110.363 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.1 tptp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.224 -0.894 . . . . 10.0 109.894 179.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.745 -0.542 . . . . 10.0 111.745 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.63 -49.26 9.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.555 0.177 . . . . 10.0 111.459 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.8 ptp 43.27 48.67 5.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.741 0.816 . . . . 10.0 111.456 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -121.96 88.44 47.73 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.438 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.81 145.9 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.348 2.699 . . . . 10.0 111.897 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -104.03 154.0 20.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.812 0.339 . . . . 10.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -144.68 132.27 21.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.24 166.55 23.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.016 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.61 -177.91 36.01 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.486 -0.864 . . . . 10.0 112.394 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 175.2 147.88 6.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.41 -0.676 . . . . 10.0 111.41 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 t -137.31 128.17 27.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.105 0.479 . . . . 10.0 110.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.81 -42.91 10.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.248 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.22 104.31 2.39 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.569 -0.612 . . . . 10.0 111.569 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -107.32 -16.49 14.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 10.0 111.387 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -156.93 145.45 19.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.503 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.9 tp -120.53 142.49 49.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.858 -0.423 . . . . 10.0 109.858 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -79.56 138.31 37.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.956 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -124.31 168.3 13.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.536 -0.542 . . . . 10.0 109.536 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -55.39 129.29 16.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.051 0.453 . . . . 10.0 111.476 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -163.08 150.67 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.645 -0.707 . . . . 10.0 109.617 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.67 143.45 38.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.571 0.224 . . . . 10.0 110.484 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.5 m -72.21 -77.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.61 -0.268 . . . . 10.0 110.469 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 t0 53.33 52.47 13.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.151 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -165.98 125.19 1.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.636 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.8 mm -77.92 -21.64 13.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.646 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.5 mt -84.46 115.78 27.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.269 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -89.89 117.36 68.04 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.18 0.514 . . . . 10.0 111.168 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 61.8 Cg_endo -86.53 -141.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.256 2.637 . . . . 10.0 110.49 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -78.6 72.22 5.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.512 . . . . 10.0 109.77 178.213 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.531 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 2.8 p -109.91 166.85 10.61 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.904 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -84.48 -34.65 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.651 -0.419 . . . . 10.0 111.157 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.04 136.98 4.33 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.013 -0.613 . . . . 10.0 111.596 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -63.45 -57.04 11.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -25.63 65.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 140' ' ' LEU . 46.0 t -63.36 -46.97 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.497 -1.229 . . . . 10.0 110.052 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.32 -38.42 95.83 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.353 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.585 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 40.1 ttmt -59.32 -49.25 78.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 10.0 109.786 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.85 -30.51 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.558 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.747 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.3 mt -59.85 -48.5 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 4.3 tt0 -67.06 -50.38 62.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.022 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 62.4 mm-40 -59.97 -36.41 77.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.23 85.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.967 -0.635 . . . . 10.0 113.281 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.747 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.9 mmt180 -79.22 -29.88 43.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.173 0.511 . . . . 10.0 109.64 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 82.0 mt-30 -78.66 -16.76 56.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.645 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 55.9 mtpt -85.79 22.13 1.72 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.955 0.407 . . . . 10.0 111.261 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.65 -8.88 36.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.883 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 53.4 104.05 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 114.902 -1.045 . . . . 10.0 112.618 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.64 -50.12 0.2 Allowed 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.486 -1.464 . . . . 10.0 113.367 0.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -168.93 132.62 1.4 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.403 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.7 tpp -73.58 134.89 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.291 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.17 145.38 51.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.902 0.382 . . . . 10.0 111.679 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.41 -37.49 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.022 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.07 -36.39 83.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.75 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.79 -39.19 57.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.094 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.547 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -61.19 -43.62 98.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.837 . . . . 10.0 108.739 178.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.74 -39.39 95.23 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.504 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -64.32 -38.27 90.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.651 0.262 . . . . 10.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.532 ' OE2' HD22 ' A' ' 103' ' ' LEU . 15.3 pt-20 -78.02 -13.9 59.7 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.119 0.785 . . . . 10.0 113.119 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 103' ' ' LEU . 41.2 pt -109.68 -7.45 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.623 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.83 30.89 19.62 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.815 -0.707 . . . . 10.0 112.807 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.94 -168.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.278 0.231 . . . . 10.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -109.91 177.25 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.528 -0.305 . . . . 10.0 110.254 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.73 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.616 -0.265 . . . . 10.0 111.351 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.29 81.34 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.039 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.45 -50.3 73.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.779 0.323 . . . . 10.0 110.723 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.12 -45.04 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.402 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.79 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 10.0 111.115 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.3 m -76.77 -27.46 55.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.943 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.871 0.693 . . . . 10.0 112.871 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -61.53 -18.66 60.13 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.195 0.442 . . . . 10.0 112.195 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 119' ' ' ARG . 0.8 OUTLIER -69.53 -22.93 63.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.197 0.522 . . . . 10.0 110.088 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.99 21.7 15.08 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.607 -0.806 . . . . 10.0 112.086 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.517 HG21 ' O ' ' A' ' 121' ' ' THR . 6.7 t -171.87 111.9 0.3 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.24 1.019 . . . . 10.0 110.396 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.57 34.58 0.27 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.561 -1.2 . . . . 10.0 109.277 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 m 55.77 85.16 0.2 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.266 -0.879 . . . . 10.0 108.839 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.531 ' HG3' ' O ' ' A' ' 78' ' ' THR . 72.8 Cg_endo -72.47 98.04 0.92 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.543 2.828 . . . . 10.0 115.544 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -82.18 128.04 33.76 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 104.638 -2.356 . . . . 10.0 104.638 174.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -54.17 -31.31 52.34 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.427 0.528 . . . . 10.0 112.427 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -72.12 -32.89 67.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.848 -0.614 . . . . 10.0 111.355 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.791 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.0 mt -71.3 -57.94 6.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.691 -0.403 . . . . 10.0 110.099 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -49.6 -43.31 46.33 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.489 0.662 . . . . 10.0 110.777 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.583 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 45.0 m -54.51 -48.95 71.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.033 -0.985 . . . . 10.0 111.828 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 135' ' ' VAL . 13.0 mttt -76.79 -37.68 55.36 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.833 0.309 . . . . 10.0 111.833 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.791 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 75.0 mtp -53.97 -58.56 6.85 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.182 0.515 . . . . 10.0 111.863 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.554 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.0 mp0 -72.52 -26.18 61.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.787 -0.642 . . . . 10.0 112.266 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.583 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.4 ttm-85 -59.3 -27.42 65.84 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.036 0.446 . . . . 10.0 110.034 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 131' ' ' LYS . 61.1 t -63.82 -41.34 92.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.689 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -94.98 -6.35 42.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 121.152 -0.219 . . . . 10.0 110.437 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 t30 64.36 49.65 2.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.494 0.664 . . . . 10.0 109.736 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 34.4 m -132.12 162.88 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.355 -0.839 . . . . 10.0 109.627 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 15.9 mmtt -131.96 140.89 49.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.342 -0.614 . . . . 10.0 109.342 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.452 ' HG ' ' HG2' ' A' ' 133' ' ' GLU . 12.2 mt -108.5 17.71 21.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.26 0.552 . . . . 10.0 110.873 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -124.25 139.63 53.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.63 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.9 -146.65 17.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.729 -0.748 . . . . 10.0 112.336 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.24 -34.99 8.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.985 0.421 . . . . 10.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -82.33 54.82 2.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.929 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 146' ' ' GLY . 52.6 mt -72.9 137.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.474 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.52 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 86.36 -0.48 87.12 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.978 -0.849 . . . . 10.0 110.978 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.71 156.87 70.38 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.476 . . . . 10.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.79 122.5 11.09 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 121.897 1.731 . . . . 10.0 110.382 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.74 68.68 1.38 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.375 0.607 . . . . 10.0 110.146 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.89 143.67 19.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.143 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.27 -78.4 0.92 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.81 -0.916 . . . . 10.0 110.81 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.86 144.44 38.74 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.572 2.182 . . . . 10.0 111.436 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -74.82 -16.86 60.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.969 0.414 . . . . 10.0 110.715 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -139.53 136.91 35.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.889 -0.596 . . . . 10.0 109.606 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.343 -0.836 . . . . 10.0 110.261 -179.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.849 -0.501 . . . . 10.0 111.849 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.45 64.87 1.47 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.082 0.468 . . . . 10.0 111.525 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -99.63 151.45 21.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.031 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -116.97 150.8 46.56 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.374 -0.375 . . . . 10.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.29 170.38 20.33 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.626 2.217 . . . . 10.0 112.379 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -123.78 152.5 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.247 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.14 151.37 49.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.394 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.05 138.05 15.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.78 -160.78 11.78 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.22 25.06 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.86 132.37 52.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.662 0.268 . . . . 10.0 110.846 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -140.14 167.6 21.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.897 -0.409 . . . . 10.0 109.897 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.25 117.92 0.8 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.455 -0.879 . . . . 10.0 112.742 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -102.8 173.43 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.19 -0.3 . . . . 10.0 110.19 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 -125.52 130.68 52.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 10.0 110.901 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.72 149.58 50.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.739 0.304 . . . . 10.0 111.069 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -167.17 151.78 7.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.069 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -158.29 159.19 35.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.542 -0.17 . . . . 10.0 110.542 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.0 162.3 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.594 -0.275 . . . . 10.0 110.863 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.63 140.23 45.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.894 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -154.19 158.96 41.11 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.351 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m -94.41 -173.77 3.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.119 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.51 119.29 19.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -97.31 7.6 46.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.738 -0.664 . . . . 10.0 112.634 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.15 106.64 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.977 0.417 . . . . 10.0 110.861 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.4 pt -91.01 160.49 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 10.0 111.529 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -140.55 98.8 7.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.641 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.71 41.09 1.07 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.729 2.286 . . . . 10.0 112.73 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -110.11 -154.77 0.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.025 -0.534 . . . . 10.0 109.602 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.481 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 5.0 p -100.07 -171.39 2.03 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.51 HG11 ' CG1' ' A' ' 83' ' ' VAL . 1.8 t -82.55 -60.15 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 10.0 110.537 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.07 137.23 4.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.33 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.7 -42.85 99.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.663 0.268 . . . . 10.0 111.269 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 -29.0 64.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.51 ' CG1' HG11 ' A' ' 79' ' ' VAL . 3.8 t -68.47 -49.28 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.338 -0.846 . . . . 10.0 109.864 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.39 97.19 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.999 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -64.03 -39.41 94.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 10.0 110.486 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.43 64.89 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.685 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.785 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.9 mt -59.89 -49.95 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.01 -53.23 58.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.956 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.39 -31.47 72.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.901 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.09 -30.73 69.6 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.731 -0.747 . . . . 10.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.785 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -81.6 -41.94 20.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 10.0 109.57 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -61.4 -36.89 81.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.535 -0.757 . . . . 10.0 111.31 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -81.75 51.21 1.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -3.54 16.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.69 0.281 . . . . 10.0 111.257 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 57.94 100.56 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.926 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.65 -45.1 0.46 Allowed 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.592 -1.42 . . . . 10.0 112.205 -0.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.2 m -161.71 133.56 5.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.541 -1.209 . . . . 10.0 110.004 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.3 127.95 32.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.23 53.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.43 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.94 85.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.692 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -71.07 -44.42 65.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.822 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.435 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -63.68 -40.19 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.42 -49.05 73.12 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.261 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -62.69 -34.68 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.4 -26.45 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.934 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 103' ' ' LEU . 25.6 pt -110.14 8.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.796 0.295 . . . . 10.0 111.796 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 20.34 71.77 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.252 -0.499 . . . . 10.0 113.097 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -118.56 -164.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.309 -0.256 . . . . 10.0 110.309 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.3 p -115.05 176.07 5.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.562 0.22 . . . . 10.0 110.589 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.04 89.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 10.0 109.998 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.9 76.12 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.563 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.3 m -62.06 -46.29 89.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 10.0 110.345 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 t -66.17 -43.47 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.071 -0.513 . . . . 10.0 109.91 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.66 -29.54 69.58 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.702 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 m -78.84 -33.77 45.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.898 0.38 . . . . 10.0 111.473 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -65.98 -33.79 76.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.81 -18.27 54.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.821 0.344 . . . . 10.0 111.8 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -71.57 -26.17 62.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.281 0.562 . . . . 10.0 110.51 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.82 12.56 55.37 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.612 -0.722 . . . . 10.0 112.482 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.587 ' O ' HG22 ' A' ' 121' ' ' THR . 8.8 t -153.39 98.68 2.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.715 1.245 . . . . 10.0 109.456 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.06 27.49 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.323 -1.308 . . . . 10.0 109.914 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m 59.37 95.5 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.199 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.481 ' HG3' ' C ' ' A' ' 78' ' ' THR . 74.4 Cg_endo -69.73 99.8 0.77 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.242 2.628 . . . . 10.0 114.646 -176.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.57 117.9 25.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.427 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 8.4 mm-40 -48.56 -39.62 24.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.471 0.915 . . . . 10.0 113.471 -174.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.555 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.4 t30 -70.55 -34.0 71.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.86 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.771 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.7 mt -68.96 -57.89 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.758 -0.377 . . . . 10.0 111.299 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -39.01 59.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.161 0.505 . . . . 10.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 m -55.02 -49.83 70.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.631 -0.713 . . . . 10.0 111.232 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.555 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 35.3 mmtt -75.77 -30.4 59.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.954 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.771 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.7 mtp -56.35 -59.59 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 4.0 mp0 -74.04 -26.49 60.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -53.92 -33.24 56.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.986 0.365 . . . . 10.0 111.986 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.69 -30.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.973 0.416 . . . . 10.0 111.245 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.451 HD11 ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -94.78 -10.73 30.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.565 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.2 t30 62.58 47.11 5.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 10.0 110.749 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.1 m -131.91 158.15 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -130.66 143.69 50.92 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.591 -0.443 . . . . 10.0 110.847 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.42 HD11 ' CG1' ' A' ' 83' ' ' VAL . 11.6 mt -103.53 40.2 1.46 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.728 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -128.26 139.88 52.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.534 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.08 -146.25 23.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.371 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.33 -21.68 14.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.89 0.376 . . . . 10.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -88.06 52.96 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 110.696 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 146' ' ' GLY . 54.5 mt -76.53 141.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.518 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.591 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 85.38 1.16 88.16 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.877 -0.678 . . . . 10.0 112.145 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.0 156.37 76.28 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 110.046 -0.353 . . . . 10.0 110.046 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.96 122.3 11.38 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.957 1.772 . . . . 10.0 109.294 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.89 76.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.483 . . . . 10.0 109.829 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 150' ' ' LEU . 6.2 mp -77.45 126.18 30.5 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.949 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.33 155.78 53.15 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.273 -0.965 . . . . 10.0 111.412 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.65 149.64 39.26 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.942 2.428 . . . . 10.0 112.434 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.58 171.71 10.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.21 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -56.61 -37.56 70.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.002 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.177 -0.916 . . . . 10.0 109.629 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 112.074 -0.41 . . . . 10.0 112.074 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.88 157.11 38.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.148 -0.316 . . . . 10.0 110.148 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -136.71 152.27 50.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.482 -0.327 . . . . 10.0 110.23 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.32 136.73 19.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.508 -0.314 . . . . 10.0 111.061 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.03 142.02 45.66 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.993 2.462 . . . . 10.0 112.104 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.12 143.66 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.911 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -136.2 132.13 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 10.0 109.652 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.55 155.56 37.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.832 0.348 . . . . 10.0 111.125 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.69 -155.07 29.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.121 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -162.72 11.79 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.542 -0.623 . . . . 10.0 111.542 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 m -154.52 108.09 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.082 0.441 . . . . 10.0 110.939 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.28 173.85 6.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.6 173.2 34.36 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.348 -0.93 . . . . 10.0 112.692 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -158.25 151.52 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -142.2 151.03 41.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.664 0.268 . . . . 10.0 110.477 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -126.11 133.22 51.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.44 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -107.59 114.05 27.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.03 0.443 . . . . 10.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -131.85 163.99 27.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.399 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.8 141.61 46.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.22 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -130.3 159.59 36.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 10.0 109.908 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -157.01 123.47 4.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.714 0.293 . . . . 10.0 110.433 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -156.79 103.44 2.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.012 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -104.33 96.5 6.67 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -172.47 132.48 0.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.884 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 mm -71.33 98.26 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.998 -0.547 . . . . 10.0 109.931 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 pt -108.76 -176.44 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.891 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -60.54 146.66 84.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 10.0 111.075 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.19 108.91 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.738 2.292 . . . . 10.0 111.474 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -119.78 -132.03 0.3 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.816 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.5 p -80.4 -176.4 5.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.629 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -76.41 -32.03 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.61 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.34 138.4 5.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.374 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -70.14 -42.65 72.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.987 0.422 . . . . 10.0 110.682 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -75.39 -25.35 57.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.655 0.74 . . . . 10.0 109.234 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 87' ' ' ILE . 37.2 t -69.28 -45.3 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 114.507 -1.224 . . . . 10.0 110.249 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.79 98.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.87 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -62.76 -40.3 96.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 10.0 110.434 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.81 66.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.064 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 83' ' ' VAL . 23.4 mt -59.93 -46.81 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.96 0.41 . . . . 10.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -71.46 -52.95 15.68 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.582 -0.447 . . . . 10.0 110.538 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.431 ' O ' ' HD3' ' A' ' 93' ' ' LYS . 46.8 mt-30 -60.61 -35.05 75.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.239 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.69 -31.9 52.28 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.636 -1.269 . . . . 10.0 112.365 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 1.3 mpt_? -81.72 -34.43 30.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.924 0.392 . . . . 10.0 111.383 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -75.19 -2.12 26.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.995 0.426 . . . . 10.0 110.451 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.431 ' HD3' ' O ' ' A' ' 89' ' ' GLN . 1.5 tptm -84.9 0.11 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.023 0.44 . . . . 10.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -171.98 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 10.0 111.185 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 52.6 mt-10 -126.46 112.1 23.2 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.54 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 65.8 Cg_endo -78.84 -31.19 5.17 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.358 -1.518 . . . . 10.0 112.558 -0.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.0 m -168.3 130.29 1.4 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.82 -1.536 . . . . 10.0 108.724 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 tpp -73.24 110.36 7.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.521 -0.472 . . . . 10.0 109.958 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -69.53 156.78 38.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.147 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.08 -35.22 76.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.582 -0.735 . . . . 10.0 109.911 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.059 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.68 -49.87 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.701 -0.227 . . . . 10.0 110.794 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.569 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.34 -46.66 85.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.48 0.488 . . . . 10.0 109.887 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.08 -47.18 92.29 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.119 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -64.26 -38.57 91.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.904 0.335 . . . . 10.0 111.904 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.416 ' OE1' HG21 ' A' ' 135' ' ' VAL . 13.5 pt-20 -73.3 -15.18 61.41 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 103' ' ' LEU . 43.4 pt -107.05 3.69 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 10.0 111.006 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.86 25.72 55.31 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.079 -0.582 . . . . 10.0 113.034 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -125.24 -157.47 0.78 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.668 0.271 . . . . 10.0 110.356 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 p -124.92 176.68 6.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.48 91.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.617 0.246 . . . . 10.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.88 76.35 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.76 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 m -60.68 -47.18 87.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.15 -45.16 97.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.246 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.07 -32.35 73.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.806 0.812 . . . . 10.0 109.834 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.633 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 11.6 m -74.66 -24.89 58.88 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.201 -0.909 . . . . 10.0 111.275 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -77.61 -34.36 53.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -66.09 -20.36 66.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.9 ptm180 -70.88 -23.05 62.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.665 0.745 . . . . 10.0 110.738 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.401 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.51 28.43 7.54 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.012 -0.995 . . . . 10.0 112.063 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 121' ' ' THR . 8.8 t -173.8 107.69 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.167 0.984 . . . . 10.0 110.201 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.04 25.95 0.26 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.843 -1.071 . . . . 10.0 109.616 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 m 62.33 99.99 0.04 OUTLIER Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.806 -0.813 . . . . 10.0 108.806 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.76 99.29 0.95 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.855 2.37 . . . . 10.0 114.042 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.635 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 4.5 t0 -87.5 120.41 28.78 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.443 -2.058 . . . . 10.0 105.443 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.423 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.6 mm-40 -52.07 -42.33 63.1 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.22 -30.88 70.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.697 ' O ' ' HG3' ' A' ' 132' ' ' MET . 73.2 mt -72.07 -56.2 10.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.0 mt -48.85 -42.78 37.53 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.615 0.572 . . . . 10.0 110.361 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 74.4 m -57.02 -47.3 81.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.152 -0.931 . . . . 10.0 111.765 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.408 ' HB3' HG22 ' A' ' 107' ' ' ILE . 2.6 mppt? -74.66 -38.01 62.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.697 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 32.9 mtp -50.42 -55.83 14.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.832 0.825 . . . . 10.0 111.161 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.628 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 53.8 mt-10 -73.24 -27.24 61.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.801 -1.09 . . . . 10.0 113.315 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -68.74 -27.39 65.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.963 1.098 . . . . 10.0 113.963 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.416 HG21 ' OE1' ' A' ' 106' ' ' GLU . 6.0 t -71.0 -22.79 23.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.158 0.429 . . . . 10.0 112.158 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -127.32 -23.85 3.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.816 1.043 . . . . 10.0 113.816 -176.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 2.8 m120 77.91 63.68 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.082 0.944 . . . . 10.0 110.099 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 2.8 t -135.96 139.86 45.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.127 -1.397 . . . . 10.0 108.178 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 12.1 mmtm -112.45 133.14 54.69 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.338 -0.545 . . . . 10.0 112.145 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.628 ' HG ' ' OE2' ' A' ' 133' ' ' GLU . 1.1 mt -93.24 -20.25 20.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.163 -0.926 . . . . 10.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -120.15 152.04 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 10.0 111.06 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.85 -156.78 15.37 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.184 -0.766 . . . . 10.0 111.184 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.8 -37.1 10.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.821 0.343 . . . . 10.0 110.628 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -89.92 55.65 3.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.646 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 146' ' ' GLY . 19.8 mt -69.84 137.63 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 10.0 110.913 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 82.09 4.66 90.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.093 -0.803 . . . . 10.0 111.093 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.31 147.77 58.68 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.301 -0.449 . . . . 10.0 110.914 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.7 123.65 13.09 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.474 2.116 . . . . 10.0 110.718 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.9 OUTLIER -169.13 98.11 0.36 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.225 -0.658 . . . . 10.0 109.225 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -53.73 -46.13 70.72 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.273 0.358 . . . . 10.0 111.135 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.427 ' N ' ' HG ' ' A' ' 150' ' ' LEU . . . 58.45 -119.85 19.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.435 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.34 107.56 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.185 1.924 . . . . 10.0 111.193 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.0 pttt -89.89 105.88 18.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.221 0.534 . . . . 10.0 110.809 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.8 tmmt? -152.41 135.06 15.36 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.491 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.57 -0.728 . . . . 10.0 110.209 179.728 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.709 -0.556 . . . . 10.0 111.709 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.55 136.25 52.33 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 122.629 -0.336 . . . . 10.0 110.701 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 44.6 mtm -141.23 144.78 34.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.141 -0.482 . . . . 10.0 110.03 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -158.57 130.03 3.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.78 46.03 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.069 2.513 . . . . 10.0 114.209 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.89 130.92 55.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -126.5 123.24 37.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 10.0 111.163 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.76 -174.07 2.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.58 -146.95 8.83 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.678 -0.569 . . . . 10.0 111.678 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.27 91.76 1.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.633 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -123.55 124.35 42.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.612 0.244 . . . . 10.0 110.373 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.86 149.83 50.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.25 -166.76 20.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.086 -0.578 . . . . 10.0 111.94 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -139.92 174.08 10.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.815 0.34 . . . . 10.0 110.777 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -141.09 155.56 46.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.699 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.4 mt -132.49 166.81 21.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.305 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.4 m -110.02 133.22 53.42 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.522 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -89.97 93.71 9.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.856 0.36 . . . . 10.0 110.56 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.87 130.27 18.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.609 . . . . 10.0 110.145 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -150.14 172.15 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.55 -0.295 . . . . 10.0 110.473 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 69' ' ' ARG . 29.9 mtm180 -92.72 151.73 19.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.797 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -98.35 62.91 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.102 0.477 . . . . 10.0 111.577 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -104.88 90.06 3.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.52 0.676 . . . . 10.0 109.861 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.29 54.74 8.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.709 0.766 . . . . 10.0 109.071 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 pt -81.77 172.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.87 -1.059 . . . . 10.0 111.824 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.0 pt -75.87 172.72 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.842 -1.072 . . . . 10.0 110.943 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -77.36 146.11 73.54 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.944 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.63 178.44 5.11 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.405 2.07 . . . . 10.0 111.705 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -97.23 -160.09 0.78 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.701 -0.481 . . . . 10.0 109.701 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.93 168.05 12.8 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.072 -0.513 . . . . 10.0 109.957 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 120' ' ' GLY . 1.9 m -83.17 -23.67 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 10.0 111.663 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.45 139.14 7.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.49 -0.862 . . . . 10.0 112.526 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -68.53 -47.64 66.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.724 0.297 . . . . 10.0 111.426 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -66.32 -33.47 75.79 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.38 0.61 . . . . 10.0 109.512 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.1 -44.52 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.021 -0.991 . . . . 10.0 109.998 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.47 -41.71 98.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.929 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.44 -41.25 98.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 10.0 110.199 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.78 -30.84 65.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.114 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.694 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.3 mt -60.71 -47.38 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.267 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.48 -53.19 46.1 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.434 0.459 . . . . 10.0 110.46 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.74 -33.44 72.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.573 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.04 -31.9 82.28 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.788 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -80.05 -32.34 39.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.483 0.658 . . . . 10.0 109.28 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -74.2 -24.99 59.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.334 -0.848 . . . . 10.0 110.764 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -84.58 54.03 2.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.978 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.94 0.68 8.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.836 0.31 . . . . 10.0 111.836 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 1.6 tt0 56.11 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 124.159 0.912 . . . . 10.0 112.016 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 75.6 Cg_endo -81.81 -37.94 1.43 Allowed 'Cis proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.545 -1.44 . . . . 10.0 113.451 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.3 m -173.88 124.88 0.36 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.395 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 98' ' ' MET . 6.7 ttm -83.57 142.36 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.286 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 75.5 p -74.52 163.55 27.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 10.0 111.142 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.27 -32.59 71.87 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.256 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.07 82.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.548 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.419 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 14.0 mm-40 -60.72 -54.45 45.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.594 -0.276 . . . . 10.0 110.445 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.416 ' HG ' HH11 ' A' ' 91' ' ' ARG . 0.2 OUTLIER -64.76 -36.91 85.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.632 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.63 -47.5 86.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.816 -0.707 . . . . 10.0 111.742 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.96 -40.48 91.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.259 -0.275 . . . . 10.0 110.259 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.4 -31.74 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.352 0.501 . . . . 10.0 112.352 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 103' ' ' LEU . 46.8 pt -90.86 1.8 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 10.0 111.42 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.36 15.24 74.55 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.96 -0.638 . . . . 10.0 113.311 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -116.63 -149.4 0.44 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.65 172.07 9.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.602 0.239 . . . . 10.0 110.988 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.91 78.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.933 0.397 . . . . 10.0 110.505 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.65 77.55 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.637 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.408 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 4.0 m -59.64 -47.5 85.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.36 -44.13 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.25 -34.95 78.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.219 0.533 . . . . 10.0 110.893 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 36.5 m -76.83 -32.51 57.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.426 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.408 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.9 m-85 -67.57 -37.37 82.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.511 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.59 -18.78 65.21 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.721 0.296 . . . . 10.0 111.514 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 116' ' ' SER . 42.8 ttt180 -70.48 -20.39 62.86 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.402 0.62 . . . . 10.0 110.105 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.427 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 93.27 23.14 25.29 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 121' ' ' THR . 4.1 t -170.21 105.18 0.3 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.888 0.851 . . . . 10.0 110.35 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.47 33.59 0.11 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.98 -1.009 . . . . 10.0 109.824 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 m 64.26 104.04 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.774 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.1 83.74 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.508 2.138 . . . . 10.0 113.353 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -84.44 120.33 26.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.412 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 4.0 mm-40 -50.09 -47.36 53.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.74 0.644 . . . . 10.0 112.74 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 26.8 p-10 -61.36 -39.28 90.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.892 -0.14 . . . . 10.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.559 ' O ' ' HG3' ' A' ' 132' ' ' MET . 77.4 mt -69.45 -50.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 12.7 mt -54.4 -41.85 69.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.901 0.381 . . . . 10.0 110.006 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -55.83 -42.47 75.78 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.463 -0.79 . . . . 10.0 111.288 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.56 ' O ' HG21 ' A' ' 135' ' ' VAL . 70.4 mmtt -73.66 -43.34 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 10.0 110.518 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.673 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 4.0 mtt -52.61 -56.13 17.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.161 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.94 -29.61 70.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.544 -0.753 . . . . 10.0 112.45 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.9 mmt180 -75.59 -45.16 39.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.931 0.715 . . . . 10.0 112.931 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 131' ' ' LYS . 17.7 t -65.39 -41.19 90.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 111.898 0.332 . . . . 10.0 111.898 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 132' ' ' MET . 0.0 OUTLIER -89.91 -10.16 46.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.87 -0.332 . . . . 10.0 111.869 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.9 t30 57.51 52.9 7.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.549 0.69 . . . . 10.0 110.481 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.59 140.66 28.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.762 -1.108 . . . . 10.0 108.19 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 1.5 mtpp -96.67 133.46 41.16 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.028 -0.669 . . . . 10.0 110.251 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 36.6 mt -101.58 14.74 31.05 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.525 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -129.37 145.86 51.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.192 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.52 -155.85 21.86 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.469 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.98 -22.79 14.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.023 0.439 . . . . 10.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.88 51.68 1.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.056 0.455 . . . . 10.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 58.7 mt -71.9 142.65 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.705 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 83.84 4.29 88.83 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.455 -0.658 . . . . 10.0 111.455 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.55 143.49 48.55 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.568 -0.316 . . . . 10.0 110.548 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 124.0 10.68 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.683 1.589 . . . . 10.0 108.061 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.5 ttp85 -168.47 80.67 0.15 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.268 0.556 . . . . 10.0 110.058 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.5 tp -85.5 87.88 7.45 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.055 -0.658 . . . . 10.0 110.919 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.78 70.05 0.07 OUTLIER Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.789 -0.719 . . . . 10.0 113.202 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.98 107.98 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.244 1.963 . . . . 10.0 112.202 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.24 148.99 52.0 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.881 -0.414 . . . . 10.0 109.881 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -85.79 -33.75 21.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.675 0.274 . . . . 10.0 111.18 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.1 pttt . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.475 -0.774 . . . . 10.0 110.4 -179.732 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 111.903 -0.479 . . . . 10.0 111.903 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.04 143.09 32.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.723 0.297 . . . . 10.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.2 ptp -147.48 139.27 24.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.223 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -150.63 130.37 6.67 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.448 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.76 122.6 7.42 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.776 2.317 . . . . 10.0 112.86 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.87 145.06 34.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.19 167.37 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 10.0 110.77 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.63 158.74 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.099 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.67 31.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.722 -0.752 . . . . 10.0 112.267 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.07 -20.02 10.79 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.704 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -96.9 112.19 24.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.291 -0.263 . . . . 10.0 110.291 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -153.12 179.47 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.807 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.8 20.02 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.378 -0.689 . . . . 10.0 111.378 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -90.51 151.16 21.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.42 . . . . 10.0 111.533 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -96.32 149.11 22.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.787 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.96 7.49 6.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.026 0.441 . . . . 10.0 110.806 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -96.76 125.88 41.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.7 162.31 19.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.049 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.8 m -103.84 167.54 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.833 0.349 . . . . 10.0 111.097 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -119.77 4.44 11.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.34 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.2 mtm-85 -96.59 133.83 40.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.285 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.2 m -149.48 101.92 3.14 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.44 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -134.49 114.29 12.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.228 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -128.88 98.32 4.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.133 0.492 . . . . 10.0 111.334 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.46 129.59 72.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.0 pt -85.12 149.09 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.808 0.337 . . . . 10.0 110.961 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.08 133.95 23.73 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.427 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.05 117.63 5.23 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.48 2.12 . . . . 10.0 111.897 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -118.35 -160.44 0.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.906 0.384 . . . . 10.0 110.312 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.627 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 3.5 p -95.67 -177.94 4.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.76 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.462 HG21 ' HB3' ' A' ' 124' ' ' PRO . 3.4 t -70.75 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.239 0.542 . . . . 10.0 110.87 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.77 153.35 5.91 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -76.48 -52.28 10.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.581 0.691 . . . . 10.0 112.543 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -30.5 69.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.605 -0.438 . . . . 10.0 111.568 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.9 m -68.01 -35.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 120.735 -0.386 . . . . 10.0 110.39 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.75 -48.66 82.69 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.277 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -63.62 -36.77 84.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 10.0 110.756 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.7 -30.75 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.963 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.824 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.7 mt -61.27 -47.88 91.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 109.381 -0.599 . . . . 10.0 109.381 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.81 -53.34 57.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.872 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.6 -35.09 79.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.676 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.26 80.34 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.925 -0.655 . . . . 10.0 113.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.824 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.8 mmt180 -75.84 -35.56 59.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.233 0.539 . . . . 10.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -78.67 -12.91 60.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.776 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -77.94 -0.79 28.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.676 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -168.56 0.47 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.145 0.498 . . . . 10.0 111.466 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 12.7 tp10 -131.05 109.95 15.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.472 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.0 Cg_endo -79.06 -29.2 6.79 Favored 'Cis proline' 0 CA--C 1.515 -0.45 0 C-N-CA 123.188 -1.588 . . . . 10.0 112.157 -0.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.0 m -168.47 136.21 2.11 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.55 -1.659 . . . . 10.0 109.198 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.9 tpp -87.01 127.57 35.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.3 p -77.25 156.82 31.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.361 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -68.13 -33.68 74.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.192 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.75 71.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.385 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.48 -42.26 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.454 -0.339 . . . . 10.0 111.461 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.542 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tm? -65.46 -44.52 86.93 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.06 96.58 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.769 -0.729 . . . . 10.0 111.394 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.72 -43.92 97.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.987 0.115 . . . . 10.0 111.297 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.91 -16.83 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 103' ' ' LEU . 33.6 pt -103.47 -3.19 9.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.255 -0.578 . . . . 10.0 110.779 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.44 50.09 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.291 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -120.32 -160.17 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.683 0.278 . . . . 10.0 110.481 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 175.09 5.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.453 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.64 -41.65 99.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.758 0.313 . . . . 10.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.82 73.62 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.07 -0.514 . . . . 10.0 110.873 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 m -59.6 -49.54 77.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.878 0.37 . . . . 10.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.36 -42.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.93 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.16 70.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.571 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 67.8 m -78.52 -31.96 47.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.141 0.423 . . . . 10.0 112.141 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -18.77 36.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.373 0.509 . . . . 10.0 112.373 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -69.18 -23.39 63.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.309 0.576 . . . . 10.0 110.339 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.62 13.91 54.23 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.677 -0.773 . . . . 10.0 112.296 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.9 t -158.94 107.32 1.87 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.233 1.016 . . . . 10.0 109.37 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.78 29.17 0.37 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.443 -1.253 . . . . 10.0 110.017 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m 58.58 87.77 0.13 Allowed Pre-proline 0 N--CA 1.463 0.214 0 N-CA-C 108.378 -0.971 . . . . 10.0 108.378 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.627 ' HG3' ' C ' ' A' ' 78' ' ' THR . 87.9 Cg_endo -78.96 110.89 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.717 2.278 . . . . 10.0 115.454 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.442 ' HB3' HG13 ' A' ' 128' ' ' ILE . 6.6 t70 -85.95 124.91 32.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.93 -2.989 . . . . 10.0 102.93 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.44 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 5.0 mm-40 -50.97 -32.04 19.8 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.14 0.793 . . . . 10.0 113.14 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.514 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.5 t30 -75.9 -31.88 59.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.449 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.745 ' O ' ' HG3' ' A' ' 132' ' ' MET . 97.9 mt -64.85 -55.96 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.955 -0.298 . . . . 10.0 110.499 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.94 -38.85 17.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.737 0.779 . . . . 10.0 110.116 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.3 m -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.463 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 67.3 mmtt -75.57 -40.16 57.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.745 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.3 mtp -53.47 -57.73 9.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.227 0.537 . . . . 10.0 111.552 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.779 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mt-10 -72.27 -27.3 62.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.461 -0.79 . . . . 10.0 112.777 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -56.06 -30.22 61.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 10.0 111.362 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.7 -30.85 19.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.443 . . . . 10.0 111.814 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.528 HD13 ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -96.18 -10.57 27.8 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 67.24 19.15 10.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.746 0.418 . . . . 10.0 111.772 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.779 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.9 m -114.03 140.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.1 mmtp -121.11 140.6 51.75 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.801 -0.76 . . . . 10.0 111.204 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.507 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 1.8 mt -102.46 41.26 1.25 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.192 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -131.3 141.21 49.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 10.0 111.092 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.52 -152.49 30.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.291 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.55 15.09 30.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.195 0.522 . . . . 10.0 110.698 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.08 45.25 2.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.251 0.548 . . . . 10.0 110.173 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 49.1 mt -68.8 138.98 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.502 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 82.72 7.03 87.93 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.367 -1.093 . . . . 10.0 110.367 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -131.62 157.63 77.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 114.833 -0.684 . . . . 10.0 109.799 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.33 122.4 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.751 . . . . 10.0 110.23 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.587 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 3.2 tpp180 -147.18 94.64 2.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 143.62 54.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.145 -0.48 . . . . 10.0 111.084 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.06 65.98 0.62 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.518 -0.765 . . . . 10.0 112.944 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.86 -17.74 13.68 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.361 2.041 . . . . 10.0 111.964 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -137.79 139.73 40.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.077 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -83.34 99.96 10.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.141 -0.933 . . . . 10.0 110.084 -179.476 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.078 -0.409 . . . . 10.0 112.078 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.81 152.34 28.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.39 -0.226 . . . . 10.0 110.39 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.5 mtm -100.72 144.51 29.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.647 0.261 . . . . 10.0 110.419 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -111.71 151.16 43.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.175 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.66 133.88 44.6 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.584 2.19 . . . . 10.0 112.318 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -76.64 152.99 35.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.365 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.37 151.37 29.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.804 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.3 153.64 27.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.402 -0.363 . . . . 10.0 110.594 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.0 -166.71 11.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.329 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.92 158.78 25.85 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.967 -0.635 . . . . 10.0 111.862 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 m -152.64 131.09 12.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.837 0.351 . . . . 10.0 110.58 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -145.01 -178.37 6.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.437 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.88 119.43 1.51 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.022 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -127.26 162.09 27.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 63' ' ' ARG . 11.6 ptm180 -160.43 149.39 17.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.815 0.34 . . . . 10.0 110.71 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -151.57 118.43 5.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.802 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.7 m -149.71 107.77 3.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.049 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -113.33 133.98 54.86 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.475 -0.565 . . . . 10.0 109.475 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.68 144.59 29.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.038 0.447 . . . . 10.0 111.501 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.23 161.88 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -159.47 152.41 21.87 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -63.21 151.39 40.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.612 0.244 . . . . 10.0 110.492 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.75 98.94 7.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.801 0.334 . . . . 10.0 111.099 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -146.77 106.12 3.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.847 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.6 pt -121.39 161.76 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.054 0.454 . . . . 10.0 111.329 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.3 pt -85.46 -179.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.54 -0.754 . . . . 10.0 110.332 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -72.21 135.79 82.07 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.606 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.3 -176.9 3.32 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.863 2.375 . . . . 10.0 112.596 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -118.48 -139.62 0.35 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.905 -0.589 . . . . 10.0 109.484 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.2 p -79.47 -171.89 2.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.3 m -77.21 -31.48 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 10.0 110.789 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.5 132.05 3.88 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.576 -0.821 . . . . 10.0 112.401 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.53 -45.19 88.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.856 0.36 . . . . 10.0 110.819 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -29.7 65.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 87' ' ' ILE . 41.2 t -65.2 -46.2 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.078 -0.965 . . . . 10.0 109.773 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.58 -45.74 95.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.538 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -61.48 -38.59 87.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.005 0.431 . . . . 10.0 110.347 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.502 ' CB ' HD22 ' A' ' 140' ' ' LEU . . . -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.399 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.807 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.9 mt -59.8 -49.17 84.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.65 -51.45 65.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.538 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.42 -32.23 73.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.744 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 93' ' ' LYS . . . -73.65 -29.78 62.98 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.796 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.807 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.6 mmt180 -82.76 -36.29 25.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 10.0 109.812 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -72.92 -15.3 61.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.445 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 13.5 ptmt -84.86 6.69 23.69 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.703 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.88 -20.96 55.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.718 0.294 . . . . 10.0 111.777 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 56.98 102.44 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.052 -0.977 . . . . 10.0 111.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.46 -62.04 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.524 -1.448 . . . . 10.0 113.234 -0.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 47.0 m -161.38 135.44 6.86 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.139 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 132.59 46.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.45 145.73 54.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -69.14 -36.59 77.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 10.0 109.879 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.49 76.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.254 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -64.19 -39.26 93.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 10.0 110.958 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.448 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -64.77 -43.89 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.35 -43.98 96.07 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.321 -0.712 . . . . 10.0 111.321 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.63 -38.63 81.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.794 0.331 . . . . 10.0 110.56 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.71 -18.78 65.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.114 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 103' ' ' LEU . 4.4 pt -117.0 5.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.676 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.42 26.72 60.82 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.306 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.41 -171.14 2.11 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 p -107.42 173.61 6.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.635 0.255 . . . . 10.0 110.958 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.04 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 10.0 110.069 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.73 84.99 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.637 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -60.78 -46.49 90.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.729 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.71 -37.2 77.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.993 0.425 . . . . 10.0 110.757 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.22 77.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.09 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.4 p -75.99 -29.83 58.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.023 0.439 . . . . 10.0 110.539 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.444 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 1.0 OUTLIER -63.35 -41.78 98.88 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.881 -0.599 . . . . 10.0 112.356 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -63.54 -18.22 63.62 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -74.08 -22.68 59.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.356 0.598 . . . . 10.0 109.864 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.47 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 101.14 21.58 11.62 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.781 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.497 ' O ' HG22 ' A' ' 121' ' ' THR . 7.5 t -170.09 113.19 0.47 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 122.108 0.956 . . . . 10.0 110.611 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.29 27.73 0.09 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.422 -1.263 . . . . 10.0 108.86 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m 65.4 106.33 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.789 -1.096 . . . . 10.0 108.708 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 85.9 Cg_endo -78.15 89.63 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.763 2.309 . . . . 10.0 115.419 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.51 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -83.28 116.49 22.45 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.566 -2.012 . . . . 10.0 105.566 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -50.73 -40.13 53.6 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.647 0.61 . . . . 10.0 112.647 -176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.71 -32.83 73.74 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.258 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 62.7 mt -69.76 -55.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 121.026 -0.27 . . . . 10.0 110.348 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -51.58 -40.11 59.17 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.582 0.706 . . . . 10.0 110.46 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.0 m -60.11 -52.96 63.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.513 -0.767 . . . . 10.0 112.032 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 -33.68 48.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.521 0.934 . . . . 10.0 113.521 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.423 ' HE3' ' HB2' ' A' ' 132' ' ' MET . 4.5 ptm -63.11 -45.32 92.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.701 0.286 . . . . 10.0 111.564 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.859 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 21.8 mt-10 -75.66 -27.71 58.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.305 0.574 . . . . 10.0 111.801 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -25.22 67.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.411 -0.813 . . . . 10.0 112.514 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.65 -25.34 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.17 0.51 . . . . 10.0 110.995 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.562 HD23 ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -111.95 -12.74 13.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.302 -178.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 70.7 43.38 0.74 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.217 1.008 . . . . 10.0 108.657 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.859 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.9 t -128.31 141.58 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 113.545 -1.662 . . . . 10.0 107.319 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.602 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.6 mmmt -128.55 136.05 50.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.583 0.706 . . . . 10.0 111.259 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.502 HD22 ' CB ' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -106.76 30.35 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.794 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -131.22 139.13 49.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.524 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.23 -149.47 18.7 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.429 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.7 -24.16 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 10.0 110.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.66 50.58 1.84 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 10.0 110.555 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.463 HG22 HD12 ' A' ' 145' ' ' ILE . 4.3 mm -65.28 138.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.987 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.44 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 85.24 3.48 87.17 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.345 -0.702 . . . . 10.0 111.345 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.04 163.06 52.97 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.938 -0.631 . . . . 10.0 109.846 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.67 123.0 11.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.217 1.945 . . . . 10.0 111.328 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.602 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 22.7 tpt180 -149.14 101.14 3.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.954 0.406 . . . . 10.0 109.973 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.07 102.41 9.31 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.542 0.687 . . . . 10.0 110.43 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.408 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . 178.64 65.07 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 114.797 -1.092 . . . . 10.0 111.646 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' A' ' 151' ' ' GLY . 16.9 Cg_exo -67.71 -23.38 42.35 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.15 2.567 . . . . 10.0 112.602 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -120.45 146.72 45.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.52 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -63.94 -55.78 20.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.382 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.258 -0.877 . . . . 10.0 110.358 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.578 -0.209 . . . . 10.0 112.578 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.2 120.32 20.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.659 0.266 . . . . 10.0 110.371 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.8 ttt -95.86 72.1 3.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.389 0.614 . . . . 10.0 110.255 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -136.88 85.43 23.42 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.101 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.41 153.91 12.22 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.467 2.111 . . . . 10.0 112.577 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.68 154.07 18.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.025 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -122.99 93.6 4.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.035 0.445 . . . . 10.0 110.223 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.96 137.54 46.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.105 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.46 -176.16 38.57 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.394 -0.908 . . . . 10.0 112.184 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.72 113.61 2.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.114 -0.565 . . . . 10.0 111.99 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.3 t -159.3 149.36 19.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.684 0.278 . . . . 10.0 110.341 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -125.0 -176.41 3.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.317 -0.402 . . . . 10.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.39 102.66 0.66 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.206 -0.997 . . . . 10.0 112.792 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -142.93 143.8 32.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.835 -0.432 . . . . 10.0 109.835 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -171.37 142.17 1.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.688 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.4 mt -141.94 119.42 11.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.509 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.06 79.82 1.81 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.794 0.33 . . . . 10.0 111.4 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -160.62 100.79 1.31 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.407 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.85 170.56 19.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.431 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.57 114.94 4.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.023 -0.535 . . . . 10.0 109.769 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -127.27 94.42 3.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.965 0.412 . . . . 10.0 110.615 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m -75.59 -35.64 60.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.802 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -135.77 113.84 11.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.871 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.24 105.91 3.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.549 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.4 pt -85.01 -21.9 7.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.47 -0.332 . . . . 10.0 111.194 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.466 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 35.5 mt -65.42 138.22 23.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.875 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.3 94.45 8.15 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.17 0.51 . . . . 10.0 110.005 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 74' ' ' ILE . 83.9 Cg_endo -85.34 -143.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.804 2.336 . . . . 10.0 111.842 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -82.1 64.23 6.68 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.195 0.521 . . . . 10.0 109.658 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.06 155.73 27.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.545 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.454 HG21 ' C ' ' A' ' 120' ' ' GLY . 2.7 m -78.88 -30.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 121.033 -0.267 . . . . 10.0 111.199 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.28 137.6 5.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.65 -52.91 39.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.637 0.256 . . . . 10.0 111.533 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.58 -31.03 71.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.533 HG12 ' CD1' ' A' ' 140' ' ' LEU . 6.0 t -62.36 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.365 -1.289 . . . . 10.0 109.856 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.4 -47.86 88.81 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.784 -0.644 . . . . 10.0 112.991 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -61.12 -38.17 85.41 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.25 0.548 . . . . 10.0 110.065 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.401 ' HB1' HG22 ' A' ' 145' ' ' ILE . . . -69.29 -30.32 68.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.357 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.777 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.5 mt -60.55 -45.81 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.763 -0.458 . . . . 10.0 109.763 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.04 -48.05 63.85 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.698 -0.482 . . . . 10.0 109.698 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.573 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 4.3 mm-40 -62.31 -34.7 77.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.33 -36.82 93.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.626 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.777 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.96 -36.25 31.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.211 0.529 . . . . 10.0 110.004 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -74.49 -24.13 58.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.39 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 12.4 mptt -87.52 23.45 1.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 10.0 111.28 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -16.12 56.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.018 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 58.65 104.23 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.759 -1.11 . . . . 10.0 111.41 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.09 -60.92 0.06 OUTLIER 'Cis proline' 0 CA--C 1.516 -0.392 0 C-N-CA 123.78 -1.342 . . . . 10.0 113.037 0.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.8 m -158.77 125.15 4.61 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.206 -0.907 . . . . 10.0 110.799 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.3 tpp -78.31 135.55 37.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.16 144.97 50.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.775 0.321 . . . . 10.0 111.09 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.35 -36.55 77.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.989 0.423 . . . . 10.0 110.215 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -65.14 -45.35 85.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 10.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -66.72 -39.95 88.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -63.6 -38.03 89.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -47.7 69.15 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.418 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 33.6 mmtp -59.2 -40.82 86.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.749 0.309 . . . . 10.0 110.663 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -33.87 73.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.066 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 103' ' ' LEU . 31.1 pt -95.54 -0.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 10.0 111.293 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.62 14.93 69.4 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.185 -0.531 . . . . 10.0 113.29 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -111.56 -157.97 0.63 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.6 p -119.3 174.7 6.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.493 0.187 . . . . 10.0 110.63 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.51 81.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.036 0.445 . . . . 10.0 109.804 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.54 72.29 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.447 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.0 m -64.78 -48.01 76.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.728 0.299 . . . . 10.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.8 -45.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 10.0 110.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.601 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.18 -31.69 72.68 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.061 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 m -76.64 -34.71 58.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.975 0.417 . . . . 10.0 111.768 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.32 -34.2 77.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.46 -17.6 59.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.819 0.342 . . . . 10.0 111.551 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -69.43 -28.09 65.83 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.226 0.536 . . . . 10.0 111.262 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.454 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 98.1 21.91 16.7 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.593 -0.813 . . . . 10.0 111.956 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 121' ' ' THR . 8.5 t -169.79 105.56 0.34 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.316 1.055 . . . . 10.0 109.438 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.88 25.13 0.09 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.497 -1.229 . . . . 10.0 109.636 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.7 m 67.56 106.7 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.111 -0.95 . . . . 10.0 110.737 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.99 88.66 1.07 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.572 2.181 . . . . 10.0 113.989 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.72 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.7 t70 -81.88 116.74 21.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 11.5 mm-40 -49.7 -46.77 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -62.09 -43.4 98.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.544 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.699 ' O ' ' HG3' ' A' ' 132' ' ' MET . 55.7 mt -63.55 -56.84 14.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.72 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 13.3 mt -47.44 -45.92 26.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.349 0.595 . . . . 10.0 110.744 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.554 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 71.4 m -56.58 -51.18 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.986 -1.006 . . . . 10.0 112.191 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.429 ' O ' HG22 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -75.17 -30.66 60.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.699 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 31.4 mtp -56.36 -61.4 2.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 10.0 111.929 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.45 ' CD ' HD11 ' A' ' 140' ' ' LEU . 3.5 mp0 -76.37 -26.37 55.59 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' A' ' 130' ' ' SER . 12.3 ptt85 -58.61 -29.66 66.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.924 0.329 . . . . 10.0 111.364 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 131' ' ' LYS . 66.7 t -71.48 -33.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.0 0.429 . . . . 10.0 110.969 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.525 HD11 ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -95.16 -17.45 21.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.488 -178.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.9 t30 62.27 56.03 2.26 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.531 0.682 . . . . 10.0 109.536 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 11.9 m -137.19 159.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.44 -1.254 . . . . 10.0 108.715 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 6.5 mmpt? -127.25 139.77 52.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.533 ' CD1' HG12 ' A' ' 83' ' ' VAL . 11.2 mt -95.13 36.11 1.24 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.39 0.614 . . . . 10.0 110.282 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -135.62 155.72 50.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.627 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.02 -163.23 43.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.057 -0.592 . . . . 10.0 112.571 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.86 -12.49 36.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 10.0 110.854 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -104.86 49.89 0.8 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.11 0.481 . . . . 10.0 110.36 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 146' ' ' GLY . 22.7 mt -70.81 137.63 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.444 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 92.96 1.89 67.05 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.77 -0.932 . . . . 10.0 110.77 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -135.24 159.19 72.79 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -0.738 . . . . 10.0 109.217 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.17 120.99 9.29 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.029 1.819 . . . . 10.0 109.905 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.508 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 7.3 tpp85 -140.17 105.69 5.1 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.899 -0.5 . . . . 10.0 110.629 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.6 mt -89.44 104.9 17.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.91 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -107.83 156.08 15.99 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.243 -0.98 . . . . 10.0 112.107 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -89.69 144.02 4.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.774 2.316 . . . . 10.0 112.047 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -96.42 4.23 52.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.286 0.565 . . . . 10.0 109.903 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -96.07 107.23 19.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.177 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.55 -0.738 . . . . 10.0 110.305 179.516 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 112.017 -0.433 . . . . 10.0 112.017 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.28 132.48 8.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.375 -0.232 . . . . 10.0 110.375 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -153.58 156.46 38.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.458 -0.337 . . . . 10.0 110.318 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.11 136.49 26.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.87 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.94 116.68 3.3 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.171 2.581 . . . . 10.0 112.685 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -83.31 115.11 21.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.156 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.93 141.53 35.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.665 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.85 149.78 22.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.852 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.13 -162.19 37.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.458 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.02 -166.64 23.24 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -154.35 148.94 26.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.907 0.384 . . . . 10.0 110.542 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -157.96 138.73 13.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.259 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.15 174.49 16.16 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.964 -0.636 . . . . 10.0 111.709 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -165.96 135.24 3.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 10.0 110.513 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 141.13 30.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.212 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.0 tp -148.98 118.89 7.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.239 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -105.49 141.42 37.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.396 -0.366 . . . . 10.0 110.335 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -122.44 108.85 13.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.337 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.92 116.45 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.173 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -163.27 -170.82 2.39 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -92.58 -178.84 5.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.242 -0.281 . . . . 10.0 110.242 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 m -93.62 70.87 4.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.267 0.556 . . . . 10.0 111.029 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -132.11 41.02 3.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.832 0.825 . . . . 10.0 109.359 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -165.3 125.59 1.87 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.783 -1.099 . . . . 10.0 108.783 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.47 86.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.317 0.58 . . . . 10.0 110.95 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 pt -134.52 -173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.612 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.93 143.21 80.74 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.71 80.83 0.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.326 2.017 . . . . 10.0 112.124 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -83.53 46.11 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.285 0.564 . . . . 10.0 110.374 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 3.1 p -126.18 157.09 39.05 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.874 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.4 m -84.31 -30.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.968 -0.293 . . . . 10.0 111.444 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.1 140.27 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.253 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.71 -51.94 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.791 0.329 . . . . 10.0 111.092 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.21 -33.93 76.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.408 HG21 HH21 ' A' ' 141' ' ' ARG . 13.1 t -61.88 -47.12 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.154 -0.93 . . . . 10.0 110.478 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -39.47 95.94 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.699 -0.762 . . . . 10.0 111.827 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.77 -40.32 91.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.38 83.18 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.822 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.456 HG21 ' CZ ' ' A' ' 91' ' ' ARG . 3.4 mt -54.25 -45.28 67.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.054 0.454 . . . . 10.0 110.503 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.87 -48.05 60.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.348 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.2 mt-30 -62.54 -37.65 86.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.147 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.98 -38.76 94.44 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.978 -0.556 . . . . 10.0 113.287 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.619 HH22 ' HB3' ' A' ' 132' ' ' MET . 0.5 OUTLIER -78.98 -38.62 36.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.808 0.337 . . . . 10.0 111.425 -178.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' HA ' HG21 ' A' ' 97' ' ' THR . 2.2 pt20 -72.49 -13.63 61.47 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.492 -0.483 . . . . 10.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 2.0 tttm -81.54 12.12 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -158.42 0.22 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 10.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 24.6 mt-10 -131.66 105.39 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.909 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 72.7 Cg_endo -81.08 -30.41 5.33 Favored 'Cis proline' 0 C--N 1.348 0.504 0 C-N-CA 123.523 -1.449 . . . . 10.0 112.725 -0.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 92' ' ' GLN . 15.2 m -161.33 135.76 7.11 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.862 -1.517 . . . . 10.0 109.445 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.18 127.72 35.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.109 -0.33 . . . . 10.0 110.109 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.578 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 59.0 p -79.99 163.69 24.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 10.0 110.641 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.88 -28.91 67.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.87 -32.59 69.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.281 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.578 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 21.4 mm-40 -66.59 -54.97 17.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.547 0.213 . . . . 10.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.548 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -63.91 -40.4 96.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.212 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.38 -46.07 93.48 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 111.352 -0.699 . . . . 10.0 111.352 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -65.48 -44.34 87.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.95 -36.54 77.3 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.611 HD11 ' SD ' ' A' ' 132' ' ' MET . 36.4 pt -87.61 -12.46 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.777 -0.369 . . . . 10.0 111.74 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.86 22.45 30.68 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.888 -0.672 . . . . 10.0 113.476 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -119.89 -154.92 0.6 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 p -115.14 176.96 4.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.568 0.223 . . . . 10.0 110.719 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -34.19 75.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.817 0.342 . . . . 10.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.98 84.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.435 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -58.33 -48.2 81.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.164 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.98 -46.66 90.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.554 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.48 -37.84 87.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.274 0.559 . . . . 10.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 58.2 m -74.23 -26.28 60.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.092 -0.503 . . . . 10.0 110.652 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -43.27 69.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.464 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.72 -18.89 57.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.957 0.408 . . . . 10.0 111.035 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 116' ' ' SER . 45.3 ttp180 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.265 0.555 . . . . 10.0 110.411 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.443 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.06 21.49 22.86 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.868 -0.606 . . . . 10.0 111.783 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 121' ' ' THR . 8.0 t -174.62 114.35 0.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.026 0.917 . . . . 10.0 109.712 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.92 29.83 0.15 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.827 -1.079 . . . . 10.0 109.863 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m 58.88 93.1 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.414 ' HG3' ' O ' ' A' ' 78' ' ' THR . 73.3 Cg_endo -71.45 104.67 1.61 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.926 2.418 . . . . 10.0 115.977 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.581 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 18.3 t70 -90.2 119.57 30.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 104.85 -2.278 . . . . 10.0 104.85 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -49.01 -46.65 44.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -63.3 -36.52 83.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.305 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.37 -55.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.852 -0.158 . . . . 10.0 110.914 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -54.42 -38.76 66.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.979 0.418 . . . . 10.0 110.616 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.661 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.6 m -58.69 -50.37 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.605 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -34.51 61.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.719 0.266 . . . . 10.0 111.719 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.619 ' HB3' HH22 ' A' ' 91' ' ' ARG . 5.3 mmm -52.52 -61.06 2.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.355 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HG3' ' HG ' ' A' ' 140' ' ' LEU . 49.4 mm-40 -76.49 -24.04 53.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.487 -0.779 . . . . 10.0 112.17 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' A' ' 130' ' ' SER . 20.9 ttp180 -52.58 -40.73 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 10.0 111.805 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.98 -24.95 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 10.0 111.197 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.2 OUTLIER -99.57 -16.39 18.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.974 -178.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 6.3 m-20 78.79 52.46 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.57 0.7 . . . . 10.0 109.908 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 133' ' ' GLU . 0.7 OUTLIER -133.17 159.49 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.886 -1.052 . . . . 10.0 108.248 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -130.15 -2.19 4.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.566 -0.854 . . . . 10.0 113.103 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.527 ' HG ' ' HG3' ' A' ' 133' ' ' GLU . 22.4 mt 54.61 10.51 0.35 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.792 -1.095 . . . . 10.0 113.699 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.408 HH21 HG21 ' A' ' 83' ' ' VAL . 4.3 mmt85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.297 -0.252 . . . . 10.0 110.47 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.74 -179.78 26.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.769 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.74 -25.05 48.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 10.0 109.9 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -89.37 56.48 3.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.571 -0.74 . . . . 10.0 110.845 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 146' ' ' GLY . 20.2 mm -65.68 139.28 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.054 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.552 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 83.64 19.54 61.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.088 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -150.46 162.0 28.82 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.577 . . . . 10.0 109.462 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -61.83 122.73 11.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.618 1.545 . . . . 10.0 110.149 177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.58 81.74 1.82 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 34.2 mt -67.91 104.33 1.69 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.632 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -113.11 -179.9 19.26 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.895 -0.882 . . . . 10.0 110.895 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.57 113.67 2.21 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.539 2.159 . . . . 10.0 111.774 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.28 169.45 17.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.515 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -104.53 165.5 11.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 10.0 111.072 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.378 -0.82 . . . . 10.0 109.862 179.636 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.69 -0.564 . . . . 10.0 111.69 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.91 45.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.841 0.353 . . . . 10.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -118.09 155.14 30.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.315 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -100.71 147.17 33.27 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.539 -0.3 . . . . 10.0 110.723 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.41 151.79 83.23 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.216 2.61 . . . . 10.0 112.507 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -117.28 156.36 27.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -151.59 154.17 35.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -177.81 6.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.763 0.316 . . . . 10.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.37 -133.96 1.86 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.19 -0.529 . . . . 10.0 111.861 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.99 158.01 7.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.148 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -141.45 170.24 16.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.13 179.65 4.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 10.0 110.71 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -125.66 1.21 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.753 -0.737 . . . . 10.0 111.922 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.02 145.22 53.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.902 0.382 . . . . 10.0 110.687 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -94.59 -48.69 5.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.991 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 pp -97.33 132.48 43.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.167 -0.47 . . . . 10.0 109.806 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 p -107.24 -66.02 1.06 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.516 -0.311 . . . . 10.0 111.062 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 143' ' ' ALA . 17.8 ptpt -142.89 147.48 35.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.498 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.8 m -78.67 165.15 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.352 -0.385 . . . . 10.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -114.56 132.03 56.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.901 0.382 . . . . 10.0 110.596 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -135.77 155.5 50.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.551 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.15 159.02 35.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.343 -0.39 . . . . 10.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -150.8 117.82 5.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.477 -0.329 . . . . 10.0 110.125 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.62 31.84 0.47 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.222 0.535 . . . . 10.0 110.908 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.6 tt -83.32 -13.2 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.441 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.7 mt 60.03 77.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.59 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -67.59 154.73 92.73 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.951 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.46 -160.41 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.56 2.173 . . . . 10.0 111.638 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -83.15 47.65 1.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.111 0.481 . . . . 10.0 110.779 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.1 p -100.36 137.35 38.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.478 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 3.1 p -71.63 -33.89 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.116 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.06 130.18 3.1 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.438 -0.887 . . . . 10.0 112.192 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.99 -53.02 61.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.313 . . . . 10.0 111.089 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -65.34 -33.02 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.51 -0.552 . . . . 10.0 109.51 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.595 ' O ' HG13 ' A' ' 87' ' ' ILE . 92.9 t -62.69 -46.09 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.096 -0.956 . . . . 10.0 110.18 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -60.14 -42.77 98.7 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.973 -0.558 . . . . 10.0 113.176 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -69.24 -34.16 74.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 10.0 110.447 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.22 -29.68 66.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.707 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 83' ' ' VAL . 39.5 mt -59.27 -44.09 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 10.0 109.99 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.38 -54.63 11.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.245 0.545 . . . . 10.0 110.028 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.532 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 47.8 mt-30 -55.2 -38.19 68.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.975 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.46 -34.38 40.39 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.158 -1.02 . . . . 10.0 113.12 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.664 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -81.7 -26.03 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.053 0.454 . . . . 10.0 111.375 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -75.21 -8.8 57.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.187 0.517 . . . . 10.0 109.905 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 8.4 mtpm? -76.63 8.13 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.973 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.62 -13.9 55.7 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.873 -0.331 . . . . 10.0 111.689 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.04 111.1 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 O-C-N 124.32 1.013 . . . . 10.0 112.096 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.0 -37.86 1.99 Allowed 'Cis proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.205 -1.581 . . . . 10.0 112.373 -0.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -170.98 135.85 1.06 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.973 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 33.9 tpp -70.79 127.02 31.21 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -63.18 146.64 52.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.572 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -64.74 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.979 0.419 . . . . 10.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.72 -47.22 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.23 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -68.31 -37.04 80.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.707 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.478 HD12 ' CG ' ' A' ' 91' ' ' ARG . 0.5 OUTLIER -61.83 -44.24 97.24 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.72 97.97 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.346 -0.843 . . . . 10.0 111.513 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -62.9 -36.05 82.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.168 0.509 . . . . 10.0 110.331 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -71.94 -40.87 68.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.193 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.8 pt -82.53 -5.9 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 111.992 0.367 . . . . 10.0 111.992 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.9 28.45 37.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.837 -0.697 . . . . 10.0 112.907 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -130.14 -146.84 0.32 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.216 -0.661 . . . . 10.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.35 175.73 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.615 0.245 . . . . 10.0 111.097 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.24 91.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.726 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.75 76.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.671 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -60.27 -46.45 89.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.398 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.2 t -65.49 -45.91 91.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.354 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.92 -32.87 74.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.86 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -77.2 -28.18 53.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.471 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -70.33 -39.71 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.125 0.417 . . . . 10.0 112.125 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.56 -19.51 57.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.091 0.472 . . . . 10.0 111.469 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' A' ' 119' ' ' ARG . 12.1 ttm180 -72.89 -29.34 63.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.738 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.99 12.21 47.07 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.998 -0.62 . . . . 10.0 113.633 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.1 t -149.38 59.33 1.02 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.795 0.807 . . . . 10.0 111.022 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.2 27.53 9.42 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.613 -0.721 . . . . 10.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.4 m 64.97 109.38 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 123.627 0.58 . . . . 10.0 110.506 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 44.0 Cg_endo -70.37 88.37 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.171 1.914 . . . . 10.0 113.642 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.713 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.0 t70 -87.35 114.43 23.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.7 -1.222 . . . . 10.0 107.7 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -49.75 -45.64 49.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.472 0.483 . . . . 10.0 111.933 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 22.6 t30 -61.25 -44.97 96.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.822 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.573 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.5 mt -63.02 -55.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.181 -0.207 . . . . 10.0 110.648 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 6.3 mt -50.12 -41.38 48.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.356 0.598 . . . . 10.0 110.321 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 73.9 m -58.97 -43.55 91.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.124 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 135' ' ' VAL . 74.2 mmtt -72.98 -43.28 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.909 0.337 . . . . 10.0 111.909 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.573 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 14.3 mtp -49.28 -56.97 7.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.752 0.786 . . . . 10.0 111.841 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 11.8 mt-10 -73.93 -27.28 60.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -1.112 . . . . 10.0 113.083 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.603 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -68.72 -22.65 64.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.261 0.467 . . . . 10.0 112.261 -178.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.6 t -66.9 -24.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 10.0 109.957 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.511 HD13 HH11 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -123.53 -96.54 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.151 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 19.0 p-10 173.42 31.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 136' ' ' LEU . 3.2 m -111.55 147.62 15.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 2.9 mmpt? -115.6 132.92 56.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 10.0 110.711 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.408 HD13 HH22 ' A' ' 91' ' ' ARG . 40.8 mt -97.42 40.58 1.15 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -139.33 139.35 37.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.794 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.58 -157.8 19.83 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.651 -0.785 . . . . 10.0 112.802 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 66' ' ' LYS . . . -96.29 -19.24 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.128 0.49 . . . . 10.0 111.16 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -97.75 54.07 1.14 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 146' ' ' GLY . 14.1 mm -63.17 136.54 25.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.389 -0.823 . . . . 10.0 112.127 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.517 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 82.2 4.01 90.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.023 -0.608 . . . . 10.0 112.144 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.76 54.66 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.942 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 12.0 Cg_endo -58.5 121.86 10.68 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.803 2.335 . . . . 10.0 110.594 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -164.24 68.05 0.17 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.556 0.693 . . . . 10.0 109.169 179.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 mt -75.69 83.58 2.69 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.216 -0.902 . . . . 10.0 111.227 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 152.87 76.16 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.82 -1.082 . . . . 10.0 111.198 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.51 170.32 18.78 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.426 2.084 . . . . 10.0 112.259 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -92.91 147.49 22.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.866 0.365 . . . . 10.0 110.346 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -107.84 149.78 27.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.921 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.676 -0.678 . . . . 10.0 109.962 179.729 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 112.321 -0.312 . . . . 10.0 112.321 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.73 104.27 16.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.805 0.336 . . . . 10.0 110.409 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.1 mtt -103.61 143.74 32.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.81 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.97 90.34 49.75 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.567 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -86.49 154.7 9.15 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.025 2.483 . . . . 10.0 112.994 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.49 141.34 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.209 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -159.89 151.68 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.712 0.291 . . . . 10.0 110.661 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.38 150.26 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.038 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.76 166.16 34.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.61 -0.805 . . . . 10.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.08 170.4 20.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.187 -0.53 . . . . 10.0 112.307 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 162.39 12.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.844 0.354 . . . . 10.0 111.274 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.91 -175.17 4.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.45 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.78 158.83 31.45 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.601 -0.6 . . . . 10.0 111.601 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.26 176.95 7.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.992 0.396 . . . . 10.0 110.975 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -118.51 179.22 4.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.095 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.3 mt -109.97 168.58 9.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.528 -0.305 . . . . 10.0 110.673 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.63 150.54 49.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.461 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -110.34 134.23 52.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.091 -0.337 . . . . 10.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.54 177.96 2.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.587 -0.278 . . . . 10.0 110.54 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.21 131.27 34.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.036 0.446 . . . . 10.0 110.333 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -147.73 -164.57 2.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.046 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.3 m -62.65 131.91 50.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.938 0.399 . . . . 10.0 111.052 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.4 91.5 2.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.679 -0.691 . . . . 10.0 110.533 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -86.05 86.14 7.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.315 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.3 pt -61.3 118.97 4.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.196 -0.911 . . . . 10.0 111.818 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.3 pt -118.09 176.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.911 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.5 pttt 38.3 77.8 0.39 Allowed Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 124.262 0.976 . . . . 10.0 112.265 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.5 -166.12 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.734 2.289 . . . . 10.0 111.811 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.37 76.95 0.55 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.252 0.549 . . . . 10.0 110.51 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -138.93 168.3 20.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.254 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.419 HG21 ' C ' ' A' ' 120' ' ' GLY . 1.1 m -88.24 -34.12 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.42 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.41 143.03 7.62 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.581 -0.818 . . . . 10.0 112.489 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -67.28 -55.67 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.641 0.237 . . . . 10.0 111.641 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.15 -35.39 80.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.543 0.687 . . . . 10.0 109.221 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 87' ' ' ILE . 38.9 t -59.51 -45.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.681 -1.145 . . . . 10.0 110.411 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.11 97.76 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.117 -0.564 . . . . 10.0 112.476 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -65.04 -37.0 86.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 10.0 110.561 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.04 -30.63 67.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.176 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.461 HG12 ' NH2' ' A' ' 91' ' ' ARG . 17.8 mt -60.95 -46.28 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.403 0.621 . . . . 10.0 109.643 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.77 -50.88 31.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.048 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.69 -35.78 75.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.565 . . . . 10.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.71 -34.92 37.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.492 -1.337 . . . . 10.0 113.203 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.597 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 1.3 mpt_? -81.24 -44.22 18.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 10.0 111.582 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 97' ' ' THR . 71.9 mt-30 -67.01 -18.33 65.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.656 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -81.16 29.58 0.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.715 0.293 . . . . 10.0 111.55 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.67 -3.84 51.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.835 0.309 . . . . 10.0 111.835 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 60.13 109.14 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.021 0.826 . . . . 10.0 112.418 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -73.62 -54.39 0.15 OUTLIER 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.816 -1.327 . . . . 10.0 112.788 -0.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 13.1 m -161.62 123.14 2.83 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.134 -0.939 . . . . 10.0 110.582 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.5 ttm -64.59 128.84 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.828 0.346 . . . . 10.0 110.438 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.6 p -76.81 157.3 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -66.97 -28.78 68.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.413 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.66 80.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.194 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 46.7 mm-40 -64.51 -53.88 41.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.747 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.508 ' O ' HG12 ' A' ' 107' ' ' ILE . 22.5 tp -60.47 -40.13 90.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.31 -45.68 95.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.684 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -64.36 -44.18 92.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 10.0 110.402 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 58.0 mm-40 -61.47 -41.0 96.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 10.0 112.113 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 103' ' ' LEU . 43.9 pt -84.59 -14.91 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 111.931 0.345 . . . . 10.0 111.931 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.16 41.34 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.969 -0.634 . . . . 10.0 113.225 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -121.95 -176.13 3.27 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.03 163.59 14.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.655 0.264 . . . . 10.0 110.767 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.81 -35.29 76.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 10.0 110.842 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.31 71.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -66.91 -47.4 71.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.46 -43.5 98.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.637 -0.71 . . . . 10.0 110.503 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.31 80.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.403 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 7.2 t -74.29 -30.77 62.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.183 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.09 -44.71 94.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.171 -0.468 . . . . 10.0 111.536 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.59 -19.08 65.69 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.985 -0.286 . . . . 10.0 111.148 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 116' ' ' SER . 20.7 ttp180 -71.92 -22.78 61.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.417 0.627 . . . . 10.0 109.534 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.419 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 100.45 25.49 8.71 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.522 -0.763 . . . . 10.0 112.132 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.3 t -174.2 111.97 0.17 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.975 0.893 . . . . 10.0 110.467 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.35 33.42 0.09 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.99 -1.005 . . . . 10.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m 60.76 99.99 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.312 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.19 88.82 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.878 2.386 . . . . 10.0 115.06 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.694 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.5 t70 -86.01 117.07 24.62 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 105.856 -1.905 . . . . 10.0 105.856 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -51.51 -41.28 60.88 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.613 0.571 . . . . 10.0 112.178 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 53.4 t30 -65.63 -44.15 87.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.598 ' O ' ' HG3' ' A' ' 132' ' ' MET . 79.4 mt -59.87 -53.93 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.7 mt -48.75 -48.02 41.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.478 0.656 . . . . 10.0 109.736 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.578 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.9 m -55.12 -39.84 69.84 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.803 -1.09 . . . . 10.0 111.189 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 66.8 mmtt -71.72 -48.07 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.598 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 10.1 mtp -52.33 -52.29 54.01 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.86 0.838 . . . . 10.0 111.213 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.508 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 32.4 mt-10 -72.56 -29.28 63.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.553 -1.203 . . . . 10.0 113.17 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.2 ttp85 -64.43 -28.92 70.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 131' ' ' LYS . 22.8 t -64.0 -31.97 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.528 HD23 HH11 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -123.16 2.77 9.25 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.539 0.94 . . . . 10.0 113.539 -178.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.51 43.38 16.19 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.508 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 31.4 m -131.96 138.47 52.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.434 ' CG ' ' H ' ' A' ' 149' ' ' ARG . 30.4 mmmt -114.06 149.98 34.68 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.466 -0.494 . . . . 10.0 111.364 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.434 HD11 HH22 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -110.6 15.34 22.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.191 -0.913 . . . . 10.0 109.866 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -115.65 140.68 48.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.434 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.46 -162.81 29.59 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.21 -26.58 21.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.978 0.418 . . . . 10.0 111.117 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -87.74 54.91 3.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.004 0.431 . . . . 10.0 111.726 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 73.6 mt -74.41 142.33 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.1 73.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.688 -0.965 . . . . 10.0 110.688 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.0 156.78 76.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.639 -0.78 . . . . 10.0 109.398 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -61.94 123.72 13.13 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.826 1.684 . . . . 10.0 109.667 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.434 ' H ' ' CG ' ' A' ' 139' ' ' LYS . 23.3 tpt180 -151.41 99.31 2.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.21 0.528 . . . . 10.0 110.931 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.56 170.91 20.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.389 -0.823 . . . . 10.0 109.107 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.59 173.46 51.69 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.455 -0.879 . . . . 10.0 111.286 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -20.28 60.8 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.507 2.138 . . . . 10.0 112.119 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -99.63 118.49 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.933 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.65 167.96 12.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.204 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.254 -0.879 . . . . 10.0 110.001 179.353 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.947 0 N-CA-C 111.697 -0.561 . . . . 10.0 111.697 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.59 138.13 32.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.825 0.345 . . . . 10.0 110.873 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mtp -98.48 139.18 34.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.147 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -151.15 145.42 18.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.124 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.06 147.79 34.19 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.71 2.274 . . . . 10.0 112.619 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.77 143.29 57.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.742 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -72.03 150.36 44.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.423 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.68 30.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.1 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.88 157.19 15.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.241 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.36 169.54 32.17 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.828 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -147.49 97.04 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.062 0.458 . . . . 10.0 110.995 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.06 149.71 24.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.623 -0.51 . . . . 10.0 109.623 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.96 -170.34 12.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.585 -0.817 . . . . 10.0 112.779 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -157.81 167.27 30.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.113 -0.328 . . . . 10.0 110.113 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -118.9 15.88 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.981 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.95 124.6 28.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.008 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -140.7 115.42 9.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.659 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -128.21 132.59 48.8 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.24 132.43 71.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.912 0.387 . . . . 10.0 110.987 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -114.67 151.55 33.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -135.75 166.6 22.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.899 0.38 . . . . 10.0 110.66 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -128.67 138.39 52.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -137.52 138.88 40.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.454 0.645 . . . . 10.0 110.515 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.13 -107.4 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.637 -1.165 . . . . 10.0 109.03 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.0 pt -92.57 -177.36 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.0 mt -63.19 108.45 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.818 0.342 . . . . 10.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -83.14 154.87 67.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.158 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.57 -176.47 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.796 2.331 . . . . 10.0 111.591 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt 64.53 104.45 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.561 0.538 . . . . 10.0 110.739 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.9 p -90.22 -168.73 2.2 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.976 -0.379 . . . . 10.0 109.976 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.411 HG21 ' C ' ' A' ' 120' ' ' GLY . 1.4 m -83.4 -27.61 7.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.759 -0.376 . . . . 10.0 110.69 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.9 139.19 6.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 10.0 111.719 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -65.23 -56.29 13.63 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.709 0.29 . . . . 10.0 111.294 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.56 -32.94 74.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 87' ' ' ILE . 38.5 t -62.15 -43.71 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.224 -0.898 . . . . 10.0 109.857 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.28 99.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.405 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -63.28 -37.81 88.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.622 . . . . 10.0 109.777 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.494 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . . . -73.92 -29.78 62.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.617 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.728 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 12.4 mt -58.39 -52.3 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.99 -48.98 66.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.552 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.501 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -60.6 -29.27 69.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.354 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.565 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -76.28 -37.84 35.66 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.422 -0.894 . . . . 10.0 113.051 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.728 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.5 mmt180 -79.65 -43.75 22.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.28 0.54 . . . . 10.0 110.747 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.2 -5.44 27.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.04 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 38.8 tttt -78.91 -10.9 59.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.835 0.35 . . . . 10.0 110.643 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.61 172.35 4.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.38 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -120.31 125.12 27.38 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.507 -0.315 . . . . 10.0 110.387 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.52 -39.51 1.3 Allowed 'Cis proline' 0 CA--C 1.519 -0.258 0 C-N-CA 123.617 -1.409 . . . . 10.0 112.544 -0.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.5 m -170.61 120.95 0.58 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.608 -1.178 . . . . 10.0 109.333 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 35.3 tpp -65.28 122.5 17.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.8 p -74.47 159.27 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.033 0.444 . . . . 10.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -68.91 -37.66 79.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.178 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.1 -41.67 90.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.02 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -66.19 -46.15 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.144 -0.222 . . . . 10.0 110.808 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tp -65.45 -39.56 92.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.15 -47.55 90.24 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.147 -0.933 . . . . 10.0 111.384 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.82 -43.41 98.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -60.65 -41.74 95.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.899 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 103' ' ' LEU . 38.9 pt -82.84 -7.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.895 0.332 . . . . 10.0 111.895 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.22 29.99 29.3 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.648 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.51 -154.0 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.51 172.36 7.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.535 -0.172 . . . . 10.0 110.535 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.42 89.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.02 0.438 . . . . 10.0 110.336 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.77 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.639 -0.71 . . . . 10.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -62.22 -46.64 87.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 10.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.0 t -65.67 -43.76 93.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.451 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -65.96 -35.09 79.64 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.208 0.527 . . . . 10.0 111.085 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.9 m -77.3 -27.71 53.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.459 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -37.92 89.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.5 -17.83 56.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -64.9 -23.84 67.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.305 0.574 . . . . 10.0 110.405 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.411 ' C ' HG21 ' A' ' 79' ' ' VAL . . . 96.42 24.28 14.53 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.678 -0.772 . . . . 10.0 111.647 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 121' ' ' THR . 8.4 t -175.0 115.02 0.15 Allowed 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.829 0.823 . . . . 10.0 109.549 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.58 30.56 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.898 -1.046 . . . . 10.0 109.585 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.7 m 62.32 97.6 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.08 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.97 90.95 0.94 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.85 2.367 . . . . 10.0 114.515 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.6 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -80.87 124.75 29.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.189 -2.152 . . . . 10.0 105.189 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -51.63 -42.69 62.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -63.99 -39.13 93.42 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.678 0.611 . . . . 10.0 110.84 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.749 ' O ' ' HG3' ' A' ' 132' ' ' MET . 96.9 mt -64.3 -57.08 12.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 120.751 -0.379 . . . . 10.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.3 mt -50.47 -45.65 56.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.505 0.503 . . . . 10.0 110.592 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.2 m -55.32 -46.44 76.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.449 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.636 ' O ' HG21 ' A' ' 135' ' ' VAL . 19.1 mtmt -73.55 -40.35 64.03 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.749 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 29.6 mtp -52.06 -55.22 22.02 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.857 0.837 . . . . 10.0 111.011 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.675 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 27.1 mt-10 -72.98 -31.81 64.78 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.463 -1.244 . . . . 10.0 113.361 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -69.88 -23.43 63.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 131' ' ' LYS . 57.4 t -61.51 -38.17 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 10.0 111.805 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -114.53 -5.91 12.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.92 46.41 0.48 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.226 1.013 . . . . 10.0 109.412 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.675 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 47.7 t -122.68 138.91 51.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.648 -1.614 . . . . 10.0 106.943 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 13.4 mmmm -122.79 140.29 53.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 118.842 0.747 . . . . 10.0 111.792 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.57 18.26 19.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.431 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -113.98 140.53 48.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.494 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.39 -156.61 25.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.749 -0.738 . . . . 10.0 111.92 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.04 0.74 41.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.089 0.471 . . . . 10.0 110.96 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -110.36 51.1 0.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.799 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 146' ' ' GLY . 49.0 mt -72.54 136.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.519 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 94.54 4.4 62.28 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.996 -0.841 . . . . 10.0 110.996 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.28 156.87 73.47 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.278 -0.461 . . . . 10.0 110.245 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -64.55 122.31 10.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.897 1.731 . . . . 10.0 109.387 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.63 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 15.7 tpt180 -155.05 102.59 2.33 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.094 0.473 . . . . 10.0 110.052 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.87 133.7 30.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.08 0.467 . . . . 10.0 111.208 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -120.21 -169.36 14.0 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.403 -1.079 . . . . 10.0 110.403 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.46 102.6 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.46 2.106 . . . . 10.0 112.068 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -148.2 96.09 2.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.672 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -147.67 166.36 27.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.202 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.0 tttm . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.135 -0.936 . . . . 10.0 109.073 179.593 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 112.386 -0.285 . . . . 10.0 112.386 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.58 157.27 41.71 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.8 tpt -149.29 120.65 7.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.875 0.369 . . . . 10.0 110.909 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.84 143.5 48.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 166.65 28.42 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.638 2.225 . . . . 10.0 113.245 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.63 162.64 16.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.847 -0.615 . . . . 10.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -145.18 157.78 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.2 144.66 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.21 175.51 42.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.247 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.62 148.85 18.68 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.751 -0.738 . . . . 10.0 112.453 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.6 m -91.64 127.88 37.26 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.039 -0.356 . . . . 10.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.73 167.17 15.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.997 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.04 166.77 28.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.714 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -123.06 165.17 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.813 0.306 . . . . 10.0 111.026 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.74 158.61 6.12 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.331 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.64 165.25 26.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.737 0.303 . . . . 10.0 110.523 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.3 m -112.95 138.14 50.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.449 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -131.33 115.54 16.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.438 -0.346 . . . . 10.0 110.458 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.98 126.72 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.893 0.377 . . . . 10.0 111.228 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -159.34 163.79 35.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.062 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -149.7 118.96 6.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.673 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.3 m -154.28 125.32 7.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.401 . . . . 10.0 110.277 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.06 119.43 10.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.069 0.461 . . . . 10.0 110.573 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.05 26.6 9.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.698 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 73' ' ' ILE . 18.7 mm 65.15 34.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.425 -0.807 . . . . 10.0 110.156 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 pt -133.77 136.07 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.357 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -132.88 76.02 71.44 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.034 -0.53 . . . . 10.0 109.644 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.73 85.56 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.016 2.477 . . . . 10.0 111.653 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 1.8 mptp? 52.74 41.66 31.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.217 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 p -131.17 161.33 32.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.196 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.407 HG23 ' C ' ' A' ' 120' ' ' GLY . 1.5 m -82.88 -29.94 8.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.831 0.308 . . . . 10.0 111.831 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.31 140.7 8.04 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.111 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.46 -49.84 67.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.882 0.341 . . . . 10.0 111.682 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -59.35 -38.45 80.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.375 0.607 . . . . 10.0 109.742 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.03 -42.93 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.1 -0.955 . . . . 10.0 110.134 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.29 -43.61 96.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.14 -0.552 . . . . 10.0 112.538 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -61.34 -43.06 99.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.188 0.518 . . . . 10.0 109.902 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.83 -29.69 67.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.33 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.792 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.2 mt -58.1 -48.54 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.981 -0.378 . . . . 10.0 109.981 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.69 -48.57 63.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.248 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.26 -33.39 73.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.67 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.73 -30.15 68.72 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.793 -0.639 . . . . 10.0 113.264 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.792 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 13.0 mmt85 -77.37 -29.41 53.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -79.1 -8.06 58.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 10.0 109.717 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -75.14 -8.5 56.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.929 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -168.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -133.21 110.35 12.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.469 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.13 -30.64 5.69 Favored 'Cis proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.225 -1.573 . . . . 10.0 112.522 -0.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.6 m -170.45 134.37 1.13 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.802 -1.544 . . . . 10.0 109.65 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 122.13 22.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.5 p -69.89 158.15 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 10.0 111.102 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -67.41 -36.08 80.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.845 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.58 78.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.358 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.47 -47.17 86.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.362 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.5 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -64.94 -40.71 95.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.574 -0.528 . . . . 10.0 109.574 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -48.38 81.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.214 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -64.02 -38.04 89.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.966 0.412 . . . . 10.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -39.39 92.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.635 -0.711 . . . . 10.0 111.296 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 103' ' ' LEU . 32.6 pt -89.07 -28.63 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.85 6.1 21.35 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.59 -0.814 . . . . 10.0 112.818 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -106.33 -164.39 1.0 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 171.07 7.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.103 -0.239 . . . . 10.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.85 -38.05 80.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 10.0 110.402 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.42 75.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.526 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 9.7 m -66.98 -40.28 87.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.283 0.563 . . . . 10.0 110.271 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.75 -37.23 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.82 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -72.44 -33.03 66.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.38 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 52.3 p -76.58 -29.1 56.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.924 0.392 . . . . 10.0 111.6 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.411 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.3 m-85 -63.18 -36.7 84.49 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -63.61 -18.57 64.05 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 116' ' ' SER . 61.5 ttt180 -68.13 -18.76 64.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.229 0.538 . . . . 10.0 110.657 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.407 ' C ' HG23 ' A' ' 79' ' ' VAL . . . 91.3 28.84 13.6 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.247 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 121' ' ' THR . 5.2 t -175.96 111.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.917 0.865 . . . . 10.0 109.793 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.94 34.34 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.946 -1.025 . . . . 10.0 110.057 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m 63.28 99.23 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.454 -0.793 . . . . 10.0 109.137 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.424 ' HA ' HD22 ' A' ' 129' ' ' LEU . 92.2 Cg_endo -77.16 88.55 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.996 2.464 . . . . 10.0 115.727 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.584 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 5.9 t70 -81.68 116.07 21.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -48.65 -41.11 30.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 -176.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.6 t30 -68.78 -42.24 77.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.783 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' A' ' 132' ' ' MET . 66.7 mt -60.46 -55.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 121.186 -0.206 . . . . 10.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 7.5 mt -47.65 -47.23 29.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.659 0.599 . . . . 10.0 110.325 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 28.0 m -57.95 -38.65 76.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.211 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 74.6 mmtt -73.66 -36.78 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 10.0 111.464 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.561 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 18.9 mtp -54.22 -57.15 12.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.481 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.588 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -73.36 -26.69 61.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.871 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.7 OUTLIER -52.58 -38.54 60.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 -177.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.43 -26.7 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.881 -0.327 . . . . 10.0 111.234 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -92.33 -21.18 20.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.252 0.464 . . . . 10.0 112.252 -178.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 57.5 m-20 70.45 48.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.601 0.715 . . . . 10.0 110.184 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.06 169.41 21.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.852 -1.067 . . . . 10.0 108.557 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -137.64 133.21 34.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.938 0.399 . . . . 10.0 110.45 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.588 ' HG ' ' OE2' ' A' ' 133' ' ' GLU . 8.2 mt -100.86 12.0 38.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.583 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -125.4 139.86 53.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.94 -153.72 17.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.342 -0.703 . . . . 10.0 111.342 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.99 -33.57 10.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.968 0.413 . . . . 10.0 111.16 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -87.43 55.65 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.263 0.554 . . . . 10.0 110.576 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.578 HG22 ' N ' ' A' ' 146' ' ' GLY . 71.0 mt -69.0 141.17 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.658 . . . . 10.0 111.323 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.578 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 86.94 -5.54 84.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.152 -0.546 . . . . 10.0 111.831 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.64 158.21 62.92 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.304 -0.448 . . . . 10.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.01 122.47 10.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.167 1.912 . . . . 10.0 110.849 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -151.33 81.23 1.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.546 0.689 . . . . 10.0 110.046 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.614 ' HB3' ' CB ' ' A' ' 154' ' ' LYS . 4.1 mm? -106.65 -26.71 11.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.356 -0.838 . . . . 10.0 110.329 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.34 -171.31 46.65 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.762 -0.653 . . . . 10.0 112.301 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.71 141.47 41.44 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.595 2.197 . . . . 10.0 111.802 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt 57.18 53.56 7.68 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.34 0.59 . . . . 10.0 110.319 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.614 ' CB ' ' HB3' ' A' ' 150' ' ' LEU . 55.3 pttt -63.7 139.62 58.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.482 -0.781 . . . . 10.0 111.467 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 42.8 tttm . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.192 -0.908 . . . . 10.0 109.888 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.81 -0.516 . . . . 10.0 111.81 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.83 134.11 21.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.928 0.394 . . . . 10.0 110.97 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.5 mtm -129.59 132.79 46.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.604 . . . . 10.0 109.835 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.18 121.85 6.7 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.612 -0.267 . . . . 10.0 110.366 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.85 122.03 10.39 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.661 2.24 . . . . 10.0 112.425 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.35 137.87 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.596 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -138.44 140.21 39.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.806 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -104.28 -44.64 4.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.032 0.444 . . . . 10.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.61 -119.8 5.06 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.416 -0.674 . . . . 10.0 111.416 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 141.36 117.37 1.34 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.9 m -103.62 142.15 34.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.749 0.309 . . . . 10.0 110.648 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.12 -150.51 0.43 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.267 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.09 -168.05 40.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.013 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -154.17 176.94 11.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 10.0 110.998 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -131.36 -173.31 3.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.108 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 pp -144.67 162.08 37.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.344 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.8 m -150.5 124.89 9.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.961 0.41 . . . . 10.0 110.925 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 144.48 30.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.915 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.61 153.34 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.703 0.287 . . . . 10.0 110.531 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.97 177.02 11.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.03 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 69' ' ' ARG . 10.6 ptt-85 -141.07 21.43 2.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.489 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 m -133.66 47.55 2.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.564 0.697 . . . . 10.0 109.393 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -97.9 97.14 8.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.306 -0.861 . . . . 10.0 111.132 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.51 -27.49 15.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.491 -0.777 . . . . 10.0 110.645 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.0 tt -84.15 138.99 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.898 -0.592 . . . . 10.0 111.004 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -70.41 154.35 8.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.535 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.44 ' HB2' HG22 ' A' ' 123' ' ' THR . 39.9 mttm -104.35 147.56 34.57 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.54 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.63 170.33 20.54 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.565 2.177 . . . . 10.0 111.683 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt 66.47 96.72 0.05 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.764 0.665 . . . . 10.0 110.661 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.428 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 23.6 p -83.72 -173.57 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.629 -0.714 . . . . 10.0 110.764 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.509 HG13 ' CG2' ' A' ' 83' ' ' VAL . 3.0 t -82.26 -68.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.628 -0.26 . . . . 10.0 111.299 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 83' ' ' VAL . . . 146.64 161.6 9.4 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 111.574 -0.611 . . . . 10.0 111.574 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -78.87 -55.02 5.47 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 -178.363 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.507 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.1 tp10 -71.97 -28.61 63.54 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.511 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.509 ' CG2' HG13 ' A' ' 79' ' ' VAL . 6.6 m -64.27 -36.4 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.252 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.16 -47.22 90.08 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.496 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.33 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 10.0 110.816 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.78 68.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.414 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.752 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.3 mt -61.23 -49.76 83.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.95 -53.06 60.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.622 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.4 mt-30 -59.22 -39.8 83.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.043 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.47 -35.34 91.59 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.855 -0.688 . . . . 10.0 113.544 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.752 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.4 -39.63 28.01 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.042 0.449 . . . . 10.0 110.509 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -69.91 -25.1 63.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.733 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 39.2 tttm -80.0 54.42 1.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.712 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -126.1 3.38 7.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 54.99 101.24 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.915 0.759 . . . . 10.0 112.817 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.79 -30.56 4.63 Favored 'Cis proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.176 -1.593 . . . . 10.0 112.61 -0.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -174.81 129.78 0.32 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.837 -1.529 . . . . 10.0 110.007 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.6 tpp -76.69 143.1 40.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.929 -0.397 . . . . 10.0 109.929 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 145.39 50.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.631 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.69 -41.89 74.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.062 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.68 83.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.953 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -70.93 -32.01 68.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.492 -0.322 . . . . 10.0 110.339 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -63.81 -43.38 96.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.02 -37.4 91.99 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.157 -0.929 . . . . 10.0 111.357 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -65.47 -35.4 80.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 10.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.71 -40.49 84.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.844 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 29.6 pt -87.81 -22.54 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 34.38 5.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.478 -0.868 . . . . 10.0 112.382 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -129.64 -171.79 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.859 0.362 . . . . 10.0 110.444 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 166.96 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.567 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.4 91.01 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.523 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.71 -32.86 70.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.55 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -60.43 -47.09 87.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.096 -0.502 . . . . 10.0 109.998 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.48 -46.47 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.8 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.32 -35.86 80.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.322 0.582 . . . . 10.0 111.069 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.3 m -75.26 -27.96 59.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.641 ' OH ' ' HA ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -63.74 -38.91 92.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.801 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -65.09 -18.42 65.29 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.053 0.39 . . . . 10.0 112.053 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -78.39 -18.67 54.71 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.62 14.54 46.7 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.431 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.457 HG21 ' O ' ' A' ' 121' ' ' THR . 7.5 t -160.04 106.1 1.58 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.173 0.987 . . . . 10.0 109.802 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.89 24.6 0.5 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.714 -1.13 . . . . 10.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 75' ' ' LYS . 3.8 m 59.67 80.63 0.27 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.288 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.641 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 72.9 Cg_endo -75.21 158.8 41.18 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.785 2.323 . . . . 10.0 114.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.697 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.6 t70 -137.48 140.17 41.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.257 -1.338 . . . . 10.0 107.86 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -54.73 -40.2 69.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.582 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.97 -35.45 72.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.548 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.74 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.1 mt -66.78 -57.33 10.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 120.581 -0.448 . . . . 10.0 110.234 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.3 mt -50.13 -39.64 43.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.744 0.783 . . . . 10.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 72.1 m -62.56 -50.32 71.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 10.0 111.488 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.582 ' HD3' ' O ' ' A' ' 127' ' ' ASN . 1.5 mptp? -74.91 -31.33 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 10.0 112.449 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.74 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 52.9 mtp -60.32 -59.38 5.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.577 0.703 . . . . 10.0 111.403 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.689 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 2.9 mp0 -74.56 -25.49 59.33 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 19.6 ptt180 -56.87 -26.9 59.63 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.358 0.526 . . . . 10.0 111.395 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.09 -25.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.148 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -100.29 -19.23 16.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.795 0.294 . . . . 10.0 111.795 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 68.34 43.16 1.52 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.606 0.717 . . . . 10.0 111.312 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.689 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.8 m -136.68 140.1 43.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.342 -1.355 . . . . 10.0 107.342 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 3.4 mmpt? -116.65 135.49 53.75 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.806 -0.758 . . . . 10.0 111.058 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.29 36.05 2.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.125 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -138.21 139.21 39.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.235 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.14 -163.07 21.99 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.309 -0.716 . . . . 10.0 111.309 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.92 23.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.968 0.413 . . . . 10.0 110.399 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -85.93 55.27 3.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.752 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.532 HG21 ' N ' ' A' ' 146' ' ' GLY . 8.2 mm -68.57 138.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.477 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.532 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 82.91 2.5 90.67 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.464 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.32 160.68 56.46 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.815 -0.192 . . . . 10.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -62.52 120.37 7.87 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.451 1.434 . . . . 10.0 109.506 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? -149.5 89.77 1.66 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.771 0.32 . . . . 10.0 110.178 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.63 82.38 6.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.799 0.809 . . . . 10.0 110.841 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -136.46 76.52 0.37 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.729 -1.123 . . . . 10.0 110.663 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.24 -178.77 2.29 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.514 2.142 . . . . 10.0 112.861 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -89.3 -172.76 3.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.977 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.87 161.01 31.24 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.579 -0.724 . . . . 10.0 110.473 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.872 0 N-CA-C 111.828 -0.509 . . . . 10.0 111.828 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.59 115.75 19.39 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.834 0.35 . . . . 10.0 110.714 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.1 mtm -127.72 146.13 50.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.239 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 t70 62.0 99.19 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 123.818 0.699 . . . . 10.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -88.9 164.61 5.98 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.995 2.463 . . . . 10.0 111.797 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.01 139.89 50.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.224 -0.287 . . . . 10.0 110.224 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -121.41 169.91 10.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.364 . . . . 10.0 110.868 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.81 172.5 17.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.901 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.94 121.0 2.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.518 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.5 124.24 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.025 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 t -144.54 139.08 27.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.006 0.432 . . . . 10.0 110.429 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -106.83 -65.79 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.66 175.27 29.63 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.771 -0.65 . . . . 10.0 111.82 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -155.3 138.89 15.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.774 -0.454 . . . . 10.0 109.774 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -125.65 136.53 53.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.58 148.65 24.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.477 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -96.76 148.87 22.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.733 -0.667 . . . . 10.0 109.775 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -83.5 114.88 21.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.616 0.245 . . . . 10.0 110.712 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 p -167.39 141.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.423 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -132.61 158.45 42.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.195 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -131.02 157.43 43.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.53 -0.305 . . . . 10.0 110.302 179.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.5 m -91.93 85.26 5.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.581 -0.526 . . . . 10.0 109.581 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -123.42 -173.72 2.8 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.759 -0.655 . . . . 10.0 109.647 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -116.34 -22.08 8.98 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.714 -0.676 . . . . 10.0 111.005 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.4 tt -66.73 126.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.152 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 pt -76.26 126.88 37.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.081 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -133.57 153.69 80.4 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.423 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.93 36.64 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.919 2.413 . . . . 10.0 112.31 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -107.5 13.63 26.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.372 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.5 p -133.02 163.45 29.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.537 -0.756 . . . . 10.0 109.796 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.587 HG11 ' O ' ' A' ' 121' ' ' THR . 4.9 m -79.87 -35.14 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.822 -0.351 . . . . 10.0 111.063 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.95 147.9 6.85 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.97 -53.05 35.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.068 0.434 . . . . 10.0 111.626 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -69.15 -33.45 73.43 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 140' ' ' LEU . 38.3 t -58.72 -41.28 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.69 -1.141 . . . . 10.0 109.951 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.8 -41.47 97.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.131 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -64.56 -45.11 88.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.946 0.403 . . . . 10.0 109.958 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.05 77.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.733 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.669 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.6 mt -58.73 -46.01 90.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.733 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.12 -49.15 59.65 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.042 0.448 . . . . 10.0 110.401 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -61.4 -36.55 80.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.7 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.56 98.01 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.039 -0.528 . . . . 10.0 114.013 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 17.7 mmt-85 -69.84 -36.58 75.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.383 0.591 . . . . 10.0 110.254 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -82.42 -5.89 58.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.781 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -89.03 14.58 10.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.846 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.87 -17.7 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.876 0.325 . . . . 10.0 111.876 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 60.55 106.95 0.03 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.937 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.98 -59.03 0.14 OUTLIER 'Cis proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.534 -1.444 . . . . 10.0 112.347 0.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.0 m -157.51 124.07 4.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.878 -1.055 . . . . 10.0 110.732 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.6 tpp -72.49 141.66 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 142.75 55.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.995 0.426 . . . . 10.0 111.037 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -70.5 -37.37 74.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.473 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.23 76.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.195 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.06 -41.93 40.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.817 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.417 ' HG ' ' HD2' ' A' ' 91' ' ' ARG . 1.2 tm? -64.11 -38.33 90.67 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.1 -46.24 59.19 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.391 -0.822 . . . . 10.0 111.555 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -58.09 -39.06 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 10.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.08 -39.29 89.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.301 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.404 HG22 HD12 ' A' ' 107' ' ' ILE . 17.6 pt -92.91 4.01 7.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.15 71.88 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.959 -0.638 . . . . 10.0 113.926 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.446 ' OE1' HG21 ' A' ' 113' ' ' THR . 32.0 mm-40 -109.46 -162.8 0.82 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.0 p -125.24 174.7 7.92 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.252 -0.28 . . . . 10.0 111.048 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.84 87.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.321 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.31 77.62 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.347 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.446 HG21 ' OE1' ' A' ' 109' ' ' GLU . 2.6 m -62.4 -50.32 72.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.43 -42.68 91.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 10.0 110.232 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.44 -37.04 82.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.925 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 m -74.84 -27.44 60.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.17 -0.468 . . . . 10.0 111.967 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.33 -32.75 70.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.153 0.427 . . . . 10.0 112.153 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -18.14 41.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.42 ' HG2' ' CG2' ' A' ' 121' ' ' THR . 1.6 ttt85 -61.89 -24.01 66.67 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.02 0.438 . . . . 10.0 111.093 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.424 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.13 23.8 11.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.348 -0.93 . . . . 10.0 113.933 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.587 ' O ' HG11 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -154.73 -88.46 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.824 0.312 . . . . 10.0 110.651 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.413 ' H ' ' CG2' ' A' ' 121' ' ' THR . . . 58.78 11.79 1.98 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.527 0.936 . . . . 10.0 113.527 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m 45.64 76.59 0.53 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.544 ' HB2' HD21 ' A' ' 129' ' ' LEU . 42.6 Cg_endo -89.01 147.46 5.58 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.308 2.672 . . . . 10.0 116.962 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.31 129.33 42.48 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 103.994 -2.595 . . . . 10.0 103.994 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.446 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.6 mm-40 -55.84 -29.55 60.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.8 mt -68.41 -48.4 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 110.431 -0.211 . . . . 10.0 110.431 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 124' ' ' PRO . 5.4 mt -57.76 -36.47 72.15 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.404 0.621 . . . . 10.0 109.883 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -66.04 -49.52 67.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.142 -0.935 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.525 ' O ' HG21 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -74.48 -38.62 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.751 1.019 . . . . 10.0 113.751 -178.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.1 ptm -61.2 -50.25 73.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.009 0.368 . . . . 10.0 111.543 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.605 ' CD ' HH22 ' A' ' 91' ' ' ARG . 15.5 mm-40 -76.91 -29.03 55.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.253 0.834 . . . . 10.0 113.253 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -62.61 -23.38 67.02 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.133 -0.354 . . . . 10.0 111.478 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 131' ' ' LYS . 59.1 t -63.1 -34.18 65.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.189 0.519 . . . . 10.0 110.311 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.59 HD11 ' OE1' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.12 3.65 28.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.881 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.6 t30 70.18 51.79 0.39 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.579 0.704 . . . . 10.0 110.27 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.421 ' CG2' HD13 ' A' ' 136' ' ' LEU . 22.2 t -132.59 152.32 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.129 -0.941 . . . . 10.0 109.606 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 26.0 mmmt -131.04 145.15 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 10.0 110.512 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.476 ' HG ' ' HG3' ' A' ' 133' ' ' GLU . 27.6 mt -106.86 20.16 19.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.118 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -134.21 139.28 45.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.841 0.353 . . . . 10.0 110.948 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.33 -157.37 15.15 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.543 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.41 -30.59 14.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.075 0.464 . . . . 10.0 110.007 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.83 59.04 5.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.645 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.51 HD13 HG21 ' A' ' 145' ' ' ILE . 15.5 mm -66.9 137.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 10.0 110.652 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.461 ' N ' HG22 ' A' ' 145' ' ' ILE . . . 80.45 10.32 85.46 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.23 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -133.81 157.14 78.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.372 -0.414 . . . . 10.0 110.381 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.12 123.82 13.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.557 2.171 . . . . 10.0 111.235 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.603 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 5.2 tmm_? -142.42 125.21 16.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.5 mt -73.85 113.69 11.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.235 0.541 . . . . 10.0 110.327 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.502 ' HA3' ' NH1' ' A' ' 149' ' ' ARG . . . 178.0 73.8 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.43 -0.804 . . . . 10.0 111.361 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.96 125.86 13.1 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.713 2.275 . . . . 10.0 112.63 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -129.35 152.55 48.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -138.94 -52.28 0.56 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.064 -0.516 . . . . 10.0 109.928 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.529 -0.748 . . . . 10.0 110.487 179.892 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 112.01 -0.436 . . . . 10.0 112.01 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.27 170.71 15.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.468 -0.197 . . . . 10.0 110.468 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.2 ttm -133.59 125.25 28.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.861 0.363 . . . . 10.0 110.916 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.08 146.04 31.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.945 -0.57 . . . . 10.0 109.903 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.9 168.46 24.15 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.402 . . . . 10.0 112.699 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -107.6 160.01 16.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.799 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.89 136.89 25.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.725 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.72 168.32 26.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 10.0 111.122 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.58 170.04 29.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.9 -178.69 25.08 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.398 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -147.72 138.42 23.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.118 -0.327 . . . . 10.0 110.118 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -94.55 -64.66 1.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.988 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.65 -166.89 13.76 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.896 -0.669 . . . . 10.0 111.475 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.54 145.76 9.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.074 0.437 . . . . 10.0 110.802 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -153.5 141.32 20.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.294 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -148.87 110.52 4.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.141 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.38 150.75 43.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.189 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -117.57 178.8 4.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.379 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.73 150.19 26.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.791 0.329 . . . . 10.0 111.241 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -100.87 151.11 22.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.83 -0.433 . . . . 10.0 109.83 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -147.76 138.14 23.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.378 -0.374 . . . . 10.0 110.679 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -55.81 4.15 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.238 -0.652 . . . . 10.0 109.238 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 50.17 56.95 7.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.088 -0.96 . . . . 10.0 112.04 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.45 12.52 33.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.688 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.6 pt -72.84 179.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.112 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.2 mt -80.25 108.58 13.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -76.1 113.17 25.35 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 10.0 110.542 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 96.3 Cg_endo -90.71 -147.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.999 2.466 . . . . 10.0 112.064 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.435 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 34.2 mmtp -89.21 33.55 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.148 0.499 . . . . 10.0 111.082 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.1 p -120.05 161.06 21.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.424 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.5 m -88.35 -25.37 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.567 -0.453 . . . . 10.0 111.541 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.32 138.57 5.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.906 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -67.65 -39.56 84.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 10.0 111.861 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.99 -31.49 50.7 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 87' ' ' ILE . 42.7 t -66.02 -40.22 86.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.184 -0.916 . . . . 10.0 110.056 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.39 -41.74 95.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.891 -0.671 . . . . 10.0 112.12 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -39.5 74.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.163 0.506 . . . . 10.0 110.051 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.32 70.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.817 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 83' ' ' VAL . 7.9 mt -59.47 -45.53 93.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.081 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.93 -53.87 13.44 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.754 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 35.0 mt-30 -54.05 -34.91 61.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.351 -0.84 . . . . 10.0 111.267 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.4 -34.87 39.04 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.754 -0.736 . . . . 10.0 112.766 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.654 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -80.13 -33.61 38.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.019 0.438 . . . . 10.0 110.357 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -73.33 -2.62 22.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.1 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 48.4 mttm -83.25 -2.68 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.015 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.457 ' CE1' HG11 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -78.0 177.06 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.584 -0.735 . . . . 10.0 110.589 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -120.69 121.27 29.13 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.319 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.98 -29.32 6.82 Favored 'Cis proline' 0 CA--C 1.515 -0.445 0 C-N-CA 123.723 -1.365 . . . . 10.0 112.693 -0.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 m -179.05 122.43 0.08 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 113.754 -1.566 . . . . 10.0 109.324 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.8 ttm -70.46 110.87 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.211 -0.292 . . . . 10.0 110.211 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.567 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.9 p -78.51 172.37 13.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.869 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -62.84 -35.7 80.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.769 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.73 -42.42 81.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.005 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.567 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 16.8 mm-40 -68.52 -48.82 63.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.917 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -61.06 -42.22 98.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.34 98.16 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.575 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -65.99 -36.03 82.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.792 0.33 . . . . 10.0 110.659 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.26 -40.99 77.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.792 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 103' ' ' LEU . 35.9 pt -83.48 -17.71 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.884 -0.326 . . . . 10.0 111.689 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.91 27.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 10.0 112.77 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -119.89 -169.71 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.769 0.318 . . . . 10.0 110.225 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.7 p -98.98 168.2 10.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.535 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.05 78.6 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.863 0.364 . . . . 10.0 110.623 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.244 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.221 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.77 -43.2 90.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.52 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -64.02 -35.23 80.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.443 0.64 . . . . 10.0 110.463 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 48.9 m -76.13 -27.03 56.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.18 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -43.16 77.39 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.676 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.24 -18.69 59.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.975 0.417 . . . . 10.0 111.729 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.498 ' HB3' ' O ' ' A' ' 116' ' ' SER . 48.3 ttp180 -67.25 -21.63 65.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.312 0.577 . . . . 10.0 110.636 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.424 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 95.22 20.34 28.02 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.728 -0.749 . . . . 10.0 111.692 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.47 HG21 ' O ' ' A' ' 121' ' ' THR . 5.3 t -172.62 108.36 0.19 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.01 0.91 . . . . 10.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.28 30.29 0.2 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.544 -1.207 . . . . 10.0 109.547 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m 60.63 96.4 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.126 -0.943 . . . . 10.0 110.032 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.42 94.84 0.26 Allowed 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 123.173 2.582 . . . . 10.0 113.952 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.705 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.0 t70 -85.97 120.0 26.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.616 -1.253 . . . . 10.0 107.616 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -52.98 -37.97 61.79 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.466 0.479 . . . . 10.0 111.89 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -68.49 -44.36 74.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.047 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.617 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.9 mt -64.13 -54.11 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.185 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 17.6 mt -50.61 -41.83 55.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.269 0.557 . . . . 10.0 110.189 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.3 m -59.61 -49.72 76.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.274 -0.875 . . . . 10.0 111.096 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.659 ' O ' HG21 ' A' ' 135' ' ' VAL . 1.8 mptp? -67.48 -40.26 85.27 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.377 0.51 . . . . 10.0 112.377 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -49.01 -58.31 5.12 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.441 0.638 . . . . 10.0 111.765 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 24.9 mt-10 -75.38 -28.63 59.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.413 -0.812 . . . . 10.0 112.805 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -64.88 -22.97 67.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.926 0.713 . . . . 10.0 112.926 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.659 HG21 ' O ' ' A' ' 131' ' ' LYS . 21.2 t -67.9 -25.0 31.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.631 . . . . 10.0 110.006 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -122.17 -100.44 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.198 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 63.5 t30 174.29 64.02 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.407 -0.815 . . . . 10.0 109.251 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.3 OUTLIER -136.23 155.83 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.274 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HA ' ' OE1' ' A' ' 133' ' ' GLU . 4.6 mmtm -130.82 132.36 45.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.044 0.45 . . . . 10.0 110.969 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.49 ' HG ' ' CD ' ' A' ' 133' ' ' GLU . 13.5 mt -104.64 17.97 23.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.196 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 141' ' ' ARG . 40.0 mtp-105 -127.96 144.42 51.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.751 -0.658 . . . . 10.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.16 -155.38 19.54 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.443 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.73 15.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.653 0.263 . . . . 10.0 111.523 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.45 52.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.035 0.445 . . . . 10.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.495 HG21 ' N ' ' A' ' 146' ' ' GLY . 54.7 mt -68.69 139.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.737 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.495 ' N ' HG21 ' A' ' 145' ' ' ILE . . . 83.95 12.01 77.86 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.176 -0.77 . . . . 10.0 111.176 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.01 152.37 64.96 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.925 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.1 120.09 7.42 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.779 1.652 . . . . 10.0 108.737 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -176.73 89.49 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.126 0.489 . . . . 10.0 110.088 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.04 167.07 12.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.952 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.65 -162.37 18.05 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.836 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.64 156.36 61.2 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.892 2.395 . . . . 10.0 112.613 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -123.59 108.74 12.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.616 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -89.89 161.01 16.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.366 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.526 -0.75 . . . . 10.0 110.477 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.666 -0.574 . . . . 10.0 111.666 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.0 87.95 3.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.856 0.36 . . . . 10.0 110.293 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.6 mmt -61.42 -46.21 91.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.328 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.57 84.12 23.63 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.96 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.27 133.66 23.28 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.273 1.982 . . . . 10.0 111.331 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.23 120.98 25.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.729 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -87.61 159.63 18.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.269 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.28 155.18 17.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.614 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.06 -135.65 8.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.919 -0.657 . . . . 10.0 111.809 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.68 171.05 34.21 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.665 -0.778 . . . . 10.0 112.424 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -137.37 136.21 37.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.743 -0.466 . . . . 10.0 109.743 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -135.43 150.54 49.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.566 0.222 . . . . 10.0 110.62 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.96 173.2 22.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 10.0 111.962 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -113.44 -172.26 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.679 0.276 . . . . 10.0 110.811 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -119.97 -179.75 4.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.74 0.305 . . . . 10.0 110.832 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.5 mt -101.9 -173.99 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.329 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.44 135.94 57.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.817 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -81.38 134.91 35.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.237 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.89 136.05 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.716 -0.675 . . . . 10.0 109.921 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.12 138.18 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 10.0 110.986 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -145.84 157.54 43.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.577 -0.738 . . . . 10.0 109.93 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.8 m -69.44 118.74 12.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.896 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -160.35 131.82 5.86 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.558 -0.534 . . . . 10.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -94.57 8.97 40.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.31 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.3 tt -60.38 140.41 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.064 0.459 . . . . 10.0 111.085 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.6 pt -69.9 142.33 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.9 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -125.64 155.22 72.67 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.67 -0.695 . . . . 10.0 109.185 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.6 -163.64 0.06 OUTLIER 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.424 2.083 . . . . 10.0 111.6 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -66.48 89.88 0.15 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.44 0.638 . . . . 10.0 110.188 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 p -135.59 168.52 19.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.144 -0.934 . . . . 10.0 109.865 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -84.93 -28.76 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 121.073 -0.251 . . . . 10.0 111.301 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.19 135.63 5.16 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.593 -0.813 . . . . 10.0 112.28 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -65.26 -48.1 74.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.615 0.245 . . . . 10.0 111.364 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.33 -34.91 79.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.456 HG23 ' HB3' ' A' ' 140' ' ' LEU . 25.0 t -59.28 -46.99 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.546 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.16 95.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.044 -0.598 . . . . 10.0 112.19 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -64.52 -43.86 92.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 10.0 110.378 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.3 82.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.794 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.78 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.8 mt -56.34 -47.67 80.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -66.16 -49.22 68.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.62 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.16 -37.16 84.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.215 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.96 -34.29 89.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.927 -0.654 . . . . 10.0 112.916 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.78 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.8 mmt180 -76.27 -34.71 59.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.287 0.565 . . . . 10.0 109.689 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.438 ' HA ' HG22 ' A' ' 97' ' ' THR . 96.8 mt-30 -75.36 -14.38 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -98.55 21.69 10.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.438 -0.346 . . . . 10.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -7.08 59.7 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.817 0.302 . . . . 10.0 111.817 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 54.41 101.17 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.662 0 O-C-N 123.984 0.803 . . . . 10.0 112.228 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.4 -50.93 0.17 OUTLIER 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.218 -1.576 . . . . 10.0 113.18 0.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 92' ' ' GLN . 21.5 m -163.49 137.15 5.72 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.891 . . . . 10.0 110.169 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.99 132.21 37.29 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.88 -0.415 . . . . 10.0 109.88 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.494 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.2 p -75.55 163.46 27.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 10.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.21 -29.69 67.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.679 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.14 84.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.127 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.494 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 55.8 mm-40 -62.8 -49.33 75.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.475 -0.329 . . . . 10.0 111.004 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.623 ' O ' HG12 ' A' ' 107' ' ' ILE . 24.5 tp -62.03 -47.08 86.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.04 -46.19 91.69 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.076 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -64.82 -42.16 95.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.754 0.279 . . . . 10.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 15.5 pt-20 -69.65 -23.99 63.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 103' ' ' LEU . 27.6 pt -97.3 -7.04 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.769 -0.582 . . . . 10.0 111.127 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.54 16.34 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.745 -0.74 . . . . 10.0 112.664 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -130.04 -156.64 0.77 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.74 -0.467 . . . . 10.0 109.74 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 p -126.11 176.35 7.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.521 0.201 . . . . 10.0 110.818 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.43 95.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.785 0.326 . . . . 10.0 111.208 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 116' ' ' SER . . . -61.11 -30.45 70.37 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.922 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.7 m -68.54 -43.79 75.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.135 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 92.8 t -64.44 -46.17 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.372 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.13 73.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.442 0.639 . . . . 10.0 110.064 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -74.69 -31.89 62.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 10.0 110.667 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.41 -41.18 66.53 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.616 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.53 -18.35 64.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.165 0.507 . . . . 10.0 110.439 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 116' ' ' SER . 19.7 tpt180 -73.97 -19.31 60.7 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.18 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.23 26.56 25.58 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.054 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' THR . 5.3 t -175.23 102.6 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.957 0.884 . . . . 10.0 110.507 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.5 33.24 0.51 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.376 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 m 63.42 98.96 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.226 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 96.54 0.59 Allowed 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 123.348 2.698 . . . . 10.0 115.169 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.92 112.39 24.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.562 -2.384 . . . . 10.0 104.562 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.5 mm-40 -46.56 -38.98 10.23 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.549 1.314 . . . . 10.0 114.549 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.26 -33.09 65.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 111.683 0.253 . . . . 10.0 111.683 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.792 ' O ' ' HG3' ' A' ' 132' ' ' MET . 68.6 mt -70.09 -58.91 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.706 -0.398 . . . . 10.0 111.484 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -35.35 71.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.798 0.332 . . . . 10.0 111.558 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 22.7 m -63.31 -44.09 95.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.545 ' O ' HG23 ' A' ' 135' ' ' VAL . 25.2 mtmt -75.14 -34.58 61.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.011 0.375 . . . . 10.0 112.011 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.792 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 44.2 mtp -51.0 -61.34 2.29 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.325 0.584 . . . . 10.0 112.251 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.601 ' OE1' HG23 ' A' ' 138' ' ' VAL . 9.2 mm-40 -74.33 -26.57 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.684 . . . . 10.0 112.074 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 130' ' ' SER . 9.0 ttp85 -55.99 -37.48 69.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.061 0.458 . . . . 10.0 110.719 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 131' ' ' LYS . 29.8 t -63.92 -31.76 54.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.545 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.599 HD22 ' NH1' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -95.51 -2.11 49.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.306 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.5 t30 65.74 45.3 2.65 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.273 0.559 . . . . 10.0 110.136 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.601 HG23 ' OE1' ' A' ' 133' ' ' GLU . 15.4 m -134.85 155.75 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.648 ' HD2' ' O ' ' A' ' 149' ' ' ARG . 32.0 mttp -133.18 136.62 45.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.255 0.55 . . . . 10.0 110.715 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.456 ' HB3' HG23 ' A' ' 83' ' ' VAL . 3.1 mt -89.38 39.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.291 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -131.32 136.96 48.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.811 -0.356 . . . . 10.0 110.176 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.14 -161.18 24.28 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.867 -0.682 . . . . 10.0 112.24 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.71 -24.73 17.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 10.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -81.37 50.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.336 0.589 . . . . 10.0 110.286 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.509 HD13 HG22 ' A' ' 145' ' ' ILE . 9.7 mm -70.1 139.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.551 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 145' ' ' ILE . . . 88.49 6.15 74.2 Favored Glycine 0 CA--C 1.509 -0.33 0 C-N-CA 120.761 -0.733 . . . . 10.0 111.762 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.31 156.76 78.69 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.274 -0.269 . . . . 10.0 110.274 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.75 124.83 16.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.186 1.924 . . . . 10.0 110.171 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.648 ' O ' ' HD2' ' A' ' 139' ' ' LYS . 4.7 ttt180 -145.95 106.61 4.1 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.07 125.5 24.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.737 0.303 . . . . 10.0 110.642 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -165.5 -172.22 32.65 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.744 -0.543 . . . . 10.0 111.744 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.63 121.72 7.29 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.947 2.432 . . . . 10.0 112.566 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -109.1 168.02 9.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -118.76 117.38 28.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.04 0.448 . . . . 10.0 110.458 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 47.9 tttm . . . . . 0 C--O 1.249 1.032 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.911 -179.538 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 110.155 -0.313 . . . . 10.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -129.05 87.59 53.95 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.326 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.44 165.77 31.42 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.697 2.265 . . . . 10.0 111.844 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -88.88 -179.84 6.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.073 0.464 . . . . 10.0 110.927 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -125.09 147.23 49.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.32 165.66 27.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 10.0 111.16 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.63 148.65 20.06 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.514 -0.635 . . . . 10.0 111.514 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.82 162.16 30.67 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.541 -0.838 . . . . 10.0 112.002 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -144.31 94.23 2.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 10.0 110.347 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -112.81 148.54 34.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.633 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.85 -137.26 2.24 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.699 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 61.51 85.62 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.279 0.561 . . . . 10.0 111.268 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.245 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.7 0.286 . . . . 10.0 111.073 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.481 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -59.35 -42.16 86.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.693 0.257 . . . . 10.0 111.693 -178.281 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 120.74 148.84 8.1 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.441 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -67.4 -55.05 15.3 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.599 0.199 . . . . 10.0 111.52 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.17 -36.22 81.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.314 -0.625 . . . . 10.0 109.314 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 87' ' ' ILE . 43.2 t -58.57 -50.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.189 -0.914 . . . . 10.0 110.553 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.02 -42.37 99.73 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.712 -0.756 . . . . 10.0 112.235 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.88 -43.36 93.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 10.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.7 68.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.861 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.0 mt -60.32 -46.32 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.394 . . . . 10.0 110.26 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.93 -52.12 18.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.235 0.54 . . . . 10.0 110.196 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 11.9 mt-30 -60.69 -34.09 73.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.131 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.5 -28.19 57.99 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.582 -0.818 . . . . 10.0 112.459 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.646 HH12 ' HG3' ' A' ' 133' ' ' GLU . 2.5 mpt_? -80.36 -27.28 38.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.481 0.657 . . . . 10.0 109.807 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.435 ' HA ' HG23 ' A' ' 97' ' ' THR . 99.1 mt-30 -76.53 -9.32 58.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.239 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 10.0 mmtp -85.73 9.06 17.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.413 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.44 -162.58 0.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.556 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 77.9 mm-40 -122.48 104.64 36.93 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.946 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.2 Cg_endo -87.99 -26.71 5.55 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.941 -1.275 . . . . 10.0 112.523 -0.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 92' ' ' GLN . 11.4 m -165.22 122.37 1.51 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.706 -1.588 . . . . 10.0 109.762 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.9 tpp -82.76 112.86 19.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.794 -0.447 . . . . 10.0 109.794 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 t -80.82 177.16 9.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.683 0.754 . . . . 10.0 111.971 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.419 ' HA ' HG11 ' A' ' 114' ' ' VAL . 89.4 mt-30 -64.72 -48.84 73.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.241 -1.345 . . . . 10.0 111.352 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.61 96.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.512 -0.313 . . . . 10.0 111.808 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.78 -50.01 66.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 10.0 111.838 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.585 ' O ' HG12 ' A' ' 107' ' ' ILE . 14.3 tp -62.43 -42.02 99.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.62 98.58 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.067 -0.813 . . . . 10.0 111.067 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.412 0.149 . . . . 10.0 111.297 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.4 ' OE1' HG21 ' A' ' 135' ' ' VAL . 12.0 pt-20 -67.58 -34.13 76.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 103' ' ' LEU . 36.7 pt -85.05 -8.32 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.536 -0.465 . . . . 10.0 111.807 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.18 31.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 10.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -123.71 -177.64 3.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.883 0.373 . . . . 10.0 110.662 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.4 170.51 9.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.889 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.8 97.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 10.0 110.783 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.68 72.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.782 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -61.07 -49.91 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.111 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 100' ' ' GLN . 58.9 t -65.46 -44.01 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.295 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.28 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.698 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 16.6 m -75.33 -29.42 59.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.829 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.02 -42.62 72.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.702 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.11 -17.79 64.76 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.765 0.316 . . . . 10.0 111.057 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.538 ' HG2' HG22 ' A' ' 121' ' ' THR . 13.2 ttp85 -69.75 -21.74 63.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.401 0.619 . . . . 10.0 109.855 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.481 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 97.41 20.53 22.35 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.922 -0.656 . . . . 10.0 111.537 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -175.14 110.17 0.12 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.939 0.876 . . . . 10.0 110.468 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.19 23.13 0.42 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.083 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m 61.19 91.72 0.07 OUTLIER Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HB3' HG12 ' A' ' 79' ' ' VAL . 74.5 Cg_endo -72.4 104.25 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.688 2.259 . . . . 10.0 115.623 -175.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 117.84 25.76 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.056 -2.572 . . . . 10.0 104.056 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 17.1 mm-40 -46.63 -38.67 10.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -64.75 -33.29 75.62 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.813 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.769 ' O ' ' HG3' ' A' ' 132' ' ' MET . 91.7 mt -69.88 -58.73 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.29 -0.256 . . . . 10.0 110.54 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -52.17 -36.99 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.318 0.58 . . . . 10.0 110.955 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.0 m -54.06 -49.94 67.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.252 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.5 mppt? -75.9 -38.5 57.74 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.146 0.424 . . . . 10.0 112.146 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.769 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 38.9 mtp -50.04 -58.27 5.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.315 0.579 . . . . 10.0 111.491 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mp0 -78.65 -29.92 46.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 115.165 1.543 . . . . 10.0 115.165 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -68.77 -34.52 75.71 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.43 0.53 . . . . 10.0 112.43 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 131' ' ' LYS . 87.1 t -60.89 -25.39 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.654 0.264 . . . . 10.0 111.117 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.605 HD21 ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -115.13 2.54 14.16 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.13 60.74 2.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.731 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 1.9 m -143.06 155.94 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 30.3 mmmt -129.98 144.57 51.4 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.871 -0.418 . . . . 10.0 109.871 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.556 ' CD1' HG13 ' A' ' 83' ' ' VAL . 10.3 mt -106.49 40.06 1.7 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.462 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -141.03 135.95 31.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.759 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.88 -149.34 16.68 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.016 -0.612 . . . . 10.0 112.384 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.58 -32.21 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 10.0 110.789 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -87.42 57.89 4.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.67 . . . . 10.0 109.986 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.2 mm -65.1 132.68 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.018 -0.992 . . . . 10.0 111.573 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.18 -1.82 84.86 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -116.31 160.32 36.34 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.555 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.17 115.05 3.09 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.268 1.312 . . . . 10.0 109.231 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? . . . . . 0 C--N 1.315 -0.909 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 110.007 -0.368 . . . . 10.0 110.007 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.57 146.64 62.31 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.679 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.16 163.99 33.92 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.734 2.289 . . . . 10.0 112.08 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 174.01 6.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.824 0.345 . . . . 10.0 111.112 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -153.53 111.55 3.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.856 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.67 155.77 47.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.943 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.91 138.38 10.11 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.082 -0.58 . . . . 10.0 112.164 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.95 126.53 2.8 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 10.0 112.153 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -157.18 131.78 8.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.927 0.394 . . . . 10.0 110.28 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -144.16 143.41 31.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.046 -0.524 . . . . 10.0 109.639 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.32 -159.3 9.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.724 -0.75 . . . . 10.0 111.726 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.39 169.1 17.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.615 0.245 . . . . 10.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 10.0 109.982 179.718 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 110.268 -0.271 . . . . 10.0 110.268 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.521 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.3 m -83.1 -33.18 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.4 145.84 8.7 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.321 -0.942 . . . . 10.0 112.302 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -71.59 -28.82 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.892 0.33 . . . . 10.0 111.892 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -38.88 72.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 140' ' ' LEU . 54.2 t -61.44 -44.7 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.461 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.04 98.03 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.944 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -62.95 -43.95 97.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.331 . . . . 10.0 110.753 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 89' ' ' GLN . . . -70.48 -37.95 74.31 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.649 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.777 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.7 mt -55.35 -48.48 76.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.655 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.08 -42.45 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.046 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 86' ' ' ALA . 2.6 pt20 -66.35 -30.7 71.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 10.0 109.926 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.676 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -71.06 -39.98 62.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.844 -0.693 . . . . 10.0 113.0 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.777 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 12.8 mmt85 -66.08 -38.32 87.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.141 0.496 . . . . 10.0 110.606 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -83.7 -0.93 52.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -80.1 -11.7 59.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.259 0.552 . . . . 10.0 110.367 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -171.97 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.803 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 29.5 mt-10 -131.55 110.87 14.94 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.658 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 72.7 Cg_endo -79.77 -32.84 3.79 Favored 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.325 -1.531 . . . . 10.0 112.543 -0.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.6 m -163.95 131.19 3.32 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.413 -1.267 . . . . 10.0 110.204 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.452 ' HG2' HD23 ' A' ' 103' ' ' LEU . 26.1 tpp -82.48 136.31 34.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.707 -0.224 . . . . 10.0 110.422 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.0 p -83.56 156.33 22.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.887 0.375 . . . . 10.0 110.941 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.7 -33.94 73.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.83 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.11 73.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.313 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.89 -33.77 76.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.701 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -70.13 -37.61 75.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.637 ' CA ' HG21 ' A' ' 114' ' ' VAL . . . -68.49 -46.84 60.67 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.498 -0.774 . . . . 10.0 112.605 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -58.67 -39.86 81.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.862 0.363 . . . . 10.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -64.03 -29.19 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 10.0 112.512 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.571 HG22 ' HB3' ' A' ' 131' ' ' LYS . 16.5 pt -106.76 3.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.0 32.96 69.65 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 121.296 -0.478 . . . . 10.0 113.402 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -120.18 163.09 18.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.849 0.357 . . . . 10.0 110.815 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -78.88 150.3 32.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.757 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.4 -44.15 68.46 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.36 93.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.741 -0.209 . . . . 10.0 110.579 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.9 m -59.18 -44.23 92.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.678 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.637 HG21 ' CA ' ' A' ' 104' ' ' GLY . 46.7 t -63.79 -43.21 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.121 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.62 -29.47 63.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 10.0 110.312 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 63.0 m -76.55 -25.8 54.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.749 . . . . 10.0 111.311 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.5 -37.76 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.998 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.443 ' HB3' HG22 ' A' ' 87' ' ' ILE . 6.8 pt-20 -66.61 -17.74 64.99 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.695 0.283 . . . . 10.0 111.693 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.6 ' HB3' ' O ' ' A' ' 116' ' ' SER . 37.3 ttm180 -67.8 -20.52 65.2 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.391 0.615 . . . . 10.0 110.462 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.521 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.88 23.66 22.38 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.339 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 121' ' ' THR . 7.3 t -170.25 107.61 0.34 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.282 1.039 . . . . 10.0 110.447 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.94 28.91 0.08 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.496 -1.229 . . . . 10.0 109.339 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m 64.63 103.04 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.416 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 84.1 Cg_endo -75.91 92.9 1.02 Allowed 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 123.058 2.505 . . . . 10.0 116.054 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.667 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.7 t70 -87.92 111.92 21.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 105.319 -2.104 . . . . 10.0 105.319 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -49.08 -38.22 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.132 0.895 . . . . 10.0 112.573 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.401 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 60.9 t30 -71.51 -45.31 62.76 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.113 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 125' ' ' ASP . 59.2 mt -60.53 -50.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.481 -0.192 . . . . 10.0 110.481 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 11.7 mt -52.75 -45.27 66.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.562 0.696 . . . . 10.0 109.66 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 74.4 m -62.63 -43.03 99.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.018 -0.992 . . . . 10.0 110.992 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HB3' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -71.36 -42.95 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -178.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.556 ' SD ' ' HA ' ' A' ' 129' ' ' LEU . 3.7 ptm -61.59 -49.76 75.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.778 0.323 . . . . 10.0 111.867 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.604 ' O ' HD22 ' A' ' 136' ' ' LEU . 27.9 mm-40 -73.77 -25.78 60.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.938 0.399 . . . . 10.0 111.464 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -56.35 -23.39 37.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 10.0 111.289 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 t -71.92 -33.67 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.996 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -113.97 7.71 16.94 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.517 -0.473 . . . . 10.0 112.241 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.443 ' ND2' ' HB3' ' A' ' 148' ' ' PRO . 56.4 t30 67.31 59.06 0.52 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.644 0.735 . . . . 10.0 111.068 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.426 ' CG2' HD23 ' A' ' 136' ' ' LEU . 3.0 t -129.53 144.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.849 -1.068 . . . . 10.0 109.292 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -119.16 132.09 55.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.244 0.545 . . . . 10.0 110.574 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 83' ' ' VAL . 19.4 mt -96.44 21.54 9.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 10.0 111.034 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -143.89 158.3 43.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.784 0.325 . . . . 10.0 110.918 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.38 -163.48 20.92 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 121.095 -0.574 . . . . 10.0 112.022 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.95 -31.82 14.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.02 0.438 . . . . 10.0 110.627 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.22 56.64 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.073 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.8 mt -62.03 137.75 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.51 79.69 Favored Glycine 0 CA--C 1.509 -0.328 0 C-N-CA 121.15 -0.548 . . . . 10.0 111.775 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.96 156.27 39.38 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.113 -0.544 . . . . 10.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.443 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 17.9 Cg_endo -63.12 124.1 13.35 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.276 1.984 . . . . 10.0 110.018 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 10.0 110.349 -178.329 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.804 0.335 . . . . 10.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -132.13 95.87 20.85 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.185 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.25 112.39 2.97 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.434 2.09 . . . . 10.0 112.088 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.66 95.57 6.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.048 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.11 155.84 42.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.395 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.05 128.64 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.814 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.91 162.12 12.49 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.104 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.84 74.65 0.22 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.975 -0.631 . . . . 10.0 112.403 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -119.88 103.43 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.788 -0.242 . . . . 10.0 110.728 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -90.3 158.2 17.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.57 124.44 2.85 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.065 -0.588 . . . . 10.0 112.22 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -158.25 150.96 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.651 0.226 . . . . 10.0 110.477 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 . . . . . 0 C--N 1.328 -0.333 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 83' ' ' VAL . 2.2 t -85.12 -71.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.815 -0.354 . . . . 10.0 110.511 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.78 157.08 7.58 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -74.89 -53.77 8.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.401 0.601 . . . . 10.0 112.144 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.81 -38.42 88.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.668 -0.242 . . . . 10.0 111.508 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.609 ' HB ' HD23 ' A' ' 140' ' ' LEU . 33.2 m -67.13 -35.91 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 120.74 -0.384 . . . . 10.0 110.391 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.81 -41.68 98.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.004 -0.617 . . . . 10.0 111.692 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -41.5 98.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.895 0.379 . . . . 10.0 110.136 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.69 -30.99 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.695 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.497 HG23 HH21 ' A' ' 91' ' ' ARG . 7.2 mt -62.84 -42.39 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 10.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -70.45 -50.33 39.39 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.93 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.64 -40.9 96.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.826 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.55 -30.38 74.9 Favored Glycine 0 C--N 1.328 0.12 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.833 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.588 HH11 HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -80.35 -42.05 23.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.846 0.355 . . . . 10.0 110.67 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.14 -21.15 63.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.236 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -87.73 19.12 3.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.455 0.539 . . . . 10.0 112.455 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.23 -0.12 56.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 62.6 mt-10 53.14 100.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 123.917 0.761 . . . . 10.0 112.831 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.6 Cg_endo -78.44 -41.85 0.83 Allowed 'Cis proline' 0 CA--C 1.517 -0.349 0 C-N-CA 123.292 -1.545 . . . . 10.0 112.524 -0.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -168.41 128.69 1.25 Allowed 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.88 -1.054 . . . . 10.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ttm -58.65 137.53 57.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.834 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.7 144.08 39.59 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.631 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -70.09 -41.03 74.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.162 0.506 . . . . 10.0 110.465 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.37 90.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.941 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.8 -43.61 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.698 -0.228 . . . . 10.0 110.978 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.486 HD23 HG13 ' A' ' 114' ' ' VAL . 56.6 tp -64.49 -39.47 93.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.41 96.06 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.865 -0.894 . . . . 10.0 110.865 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -39.64 91.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.809 0.338 . . . . 10.0 110.213 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.91 -41.54 98.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.161 -0.472 . . . . 10.0 112.049 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 103' ' ' LEU . 29.3 pt -93.24 -7.83 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.615 0.598 . . . . 10.0 112.615 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.77 34.12 22.74 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.549 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -125.99 176.67 6.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.93 0.395 . . . . 10.0 110.576 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.35 161.16 15.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.19 94.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 10.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.79 76.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.464 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.3 m -63.39 -46.34 86.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.157 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.486 HG13 HD23 ' A' ' 103' ' ' LEU . 90.0 t -62.28 -43.08 97.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.194 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -66.47 -35.23 79.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.728 -0.669 . . . . 10.0 111.598 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 25.8 p -77.76 -26.27 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.77 0.319 . . . . 10.0 111.496 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.48 70.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 8.2 pt-20 -63.11 -20.48 65.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 116' ' ' SER . 72.9 ttt180 -71.54 -20.34 62.04 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.611 0.719 . . . . 10.0 109.828 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.86 15.91 43.86 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.422 -0.808 . . . . 10.0 112.352 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 121' ' ' THR . 12.9 t -164.15 108.56 0.98 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.285 1.04 . . . . 10.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.09 19.06 0.5 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.724 -1.125 . . . . 10.0 110.999 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m 58.51 83.71 0.21 Allowed Pre-proline 0 C--O 1.235 0.294 0 CA-C-O 121.622 0.725 . . . . 10.0 110.031 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.495 ' HB2' HD21 ' A' ' 129' ' ' LEU . 27.6 Cg_endo -96.13 178.44 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.409 2.739 . . . . 10.0 114.868 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.607 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.2 t70 -139.94 150.68 44.83 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -58.32 -37.51 75.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 10.0 110.707 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 9.9 t30 -63.72 -41.66 98.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.466 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.9 mt -63.75 -55.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 110.362 -0.236 . . . . 10.0 110.362 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.1 mt -48.84 -45.88 41.32 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.312 0.577 . . . . 10.0 110.348 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.9 m -55.01 -47.0 75.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.953 -1.021 . . . . 10.0 111.604 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 49.7 mmtt -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.74 0.305 . . . . 10.0 111.014 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.495 ' HB3' HH22 ' A' ' 91' ' ' ARG . 3.5 mtp -51.28 -56.41 13.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.762 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.635 ' HG2' HD13 ' A' ' 140' ' ' LEU . 16.0 mt-10 -72.45 -29.56 63.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.144 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -62.07 -43.96 97.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.099 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 131' ' ' LYS . 48.3 t -62.32 -25.54 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.322 -0.399 . . . . 10.0 112.006 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.588 HD21 HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -107.14 -3.61 19.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 10.0 112.904 -177.297 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.1 t30 56.57 55.32 6.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.524 0.678 . . . . 10.0 109.706 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 35.5 m -140.99 164.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.736 -1.12 . . . . 10.0 108.754 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -124.19 129.0 50.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.151 0.501 . . . . 10.0 110.261 178.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.635 HD13 ' HG2' ' A' ' 133' ' ' GLU . 5.4 mp -92.66 13.01 21.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.751 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -128.31 139.4 52.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.36 -159.03 16.39 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.095 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.66 -33.29 13.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.926 0.393 . . . . 10.0 110.606 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -86.57 53.14 2.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.095 0.474 . . . . 10.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.581 HG23 ' HA ' ' A' ' 140' ' ' LEU . 61.1 mt -75.03 137.55 22.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.27 70.0 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.124 -0.79 . . . . 10.0 111.124 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.09 155.41 80.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.035 -0.583 . . . . 10.0 109.857 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.38 120.05 7.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.617 1.545 . . . . 10.0 110.177 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? . . . . . 0 C--N 1.322 -0.627 0 CA-C-O 121.228 0.537 . . . . 10.0 109.606 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.9 ttm . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.971 0.415 . . . . 10.0 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.28 85.94 6.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.102 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.93 177.83 8.39 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.689 2.259 . . . . 10.0 112.219 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.55 131.56 36.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.928 0.394 . . . . 10.0 110.833 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -152.94 126.33 8.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.808 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.79 150.96 38.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.707 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.31 171.08 13.57 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.55 145.65 13.23 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.385 -0.912 . . . . 10.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -142.15 127.16 18.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.767 -0.456 . . . . 10.0 109.767 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.23 148.78 42.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 10.0 111.504 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.78 132.46 2.52 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.16 -0.776 . . . . 10.0 111.16 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -156.94 156.85 33.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.247 0.523 . . . . 10.0 111.743 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.693 . . . . 10.0 109.154 179.17 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 19.2 p . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.563 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -91.57 -30.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.386 . . . . 10.0 111.751 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.65 141.95 5.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.542 -0.837 . . . . 10.0 112.333 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -66.58 -52.35 46.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 10.0 111.123 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -32.91 74.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.376 0.608 . . . . 10.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 140' ' ' LEU . 55.3 t -61.87 -50.39 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 114.88 -1.055 . . . . 10.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.39 98.89 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -60.14 -51.14 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 10.0 110.493 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -66.15 -30.77 71.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.999 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.836 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.6 mt -57.88 -47.33 86.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -70.9 -47.05 61.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.941 0.4 . . . . 10.0 110.4 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -62.18 -34.14 75.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.428 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.64 -30.29 68.76 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.21 -0.995 . . . . 10.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.836 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.6 mmt180 -81.47 -33.81 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 10.0 111.373 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -77.33 -16.56 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.097 0.475 . . . . 10.0 110.536 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -80.44 12.61 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -19.86 23.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 10.0 111.561 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 4.5 tp10 59.89 110.1 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.904 -1.044 . . . . 10.0 111.777 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 45.2 Cg_endo -72.05 -59.11 0.13 OUTLIER 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.279 -1.551 . . . . 10.0 113.026 -0.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.2 m -163.97 135.8 4.79 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.492 -0.776 . . . . 10.0 110.903 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 36.4 tpp -74.57 136.85 42.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.539 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 64.7 p -84.03 160.41 20.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.359 -0.537 . . . . 10.0 111.251 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.56 -26.94 64.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.668 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.02 -57.98 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.408 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.539 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 13.7 pt-20 -62.52 -36.85 83.88 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.914 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 2.4 tt -61.91 -42.48 99.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.682 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.76 -39.74 90.0 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.463 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -62.3 -39.53 93.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.705 0.288 . . . . 10.0 111.574 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 17.3 pt-20 -73.62 -16.59 61.23 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 103' ' ' LEU . 40.6 pt -113.43 0.08 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.623 -0.431 . . . . 10.0 111.738 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.42 37.61 53.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.593 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -133.19 -168.92 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 10.0 110.52 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -111.95 177.25 4.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.738 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.12 79.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 10.0 110.656 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.89 -47.07 87.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.657 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.9 m -55.74 -45.3 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.55 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.82 -50.54 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -64.92 -32.12 73.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.331 0.586 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.0 m -73.6 -28.19 61.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.424 ' CE1' HG11 ' A' ' 79' ' ' VAL . 2.4 m-85 -75.34 -35.62 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 12.5 pt-20 -67.42 -17.8 64.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 10.0 110.799 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.732 ' HG2' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -74.61 -20.93 59.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.21 0.529 . . . . 10.0 109.79 178.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.563 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.52 21.49 29.05 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.43 -0.891 . . . . 10.0 112.053 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 119' ' ' ARG . 9.9 t -170.07 104.22 0.3 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.437 1.113 . . . . 10.0 110.113 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.33 27.7 0.51 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.747 -1.115 . . . . 10.0 109.212 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 m 61.61 96.98 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.8 -1.091 . . . . 10.0 108.594 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 78' ' ' THR . 70.8 Cg_endo -68.18 99.84 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.655 2.236 . . . . 10.0 115.256 -175.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.57 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -85.72 116.12 23.8 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.92 -2.252 . . . . 10.0 104.92 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.411 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 21.9 mm-40 -48.91 -40.17 28.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.142 -0.481 . . . . 10.0 112.147 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.2 t30 -66.93 -44.06 81.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.675 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.673 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.8 mt -58.62 -55.17 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 119.585 -0.245 . . . . 10.0 110.651 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.0 mt -50.24 -42.24 51.47 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.571 0.7 . . . . 10.0 110.235 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 66.7 m -59.86 -45.72 91.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.983 -1.008 . . . . 10.0 111.497 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 29.2 mmtt -73.75 -40.86 63.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 10.0 111.234 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.673 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -50.65 -59.46 4.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.207 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.745 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 5.8 mt-10 -74.12 -26.84 60.57 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.045 -0.98 . . . . 10.0 112.997 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -54.63 -27.25 38.22 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.91 -25.64 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.81 0.338 . . . . 10.0 111.796 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.833 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -99.0 -16.32 18.76 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -177.107 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 67.84 25.99 7.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.262 0.553 . . . . 10.0 110.527 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.833 HG22 ' HB2' ' A' ' 136' ' ' LEU . 26.8 m -121.94 142.9 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 23.9 mmmt -119.19 142.97 47.51 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HA ' HG23 ' A' ' 145' ' ' ILE . 8.9 mt -102.71 39.44 1.53 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.658 0.742 . . . . 10.0 109.783 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 141' ' ' ARG . 49.2 mtt180 -129.54 141.32 51.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.089 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.22 -162.19 43.93 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.233 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.34 3.24 55.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.885 0.374 . . . . 10.0 111.399 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -110.31 40.95 1.84 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 10.0 110.672 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 140' ' ' LEU . 44.9 mt -67.17 136.71 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.727 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.9 0.3 71.91 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.937 -0.865 . . . . 10.0 110.937 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.56 158.45 75.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.546 . . . . 10.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.29 121.68 10.3 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.284 1.989 . . . . 10.0 109.914 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.844 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.8 ptp . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.693 0.759 . . . . 10.0 111.456 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -121.96 88.44 47.73 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.438 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.81 145.9 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.348 2.699 . . . . 10.0 111.897 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -104.03 154.0 20.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.812 0.339 . . . . 10.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -144.68 132.27 21.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.24 166.55 23.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.016 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.61 -177.91 36.01 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.486 -0.864 . . . . 10.0 112.394 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 175.2 147.88 6.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.41 -0.676 . . . . 10.0 111.41 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 t -137.31 128.17 27.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.105 0.479 . . . . 10.0 110.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.81 -42.91 10.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.248 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.22 104.31 2.39 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.569 -0.612 . . . . 10.0 111.569 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -107.32 -16.49 14.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 10.0 111.387 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.503 -179.207 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 2.8 p . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.904 -0.406 . . . . 10.0 109.904 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -84.48 -34.65 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.651 -0.419 . . . . 10.0 111.157 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.04 136.98 4.33 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.013 -0.613 . . . . 10.0 111.596 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -63.45 -57.04 11.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -25.63 65.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.702 HG13 HD13 ' A' ' 140' ' ' LEU . 46.0 t -63.36 -46.97 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.497 -1.229 . . . . 10.0 110.052 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.32 -38.42 95.83 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.353 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 40.1 ttmt -59.32 -49.25 78.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 10.0 109.786 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -65.85 -30.51 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.558 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.753 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.3 mt -59.85 -48.5 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 4.3 tt0 -67.06 -50.38 62.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.022 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 62.4 mm-40 -59.97 -36.41 77.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.23 85.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.967 -0.635 . . . . 10.0 113.281 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.753 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.9 mmt180 -79.22 -29.88 43.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.173 0.511 . . . . 10.0 109.64 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 82.0 mt-30 -78.66 -16.76 56.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.645 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 55.9 mtpt -85.79 22.13 1.72 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.955 0.407 . . . . 10.0 111.261 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.65 -8.88 36.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.883 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 6.1 mm-40 53.4 104.05 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 114.902 -1.045 . . . . 10.0 112.618 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 56.0 Cg_endo -73.64 -50.12 0.2 Allowed 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.486 -1.464 . . . . 10.0 113.367 0.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -168.93 132.62 1.4 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.403 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.7 tpp -73.58 134.89 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.291 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.17 145.38 51.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.902 0.382 . . . . 10.0 111.679 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.41 -37.49 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.022 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.07 -36.39 83.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.75 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.79 -39.19 57.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.094 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.552 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -61.19 -43.62 98.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.837 . . . . 10.0 108.739 178.444 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.74 -39.39 95.23 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.504 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -64.32 -38.27 90.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.651 0.262 . . . . 10.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.545 ' OE2' HD22 ' A' ' 103' ' ' LEU . 15.3 pt-20 -78.02 -13.9 59.7 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.119 0.785 . . . . 10.0 113.119 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 103' ' ' LEU . 41.2 pt -109.68 -7.45 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.623 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.83 30.89 19.62 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.815 -0.707 . . . . 10.0 112.807 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.94 -168.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.278 0.231 . . . . 10.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -109.91 177.25 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.528 -0.305 . . . . 10.0 110.254 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.73 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.616 -0.265 . . . . 10.0 111.351 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.29 81.34 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.039 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.45 -50.3 73.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.779 0.323 . . . . 10.0 110.723 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.12 -45.04 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.79 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 10.0 111.115 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.3 m -76.77 -27.46 55.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.943 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.871 0.693 . . . . 10.0 112.871 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -61.53 -18.66 60.13 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.195 0.442 . . . . 10.0 112.195 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 119' ' ' ARG . 0.8 OUTLIER -69.53 -22.93 63.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.197 0.522 . . . . 10.0 110.088 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.99 21.7 15.08 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.607 -0.806 . . . . 10.0 112.086 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.439 ' OG1' HG22 ' A' ' 78' ' ' THR . 6.7 t -171.87 111.9 0.3 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.24 1.019 . . . . 10.0 110.396 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.57 34.58 0.27 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.561 -1.2 . . . . 10.0 109.277 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 m 55.77 85.16 0.2 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.266 -0.879 . . . . 10.0 108.839 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.551 ' HG3' ' O ' ' A' ' 78' ' ' THR . 72.8 Cg_endo -72.47 98.04 0.92 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.543 2.828 . . . . 10.0 115.544 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.4 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.9 t70 -82.18 128.04 33.76 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 104.638 -2.356 . . . . 10.0 104.638 174.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -54.17 -31.31 52.34 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.427 0.528 . . . . 10.0 112.427 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -72.12 -32.89 67.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.848 -0.614 . . . . 10.0 111.355 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.796 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.0 mt -71.3 -57.94 6.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.691 -0.403 . . . . 10.0 110.099 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -49.6 -43.31 46.33 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.489 0.662 . . . . 10.0 110.777 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.59 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 45.0 m -54.51 -48.95 71.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.033 -0.985 . . . . 10.0 111.828 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 135' ' ' VAL . 13.0 mttt -76.79 -37.68 55.36 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.833 0.309 . . . . 10.0 111.833 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.796 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 75.0 mtp -53.97 -58.56 6.85 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.182 0.515 . . . . 10.0 111.863 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.575 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.0 mp0 -72.52 -26.18 61.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.787 -0.642 . . . . 10.0 112.266 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.4 ttm-85 -59.3 -27.42 65.84 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.036 0.446 . . . . 10.0 110.034 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 131' ' ' LYS . 61.1 t -63.82 -41.34 92.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.689 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.571 HD22 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -94.98 -6.35 42.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 121.152 -0.219 . . . . 10.0 110.437 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 t30 64.36 49.65 2.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.494 0.664 . . . . 10.0 109.736 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 34.4 m -132.12 162.88 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.355 -0.839 . . . . 10.0 109.627 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 15.9 mmtt -131.96 140.89 49.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.342 -0.614 . . . . 10.0 109.342 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.702 HD13 HG13 ' A' ' 83' ' ' VAL . 12.2 mt -108.5 17.71 21.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.26 0.552 . . . . 10.0 110.873 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -124.25 139.63 53.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.63 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.9 -146.65 17.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.729 -0.748 . . . . 10.0 112.336 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.24 -34.99 8.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.985 0.421 . . . . 10.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -82.33 54.82 2.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.929 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.602 HG23 ' HA ' ' A' ' 140' ' ' LEU . 52.6 mt -72.9 137.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.474 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.36 -0.48 87.12 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.978 -0.849 . . . . 10.0 110.978 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.71 156.87 70.38 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.476 . . . . 10.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.79 122.5 11.09 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 121.897 1.731 . . . . 10.0 110.382 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.375 0.607 . . . . 10.0 110.146 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.031 -0.359 . . . . 10.0 110.031 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -116.97 150.8 46.56 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.374 -0.375 . . . . 10.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.29 170.38 20.33 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.626 2.217 . . . . 10.0 112.379 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -123.78 152.5 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.247 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.14 151.37 49.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.394 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.05 138.05 15.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.78 -160.78 11.78 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.22 25.06 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.86 132.37 52.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.662 0.268 . . . . 10.0 110.846 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -140.14 167.6 21.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.897 -0.409 . . . . 10.0 109.897 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.25 117.92 0.8 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.455 -0.879 . . . . 10.0 112.742 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -102.8 173.43 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.19 -0.3 . . . . 10.0 110.19 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 10.0 110.901 -179.396 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.48 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 5.0 p . . . . . 0 C--O 1.235 0.305 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.937 HG12 HG11 ' A' ' 83' ' ' VAL . 1.8 t -82.55 -60.15 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 10.0 110.537 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.07 137.23 4.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.33 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.7 -42.85 99.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.663 0.268 . . . . 10.0 111.269 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 -29.0 64.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.996 HG13 HD13 ' A' ' 140' ' ' LEU . 3.8 t -68.47 -49.28 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.338 -0.846 . . . . 10.0 109.864 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.36 -39.39 97.19 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -64.03 -39.41 94.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 10.0 110.486 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.43 64.89 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.685 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.79 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.9 mt -59.89 -49.95 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.01 -53.23 58.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.956 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.39 -31.47 72.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.901 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.09 -30.73 69.6 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.731 -0.747 . . . . 10.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.79 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -81.6 -41.94 20.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 10.0 109.57 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.81 ' HA ' HG23 ' A' ' 97' ' ' THR . 53.2 mt-30 -61.4 -36.89 81.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.535 -0.757 . . . . 10.0 111.31 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -81.75 51.21 1.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -3.54 16.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.69 0.281 . . . . 10.0 111.257 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 22.2 mm-40 57.94 100.56 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 2.8 Cg_exo -76.65 -45.1 0.46 Allowed 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.592 -1.42 . . . . 10.0 112.205 -0.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.81 HG23 ' HA ' ' A' ' 92' ' ' GLN . 38.2 m -161.71 133.56 5.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.541 -1.209 . . . . 10.0 110.004 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.3 127.95 32.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.23 53.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.43 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.94 85.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.692 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -71.07 -44.42 65.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.822 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -63.68 -40.19 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.42 -49.05 73.12 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.261 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -62.69 -34.68 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.4 -26.45 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.934 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 103' ' ' LEU . 25.6 pt -110.14 8.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.796 0.295 . . . . 10.0 111.796 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 20.34 71.77 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.252 -0.499 . . . . 10.0 113.097 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -118.56 -164.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.309 -0.256 . . . . 10.0 110.309 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.3 p -115.05 176.07 5.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.562 0.22 . . . . 10.0 110.589 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.04 89.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 10.0 109.998 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.9 76.12 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.563 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.3 m -62.06 -46.29 89.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 10.0 110.345 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 t -66.17 -43.47 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.071 -0.513 . . . . 10.0 109.91 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.66 -29.54 69.58 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.702 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 m -78.84 -33.77 45.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.898 0.38 . . . . 10.0 111.473 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -65.98 -33.79 76.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.81 -18.27 54.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.821 0.344 . . . . 10.0 111.8 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.432 ' HG2' HG22 ' A' ' 121' ' ' THR . 12.1 ttm180 -71.57 -26.17 62.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.281 0.562 . . . . 10.0 110.51 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.82 12.56 55.37 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.612 -0.722 . . . . 10.0 112.482 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 121' ' ' THR . 8.8 t -153.39 98.68 2.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.715 1.245 . . . . 10.0 109.456 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.06 27.49 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.323 -1.308 . . . . 10.0 109.914 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m 59.37 95.5 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.199 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.48 ' HG3' ' C ' ' A' ' 78' ' ' THR . 74.4 Cg_endo -69.73 99.8 0.77 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.242 2.628 . . . . 10.0 114.646 -176.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.57 117.9 25.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 8.4 mm-40 -48.56 -39.62 24.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.471 0.915 . . . . 10.0 113.471 -174.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.4 t30 -70.55 -34.0 71.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.86 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.79 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.7 mt -68.96 -57.89 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.758 -0.377 . . . . 10.0 111.299 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -39.01 59.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.161 0.505 . . . . 10.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 m -55.02 -49.83 70.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.631 -0.713 . . . . 10.0 111.232 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 35.3 mmtt -75.77 -30.4 59.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.954 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.79 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.7 mtp -56.35 -59.59 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 4.0 mp0 -74.04 -26.49 60.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -53.92 -33.24 56.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.986 0.365 . . . . 10.0 111.986 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.69 -30.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.973 0.416 . . . . 10.0 111.245 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.473 HD12 ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -94.78 -10.73 30.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.565 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.2 t30 62.58 47.11 5.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 10.0 110.749 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.1 m -131.91 158.15 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -130.66 143.69 50.92 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.591 -0.443 . . . . 10.0 110.847 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.996 HD13 HG13 ' A' ' 83' ' ' VAL . 11.6 mt -103.53 40.2 1.46 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.728 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 141' ' ' ARG . 14.8 mmm180 -128.26 139.88 52.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.534 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.08 -146.25 23.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.371 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.33 -21.68 14.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.89 0.376 . . . . 10.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -88.06 52.96 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 110.696 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 140' ' ' LEU . 54.5 mt -76.53 141.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.518 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 1.16 88.16 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.877 -0.678 . . . . 10.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.0 156.37 76.28 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 110.046 -0.353 . . . . 10.0 110.046 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.96 122.3 11.38 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.957 1.772 . . . . 10.0 109.294 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.483 . . . . 10.0 109.829 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 110.23 -0.285 . . . . 10.0 110.23 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.32 136.73 19.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.508 -0.314 . . . . 10.0 111.061 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.03 142.02 45.66 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.993 2.462 . . . . 10.0 112.104 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.12 143.66 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.911 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -136.2 132.13 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 10.0 109.652 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.55 155.56 37.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.832 0.348 . . . . 10.0 111.125 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.69 -155.07 29.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.121 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -162.72 11.79 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.542 -0.623 . . . . 10.0 111.542 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 m -154.52 108.09 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.082 0.441 . . . . 10.0 110.939 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.28 173.85 6.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.6 173.2 34.36 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.348 -0.93 . . . . 10.0 112.692 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -158.25 151.52 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.664 0.268 . . . . 10.0 110.477 179.218 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.783 0.325 . . . . 10.0 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.408 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -76.41 -32.03 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.61 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.34 138.4 5.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.374 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -70.14 -42.65 72.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.987 0.422 . . . . 10.0 110.682 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -75.39 -25.35 57.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.655 0.74 . . . . 10.0 109.234 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 87' ' ' ILE . 37.2 t -69.28 -45.3 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 114.507 -1.224 . . . . 10.0 110.249 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.79 98.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.87 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -62.76 -40.3 96.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 10.0 110.434 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.81 66.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.064 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 83' ' ' VAL . 23.4 mt -59.93 -46.81 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.96 0.41 . . . . 10.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -71.46 -52.95 15.68 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.582 -0.447 . . . . 10.0 110.538 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.45 ' O ' ' HD3' ' A' ' 93' ' ' LYS . 46.8 mt-30 -60.61 -35.05 75.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.239 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.69 -31.9 52.28 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.636 -1.269 . . . . 10.0 112.365 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.647 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 1.3 mpt_? -81.72 -34.43 30.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.924 0.392 . . . . 10.0 111.383 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.522 ' HA ' HG23 ' A' ' 97' ' ' THR . 33.5 mt-30 -75.19 -2.12 26.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.995 0.426 . . . . 10.0 110.451 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 89' ' ' GLN . 1.5 tptm -84.9 0.11 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.023 0.44 . . . . 10.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -171.98 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 10.0 111.185 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.46 112.1 23.2 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.54 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -78.84 -31.19 5.17 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.358 -1.518 . . . . 10.0 112.558 -0.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 92' ' ' GLN . 99.0 m -168.3 130.29 1.4 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.82 -1.536 . . . . 10.0 108.724 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 tpp -73.24 110.36 7.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.521 -0.472 . . . . 10.0 109.958 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -69.53 156.78 38.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.147 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.08 -35.22 76.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.582 -0.735 . . . . 10.0 109.911 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.059 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.68 -49.87 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.701 -0.227 . . . . 10.0 110.794 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.574 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.34 -46.66 85.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.48 0.488 . . . . 10.0 109.887 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.08 -47.18 92.29 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.119 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -64.26 -38.57 91.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.904 0.335 . . . . 10.0 111.904 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.3 -15.18 61.41 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 103' ' ' LEU . 43.4 pt -107.05 3.69 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 10.0 111.006 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.86 25.72 55.31 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.079 -0.582 . . . . 10.0 113.034 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -125.24 -157.47 0.78 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.668 0.271 . . . . 10.0 110.356 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 p -124.92 176.68 6.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.48 91.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.617 0.246 . . . . 10.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.88 76.35 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.76 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 m -60.68 -47.18 87.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.15 -45.16 97.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.246 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.07 -32.35 73.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.806 0.812 . . . . 10.0 109.834 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 11.6 m -74.66 -24.89 58.88 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.201 -0.909 . . . . 10.0 111.275 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -77.61 -34.36 53.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -66.09 -20.36 66.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.9 ptm180 -70.88 -23.05 62.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.665 0.745 . . . . 10.0 110.738 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.51 28.43 7.54 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.012 -0.995 . . . . 10.0 112.063 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 121' ' ' THR . 8.8 t -173.8 107.69 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.167 0.984 . . . . 10.0 110.201 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.04 25.95 0.26 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.843 -1.071 . . . . 10.0 109.616 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 m 62.33 99.99 0.04 OUTLIER Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.806 -0.813 . . . . 10.0 108.806 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.76 99.29 0.95 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.855 2.37 . . . . 10.0 114.042 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.643 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 4.5 t0 -87.5 120.41 28.78 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.443 -2.058 . . . . 10.0 105.443 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 5.0 mm100 -52.07 -42.33 63.1 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.22 -30.88 70.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.718 ' O ' ' HG3' ' A' ' 132' ' ' MET . 73.2 mt -72.07 -56.2 10.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.0 mt -48.85 -42.78 37.53 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.615 0.572 . . . . 10.0 110.361 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 74.4 m -57.02 -47.3 81.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.152 -0.931 . . . . 10.0 111.765 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 135' ' ' VAL . 2.6 mppt? -74.66 -38.01 62.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.718 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 32.9 mtp -50.42 -55.83 14.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.832 0.825 . . . . 10.0 111.161 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.633 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 53.8 mt-10 -73.24 -27.24 61.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.801 -1.09 . . . . 10.0 113.315 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -68.74 -27.39 65.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.963 1.098 . . . . 10.0 113.963 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 131' ' ' LYS . 6.0 t -71.0 -22.79 23.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.158 0.429 . . . . 10.0 112.158 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -127.32 -23.85 3.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.816 1.043 . . . . 10.0 113.816 -176.167 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 2.8 m120 77.91 63.68 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.082 0.944 . . . . 10.0 110.099 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 2.8 t -135.96 139.86 45.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.127 -1.397 . . . . 10.0 108.178 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 12.1 mmtm -112.45 133.14 54.69 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.338 -0.545 . . . . 10.0 112.145 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.633 ' HG ' ' OE2' ' A' ' 133' ' ' GLU . 1.1 mt -93.24 -20.25 20.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.163 -0.926 . . . . 10.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -120.15 152.04 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 10.0 111.06 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.85 -156.78 15.37 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.184 -0.766 . . . . 10.0 111.184 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.8 -37.1 10.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.821 0.343 . . . . 10.0 110.628 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -89.92 55.65 3.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.646 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.84 137.63 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 10.0 110.913 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.66 90.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.093 -0.803 . . . . 10.0 111.093 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.31 147.77 58.68 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.301 -0.449 . . . . 10.0 110.914 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.7 123.65 13.09 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.474 2.116 . . . . 10.0 110.718 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 109.225 -0.658 . . . . 10.0 109.225 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -158.57 130.03 3.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.78 46.03 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.069 2.513 . . . . 10.0 114.209 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.89 130.92 55.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -126.5 123.24 37.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 10.0 111.163 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.76 -174.07 2.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.58 -146.95 8.83 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.678 -0.569 . . . . 10.0 111.678 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.27 91.76 1.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.633 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -123.55 124.35 42.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.612 0.244 . . . . 10.0 110.373 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.86 149.83 50.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.25 -166.76 20.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.086 -0.578 . . . . 10.0 111.94 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -139.92 174.08 10.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.815 0.34 . . . . 10.0 110.777 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.699 -179.922 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.9 m -83.17 -23.67 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 10.0 111.663 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.45 139.14 7.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.49 -0.862 . . . . 10.0 112.526 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -68.53 -47.64 66.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.724 0.297 . . . . 10.0 111.426 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -66.32 -33.47 75.79 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.38 0.61 . . . . 10.0 109.512 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.1 -44.52 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.021 -0.991 . . . . 10.0 109.998 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.47 -41.71 98.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.929 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.44 -41.25 98.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 10.0 110.199 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.78 -30.84 65.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.114 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.699 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.3 mt -60.71 -47.38 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.267 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.48 -53.19 46.1 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.434 0.459 . . . . 10.0 110.46 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.74 -33.44 72.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.573 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.04 -31.9 82.28 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.788 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -80.05 -32.34 39.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.483 0.658 . . . . 10.0 109.28 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.442 ' HA ' HG23 ' A' ' 97' ' ' THR . 84.4 mt-30 -74.2 -24.99 59.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.334 -0.848 . . . . 10.0 110.764 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -84.58 54.03 2.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.978 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.94 0.68 8.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.836 0.31 . . . . 10.0 111.836 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 1.6 tt0 56.11 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 124.159 0.912 . . . . 10.0 112.016 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 75.6 Cg_endo -81.81 -37.94 1.43 Allowed 'Cis proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.545 -1.44 . . . . 10.0 113.451 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 92' ' ' GLN . 2.3 m -173.88 124.88 0.36 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.395 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 ttm -83.57 142.36 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.286 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 75.5 p -74.52 163.55 27.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 10.0 111.142 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.27 -32.59 71.87 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.256 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.07 82.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.548 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.435 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 14.0 mm-40 -60.72 -54.45 45.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.594 -0.276 . . . . 10.0 110.445 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HG ' HH11 ' A' ' 91' ' ' ARG . 0.2 OUTLIER -64.76 -36.91 85.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.632 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.63 -47.5 86.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.816 -0.707 . . . . 10.0 111.742 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.96 -40.48 91.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.259 -0.275 . . . . 10.0 110.259 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.4 -31.74 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.352 0.501 . . . . 10.0 112.352 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 103' ' ' LEU . 46.8 pt -90.86 1.8 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 10.0 111.42 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.36 15.24 74.55 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.96 -0.638 . . . . 10.0 113.311 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -116.63 -149.4 0.44 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.65 172.07 9.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.602 0.239 . . . . 10.0 110.988 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.91 78.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.933 0.397 . . . . 10.0 110.505 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.65 77.55 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.637 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 4.0 m -59.64 -47.5 85.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.36 -44.13 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.25 -34.95 78.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.219 0.533 . . . . 10.0 110.893 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 36.5 m -76.83 -32.51 57.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.426 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.402 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.9 m-85 -67.57 -37.37 82.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.511 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.59 -18.78 65.21 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.721 0.296 . . . . 10.0 111.514 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 121' ' ' THR . 42.8 ttt180 -70.48 -20.39 62.86 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.402 0.62 . . . . 10.0 110.105 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.446 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.27 23.14 25.29 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 119' ' ' ARG . 4.1 t -170.21 105.18 0.3 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.888 0.851 . . . . 10.0 110.35 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.47 33.59 0.11 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.98 -1.009 . . . . 10.0 109.824 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 m 64.26 104.04 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.774 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.1 83.74 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.508 2.138 . . . . 10.0 113.353 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.713 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -84.44 120.33 26.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -50.09 -47.36 53.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.74 0.644 . . . . 10.0 112.74 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 26.8 p-10 -61.36 -39.28 90.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.892 -0.14 . . . . 10.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.572 ' O ' ' HG3' ' A' ' 132' ' ' MET . 77.4 mt -69.45 -50.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 12.7 mt -54.4 -41.85 69.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.901 0.381 . . . . 10.0 110.006 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -55.83 -42.47 75.78 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.463 -0.79 . . . . 10.0 111.288 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.575 ' O ' HG23 ' A' ' 135' ' ' VAL . 70.4 mmtt -73.66 -43.34 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 10.0 110.518 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.673 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 4.0 mtt -52.61 -56.13 17.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.161 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.94 -29.61 70.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.544 -0.753 . . . . 10.0 112.45 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.9 mmt180 -75.59 -45.16 39.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.931 0.715 . . . . 10.0 112.931 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 131' ' ' LYS . 17.7 t -65.39 -41.19 90.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 111.898 0.332 . . . . 10.0 111.898 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 132' ' ' MET . 0.0 OUTLIER -89.91 -10.16 46.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.87 -0.332 . . . . 10.0 111.869 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.9 t30 57.51 52.9 7.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.549 0.69 . . . . 10.0 110.481 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 136' ' ' LEU . 27.5 m -142.59 140.66 28.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.762 -1.108 . . . . 10.0 108.19 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 1.5 mtpp -96.67 133.46 41.16 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.028 -0.669 . . . . 10.0 110.251 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.525 ' HA ' HG23 ' A' ' 145' ' ' ILE . 36.6 mt -101.58 14.74 31.05 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.525 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -129.37 145.86 51.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.192 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.52 -155.85 21.86 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.469 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.98 -22.79 14.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.023 0.439 . . . . 10.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.88 51.68 1.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.056 0.455 . . . . 10.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 58.7 mt -71.9 142.65 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.705 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.84 4.29 88.83 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.455 -0.658 . . . . 10.0 111.455 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.55 143.49 48.55 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.568 -0.316 . . . . 10.0 110.548 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 124.0 10.68 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.683 1.589 . . . . 10.0 108.061 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.5 ttp85 . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 121.268 0.556 . . . . 10.0 110.058 -178.959 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.2 ptp . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.864 0.364 . . . . 10.0 110.223 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -150.63 130.37 6.67 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.448 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.76 122.6 7.42 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.776 2.317 . . . . 10.0 112.86 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.87 145.06 34.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.19 167.37 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 10.0 110.77 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.63 158.74 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.099 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.67 31.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.722 -0.752 . . . . 10.0 112.267 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.07 -20.02 10.79 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.704 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -96.9 112.19 24.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.291 -0.263 . . . . 10.0 110.291 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -153.12 179.47 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.807 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.8 20.02 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.378 -0.689 . . . . 10.0 111.378 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -90.51 151.16 21.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.42 . . . . 10.0 111.533 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.787 179.784 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.637 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 3.5 p . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.76 -0.459 . . . . 10.0 109.76 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.583 HG12 HG21 ' A' ' 83' ' ' VAL . 3.4 t -70.75 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.239 0.542 . . . . 10.0 110.87 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.77 153.35 5.91 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -76.48 -52.28 10.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.581 0.691 . . . . 10.0 112.543 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -30.5 69.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.605 -0.438 . . . . 10.0 111.568 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.583 HG21 HG12 ' A' ' 79' ' ' VAL . 25.9 m -68.01 -35.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 120.735 -0.386 . . . . 10.0 110.39 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.75 -48.66 82.69 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.277 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -63.62 -36.77 84.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 10.0 110.756 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -69.7 -30.75 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.963 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.834 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.7 mt -61.27 -47.88 91.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 109.381 -0.599 . . . . 10.0 109.381 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.81 -53.34 57.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.872 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.6 -35.09 79.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.676 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.26 80.34 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.925 -0.655 . . . . 10.0 113.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.834 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.8 mmt180 -75.84 -35.56 59.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.233 0.539 . . . . 10.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.47 ' HA ' HG23 ' A' ' 97' ' ' THR . 77.6 mt-30 -78.67 -12.91 60.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.776 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -77.94 -0.79 28.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.676 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -168.56 0.47 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.145 0.498 . . . . 10.0 111.466 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 12.7 tp10 -131.05 109.95 15.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.472 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.0 Cg_endo -79.06 -29.2 6.79 Favored 'Cis proline' 0 CA--C 1.515 -0.45 0 C-N-CA 123.188 -1.588 . . . . 10.0 112.157 -0.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 92' ' ' GLN . 38.0 m -168.47 136.21 2.11 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.55 -1.659 . . . . 10.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.9 tpp -87.01 127.57 35.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.3 p -77.25 156.82 31.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.361 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -68.13 -33.68 74.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.192 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.75 71.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.385 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.48 -42.26 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.454 -0.339 . . . . 10.0 111.461 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.551 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tm? -65.46 -44.52 86.93 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.06 96.58 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.769 -0.729 . . . . 10.0 111.394 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.72 -43.92 97.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.987 0.115 . . . . 10.0 111.297 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.91 -16.83 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 103' ' ' LEU . 33.6 pt -103.47 -3.19 9.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.255 -0.578 . . . . 10.0 110.779 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.44 50.09 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.291 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -120.32 -160.17 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.683 0.278 . . . . 10.0 110.481 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 175.09 5.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.453 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.64 -41.65 99.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.758 0.313 . . . . 10.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.82 73.62 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.07 -0.514 . . . . 10.0 110.873 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 m -59.6 -49.54 77.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.878 0.37 . . . . 10.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.36 -42.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.93 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.16 70.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.571 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 67.8 m -78.52 -31.96 47.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.141 0.423 . . . . 10.0 112.141 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -18.77 36.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.373 0.509 . . . . 10.0 112.373 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.444 ' HG3' HG22 ' A' ' 121' ' ' THR . 5.6 tpp180 -69.18 -23.39 63.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.309 0.576 . . . . 10.0 110.339 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.62 13.91 54.23 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.677 -0.773 . . . . 10.0 112.296 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 121' ' ' THR . 9.9 t -158.94 107.32 1.87 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.233 1.016 . . . . 10.0 109.37 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.78 29.17 0.37 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.443 -1.253 . . . . 10.0 110.017 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m 58.58 87.77 0.13 Allowed Pre-proline 0 N--CA 1.463 0.214 0 N-CA-C 108.378 -0.971 . . . . 10.0 108.378 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.637 ' HG3' ' C ' ' A' ' 78' ' ' THR . 87.9 Cg_endo -78.96 110.89 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.717 2.278 . . . . 10.0 115.454 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 128' ' ' ILE . 6.6 t70 -85.95 124.91 32.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.93 -2.989 . . . . 10.0 102.93 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 3.5 mm100 -50.97 -32.04 19.8 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.14 0.793 . . . . 10.0 113.14 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.531 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.5 t30 -75.9 -31.88 59.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.449 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.756 ' O ' ' HG3' ' A' ' 132' ' ' MET . 97.9 mt -64.85 -55.96 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.955 -0.298 . . . . 10.0 110.499 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -47.94 -38.85 17.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.737 0.779 . . . . 10.0 110.116 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.3 m -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.463 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 67.3 mmtt -75.57 -40.16 57.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.3 mtp -53.47 -57.73 9.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.227 0.537 . . . . 10.0 111.552 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mt-10 -72.27 -27.3 62.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.461 -0.79 . . . . 10.0 112.777 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -56.06 -30.22 61.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 10.0 111.362 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.7 -30.85 19.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.443 . . . . 10.0 111.814 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.713 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -96.18 -10.57 27.8 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 67.24 19.15 10.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.746 0.418 . . . . 10.0 111.772 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.776 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.9 m -114.03 140.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.1 mmtp -121.11 140.6 51.75 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.801 -0.76 . . . . 10.0 111.204 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.684 ' HA ' HG23 ' A' ' 145' ' ' ILE . 1.8 mt -102.46 41.26 1.25 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.192 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -131.3 141.21 49.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 10.0 111.092 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.52 -152.49 30.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.291 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.55 15.09 30.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.195 0.522 . . . . 10.0 110.698 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.08 45.25 2.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.251 0.548 . . . . 10.0 110.173 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.684 HG23 ' HA ' ' A' ' 140' ' ' LEU . 49.1 mt -68.8 138.98 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.72 7.03 87.93 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.367 -1.093 . . . . 10.0 110.367 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -131.62 157.63 77.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 114.833 -0.684 . . . . 10.0 109.799 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.33 122.4 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.751 . . . . 10.0 110.23 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.589 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 3.2 tpp180 . . . . . 0 C--N 1.318 -0.776 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.5 mtm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.647 0.261 . . . . 10.0 110.419 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -111.71 151.16 43.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.175 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.66 133.88 44.6 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.584 2.19 . . . . 10.0 112.318 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -76.64 152.99 35.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.365 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.37 151.37 29.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.804 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.3 153.64 27.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.402 -0.363 . . . . 10.0 110.594 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.0 -166.71 11.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.329 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.92 158.78 25.85 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.967 -0.635 . . . . 10.0 111.862 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 m -152.64 131.09 12.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.837 0.351 . . . . 10.0 110.58 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -145.01 -178.37 6.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.437 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.88 119.43 1.51 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.022 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -127.26 162.09 27.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 63' ' ' ARG . 11.6 ptm180 . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.815 0.34 . . . . 10.0 110.71 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.232 0.177 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.3 m -77.21 -31.48 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 10.0 110.789 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.5 132.05 3.88 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.576 -0.821 . . . . 10.0 112.401 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.53 -45.19 88.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.856 0.36 . . . . 10.0 110.819 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -29.7 65.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 87' ' ' ILE . 41.2 t -65.2 -46.2 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.078 -0.965 . . . . 10.0 109.773 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.58 -45.74 95.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.538 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -61.48 -38.59 87.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.005 0.431 . . . . 10.0 110.347 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.491 ' CB ' HD22 ' A' ' 140' ' ' LEU . . . -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.399 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.812 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.9 mt -59.8 -49.17 84.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.65 -51.45 65.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.538 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.42 -32.23 73.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.744 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 93' ' ' LYS . . . -73.65 -29.78 62.98 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.796 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.812 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.6 mmt180 -82.76 -36.29 25.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 10.0 109.812 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HA ' HG23 ' A' ' 97' ' ' THR . 37.2 mt-30 -72.92 -15.3 61.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 13.5 ptmt -84.86 6.69 23.69 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.703 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.88 -20.96 55.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.718 0.294 . . . . 10.0 111.777 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 56.98 102.44 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.052 -0.977 . . . . 10.0 111.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.46 -62.04 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.524 -1.448 . . . . 10.0 113.234 -0.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 92' ' ' GLN . 47.0 m -161.38 135.44 6.86 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.139 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 132.59 46.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.45 145.73 54.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -69.14 -36.59 77.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 10.0 109.879 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.49 76.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.254 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -64.19 -39.26 93.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 10.0 110.958 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -64.77 -43.89 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.35 -43.98 96.07 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.321 -0.712 . . . . 10.0 111.321 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.63 -38.63 81.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.794 0.331 . . . . 10.0 110.56 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.71 -18.78 65.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.114 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 103' ' ' LEU . 4.4 pt -117.0 5.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.676 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.42 26.72 60.82 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.306 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.41 -171.14 2.11 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 p -107.42 173.61 6.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.635 0.255 . . . . 10.0 110.958 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.04 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 10.0 110.069 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.73 84.99 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.637 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -60.78 -46.49 90.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.729 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.71 -37.2 77.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.993 0.425 . . . . 10.0 110.757 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.22 77.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.09 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.4 p -75.99 -29.83 58.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.023 0.439 . . . . 10.0 110.539 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.449 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 1.0 OUTLIER -63.35 -41.78 98.88 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.881 -0.599 . . . . 10.0 112.356 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -63.54 -18.22 63.62 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.528 ' HG2' HG22 ' A' ' 121' ' ' THR . 17.7 ttt180 -74.08 -22.68 59.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.356 0.598 . . . . 10.0 109.864 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.482 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 101.14 21.58 11.62 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.781 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.528 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -170.09 113.19 0.47 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 122.108 0.956 . . . . 10.0 110.611 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.29 27.73 0.09 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.422 -1.263 . . . . 10.0 108.86 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m 65.4 106.33 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.789 -1.096 . . . . 10.0 108.708 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 85.9 Cg_endo -78.15 89.63 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.763 2.309 . . . . 10.0 115.419 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -83.28 116.49 22.45 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.566 -2.012 . . . . 10.0 105.566 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.421 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 16.3 mm-40 -50.73 -40.13 53.6 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.647 0.61 . . . . 10.0 112.647 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.71 -32.83 73.74 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.258 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.448 HG23 HD12 ' A' ' 107' ' ' ILE . 62.7 mt -69.76 -55.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 121.026 -0.27 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -51.58 -40.11 59.17 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.582 0.706 . . . . 10.0 110.46 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.0 m -60.11 -52.96 63.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.513 -0.767 . . . . 10.0 112.032 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 -33.68 48.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.521 0.934 . . . . 10.0 113.521 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 ptm -63.11 -45.32 92.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.701 0.286 . . . . 10.0 111.564 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.871 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 21.8 mt-10 -75.66 -27.71 58.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.305 0.574 . . . . 10.0 111.801 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -25.22 67.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.411 -0.813 . . . . 10.0 112.514 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.65 -25.34 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.17 0.51 . . . . 10.0 110.995 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.645 HD21 ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -111.95 -12.74 13.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.302 -178.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 70.7 43.38 0.74 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.217 1.008 . . . . 10.0 108.657 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.871 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.9 t -128.31 141.58 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 113.545 -1.662 . . . . 10.0 107.319 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.6 mmmt -128.55 136.05 50.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.583 0.706 . . . . 10.0 111.259 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.521 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -106.76 30.35 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.794 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -131.22 139.13 49.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.524 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.23 -149.47 18.7 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.429 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.7 -24.16 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 10.0 110.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.66 50.58 1.84 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 10.0 110.555 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.521 HG23 ' HA ' ' A' ' 140' ' ' LEU . 4.3 mm -65.28 138.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.987 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.24 3.48 87.17 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.345 -0.702 . . . . 10.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -136.04 163.06 52.97 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.938 -0.631 . . . . 10.0 109.846 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 20.6 Cg_endo -63.67 123.0 11.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.217 1.945 . . . . 10.0 111.328 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.606 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 22.7 tpt180 . . . . . 0 C--N 1.321 -0.639 0 CA-C-O 120.954 0.406 . . . . 10.0 109.973 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.8 ttt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.389 0.614 . . . . 10.0 110.255 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -136.88 85.43 23.42 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.101 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.41 153.91 12.22 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.467 2.111 . . . . 10.0 112.577 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.68 154.07 18.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.025 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -122.99 93.6 4.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.035 0.445 . . . . 10.0 110.223 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.96 137.54 46.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.105 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.46 -176.16 38.57 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.394 -0.908 . . . . 10.0 112.184 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.72 113.61 2.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.114 -0.565 . . . . 10.0 111.99 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.3 t -159.3 149.36 19.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.684 0.278 . . . . 10.0 110.341 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -125.0 -176.41 3.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.317 -0.402 . . . . 10.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.39 102.66 0.66 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.206 -0.997 . . . . 10.0 112.792 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -142.93 143.8 32.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.835 -0.432 . . . . 10.0 109.835 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.688 179.765 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.569 0.223 . . . . 10.0 110.545 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.475 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.7 m -78.88 -30.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 121.033 -0.267 . . . . 10.0 111.199 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.28 137.6 5.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.65 -52.91 39.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.637 0.256 . . . . 10.0 111.533 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.58 -31.03 71.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.902 HG13 HD13 ' A' ' 140' ' ' LEU . 6.0 t -62.36 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.365 -1.289 . . . . 10.0 109.856 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -59.4 -47.86 88.81 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.784 -0.644 . . . . 10.0 112.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -61.12 -38.17 85.41 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.25 0.548 . . . . 10.0 110.065 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.32 68.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.357 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.784 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.5 mt -60.55 -45.81 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.763 -0.458 . . . . 10.0 109.763 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HG2' HE21 ' A' ' 89' ' ' GLN . 0.6 OUTLIER -69.04 -48.05 63.85 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.698 -0.482 . . . . 10.0 109.698 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 4.3 mm-40 -62.31 -34.7 77.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.33 -36.82 93.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.626 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.96 -36.25 31.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.211 0.529 . . . . 10.0 110.004 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.625 ' HA ' HG23 ' A' ' 97' ' ' THR . 86.6 mt-30 -74.49 -24.13 58.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.39 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 12.4 mptt -87.52 23.45 1.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 10.0 111.28 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -16.12 56.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.018 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 58.65 104.23 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.759 -1.11 . . . . 10.0 111.41 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.09 -60.92 0.06 OUTLIER 'Cis proline' 0 CA--C 1.516 -0.392 0 C-N-CA 123.78 -1.342 . . . . 10.0 113.037 0.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 92' ' ' GLN . 74.8 m -158.77 125.15 4.61 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.206 -0.907 . . . . 10.0 110.799 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.3 tpp -78.31 135.55 37.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.16 144.97 50.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.775 0.321 . . . . 10.0 111.09 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.35 -36.55 77.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.989 0.423 . . . . 10.0 110.215 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -65.14 -45.35 85.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 10.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -66.72 -39.95 88.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -63.6 -38.03 89.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -47.7 69.15 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.418 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 33.6 mmtp -59.2 -40.82 86.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.749 0.309 . . . . 10.0 110.663 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -33.87 73.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.066 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 103' ' ' LEU . 31.1 pt -95.54 -0.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 10.0 111.293 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.62 14.93 69.4 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.185 -0.531 . . . . 10.0 113.29 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -111.56 -157.97 0.63 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.6 p -119.3 174.7 6.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.493 0.187 . . . . 10.0 110.63 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.51 81.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.036 0.445 . . . . 10.0 109.804 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.54 72.29 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.447 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.0 m -64.78 -48.01 76.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.728 0.299 . . . . 10.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.8 -45.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 10.0 110.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.18 -31.69 72.68 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.061 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 m -76.64 -34.71 58.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.975 0.417 . . . . 10.0 111.768 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.32 -34.2 77.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.618 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.46 -17.6 59.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.819 0.342 . . . . 10.0 111.551 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 121' ' ' THR . 25.3 ttm180 -69.43 -28.09 65.83 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.226 0.536 . . . . 10.0 111.262 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.475 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.1 21.91 16.7 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.593 -0.813 . . . . 10.0 111.956 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 121' ' ' THR . 8.5 t -169.79 105.56 0.34 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.316 1.055 . . . . 10.0 109.438 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.88 25.13 0.09 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.497 -1.229 . . . . 10.0 109.636 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.7 m 67.56 106.7 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.111 -0.95 . . . . 10.0 110.737 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 129' ' ' LEU . 65.3 Cg_endo -73.99 88.66 1.07 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.572 2.181 . . . . 10.0 113.989 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.73 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.7 t70 -81.88 116.74 21.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.411 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 11.5 mm-40 -49.7 -46.77 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -62.09 -43.4 98.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.544 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.705 ' O ' ' HG3' ' A' ' 132' ' ' MET . 55.7 mt -63.55 -56.84 14.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 13.3 mt -47.44 -45.92 26.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.349 0.595 . . . . 10.0 110.744 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 71.4 m -56.58 -51.18 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.986 -1.006 . . . . 10.0 112.191 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -75.17 -30.66 60.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.705 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 31.4 mtp -56.36 -61.4 2.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 10.0 111.929 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.5 mp0 -76.37 -26.37 55.59 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HB3' ' O ' ' A' ' 130' ' ' SER . 12.3 ptt85 -58.61 -29.66 66.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.924 0.329 . . . . 10.0 111.364 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 131' ' ' LYS . 66.7 t -71.48 -33.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.0 0.429 . . . . 10.0 110.969 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.597 HD12 HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -95.16 -17.45 21.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.488 -178.363 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.9 t30 62.27 56.03 2.26 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.531 0.682 . . . . 10.0 109.536 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.597 HG22 HD12 ' A' ' 136' ' ' LEU . 11.9 m -137.19 159.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.44 -1.254 . . . . 10.0 108.715 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.5 mmpt? -127.25 139.77 52.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.905 ' HA ' HG23 ' A' ' 145' ' ' ILE . 11.2 mt -95.13 36.11 1.24 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.39 0.614 . . . . 10.0 110.282 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -135.62 155.72 50.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.627 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.02 -163.23 43.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.057 -0.592 . . . . 10.0 112.571 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.86 -12.49 36.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 10.0 110.854 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -104.86 49.89 0.8 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.11 0.481 . . . . 10.0 110.36 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 140' ' ' LEU . 22.7 mt -70.81 137.63 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.96 1.89 67.05 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.77 -0.932 . . . . 10.0 110.77 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -135.24 159.19 72.79 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -0.738 . . . . 10.0 109.217 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.17 120.99 9.29 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.029 1.819 . . . . 10.0 109.905 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 139' ' ' LYS . 7.3 tpp85 . . . . . 0 C--N 1.321 -0.666 0 O-C-N 121.899 -0.5 . . . . 10.0 110.629 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.747 0.308 . . . . 10.0 110.318 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.11 136.49 26.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.87 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.94 116.68 3.3 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.171 2.581 . . . . 10.0 112.685 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -83.31 115.11 21.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.156 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.93 141.53 35.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.665 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.85 149.78 22.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.852 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.13 -162.19 37.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.458 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.02 -166.64 23.24 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -154.35 148.94 26.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.907 0.384 . . . . 10.0 110.542 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -157.96 138.73 13.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.259 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.15 174.49 16.16 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.964 -0.636 . . . . 10.0 111.709 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -165.96 135.24 3.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 10.0 110.513 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.212 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 3.1 p . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 109.874 -0.417 . . . . 10.0 109.874 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.456 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.4 m -84.31 -30.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.968 -0.293 . . . . 10.0 111.444 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.1 140.27 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.253 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.71 -51.94 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.791 0.329 . . . . 10.0 111.092 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.21 -33.93 76.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 140' ' ' LEU . 13.1 t -61.88 -47.12 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.154 -0.93 . . . . 10.0 110.478 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -39.47 95.94 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.699 -0.762 . . . . 10.0 111.827 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.77 -40.32 91.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.38 83.18 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.822 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.465 HG23 ' CZ ' ' A' ' 91' ' ' ARG . 3.4 mt -54.25 -45.28 67.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.054 0.454 . . . . 10.0 110.503 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.87 -48.05 60.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.348 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 53.4 mt-30 -62.54 -37.65 86.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.147 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.98 -38.76 94.44 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.978 -0.556 . . . . 10.0 113.287 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.651 HH22 ' HB3' ' A' ' 132' ' ' MET . 0.5 OUTLIER -78.98 -38.62 36.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.808 0.337 . . . . 10.0 111.425 -178.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.678 ' HA ' HG23 ' A' ' 97' ' ' THR . 8.8 pt20 -72.49 -13.63 61.47 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.492 -0.483 . . . . 10.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 2.0 tttm -81.54 12.12 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -158.42 0.22 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 10.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.66 105.39 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.909 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.08 -30.41 5.33 Favored 'Cis proline' 0 C--N 1.348 0.504 0 C-N-CA 123.523 -1.449 . . . . 10.0 112.725 -0.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 92' ' ' GLN . 15.2 m -161.33 135.76 7.11 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.862 -1.517 . . . . 10.0 109.445 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.18 127.72 35.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.109 -0.33 . . . . 10.0 110.109 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.592 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 59.0 p -79.99 163.69 24.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 10.0 110.641 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.88 -28.91 67.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.87 -32.59 69.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.281 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.592 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 21.4 mm-40 -66.59 -54.97 17.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.547 0.213 . . . . 10.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.559 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -63.91 -40.4 96.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.212 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.38 -46.07 93.48 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 111.352 -0.699 . . . . 10.0 111.352 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -65.48 -44.34 87.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.95 -36.54 77.3 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.634 HD13 ' SD ' ' A' ' 132' ' ' MET . 36.4 pt -87.61 -12.46 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.777 -0.369 . . . . 10.0 111.74 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.86 22.45 30.68 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.888 -0.672 . . . . 10.0 113.476 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -119.89 -154.92 0.6 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 p -115.14 176.96 4.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.568 0.223 . . . . 10.0 110.719 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -34.19 75.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.817 0.342 . . . . 10.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.98 84.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.435 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -58.33 -48.2 81.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.164 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.98 -46.66 90.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.48 -37.84 87.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.274 0.559 . . . . 10.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 58.2 m -74.23 -26.28 60.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.092 -0.503 . . . . 10.0 110.652 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -43.27 69.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.464 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.72 -18.89 57.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.957 0.408 . . . . 10.0 111.035 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 116' ' ' SER . 45.3 ttp180 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.265 0.555 . . . . 10.0 110.411 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.456 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.06 21.49 22.86 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.868 -0.606 . . . . 10.0 111.783 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 121' ' ' THR . 8.0 t -174.62 114.35 0.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.026 0.917 . . . . 10.0 109.712 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.92 29.83 0.15 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.827 -1.079 . . . . 10.0 109.863 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m 58.88 93.1 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HG3' ' O ' ' A' ' 78' ' ' THR . 73.3 Cg_endo -71.45 104.67 1.61 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.926 2.418 . . . . 10.0 115.977 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.585 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 18.3 t70 -90.2 119.57 30.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 104.85 -2.278 . . . . 10.0 104.85 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -49.01 -46.65 44.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -63.3 -36.52 83.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.305 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.37 -55.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.852 -0.158 . . . . 10.0 110.914 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -54.42 -38.76 66.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.979 0.418 . . . . 10.0 110.616 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.6 m -58.69 -50.37 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.605 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -34.51 61.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.719 0.266 . . . . 10.0 111.719 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.651 ' HB3' HH22 ' A' ' 91' ' ' ARG . 5.3 mmm -52.52 -61.06 2.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.355 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HG3' ' HG ' ' A' ' 140' ' ' LEU . 49.4 mm-40 -76.49 -24.04 53.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.487 -0.779 . . . . 10.0 112.17 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 130' ' ' SER . 20.9 ttp180 -52.58 -40.73 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 10.0 111.805 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.98 -24.95 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 10.0 111.197 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -99.57 -16.39 18.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.974 -178.187 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 6.3 m-20 78.79 52.46 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.57 0.7 . . . . 10.0 109.908 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -133.17 159.49 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.886 -1.052 . . . . 10.0 108.248 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -130.15 -2.19 4.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.566 -0.854 . . . . 10.0 113.103 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.678 ' HB3' HG22 ' A' ' 83' ' ' VAL . 22.4 mt 54.61 10.51 0.35 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.792 -1.095 . . . . 10.0 113.699 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.573 HH21 HG21 ' A' ' 83' ' ' VAL . 4.3 mmt85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.297 -0.252 . . . . 10.0 110.47 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.74 -179.78 26.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.769 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.74 -25.05 48.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 10.0 109.9 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -89.37 56.48 3.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.571 -0.74 . . . . 10.0 110.845 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.68 139.28 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.054 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.54 61.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.088 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -150.46 162.0 28.82 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.577 . . . . 10.0 109.462 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 14.2 Cg_endo -61.83 122.73 11.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.618 1.545 . . . . 10.0 110.149 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 149' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 110.315 -0.254 . . . . 10.0 110.315 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -100.71 147.17 33.27 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.539 -0.3 . . . . 10.0 110.723 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.41 151.79 83.23 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.216 2.61 . . . . 10.0 112.507 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -117.28 156.36 27.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -151.59 154.17 35.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -177.81 6.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.763 0.316 . . . . 10.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.37 -133.96 1.86 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.19 -0.529 . . . . 10.0 111.861 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.99 158.01 7.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.148 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -141.45 170.24 16.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.13 179.65 4.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 10.0 110.71 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -125.66 1.21 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.753 -0.737 . . . . 10.0 111.922 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.02 145.22 53.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.902 0.382 . . . . 10.0 110.687 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.991 179.845 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.659 0.266 . . . . 10.0 110.478 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 3.1 p -71.63 -33.89 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.116 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.06 130.18 3.1 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.438 -0.887 . . . . 10.0 112.192 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.99 -53.02 61.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.313 . . . . 10.0 111.089 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -65.34 -33.02 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.51 -0.552 . . . . 10.0 109.51 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 87' ' ' ILE . 92.9 t -62.69 -46.09 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.096 -0.956 . . . . 10.0 110.18 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -60.14 -42.77 98.7 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.973 -0.558 . . . . 10.0 113.176 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -69.24 -34.16 74.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 10.0 110.447 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.22 -29.68 66.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.707 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 83' ' ' VAL . 39.5 mt -59.27 -44.09 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 10.0 109.99 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.38 -54.63 11.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.245 0.545 . . . . 10.0 110.028 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 47.8 mt-30 -55.2 -38.19 68.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.975 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.46 -34.38 40.39 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.158 -1.02 . . . . 10.0 113.12 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.666 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -81.7 -26.03 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.053 0.454 . . . . 10.0 111.375 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG2' HG23 ' A' ' 97' ' ' THR . 71.5 mt-30 -75.21 -8.8 57.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.187 0.517 . . . . 10.0 109.905 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 8.4 mtpm? -76.63 8.13 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.973 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.62 -13.9 55.7 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.873 -0.331 . . . . 10.0 111.689 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER 61.04 111.1 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 O-C-N 124.32 1.013 . . . . 10.0 112.096 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.1 Cg_endo -76.0 -37.86 1.99 Allowed 'Cis proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.205 -1.581 . . . . 10.0 112.373 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 92' ' ' GLN . 3.0 m -170.98 135.85 1.06 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.973 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 33.9 tpp -70.79 127.02 31.21 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -63.18 146.64 52.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.572 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -64.74 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.979 0.419 . . . . 10.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.72 -47.22 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.23 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -68.31 -37.04 80.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.707 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -61.83 -44.24 97.24 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.72 97.97 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.346 -0.843 . . . . 10.0 111.513 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -62.9 -36.05 82.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.168 0.509 . . . . 10.0 110.331 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -71.94 -40.87 68.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.193 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.8 pt -82.53 -5.9 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 111.992 0.367 . . . . 10.0 111.992 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.9 28.45 37.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.837 -0.697 . . . . 10.0 112.907 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -130.14 -146.84 0.32 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.216 -0.661 . . . . 10.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.35 175.73 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.615 0.245 . . . . 10.0 111.097 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.24 91.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.726 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.75 76.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.671 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -60.27 -46.45 89.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.398 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 103' ' ' LEU . 39.2 t -65.49 -45.91 91.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.354 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.92 -32.87 74.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.86 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -77.2 -28.18 53.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.471 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -70.33 -39.71 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.125 0.417 . . . . 10.0 112.125 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.56 -19.51 57.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.091 0.472 . . . . 10.0 111.469 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.57 ' HG2' HG22 ' A' ' 121' ' ' THR . 12.1 ttm180 -72.89 -29.34 63.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.738 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.99 12.21 47.07 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.998 -0.62 . . . . 10.0 113.633 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.1 t -149.38 59.33 1.02 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.795 0.807 . . . . 10.0 111.022 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.2 27.53 9.42 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.613 -0.721 . . . . 10.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.4 m 64.97 109.38 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 123.627 0.58 . . . . 10.0 110.506 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 44.0 Cg_endo -70.37 88.37 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.171 1.914 . . . . 10.0 113.642 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.718 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.0 t70 -87.35 114.43 23.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.7 -1.222 . . . . 10.0 107.7 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.8 mm-40 -49.75 -45.64 49.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.472 0.483 . . . . 10.0 111.933 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 22.6 t30 -61.25 -44.97 96.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.822 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.594 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.5 mt -63.02 -55.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.181 -0.207 . . . . 10.0 110.648 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 6.3 mt -50.12 -41.38 48.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.356 0.598 . . . . 10.0 110.321 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 73.9 m -58.97 -43.55 91.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.124 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 135' ' ' VAL . 74.2 mmtt -72.98 -43.28 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.909 0.337 . . . . 10.0 111.909 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.594 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 14.3 mtp -49.28 -56.97 7.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.752 0.786 . . . . 10.0 111.841 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.442 ' CG ' HH12 ' A' ' 91' ' ' ARG . 11.8 mt-10 -73.93 -27.28 60.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -1.112 . . . . 10.0 113.083 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.604 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -68.72 -22.65 64.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.261 0.467 . . . . 10.0 112.261 -178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.6 t -66.9 -24.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 10.0 109.957 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.55 HD11 HH11 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -123.53 -96.54 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.151 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 19.0 p-10 173.42 31.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.2 m -111.55 147.62 15.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 2.9 mmpt? -115.6 132.92 56.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 10.0 110.711 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD13 HG13 ' A' ' 83' ' ' VAL . 40.8 mt -97.42 40.58 1.15 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -139.33 139.35 37.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.794 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.58 -157.8 19.83 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.651 -0.785 . . . . 10.0 112.802 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.29 -19.24 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.128 0.49 . . . . 10.0 111.16 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -97.75 54.07 1.14 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 14.1 mm -63.17 136.54 25.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.389 -0.823 . . . . 10.0 112.127 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.2 4.01 90.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.023 -0.608 . . . . 10.0 112.144 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.76 54.66 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.942 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 12.0 Cg_endo -58.5 121.86 10.68 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.803 2.335 . . . . 10.0 110.594 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 121.556 0.693 . . . . 10.0 109.169 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.1 mtt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.583 0.23 . . . . 10.0 110.81 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.97 90.34 49.75 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.567 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -86.49 154.7 9.15 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.025 2.483 . . . . 10.0 112.994 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.49 141.34 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.209 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -159.89 151.68 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.712 0.291 . . . . 10.0 110.661 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.38 150.26 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.038 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.76 166.16 34.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.61 -0.805 . . . . 10.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.08 170.4 20.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.187 -0.53 . . . . 10.0 112.307 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 162.39 12.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.844 0.354 . . . . 10.0 111.274 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.91 -175.17 4.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.45 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.78 158.83 31.45 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.601 -0.6 . . . . 10.0 111.601 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.26 176.95 7.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.992 0.396 . . . . 10.0 110.975 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.095 179.749 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.1 m -88.24 -34.12 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.42 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.41 143.03 7.62 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.581 -0.818 . . . . 10.0 112.489 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -67.28 -55.67 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.641 0.237 . . . . 10.0 111.641 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.15 -35.39 80.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.543 0.687 . . . . 10.0 109.221 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.533 HG13 HD13 ' A' ' 140' ' ' LEU . 38.9 t -59.51 -45.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.681 -1.145 . . . . 10.0 110.411 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.11 97.76 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.117 -0.564 . . . . 10.0 112.476 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -65.04 -37.0 86.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 10.0 110.561 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.04 -30.63 67.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.176 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.468 HG12 ' NH2' ' A' ' 91' ' ' ARG . 17.8 mt -60.95 -46.28 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.403 0.621 . . . . 10.0 109.643 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.77 -50.88 31.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.048 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.69 -35.78 75.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.565 . . . . 10.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.71 -34.92 37.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.492 -1.337 . . . . 10.0 113.203 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HD2' HD21 ' A' ' 136' ' ' LEU . 1.3 mpt_? -81.24 -44.22 18.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 10.0 111.582 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' THR . 71.9 mt-30 -67.01 -18.33 65.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.656 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -81.16 29.58 0.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.715 0.293 . . . . 10.0 111.55 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.67 -3.84 51.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.835 0.309 . . . . 10.0 111.835 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 44.0 mt-10 60.13 109.14 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.021 0.826 . . . . 10.0 112.418 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 11.9 Cg_exo -73.62 -54.39 0.15 OUTLIER 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.816 -1.327 . . . . 10.0 112.788 -0.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 13.1 m -161.62 123.14 2.83 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.134 -0.939 . . . . 10.0 110.582 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.5 ttm -64.59 128.84 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.828 0.346 . . . . 10.0 110.438 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.6 p -76.81 157.3 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -66.97 -28.78 68.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.413 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.66 80.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.194 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 46.7 mm-40 -64.51 -53.88 41.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.747 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 114' ' ' VAL . 22.5 tp -60.47 -40.13 90.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.31 -45.68 95.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.684 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -64.36 -44.18 92.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 10.0 110.402 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 58.0 mm-40 -61.47 -41.0 96.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 10.0 112.113 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 131' ' ' LYS . 43.9 pt -84.59 -14.91 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 111.931 0.345 . . . . 10.0 111.931 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.16 41.34 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.969 -0.634 . . . . 10.0 113.225 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -121.95 -176.13 3.27 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.03 163.59 14.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.655 0.264 . . . . 10.0 110.767 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.81 -35.29 76.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 10.0 110.842 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.31 71.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -66.91 -47.4 71.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.599 HG13 HD23 ' A' ' 103' ' ' LEU . 61.2 t -62.46 -43.5 98.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.637 -0.71 . . . . 10.0 110.503 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.31 80.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.403 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 7.2 t -74.29 -30.77 62.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.183 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.09 -44.71 94.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.171 -0.468 . . . . 10.0 111.536 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.59 -19.08 65.69 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.985 -0.286 . . . . 10.0 111.148 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 116' ' ' SER . 20.7 ttp180 -71.92 -22.78 61.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.417 0.627 . . . . 10.0 109.534 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.422 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 100.45 25.49 8.71 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.522 -0.763 . . . . 10.0 112.132 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 121' ' ' THR . 10.3 t -174.2 111.97 0.17 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.975 0.893 . . . . 10.0 110.467 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.35 33.42 0.09 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.99 -1.005 . . . . 10.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m 60.76 99.99 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.312 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.19 88.82 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.878 2.386 . . . . 10.0 115.06 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.5 t70 -86.01 117.07 24.62 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 105.856 -1.905 . . . . 10.0 105.856 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -51.51 -41.28 60.88 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.613 0.571 . . . . 10.0 112.178 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.495 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 53.4 t30 -65.63 -44.15 87.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.62 ' O ' ' HG3' ' A' ' 132' ' ' MET . 79.4 mt -59.87 -53.93 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.7 mt -48.75 -48.02 41.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.478 0.656 . . . . 10.0 109.736 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.9 m -55.12 -39.84 69.84 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.803 -1.09 . . . . 10.0 111.189 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HB2' HG22 ' A' ' 107' ' ' ILE . 66.8 mmtt -71.72 -48.07 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.62 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 10.1 mtp -52.33 -52.29 54.01 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.86 0.838 . . . . 10.0 111.213 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 32.4 mt-10 -72.56 -29.28 63.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.553 -1.203 . . . . 10.0 113.17 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.2 ttp85 -64.43 -28.92 70.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.8 t -64.0 -31.97 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.917 HD23 HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.16 2.77 9.25 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.539 0.94 . . . . 10.0 113.539 -178.278 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.51 43.38 16.19 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.917 HG22 HD23 ' A' ' 136' ' ' LEU . 31.4 m -131.96 138.47 52.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.501 ' CG ' ' H ' ' A' ' 149' ' ' ARG . 30.4 mmmt -114.06 149.98 34.68 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.466 -0.494 . . . . 10.0 111.364 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.765 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -110.6 15.34 22.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.191 -0.913 . . . . 10.0 109.866 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -115.65 140.68 48.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.434 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.46 -162.81 29.59 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.21 -26.58 21.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.978 0.418 . . . . 10.0 111.117 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -87.74 54.91 3.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.004 0.431 . . . . 10.0 111.726 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.765 HG23 ' HA ' ' A' ' 140' ' ' LEU . 73.6 mt -74.41 142.33 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.1 73.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.688 -0.965 . . . . 10.0 110.688 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.0 156.78 76.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.639 -0.78 . . . . 10.0 109.398 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -61.94 123.72 13.13 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.826 1.684 . . . . 10.0 109.667 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.501 ' H ' ' CG ' ' A' ' 139' ' ' LYS . 23.3 tpt180 . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 121.21 0.528 . . . . 10.0 110.931 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mtp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -151.15 145.42 18.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.124 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.06 147.79 34.19 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.71 2.274 . . . . 10.0 112.619 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.77 143.29 57.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.742 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -72.03 150.36 44.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.423 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.68 30.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.1 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.88 157.19 15.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.241 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.36 169.54 32.17 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.828 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -147.49 97.04 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.062 0.458 . . . . 10.0 110.995 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.06 149.71 24.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.623 -0.51 . . . . 10.0 109.623 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.96 -170.34 12.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.585 -0.817 . . . . 10.0 112.779 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -157.81 167.27 30.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.113 -0.328 . . . . 10.0 110.113 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.981 -179.51 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 109.976 -0.379 . . . . 10.0 109.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.4 m -83.4 -27.61 7.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.759 -0.376 . . . . 10.0 110.69 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.9 139.19 6.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 10.0 111.719 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -65.23 -56.29 13.63 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.709 0.29 . . . . 10.0 111.294 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.56 -32.94 74.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' ILE . 38.5 t -62.15 -43.71 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.224 -0.898 . . . . 10.0 109.857 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.28 99.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.405 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -63.28 -37.81 88.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.622 . . . . 10.0 109.777 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' CB ' HD22 ' A' ' 140' ' ' LEU . . . -73.92 -29.78 62.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.617 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.729 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 12.4 mt -58.39 -52.3 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.99 -48.98 66.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.552 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -60.6 -29.27 69.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.354 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.56 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -76.28 -37.84 35.66 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.422 -0.894 . . . . 10.0 113.051 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.5 mmt180 -79.65 -43.75 22.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.28 0.54 . . . . 10.0 110.747 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.2 -5.44 27.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.04 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 38.8 tttt -78.91 -10.9 59.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.835 0.35 . . . . 10.0 110.643 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.61 172.35 4.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.38 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -120.31 125.12 27.38 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.507 -0.315 . . . . 10.0 110.387 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.52 -39.51 1.3 Allowed 'Cis proline' 0 CA--C 1.519 -0.258 0 C-N-CA 123.617 -1.409 . . . . 10.0 112.544 -0.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.5 m -170.61 120.95 0.58 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.608 -1.178 . . . . 10.0 109.333 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 35.3 tpp -65.28 122.5 17.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.8 p -74.47 159.27 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.033 0.444 . . . . 10.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -68.91 -37.66 79.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.178 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.1 -41.67 90.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.02 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -66.19 -46.15 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.144 -0.222 . . . . 10.0 110.808 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tp -65.45 -39.56 92.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.15 -47.55 90.24 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.147 -0.933 . . . . 10.0 111.384 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.82 -43.41 98.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -60.65 -41.74 95.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.899 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 103' ' ' LEU . 38.9 pt -82.84 -7.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.895 0.332 . . . . 10.0 111.895 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.22 29.99 29.3 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.648 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.51 -154.0 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.51 172.36 7.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.535 -0.172 . . . . 10.0 110.535 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.42 89.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.02 0.438 . . . . 10.0 110.336 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.77 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.639 -0.71 . . . . 10.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -62.22 -46.64 87.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 10.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.0 t -65.67 -43.76 93.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.451 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -65.96 -35.09 79.64 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.208 0.527 . . . . 10.0 111.085 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 68.9 m -77.3 -27.71 53.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.459 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -37.92 89.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.5 -17.83 56.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.575 ' HG2' HG22 ' A' ' 121' ' ' THR . 5.1 ttm180 -64.9 -23.84 67.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.305 0.574 . . . . 10.0 110.405 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.422 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.42 24.28 14.53 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.678 -0.772 . . . . 10.0 111.647 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.575 HG22 ' HG2' ' A' ' 119' ' ' ARG . 8.4 t -175.0 115.02 0.15 Allowed 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.829 0.823 . . . . 10.0 109.549 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.58 30.56 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.898 -1.046 . . . . 10.0 109.585 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.7 m 62.32 97.6 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.08 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.97 90.95 0.94 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.85 2.367 . . . . 10.0 114.515 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.611 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -80.87 124.75 29.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.189 -2.152 . . . . 10.0 105.189 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.3 mm-40 -51.63 -42.69 62.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -176.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -63.99 -39.13 93.42 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.678 0.611 . . . . 10.0 110.84 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.768 ' O ' ' HG3' ' A' ' 132' ' ' MET . 96.9 mt -64.3 -57.08 12.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 120.751 -0.379 . . . . 10.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.3 mt -50.47 -45.65 56.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.505 0.503 . . . . 10.0 110.592 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.2 m -55.32 -46.44 76.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.449 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 135' ' ' VAL . 19.1 mtmt -73.55 -40.35 64.03 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.768 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 29.6 mtp -52.06 -55.22 22.02 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.857 0.837 . . . . 10.0 111.011 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.669 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 27.1 mt-10 -72.98 -31.81 64.78 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.463 -1.244 . . . . 10.0 113.361 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -69.88 -23.43 63.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 131' ' ' LYS . 57.4 t -61.51 -38.17 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 10.0 111.805 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.909 HD22 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -114.53 -5.91 12.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.92 46.41 0.48 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.226 1.013 . . . . 10.0 109.412 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.669 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 47.7 t -122.68 138.91 51.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.648 -1.614 . . . . 10.0 106.943 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 13.4 mmmm -122.79 140.29 53.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 118.842 0.747 . . . . 10.0 111.792 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.726 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -111.57 18.26 19.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -113.98 140.53 48.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.494 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.39 -156.61 25.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.749 -0.738 . . . . 10.0 111.92 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.04 0.74 41.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.089 0.471 . . . . 10.0 110.96 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -110.36 51.1 0.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.799 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.726 HG23 ' HA ' ' A' ' 140' ' ' LEU . 49.0 mt -72.54 136.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.519 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.54 4.4 62.28 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.996 -0.841 . . . . 10.0 110.996 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.28 156.87 73.47 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.278 -0.461 . . . . 10.0 110.245 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -64.55 122.31 10.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.897 1.731 . . . . 10.0 109.387 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.635 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 15.7 tpt180 . . . . . 0 C--N 1.319 -0.735 0 CA-C-O 121.094 0.473 . . . . 10.0 110.052 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.8 tpt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.875 0.369 . . . . 10.0 110.909 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.84 143.5 48.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 166.65 28.42 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.638 2.225 . . . . 10.0 113.245 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.63 162.64 16.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.847 -0.615 . . . . 10.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -145.18 157.78 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.2 144.66 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.21 175.51 42.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.247 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.62 148.85 18.68 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.751 -0.738 . . . . 10.0 112.453 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.6 m -91.64 127.88 37.26 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.039 -0.356 . . . . 10.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.73 167.17 15.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.997 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.04 166.77 28.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.714 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -123.06 165.17 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.813 0.306 . . . . 10.0 111.026 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.331 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 110.196 -0.298 . . . . 10.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.5 m -82.88 -29.94 8.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.831 0.308 . . . . 10.0 111.831 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.31 140.7 8.04 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.111 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.46 -49.84 67.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.882 0.341 . . . . 10.0 111.682 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -59.35 -38.45 80.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.375 0.607 . . . . 10.0 109.742 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.03 -42.93 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.1 -0.955 . . . . 10.0 110.134 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -64.29 -43.61 96.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.14 -0.552 . . . . 10.0 112.538 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -61.34 -43.06 99.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.188 0.518 . . . . 10.0 109.902 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -69.83 -29.69 67.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.33 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.799 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.2 mt -58.1 -48.54 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.981 -0.378 . . . . 10.0 109.981 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.69 -48.57 63.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.248 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.26 -33.39 73.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.67 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.73 -30.15 68.72 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.793 -0.639 . . . . 10.0 113.264 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.799 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 13.0 mmt85 -77.37 -29.41 53.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -79.1 -8.06 58.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 10.0 109.717 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -75.14 -8.5 56.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.929 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -168.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 40.8 mt-10 -133.21 110.35 12.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.469 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.7 Cg_endo -78.13 -30.64 5.69 Favored 'Cis proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.225 -1.573 . . . . 10.0 112.522 -0.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.6 m -170.45 134.37 1.13 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.802 -1.544 . . . . 10.0 109.65 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 122.13 22.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.5 p -69.89 158.15 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 10.0 111.102 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -67.41 -36.08 80.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.845 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.58 78.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.358 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.47 -47.17 86.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.362 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -64.94 -40.71 95.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.574 -0.528 . . . . 10.0 109.574 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -48.38 81.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.214 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -64.02 -38.04 89.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.966 0.412 . . . . 10.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -39.39 92.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.635 -0.711 . . . . 10.0 111.296 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 103' ' ' LEU . 32.6 pt -89.07 -28.63 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.85 6.1 21.35 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.59 -0.814 . . . . 10.0 112.818 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -106.33 -164.39 1.0 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 171.07 7.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.103 -0.239 . . . . 10.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.85 -38.05 80.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 10.0 110.402 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.42 75.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.526 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 9.7 m -66.98 -40.28 87.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.283 0.563 . . . . 10.0 110.271 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.75 -37.23 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.82 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -72.44 -33.03 66.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.38 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 52.3 p -76.58 -29.1 56.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.924 0.392 . . . . 10.0 111.6 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.3 m-85 -63.18 -36.7 84.49 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -63.61 -18.57 64.05 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' A' ' 121' ' ' THR . 61.5 ttt180 -68.13 -18.76 64.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.229 0.538 . . . . 10.0 110.657 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.417 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 91.3 28.84 13.6 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.247 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.527 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.2 t -175.96 111.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.917 0.865 . . . . 10.0 109.793 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.94 34.34 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.946 -1.025 . . . . 10.0 110.057 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m 63.28 99.23 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.454 -0.793 . . . . 10.0 109.137 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' HD21 ' A' ' 129' ' ' LEU . 92.2 Cg_endo -77.16 88.55 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.996 2.464 . . . . 10.0 115.727 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.592 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 5.9 t70 -81.68 116.07 21.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 17.6 mm-40 -48.65 -41.11 30.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.6 t30 -68.78 -42.24 77.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.783 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.583 ' O ' ' HG3' ' A' ' 132' ' ' MET . 66.7 mt -60.46 -55.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 121.186 -0.206 . . . . 10.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 7.5 mt -47.65 -47.23 29.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.659 0.599 . . . . 10.0 110.325 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.0 m -57.95 -38.65 76.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.211 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 74.6 mmtt -73.66 -36.78 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 10.0 111.464 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.583 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 18.9 mtp -54.22 -57.15 12.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.481 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.604 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -73.36 -26.69 61.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.871 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.58 -38.54 60.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.43 -26.7 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.881 -0.327 . . . . 10.0 111.234 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -92.33 -21.18 20.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.252 0.464 . . . . 10.0 112.252 -178.198 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 57.5 m-20 70.45 48.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.601 0.715 . . . . 10.0 110.184 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.06 169.41 21.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.852 -1.067 . . . . 10.0 108.557 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -137.64 133.21 34.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.938 0.399 . . . . 10.0 110.45 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.695 ' HA ' HG23 ' A' ' 145' ' ' ILE . 8.2 mt -100.86 12.0 38.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.583 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -125.4 139.86 53.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.94 -153.72 17.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.342 -0.703 . . . . 10.0 111.342 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.99 -33.57 10.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.968 0.413 . . . . 10.0 111.16 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -87.43 55.65 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.263 0.554 . . . . 10.0 110.576 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.695 HG23 ' HA ' ' A' ' 140' ' ' LEU . 71.0 mt -69.0 141.17 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.658 . . . . 10.0 111.323 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.94 -5.54 84.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.152 -0.546 . . . . 10.0 111.831 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.64 158.21 62.92 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.304 -0.448 . . . . 10.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.01 122.47 10.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.167 1.912 . . . . 10.0 110.849 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 121.546 0.689 . . . . 10.0 110.046 -179.711 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.5 mtm . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.835 -0.431 . . . . 10.0 109.835 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.18 121.85 6.7 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.612 -0.267 . . . . 10.0 110.366 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.85 122.03 10.39 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.661 2.24 . . . . 10.0 112.425 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.35 137.87 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.596 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -138.44 140.21 39.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.806 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -104.28 -44.64 4.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.032 0.444 . . . . 10.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.61 -119.8 5.06 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.416 -0.674 . . . . 10.0 111.416 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 141.36 117.37 1.34 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.9 m -103.62 142.15 34.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.749 0.309 . . . . 10.0 110.648 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.12 -150.51 0.43 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.267 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.09 -168.05 40.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.013 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -154.17 176.94 11.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 10.0 110.998 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.108 179.738 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.449 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 23.6 p . . . . . 0 CA--C 1.531 0.228 0 CA-C-O 120.702 0.287 . . . . 10.0 110.764 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.676 HG12 HG21 ' A' ' 83' ' ' VAL . 3.0 t -82.26 -68.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.628 -0.26 . . . . 10.0 111.299 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.438 ' C ' HG22 ' A' ' 83' ' ' VAL . . . 146.64 161.6 9.4 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 111.574 -0.611 . . . . 10.0 111.574 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.5 ' HG2' ' H ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -78.87 -55.02 5.47 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 -178.363 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.1 tp10 -71.97 -28.61 63.54 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.511 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.676 HG21 HG12 ' A' ' 79' ' ' VAL . 6.6 m -64.27 -36.4 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.252 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.16 -47.22 90.08 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.496 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.33 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 10.0 110.816 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.78 68.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.414 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.757 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.3 mt -61.23 -49.76 83.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.95 -53.06 60.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.622 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.4 mt-30 -59.22 -39.8 83.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.043 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.47 -35.34 91.59 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.855 -0.688 . . . . 10.0 113.544 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.4 -39.63 28.01 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.042 0.449 . . . . 10.0 110.509 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -69.91 -25.1 63.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.733 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 39.2 tttm -80.0 54.42 1.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.712 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -126.1 3.38 7.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 38.7 mt-10 54.99 101.24 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.915 0.759 . . . . 10.0 112.817 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.5 Cg_endo -82.79 -30.56 4.63 Favored 'Cis proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.176 -1.593 . . . . 10.0 112.61 -0.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -174.81 129.78 0.32 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.837 -1.529 . . . . 10.0 110.007 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.6 tpp -76.69 143.1 40.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.929 -0.397 . . . . 10.0 109.929 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 145.39 50.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.631 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.69 -41.89 74.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.062 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.68 83.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.953 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -70.93 -32.01 68.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.492 -0.322 . . . . 10.0 110.339 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 103' ' ' LEU . 1.1 tm? -63.81 -43.38 96.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.02 -37.4 91.99 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.157 -0.929 . . . . 10.0 111.357 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -65.47 -35.4 80.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 10.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.71 -40.49 84.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.844 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 29.6 pt -87.81 -22.54 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 34.38 5.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.478 -0.868 . . . . 10.0 112.382 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -129.64 -171.79 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.859 0.362 . . . . 10.0 110.444 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 166.96 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.567 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.4 91.01 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.523 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.71 -32.86 70.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.55 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -60.43 -47.09 87.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.096 -0.502 . . . . 10.0 109.998 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.48 -46.47 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.8 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.59 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.32 -35.86 80.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.322 0.582 . . . . 10.0 111.069 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.3 m -75.26 -27.96 59.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.635 ' OH ' ' HA ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -63.74 -38.91 92.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.801 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -65.09 -18.42 65.29 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.053 0.39 . . . . 10.0 112.053 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.621 ' HG2' HG22 ' A' ' 121' ' ' THR . 19.4 ttt180 -78.39 -18.67 54.71 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.62 14.54 46.7 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.431 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.621 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -160.04 106.1 1.58 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.173 0.987 . . . . 10.0 109.802 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.89 24.6 0.5 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.714 -1.13 . . . . 10.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m 59.67 80.63 0.27 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.288 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.635 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 72.9 Cg_endo -75.21 158.8 41.18 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.785 2.323 . . . . 10.0 114.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.6 t70 -137.48 140.17 41.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.257 -1.338 . . . . 10.0 107.86 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.4 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 5.6 mm100 -54.73 -40.2 69.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.586 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.97 -35.45 72.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.548 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.738 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.1 mt -66.78 -57.33 10.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 120.581 -0.448 . . . . 10.0 110.234 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.3 mt -50.13 -39.64 43.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.744 0.783 . . . . 10.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 72.1 m -62.56 -50.32 71.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 10.0 111.488 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.586 ' HD3' ' O ' ' A' ' 127' ' ' ASN . 1.5 mptp? -74.91 -31.33 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 10.0 112.449 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.738 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 52.9 mtp -60.32 -59.38 5.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.577 0.703 . . . . 10.0 111.403 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.695 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 2.9 mp0 -74.56 -25.49 59.33 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 19.6 ptt180 -56.87 -26.9 59.63 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.358 0.526 . . . . 10.0 111.395 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.09 -25.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.148 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.637 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -100.29 -19.23 16.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.795 0.294 . . . . 10.0 111.795 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 68.34 43.16 1.52 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.606 0.717 . . . . 10.0 111.312 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.695 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.8 m -136.68 140.1 43.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.342 -1.355 . . . . 10.0 107.342 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 3.4 mmpt? -116.65 135.49 53.75 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.806 -0.758 . . . . 10.0 111.058 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.416 HD13 ' HB ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -102.29 36.05 2.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.125 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -138.21 139.21 39.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.235 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.14 -163.07 21.99 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.309 -0.716 . . . . 10.0 111.309 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.92 23.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.968 0.413 . . . . 10.0 110.399 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -85.93 55.27 3.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.752 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.57 138.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.91 2.5 90.67 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.464 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.32 160.68 56.46 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.815 -0.192 . . . . 10.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -62.52 120.37 7.87 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.451 1.434 . . . . 10.0 109.506 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? . . . . . 0 C--N 1.318 -0.787 0 CA-C-O 120.771 0.32 . . . . 10.0 110.178 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.1 mtm . . . . . 0 CA--C 1.521 -0.157 0 N-CA-C 110.239 -0.282 . . . . 10.0 110.239 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 t70 62.0 99.19 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 123.818 0.699 . . . . 10.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -88.9 164.61 5.98 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.995 2.463 . . . . 10.0 111.797 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.01 139.89 50.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.224 -0.287 . . . . 10.0 110.224 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -121.41 169.91 10.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.364 . . . . 10.0 110.868 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.81 172.5 17.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.901 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.94 121.0 2.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.518 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.5 124.24 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.025 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 t -144.54 139.08 27.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.006 0.432 . . . . 10.0 110.429 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -106.83 -65.79 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.66 175.27 29.63 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.771 -0.65 . . . . 10.0 111.82 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -155.3 138.89 15.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.774 -0.454 . . . . 10.0 109.774 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 63' ' ' ARG . 14.9 tpt180 . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 121' ' ' THR . 4.9 m -79.87 -35.14 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.822 -0.351 . . . . 10.0 111.063 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.95 147.9 6.85 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.97 -53.05 35.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.068 0.434 . . . . 10.0 111.626 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -69.15 -33.45 73.43 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.759 HG13 HD22 ' A' ' 140' ' ' LEU . 38.3 t -58.72 -41.28 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.69 -1.141 . . . . 10.0 109.951 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.8 -41.47 97.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.131 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -64.56 -45.11 88.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.946 0.403 . . . . 10.0 109.958 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.05 77.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.733 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.678 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.6 mt -58.73 -46.01 90.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.733 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.12 -49.15 59.65 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.042 0.448 . . . . 10.0 110.401 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -61.4 -36.55 80.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.7 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.56 98.01 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.039 -0.528 . . . . 10.0 114.013 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 17.7 mmt-85 -69.84 -36.58 75.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.383 0.591 . . . . 10.0 110.254 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 97' ' ' THR . 70.3 mt-30 -82.42 -5.89 58.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.781 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -89.03 14.58 10.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.846 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.87 -17.7 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.876 0.325 . . . . 10.0 111.876 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 60.55 106.95 0.03 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.937 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.98 -59.03 0.14 OUTLIER 'Cis proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.534 -1.444 . . . . 10.0 112.347 0.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 92' ' ' GLN . 72.0 m -157.51 124.07 4.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.878 -1.055 . . . . 10.0 110.732 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.6 tpp -72.49 141.66 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 142.75 55.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.995 0.426 . . . . 10.0 111.037 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -70.5 -37.37 74.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.473 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.23 76.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.195 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.06 -41.93 40.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.817 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.453 ' HG ' ' HD2' ' A' ' 91' ' ' ARG . 1.2 tm? -64.11 -38.33 90.67 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.1 -46.24 59.19 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.391 -0.822 . . . . 10.0 111.555 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -58.09 -39.06 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 10.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.08 -39.29 89.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.301 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.453 HD12 HG23 ' A' ' 128' ' ' ILE . 17.6 pt -92.91 4.01 7.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.15 71.88 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.959 -0.638 . . . . 10.0 113.926 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.414 ' OE1' HG21 ' A' ' 113' ' ' THR . 32.0 mm-40 -109.46 -162.8 0.82 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.0 p -125.24 174.7 7.92 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.252 -0.28 . . . . 10.0 111.048 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.84 87.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.321 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.31 77.62 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.347 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.414 HG21 ' OE1' ' A' ' 109' ' ' GLU . 2.6 m -62.4 -50.32 72.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.43 -42.68 91.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 10.0 110.232 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.44 -37.04 82.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.925 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 m -74.84 -27.44 60.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.17 -0.468 . . . . 10.0 111.967 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.33 -32.75 70.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.153 0.427 . . . . 10.0 112.153 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -18.14 41.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 121' ' ' THR . 1.6 ttt85 -61.89 -24.01 66.67 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.02 0.438 . . . . 10.0 111.093 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.13 23.8 11.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.348 -0.93 . . . . 10.0 113.933 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -154.73 -88.46 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.824 0.312 . . . . 10.0 110.651 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.684 ' H ' HG23 ' A' ' 121' ' ' THR . . . 58.78 11.79 1.98 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.527 0.936 . . . . 10.0 113.527 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m 45.64 76.59 0.53 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.608 ' HB2' HD21 ' A' ' 129' ' ' LEU . 42.6 Cg_endo -89.01 147.46 5.58 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.308 2.672 . . . . 10.0 116.962 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.31 129.33 42.48 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 103.994 -2.595 . . . . 10.0 103.994 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -55.84 -29.55 60.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 107' ' ' ILE . 68.8 mt -68.41 -48.4 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 110.431 -0.211 . . . . 10.0 110.431 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' A' ' 124' ' ' PRO . 5.4 mt -57.76 -36.47 72.15 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.404 0.621 . . . . 10.0 109.883 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -66.04 -49.52 67.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.142 -0.935 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -74.48 -38.62 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.751 1.019 . . . . 10.0 113.751 -178.434 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.418 ' HG3' ' HG2' ' A' ' 133' ' ' GLU . 7.1 ptm -61.2 -50.25 73.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.009 0.368 . . . . 10.0 111.543 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.627 ' CD ' HH22 ' A' ' 91' ' ' ARG . 15.5 mm-40 -76.91 -29.03 55.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.253 0.834 . . . . 10.0 113.253 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -62.61 -23.38 67.02 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.133 -0.354 . . . . 10.0 111.478 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 131' ' ' LYS . 59.1 t -63.1 -34.18 65.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.189 0.519 . . . . 10.0 110.311 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.516 HD11 ' OE1' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.12 3.65 28.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.881 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.6 t30 70.18 51.79 0.39 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.579 0.704 . . . . 10.0 110.27 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.484 ' CG2' HD12 ' A' ' 136' ' ' LEU . 22.2 t -132.59 152.32 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.129 -0.941 . . . . 10.0 109.606 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 26.0 mmmt -131.04 145.15 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 10.0 110.512 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.759 HD22 HG13 ' A' ' 83' ' ' VAL . 27.6 mt -106.86 20.16 19.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.118 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -134.21 139.28 45.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.841 0.353 . . . . 10.0 110.948 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.33 -157.37 15.15 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.543 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.41 -30.59 14.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.075 0.464 . . . . 10.0 110.007 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.83 59.04 5.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.645 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.5 mm -66.9 137.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 10.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.45 10.32 85.46 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.23 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -133.81 157.14 78.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.372 -0.414 . . . . 10.0 110.381 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.12 123.82 13.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.557 2.171 . . . . 10.0 111.235 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 5.2 tmm_? . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.2 ttm . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.861 0.363 . . . . 10.0 110.916 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.08 146.04 31.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.945 -0.57 . . . . 10.0 109.903 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.9 168.46 24.15 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.402 . . . . 10.0 112.699 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -107.6 160.01 16.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.799 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.89 136.89 25.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.725 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.72 168.32 26.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 10.0 111.122 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.58 170.04 29.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.9 -178.69 25.08 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.398 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -147.72 138.42 23.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.118 -0.327 . . . . 10.0 110.118 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -94.55 -64.66 1.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.988 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.65 -166.89 13.76 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.896 -0.669 . . . . 10.0 111.475 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.54 145.76 9.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.074 0.437 . . . . 10.0 110.802 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.294 179.525 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.1 p . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.449 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.5 m -88.35 -25.37 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.567 -0.453 . . . . 10.0 111.541 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.32 138.57 5.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.906 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -67.65 -39.56 84.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 10.0 111.861 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.99 -31.49 50.7 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 140' ' ' LEU . 42.7 t -66.02 -40.22 86.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.184 -0.916 . . . . 10.0 110.056 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.39 -41.74 95.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.891 -0.671 . . . . 10.0 112.12 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -39.5 74.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.163 0.506 . . . . 10.0 110.051 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.32 70.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.817 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 83' ' ' VAL . 7.9 mt -59.47 -45.53 93.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.081 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.93 -53.87 13.44 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.754 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 35.0 mt-30 -54.05 -34.91 61.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.351 -0.84 . . . . 10.0 111.267 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.4 -34.87 39.04 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.754 -0.736 . . . . 10.0 112.766 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.651 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -80.13 -33.61 38.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.019 0.438 . . . . 10.0 110.357 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -73.33 -2.62 22.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.1 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 48.4 mttm -83.25 -2.68 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.015 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -78.0 177.06 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.584 -0.735 . . . . 10.0 110.589 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -120.69 121.27 29.13 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.319 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.98 -29.32 6.82 Favored 'Cis proline' 0 CA--C 1.515 -0.445 0 C-N-CA 123.723 -1.365 . . . . 10.0 112.693 -0.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 m -179.05 122.43 0.08 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 113.754 -1.566 . . . . 10.0 109.324 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.8 ttm -70.46 110.87 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.211 -0.292 . . . . 10.0 110.211 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.577 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.9 p -78.51 172.37 13.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.869 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -62.84 -35.7 80.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.769 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.73 -42.42 81.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.005 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.577 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 16.8 mm-40 -68.52 -48.82 63.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.917 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -61.06 -42.22 98.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.34 98.16 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.575 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -65.99 -36.03 82.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.792 0.33 . . . . 10.0 110.659 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.26 -40.99 77.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.792 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.52 HG22 ' HB3' ' A' ' 131' ' ' LYS . 35.9 pt -83.48 -17.71 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.884 -0.326 . . . . 10.0 111.689 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.91 27.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 10.0 112.77 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -119.89 -169.71 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.769 0.318 . . . . 10.0 110.225 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.7 p -98.98 168.2 10.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.535 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.05 78.6 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.863 0.364 . . . . 10.0 110.623 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.244 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.221 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.77 -43.2 90.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -64.02 -35.23 80.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.443 0.64 . . . . 10.0 110.463 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 48.9 m -76.13 -27.03 56.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.18 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -43.16 77.39 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.676 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.24 -18.69 59.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.975 0.417 . . . . 10.0 111.729 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 116' ' ' SER . 48.3 ttp180 -67.25 -21.63 65.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.312 0.577 . . . . 10.0 110.636 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 95.22 20.34 28.02 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.728 -0.749 . . . . 10.0 111.692 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.416 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.3 t -172.62 108.36 0.19 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.01 0.91 . . . . 10.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.28 30.29 0.2 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.544 -1.207 . . . . 10.0 109.547 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.8 m 60.63 96.4 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.126 -0.943 . . . . 10.0 110.032 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 123' ' ' THR . 47.2 Cg_endo -65.42 94.84 0.26 Allowed 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 123.173 2.582 . . . . 10.0 113.952 -177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.715 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.0 t70 -85.97 120.0 26.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.616 -1.253 . . . . 10.0 107.616 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.2 mm-40 -52.98 -37.97 61.79 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.466 0.479 . . . . 10.0 111.89 -177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -68.49 -44.36 74.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.047 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.639 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.9 mt -64.13 -54.11 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.185 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 17.6 mt -50.61 -41.83 55.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.269 0.557 . . . . 10.0 110.189 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.3 m -59.61 -49.72 76.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.274 -0.875 . . . . 10.0 111.096 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.8 mptp? -67.48 -40.26 85.27 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.377 0.51 . . . . 10.0 112.377 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.639 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -49.01 -58.31 5.12 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.441 0.638 . . . . 10.0 111.765 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 24.9 mt-10 -75.38 -28.63 59.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.413 -0.812 . . . . 10.0 112.805 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -64.88 -22.97 67.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.926 0.713 . . . . 10.0 112.926 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 131' ' ' LYS . 21.2 t -67.9 -25.0 31.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.631 . . . . 10.0 110.006 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -122.17 -100.44 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.198 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.593 ' H ' HD12 ' A' ' 136' ' ' LEU . 63.5 t30 174.29 64.02 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.407 -0.815 . . . . 10.0 109.251 -177.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.3 OUTLIER -136.23 155.83 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.274 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.489 ' HA ' ' OE1' ' A' ' 133' ' ' GLU . 4.6 mmtm -130.82 132.36 45.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.044 0.45 . . . . 10.0 110.969 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.772 ' HA ' HG23 ' A' ' 145' ' ' ILE . 13.5 mt -104.64 17.97 23.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.196 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 141' ' ' ARG . 40.0 mtp-105 -127.96 144.42 51.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.751 -0.658 . . . . 10.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.16 -155.38 19.54 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.443 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.73 15.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.653 0.263 . . . . 10.0 111.523 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.45 52.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.035 0.445 . . . . 10.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.772 HG23 ' HA ' ' A' ' 140' ' ' LEU . 54.7 mt -68.69 139.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.737 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.95 12.01 77.86 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.176 -0.77 . . . . 10.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.01 152.37 64.96 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.925 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.1 120.09 7.42 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.779 1.652 . . . . 10.0 108.737 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 . . . . . 0 C--N 1.322 -0.607 0 CA-C-O 121.126 0.489 . . . . 10.0 110.088 -178.338 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.012 0.434 . . . . 10.0 110.328 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.57 84.12 23.63 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.96 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.27 133.66 23.28 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.273 1.982 . . . . 10.0 111.331 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.23 120.98 25.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.729 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -87.61 159.63 18.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.269 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.28 155.18 17.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.614 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.06 -135.65 8.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.919 -0.657 . . . . 10.0 111.809 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.68 171.05 34.21 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.665 -0.778 . . . . 10.0 112.424 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -137.37 136.21 37.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.743 -0.466 . . . . 10.0 109.743 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -135.43 150.54 49.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.566 0.222 . . . . 10.0 110.62 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.96 173.2 22.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 10.0 111.962 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -113.44 -172.26 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.679 0.276 . . . . 10.0 110.811 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.74 0.305 . . . . 10.0 110.832 -179.837 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 117' ' ' TYR . 1.4 m -84.93 -28.76 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 121.073 -0.251 . . . . 10.0 111.301 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.19 135.63 5.16 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.593 -0.813 . . . . 10.0 112.28 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -65.26 -48.1 74.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.615 0.245 . . . . 10.0 111.364 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.33 -34.91 79.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 140' ' ' LEU . 25.0 t -59.28 -46.99 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.546 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.16 95.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.044 -0.598 . . . . 10.0 112.19 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -64.52 -43.86 92.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 10.0 110.378 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.3 82.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.794 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.786 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.8 mt -56.34 -47.67 80.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -66.16 -49.22 68.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.62 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.16 -37.16 84.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.215 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.96 -34.29 89.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.927 -0.654 . . . . 10.0 112.916 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.809 ' HD2' HD22 ' A' ' 103' ' ' LEU . 5.8 mmt180 -76.27 -34.71 59.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.287 0.565 . . . . 10.0 109.689 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' HA ' HG23 ' A' ' 97' ' ' THR . 96.8 mt-30 -75.36 -14.38 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -98.55 21.69 10.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.438 -0.346 . . . . 10.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -7.08 59.7 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.817 0.302 . . . . 10.0 111.817 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 37.7 mt-10 54.41 101.17 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.662 0 O-C-N 123.984 0.803 . . . . 10.0 112.228 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 55.4 Cg_endo -74.4 -50.93 0.17 OUTLIER 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.218 -1.576 . . . . 10.0 113.18 0.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 92' ' ' GLN . 21.5 m -163.49 137.15 5.72 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.891 . . . . 10.0 110.169 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.99 132.21 37.29 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.88 -0.415 . . . . 10.0 109.88 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.2 p -75.55 163.46 27.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 10.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.21 -29.69 67.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.679 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.14 84.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.127 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.5 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 55.8 mm-40 -62.8 -49.33 75.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.475 -0.329 . . . . 10.0 111.004 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.809 HD22 ' HD2' ' A' ' 91' ' ' ARG . 24.5 tp -62.03 -47.08 86.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.04 -46.19 91.69 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.076 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -64.82 -42.16 95.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.754 0.279 . . . . 10.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 15.5 pt-20 -69.65 -23.99 63.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 103' ' ' LEU . 27.6 pt -97.3 -7.04 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.769 -0.582 . . . . 10.0 111.127 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.54 16.34 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.745 -0.74 . . . . 10.0 112.664 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 110' ' ' THR . 54.5 mm-40 -130.04 -156.64 0.77 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.74 -0.467 . . . . 10.0 109.74 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 109' ' ' GLU . 3.2 p -126.11 176.35 7.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.521 0.201 . . . . 10.0 110.818 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.43 95.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.785 0.326 . . . . 10.0 111.208 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 116' ' ' SER . . . -61.11 -30.45 70.37 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.922 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.7 m -68.54 -43.79 75.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.135 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.674 HG13 HD23 ' A' ' 103' ' ' LEU . 92.8 t -64.44 -46.17 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.372 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.13 73.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.442 0.639 . . . . 10.0 110.064 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -74.69 -31.89 62.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 10.0 110.667 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.413 ' CE1' HG11 ' A' ' 79' ' ' VAL . 1.9 m-85 -72.41 -41.18 66.53 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.616 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.53 -18.35 64.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.165 0.507 . . . . 10.0 110.439 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 116' ' ' SER . 19.7 tpt180 -73.97 -19.31 60.7 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.18 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.23 26.56 25.58 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.054 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 121' ' ' THR . 5.3 t -175.23 102.6 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.957 0.884 . . . . 10.0 110.507 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 116' ' ' SER . . . -152.5 33.24 0.51 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.376 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 m 63.42 98.96 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.226 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 96.54 0.59 Allowed 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 123.348 2.698 . . . . 10.0 115.169 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.92 112.39 24.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.562 -2.384 . . . . 10.0 104.562 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.5 mm-40 -46.56 -38.98 10.23 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.549 1.314 . . . . 10.0 114.549 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.26 -33.09 65.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 111.683 0.253 . . . . 10.0 111.683 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 132' ' ' MET . 68.6 mt -70.09 -58.91 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.706 -0.398 . . . . 10.0 111.484 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -35.35 71.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.798 0.332 . . . . 10.0 111.558 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 22.7 m -63.31 -44.09 95.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 135' ' ' VAL . 25.2 mtmt -75.14 -34.58 61.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.011 0.375 . . . . 10.0 112.011 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.813 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 44.2 mtp -51.0 -61.34 2.29 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.325 0.584 . . . . 10.0 112.251 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.67 ' HB3' HG23 ' A' ' 138' ' ' VAL . 9.2 mm-40 -74.33 -26.57 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.684 . . . . 10.0 112.074 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 130' ' ' SER . 9.0 ttp85 -55.99 -37.48 69.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.061 0.458 . . . . 10.0 110.719 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 131' ' ' LYS . 29.8 t -63.92 -31.76 54.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.545 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.622 HD21 ' NH1' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -95.51 -2.11 49.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.306 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.5 t30 65.74 45.3 2.65 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.273 0.559 . . . . 10.0 110.136 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' A' ' 133' ' ' GLU . 15.4 m -134.85 155.75 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.651 ' HD2' ' O ' ' A' ' 149' ' ' ARG . 32.0 mttp -133.18 136.62 45.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.255 0.55 . . . . 10.0 110.715 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.642 HD13 HG13 ' A' ' 83' ' ' VAL . 3.1 mt -89.38 39.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.291 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -131.32 136.96 48.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.811 -0.356 . . . . 10.0 110.176 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.14 -161.18 24.28 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.867 -0.682 . . . . 10.0 112.24 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.71 -24.73 17.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 10.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -81.37 50.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.336 0.589 . . . . 10.0 110.286 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.7 mm -70.1 139.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.551 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.49 6.15 74.2 Favored Glycine 0 CA--C 1.509 -0.33 0 C-N-CA 120.761 -0.733 . . . . 10.0 111.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.31 156.76 78.69 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.274 -0.269 . . . . 10.0 110.274 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.75 124.83 16.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.186 1.924 . . . . 10.0 110.171 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.651 ' O ' ' HD2' ' A' ' 139' ' ' LYS . 4.7 ttt180 . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 111.793 -0.523 . . . . 10.0 111.793 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.2 160.22 42.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.631 0.253 . . . . 10.0 110.659 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.7 tpt -148.61 128.78 13.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.155 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -129.05 87.59 53.95 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.326 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.44 165.77 31.42 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.697 2.265 . . . . 10.0 111.844 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -88.88 -179.84 6.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.073 0.464 . . . . 10.0 110.927 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -125.09 147.23 49.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.32 165.66 27.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 10.0 111.16 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.63 148.65 20.06 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.514 -0.635 . . . . 10.0 111.514 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.82 162.16 30.67 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.541 -0.838 . . . . 10.0 112.002 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -144.31 94.23 2.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 10.0 110.347 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -112.81 148.54 34.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.633 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.85 -137.26 2.24 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.699 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 61.51 85.62 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.279 0.561 . . . . 10.0 111.268 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.74 140.24 41.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.245 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -127.2 135.99 51.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.469 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.17 148.46 25.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.05 -0.352 . . . . 10.0 110.05 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -132.34 148.04 52.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.851 0.358 . . . . 10.0 110.847 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.3 t -102.71 143.69 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.075 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.92 157.25 28.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.924 0.392 . . . . 10.0 110.403 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -125.61 93.14 3.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.946 0.403 . . . . 10.0 110.454 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 m -122.62 97.88 5.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.588 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -147.07 74.11 1.33 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.251 0.548 . . . . 10.0 109.707 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -132.33 55.22 1.89 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.641 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.0 mt -88.88 90.39 3.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.902 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 mm -87.63 95.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.035 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -126.45 111.49 23.26 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.011 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.42 85.39 1.79 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.743 2.295 . . . . 10.0 111.856 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -140.91 137.74 33.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.955 -0.566 . . . . 10.0 109.837 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.4 p -56.69 165.88 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 10.0 111.073 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.481 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -59.35 -42.16 86.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.693 0.257 . . . . 10.0 111.693 -178.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 120.74 148.84 8.1 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.441 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -67.4 -55.05 15.3 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.599 0.199 . . . . 10.0 111.52 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.17 -36.22 81.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.314 -0.625 . . . . 10.0 109.314 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 87' ' ' ILE . 43.2 t -58.57 -50.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.189 -0.914 . . . . 10.0 110.553 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.02 -42.37 99.73 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.712 -0.756 . . . . 10.0 112.235 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.88 -43.36 93.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 10.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.7 68.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.861 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.0 mt -60.32 -46.32 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.394 . . . . 10.0 110.26 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.93 -52.12 18.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.235 0.54 . . . . 10.0 110.196 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 11.9 mt-30 -60.69 -34.09 73.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.131 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.5 -28.19 57.99 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.582 -0.818 . . . . 10.0 112.459 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.646 HH12 ' HG3' ' A' ' 133' ' ' GLU . 2.5 mpt_? -80.36 -27.28 38.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.481 0.657 . . . . 10.0 109.807 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.435 ' HA ' HG23 ' A' ' 97' ' ' THR . 99.1 mt-30 -76.53 -9.32 58.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.239 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 10.0 mmtp -85.73 9.06 17.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.413 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.44 -162.58 0.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.556 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 77.9 mm-40 -122.48 104.64 36.93 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.946 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.2 Cg_endo -87.99 -26.71 5.55 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.941 -1.275 . . . . 10.0 112.523 -0.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 92' ' ' GLN . 11.4 m -165.22 122.37 1.51 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.706 -1.588 . . . . 10.0 109.762 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.9 tpp -82.76 112.86 19.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.794 -0.447 . . . . 10.0 109.794 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 t -80.82 177.16 9.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.683 0.754 . . . . 10.0 111.971 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.419 ' HA ' HG11 ' A' ' 114' ' ' VAL . 89.4 mt-30 -64.72 -48.84 73.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.241 -1.345 . . . . 10.0 111.352 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.61 96.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.512 -0.313 . . . . 10.0 111.808 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.78 -50.01 66.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 10.0 111.838 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.585 ' O ' HG12 ' A' ' 107' ' ' ILE . 14.3 tp -62.43 -42.02 99.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.62 98.58 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.067 -0.813 . . . . 10.0 111.067 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.412 0.149 . . . . 10.0 111.297 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.4 ' OE1' HG21 ' A' ' 135' ' ' VAL . 12.0 pt-20 -67.58 -34.13 76.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 103' ' ' LEU . 36.7 pt -85.05 -8.32 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.536 -0.465 . . . . 10.0 111.807 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.18 31.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 10.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -123.71 -177.64 3.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.883 0.373 . . . . 10.0 110.662 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.4 170.51 9.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.889 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.8 97.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 10.0 110.783 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.68 72.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.782 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -61.07 -49.91 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.111 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 100' ' ' GLN . 58.9 t -65.46 -44.01 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.295 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.28 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.698 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 16.6 m -75.33 -29.42 59.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.829 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.02 -42.62 72.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.702 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.11 -17.79 64.76 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.765 0.316 . . . . 10.0 111.057 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.538 ' HG2' HG22 ' A' ' 121' ' ' THR . 13.2 ttp85 -69.75 -21.74 63.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.401 0.619 . . . . 10.0 109.855 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.481 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 97.41 20.53 22.35 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.922 -0.656 . . . . 10.0 111.537 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -175.14 110.17 0.12 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.939 0.876 . . . . 10.0 110.468 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.19 23.13 0.42 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.083 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m 61.19 91.72 0.07 OUTLIER Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HB3' HG12 ' A' ' 79' ' ' VAL . 74.5 Cg_endo -72.4 104.25 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.688 2.259 . . . . 10.0 115.623 -175.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 117.84 25.76 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.056 -2.572 . . . . 10.0 104.056 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 17.1 mm-40 -46.63 -38.67 10.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -64.75 -33.29 75.62 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.813 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.769 ' O ' ' HG3' ' A' ' 132' ' ' MET . 91.7 mt -69.88 -58.73 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.29 -0.256 . . . . 10.0 110.54 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -52.17 -36.99 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.318 0.58 . . . . 10.0 110.955 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.0 m -54.06 -49.94 67.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.252 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.5 mppt? -75.9 -38.5 57.74 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.146 0.424 . . . . 10.0 112.146 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.769 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 38.9 mtp -50.04 -58.27 5.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.315 0.579 . . . . 10.0 111.491 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mp0 -78.65 -29.92 46.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 115.165 1.543 . . . . 10.0 115.165 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -68.77 -34.52 75.71 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.43 0.53 . . . . 10.0 112.43 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 131' ' ' LYS . 87.1 t -60.89 -25.39 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.654 0.264 . . . . 10.0 111.117 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.605 HD21 ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -115.13 2.54 14.16 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.13 60.74 2.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.731 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 1.9 m -143.06 155.94 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 30.3 mmmt -129.98 144.57 51.4 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.871 -0.418 . . . . 10.0 109.871 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.556 ' CD1' HG13 ' A' ' 83' ' ' VAL . 10.3 mt -106.49 40.06 1.7 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.462 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -141.03 135.95 31.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.759 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.88 -149.34 16.68 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.016 -0.612 . . . . 10.0 112.384 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.58 -32.21 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 10.0 110.789 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -87.42 57.89 4.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.67 . . . . 10.0 109.986 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.2 mm -65.1 132.68 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.018 -0.992 . . . . 10.0 111.573 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.18 -1.82 84.86 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -116.31 160.32 36.34 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.555 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.17 115.05 3.09 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.268 1.312 . . . . 10.0 109.231 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? -137.5 93.91 2.86 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 29.5 mt 63.57 24.57 14.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.837 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.93 -84.02 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.417 -0.81 . . . . 10.0 111.673 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.38 -36.44 66.78 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.099 1.866 . . . . 10.0 110.403 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -136.92 121.21 18.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.293 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 150' ' ' LEU . 19.9 pttp -88.51 50.45 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.486 0.66 . . . . 10.0 110.852 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.489 -0.778 . . . . 10.0 109.818 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.002 -0.439 . . . . 10.0 112.002 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.58 164.66 34.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.353 -0.24 . . . . 10.0 110.353 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -148.58 162.26 40.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.57 146.64 62.31 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.679 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.16 163.99 33.92 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.734 2.289 . . . . 10.0 112.08 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 174.01 6.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.824 0.345 . . . . 10.0 111.112 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -153.53 111.55 3.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.856 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.67 155.77 47.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.943 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.91 138.38 10.11 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.082 -0.58 . . . . 10.0 112.164 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.95 126.53 2.8 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 10.0 112.153 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -157.18 131.78 8.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.927 0.394 . . . . 10.0 110.28 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -144.16 143.41 31.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.046 -0.524 . . . . 10.0 109.639 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.32 -159.3 9.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.724 -0.75 . . . . 10.0 111.726 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.39 169.1 17.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.615 0.245 . . . . 10.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -117.93 120.69 38.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 10.0 109.982 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.9 mt -83.73 84.29 7.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.815 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -76.58 76.45 3.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.44 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -106.97 118.95 38.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.142 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.48 119.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.362 0.601 . . . . 10.0 110.506 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -140.42 102.35 4.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.388 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.428 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 11.5 ptm180 -161.03 152.86 19.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.4 -0.818 . . . . 10.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.33 -3.43 22.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.206 0.527 . . . . 10.0 110.115 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 69' ' ' ARG . 13.8 p-10 -101.96 35.7 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.782 -0.645 . . . . 10.0 110.452 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -84.06 52.28 2.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.256 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.4 mt -73.84 -44.96 50.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.289 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.2 pt -96.78 15.13 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.458 0.647 . . . . 10.0 110.814 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -126.28 97.34 34.62 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.575 -0.739 . . . . 10.0 110.458 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.38 80.42 3.04 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.54 2.16 . . . . 10.0 111.992 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -114.44 21.94 14.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.921 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 p -116.77 147.32 42.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.268 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.521 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.3 m -83.1 -33.18 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.4 145.84 8.7 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.321 -0.942 . . . . 10.0 112.302 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -71.59 -28.82 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.892 0.33 . . . . 10.0 111.892 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -38.88 72.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 140' ' ' LEU . 54.2 t -61.44 -44.7 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.461 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.04 98.03 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.944 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -62.95 -43.95 97.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.331 . . . . 10.0 110.753 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 89' ' ' GLN . . . -70.48 -37.95 74.31 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.649 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.777 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.7 mt -55.35 -48.48 76.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.655 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.08 -42.45 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.046 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 86' ' ' ALA . 2.6 pt20 -66.35 -30.7 71.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 10.0 109.926 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.676 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -71.06 -39.98 62.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.844 -0.693 . . . . 10.0 113.0 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.777 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 12.8 mmt85 -66.08 -38.32 87.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.141 0.496 . . . . 10.0 110.606 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -83.7 -0.93 52.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -80.1 -11.7 59.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.259 0.552 . . . . 10.0 110.367 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -171.97 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.803 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 29.5 mt-10 -131.55 110.87 14.94 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.658 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 72.7 Cg_endo -79.77 -32.84 3.79 Favored 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.325 -1.531 . . . . 10.0 112.543 -0.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.6 m -163.95 131.19 3.32 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.413 -1.267 . . . . 10.0 110.204 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.452 ' HG2' HD23 ' A' ' 103' ' ' LEU . 26.1 tpp -82.48 136.31 34.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.707 -0.224 . . . . 10.0 110.422 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.0 p -83.56 156.33 22.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.887 0.375 . . . . 10.0 110.941 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.7 -33.94 73.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.83 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.11 73.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.313 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.89 -33.77 76.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.701 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -70.13 -37.61 75.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.637 ' CA ' HG21 ' A' ' 114' ' ' VAL . . . -68.49 -46.84 60.67 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.498 -0.774 . . . . 10.0 112.605 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -58.67 -39.86 81.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.862 0.363 . . . . 10.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -64.03 -29.19 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 10.0 112.512 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.571 HG22 ' HB3' ' A' ' 131' ' ' LYS . 16.5 pt -106.76 3.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.0 32.96 69.65 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 121.296 -0.478 . . . . 10.0 113.402 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -120.18 163.09 18.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.849 0.357 . . . . 10.0 110.815 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -78.88 150.3 32.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.757 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.4 -44.15 68.46 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.36 93.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.741 -0.209 . . . . 10.0 110.579 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.9 m -59.18 -44.23 92.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.678 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.637 HG21 ' CA ' ' A' ' 104' ' ' GLY . 46.7 t -63.79 -43.21 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.121 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.62 -29.47 63.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 10.0 110.312 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 63.0 m -76.55 -25.8 54.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.749 . . . . 10.0 111.311 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.5 -37.76 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.998 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.443 ' HB3' HG22 ' A' ' 87' ' ' ILE . 6.8 pt-20 -66.61 -17.74 64.99 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.695 0.283 . . . . 10.0 111.693 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.6 ' HB3' ' O ' ' A' ' 116' ' ' SER . 37.3 ttm180 -67.8 -20.52 65.2 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.391 0.615 . . . . 10.0 110.462 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.521 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.88 23.66 22.38 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.339 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 121' ' ' THR . 7.3 t -170.25 107.61 0.34 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.282 1.039 . . . . 10.0 110.447 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.94 28.91 0.08 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.496 -1.229 . . . . 10.0 109.339 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m 64.63 103.04 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.416 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 84.1 Cg_endo -75.91 92.9 1.02 Allowed 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 123.058 2.505 . . . . 10.0 116.054 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.667 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.7 t70 -87.92 111.92 21.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 105.319 -2.104 . . . . 10.0 105.319 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -49.08 -38.22 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.132 0.895 . . . . 10.0 112.573 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.401 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 60.9 t30 -71.51 -45.31 62.76 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.113 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 125' ' ' ASP . 59.2 mt -60.53 -50.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.481 -0.192 . . . . 10.0 110.481 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 11.7 mt -52.75 -45.27 66.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.562 0.696 . . . . 10.0 109.66 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 74.4 m -62.63 -43.03 99.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.018 -0.992 . . . . 10.0 110.992 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HB3' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -71.36 -42.95 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -178.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.556 ' SD ' ' HA ' ' A' ' 129' ' ' LEU . 3.7 ptm -61.59 -49.76 75.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.778 0.323 . . . . 10.0 111.867 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.604 ' O ' HD22 ' A' ' 136' ' ' LEU . 27.9 mm-40 -73.77 -25.78 60.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.938 0.399 . . . . 10.0 111.464 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -56.35 -23.39 37.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 10.0 111.289 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 t -71.92 -33.67 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.996 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -113.97 7.71 16.94 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.517 -0.473 . . . . 10.0 112.241 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.443 ' ND2' ' HB3' ' A' ' 148' ' ' PRO . 56.4 t30 67.31 59.06 0.52 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.644 0.735 . . . . 10.0 111.068 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.426 ' CG2' HD23 ' A' ' 136' ' ' LEU . 3.0 t -129.53 144.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.849 -1.068 . . . . 10.0 109.292 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -119.16 132.09 55.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.244 0.545 . . . . 10.0 110.574 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 83' ' ' VAL . 19.4 mt -96.44 21.54 9.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 10.0 111.034 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -143.89 158.3 43.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.784 0.325 . . . . 10.0 110.918 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.38 -163.48 20.92 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 121.095 -0.574 . . . . 10.0 112.022 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.95 -31.82 14.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.02 0.438 . . . . 10.0 110.627 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.22 56.64 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.073 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.8 mt -62.03 137.75 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.51 79.69 Favored Glycine 0 CA--C 1.509 -0.328 0 C-N-CA 121.15 -0.548 . . . . 10.0 111.775 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.96 156.27 39.38 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.113 -0.544 . . . . 10.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.443 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 17.9 Cg_endo -63.12 124.1 13.35 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.276 1.984 . . . . 10.0 110.018 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -149.69 -159.59 1.05 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 10.0 110.349 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.507 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 31.1 mt -129.31 151.16 50.26 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.376 -0.602 . . . . 10.0 109.376 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -112.52 89.24 0.52 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.62 -0.8 . . . . 10.0 111.717 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 150' ' ' LEU . 1.6 Cg_endo -84.39 97.34 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.028 2.486 . . . . 10.0 111.376 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -141.49 102.02 4.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.308 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -74.26 119.05 17.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.044 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.9 mttp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.278 -0.868 . . . . 10.0 110.495 -179.373 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.963 -0.455 . . . . 10.0 111.963 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.87 110.4 5.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.13 -0.322 . . . . 10.0 110.13 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -120.29 150.31 40.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.792 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -132.13 95.87 20.85 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.185 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.25 112.39 2.97 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.434 2.09 . . . . 10.0 112.088 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.66 95.57 6.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.048 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.11 155.84 42.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.395 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.05 128.64 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.814 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.91 162.12 12.49 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.104 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.84 74.65 0.22 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.975 -0.631 . . . . 10.0 112.403 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -119.88 103.43 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.788 -0.242 . . . . 10.0 110.728 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -90.3 158.2 17.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.57 124.44 2.85 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.065 -0.588 . . . . 10.0 112.22 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -158.25 150.96 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.651 0.226 . . . . 10.0 110.477 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -130.73 137.99 49.77 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.2 mt -84.96 149.39 25.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.538 -0.301 . . . . 10.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m 57.91 41.62 24.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.736 0.779 . . . . 10.0 110.204 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -95.65 2.54 54.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.206 -0.907 . . . . 10.0 110.987 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.0 131.76 32.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.885 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -162.45 135.61 5.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.018 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -178.29 130.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.96 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -132.65 21.11 4.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.84 0.352 . . . . 10.0 111.247 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -138.99 116.17 11.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.462 0.649 . . . . 10.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.91 -19.87 13.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.535 -0.757 . . . . 10.0 109.973 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.3 mt -114.82 138.59 44.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.652 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.1 mt -75.24 106.58 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.946 0.403 . . . . 10.0 110.675 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -124.0 89.59 51.52 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.395 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.74 126.4 18.13 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.892 2.395 . . . . 10.0 111.872 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -138.55 -177.31 4.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.092 0.472 . . . . 10.0 109.81 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -107.68 -179.76 4.0 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.374 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 83' ' ' VAL . 2.2 t -85.12 -71.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.815 -0.354 . . . . 10.0 110.511 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.78 157.08 7.58 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -74.89 -53.77 8.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.401 0.601 . . . . 10.0 112.144 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.81 -38.42 88.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.668 -0.242 . . . . 10.0 111.508 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.609 ' HB ' HD23 ' A' ' 140' ' ' LEU . 33.2 m -67.13 -35.91 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 120.74 -0.384 . . . . 10.0 110.391 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.81 -41.68 98.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.004 -0.617 . . . . 10.0 111.692 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -41.5 98.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.895 0.379 . . . . 10.0 110.136 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.69 -30.99 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.695 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.497 HG23 HH21 ' A' ' 91' ' ' ARG . 7.2 mt -62.84 -42.39 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 10.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -70.45 -50.33 39.39 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.93 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.64 -40.9 96.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.826 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.55 -30.38 74.9 Favored Glycine 0 C--N 1.328 0.12 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.833 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.588 HH11 HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -80.35 -42.05 23.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.846 0.355 . . . . 10.0 110.67 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.14 -21.15 63.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.236 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -87.73 19.12 3.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.455 0.539 . . . . 10.0 112.455 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.23 -0.12 56.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 62.6 mt-10 53.14 100.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 123.917 0.761 . . . . 10.0 112.831 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.6 Cg_endo -78.44 -41.85 0.83 Allowed 'Cis proline' 0 CA--C 1.517 -0.349 0 C-N-CA 123.292 -1.545 . . . . 10.0 112.524 -0.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -168.41 128.69 1.25 Allowed 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.88 -1.054 . . . . 10.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ttm -58.65 137.53 57.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.834 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.7 144.08 39.59 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.631 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -70.09 -41.03 74.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.162 0.506 . . . . 10.0 110.465 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.37 90.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.941 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.8 -43.61 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.698 -0.228 . . . . 10.0 110.978 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.486 HD23 HG13 ' A' ' 114' ' ' VAL . 56.6 tp -64.49 -39.47 93.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.41 96.06 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.865 -0.894 . . . . 10.0 110.865 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -39.64 91.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.809 0.338 . . . . 10.0 110.213 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.91 -41.54 98.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.161 -0.472 . . . . 10.0 112.049 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 103' ' ' LEU . 29.3 pt -93.24 -7.83 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.615 0.598 . . . . 10.0 112.615 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.77 34.12 22.74 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.549 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -125.99 176.67 6.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.93 0.395 . . . . 10.0 110.576 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.35 161.16 15.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.19 94.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 10.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.79 76.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.464 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.3 m -63.39 -46.34 86.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.157 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.486 HG13 HD23 ' A' ' 103' ' ' LEU . 90.0 t -62.28 -43.08 97.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.194 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -66.47 -35.23 79.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.728 -0.669 . . . . 10.0 111.598 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 25.8 p -77.76 -26.27 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.77 0.319 . . . . 10.0 111.496 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.48 70.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 8.2 pt-20 -63.11 -20.48 65.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 116' ' ' SER . 72.9 ttt180 -71.54 -20.34 62.04 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.611 0.719 . . . . 10.0 109.828 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.86 15.91 43.86 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.422 -0.808 . . . . 10.0 112.352 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 121' ' ' THR . 12.9 t -164.15 108.56 0.98 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.285 1.04 . . . . 10.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.09 19.06 0.5 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.724 -1.125 . . . . 10.0 110.999 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m 58.51 83.71 0.21 Allowed Pre-proline 0 C--O 1.235 0.294 0 CA-C-O 121.622 0.725 . . . . 10.0 110.031 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.495 ' HB2' HD21 ' A' ' 129' ' ' LEU . 27.6 Cg_endo -96.13 178.44 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.409 2.739 . . . . 10.0 114.868 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.607 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.2 t70 -139.94 150.68 44.83 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -58.32 -37.51 75.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 10.0 110.707 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 9.9 t30 -63.72 -41.66 98.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.466 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.9 mt -63.75 -55.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 110.362 -0.236 . . . . 10.0 110.362 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.1 mt -48.84 -45.88 41.32 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.312 0.577 . . . . 10.0 110.348 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.9 m -55.01 -47.0 75.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.953 -1.021 . . . . 10.0 111.604 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 49.7 mmtt -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.74 0.305 . . . . 10.0 111.014 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.495 ' HB3' HH22 ' A' ' 91' ' ' ARG . 3.5 mtp -51.28 -56.41 13.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.762 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.635 ' HG2' HD13 ' A' ' 140' ' ' LEU . 16.0 mt-10 -72.45 -29.56 63.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.144 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -62.07 -43.96 97.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.099 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 131' ' ' LYS . 48.3 t -62.32 -25.54 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.322 -0.399 . . . . 10.0 112.006 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.588 HD21 HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -107.14 -3.61 19.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 10.0 112.904 -177.297 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.1 t30 56.57 55.32 6.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.524 0.678 . . . . 10.0 109.706 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 35.5 m -140.99 164.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.736 -1.12 . . . . 10.0 108.754 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -124.19 129.0 50.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.151 0.501 . . . . 10.0 110.261 178.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.635 HD13 ' HG2' ' A' ' 133' ' ' GLU . 5.4 mp -92.66 13.01 21.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.751 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -128.31 139.4 52.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.36 -159.03 16.39 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.095 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.66 -33.29 13.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.926 0.393 . . . . 10.0 110.606 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -86.57 53.14 2.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.095 0.474 . . . . 10.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.581 HG23 ' HA ' ' A' ' 140' ' ' LEU . 61.1 mt -75.03 137.55 22.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.27 70.0 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.124 -0.79 . . . . 10.0 111.124 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.09 155.41 80.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.035 -0.583 . . . . 10.0 109.857 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.38 120.05 7.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.617 1.545 . . . . 10.0 110.177 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -137.11 65.96 1.48 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.228 0.537 . . . . 10.0 109.606 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.3 mt -90.23 87.46 6.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.535 -0.757 . . . . 10.0 110.588 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -118.61 150.9 17.95 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.42 -0.809 . . . . 10.0 111.622 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.36 -5.44 17.13 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.698 2.265 . . . . 10.0 112.861 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -78.15 115.51 17.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.039 0.447 . . . . 10.0 111.014 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -133.02 -169.46 2.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.675 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.879 -0.582 . . . . 10.0 110.203 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.439 ' HA3' ' OD2' ' A' ' 52' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 112.08 -0.408 . . . . 10.0 112.08 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.79 74.46 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.105 0.409 . . . . 10.0 112.105 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.9 ttm -147.06 102.53 3.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.971 0.415 . . . . 10.0 111.442 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.439 ' OD2' ' HA3' ' A' ' 49' ' ' GLY . 0.3 OUTLIER -148.28 85.94 6.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.102 179.332 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.93 177.83 8.39 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.689 2.259 . . . . 10.0 112.219 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.55 131.56 36.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.928 0.394 . . . . 10.0 110.833 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -152.94 126.33 8.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.808 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.79 150.96 38.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.707 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.31 171.08 13.57 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.55 145.65 13.23 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.385 -0.912 . . . . 10.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -142.15 127.16 18.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.767 -0.456 . . . . 10.0 109.767 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.23 148.78 42.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 10.0 111.504 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.78 132.46 2.52 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.16 -0.776 . . . . 10.0 111.16 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -156.94 156.85 33.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.247 0.523 . . . . 10.0 111.743 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -113.26 141.37 47.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.693 . . . . 10.0 109.154 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.436 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -145.56 167.88 21.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.068 0.461 . . . . 10.0 111.814 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.3 m -153.65 137.92 16.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.076 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.1 159.23 19.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.301 . . . . 10.0 110.354 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 p -158.28 117.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.134 -0.485 . . . . 10.0 110.239 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -69.62 151.57 45.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.473 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HB3' ' H ' ' A' ' 70' ' ' SER . 78.9 mtt180 -147.45 -159.19 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.468 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.417 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 0.7 OUTLIER -80.86 178.27 8.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.873 0.368 . . . . 10.0 110.848 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -103.56 8.94 37.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.025 0.44 . . . . 10.0 111.192 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -86.91 53.58 2.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.433 0.635 . . . . 10.0 110.375 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pt -134.62 160.87 41.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.732 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.454 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 43.3 pt -80.93 174.7 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.264 -0.426 . . . . 10.0 110.466 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.57 87.57 17.66 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.296 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 74' ' ' ILE . 16.4 Cg_endo -90.93 -143.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.713 2.942 . . . . 10.0 111.71 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -88.69 33.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.018 0.437 . . . . 10.0 110.766 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 19.2 p -110.76 158.78 18.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.563 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -91.57 -30.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.386 . . . . 10.0 111.751 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.65 141.95 5.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.542 -0.837 . . . . 10.0 112.333 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -66.58 -52.35 46.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 10.0 111.123 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -32.91 74.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.376 0.608 . . . . 10.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 140' ' ' LEU . 55.3 t -61.87 -50.39 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 114.88 -1.055 . . . . 10.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.39 98.89 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -60.14 -51.14 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 10.0 110.493 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -66.15 -30.77 71.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.999 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.836 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.6 mt -57.88 -47.33 86.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -70.9 -47.05 61.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.941 0.4 . . . . 10.0 110.4 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -62.18 -34.14 75.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.428 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.64 -30.29 68.76 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.21 -0.995 . . . . 10.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.836 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.6 mmt180 -81.47 -33.81 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 10.0 111.373 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -77.33 -16.56 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.097 0.475 . . . . 10.0 110.536 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -80.44 12.61 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -19.86 23.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 10.0 111.561 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 4.5 tp10 59.89 110.1 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.904 -1.044 . . . . 10.0 111.777 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 45.2 Cg_endo -72.05 -59.11 0.13 OUTLIER 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.279 -1.551 . . . . 10.0 113.026 -0.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.2 m -163.97 135.8 4.79 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.492 -0.776 . . . . 10.0 110.903 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 36.4 tpp -74.57 136.85 42.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.539 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 64.7 p -84.03 160.41 20.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.359 -0.537 . . . . 10.0 111.251 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.56 -26.94 64.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.668 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.02 -57.98 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.408 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.539 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 13.7 pt-20 -62.52 -36.85 83.88 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.914 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 2.4 tt -61.91 -42.48 99.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.682 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.76 -39.74 90.0 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.463 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -62.3 -39.53 93.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.705 0.288 . . . . 10.0 111.574 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 17.3 pt-20 -73.62 -16.59 61.23 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 103' ' ' LEU . 40.6 pt -113.43 0.08 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.623 -0.431 . . . . 10.0 111.738 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.42 37.61 53.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.593 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -133.19 -168.92 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 10.0 110.52 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -111.95 177.25 4.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.738 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.12 79.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 10.0 110.656 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.89 -47.07 87.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.657 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.9 m -55.74 -45.3 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.55 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.82 -50.54 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -64.92 -32.12 73.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.331 0.586 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.0 m -73.6 -28.19 61.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.424 ' CE1' HG11 ' A' ' 79' ' ' VAL . 2.4 m-85 -75.34 -35.62 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 12.5 pt-20 -67.42 -17.8 64.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 10.0 110.799 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.732 ' HG2' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -74.61 -20.93 59.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.21 0.529 . . . . 10.0 109.79 178.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.563 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.52 21.49 29.05 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.43 -0.891 . . . . 10.0 112.053 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 119' ' ' ARG . 9.9 t -170.07 104.22 0.3 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.437 1.113 . . . . 10.0 110.113 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.33 27.7 0.51 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.747 -1.115 . . . . 10.0 109.212 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 m 61.61 96.98 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.8 -1.091 . . . . 10.0 108.594 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 78' ' ' THR . 70.8 Cg_endo -68.18 99.84 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.655 2.236 . . . . 10.0 115.256 -175.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.57 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -85.72 116.12 23.8 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.92 -2.252 . . . . 10.0 104.92 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.411 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 21.9 mm-40 -48.91 -40.17 28.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.142 -0.481 . . . . 10.0 112.147 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.2 t30 -66.93 -44.06 81.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.675 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.673 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.8 mt -58.62 -55.17 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 119.585 -0.245 . . . . 10.0 110.651 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.0 mt -50.24 -42.24 51.47 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.571 0.7 . . . . 10.0 110.235 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 66.7 m -59.86 -45.72 91.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.983 -1.008 . . . . 10.0 111.497 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 29.2 mmtt -73.75 -40.86 63.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 10.0 111.234 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.673 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -50.65 -59.46 4.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.207 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.745 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 5.8 mt-10 -74.12 -26.84 60.57 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.045 -0.98 . . . . 10.0 112.997 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -54.63 -27.25 38.22 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.91 -25.64 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.81 0.338 . . . . 10.0 111.796 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.833 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -99.0 -16.32 18.76 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -177.107 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 67.84 25.99 7.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.262 0.553 . . . . 10.0 110.527 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.833 HG22 ' HB2' ' A' ' 136' ' ' LEU . 26.8 m -121.94 142.9 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 23.9 mmmt -119.19 142.97 47.51 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HA ' HG23 ' A' ' 145' ' ' ILE . 8.9 mt -102.71 39.44 1.53 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.658 0.742 . . . . 10.0 109.783 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 141' ' ' ARG . 49.2 mtt180 -129.54 141.32 51.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.089 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.22 -162.19 43.93 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.233 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.34 3.24 55.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.885 0.374 . . . . 10.0 111.399 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -110.31 40.95 1.84 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 10.0 110.672 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 140' ' ' LEU . 44.9 mt -67.17 136.71 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.727 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.9 0.3 71.91 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.937 -0.865 . . . . 10.0 110.937 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.56 158.45 75.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.546 . . . . 10.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.29 121.68 10.3 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.284 1.989 . . . . 10.0 109.914 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -146.64 100.84 3.39 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.3 tp -77.68 72.44 4.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.274 0.559 . . . . 10.0 110.712 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -126.63 72.96 0.45 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.454 -0.793 . . . . 10.0 111.338 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.66 152.68 29.55 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.772 2.315 . . . . 10.0 112.784 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -103.83 -31.99 9.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.684 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -143.78 145.62 32.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.189 -0.459 . . . . 10.0 110.363 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.1 tptp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.224 -0.894 . . . . 10.0 109.894 179.734 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.745 -0.542 . . . . 10.0 111.745 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.63 -49.26 9.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.555 0.177 . . . . 10.0 111.459 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.8 ptp 43.27 48.67 5.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.741 0.816 . . . . 10.0 111.456 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -121.96 88.44 47.73 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.438 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.81 145.9 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.348 2.699 . . . . 10.0 111.897 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -104.03 154.0 20.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.812 0.339 . . . . 10.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -144.68 132.27 21.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.24 166.55 23.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.016 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.61 -177.91 36.01 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.486 -0.864 . . . . 10.0 112.394 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 175.2 147.88 6.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.41 -0.676 . . . . 10.0 111.41 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 t -137.31 128.17 27.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.105 0.479 . . . . 10.0 110.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.81 -42.91 10.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.248 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.22 104.31 2.39 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.569 -0.612 . . . . 10.0 111.569 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -107.32 -16.49 14.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 10.0 111.387 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -156.93 145.45 19.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.503 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.9 tp -120.53 142.49 49.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.858 -0.423 . . . . 10.0 109.858 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -79.56 138.31 37.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.956 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -124.31 168.3 13.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.536 -0.542 . . . . 10.0 109.536 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -55.39 129.29 16.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.051 0.453 . . . . 10.0 111.476 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -163.08 150.67 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.645 -0.707 . . . . 10.0 109.617 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.67 143.45 38.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.571 0.224 . . . . 10.0 110.484 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.5 m -72.21 -77.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.61 -0.268 . . . . 10.0 110.469 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 t0 53.33 52.47 13.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.151 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -165.98 125.19 1.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.636 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.8 mm -77.92 -21.64 13.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.646 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.5 mt -84.46 115.78 27.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.269 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -89.89 117.36 68.04 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.18 0.514 . . . . 10.0 111.168 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 61.8 Cg_endo -86.53 -141.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.256 2.637 . . . . 10.0 110.49 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.436 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -78.6 72.22 5.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.512 . . . . 10.0 109.77 178.213 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 2.8 p -109.91 166.85 10.61 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.904 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -84.48 -34.65 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.651 -0.419 . . . . 10.0 111.157 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.04 136.98 4.33 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.013 -0.613 . . . . 10.0 111.596 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -63.45 -57.04 11.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -25.63 65.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.702 HG13 HD13 ' A' ' 140' ' ' LEU . 46.0 t -63.36 -46.97 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.497 -1.229 . . . . 10.0 110.052 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.32 -38.42 95.83 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.353 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 40.1 ttmt -59.32 -49.25 78.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 10.0 109.786 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -65.85 -30.51 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.558 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.753 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.3 mt -59.85 -48.5 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 4.3 tt0 -67.06 -50.38 62.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.022 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 62.4 mm-40 -59.97 -36.41 77.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.23 85.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.967 -0.635 . . . . 10.0 113.281 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.753 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.9 mmt180 -79.22 -29.88 43.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.173 0.511 . . . . 10.0 109.64 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 82.0 mt-30 -78.66 -16.76 56.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.645 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 55.9 mtpt -85.79 22.13 1.72 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.955 0.407 . . . . 10.0 111.261 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.65 -8.88 36.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.883 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 6.1 mm-40 53.4 104.05 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 114.902 -1.045 . . . . 10.0 112.618 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 56.0 Cg_endo -73.64 -50.12 0.2 Allowed 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.486 -1.464 . . . . 10.0 113.367 0.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -168.93 132.62 1.4 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.403 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.7 tpp -73.58 134.89 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.291 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.17 145.38 51.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.902 0.382 . . . . 10.0 111.679 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.41 -37.49 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.022 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.07 -36.39 83.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.75 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.79 -39.19 57.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.094 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.552 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -61.19 -43.62 98.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.837 . . . . 10.0 108.739 178.444 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.74 -39.39 95.23 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.504 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -64.32 -38.27 90.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.651 0.262 . . . . 10.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.545 ' OE2' HD22 ' A' ' 103' ' ' LEU . 15.3 pt-20 -78.02 -13.9 59.7 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.119 0.785 . . . . 10.0 113.119 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 103' ' ' LEU . 41.2 pt -109.68 -7.45 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.623 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.83 30.89 19.62 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.815 -0.707 . . . . 10.0 112.807 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.94 -168.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.278 0.231 . . . . 10.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -109.91 177.25 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.528 -0.305 . . . . 10.0 110.254 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.73 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.616 -0.265 . . . . 10.0 111.351 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.29 81.34 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.039 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.45 -50.3 73.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.779 0.323 . . . . 10.0 110.723 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.12 -45.04 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.79 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 10.0 111.115 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.3 m -76.77 -27.46 55.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.943 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.871 0.693 . . . . 10.0 112.871 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -61.53 -18.66 60.13 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.195 0.442 . . . . 10.0 112.195 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 119' ' ' ARG . 0.8 OUTLIER -69.53 -22.93 63.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.197 0.522 . . . . 10.0 110.088 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.99 21.7 15.08 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.607 -0.806 . . . . 10.0 112.086 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.439 ' OG1' HG22 ' A' ' 78' ' ' THR . 6.7 t -171.87 111.9 0.3 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.24 1.019 . . . . 10.0 110.396 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.57 34.58 0.27 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.561 -1.2 . . . . 10.0 109.277 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 m 55.77 85.16 0.2 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.266 -0.879 . . . . 10.0 108.839 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.551 ' HG3' ' O ' ' A' ' 78' ' ' THR . 72.8 Cg_endo -72.47 98.04 0.92 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.543 2.828 . . . . 10.0 115.544 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.9 t70 -82.18 128.04 33.76 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 104.638 -2.356 . . . . 10.0 104.638 174.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -54.17 -31.31 52.34 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.427 0.528 . . . . 10.0 112.427 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -72.12 -32.89 67.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.848 -0.614 . . . . 10.0 111.355 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.796 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.0 mt -71.3 -57.94 6.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.691 -0.403 . . . . 10.0 110.099 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -49.6 -43.31 46.33 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.489 0.662 . . . . 10.0 110.777 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.59 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 45.0 m -54.51 -48.95 71.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.033 -0.985 . . . . 10.0 111.828 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 135' ' ' VAL . 13.0 mttt -76.79 -37.68 55.36 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.833 0.309 . . . . 10.0 111.833 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.796 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 75.0 mtp -53.97 -58.56 6.85 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.182 0.515 . . . . 10.0 111.863 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.575 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.0 mp0 -72.52 -26.18 61.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.787 -0.642 . . . . 10.0 112.266 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.4 ttm-85 -59.3 -27.42 65.84 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.036 0.446 . . . . 10.0 110.034 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 131' ' ' LYS . 61.1 t -63.82 -41.34 92.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.689 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.571 HD22 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -94.98 -6.35 42.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 121.152 -0.219 . . . . 10.0 110.437 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 t30 64.36 49.65 2.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.494 0.664 . . . . 10.0 109.736 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 34.4 m -132.12 162.88 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.355 -0.839 . . . . 10.0 109.627 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 15.9 mmtt -131.96 140.89 49.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.342 -0.614 . . . . 10.0 109.342 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.702 HD13 HG13 ' A' ' 83' ' ' VAL . 12.2 mt -108.5 17.71 21.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.26 0.552 . . . . 10.0 110.873 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -124.25 139.63 53.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.63 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.9 -146.65 17.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.729 -0.748 . . . . 10.0 112.336 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.24 -34.99 8.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.985 0.421 . . . . 10.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -82.33 54.82 2.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.929 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.602 HG23 ' HA ' ' A' ' 140' ' ' LEU . 52.6 mt -72.9 137.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.474 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.36 -0.48 87.12 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.978 -0.849 . . . . 10.0 110.978 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.71 156.87 70.38 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.476 . . . . 10.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.79 122.5 11.09 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 121.897 1.731 . . . . 10.0 110.382 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.74 68.68 1.38 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.375 0.607 . . . . 10.0 110.146 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.89 143.67 19.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.143 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.27 -78.4 0.92 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.81 -0.916 . . . . 10.0 110.81 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.86 144.44 38.74 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.572 2.182 . . . . 10.0 111.436 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 13.8 pttm -74.82 -16.86 60.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.969 0.414 . . . . 10.0 110.715 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -139.53 136.91 35.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.889 -0.596 . . . . 10.0 109.606 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.343 -0.836 . . . . 10.0 110.261 -179.927 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.849 -0.501 . . . . 10.0 111.849 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.45 64.87 1.47 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.082 0.468 . . . . 10.0 111.525 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -99.63 151.45 21.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.031 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -116.97 150.8 46.56 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.374 -0.375 . . . . 10.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.29 170.38 20.33 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.626 2.217 . . . . 10.0 112.379 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -123.78 152.5 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.247 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.14 151.37 49.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.394 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.05 138.05 15.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.78 -160.78 11.78 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.22 25.06 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.86 132.37 52.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.662 0.268 . . . . 10.0 110.846 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -140.14 167.6 21.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.897 -0.409 . . . . 10.0 109.897 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.25 117.92 0.8 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.455 -0.879 . . . . 10.0 112.742 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -102.8 173.43 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.19 -0.3 . . . . 10.0 110.19 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 -125.52 130.68 52.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 10.0 110.901 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.72 149.58 50.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.739 0.304 . . . . 10.0 111.069 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -167.17 151.78 7.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.069 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -158.29 159.19 35.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.542 -0.17 . . . . 10.0 110.542 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.0 162.3 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.594 -0.275 . . . . 10.0 110.863 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.63 140.23 45.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.894 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -154.19 158.96 41.11 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.351 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m -94.41 -173.77 3.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.119 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.51 119.29 19.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -97.31 7.6 46.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.738 -0.664 . . . . 10.0 112.634 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.15 106.64 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.977 0.417 . . . . 10.0 110.861 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.4 pt -91.01 160.49 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 10.0 111.529 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -140.55 98.8 7.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.641 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.71 41.09 1.07 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.729 2.286 . . . . 10.0 112.73 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -110.11 -154.77 0.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.025 -0.534 . . . . 10.0 109.602 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.48 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 5.0 p -100.07 -171.39 2.03 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.937 HG12 HG11 ' A' ' 83' ' ' VAL . 1.8 t -82.55 -60.15 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 10.0 110.537 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.07 137.23 4.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.33 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.7 -42.85 99.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.663 0.268 . . . . 10.0 111.269 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 -29.0 64.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.996 HG13 HD13 ' A' ' 140' ' ' LEU . 3.8 t -68.47 -49.28 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.338 -0.846 . . . . 10.0 109.864 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.36 -39.39 97.19 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -64.03 -39.41 94.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 10.0 110.486 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.43 64.89 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.685 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.79 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.9 mt -59.89 -49.95 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.01 -53.23 58.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.956 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.39 -31.47 72.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.901 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.09 -30.73 69.6 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.731 -0.747 . . . . 10.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.79 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -81.6 -41.94 20.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 10.0 109.57 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.81 ' HA ' HG23 ' A' ' 97' ' ' THR . 53.2 mt-30 -61.4 -36.89 81.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.535 -0.757 . . . . 10.0 111.31 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -81.75 51.21 1.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -3.54 16.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.69 0.281 . . . . 10.0 111.257 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 22.2 mm-40 57.94 100.56 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 2.8 Cg_exo -76.65 -45.1 0.46 Allowed 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.592 -1.42 . . . . 10.0 112.205 -0.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.81 HG23 ' HA ' ' A' ' 92' ' ' GLN . 38.2 m -161.71 133.56 5.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.541 -1.209 . . . . 10.0 110.004 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.3 127.95 32.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.23 53.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.43 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.94 85.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.692 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -71.07 -44.42 65.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.822 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -63.68 -40.19 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.42 -49.05 73.12 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.261 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -62.69 -34.68 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.4 -26.45 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.934 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 103' ' ' LEU . 25.6 pt -110.14 8.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.796 0.295 . . . . 10.0 111.796 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 20.34 71.77 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.252 -0.499 . . . . 10.0 113.097 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -118.56 -164.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.309 -0.256 . . . . 10.0 110.309 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.3 p -115.05 176.07 5.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.562 0.22 . . . . 10.0 110.589 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.04 89.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 10.0 109.998 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.9 76.12 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.563 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.3 m -62.06 -46.29 89.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 10.0 110.345 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 t -66.17 -43.47 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.071 -0.513 . . . . 10.0 109.91 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.66 -29.54 69.58 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.702 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 m -78.84 -33.77 45.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.898 0.38 . . . . 10.0 111.473 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -65.98 -33.79 76.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.81 -18.27 54.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.821 0.344 . . . . 10.0 111.8 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.432 ' HG2' HG22 ' A' ' 121' ' ' THR . 12.1 ttm180 -71.57 -26.17 62.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.281 0.562 . . . . 10.0 110.51 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.82 12.56 55.37 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.612 -0.722 . . . . 10.0 112.482 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 121' ' ' THR . 8.8 t -153.39 98.68 2.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.715 1.245 . . . . 10.0 109.456 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.06 27.49 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.323 -1.308 . . . . 10.0 109.914 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m 59.37 95.5 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.199 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.48 ' HG3' ' C ' ' A' ' 78' ' ' THR . 74.4 Cg_endo -69.73 99.8 0.77 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.242 2.628 . . . . 10.0 114.646 -176.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.57 117.9 25.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 8.4 mm-40 -48.56 -39.62 24.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.471 0.915 . . . . 10.0 113.471 -174.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.4 t30 -70.55 -34.0 71.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.86 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.79 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.7 mt -68.96 -57.89 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.758 -0.377 . . . . 10.0 111.299 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -39.01 59.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.161 0.505 . . . . 10.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 m -55.02 -49.83 70.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.631 -0.713 . . . . 10.0 111.232 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 35.3 mmtt -75.77 -30.4 59.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.954 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.79 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.7 mtp -56.35 -59.59 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 4.0 mp0 -74.04 -26.49 60.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -53.92 -33.24 56.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.986 0.365 . . . . 10.0 111.986 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.69 -30.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.973 0.416 . . . . 10.0 111.245 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.473 HD12 ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -94.78 -10.73 30.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.565 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.2 t30 62.58 47.11 5.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 10.0 110.749 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.1 m -131.91 158.15 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -130.66 143.69 50.92 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.591 -0.443 . . . . 10.0 110.847 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.996 HD13 HG13 ' A' ' 83' ' ' VAL . 11.6 mt -103.53 40.2 1.46 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.728 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 141' ' ' ARG . 14.8 mmm180 -128.26 139.88 52.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.534 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.08 -146.25 23.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.371 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.33 -21.68 14.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.89 0.376 . . . . 10.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -88.06 52.96 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 110.696 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 140' ' ' LEU . 54.5 mt -76.53 141.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.518 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 1.16 88.16 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.877 -0.678 . . . . 10.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.0 156.37 76.28 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 110.046 -0.353 . . . . 10.0 110.046 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.96 122.3 11.38 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.957 1.772 . . . . 10.0 109.294 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.89 76.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.483 . . . . 10.0 109.829 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.2 mp -77.45 126.18 30.5 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.949 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.33 155.78 53.15 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.273 -0.965 . . . . 10.0 111.412 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.65 149.64 39.26 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.942 2.428 . . . . 10.0 112.434 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.58 171.71 10.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.21 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -56.61 -37.56 70.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.002 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.177 -0.916 . . . . 10.0 109.629 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 112.074 -0.41 . . . . 10.0 112.074 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.88 157.11 38.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.148 -0.316 . . . . 10.0 110.148 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -136.71 152.27 50.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.482 -0.327 . . . . 10.0 110.23 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.32 136.73 19.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.508 -0.314 . . . . 10.0 111.061 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.03 142.02 45.66 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.993 2.462 . . . . 10.0 112.104 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.12 143.66 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.911 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -136.2 132.13 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 10.0 109.652 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.55 155.56 37.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.832 0.348 . . . . 10.0 111.125 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.69 -155.07 29.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.121 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -162.72 11.79 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.542 -0.623 . . . . 10.0 111.542 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 m -154.52 108.09 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.082 0.441 . . . . 10.0 110.939 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.28 173.85 6.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.6 173.2 34.36 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.348 -0.93 . . . . 10.0 112.692 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -158.25 151.52 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -142.2 151.03 41.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.664 0.268 . . . . 10.0 110.477 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -126.11 133.22 51.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.44 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -107.59 114.05 27.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.03 0.443 . . . . 10.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -131.85 163.99 27.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.399 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.8 141.61 46.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.22 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -130.3 159.59 36.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 10.0 109.908 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -157.01 123.47 4.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.714 0.293 . . . . 10.0 110.433 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -156.79 103.44 2.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.012 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -104.33 96.5 6.67 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -172.47 132.48 0.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.884 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 mm -71.33 98.26 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.998 -0.547 . . . . 10.0 109.931 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 pt -108.76 -176.44 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.891 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -60.54 146.66 84.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 10.0 111.075 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.19 108.91 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.738 2.292 . . . . 10.0 111.474 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -119.78 -132.03 0.3 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.816 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.5 p -80.4 -176.4 5.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.629 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.408 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -76.41 -32.03 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.61 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.34 138.4 5.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.374 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -70.14 -42.65 72.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.987 0.422 . . . . 10.0 110.682 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -75.39 -25.35 57.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.655 0.74 . . . . 10.0 109.234 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 87' ' ' ILE . 37.2 t -69.28 -45.3 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 114.507 -1.224 . . . . 10.0 110.249 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.79 98.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.87 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -62.76 -40.3 96.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 10.0 110.434 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.81 66.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.064 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 83' ' ' VAL . 23.4 mt -59.93 -46.81 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.96 0.41 . . . . 10.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -71.46 -52.95 15.68 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.582 -0.447 . . . . 10.0 110.538 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.45 ' O ' ' HD3' ' A' ' 93' ' ' LYS . 46.8 mt-30 -60.61 -35.05 75.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.239 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.69 -31.9 52.28 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.636 -1.269 . . . . 10.0 112.365 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.647 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 1.3 mpt_? -81.72 -34.43 30.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.924 0.392 . . . . 10.0 111.383 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.522 ' HA ' HG23 ' A' ' 97' ' ' THR . 33.5 mt-30 -75.19 -2.12 26.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.995 0.426 . . . . 10.0 110.451 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 89' ' ' GLN . 1.5 tptm -84.9 0.11 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.023 0.44 . . . . 10.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -171.98 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 10.0 111.185 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.46 112.1 23.2 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.54 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -78.84 -31.19 5.17 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.358 -1.518 . . . . 10.0 112.558 -0.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 92' ' ' GLN . 99.0 m -168.3 130.29 1.4 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.82 -1.536 . . . . 10.0 108.724 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 tpp -73.24 110.36 7.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.521 -0.472 . . . . 10.0 109.958 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -69.53 156.78 38.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.147 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.08 -35.22 76.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.582 -0.735 . . . . 10.0 109.911 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.059 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.68 -49.87 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.701 -0.227 . . . . 10.0 110.794 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.574 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.34 -46.66 85.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.48 0.488 . . . . 10.0 109.887 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.08 -47.18 92.29 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.119 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -64.26 -38.57 91.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.904 0.335 . . . . 10.0 111.904 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.3 -15.18 61.41 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 103' ' ' LEU . 43.4 pt -107.05 3.69 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 10.0 111.006 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.86 25.72 55.31 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.079 -0.582 . . . . 10.0 113.034 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -125.24 -157.47 0.78 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.668 0.271 . . . . 10.0 110.356 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 p -124.92 176.68 6.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.48 91.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.617 0.246 . . . . 10.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.88 76.35 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.76 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 m -60.68 -47.18 87.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.15 -45.16 97.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.246 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.07 -32.35 73.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.806 0.812 . . . . 10.0 109.834 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 11.6 m -74.66 -24.89 58.88 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.201 -0.909 . . . . 10.0 111.275 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -77.61 -34.36 53.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -66.09 -20.36 66.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.9 ptm180 -70.88 -23.05 62.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.665 0.745 . . . . 10.0 110.738 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.51 28.43 7.54 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.012 -0.995 . . . . 10.0 112.063 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 121' ' ' THR . 8.8 t -173.8 107.69 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.167 0.984 . . . . 10.0 110.201 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.04 25.95 0.26 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.843 -1.071 . . . . 10.0 109.616 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 m 62.33 99.99 0.04 OUTLIER Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.806 -0.813 . . . . 10.0 108.806 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.76 99.29 0.95 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.855 2.37 . . . . 10.0 114.042 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.643 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 4.5 t0 -87.5 120.41 28.78 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.443 -2.058 . . . . 10.0 105.443 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 5.0 mm100 -52.07 -42.33 63.1 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.22 -30.88 70.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.718 ' O ' ' HG3' ' A' ' 132' ' ' MET . 73.2 mt -72.07 -56.2 10.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.0 mt -48.85 -42.78 37.53 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.615 0.572 . . . . 10.0 110.361 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 74.4 m -57.02 -47.3 81.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.152 -0.931 . . . . 10.0 111.765 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 135' ' ' VAL . 2.6 mppt? -74.66 -38.01 62.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.718 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 32.9 mtp -50.42 -55.83 14.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.832 0.825 . . . . 10.0 111.161 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.633 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 53.8 mt-10 -73.24 -27.24 61.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.801 -1.09 . . . . 10.0 113.315 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -68.74 -27.39 65.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.963 1.098 . . . . 10.0 113.963 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 131' ' ' LYS . 6.0 t -71.0 -22.79 23.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.158 0.429 . . . . 10.0 112.158 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -127.32 -23.85 3.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.816 1.043 . . . . 10.0 113.816 -176.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 2.8 m120 77.91 63.68 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.082 0.944 . . . . 10.0 110.099 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 2.8 t -135.96 139.86 45.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.127 -1.397 . . . . 10.0 108.178 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 12.1 mmtm -112.45 133.14 54.69 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.338 -0.545 . . . . 10.0 112.145 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.633 ' HG ' ' OE2' ' A' ' 133' ' ' GLU . 1.1 mt -93.24 -20.25 20.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.163 -0.926 . . . . 10.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -120.15 152.04 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 10.0 111.06 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.85 -156.78 15.37 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.184 -0.766 . . . . 10.0 111.184 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.8 -37.1 10.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.821 0.343 . . . . 10.0 110.628 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -89.92 55.65 3.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.646 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.84 137.63 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 10.0 110.913 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.66 90.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.093 -0.803 . . . . 10.0 111.093 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.31 147.77 58.68 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.301 -0.449 . . . . 10.0 110.914 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.7 123.65 13.09 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.474 2.116 . . . . 10.0 110.718 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.9 OUTLIER -169.13 98.11 0.36 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.225 -0.658 . . . . 10.0 109.225 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -53.73 -46.13 70.72 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.273 0.358 . . . . 10.0 111.135 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.447 ' N ' ' HG ' ' A' ' 150' ' ' LEU . . . 58.45 -119.85 19.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.435 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.34 107.56 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.185 1.924 . . . . 10.0 111.193 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 38.0 pttt -89.89 105.88 18.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.221 0.534 . . . . 10.0 110.809 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.8 tmmt? -152.41 135.06 15.36 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.491 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.57 -0.728 . . . . 10.0 110.209 179.728 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.709 -0.556 . . . . 10.0 111.709 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.55 136.25 52.33 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 122.629 -0.336 . . . . 10.0 110.701 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 44.6 mtm -141.23 144.78 34.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.141 -0.482 . . . . 10.0 110.03 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -158.57 130.03 3.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.78 46.03 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.069 2.513 . . . . 10.0 114.209 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.89 130.92 55.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -126.5 123.24 37.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 10.0 111.163 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.76 -174.07 2.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.58 -146.95 8.83 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.678 -0.569 . . . . 10.0 111.678 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.27 91.76 1.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.633 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -123.55 124.35 42.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.612 0.244 . . . . 10.0 110.373 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.86 149.83 50.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.25 -166.76 20.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.086 -0.578 . . . . 10.0 111.94 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -139.92 174.08 10.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.815 0.34 . . . . 10.0 110.777 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -141.09 155.56 46.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.699 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.4 mt -132.49 166.81 21.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.305 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.4 m -110.02 133.22 53.42 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.522 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -89.97 93.71 9.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.856 0.36 . . . . 10.0 110.56 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.87 130.27 18.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.609 . . . . 10.0 110.145 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -150.14 172.15 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.55 -0.295 . . . . 10.0 110.473 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 69' ' ' ARG . 29.9 mtm180 -92.72 151.73 19.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.797 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -98.35 62.91 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.102 0.477 . . . . 10.0 111.577 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -104.88 90.06 3.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.52 0.676 . . . . 10.0 109.861 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.29 54.74 8.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.709 0.766 . . . . 10.0 109.071 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 pt -81.77 172.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.87 -1.059 . . . . 10.0 111.824 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.0 pt -75.87 172.72 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.842 -1.072 . . . . 10.0 110.943 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -77.36 146.11 73.54 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.944 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.63 178.44 5.11 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.405 2.07 . . . . 10.0 111.705 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -97.23 -160.09 0.78 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.701 -0.481 . . . . 10.0 109.701 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.93 168.05 12.8 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.072 -0.513 . . . . 10.0 109.957 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.9 m -83.17 -23.67 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 10.0 111.663 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.45 139.14 7.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.49 -0.862 . . . . 10.0 112.526 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -68.53 -47.64 66.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.724 0.297 . . . . 10.0 111.426 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -66.32 -33.47 75.79 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.38 0.61 . . . . 10.0 109.512 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.1 -44.52 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.021 -0.991 . . . . 10.0 109.998 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.47 -41.71 98.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.929 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.44 -41.25 98.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 10.0 110.199 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.78 -30.84 65.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.114 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.699 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.3 mt -60.71 -47.38 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.267 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.48 -53.19 46.1 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.434 0.459 . . . . 10.0 110.46 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.74 -33.44 72.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.573 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.04 -31.9 82.28 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.788 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -80.05 -32.34 39.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.483 0.658 . . . . 10.0 109.28 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.442 ' HA ' HG23 ' A' ' 97' ' ' THR . 84.4 mt-30 -74.2 -24.99 59.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.334 -0.848 . . . . 10.0 110.764 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -84.58 54.03 2.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.978 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.94 0.68 8.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.836 0.31 . . . . 10.0 111.836 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 1.6 tt0 56.11 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 124.159 0.912 . . . . 10.0 112.016 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 75.6 Cg_endo -81.81 -37.94 1.43 Allowed 'Cis proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.545 -1.44 . . . . 10.0 113.451 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 92' ' ' GLN . 2.3 m -173.88 124.88 0.36 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.395 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 ttm -83.57 142.36 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.286 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 75.5 p -74.52 163.55 27.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 10.0 111.142 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.27 -32.59 71.87 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.256 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.07 82.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.548 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.435 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 14.0 mm-40 -60.72 -54.45 45.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.594 -0.276 . . . . 10.0 110.445 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HG ' HH11 ' A' ' 91' ' ' ARG . 0.2 OUTLIER -64.76 -36.91 85.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.632 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.63 -47.5 86.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.816 -0.707 . . . . 10.0 111.742 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.96 -40.48 91.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.259 -0.275 . . . . 10.0 110.259 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.4 -31.74 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.352 0.501 . . . . 10.0 112.352 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 103' ' ' LEU . 46.8 pt -90.86 1.8 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 10.0 111.42 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.36 15.24 74.55 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.96 -0.638 . . . . 10.0 113.311 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -116.63 -149.4 0.44 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.65 172.07 9.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.602 0.239 . . . . 10.0 110.988 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.91 78.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.933 0.397 . . . . 10.0 110.505 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.65 77.55 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.637 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 4.0 m -59.64 -47.5 85.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.36 -44.13 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.25 -34.95 78.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.219 0.533 . . . . 10.0 110.893 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 36.5 m -76.83 -32.51 57.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.426 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.402 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.9 m-85 -67.57 -37.37 82.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.511 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.59 -18.78 65.21 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.721 0.296 . . . . 10.0 111.514 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 121' ' ' THR . 42.8 ttt180 -70.48 -20.39 62.86 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.402 0.62 . . . . 10.0 110.105 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.446 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.27 23.14 25.29 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 119' ' ' ARG . 4.1 t -170.21 105.18 0.3 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.888 0.851 . . . . 10.0 110.35 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.47 33.59 0.11 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.98 -1.009 . . . . 10.0 109.824 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 m 64.26 104.04 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.774 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.1 83.74 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.508 2.138 . . . . 10.0 113.353 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.713 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -84.44 120.33 26.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -50.09 -47.36 53.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.74 0.644 . . . . 10.0 112.74 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 26.8 p-10 -61.36 -39.28 90.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.892 -0.14 . . . . 10.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.572 ' O ' ' HG3' ' A' ' 132' ' ' MET . 77.4 mt -69.45 -50.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 12.7 mt -54.4 -41.85 69.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.901 0.381 . . . . 10.0 110.006 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -55.83 -42.47 75.78 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.463 -0.79 . . . . 10.0 111.288 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.575 ' O ' HG23 ' A' ' 135' ' ' VAL . 70.4 mmtt -73.66 -43.34 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 10.0 110.518 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.673 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 4.0 mtt -52.61 -56.13 17.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.161 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.94 -29.61 70.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.544 -0.753 . . . . 10.0 112.45 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.9 mmt180 -75.59 -45.16 39.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.931 0.715 . . . . 10.0 112.931 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 131' ' ' LYS . 17.7 t -65.39 -41.19 90.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 111.898 0.332 . . . . 10.0 111.898 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 132' ' ' MET . 0.0 OUTLIER -89.91 -10.16 46.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.87 -0.332 . . . . 10.0 111.869 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.9 t30 57.51 52.9 7.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.549 0.69 . . . . 10.0 110.481 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 136' ' ' LEU . 27.5 m -142.59 140.66 28.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.762 -1.108 . . . . 10.0 108.19 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 1.5 mtpp -96.67 133.46 41.16 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.028 -0.669 . . . . 10.0 110.251 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.525 ' HA ' HG23 ' A' ' 145' ' ' ILE . 36.6 mt -101.58 14.74 31.05 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.525 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -129.37 145.86 51.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.192 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.52 -155.85 21.86 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.469 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.98 -22.79 14.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.023 0.439 . . . . 10.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.88 51.68 1.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.056 0.455 . . . . 10.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 58.7 mt -71.9 142.65 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.705 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.84 4.29 88.83 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.455 -0.658 . . . . 10.0 111.455 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.55 143.49 48.55 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.568 -0.316 . . . . 10.0 110.548 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 124.0 10.68 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.683 1.589 . . . . 10.0 108.061 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.5 ttp85 -168.47 80.67 0.15 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.268 0.556 . . . . 10.0 110.058 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 150' ' ' LEU . 12.5 tp -85.5 87.88 7.45 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.055 -0.658 . . . . 10.0 110.919 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.78 70.05 0.07 OUTLIER Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.789 -0.719 . . . . 10.0 113.202 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.98 107.98 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.244 1.963 . . . . 10.0 112.202 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.24 148.99 52.0 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.881 -0.414 . . . . 10.0 109.881 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -85.79 -33.75 21.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.675 0.274 . . . . 10.0 111.18 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.1 pttt . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.475 -0.774 . . . . 10.0 110.4 -179.732 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 111.903 -0.479 . . . . 10.0 111.903 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.04 143.09 32.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.723 0.297 . . . . 10.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.2 ptp -147.48 139.27 24.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.223 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -150.63 130.37 6.67 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.448 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.76 122.6 7.42 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.776 2.317 . . . . 10.0 112.86 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.87 145.06 34.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.19 167.37 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 10.0 110.77 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.63 158.74 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.099 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.67 31.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.722 -0.752 . . . . 10.0 112.267 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.07 -20.02 10.79 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.704 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -96.9 112.19 24.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.291 -0.263 . . . . 10.0 110.291 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -153.12 179.47 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.807 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.8 20.02 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.378 -0.689 . . . . 10.0 111.378 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -90.51 151.16 21.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.42 . . . . 10.0 111.533 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -96.32 149.11 22.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.787 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.509 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.96 7.49 6.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.026 0.441 . . . . 10.0 110.806 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -96.76 125.88 41.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.7 162.31 19.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.049 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.8 m -103.84 167.54 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.833 0.349 . . . . 10.0 111.097 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -119.77 4.44 11.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.34 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.2 mtm-85 -96.59 133.83 40.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.285 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.2 m -149.48 101.92 3.14 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.44 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -134.49 114.29 12.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.228 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -128.88 98.32 4.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.133 0.492 . . . . 10.0 111.334 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.46 129.59 72.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.0 pt -85.12 149.09 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.808 0.337 . . . . 10.0 110.961 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.08 133.95 23.73 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.427 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.05 117.63 5.23 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.48 2.12 . . . . 10.0 111.897 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -118.35 -160.44 0.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.906 0.384 . . . . 10.0 110.312 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.637 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 3.5 p -95.67 -177.94 4.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.76 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.583 HG12 HG21 ' A' ' 83' ' ' VAL . 3.4 t -70.75 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.239 0.542 . . . . 10.0 110.87 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.77 153.35 5.91 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -76.48 -52.28 10.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.581 0.691 . . . . 10.0 112.543 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -30.5 69.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.605 -0.438 . . . . 10.0 111.568 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.583 HG21 HG12 ' A' ' 79' ' ' VAL . 25.9 m -68.01 -35.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 120.735 -0.386 . . . . 10.0 110.39 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.75 -48.66 82.69 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.277 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -63.62 -36.77 84.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 10.0 110.756 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -69.7 -30.75 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.963 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.834 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.7 mt -61.27 -47.88 91.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 109.381 -0.599 . . . . 10.0 109.381 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.81 -53.34 57.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.872 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.6 -35.09 79.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.676 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.26 80.34 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.925 -0.655 . . . . 10.0 113.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.834 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.8 mmt180 -75.84 -35.56 59.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.233 0.539 . . . . 10.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.47 ' HA ' HG23 ' A' ' 97' ' ' THR . 77.6 mt-30 -78.67 -12.91 60.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.776 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -77.94 -0.79 28.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.676 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -168.56 0.47 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.145 0.498 . . . . 10.0 111.466 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 12.7 tp10 -131.05 109.95 15.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.472 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.0 Cg_endo -79.06 -29.2 6.79 Favored 'Cis proline' 0 CA--C 1.515 -0.45 0 C-N-CA 123.188 -1.588 . . . . 10.0 112.157 -0.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 92' ' ' GLN . 38.0 m -168.47 136.21 2.11 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.55 -1.659 . . . . 10.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.9 tpp -87.01 127.57 35.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.3 p -77.25 156.82 31.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.361 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -68.13 -33.68 74.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.192 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.75 71.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.385 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.48 -42.26 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.454 -0.339 . . . . 10.0 111.461 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.551 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tm? -65.46 -44.52 86.93 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.06 96.58 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.769 -0.729 . . . . 10.0 111.394 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.72 -43.92 97.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.987 0.115 . . . . 10.0 111.297 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.91 -16.83 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 103' ' ' LEU . 33.6 pt -103.47 -3.19 9.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.255 -0.578 . . . . 10.0 110.779 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.44 50.09 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.291 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -120.32 -160.17 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.683 0.278 . . . . 10.0 110.481 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 175.09 5.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.453 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.64 -41.65 99.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.758 0.313 . . . . 10.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.82 73.62 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.07 -0.514 . . . . 10.0 110.873 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 m -59.6 -49.54 77.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.878 0.37 . . . . 10.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.36 -42.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.93 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.16 70.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.571 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 67.8 m -78.52 -31.96 47.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.141 0.423 . . . . 10.0 112.141 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -18.77 36.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.373 0.509 . . . . 10.0 112.373 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.444 ' HG3' HG22 ' A' ' 121' ' ' THR . 5.6 tpp180 -69.18 -23.39 63.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.309 0.576 . . . . 10.0 110.339 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.62 13.91 54.23 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.677 -0.773 . . . . 10.0 112.296 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 121' ' ' THR . 9.9 t -158.94 107.32 1.87 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.233 1.016 . . . . 10.0 109.37 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.78 29.17 0.37 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.443 -1.253 . . . . 10.0 110.017 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m 58.58 87.77 0.13 Allowed Pre-proline 0 N--CA 1.463 0.214 0 N-CA-C 108.378 -0.971 . . . . 10.0 108.378 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.637 ' HG3' ' C ' ' A' ' 78' ' ' THR . 87.9 Cg_endo -78.96 110.89 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.717 2.278 . . . . 10.0 115.454 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 128' ' ' ILE . 6.6 t70 -85.95 124.91 32.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.93 -2.989 . . . . 10.0 102.93 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 3.5 mm100 -50.97 -32.04 19.8 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.14 0.793 . . . . 10.0 113.14 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.531 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.5 t30 -75.9 -31.88 59.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.449 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.756 ' O ' ' HG3' ' A' ' 132' ' ' MET . 97.9 mt -64.85 -55.96 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.955 -0.298 . . . . 10.0 110.499 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -47.94 -38.85 17.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.737 0.779 . . . . 10.0 110.116 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.3 m -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.463 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 67.3 mmtt -75.57 -40.16 57.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.3 mtp -53.47 -57.73 9.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.227 0.537 . . . . 10.0 111.552 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mt-10 -72.27 -27.3 62.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.461 -0.79 . . . . 10.0 112.777 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -56.06 -30.22 61.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 10.0 111.362 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.7 -30.85 19.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.443 . . . . 10.0 111.814 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.713 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -96.18 -10.57 27.8 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 67.24 19.15 10.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.746 0.418 . . . . 10.0 111.772 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.776 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.9 m -114.03 140.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.1 mmtp -121.11 140.6 51.75 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.801 -0.76 . . . . 10.0 111.204 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.684 ' HA ' HG23 ' A' ' 145' ' ' ILE . 1.8 mt -102.46 41.26 1.25 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.192 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -131.3 141.21 49.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 10.0 111.092 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.52 -152.49 30.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.291 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.55 15.09 30.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.195 0.522 . . . . 10.0 110.698 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.08 45.25 2.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.251 0.548 . . . . 10.0 110.173 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.684 HG23 ' HA ' ' A' ' 140' ' ' LEU . 49.1 mt -68.8 138.98 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.72 7.03 87.93 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.367 -1.093 . . . . 10.0 110.367 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -131.62 157.63 77.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 114.833 -0.684 . . . . 10.0 109.799 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.33 122.4 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.751 . . . . 10.0 110.23 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.589 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 3.2 tpp180 -147.18 94.64 2.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 143.62 54.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.145 -0.48 . . . . 10.0 111.084 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.06 65.98 0.62 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.518 -0.765 . . . . 10.0 112.944 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.86 -17.74 13.68 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.361 2.041 . . . . 10.0 111.964 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -137.79 139.73 40.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.077 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -83.34 99.96 10.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.141 -0.933 . . . . 10.0 110.084 -179.476 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.078 -0.409 . . . . 10.0 112.078 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.81 152.34 28.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.39 -0.226 . . . . 10.0 110.39 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.5 mtm -100.72 144.51 29.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.647 0.261 . . . . 10.0 110.419 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -111.71 151.16 43.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.175 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.66 133.88 44.6 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.584 2.19 . . . . 10.0 112.318 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -76.64 152.99 35.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.365 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.37 151.37 29.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.804 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.3 153.64 27.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.402 -0.363 . . . . 10.0 110.594 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.0 -166.71 11.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.329 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.92 158.78 25.85 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.967 -0.635 . . . . 10.0 111.862 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 m -152.64 131.09 12.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.837 0.351 . . . . 10.0 110.58 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -145.01 -178.37 6.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.437 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.88 119.43 1.51 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.022 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -127.26 162.09 27.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 63' ' ' ARG . 11.6 ptm180 -160.43 149.39 17.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.815 0.34 . . . . 10.0 110.71 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 64' ' ' LEU . 1.3 tm? -151.57 118.43 5.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.802 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.7 m -149.71 107.77 3.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.049 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -113.33 133.98 54.86 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.475 -0.565 . . . . 10.0 109.475 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.68 144.59 29.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.038 0.447 . . . . 10.0 111.501 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.23 161.88 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -159.47 152.41 21.87 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -63.21 151.39 40.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.612 0.244 . . . . 10.0 110.492 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.75 98.94 7.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.801 0.334 . . . . 10.0 111.099 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -146.77 106.12 3.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.847 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.6 pt -121.39 161.76 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.054 0.454 . . . . 10.0 111.329 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.3 pt -85.46 -179.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.54 -0.754 . . . . 10.0 110.332 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -72.21 135.79 82.07 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.606 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.3 -176.9 3.32 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.863 2.375 . . . . 10.0 112.596 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -118.48 -139.62 0.35 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.905 -0.589 . . . . 10.0 109.484 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.2 p -79.47 -171.89 2.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.3 m -77.21 -31.48 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 10.0 110.789 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.5 132.05 3.88 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.576 -0.821 . . . . 10.0 112.401 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.53 -45.19 88.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.856 0.36 . . . . 10.0 110.819 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -29.7 65.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 87' ' ' ILE . 41.2 t -65.2 -46.2 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.078 -0.965 . . . . 10.0 109.773 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.58 -45.74 95.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.538 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -61.48 -38.59 87.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.005 0.431 . . . . 10.0 110.347 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.491 ' CB ' HD22 ' A' ' 140' ' ' LEU . . . -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.399 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.812 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.9 mt -59.8 -49.17 84.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.65 -51.45 65.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.538 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.42 -32.23 73.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.744 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 93' ' ' LYS . . . -73.65 -29.78 62.98 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.796 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.812 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.6 mmt180 -82.76 -36.29 25.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 10.0 109.812 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HA ' HG23 ' A' ' 97' ' ' THR . 37.2 mt-30 -72.92 -15.3 61.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 13.5 ptmt -84.86 6.69 23.69 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.703 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.88 -20.96 55.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.718 0.294 . . . . 10.0 111.777 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 56.98 102.44 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.052 -0.977 . . . . 10.0 111.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.46 -62.04 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.524 -1.448 . . . . 10.0 113.234 -0.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 92' ' ' GLN . 47.0 m -161.38 135.44 6.86 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.139 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 132.59 46.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.45 145.73 54.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -69.14 -36.59 77.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 10.0 109.879 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.49 76.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.254 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -64.19 -39.26 93.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 10.0 110.958 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -64.77 -43.89 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.35 -43.98 96.07 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.321 -0.712 . . . . 10.0 111.321 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.63 -38.63 81.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.794 0.331 . . . . 10.0 110.56 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.71 -18.78 65.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.114 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 103' ' ' LEU . 4.4 pt -117.0 5.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.676 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.42 26.72 60.82 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.306 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.41 -171.14 2.11 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 p -107.42 173.61 6.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.635 0.255 . . . . 10.0 110.958 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.04 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 10.0 110.069 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.73 84.99 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.637 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -60.78 -46.49 90.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.729 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.71 -37.2 77.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.993 0.425 . . . . 10.0 110.757 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.22 77.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.09 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.4 p -75.99 -29.83 58.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.023 0.439 . . . . 10.0 110.539 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.449 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 1.0 OUTLIER -63.35 -41.78 98.88 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.881 -0.599 . . . . 10.0 112.356 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -63.54 -18.22 63.62 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.528 ' HG2' HG22 ' A' ' 121' ' ' THR . 17.7 ttt180 -74.08 -22.68 59.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.356 0.598 . . . . 10.0 109.864 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.482 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 101.14 21.58 11.62 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.781 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.528 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -170.09 113.19 0.47 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 122.108 0.956 . . . . 10.0 110.611 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.29 27.73 0.09 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.422 -1.263 . . . . 10.0 108.86 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m 65.4 106.33 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.789 -1.096 . . . . 10.0 108.708 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 85.9 Cg_endo -78.15 89.63 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.763 2.309 . . . . 10.0 115.419 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -83.28 116.49 22.45 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.566 -2.012 . . . . 10.0 105.566 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.421 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 16.3 mm-40 -50.73 -40.13 53.6 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.647 0.61 . . . . 10.0 112.647 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.71 -32.83 73.74 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.258 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.448 HG23 HD12 ' A' ' 107' ' ' ILE . 62.7 mt -69.76 -55.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 121.026 -0.27 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -51.58 -40.11 59.17 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.582 0.706 . . . . 10.0 110.46 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.0 m -60.11 -52.96 63.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.513 -0.767 . . . . 10.0 112.032 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 -33.68 48.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.521 0.934 . . . . 10.0 113.521 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 ptm -63.11 -45.32 92.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.701 0.286 . . . . 10.0 111.564 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.871 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 21.8 mt-10 -75.66 -27.71 58.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.305 0.574 . . . . 10.0 111.801 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -25.22 67.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.411 -0.813 . . . . 10.0 112.514 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.65 -25.34 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.17 0.51 . . . . 10.0 110.995 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.645 HD21 ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -111.95 -12.74 13.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.302 -178.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 70.7 43.38 0.74 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.217 1.008 . . . . 10.0 108.657 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.871 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.9 t -128.31 141.58 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 113.545 -1.662 . . . . 10.0 107.319 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.6 mmmt -128.55 136.05 50.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.583 0.706 . . . . 10.0 111.259 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.521 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -106.76 30.35 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.794 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -131.22 139.13 49.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.524 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.23 -149.47 18.7 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.429 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.7 -24.16 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 10.0 110.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.66 50.58 1.84 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 10.0 110.555 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.521 HG23 ' HA ' ' A' ' 140' ' ' LEU . 4.3 mm -65.28 138.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.987 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.24 3.48 87.17 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.345 -0.702 . . . . 10.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -136.04 163.06 52.97 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.938 -0.631 . . . . 10.0 109.846 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 20.6 Cg_endo -63.67 123.0 11.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.217 1.945 . . . . 10.0 111.328 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.606 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 22.7 tpt180 -149.14 101.14 3.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.954 0.406 . . . . 10.0 109.973 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.07 102.41 9.31 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.542 0.687 . . . . 10.0 110.43 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.405 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . 178.64 65.07 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 114.797 -1.092 . . . . 10.0 111.646 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 151' ' ' GLY . 16.9 Cg_exo -67.71 -23.38 42.35 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.15 2.567 . . . . 10.0 112.602 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -120.45 146.72 45.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.52 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -63.94 -55.78 20.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.382 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.258 -0.877 . . . . 10.0 110.358 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.578 -0.209 . . . . 10.0 112.578 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.2 120.32 20.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.659 0.266 . . . . 10.0 110.371 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.8 ttt -95.86 72.1 3.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.389 0.614 . . . . 10.0 110.255 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -136.88 85.43 23.42 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.101 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.41 153.91 12.22 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.467 2.111 . . . . 10.0 112.577 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.68 154.07 18.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.025 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -122.99 93.6 4.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.035 0.445 . . . . 10.0 110.223 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.96 137.54 46.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.105 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.46 -176.16 38.57 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.394 -0.908 . . . . 10.0 112.184 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.72 113.61 2.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.114 -0.565 . . . . 10.0 111.99 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.3 t -159.3 149.36 19.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.684 0.278 . . . . 10.0 110.341 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -125.0 -176.41 3.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.317 -0.402 . . . . 10.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.39 102.66 0.66 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.206 -0.997 . . . . 10.0 112.792 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -142.93 143.8 32.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.835 -0.432 . . . . 10.0 109.835 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -171.37 142.17 1.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.688 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.4 mt -141.94 119.42 11.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.509 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.06 79.82 1.81 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.794 0.33 . . . . 10.0 111.4 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -160.62 100.79 1.31 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.407 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.85 170.56 19.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.431 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.57 114.94 4.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.023 -0.535 . . . . 10.0 109.769 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -127.27 94.42 3.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.965 0.412 . . . . 10.0 110.615 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m -75.59 -35.64 60.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.802 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -135.77 113.84 11.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.871 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.24 105.91 3.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.549 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.4 pt -85.01 -21.9 7.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.47 -0.332 . . . . 10.0 111.194 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.486 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 35.5 mt -65.42 138.22 23.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.875 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -105.3 94.45 8.15 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.17 0.51 . . . . 10.0 110.005 178.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 74' ' ' ILE . 83.9 Cg_endo -85.34 -143.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.804 2.336 . . . . 10.0 111.842 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 6.4 mtpm? -82.1 64.23 6.68 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.195 0.521 . . . . 10.0 109.658 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.06 155.73 27.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.545 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.475 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.7 m -78.88 -30.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 121.033 -0.267 . . . . 10.0 111.199 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.28 137.6 5.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.65 -52.91 39.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.637 0.256 . . . . 10.0 111.533 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.58 -31.03 71.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.902 HG13 HD13 ' A' ' 140' ' ' LEU . 6.0 t -62.36 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.365 -1.289 . . . . 10.0 109.856 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -59.4 -47.86 88.81 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.784 -0.644 . . . . 10.0 112.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -61.12 -38.17 85.41 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.25 0.548 . . . . 10.0 110.065 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.32 68.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.357 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.784 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.5 mt -60.55 -45.81 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.763 -0.458 . . . . 10.0 109.763 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HG2' HE21 ' A' ' 89' ' ' GLN . 0.6 OUTLIER -69.04 -48.05 63.85 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.698 -0.482 . . . . 10.0 109.698 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 4.3 mm-40 -62.31 -34.7 77.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.33 -36.82 93.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.626 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.96 -36.25 31.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.211 0.529 . . . . 10.0 110.004 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.625 ' HA ' HG23 ' A' ' 97' ' ' THR . 86.6 mt-30 -74.49 -24.13 58.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.39 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 12.4 mptt -87.52 23.45 1.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 10.0 111.28 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -16.12 56.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.018 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 58.65 104.23 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.759 -1.11 . . . . 10.0 111.41 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.09 -60.92 0.06 OUTLIER 'Cis proline' 0 CA--C 1.516 -0.392 0 C-N-CA 123.78 -1.342 . . . . 10.0 113.037 0.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 92' ' ' GLN . 74.8 m -158.77 125.15 4.61 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.206 -0.907 . . . . 10.0 110.799 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.3 tpp -78.31 135.55 37.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.16 144.97 50.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.775 0.321 . . . . 10.0 111.09 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.35 -36.55 77.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.989 0.423 . . . . 10.0 110.215 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -65.14 -45.35 85.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 10.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -66.72 -39.95 88.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -63.6 -38.03 89.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -47.7 69.15 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.418 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 33.6 mmtp -59.2 -40.82 86.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.749 0.309 . . . . 10.0 110.663 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -33.87 73.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.066 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 103' ' ' LEU . 31.1 pt -95.54 -0.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 10.0 111.293 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.62 14.93 69.4 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.185 -0.531 . . . . 10.0 113.29 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -111.56 -157.97 0.63 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.6 p -119.3 174.7 6.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.493 0.187 . . . . 10.0 110.63 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.51 81.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.036 0.445 . . . . 10.0 109.804 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.54 72.29 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.447 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.0 m -64.78 -48.01 76.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.728 0.299 . . . . 10.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.8 -45.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 10.0 110.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.18 -31.69 72.68 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.061 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 m -76.64 -34.71 58.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.975 0.417 . . . . 10.0 111.768 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.32 -34.2 77.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.618 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.46 -17.6 59.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.819 0.342 . . . . 10.0 111.551 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 121' ' ' THR . 25.3 ttm180 -69.43 -28.09 65.83 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.226 0.536 . . . . 10.0 111.262 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.475 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.1 21.91 16.7 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.593 -0.813 . . . . 10.0 111.956 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 121' ' ' THR . 8.5 t -169.79 105.56 0.34 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.316 1.055 . . . . 10.0 109.438 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.88 25.13 0.09 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.497 -1.229 . . . . 10.0 109.636 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.7 m 67.56 106.7 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.111 -0.95 . . . . 10.0 110.737 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 129' ' ' LEU . 65.3 Cg_endo -73.99 88.66 1.07 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.572 2.181 . . . . 10.0 113.989 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.73 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.7 t70 -81.88 116.74 21.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.411 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 11.5 mm-40 -49.7 -46.77 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -62.09 -43.4 98.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.544 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.705 ' O ' ' HG3' ' A' ' 132' ' ' MET . 55.7 mt -63.55 -56.84 14.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 13.3 mt -47.44 -45.92 26.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.349 0.595 . . . . 10.0 110.744 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 71.4 m -56.58 -51.18 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.986 -1.006 . . . . 10.0 112.191 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -75.17 -30.66 60.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.705 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 31.4 mtp -56.36 -61.4 2.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 10.0 111.929 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.5 mp0 -76.37 -26.37 55.59 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HB3' ' O ' ' A' ' 130' ' ' SER . 12.3 ptt85 -58.61 -29.66 66.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.924 0.329 . . . . 10.0 111.364 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 131' ' ' LYS . 66.7 t -71.48 -33.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.0 0.429 . . . . 10.0 110.969 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.597 HD12 HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -95.16 -17.45 21.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.488 -178.363 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.9 t30 62.27 56.03 2.26 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.531 0.682 . . . . 10.0 109.536 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.597 HG22 HD12 ' A' ' 136' ' ' LEU . 11.9 m -137.19 159.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.44 -1.254 . . . . 10.0 108.715 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.5 mmpt? -127.25 139.77 52.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.905 ' HA ' HG23 ' A' ' 145' ' ' ILE . 11.2 mt -95.13 36.11 1.24 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.39 0.614 . . . . 10.0 110.282 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -135.62 155.72 50.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.627 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.02 -163.23 43.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.057 -0.592 . . . . 10.0 112.571 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.86 -12.49 36.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 10.0 110.854 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -104.86 49.89 0.8 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.11 0.481 . . . . 10.0 110.36 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 140' ' ' LEU . 22.7 mt -70.81 137.63 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.96 1.89 67.05 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.77 -0.932 . . . . 10.0 110.77 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -135.24 159.19 72.79 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -0.738 . . . . 10.0 109.217 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.17 120.99 9.29 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.029 1.819 . . . . 10.0 109.905 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 139' ' ' LYS . 7.3 tpp85 -140.17 105.69 5.1 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.899 -0.5 . . . . 10.0 110.629 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.6 mt -89.44 104.9 17.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.91 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -107.83 156.08 15.99 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.243 -0.98 . . . . 10.0 112.107 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -89.69 144.02 4.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.774 2.316 . . . . 10.0 112.047 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -96.42 4.23 52.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.286 0.565 . . . . 10.0 109.903 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -96.07 107.23 19.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.177 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.55 -0.738 . . . . 10.0 110.305 179.516 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 112.017 -0.433 . . . . 10.0 112.017 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.28 132.48 8.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.375 -0.232 . . . . 10.0 110.375 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -153.58 156.46 38.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.458 -0.337 . . . . 10.0 110.318 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.11 136.49 26.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.87 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.94 116.68 3.3 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.171 2.581 . . . . 10.0 112.685 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -83.31 115.11 21.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.156 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.93 141.53 35.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.665 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.85 149.78 22.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.852 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.13 -162.19 37.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.458 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.02 -166.64 23.24 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -154.35 148.94 26.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.907 0.384 . . . . 10.0 110.542 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -157.96 138.73 13.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.259 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.15 174.49 16.16 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.964 -0.636 . . . . 10.0 111.709 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -165.96 135.24 3.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 10.0 110.513 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 141.13 30.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.212 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.0 tp -148.98 118.89 7.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.239 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -105.49 141.42 37.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.396 -0.366 . . . . 10.0 110.335 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -122.44 108.85 13.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.337 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.92 116.45 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.173 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -163.27 -170.82 2.39 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -92.58 -178.84 5.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.242 -0.281 . . . . 10.0 110.242 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 m -93.62 70.87 4.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.267 0.556 . . . . 10.0 111.029 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -132.11 41.02 3.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.832 0.825 . . . . 10.0 109.359 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -165.3 125.59 1.87 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.783 -1.099 . . . . 10.0 108.783 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.47 86.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.317 0.58 . . . . 10.0 110.95 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 pt -134.52 -173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.612 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.93 143.21 80.74 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.71 80.83 0.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.326 2.017 . . . . 10.0 112.124 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -83.53 46.11 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.285 0.564 . . . . 10.0 110.374 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 3.1 p -126.18 157.09 39.05 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.874 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.456 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.4 m -84.31 -30.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.968 -0.293 . . . . 10.0 111.444 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.1 140.27 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.253 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.71 -51.94 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.791 0.329 . . . . 10.0 111.092 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.21 -33.93 76.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 140' ' ' LEU . 13.1 t -61.88 -47.12 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.154 -0.93 . . . . 10.0 110.478 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -39.47 95.94 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.699 -0.762 . . . . 10.0 111.827 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.77 -40.32 91.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.38 83.18 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.822 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.465 HG23 ' CZ ' ' A' ' 91' ' ' ARG . 3.4 mt -54.25 -45.28 67.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.054 0.454 . . . . 10.0 110.503 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.87 -48.05 60.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.348 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 53.4 mt-30 -62.54 -37.65 86.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.147 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.98 -38.76 94.44 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.978 -0.556 . . . . 10.0 113.287 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.651 HH22 ' HB3' ' A' ' 132' ' ' MET . 0.5 OUTLIER -78.98 -38.62 36.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.808 0.337 . . . . 10.0 111.425 -178.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.678 ' HA ' HG23 ' A' ' 97' ' ' THR . 8.8 pt20 -72.49 -13.63 61.47 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.492 -0.483 . . . . 10.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 2.0 tttm -81.54 12.12 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -158.42 0.22 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 10.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.66 105.39 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.909 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.08 -30.41 5.33 Favored 'Cis proline' 0 C--N 1.348 0.504 0 C-N-CA 123.523 -1.449 . . . . 10.0 112.725 -0.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 92' ' ' GLN . 15.2 m -161.33 135.76 7.11 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.862 -1.517 . . . . 10.0 109.445 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.18 127.72 35.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.109 -0.33 . . . . 10.0 110.109 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.592 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 59.0 p -79.99 163.69 24.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 10.0 110.641 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.88 -28.91 67.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.87 -32.59 69.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.281 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.592 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 21.4 mm-40 -66.59 -54.97 17.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.547 0.213 . . . . 10.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.559 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -63.91 -40.4 96.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.212 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.38 -46.07 93.48 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 111.352 -0.699 . . . . 10.0 111.352 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -65.48 -44.34 87.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.95 -36.54 77.3 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.634 HD13 ' SD ' ' A' ' 132' ' ' MET . 36.4 pt -87.61 -12.46 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.777 -0.369 . . . . 10.0 111.74 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.86 22.45 30.68 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.888 -0.672 . . . . 10.0 113.476 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -119.89 -154.92 0.6 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 p -115.14 176.96 4.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.568 0.223 . . . . 10.0 110.719 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -34.19 75.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.817 0.342 . . . . 10.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.98 84.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.435 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -58.33 -48.2 81.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.164 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.98 -46.66 90.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.48 -37.84 87.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.274 0.559 . . . . 10.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 58.2 m -74.23 -26.28 60.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.092 -0.503 . . . . 10.0 110.652 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -43.27 69.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.464 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.72 -18.89 57.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.957 0.408 . . . . 10.0 111.035 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 116' ' ' SER . 45.3 ttp180 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.265 0.555 . . . . 10.0 110.411 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.456 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.06 21.49 22.86 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.868 -0.606 . . . . 10.0 111.783 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 121' ' ' THR . 8.0 t -174.62 114.35 0.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.026 0.917 . . . . 10.0 109.712 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.92 29.83 0.15 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.827 -1.079 . . . . 10.0 109.863 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m 58.88 93.1 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HG3' ' O ' ' A' ' 78' ' ' THR . 73.3 Cg_endo -71.45 104.67 1.61 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.926 2.418 . . . . 10.0 115.977 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.585 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 18.3 t70 -90.2 119.57 30.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 104.85 -2.278 . . . . 10.0 104.85 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -49.01 -46.65 44.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -63.3 -36.52 83.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.305 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.37 -55.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.852 -0.158 . . . . 10.0 110.914 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -54.42 -38.76 66.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.979 0.418 . . . . 10.0 110.616 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.6 m -58.69 -50.37 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.605 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -34.51 61.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.719 0.266 . . . . 10.0 111.719 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.651 ' HB3' HH22 ' A' ' 91' ' ' ARG . 5.3 mmm -52.52 -61.06 2.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.355 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HG3' ' HG ' ' A' ' 140' ' ' LEU . 49.4 mm-40 -76.49 -24.04 53.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.487 -0.779 . . . . 10.0 112.17 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 130' ' ' SER . 20.9 ttp180 -52.58 -40.73 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 10.0 111.805 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.98 -24.95 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 10.0 111.197 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -99.57 -16.39 18.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.974 -178.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 6.3 m-20 78.79 52.46 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.57 0.7 . . . . 10.0 109.908 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -133.17 159.49 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.886 -1.052 . . . . 10.0 108.248 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -130.15 -2.19 4.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.566 -0.854 . . . . 10.0 113.103 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.678 ' HB3' HG22 ' A' ' 83' ' ' VAL . 22.4 mt 54.61 10.51 0.35 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.792 -1.095 . . . . 10.0 113.699 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.573 HH21 HG21 ' A' ' 83' ' ' VAL . 4.3 mmt85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.297 -0.252 . . . . 10.0 110.47 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.74 -179.78 26.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.769 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.74 -25.05 48.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 10.0 109.9 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -89.37 56.48 3.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.571 -0.74 . . . . 10.0 110.845 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.68 139.28 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.054 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.54 61.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.088 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -150.46 162.0 28.82 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.577 . . . . 10.0 109.462 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 14.2 Cg_endo -61.83 122.73 11.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.618 1.545 . . . . 10.0 110.149 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 149' ' ' ARG . 0.9 OUTLIER -140.58 81.74 1.82 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 -178.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 34.2 mt -67.91 104.33 1.69 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.632 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -113.11 -179.9 19.26 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.895 -0.882 . . . . 10.0 110.895 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.57 113.67 2.21 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.539 2.159 . . . . 10.0 111.774 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.28 169.45 17.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.515 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -104.53 165.5 11.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 10.0 111.072 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.378 -0.82 . . . . 10.0 109.862 179.636 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.69 -0.564 . . . . 10.0 111.69 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.91 45.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.841 0.353 . . . . 10.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -118.09 155.14 30.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.315 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -100.71 147.17 33.27 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.539 -0.3 . . . . 10.0 110.723 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.41 151.79 83.23 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.216 2.61 . . . . 10.0 112.507 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -117.28 156.36 27.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -151.59 154.17 35.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -177.81 6.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.763 0.316 . . . . 10.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.37 -133.96 1.86 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.19 -0.529 . . . . 10.0 111.861 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.99 158.01 7.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.148 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -141.45 170.24 16.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.13 179.65 4.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 10.0 110.71 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -125.66 1.21 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.753 -0.737 . . . . 10.0 111.922 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.02 145.22 53.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.902 0.382 . . . . 10.0 110.687 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -94.59 -48.69 5.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.991 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 pp -97.33 132.48 43.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.167 -0.47 . . . . 10.0 109.806 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 p -107.24 -66.02 1.06 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.516 -0.311 . . . . 10.0 111.062 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 143' ' ' ALA . 17.8 ptpt -142.89 147.48 35.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.498 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.8 m -78.67 165.15 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.352 -0.385 . . . . 10.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -114.56 132.03 56.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.901 0.382 . . . . 10.0 110.596 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -135.77 155.5 50.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.551 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.15 159.02 35.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.343 -0.39 . . . . 10.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -150.8 117.82 5.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.477 -0.329 . . . . 10.0 110.125 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.62 31.84 0.47 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.222 0.535 . . . . 10.0 110.908 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.6 tt -83.32 -13.2 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.441 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.7 mt 60.03 77.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.59 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -67.59 154.73 92.73 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.951 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.46 -160.41 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.56 2.173 . . . . 10.0 111.638 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -83.15 47.65 1.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.111 0.481 . . . . 10.0 110.779 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.1 p -100.36 137.35 38.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.478 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 3.1 p -71.63 -33.89 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.116 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.06 130.18 3.1 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.438 -0.887 . . . . 10.0 112.192 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.99 -53.02 61.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.313 . . . . 10.0 111.089 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -65.34 -33.02 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.51 -0.552 . . . . 10.0 109.51 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 87' ' ' ILE . 92.9 t -62.69 -46.09 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.096 -0.956 . . . . 10.0 110.18 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -60.14 -42.77 98.7 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.973 -0.558 . . . . 10.0 113.176 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -69.24 -34.16 74.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 10.0 110.447 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.22 -29.68 66.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.707 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 83' ' ' VAL . 39.5 mt -59.27 -44.09 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 10.0 109.99 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.38 -54.63 11.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.245 0.545 . . . . 10.0 110.028 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 47.8 mt-30 -55.2 -38.19 68.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.975 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.46 -34.38 40.39 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.158 -1.02 . . . . 10.0 113.12 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.666 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -81.7 -26.03 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.053 0.454 . . . . 10.0 111.375 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG2' HG23 ' A' ' 97' ' ' THR . 71.5 mt-30 -75.21 -8.8 57.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.187 0.517 . . . . 10.0 109.905 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 8.4 mtpm? -76.63 8.13 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.973 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.62 -13.9 55.7 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.873 -0.331 . . . . 10.0 111.689 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER 61.04 111.1 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 O-C-N 124.32 1.013 . . . . 10.0 112.096 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.1 Cg_endo -76.0 -37.86 1.99 Allowed 'Cis proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.205 -1.581 . . . . 10.0 112.373 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 92' ' ' GLN . 3.0 m -170.98 135.85 1.06 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.973 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 33.9 tpp -70.79 127.02 31.21 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -63.18 146.64 52.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.572 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -64.74 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.979 0.419 . . . . 10.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.72 -47.22 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.23 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -68.31 -37.04 80.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.707 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -61.83 -44.24 97.24 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.72 97.97 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.346 -0.843 . . . . 10.0 111.513 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -62.9 -36.05 82.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.168 0.509 . . . . 10.0 110.331 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -71.94 -40.87 68.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.193 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.8 pt -82.53 -5.9 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 111.992 0.367 . . . . 10.0 111.992 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.9 28.45 37.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.837 -0.697 . . . . 10.0 112.907 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -130.14 -146.84 0.32 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.216 -0.661 . . . . 10.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.35 175.73 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.615 0.245 . . . . 10.0 111.097 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.24 91.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.726 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.75 76.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.671 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -60.27 -46.45 89.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.398 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 103' ' ' LEU . 39.2 t -65.49 -45.91 91.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.354 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.92 -32.87 74.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.86 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -77.2 -28.18 53.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.471 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -70.33 -39.71 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.125 0.417 . . . . 10.0 112.125 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.56 -19.51 57.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.091 0.472 . . . . 10.0 111.469 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.57 ' HG2' HG22 ' A' ' 121' ' ' THR . 12.1 ttm180 -72.89 -29.34 63.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.738 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.99 12.21 47.07 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.998 -0.62 . . . . 10.0 113.633 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.1 t -149.38 59.33 1.02 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.795 0.807 . . . . 10.0 111.022 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.2 27.53 9.42 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.613 -0.721 . . . . 10.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.4 m 64.97 109.38 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 123.627 0.58 . . . . 10.0 110.506 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 44.0 Cg_endo -70.37 88.37 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.171 1.914 . . . . 10.0 113.642 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.718 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.0 t70 -87.35 114.43 23.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.7 -1.222 . . . . 10.0 107.7 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.8 mm-40 -49.75 -45.64 49.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.472 0.483 . . . . 10.0 111.933 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 22.6 t30 -61.25 -44.97 96.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.822 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.594 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.5 mt -63.02 -55.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.181 -0.207 . . . . 10.0 110.648 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 6.3 mt -50.12 -41.38 48.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.356 0.598 . . . . 10.0 110.321 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 73.9 m -58.97 -43.55 91.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.124 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 135' ' ' VAL . 74.2 mmtt -72.98 -43.28 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.909 0.337 . . . . 10.0 111.909 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.594 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 14.3 mtp -49.28 -56.97 7.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.752 0.786 . . . . 10.0 111.841 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.442 ' CG ' HH12 ' A' ' 91' ' ' ARG . 11.8 mt-10 -73.93 -27.28 60.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -1.112 . . . . 10.0 113.083 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.604 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -68.72 -22.65 64.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.261 0.467 . . . . 10.0 112.261 -178.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.6 t -66.9 -24.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 10.0 109.957 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.55 HD11 HH11 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -123.53 -96.54 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.151 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 19.0 p-10 173.42 31.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.2 m -111.55 147.62 15.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 2.9 mmpt? -115.6 132.92 56.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 10.0 110.711 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD13 HG13 ' A' ' 83' ' ' VAL . 40.8 mt -97.42 40.58 1.15 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -139.33 139.35 37.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.794 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.58 -157.8 19.83 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.651 -0.785 . . . . 10.0 112.802 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' LYS . . . -96.29 -19.24 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.128 0.49 . . . . 10.0 111.16 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -97.75 54.07 1.14 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 14.1 mm -63.17 136.54 25.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.389 -0.823 . . . . 10.0 112.127 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.2 4.01 90.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.023 -0.608 . . . . 10.0 112.144 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.76 54.66 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.942 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 12.0 Cg_endo -58.5 121.86 10.68 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.803 2.335 . . . . 10.0 110.594 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -164.24 68.05 0.17 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.556 0.693 . . . . 10.0 109.169 179.459 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 mt -75.69 83.58 2.69 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.216 -0.902 . . . . 10.0 111.227 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 152.87 76.16 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.82 -1.082 . . . . 10.0 111.198 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.51 170.32 18.78 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.426 2.084 . . . . 10.0 112.259 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -92.91 147.49 22.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.866 0.365 . . . . 10.0 110.346 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -107.84 149.78 27.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.921 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.676 -0.678 . . . . 10.0 109.962 179.729 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 112.321 -0.312 . . . . 10.0 112.321 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.73 104.27 16.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.805 0.336 . . . . 10.0 110.409 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.1 mtt -103.61 143.74 32.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.81 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.97 90.34 49.75 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.567 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -86.49 154.7 9.15 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.025 2.483 . . . . 10.0 112.994 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.49 141.34 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.209 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -159.89 151.68 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.712 0.291 . . . . 10.0 110.661 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.38 150.26 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.038 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.76 166.16 34.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.61 -0.805 . . . . 10.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.08 170.4 20.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.187 -0.53 . . . . 10.0 112.307 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 162.39 12.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.844 0.354 . . . . 10.0 111.274 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.91 -175.17 4.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.45 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.78 158.83 31.45 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.601 -0.6 . . . . 10.0 111.601 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.26 176.95 7.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.992 0.396 . . . . 10.0 110.975 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -118.51 179.22 4.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.095 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.3 mt -109.97 168.58 9.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.528 -0.305 . . . . 10.0 110.673 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.63 150.54 49.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.461 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -110.34 134.23 52.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.091 -0.337 . . . . 10.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.54 177.96 2.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.587 -0.278 . . . . 10.0 110.54 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.21 131.27 34.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.036 0.446 . . . . 10.0 110.333 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -147.73 -164.57 2.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.046 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.3 m -62.65 131.91 50.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.938 0.399 . . . . 10.0 111.052 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.4 91.5 2.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.679 -0.691 . . . . 10.0 110.533 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -86.05 86.14 7.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.315 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.3 pt -61.3 118.97 4.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.196 -0.911 . . . . 10.0 111.818 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.3 pt -118.09 176.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.911 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.5 pttt 38.3 77.8 0.39 Allowed Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 124.262 0.976 . . . . 10.0 112.265 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.5 -166.12 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.734 2.289 . . . . 10.0 111.811 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.37 76.95 0.55 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.252 0.549 . . . . 10.0 110.51 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -138.93 168.3 20.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.254 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.1 m -88.24 -34.12 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.42 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.41 143.03 7.62 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.581 -0.818 . . . . 10.0 112.489 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -67.28 -55.67 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.641 0.237 . . . . 10.0 111.641 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.15 -35.39 80.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.543 0.687 . . . . 10.0 109.221 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.533 HG13 HD13 ' A' ' 140' ' ' LEU . 38.9 t -59.51 -45.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.681 -1.145 . . . . 10.0 110.411 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.11 97.76 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.117 -0.564 . . . . 10.0 112.476 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -65.04 -37.0 86.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 10.0 110.561 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.04 -30.63 67.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.176 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.468 HG12 ' NH2' ' A' ' 91' ' ' ARG . 17.8 mt -60.95 -46.28 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.403 0.621 . . . . 10.0 109.643 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.77 -50.88 31.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.048 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.69 -35.78 75.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.565 . . . . 10.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.71 -34.92 37.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.492 -1.337 . . . . 10.0 113.203 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HD2' HD21 ' A' ' 136' ' ' LEU . 1.3 mpt_? -81.24 -44.22 18.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 10.0 111.582 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' THR . 71.9 mt-30 -67.01 -18.33 65.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.656 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -81.16 29.58 0.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.715 0.293 . . . . 10.0 111.55 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.67 -3.84 51.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.835 0.309 . . . . 10.0 111.835 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 44.0 mt-10 60.13 109.14 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.021 0.826 . . . . 10.0 112.418 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 11.9 Cg_exo -73.62 -54.39 0.15 OUTLIER 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.816 -1.327 . . . . 10.0 112.788 -0.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 13.1 m -161.62 123.14 2.83 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.134 -0.939 . . . . 10.0 110.582 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.5 ttm -64.59 128.84 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.828 0.346 . . . . 10.0 110.438 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.6 p -76.81 157.3 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -66.97 -28.78 68.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.413 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.66 80.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.194 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 46.7 mm-40 -64.51 -53.88 41.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.747 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 114' ' ' VAL . 22.5 tp -60.47 -40.13 90.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.31 -45.68 95.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.684 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -64.36 -44.18 92.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 10.0 110.402 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 58.0 mm-40 -61.47 -41.0 96.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 10.0 112.113 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 131' ' ' LYS . 43.9 pt -84.59 -14.91 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 111.931 0.345 . . . . 10.0 111.931 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.16 41.34 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.969 -0.634 . . . . 10.0 113.225 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -121.95 -176.13 3.27 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.03 163.59 14.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.655 0.264 . . . . 10.0 110.767 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.81 -35.29 76.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 10.0 110.842 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.31 71.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -66.91 -47.4 71.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.599 HG13 HD23 ' A' ' 103' ' ' LEU . 61.2 t -62.46 -43.5 98.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.637 -0.71 . . . . 10.0 110.503 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.31 80.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.403 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 7.2 t -74.29 -30.77 62.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.183 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.09 -44.71 94.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.171 -0.468 . . . . 10.0 111.536 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.59 -19.08 65.69 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.985 -0.286 . . . . 10.0 111.148 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 116' ' ' SER . 20.7 ttp180 -71.92 -22.78 61.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.417 0.627 . . . . 10.0 109.534 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.422 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 100.45 25.49 8.71 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.522 -0.763 . . . . 10.0 112.132 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 121' ' ' THR . 10.3 t -174.2 111.97 0.17 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.975 0.893 . . . . 10.0 110.467 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.35 33.42 0.09 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.99 -1.005 . . . . 10.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m 60.76 99.99 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.312 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.19 88.82 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.878 2.386 . . . . 10.0 115.06 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.5 t70 -86.01 117.07 24.62 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 105.856 -1.905 . . . . 10.0 105.856 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -51.51 -41.28 60.88 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.613 0.571 . . . . 10.0 112.178 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.495 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 53.4 t30 -65.63 -44.15 87.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.62 ' O ' ' HG3' ' A' ' 132' ' ' MET . 79.4 mt -59.87 -53.93 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.7 mt -48.75 -48.02 41.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.478 0.656 . . . . 10.0 109.736 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.9 m -55.12 -39.84 69.84 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.803 -1.09 . . . . 10.0 111.189 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HB2' HG22 ' A' ' 107' ' ' ILE . 66.8 mmtt -71.72 -48.07 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.62 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 10.1 mtp -52.33 -52.29 54.01 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.86 0.838 . . . . 10.0 111.213 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 32.4 mt-10 -72.56 -29.28 63.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.553 -1.203 . . . . 10.0 113.17 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.2 ttp85 -64.43 -28.92 70.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.8 t -64.0 -31.97 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.917 HD23 HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.16 2.77 9.25 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.539 0.94 . . . . 10.0 113.539 -178.278 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.51 43.38 16.19 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.917 HG22 HD23 ' A' ' 136' ' ' LEU . 31.4 m -131.96 138.47 52.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.501 ' CG ' ' H ' ' A' ' 149' ' ' ARG . 30.4 mmmt -114.06 149.98 34.68 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.466 -0.494 . . . . 10.0 111.364 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.765 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -110.6 15.34 22.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.191 -0.913 . . . . 10.0 109.866 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -115.65 140.68 48.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.434 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.46 -162.81 29.59 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.21 -26.58 21.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.978 0.418 . . . . 10.0 111.117 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -87.74 54.91 3.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.004 0.431 . . . . 10.0 111.726 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.765 HG23 ' HA ' ' A' ' 140' ' ' LEU . 73.6 mt -74.41 142.33 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.1 73.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.688 -0.965 . . . . 10.0 110.688 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.0 156.78 76.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.639 -0.78 . . . . 10.0 109.398 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -61.94 123.72 13.13 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.826 1.684 . . . . 10.0 109.667 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.501 ' H ' ' CG ' ' A' ' 139' ' ' LYS . 23.3 tpt180 -151.41 99.31 2.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.21 0.528 . . . . 10.0 110.931 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.56 170.91 20.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.389 -0.823 . . . . 10.0 109.107 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.59 173.46 51.69 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.455 -0.879 . . . . 10.0 111.286 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -20.28 60.8 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.507 2.138 . . . . 10.0 112.119 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -99.63 118.49 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.933 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.65 167.96 12.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.204 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.254 -0.879 . . . . 10.0 110.001 179.353 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.947 0 N-CA-C 111.697 -0.561 . . . . 10.0 111.697 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.59 138.13 32.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.825 0.345 . . . . 10.0 110.873 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mtp -98.48 139.18 34.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.147 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -151.15 145.42 18.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.124 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.06 147.79 34.19 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.71 2.274 . . . . 10.0 112.619 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.77 143.29 57.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.742 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -72.03 150.36 44.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.423 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.68 30.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.1 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.88 157.19 15.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.241 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.36 169.54 32.17 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.828 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -147.49 97.04 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.062 0.458 . . . . 10.0 110.995 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.06 149.71 24.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.623 -0.51 . . . . 10.0 109.623 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.96 -170.34 12.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.585 -0.817 . . . . 10.0 112.779 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -157.81 167.27 30.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.113 -0.328 . . . . 10.0 110.113 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -118.9 15.88 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.981 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.95 124.6 28.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.008 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -140.7 115.42 9.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.659 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -128.21 132.59 48.8 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.24 132.43 71.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.912 0.387 . . . . 10.0 110.987 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -114.67 151.55 33.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -135.75 166.6 22.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.899 0.38 . . . . 10.0 110.66 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -128.67 138.39 52.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -137.52 138.88 40.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.454 0.645 . . . . 10.0 110.515 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.13 -107.4 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.637 -1.165 . . . . 10.0 109.03 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.0 pt -92.57 -177.36 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.0 mt -63.19 108.45 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.818 0.342 . . . . 10.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -83.14 154.87 67.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.158 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.57 -176.47 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.796 2.331 . . . . 10.0 111.591 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt 64.53 104.45 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.561 0.538 . . . . 10.0 110.739 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.9 p -90.22 -168.73 2.2 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.976 -0.379 . . . . 10.0 109.976 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.4 m -83.4 -27.61 7.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.759 -0.376 . . . . 10.0 110.69 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.9 139.19 6.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 10.0 111.719 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -65.23 -56.29 13.63 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.709 0.29 . . . . 10.0 111.294 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.56 -32.94 74.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' ILE . 38.5 t -62.15 -43.71 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.224 -0.898 . . . . 10.0 109.857 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.28 99.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.405 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -63.28 -37.81 88.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.622 . . . . 10.0 109.777 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' CB ' HD22 ' A' ' 140' ' ' LEU . . . -73.92 -29.78 62.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.617 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.729 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 12.4 mt -58.39 -52.3 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.99 -48.98 66.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.552 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -60.6 -29.27 69.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.354 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.56 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -76.28 -37.84 35.66 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.422 -0.894 . . . . 10.0 113.051 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.5 mmt180 -79.65 -43.75 22.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.28 0.54 . . . . 10.0 110.747 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.2 -5.44 27.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.04 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 38.8 tttt -78.91 -10.9 59.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.835 0.35 . . . . 10.0 110.643 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.61 172.35 4.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.38 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -120.31 125.12 27.38 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.507 -0.315 . . . . 10.0 110.387 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.52 -39.51 1.3 Allowed 'Cis proline' 0 CA--C 1.519 -0.258 0 C-N-CA 123.617 -1.409 . . . . 10.0 112.544 -0.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.5 m -170.61 120.95 0.58 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.608 -1.178 . . . . 10.0 109.333 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 35.3 tpp -65.28 122.5 17.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.8 p -74.47 159.27 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.033 0.444 . . . . 10.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -68.91 -37.66 79.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.178 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.1 -41.67 90.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.02 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -66.19 -46.15 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.144 -0.222 . . . . 10.0 110.808 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tp -65.45 -39.56 92.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.15 -47.55 90.24 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.147 -0.933 . . . . 10.0 111.384 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.82 -43.41 98.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -60.65 -41.74 95.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.899 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 103' ' ' LEU . 38.9 pt -82.84 -7.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.895 0.332 . . . . 10.0 111.895 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.22 29.99 29.3 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.648 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.51 -154.0 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.51 172.36 7.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.535 -0.172 . . . . 10.0 110.535 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.42 89.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.02 0.438 . . . . 10.0 110.336 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.77 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.639 -0.71 . . . . 10.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -62.22 -46.64 87.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 10.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.0 t -65.67 -43.76 93.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.451 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -65.96 -35.09 79.64 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.208 0.527 . . . . 10.0 111.085 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 68.9 m -77.3 -27.71 53.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.459 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -37.92 89.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.5 -17.83 56.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.575 ' HG2' HG22 ' A' ' 121' ' ' THR . 5.1 ttm180 -64.9 -23.84 67.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.305 0.574 . . . . 10.0 110.405 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.422 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.42 24.28 14.53 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.678 -0.772 . . . . 10.0 111.647 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.575 HG22 ' HG2' ' A' ' 119' ' ' ARG . 8.4 t -175.0 115.02 0.15 Allowed 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.829 0.823 . . . . 10.0 109.549 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.58 30.56 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.898 -1.046 . . . . 10.0 109.585 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.7 m 62.32 97.6 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.08 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.97 90.95 0.94 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.85 2.367 . . . . 10.0 114.515 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.611 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -80.87 124.75 29.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.189 -2.152 . . . . 10.0 105.189 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.3 mm-40 -51.63 -42.69 62.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -176.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -63.99 -39.13 93.42 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.678 0.611 . . . . 10.0 110.84 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.768 ' O ' ' HG3' ' A' ' 132' ' ' MET . 96.9 mt -64.3 -57.08 12.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 120.751 -0.379 . . . . 10.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.3 mt -50.47 -45.65 56.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.505 0.503 . . . . 10.0 110.592 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.2 m -55.32 -46.44 76.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.449 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 135' ' ' VAL . 19.1 mtmt -73.55 -40.35 64.03 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.768 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 29.6 mtp -52.06 -55.22 22.02 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.857 0.837 . . . . 10.0 111.011 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.669 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 27.1 mt-10 -72.98 -31.81 64.78 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.463 -1.244 . . . . 10.0 113.361 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -69.88 -23.43 63.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 131' ' ' LYS . 57.4 t -61.51 -38.17 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 10.0 111.805 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.909 HD22 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -114.53 -5.91 12.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.92 46.41 0.48 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.226 1.013 . . . . 10.0 109.412 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.669 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 47.7 t -122.68 138.91 51.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.648 -1.614 . . . . 10.0 106.943 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 13.4 mmmm -122.79 140.29 53.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 118.842 0.747 . . . . 10.0 111.792 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.726 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -111.57 18.26 19.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -113.98 140.53 48.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.494 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.39 -156.61 25.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.749 -0.738 . . . . 10.0 111.92 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.04 0.74 41.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.089 0.471 . . . . 10.0 110.96 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -110.36 51.1 0.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.799 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.726 HG23 ' HA ' ' A' ' 140' ' ' LEU . 49.0 mt -72.54 136.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.519 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.54 4.4 62.28 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.996 -0.841 . . . . 10.0 110.996 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.28 156.87 73.47 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.278 -0.461 . . . . 10.0 110.245 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -64.55 122.31 10.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.897 1.731 . . . . 10.0 109.387 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.635 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 15.7 tpt180 -155.05 102.59 2.33 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.094 0.473 . . . . 10.0 110.052 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.87 133.7 30.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.08 0.467 . . . . 10.0 111.208 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -120.21 -169.36 14.0 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.403 -1.079 . . . . 10.0 110.403 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.46 102.6 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.46 2.106 . . . . 10.0 112.068 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -148.2 96.09 2.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.672 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -147.67 166.36 27.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.202 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.0 tttm . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.135 -0.936 . . . . 10.0 109.073 179.593 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 112.386 -0.285 . . . . 10.0 112.386 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.58 157.27 41.71 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.8 tpt -149.29 120.65 7.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.875 0.369 . . . . 10.0 110.909 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.84 143.5 48.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 166.65 28.42 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.638 2.225 . . . . 10.0 113.245 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.63 162.64 16.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.847 -0.615 . . . . 10.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -145.18 157.78 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.2 144.66 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.21 175.51 42.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.247 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.62 148.85 18.68 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.751 -0.738 . . . . 10.0 112.453 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.6 m -91.64 127.88 37.26 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.039 -0.356 . . . . 10.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.73 167.17 15.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.997 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.04 166.77 28.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.714 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -123.06 165.17 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.813 0.306 . . . . 10.0 111.026 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.74 158.61 6.12 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.331 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.64 165.25 26.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.737 0.303 . . . . 10.0 110.523 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.3 m -112.95 138.14 50.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.449 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -131.33 115.54 16.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.438 -0.346 . . . . 10.0 110.458 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.98 126.72 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.893 0.377 . . . . 10.0 111.228 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -159.34 163.79 35.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.062 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -149.7 118.96 6.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.673 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.3 m -154.28 125.32 7.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.401 . . . . 10.0 110.277 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.06 119.43 10.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.069 0.461 . . . . 10.0 110.573 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.05 26.6 9.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.698 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 73' ' ' ILE . 18.7 mm 65.15 34.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.425 -0.807 . . . . 10.0 110.156 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 pt -133.77 136.07 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.357 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -132.88 76.02 71.44 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.034 -0.53 . . . . 10.0 109.644 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.73 85.56 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.016 2.477 . . . . 10.0 111.653 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 1.8 mptp? 52.74 41.66 31.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.217 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 p -131.17 161.33 32.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.196 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.5 m -82.88 -29.94 8.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.831 0.308 . . . . 10.0 111.831 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.31 140.7 8.04 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.111 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.46 -49.84 67.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.882 0.341 . . . . 10.0 111.682 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -59.35 -38.45 80.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.375 0.607 . . . . 10.0 109.742 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.03 -42.93 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.1 -0.955 . . . . 10.0 110.134 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -64.29 -43.61 96.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.14 -0.552 . . . . 10.0 112.538 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -61.34 -43.06 99.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.188 0.518 . . . . 10.0 109.902 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -69.83 -29.69 67.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.33 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.799 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.2 mt -58.1 -48.54 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.981 -0.378 . . . . 10.0 109.981 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.69 -48.57 63.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.248 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.26 -33.39 73.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.67 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.73 -30.15 68.72 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.793 -0.639 . . . . 10.0 113.264 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.799 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 13.0 mmt85 -77.37 -29.41 53.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -79.1 -8.06 58.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 10.0 109.717 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -75.14 -8.5 56.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.929 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -168.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 40.8 mt-10 -133.21 110.35 12.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.469 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.7 Cg_endo -78.13 -30.64 5.69 Favored 'Cis proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.225 -1.573 . . . . 10.0 112.522 -0.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.6 m -170.45 134.37 1.13 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.802 -1.544 . . . . 10.0 109.65 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 122.13 22.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.5 p -69.89 158.15 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 10.0 111.102 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -67.41 -36.08 80.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.845 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.58 78.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.358 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.47 -47.17 86.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.362 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -64.94 -40.71 95.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.574 -0.528 . . . . 10.0 109.574 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -48.38 81.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.214 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -64.02 -38.04 89.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.966 0.412 . . . . 10.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -39.39 92.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.635 -0.711 . . . . 10.0 111.296 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 103' ' ' LEU . 32.6 pt -89.07 -28.63 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.85 6.1 21.35 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.59 -0.814 . . . . 10.0 112.818 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -106.33 -164.39 1.0 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 171.07 7.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.103 -0.239 . . . . 10.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.85 -38.05 80.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 10.0 110.402 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.42 75.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.526 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 9.7 m -66.98 -40.28 87.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.283 0.563 . . . . 10.0 110.271 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.75 -37.23 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.82 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -72.44 -33.03 66.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.38 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 52.3 p -76.58 -29.1 56.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.924 0.392 . . . . 10.0 111.6 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.3 m-85 -63.18 -36.7 84.49 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -63.61 -18.57 64.05 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' A' ' 121' ' ' THR . 61.5 ttt180 -68.13 -18.76 64.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.229 0.538 . . . . 10.0 110.657 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.417 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 91.3 28.84 13.6 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.247 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.527 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.2 t -175.96 111.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.917 0.865 . . . . 10.0 109.793 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.94 34.34 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.946 -1.025 . . . . 10.0 110.057 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m 63.28 99.23 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.454 -0.793 . . . . 10.0 109.137 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' HD21 ' A' ' 129' ' ' LEU . 92.2 Cg_endo -77.16 88.55 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.996 2.464 . . . . 10.0 115.727 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.592 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 5.9 t70 -81.68 116.07 21.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 17.6 mm-40 -48.65 -41.11 30.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.6 t30 -68.78 -42.24 77.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.783 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.583 ' O ' ' HG3' ' A' ' 132' ' ' MET . 66.7 mt -60.46 -55.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 121.186 -0.206 . . . . 10.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 7.5 mt -47.65 -47.23 29.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.659 0.599 . . . . 10.0 110.325 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.0 m -57.95 -38.65 76.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.211 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 74.6 mmtt -73.66 -36.78 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 10.0 111.464 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.583 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 18.9 mtp -54.22 -57.15 12.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.481 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.604 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -73.36 -26.69 61.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.871 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.58 -38.54 60.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.43 -26.7 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.881 -0.327 . . . . 10.0 111.234 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -92.33 -21.18 20.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.252 0.464 . . . . 10.0 112.252 -178.198 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 57.5 m-20 70.45 48.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.601 0.715 . . . . 10.0 110.184 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.06 169.41 21.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.852 -1.067 . . . . 10.0 108.557 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -137.64 133.21 34.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.938 0.399 . . . . 10.0 110.45 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.695 ' HA ' HG23 ' A' ' 145' ' ' ILE . 8.2 mt -100.86 12.0 38.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.583 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -125.4 139.86 53.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.94 -153.72 17.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.342 -0.703 . . . . 10.0 111.342 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.99 -33.57 10.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.968 0.413 . . . . 10.0 111.16 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -87.43 55.65 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.263 0.554 . . . . 10.0 110.576 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.695 HG23 ' HA ' ' A' ' 140' ' ' LEU . 71.0 mt -69.0 141.17 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.658 . . . . 10.0 111.323 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.94 -5.54 84.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.152 -0.546 . . . . 10.0 111.831 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.64 158.21 62.92 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.304 -0.448 . . . . 10.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.01 122.47 10.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.167 1.912 . . . . 10.0 110.849 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -151.33 81.23 1.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.546 0.689 . . . . 10.0 110.046 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.638 ' HB3' ' CB ' ' A' ' 154' ' ' LYS . 4.1 mm? -106.65 -26.71 11.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.356 -0.838 . . . . 10.0 110.329 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.34 -171.31 46.65 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.762 -0.653 . . . . 10.0 112.301 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.71 141.47 41.44 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.595 2.197 . . . . 10.0 111.802 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt 57.18 53.56 7.68 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.34 0.59 . . . . 10.0 110.319 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.638 ' CB ' ' HB3' ' A' ' 150' ' ' LEU . 55.3 pttt -63.7 139.62 58.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.482 -0.781 . . . . 10.0 111.467 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 42.8 tttm . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.192 -0.908 . . . . 10.0 109.888 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.81 -0.516 . . . . 10.0 111.81 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.83 134.11 21.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.928 0.394 . . . . 10.0 110.97 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.5 mtm -129.59 132.79 46.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.604 . . . . 10.0 109.835 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.18 121.85 6.7 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.612 -0.267 . . . . 10.0 110.366 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.85 122.03 10.39 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.661 2.24 . . . . 10.0 112.425 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.35 137.87 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.596 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -138.44 140.21 39.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.806 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -104.28 -44.64 4.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.032 0.444 . . . . 10.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.61 -119.8 5.06 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.416 -0.674 . . . . 10.0 111.416 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 141.36 117.37 1.34 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.9 m -103.62 142.15 34.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.749 0.309 . . . . 10.0 110.648 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.12 -150.51 0.43 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.267 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.09 -168.05 40.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.013 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -154.17 176.94 11.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 10.0 110.998 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -131.36 -173.31 3.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.108 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 pp -144.67 162.08 37.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.344 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.8 m -150.5 124.89 9.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.961 0.41 . . . . 10.0 110.925 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 144.48 30.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.915 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.61 153.34 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.703 0.287 . . . . 10.0 110.531 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.97 177.02 11.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.03 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 69' ' ' ARG . 10.6 ptt-85 -141.07 21.43 2.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.489 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 m -133.66 47.55 2.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.564 0.697 . . . . 10.0 109.393 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -97.9 97.14 8.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.306 -0.861 . . . . 10.0 111.132 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.51 -27.49 15.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.491 -0.777 . . . . 10.0 110.645 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.0 tt -84.15 138.99 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.898 -0.592 . . . . 10.0 111.004 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.657 HD13 ' H ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -70.41 154.35 8.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.535 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HB2' HG23 ' A' ' 123' ' ' THR . 39.9 mttm -104.35 147.56 34.57 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.54 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.63 170.33 20.54 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.565 2.177 . . . . 10.0 111.683 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt 66.47 96.72 0.05 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.764 0.665 . . . . 10.0 110.661 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.449 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 23.6 p -83.72 -173.57 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.629 -0.714 . . . . 10.0 110.764 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.676 HG12 HG21 ' A' ' 83' ' ' VAL . 3.0 t -82.26 -68.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.628 -0.26 . . . . 10.0 111.299 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.438 ' C ' HG22 ' A' ' 83' ' ' VAL . . . 146.64 161.6 9.4 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 111.574 -0.611 . . . . 10.0 111.574 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.5 ' HG2' ' H ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -78.87 -55.02 5.47 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 -178.363 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.1 tp10 -71.97 -28.61 63.54 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.511 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.676 HG21 HG12 ' A' ' 79' ' ' VAL . 6.6 m -64.27 -36.4 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.252 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.16 -47.22 90.08 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.496 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.33 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 10.0 110.816 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.78 68.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.414 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.757 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.3 mt -61.23 -49.76 83.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.95 -53.06 60.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.622 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.4 mt-30 -59.22 -39.8 83.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.043 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.47 -35.34 91.59 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.855 -0.688 . . . . 10.0 113.544 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.4 -39.63 28.01 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.042 0.449 . . . . 10.0 110.509 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -69.91 -25.1 63.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.733 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 39.2 tttm -80.0 54.42 1.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.712 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -126.1 3.38 7.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 38.7 mt-10 54.99 101.24 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.915 0.759 . . . . 10.0 112.817 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.5 Cg_endo -82.79 -30.56 4.63 Favored 'Cis proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.176 -1.593 . . . . 10.0 112.61 -0.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -174.81 129.78 0.32 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.837 -1.529 . . . . 10.0 110.007 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.6 tpp -76.69 143.1 40.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.929 -0.397 . . . . 10.0 109.929 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 145.39 50.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.631 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.69 -41.89 74.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.062 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.68 83.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.953 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -70.93 -32.01 68.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.492 -0.322 . . . . 10.0 110.339 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 103' ' ' LEU . 1.1 tm? -63.81 -43.38 96.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.02 -37.4 91.99 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.157 -0.929 . . . . 10.0 111.357 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -65.47 -35.4 80.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 10.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.71 -40.49 84.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.844 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 29.6 pt -87.81 -22.54 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 34.38 5.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.478 -0.868 . . . . 10.0 112.382 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -129.64 -171.79 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.859 0.362 . . . . 10.0 110.444 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 166.96 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.567 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.4 91.01 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.523 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.71 -32.86 70.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.55 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -60.43 -47.09 87.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.096 -0.502 . . . . 10.0 109.998 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.48 -46.47 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.8 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.59 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.32 -35.86 80.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.322 0.582 . . . . 10.0 111.069 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.3 m -75.26 -27.96 59.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.635 ' OH ' ' HA ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -63.74 -38.91 92.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.801 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -65.09 -18.42 65.29 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.053 0.39 . . . . 10.0 112.053 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.621 ' HG2' HG22 ' A' ' 121' ' ' THR . 19.4 ttt180 -78.39 -18.67 54.71 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.62 14.54 46.7 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.431 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.621 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -160.04 106.1 1.58 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.173 0.987 . . . . 10.0 109.802 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.89 24.6 0.5 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.714 -1.13 . . . . 10.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' ' 75' ' ' LYS . 3.8 m 59.67 80.63 0.27 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.288 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.635 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 72.9 Cg_endo -75.21 158.8 41.18 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.785 2.323 . . . . 10.0 114.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.6 t70 -137.48 140.17 41.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.257 -1.338 . . . . 10.0 107.86 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.4 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 5.6 mm100 -54.73 -40.2 69.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.586 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.97 -35.45 72.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.548 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.738 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.1 mt -66.78 -57.33 10.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 120.581 -0.448 . . . . 10.0 110.234 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.3 mt -50.13 -39.64 43.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.744 0.783 . . . . 10.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 72.1 m -62.56 -50.32 71.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 10.0 111.488 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.586 ' HD3' ' O ' ' A' ' 127' ' ' ASN . 1.5 mptp? -74.91 -31.33 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 10.0 112.449 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.738 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 52.9 mtp -60.32 -59.38 5.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.577 0.703 . . . . 10.0 111.403 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.695 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 2.9 mp0 -74.56 -25.49 59.33 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 19.6 ptt180 -56.87 -26.9 59.63 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.358 0.526 . . . . 10.0 111.395 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.09 -25.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.148 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.637 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -100.29 -19.23 16.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.795 0.294 . . . . 10.0 111.795 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 68.34 43.16 1.52 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.606 0.717 . . . . 10.0 111.312 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.695 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.8 m -136.68 140.1 43.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.342 -1.355 . . . . 10.0 107.342 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 3.4 mmpt? -116.65 135.49 53.75 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.806 -0.758 . . . . 10.0 111.058 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.416 HD13 ' HB ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -102.29 36.05 2.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.125 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -138.21 139.21 39.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.235 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.14 -163.07 21.99 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.309 -0.716 . . . . 10.0 111.309 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.92 23.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.968 0.413 . . . . 10.0 110.399 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -85.93 55.27 3.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.752 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.57 138.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.91 2.5 90.67 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.464 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.32 160.68 56.46 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.815 -0.192 . . . . 10.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -62.52 120.37 7.87 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.451 1.434 . . . . 10.0 109.506 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? -149.5 89.77 1.66 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.771 0.32 . . . . 10.0 110.178 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.63 82.38 6.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.799 0.809 . . . . 10.0 110.841 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -136.46 76.52 0.37 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.729 -1.123 . . . . 10.0 110.663 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.24 -178.77 2.29 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.514 2.142 . . . . 10.0 112.861 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -89.3 -172.76 3.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.977 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.87 161.01 31.24 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.579 -0.724 . . . . 10.0 110.473 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.872 0 N-CA-C 111.828 -0.509 . . . . 10.0 111.828 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.59 115.75 19.39 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.834 0.35 . . . . 10.0 110.714 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.1 mtm -127.72 146.13 50.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.239 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 t70 62.0 99.19 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 123.818 0.699 . . . . 10.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -88.9 164.61 5.98 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.995 2.463 . . . . 10.0 111.797 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.01 139.89 50.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.224 -0.287 . . . . 10.0 110.224 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -121.41 169.91 10.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.364 . . . . 10.0 110.868 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.81 172.5 17.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.901 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.94 121.0 2.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.518 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.5 124.24 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.025 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 t -144.54 139.08 27.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.006 0.432 . . . . 10.0 110.429 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -106.83 -65.79 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.66 175.27 29.63 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.771 -0.65 . . . . 10.0 111.82 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -155.3 138.89 15.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.774 -0.454 . . . . 10.0 109.774 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 63' ' ' ARG . 14.9 tpt180 -125.65 136.53 53.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.58 148.65 24.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.477 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -96.76 148.87 22.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.733 -0.667 . . . . 10.0 109.775 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.422 ' HG3' ' HB ' ' A' ' 123' ' ' THR . 24.8 tttp -83.5 114.88 21.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.616 0.245 . . . . 10.0 110.712 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 p -167.39 141.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.423 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -132.61 158.45 42.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.195 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -131.02 157.43 43.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.53 -0.305 . . . . 10.0 110.302 179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.5 m -91.93 85.26 5.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.581 -0.526 . . . . 10.0 109.581 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -123.42 -173.72 2.8 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.759 -0.655 . . . . 10.0 109.647 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -116.34 -22.08 8.98 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.714 -0.676 . . . . 10.0 111.005 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.4 tt -66.73 126.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.152 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 pt -76.26 126.88 37.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.081 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -133.57 153.69 80.4 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.423 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.93 36.64 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.919 2.413 . . . . 10.0 112.31 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -107.5 13.63 26.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.372 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.5 p -133.02 163.45 29.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.537 -0.756 . . . . 10.0 109.796 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 121' ' ' THR . 4.9 m -79.87 -35.14 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.822 -0.351 . . . . 10.0 111.063 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.95 147.9 6.85 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.97 -53.05 35.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.068 0.434 . . . . 10.0 111.626 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -69.15 -33.45 73.43 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.759 HG13 HD22 ' A' ' 140' ' ' LEU . 38.3 t -58.72 -41.28 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.69 -1.141 . . . . 10.0 109.951 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.8 -41.47 97.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.131 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -64.56 -45.11 88.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.946 0.403 . . . . 10.0 109.958 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.05 77.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.733 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.678 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.6 mt -58.73 -46.01 90.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.733 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.12 -49.15 59.65 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.042 0.448 . . . . 10.0 110.401 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -61.4 -36.55 80.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.7 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.56 98.01 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.039 -0.528 . . . . 10.0 114.013 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 17.7 mmt-85 -69.84 -36.58 75.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.383 0.591 . . . . 10.0 110.254 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 97' ' ' THR . 70.3 mt-30 -82.42 -5.89 58.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.781 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -89.03 14.58 10.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.846 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.87 -17.7 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.876 0.325 . . . . 10.0 111.876 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 60.55 106.95 0.03 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.937 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.98 -59.03 0.14 OUTLIER 'Cis proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.534 -1.444 . . . . 10.0 112.347 0.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 92' ' ' GLN . 72.0 m -157.51 124.07 4.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.878 -1.055 . . . . 10.0 110.732 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.6 tpp -72.49 141.66 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 142.75 55.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.995 0.426 . . . . 10.0 111.037 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -70.5 -37.37 74.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.473 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.23 76.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.195 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.06 -41.93 40.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.817 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.453 ' HG ' ' HD2' ' A' ' 91' ' ' ARG . 1.2 tm? -64.11 -38.33 90.67 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.1 -46.24 59.19 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.391 -0.822 . . . . 10.0 111.555 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -58.09 -39.06 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 10.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.08 -39.29 89.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.301 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.453 HD12 HG23 ' A' ' 128' ' ' ILE . 17.6 pt -92.91 4.01 7.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.15 71.88 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.959 -0.638 . . . . 10.0 113.926 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.414 ' OE1' HG21 ' A' ' 113' ' ' THR . 32.0 mm-40 -109.46 -162.8 0.82 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.0 p -125.24 174.7 7.92 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.252 -0.28 . . . . 10.0 111.048 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.84 87.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.321 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.31 77.62 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.347 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.414 HG21 ' OE1' ' A' ' 109' ' ' GLU . 2.6 m -62.4 -50.32 72.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.43 -42.68 91.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 10.0 110.232 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.44 -37.04 82.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.925 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 m -74.84 -27.44 60.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.17 -0.468 . . . . 10.0 111.967 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.33 -32.75 70.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.153 0.427 . . . . 10.0 112.153 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -18.14 41.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 121' ' ' THR . 1.6 ttt85 -61.89 -24.01 66.67 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.02 0.438 . . . . 10.0 111.093 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.13 23.8 11.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.348 -0.93 . . . . 10.0 113.933 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -154.73 -88.46 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.824 0.312 . . . . 10.0 110.651 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.684 ' H ' HG23 ' A' ' 121' ' ' THR . . . 58.78 11.79 1.98 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.527 0.936 . . . . 10.0 113.527 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.422 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 2.8 m 45.64 76.59 0.53 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 -177.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.608 ' HB2' HD21 ' A' ' 129' ' ' LEU . 42.6 Cg_endo -89.01 147.46 5.58 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.308 2.672 . . . . 10.0 116.962 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.31 129.33 42.48 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 103.994 -2.595 . . . . 10.0 103.994 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -55.84 -29.55 60.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 107' ' ' ILE . 68.8 mt -68.41 -48.4 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 110.431 -0.211 . . . . 10.0 110.431 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' A' ' 124' ' ' PRO . 5.4 mt -57.76 -36.47 72.15 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.404 0.621 . . . . 10.0 109.883 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -66.04 -49.52 67.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.142 -0.935 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -74.48 -38.62 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.751 1.019 . . . . 10.0 113.751 -178.434 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.418 ' HG3' ' HG2' ' A' ' 133' ' ' GLU . 7.1 ptm -61.2 -50.25 73.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.009 0.368 . . . . 10.0 111.543 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.627 ' CD ' HH22 ' A' ' 91' ' ' ARG . 15.5 mm-40 -76.91 -29.03 55.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.253 0.834 . . . . 10.0 113.253 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -62.61 -23.38 67.02 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.133 -0.354 . . . . 10.0 111.478 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 131' ' ' LYS . 59.1 t -63.1 -34.18 65.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.189 0.519 . . . . 10.0 110.311 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.516 HD11 ' OE1' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.12 3.65 28.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.881 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.6 t30 70.18 51.79 0.39 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.579 0.704 . . . . 10.0 110.27 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.484 ' CG2' HD12 ' A' ' 136' ' ' LEU . 22.2 t -132.59 152.32 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.129 -0.941 . . . . 10.0 109.606 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 26.0 mmmt -131.04 145.15 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 10.0 110.512 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.759 HD22 HG13 ' A' ' 83' ' ' VAL . 27.6 mt -106.86 20.16 19.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.118 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -134.21 139.28 45.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.841 0.353 . . . . 10.0 110.948 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.33 -157.37 15.15 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.543 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.41 -30.59 14.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.075 0.464 . . . . 10.0 110.007 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.83 59.04 5.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.645 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.5 mm -66.9 137.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 10.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.45 10.32 85.46 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.23 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -133.81 157.14 78.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.372 -0.414 . . . . 10.0 110.381 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.12 123.82 13.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.557 2.171 . . . . 10.0 111.235 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 5.2 tmm_? -142.42 125.21 16.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.5 mt -73.85 113.69 11.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.235 0.541 . . . . 10.0 110.327 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.518 ' HA3' ' NH1' ' A' ' 149' ' ' ARG . . . 178.0 73.8 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.43 -0.804 . . . . 10.0 111.361 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.96 125.86 13.1 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.713 2.275 . . . . 10.0 112.63 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -129.35 152.55 48.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -138.94 -52.28 0.56 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.064 -0.516 . . . . 10.0 109.928 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.529 -0.748 . . . . 10.0 110.487 179.892 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 112.01 -0.436 . . . . 10.0 112.01 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.27 170.71 15.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.468 -0.197 . . . . 10.0 110.468 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.2 ttm -133.59 125.25 28.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.861 0.363 . . . . 10.0 110.916 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.08 146.04 31.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.945 -0.57 . . . . 10.0 109.903 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.9 168.46 24.15 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.402 . . . . 10.0 112.699 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -107.6 160.01 16.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.799 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.89 136.89 25.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.725 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.72 168.32 26.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 10.0 111.122 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.58 170.04 29.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.9 -178.69 25.08 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.398 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -147.72 138.42 23.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.118 -0.327 . . . . 10.0 110.118 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -94.55 -64.66 1.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.988 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.65 -166.89 13.76 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.896 -0.669 . . . . 10.0 111.475 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.54 145.76 9.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.074 0.437 . . . . 10.0 110.802 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -153.5 141.32 20.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.294 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -148.87 110.52 4.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.141 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.38 150.75 43.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.189 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.54 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 51.1 mttp -117.57 178.8 4.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.379 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.73 150.19 26.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.791 0.329 . . . . 10.0 111.241 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -100.87 151.11 22.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.83 -0.433 . . . . 10.0 109.83 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -147.76 138.14 23.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.378 -0.374 . . . . 10.0 110.679 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -55.81 4.15 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.238 -0.652 . . . . 10.0 109.238 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 50.17 56.95 7.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.088 -0.96 . . . . 10.0 112.04 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.45 12.52 33.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.688 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.6 pt -72.84 179.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.112 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.2 mt -80.25 108.58 13.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -76.1 113.17 25.35 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 10.0 110.542 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.71 -147.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.999 2.466 . . . . 10.0 112.064 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -89.21 33.55 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.148 0.499 . . . . 10.0 111.082 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.1 p -120.05 161.06 21.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.5 m -88.35 -25.37 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.567 -0.453 . . . . 10.0 111.541 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.32 138.57 5.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.906 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -67.65 -39.56 84.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 10.0 111.861 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.99 -31.49 50.7 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 140' ' ' LEU . 42.7 t -66.02 -40.22 86.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.184 -0.916 . . . . 10.0 110.056 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.39 -41.74 95.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.891 -0.671 . . . . 10.0 112.12 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -39.5 74.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.163 0.506 . . . . 10.0 110.051 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.32 70.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.817 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 83' ' ' VAL . 7.9 mt -59.47 -45.53 93.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.081 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.93 -53.87 13.44 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.754 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 35.0 mt-30 -54.05 -34.91 61.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.351 -0.84 . . . . 10.0 111.267 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.4 -34.87 39.04 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.754 -0.736 . . . . 10.0 112.766 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.651 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -80.13 -33.61 38.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.019 0.438 . . . . 10.0 110.357 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -73.33 -2.62 22.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.1 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 48.4 mttm -83.25 -2.68 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.015 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -78.0 177.06 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.584 -0.735 . . . . 10.0 110.589 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -120.69 121.27 29.13 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.319 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.98 -29.32 6.82 Favored 'Cis proline' 0 CA--C 1.515 -0.445 0 C-N-CA 123.723 -1.365 . . . . 10.0 112.693 -0.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 m -179.05 122.43 0.08 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 113.754 -1.566 . . . . 10.0 109.324 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.8 ttm -70.46 110.87 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.211 -0.292 . . . . 10.0 110.211 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.577 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.9 p -78.51 172.37 13.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.869 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -62.84 -35.7 80.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.769 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.73 -42.42 81.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.005 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.577 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 16.8 mm-40 -68.52 -48.82 63.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.917 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -61.06 -42.22 98.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.34 98.16 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.575 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -65.99 -36.03 82.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.792 0.33 . . . . 10.0 110.659 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.26 -40.99 77.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.792 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.52 HG22 ' HB3' ' A' ' 131' ' ' LYS . 35.9 pt -83.48 -17.71 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.884 -0.326 . . . . 10.0 111.689 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.91 27.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 10.0 112.77 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -119.89 -169.71 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.769 0.318 . . . . 10.0 110.225 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.7 p -98.98 168.2 10.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.535 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.05 78.6 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.863 0.364 . . . . 10.0 110.623 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.244 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.221 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.77 -43.2 90.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -64.02 -35.23 80.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.443 0.64 . . . . 10.0 110.463 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 48.9 m -76.13 -27.03 56.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.18 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -43.16 77.39 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.676 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.24 -18.69 59.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.975 0.417 . . . . 10.0 111.729 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 116' ' ' SER . 48.3 ttp180 -67.25 -21.63 65.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.312 0.577 . . . . 10.0 110.636 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 95.22 20.34 28.02 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.728 -0.749 . . . . 10.0 111.692 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.416 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.3 t -172.62 108.36 0.19 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.01 0.91 . . . . 10.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.28 30.29 0.2 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.544 -1.207 . . . . 10.0 109.547 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.8 m 60.63 96.4 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.126 -0.943 . . . . 10.0 110.032 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 123' ' ' THR . 47.2 Cg_endo -65.42 94.84 0.26 Allowed 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 123.173 2.582 . . . . 10.0 113.952 -177.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.715 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.0 t70 -85.97 120.0 26.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.616 -1.253 . . . . 10.0 107.616 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.2 mm-40 -52.98 -37.97 61.79 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.466 0.479 . . . . 10.0 111.89 -177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -68.49 -44.36 74.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.047 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.639 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.9 mt -64.13 -54.11 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.185 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 17.6 mt -50.61 -41.83 55.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.269 0.557 . . . . 10.0 110.189 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.3 m -59.61 -49.72 76.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.274 -0.875 . . . . 10.0 111.096 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.8 mptp? -67.48 -40.26 85.27 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.377 0.51 . . . . 10.0 112.377 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.639 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -49.01 -58.31 5.12 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.441 0.638 . . . . 10.0 111.765 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 24.9 mt-10 -75.38 -28.63 59.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.413 -0.812 . . . . 10.0 112.805 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -64.88 -22.97 67.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.926 0.713 . . . . 10.0 112.926 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 131' ' ' LYS . 21.2 t -67.9 -25.0 31.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.631 . . . . 10.0 110.006 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -122.17 -100.44 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.198 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.593 ' H ' HD12 ' A' ' 136' ' ' LEU . 63.5 t30 174.29 64.02 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.407 -0.815 . . . . 10.0 109.251 -177.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.3 OUTLIER -136.23 155.83 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.274 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.489 ' HA ' ' OE1' ' A' ' 133' ' ' GLU . 4.6 mmtm -130.82 132.36 45.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.044 0.45 . . . . 10.0 110.969 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.772 ' HA ' HG23 ' A' ' 145' ' ' ILE . 13.5 mt -104.64 17.97 23.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.196 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 141' ' ' ARG . 40.0 mtp-105 -127.96 144.42 51.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.751 -0.658 . . . . 10.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.16 -155.38 19.54 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.443 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.73 15.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.653 0.263 . . . . 10.0 111.523 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.45 52.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.035 0.445 . . . . 10.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.772 HG23 ' HA ' ' A' ' 140' ' ' LEU . 54.7 mt -68.69 139.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.737 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.95 12.01 77.86 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.176 -0.77 . . . . 10.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.54 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . . . -141.01 152.37 64.96 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.925 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.1 120.09 7.42 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.779 1.652 . . . . 10.0 108.737 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -176.73 89.49 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.126 0.489 . . . . 10.0 110.088 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.04 167.07 12.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.952 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.65 -162.37 18.05 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.836 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.64 156.36 61.2 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.892 2.395 . . . . 10.0 112.613 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -123.59 108.74 12.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.616 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -89.89 161.01 16.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.366 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.526 -0.75 . . . . 10.0 110.477 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.666 -0.574 . . . . 10.0 111.666 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.0 87.95 3.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.856 0.36 . . . . 10.0 110.293 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.6 mmt -61.42 -46.21 91.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.328 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.57 84.12 23.63 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.96 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.27 133.66 23.28 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.273 1.982 . . . . 10.0 111.331 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.23 120.98 25.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.729 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -87.61 159.63 18.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.269 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.28 155.18 17.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.614 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.06 -135.65 8.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.919 -0.657 . . . . 10.0 111.809 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.68 171.05 34.21 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.665 -0.778 . . . . 10.0 112.424 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -137.37 136.21 37.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.743 -0.466 . . . . 10.0 109.743 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -135.43 150.54 49.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.566 0.222 . . . . 10.0 110.62 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.96 173.2 22.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 10.0 111.962 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -113.44 -172.26 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.679 0.276 . . . . 10.0 110.811 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -119.97 -179.75 4.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.74 0.305 . . . . 10.0 110.832 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.5 mt -101.9 -173.99 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.329 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.44 135.94 57.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.817 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -81.38 134.91 35.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.237 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.89 136.05 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.716 -0.675 . . . . 10.0 109.921 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -149.12 138.18 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 10.0 110.986 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -145.84 157.54 43.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.577 -0.738 . . . . 10.0 109.93 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.8 m -69.44 118.74 12.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.896 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -160.35 131.82 5.86 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.558 -0.534 . . . . 10.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -94.57 8.97 40.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.31 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.3 tt -60.38 140.41 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.064 0.459 . . . . 10.0 111.085 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.6 pt -69.9 142.33 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.9 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -125.64 155.22 72.67 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.67 -0.695 . . . . 10.0 109.185 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.6 -163.64 0.06 OUTLIER 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.424 2.083 . . . . 10.0 111.6 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -66.48 89.88 0.15 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.44 0.638 . . . . 10.0 110.188 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 p -135.59 168.52 19.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.144 -0.934 . . . . 10.0 109.865 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 117' ' ' TYR . 1.4 m -84.93 -28.76 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 121.073 -0.251 . . . . 10.0 111.301 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.19 135.63 5.16 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.593 -0.813 . . . . 10.0 112.28 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 68' ' ' ASP . 28.9 mtpp -65.26 -48.1 74.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.615 0.245 . . . . 10.0 111.364 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.33 -34.91 79.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 140' ' ' LEU . 25.0 t -59.28 -46.99 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.546 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.16 95.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.044 -0.598 . . . . 10.0 112.19 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -64.52 -43.86 92.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 10.0 110.378 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.3 82.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.794 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.786 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.8 mt -56.34 -47.67 80.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -66.16 -49.22 68.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.62 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.16 -37.16 84.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.215 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.96 -34.29 89.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.927 -0.654 . . . . 10.0 112.916 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.809 ' HD2' HD22 ' A' ' 103' ' ' LEU . 5.8 mmt180 -76.27 -34.71 59.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.287 0.565 . . . . 10.0 109.689 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' HA ' HG23 ' A' ' 97' ' ' THR . 96.8 mt-30 -75.36 -14.38 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -98.55 21.69 10.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.438 -0.346 . . . . 10.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -7.08 59.7 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.817 0.302 . . . . 10.0 111.817 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 37.7 mt-10 54.41 101.17 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.662 0 O-C-N 123.984 0.803 . . . . 10.0 112.228 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 55.4 Cg_endo -74.4 -50.93 0.17 OUTLIER 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.218 -1.576 . . . . 10.0 113.18 0.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 92' ' ' GLN . 21.5 m -163.49 137.15 5.72 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.891 . . . . 10.0 110.169 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.99 132.21 37.29 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.88 -0.415 . . . . 10.0 109.88 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.2 p -75.55 163.46 27.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 10.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.21 -29.69 67.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.679 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.14 84.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.127 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.5 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 55.8 mm-40 -62.8 -49.33 75.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.475 -0.329 . . . . 10.0 111.004 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.809 HD22 ' HD2' ' A' ' 91' ' ' ARG . 24.5 tp -62.03 -47.08 86.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.04 -46.19 91.69 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.076 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -64.82 -42.16 95.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.754 0.279 . . . . 10.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 15.5 pt-20 -69.65 -23.99 63.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 103' ' ' LEU . 27.6 pt -97.3 -7.04 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.769 -0.582 . . . . 10.0 111.127 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.54 16.34 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.745 -0.74 . . . . 10.0 112.664 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 110' ' ' THR . 54.5 mm-40 -130.04 -156.64 0.77 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.74 -0.467 . . . . 10.0 109.74 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 109' ' ' GLU . 3.2 p -126.11 176.35 7.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.521 0.201 . . . . 10.0 110.818 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.43 95.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.785 0.326 . . . . 10.0 111.208 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 116' ' ' SER . . . -61.11 -30.45 70.37 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.922 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.7 m -68.54 -43.79 75.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.135 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.674 HG13 HD23 ' A' ' 103' ' ' LEU . 92.8 t -64.44 -46.17 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.372 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.13 73.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.442 0.639 . . . . 10.0 110.064 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -74.69 -31.89 62.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 10.0 110.667 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.413 ' CE1' HG11 ' A' ' 79' ' ' VAL . 1.9 m-85 -72.41 -41.18 66.53 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.616 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.53 -18.35 64.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.165 0.507 . . . . 10.0 110.439 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 116' ' ' SER . 19.7 tpt180 -73.97 -19.31 60.7 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.18 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.23 26.56 25.58 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.054 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 121' ' ' THR . 5.3 t -175.23 102.6 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.957 0.884 . . . . 10.0 110.507 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 116' ' ' SER . . . -152.5 33.24 0.51 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.376 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 m 63.42 98.96 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.226 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 96.54 0.59 Allowed 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 123.348 2.698 . . . . 10.0 115.169 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.92 112.39 24.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.562 -2.384 . . . . 10.0 104.562 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.5 mm-40 -46.56 -38.98 10.23 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.549 1.314 . . . . 10.0 114.549 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.26 -33.09 65.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 111.683 0.253 . . . . 10.0 111.683 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 132' ' ' MET . 68.6 mt -70.09 -58.91 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.706 -0.398 . . . . 10.0 111.484 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -35.35 71.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.798 0.332 . . . . 10.0 111.558 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 22.7 m -63.31 -44.09 95.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 135' ' ' VAL . 25.2 mtmt -75.14 -34.58 61.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.011 0.375 . . . . 10.0 112.011 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.813 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 44.2 mtp -51.0 -61.34 2.29 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.325 0.584 . . . . 10.0 112.251 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.67 ' HB3' HG23 ' A' ' 138' ' ' VAL . 9.2 mm-40 -74.33 -26.57 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.684 . . . . 10.0 112.074 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 130' ' ' SER . 9.0 ttp85 -55.99 -37.48 69.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.061 0.458 . . . . 10.0 110.719 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 131' ' ' LYS . 29.8 t -63.92 -31.76 54.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.545 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.622 HD21 ' NH1' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -95.51 -2.11 49.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.306 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.5 t30 65.74 45.3 2.65 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.273 0.559 . . . . 10.0 110.136 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' A' ' 133' ' ' GLU . 15.4 m -134.85 155.75 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.651 ' HD2' ' O ' ' A' ' 149' ' ' ARG . 32.0 mttp -133.18 136.62 45.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.255 0.55 . . . . 10.0 110.715 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.642 HD13 HG13 ' A' ' 83' ' ' VAL . 3.1 mt -89.38 39.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.291 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -131.32 136.96 48.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.811 -0.356 . . . . 10.0 110.176 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.14 -161.18 24.28 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.867 -0.682 . . . . 10.0 112.24 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.71 -24.73 17.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 10.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -81.37 50.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.336 0.589 . . . . 10.0 110.286 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.7 mm -70.1 139.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.551 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.49 6.15 74.2 Favored Glycine 0 CA--C 1.509 -0.33 0 C-N-CA 120.761 -0.733 . . . . 10.0 111.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.31 156.76 78.69 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.274 -0.269 . . . . 10.0 110.274 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.75 124.83 16.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.186 1.924 . . . . 10.0 110.171 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.651 ' O ' ' HD2' ' A' ' 139' ' ' LYS . 4.7 ttt180 -145.95 106.61 4.1 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.07 125.5 24.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.737 0.303 . . . . 10.0 110.642 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -165.5 -172.22 32.65 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.744 -0.543 . . . . 10.0 111.744 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.63 121.72 7.29 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.947 2.432 . . . . 10.0 112.566 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -109.1 168.02 9.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 126' ' ' GLN . 52.4 tptt -118.76 117.38 28.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.04 0.448 . . . . 10.0 110.458 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 47.9 tttm . . . . . 0 C--O 1.249 1.032 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.911 -179.538 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 110.155 -0.313 . . . . 10.0 110.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -129.05 87.59 53.95 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.326 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.44 165.77 31.42 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.697 2.265 . . . . 10.0 111.844 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -88.88 -179.84 6.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.073 0.464 . . . . 10.0 110.927 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -125.09 147.23 49.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.32 165.66 27.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 10.0 111.16 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.63 148.65 20.06 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.514 -0.635 . . . . 10.0 111.514 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.82 162.16 30.67 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.541 -0.838 . . . . 10.0 112.002 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -144.31 94.23 2.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 10.0 110.347 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -112.81 148.54 34.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.633 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.85 -137.26 2.24 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.699 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 61.51 85.62 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.279 0.561 . . . . 10.0 111.268 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.245 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.7 0.286 . . . . 10.0 111.073 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.481 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -59.35 -42.16 86.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.693 0.257 . . . . 10.0 111.693 -178.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 120.74 148.84 8.1 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.441 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -67.4 -55.05 15.3 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.599 0.199 . . . . 10.0 111.52 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.17 -36.22 81.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.314 -0.625 . . . . 10.0 109.314 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 87' ' ' ILE . 43.2 t -58.57 -50.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.189 -0.914 . . . . 10.0 110.553 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.02 -42.37 99.73 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.712 -0.756 . . . . 10.0 112.235 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.88 -43.36 93.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 10.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.7 68.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.861 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.0 mt -60.32 -46.32 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.394 . . . . 10.0 110.26 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.93 -52.12 18.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.235 0.54 . . . . 10.0 110.196 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 11.9 mt-30 -60.69 -34.09 73.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.131 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.5 -28.19 57.99 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.582 -0.818 . . . . 10.0 112.459 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.646 HH12 ' HG3' ' A' ' 133' ' ' GLU . 2.5 mpt_? -80.36 -27.28 38.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.481 0.657 . . . . 10.0 109.807 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.435 ' HA ' HG23 ' A' ' 97' ' ' THR . 99.1 mt-30 -76.53 -9.32 58.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.239 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 10.0 mmtp -85.73 9.06 17.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.413 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.44 -162.58 0.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.556 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 77.9 mm-40 -122.48 104.64 36.93 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.946 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.2 Cg_endo -87.99 -26.71 5.55 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.941 -1.275 . . . . 10.0 112.523 -0.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 92' ' ' GLN . 11.4 m -165.22 122.37 1.51 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.706 -1.588 . . . . 10.0 109.762 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.9 tpp -82.76 112.86 19.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.794 -0.447 . . . . 10.0 109.794 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 t -80.82 177.16 9.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.683 0.754 . . . . 10.0 111.971 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.419 ' HA ' HG11 ' A' ' 114' ' ' VAL . 89.4 mt-30 -64.72 -48.84 73.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.241 -1.345 . . . . 10.0 111.352 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.61 96.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.512 -0.313 . . . . 10.0 111.808 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.78 -50.01 66.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 10.0 111.838 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.585 ' O ' HG12 ' A' ' 107' ' ' ILE . 14.3 tp -62.43 -42.02 99.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.62 98.58 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.067 -0.813 . . . . 10.0 111.067 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.412 0.149 . . . . 10.0 111.297 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.4 ' OE1' HG21 ' A' ' 135' ' ' VAL . 12.0 pt-20 -67.58 -34.13 76.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 103' ' ' LEU . 36.7 pt -85.05 -8.32 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.536 -0.465 . . . . 10.0 111.807 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.18 31.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 10.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -123.71 -177.64 3.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.883 0.373 . . . . 10.0 110.662 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.4 170.51 9.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.889 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.8 97.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 10.0 110.783 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.68 72.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.782 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -61.07 -49.91 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.111 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 100' ' ' GLN . 58.9 t -65.46 -44.01 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.295 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.28 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.698 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 16.6 m -75.33 -29.42 59.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.829 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.02 -42.62 72.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.702 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.11 -17.79 64.76 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.765 0.316 . . . . 10.0 111.057 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.538 ' HG2' HG22 ' A' ' 121' ' ' THR . 13.2 ttp85 -69.75 -21.74 63.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.401 0.619 . . . . 10.0 109.855 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.481 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 97.41 20.53 22.35 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.922 -0.656 . . . . 10.0 111.537 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -175.14 110.17 0.12 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.939 0.876 . . . . 10.0 110.468 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.19 23.13 0.42 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.083 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m 61.19 91.72 0.07 OUTLIER Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HB3' HG12 ' A' ' 79' ' ' VAL . 74.5 Cg_endo -72.4 104.25 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.688 2.259 . . . . 10.0 115.623 -175.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 117.84 25.76 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.056 -2.572 . . . . 10.0 104.056 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 17.1 mm-40 -46.63 -38.67 10.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -64.75 -33.29 75.62 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.813 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.769 ' O ' ' HG3' ' A' ' 132' ' ' MET . 91.7 mt -69.88 -58.73 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.29 -0.256 . . . . 10.0 110.54 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -52.17 -36.99 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.318 0.58 . . . . 10.0 110.955 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.0 m -54.06 -49.94 67.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.252 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.5 mppt? -75.9 -38.5 57.74 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.146 0.424 . . . . 10.0 112.146 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.769 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 38.9 mtp -50.04 -58.27 5.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.315 0.579 . . . . 10.0 111.491 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mp0 -78.65 -29.92 46.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 115.165 1.543 . . . . 10.0 115.165 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -68.77 -34.52 75.71 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.43 0.53 . . . . 10.0 112.43 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 131' ' ' LYS . 87.1 t -60.89 -25.39 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.654 0.264 . . . . 10.0 111.117 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.605 HD21 ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -115.13 2.54 14.16 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.13 60.74 2.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.731 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 1.9 m -143.06 155.94 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 30.3 mmmt -129.98 144.57 51.4 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.871 -0.418 . . . . 10.0 109.871 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.556 ' CD1' HG13 ' A' ' 83' ' ' VAL . 10.3 mt -106.49 40.06 1.7 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.462 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -141.03 135.95 31.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.759 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.88 -149.34 16.68 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.016 -0.612 . . . . 10.0 112.384 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.58 -32.21 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 10.0 110.789 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -87.42 57.89 4.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.67 . . . . 10.0 109.986 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.2 mm -65.1 132.68 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.018 -0.992 . . . . 10.0 111.573 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.18 -1.82 84.86 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -116.31 160.32 36.34 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.555 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.17 115.05 3.09 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.268 1.312 . . . . 10.0 109.231 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? . . . . . 0 C--N 1.315 -0.909 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 110.007 -0.368 . . . . 10.0 110.007 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.57 146.64 62.31 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.679 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.16 163.99 33.92 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.734 2.289 . . . . 10.0 112.08 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 174.01 6.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.824 0.345 . . . . 10.0 111.112 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -153.53 111.55 3.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.856 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.67 155.77 47.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.943 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.91 138.38 10.11 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.082 -0.58 . . . . 10.0 112.164 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.95 126.53 2.8 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 10.0 112.153 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -157.18 131.78 8.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.927 0.394 . . . . 10.0 110.28 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -144.16 143.41 31.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.046 -0.524 . . . . 10.0 109.639 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.32 -159.3 9.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.724 -0.75 . . . . 10.0 111.726 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.39 169.1 17.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.615 0.245 . . . . 10.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 10.0 109.982 179.718 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 110.268 -0.271 . . . . 10.0 110.268 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.521 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.3 m -83.1 -33.18 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.4 145.84 8.7 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.321 -0.942 . . . . 10.0 112.302 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -71.59 -28.82 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.892 0.33 . . . . 10.0 111.892 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -38.88 72.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 140' ' ' LEU . 54.2 t -61.44 -44.7 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.461 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.04 98.03 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.944 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -62.95 -43.95 97.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.331 . . . . 10.0 110.753 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . . . -70.48 -37.95 74.31 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.649 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.777 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.7 mt -55.35 -48.48 76.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.655 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.08 -42.45 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.046 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.448 ' NE2' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -66.35 -30.7 71.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 10.0 109.926 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.676 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -71.06 -39.98 62.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.844 -0.693 . . . . 10.0 113.0 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.777 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 12.8 mmt85 -66.08 -38.32 87.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.141 0.496 . . . . 10.0 110.606 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -83.7 -0.93 52.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -80.1 -11.7 59.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.259 0.552 . . . . 10.0 110.367 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -171.97 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.803 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 29.5 mt-10 -131.55 110.87 14.94 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.658 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 72.7 Cg_endo -79.77 -32.84 3.79 Favored 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.325 -1.531 . . . . 10.0 112.543 -0.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.6 m -163.95 131.19 3.32 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.413 -1.267 . . . . 10.0 110.204 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.452 ' HG2' HD23 ' A' ' 103' ' ' LEU . 26.1 tpp -82.48 136.31 34.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.707 -0.224 . . . . 10.0 110.422 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.0 p -83.56 156.33 22.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.887 0.375 . . . . 10.0 110.941 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.7 -33.94 73.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.83 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.11 73.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.313 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.89 -33.77 76.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.701 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -70.13 -37.61 75.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.637 ' CA ' HG21 ' A' ' 114' ' ' VAL . . . -68.49 -46.84 60.67 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.498 -0.774 . . . . 10.0 112.605 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -58.67 -39.86 81.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.862 0.363 . . . . 10.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -64.03 -29.19 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 10.0 112.512 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.571 HG22 ' HB3' ' A' ' 131' ' ' LYS . 16.5 pt -106.76 3.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.0 32.96 69.65 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 121.296 -0.478 . . . . 10.0 113.402 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -120.18 163.09 18.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.849 0.357 . . . . 10.0 110.815 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -78.88 150.3 32.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.757 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.4 -44.15 68.46 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.36 93.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.741 -0.209 . . . . 10.0 110.579 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.9 m -59.18 -44.23 92.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.678 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.637 HG21 ' CA ' ' A' ' 104' ' ' GLY . 46.7 t -63.79 -43.21 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.121 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.62 -29.47 63.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 10.0 110.312 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 63.0 m -76.55 -25.8 54.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.749 . . . . 10.0 111.311 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.5 -37.76 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.998 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.443 ' HB3' HG22 ' A' ' 87' ' ' ILE . 6.8 pt-20 -66.61 -17.74 64.99 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.695 0.283 . . . . 10.0 111.693 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.6 ' HB3' ' O ' ' A' ' 116' ' ' SER . 37.3 ttm180 -67.8 -20.52 65.2 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.391 0.615 . . . . 10.0 110.462 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.521 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.88 23.66 22.38 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.339 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 121' ' ' THR . 7.3 t -170.25 107.61 0.34 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.282 1.039 . . . . 10.0 110.447 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.94 28.91 0.08 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.496 -1.229 . . . . 10.0 109.339 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m 64.63 103.04 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.416 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 84.1 Cg_endo -75.91 92.9 1.02 Allowed 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 123.058 2.505 . . . . 10.0 116.054 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.667 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.7 t70 -87.92 111.92 21.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 105.319 -2.104 . . . . 10.0 105.319 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -49.08 -38.22 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.132 0.895 . . . . 10.0 112.573 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.401 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 60.9 t30 -71.51 -45.31 62.76 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.113 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 125' ' ' ASP . 59.2 mt -60.53 -50.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.481 -0.192 . . . . 10.0 110.481 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 11.7 mt -52.75 -45.27 66.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.562 0.696 . . . . 10.0 109.66 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 74.4 m -62.63 -43.03 99.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.018 -0.992 . . . . 10.0 110.992 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HB3' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -71.36 -42.95 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -178.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.556 ' SD ' ' HA ' ' A' ' 129' ' ' LEU . 3.7 ptm -61.59 -49.76 75.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.778 0.323 . . . . 10.0 111.867 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.604 ' O ' HD22 ' A' ' 136' ' ' LEU . 27.9 mm-40 -73.77 -25.78 60.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.938 0.399 . . . . 10.0 111.464 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -56.35 -23.39 37.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 10.0 111.289 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 t -71.92 -33.67 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.996 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -113.97 7.71 16.94 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.517 -0.473 . . . . 10.0 112.241 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.443 ' ND2' ' HB3' ' A' ' 148' ' ' PRO . 56.4 t30 67.31 59.06 0.52 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.644 0.735 . . . . 10.0 111.068 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.426 ' CG2' HD23 ' A' ' 136' ' ' LEU . 3.0 t -129.53 144.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.849 -1.068 . . . . 10.0 109.292 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -119.16 132.09 55.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.244 0.545 . . . . 10.0 110.574 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 83' ' ' VAL . 19.4 mt -96.44 21.54 9.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 10.0 111.034 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -143.89 158.3 43.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.784 0.325 . . . . 10.0 110.918 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.38 -163.48 20.92 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 121.095 -0.574 . . . . 10.0 112.022 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.95 -31.82 14.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.02 0.438 . . . . 10.0 110.627 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.22 56.64 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.073 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.8 mt -62.03 137.75 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.51 79.69 Favored Glycine 0 CA--C 1.509 -0.328 0 C-N-CA 121.15 -0.548 . . . . 10.0 111.775 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.96 156.27 39.38 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.113 -0.544 . . . . 10.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.443 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 17.9 Cg_endo -63.12 124.1 13.35 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.276 1.984 . . . . 10.0 110.018 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 10.0 110.349 -178.329 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.804 0.335 . . . . 10.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -132.13 95.87 20.85 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.185 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.25 112.39 2.97 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.434 2.09 . . . . 10.0 112.088 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.66 95.57 6.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.048 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.11 155.84 42.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.395 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.05 128.64 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.814 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.91 162.12 12.49 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.104 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.84 74.65 0.22 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.975 -0.631 . . . . 10.0 112.403 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -119.88 103.43 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.788 -0.242 . . . . 10.0 110.728 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -90.3 158.2 17.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.57 124.44 2.85 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.065 -0.588 . . . . 10.0 112.22 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -158.25 150.96 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.651 0.226 . . . . 10.0 110.477 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 . . . . . 0 C--N 1.328 -0.333 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 83' ' ' VAL . 2.2 t -85.12 -71.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.815 -0.354 . . . . 10.0 110.511 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.78 157.08 7.58 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -74.89 -53.77 8.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.401 0.601 . . . . 10.0 112.144 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.81 -38.42 88.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.668 -0.242 . . . . 10.0 111.508 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.609 ' HB ' HD23 ' A' ' 140' ' ' LEU . 33.2 m -67.13 -35.91 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 120.74 -0.384 . . . . 10.0 110.391 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.81 -41.68 98.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.004 -0.617 . . . . 10.0 111.692 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -41.5 98.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.895 0.379 . . . . 10.0 110.136 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.69 -30.99 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.695 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.497 HG23 HH21 ' A' ' 91' ' ' ARG . 7.2 mt -62.84 -42.39 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 10.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -70.45 -50.33 39.39 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.93 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.64 -40.9 96.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.826 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.55 -30.38 74.9 Favored Glycine 0 C--N 1.328 0.12 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.833 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.588 HH11 HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -80.35 -42.05 23.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.846 0.355 . . . . 10.0 110.67 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.14 -21.15 63.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.236 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -87.73 19.12 3.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.455 0.539 . . . . 10.0 112.455 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.23 -0.12 56.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 62.6 mt-10 53.14 100.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 123.917 0.761 . . . . 10.0 112.831 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.6 Cg_endo -78.44 -41.85 0.83 Allowed 'Cis proline' 0 CA--C 1.517 -0.349 0 C-N-CA 123.292 -1.545 . . . . 10.0 112.524 -0.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -168.41 128.69 1.25 Allowed 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.88 -1.054 . . . . 10.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ttm -58.65 137.53 57.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.834 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.7 144.08 39.59 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.631 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -70.09 -41.03 74.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.162 0.506 . . . . 10.0 110.465 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.37 90.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.941 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.8 -43.61 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.698 -0.228 . . . . 10.0 110.978 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.486 HD23 HG13 ' A' ' 114' ' ' VAL . 56.6 tp -64.49 -39.47 93.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.41 96.06 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.865 -0.894 . . . . 10.0 110.865 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -39.64 91.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.809 0.338 . . . . 10.0 110.213 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.91 -41.54 98.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.161 -0.472 . . . . 10.0 112.049 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 103' ' ' LEU . 29.3 pt -93.24 -7.83 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.615 0.598 . . . . 10.0 112.615 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.77 34.12 22.74 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.549 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -125.99 176.67 6.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.93 0.395 . . . . 10.0 110.576 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.35 161.16 15.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.19 94.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 10.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.79 76.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.464 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.3 m -63.39 -46.34 86.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.157 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.486 HG13 HD23 ' A' ' 103' ' ' LEU . 90.0 t -62.28 -43.08 97.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.194 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -66.47 -35.23 79.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.728 -0.669 . . . . 10.0 111.598 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 25.8 p -77.76 -26.27 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.77 0.319 . . . . 10.0 111.496 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.48 70.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 8.2 pt-20 -63.11 -20.48 65.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 116' ' ' SER . 72.9 ttt180 -71.54 -20.34 62.04 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.611 0.719 . . . . 10.0 109.828 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.86 15.91 43.86 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.422 -0.808 . . . . 10.0 112.352 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 121' ' ' THR . 12.9 t -164.15 108.56 0.98 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.285 1.04 . . . . 10.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.09 19.06 0.5 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.724 -1.125 . . . . 10.0 110.999 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m 58.51 83.71 0.21 Allowed Pre-proline 0 C--O 1.235 0.294 0 CA-C-O 121.622 0.725 . . . . 10.0 110.031 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.495 ' HB2' HD21 ' A' ' 129' ' ' LEU . 27.6 Cg_endo -96.13 178.44 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.409 2.739 . . . . 10.0 114.868 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.607 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.2 t70 -139.94 150.68 44.83 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -58.32 -37.51 75.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 10.0 110.707 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 9.9 t30 -63.72 -41.66 98.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.466 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.9 mt -63.75 -55.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 110.362 -0.236 . . . . 10.0 110.362 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.1 mt -48.84 -45.88 41.32 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.312 0.577 . . . . 10.0 110.348 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.9 m -55.01 -47.0 75.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.953 -1.021 . . . . 10.0 111.604 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 49.7 mmtt -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.74 0.305 . . . . 10.0 111.014 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.495 ' HB3' HH22 ' A' ' 91' ' ' ARG . 3.5 mtp -51.28 -56.41 13.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.762 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.635 ' HG2' HD13 ' A' ' 140' ' ' LEU . 16.0 mt-10 -72.45 -29.56 63.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.144 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -62.07 -43.96 97.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.099 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 131' ' ' LYS . 48.3 t -62.32 -25.54 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.322 -0.399 . . . . 10.0 112.006 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.588 HD21 HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -107.14 -3.61 19.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 10.0 112.904 -177.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.1 t30 56.57 55.32 6.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.524 0.678 . . . . 10.0 109.706 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 35.5 m -140.99 164.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.736 -1.12 . . . . 10.0 108.754 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -124.19 129.0 50.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.151 0.501 . . . . 10.0 110.261 178.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.635 HD13 ' HG2' ' A' ' 133' ' ' GLU . 5.4 mp -92.66 13.01 21.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.751 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -128.31 139.4 52.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.36 -159.03 16.39 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.095 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.66 -33.29 13.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.926 0.393 . . . . 10.0 110.606 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -86.57 53.14 2.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.095 0.474 . . . . 10.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.581 HG23 ' HA ' ' A' ' 140' ' ' LEU . 61.1 mt -75.03 137.55 22.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.27 70.0 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.124 -0.79 . . . . 10.0 111.124 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.09 155.41 80.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.035 -0.583 . . . . 10.0 109.857 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.38 120.05 7.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.617 1.545 . . . . 10.0 110.177 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? . . . . . 0 C--N 1.322 -0.627 0 CA-C-O 121.228 0.537 . . . . 10.0 109.606 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.9 ttm . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.971 0.415 . . . . 10.0 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -148.28 85.94 6.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.102 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.93 177.83 8.39 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.689 2.259 . . . . 10.0 112.219 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.55 131.56 36.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.928 0.394 . . . . 10.0 110.833 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -152.94 126.33 8.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.808 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.79 150.96 38.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.707 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.31 171.08 13.57 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.55 145.65 13.23 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.385 -0.912 . . . . 10.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -142.15 127.16 18.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.767 -0.456 . . . . 10.0 109.767 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.23 148.78 42.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 10.0 111.504 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.78 132.46 2.52 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.16 -0.776 . . . . 10.0 111.16 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -156.94 156.85 33.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.247 0.523 . . . . 10.0 111.743 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.693 . . . . 10.0 109.154 179.17 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 19.2 p . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.563 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -91.57 -30.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.386 . . . . 10.0 111.751 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.65 141.95 5.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.542 -0.837 . . . . 10.0 112.333 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -66.58 -52.35 46.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 10.0 111.123 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -32.91 74.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.376 0.608 . . . . 10.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 140' ' ' LEU . 55.3 t -61.87 -50.39 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 114.88 -1.055 . . . . 10.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.39 98.89 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -60.14 -51.14 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 10.0 110.493 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -66.15 -30.77 71.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.999 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.836 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.6 mt -57.88 -47.33 86.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -70.9 -47.05 61.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.941 0.4 . . . . 10.0 110.4 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -62.18 -34.14 75.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.428 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.64 -30.29 68.76 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.21 -0.995 . . . . 10.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.836 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.6 mmt180 -81.47 -33.81 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 10.0 111.373 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -77.33 -16.56 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.097 0.475 . . . . 10.0 110.536 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -80.44 12.61 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -19.86 23.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 10.0 111.561 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 4.5 tp10 59.89 110.1 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.904 -1.044 . . . . 10.0 111.777 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 45.2 Cg_endo -72.05 -59.11 0.13 OUTLIER 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.279 -1.551 . . . . 10.0 113.026 -0.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.2 m -163.97 135.8 4.79 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.492 -0.776 . . . . 10.0 110.903 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 36.4 tpp -74.57 136.85 42.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.539 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 64.7 p -84.03 160.41 20.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.359 -0.537 . . . . 10.0 111.251 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.56 -26.94 64.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.668 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.02 -57.98 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.408 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.539 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 13.7 pt-20 -62.52 -36.85 83.88 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.914 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 2.4 tt -61.91 -42.48 99.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.682 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.76 -39.74 90.0 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.463 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -62.3 -39.53 93.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.705 0.288 . . . . 10.0 111.574 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 17.3 pt-20 -73.62 -16.59 61.23 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 103' ' ' LEU . 40.6 pt -113.43 0.08 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.623 -0.431 . . . . 10.0 111.738 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.42 37.61 53.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.593 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -133.19 -168.92 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 10.0 110.52 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -111.95 177.25 4.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.738 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.12 79.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 10.0 110.656 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.89 -47.07 87.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.657 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.9 m -55.74 -45.3 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.55 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.82 -50.54 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -64.92 -32.12 73.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.331 0.586 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.0 m -73.6 -28.19 61.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.424 ' CE1' HG11 ' A' ' 79' ' ' VAL . 2.4 m-85 -75.34 -35.62 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 12.5 pt-20 -67.42 -17.8 64.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 10.0 110.799 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.732 ' HG2' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -74.61 -20.93 59.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.21 0.529 . . . . 10.0 109.79 178.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.563 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.52 21.49 29.05 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.43 -0.891 . . . . 10.0 112.053 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 119' ' ' ARG . 9.9 t -170.07 104.22 0.3 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.437 1.113 . . . . 10.0 110.113 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.33 27.7 0.51 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.747 -1.115 . . . . 10.0 109.212 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 m 61.61 96.98 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.8 -1.091 . . . . 10.0 108.594 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 78' ' ' THR . 70.8 Cg_endo -68.18 99.84 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.655 2.236 . . . . 10.0 115.256 -175.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.57 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -85.72 116.12 23.8 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.92 -2.252 . . . . 10.0 104.92 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.411 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 21.9 mm-40 -48.91 -40.17 28.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.142 -0.481 . . . . 10.0 112.147 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.2 t30 -66.93 -44.06 81.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.675 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.673 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.8 mt -58.62 -55.17 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 119.585 -0.245 . . . . 10.0 110.651 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.0 mt -50.24 -42.24 51.47 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.571 0.7 . . . . 10.0 110.235 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 66.7 m -59.86 -45.72 91.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.983 -1.008 . . . . 10.0 111.497 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 29.2 mmtt -73.75 -40.86 63.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 10.0 111.234 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.673 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -50.65 -59.46 4.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.207 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.745 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 5.8 mt-10 -74.12 -26.84 60.57 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.045 -0.98 . . . . 10.0 112.997 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -54.63 -27.25 38.22 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.91 -25.64 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.81 0.338 . . . . 10.0 111.796 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.833 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -99.0 -16.32 18.76 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -177.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 67.84 25.99 7.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.262 0.553 . . . . 10.0 110.527 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.833 HG22 ' HB2' ' A' ' 136' ' ' LEU . 26.8 m -121.94 142.9 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 23.9 mmmt -119.19 142.97 47.51 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HA ' HG23 ' A' ' 145' ' ' ILE . 8.9 mt -102.71 39.44 1.53 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.658 0.742 . . . . 10.0 109.783 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 141' ' ' ARG . 49.2 mtt180 -129.54 141.32 51.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.089 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.22 -162.19 43.93 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.233 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.34 3.24 55.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.885 0.374 . . . . 10.0 111.399 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -110.31 40.95 1.84 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 10.0 110.672 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 140' ' ' LEU . 44.9 mt -67.17 136.71 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.727 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.9 0.3 71.91 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.937 -0.865 . . . . 10.0 110.937 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.56 158.45 75.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.546 . . . . 10.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.29 121.68 10.3 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.284 1.989 . . . . 10.0 109.914 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--N 1.317 -0.844 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.8 ptp . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.693 0.759 . . . . 10.0 111.456 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -121.96 88.44 47.73 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.438 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.81 145.9 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.348 2.699 . . . . 10.0 111.897 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -104.03 154.0 20.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.812 0.339 . . . . 10.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -144.68 132.27 21.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.24 166.55 23.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.016 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.61 -177.91 36.01 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.486 -0.864 . . . . 10.0 112.394 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 175.2 147.88 6.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.41 -0.676 . . . . 10.0 111.41 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 t -137.31 128.17 27.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.105 0.479 . . . . 10.0 110.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.81 -42.91 10.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.248 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.22 104.31 2.39 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.569 -0.612 . . . . 10.0 111.569 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -107.32 -16.49 14.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 10.0 111.387 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 . . . . . 0 C--N 1.322 -0.62 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.503 -179.207 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 2.8 p . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.904 -0.406 . . . . 10.0 109.904 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -84.48 -34.65 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.651 -0.419 . . . . 10.0 111.157 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.04 136.98 4.33 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.013 -0.613 . . . . 10.0 111.596 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -63.45 -57.04 11.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -25.63 65.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.702 HG13 HD13 ' A' ' 140' ' ' LEU . 46.0 t -63.36 -46.97 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.497 -1.229 . . . . 10.0 110.052 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.32 -38.42 95.83 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.353 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 40.1 ttmt -59.32 -49.25 78.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 10.0 109.786 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -65.85 -30.51 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.558 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.753 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.3 mt -59.85 -48.5 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 4.3 tt0 -67.06 -50.38 62.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.022 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 62.4 mm-40 -59.97 -36.41 77.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.23 85.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.967 -0.635 . . . . 10.0 113.281 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.753 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.9 mmt180 -79.22 -29.88 43.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.173 0.511 . . . . 10.0 109.64 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 82.0 mt-30 -78.66 -16.76 56.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.645 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 55.9 mtpt -85.79 22.13 1.72 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.955 0.407 . . . . 10.0 111.261 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.65 -8.88 36.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.883 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 6.1 mm-40 53.4 104.05 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 114.902 -1.045 . . . . 10.0 112.618 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 56.0 Cg_endo -73.64 -50.12 0.2 Allowed 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.486 -1.464 . . . . 10.0 113.367 0.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -168.93 132.62 1.4 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.403 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.7 tpp -73.58 134.89 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.291 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.17 145.38 51.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.902 0.382 . . . . 10.0 111.679 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.41 -37.49 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.022 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.07 -36.39 83.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.75 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.79 -39.19 57.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.094 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.552 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -61.19 -43.62 98.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.837 . . . . 10.0 108.739 178.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.74 -39.39 95.23 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.504 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -64.32 -38.27 90.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.651 0.262 . . . . 10.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.545 ' OE2' HD22 ' A' ' 103' ' ' LEU . 15.3 pt-20 -78.02 -13.9 59.7 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.119 0.785 . . . . 10.0 113.119 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 103' ' ' LEU . 41.2 pt -109.68 -7.45 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.623 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.83 30.89 19.62 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.815 -0.707 . . . . 10.0 112.807 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.94 -168.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.278 0.231 . . . . 10.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -109.91 177.25 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.528 -0.305 . . . . 10.0 110.254 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.73 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.616 -0.265 . . . . 10.0 111.351 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.29 81.34 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.039 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.45 -50.3 73.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.779 0.323 . . . . 10.0 110.723 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.12 -45.04 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.79 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 10.0 111.115 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.3 m -76.77 -27.46 55.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.943 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.871 0.693 . . . . 10.0 112.871 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -61.53 -18.66 60.13 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.195 0.442 . . . . 10.0 112.195 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 119' ' ' ARG . 0.8 OUTLIER -69.53 -22.93 63.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.197 0.522 . . . . 10.0 110.088 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.99 21.7 15.08 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.607 -0.806 . . . . 10.0 112.086 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.439 ' OG1' HG22 ' A' ' 78' ' ' THR . 6.7 t -171.87 111.9 0.3 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.24 1.019 . . . . 10.0 110.396 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.57 34.58 0.27 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.561 -1.2 . . . . 10.0 109.277 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 m 55.77 85.16 0.2 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.266 -0.879 . . . . 10.0 108.839 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.551 ' HG3' ' O ' ' A' ' 78' ' ' THR . 72.8 Cg_endo -72.47 98.04 0.92 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.543 2.828 . . . . 10.0 115.544 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.4 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.9 t70 -82.18 128.04 33.76 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 104.638 -2.356 . . . . 10.0 104.638 174.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -54.17 -31.31 52.34 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.427 0.528 . . . . 10.0 112.427 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -72.12 -32.89 67.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.848 -0.614 . . . . 10.0 111.355 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.796 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.0 mt -71.3 -57.94 6.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.691 -0.403 . . . . 10.0 110.099 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -49.6 -43.31 46.33 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.489 0.662 . . . . 10.0 110.777 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.59 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 45.0 m -54.51 -48.95 71.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.033 -0.985 . . . . 10.0 111.828 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 135' ' ' VAL . 13.0 mttt -76.79 -37.68 55.36 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.833 0.309 . . . . 10.0 111.833 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.796 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 75.0 mtp -53.97 -58.56 6.85 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.182 0.515 . . . . 10.0 111.863 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.575 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.0 mp0 -72.52 -26.18 61.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.787 -0.642 . . . . 10.0 112.266 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.4 ttm-85 -59.3 -27.42 65.84 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.036 0.446 . . . . 10.0 110.034 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 131' ' ' LYS . 61.1 t -63.82 -41.34 92.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.689 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.571 HD22 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -94.98 -6.35 42.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 121.152 -0.219 . . . . 10.0 110.437 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 t30 64.36 49.65 2.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.494 0.664 . . . . 10.0 109.736 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 34.4 m -132.12 162.88 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.355 -0.839 . . . . 10.0 109.627 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 15.9 mmtt -131.96 140.89 49.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.342 -0.614 . . . . 10.0 109.342 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.702 HD13 HG13 ' A' ' 83' ' ' VAL . 12.2 mt -108.5 17.71 21.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.26 0.552 . . . . 10.0 110.873 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -124.25 139.63 53.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.63 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.9 -146.65 17.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.729 -0.748 . . . . 10.0 112.336 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.24 -34.99 8.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.985 0.421 . . . . 10.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -82.33 54.82 2.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.929 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.602 HG23 ' HA ' ' A' ' 140' ' ' LEU . 52.6 mt -72.9 137.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.474 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.36 -0.48 87.12 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.978 -0.849 . . . . 10.0 110.978 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.71 156.87 70.38 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.476 . . . . 10.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.79 122.5 11.09 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 121.897 1.731 . . . . 10.0 110.382 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.375 0.607 . . . . 10.0 110.146 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 110.031 -0.359 . . . . 10.0 110.031 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -116.97 150.8 46.56 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.374 -0.375 . . . . 10.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.29 170.38 20.33 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.626 2.217 . . . . 10.0 112.379 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -123.78 152.5 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.247 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.14 151.37 49.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.394 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.05 138.05 15.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.78 -160.78 11.78 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.22 25.06 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.86 132.37 52.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.662 0.268 . . . . 10.0 110.846 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -140.14 167.6 21.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.897 -0.409 . . . . 10.0 109.897 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.25 117.92 0.8 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.455 -0.879 . . . . 10.0 112.742 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -102.8 173.43 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.19 -0.3 . . . . 10.0 110.19 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 10.0 110.901 -179.396 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.48 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 5.0 p . . . . . 0 C--O 1.235 0.305 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.937 HG12 HG11 ' A' ' 83' ' ' VAL . 1.8 t -82.55 -60.15 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 10.0 110.537 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.07 137.23 4.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.33 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.7 -42.85 99.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.663 0.268 . . . . 10.0 111.269 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 -29.0 64.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.996 HG13 HD13 ' A' ' 140' ' ' LEU . 3.8 t -68.47 -49.28 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.338 -0.846 . . . . 10.0 109.864 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.36 -39.39 97.19 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -64.03 -39.41 94.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 10.0 110.486 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.43 64.89 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.685 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.79 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.9 mt -59.89 -49.95 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.01 -53.23 58.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.956 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.39 -31.47 72.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.901 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.09 -30.73 69.6 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.731 -0.747 . . . . 10.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.79 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -81.6 -41.94 20.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 10.0 109.57 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.81 ' HA ' HG23 ' A' ' 97' ' ' THR . 53.2 mt-30 -61.4 -36.89 81.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.535 -0.757 . . . . 10.0 111.31 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -81.75 51.21 1.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -3.54 16.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.69 0.281 . . . . 10.0 111.257 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 22.2 mm-40 57.94 100.56 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 2.8 Cg_exo -76.65 -45.1 0.46 Allowed 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.592 -1.42 . . . . 10.0 112.205 -0.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.81 HG23 ' HA ' ' A' ' 92' ' ' GLN . 38.2 m -161.71 133.56 5.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.541 -1.209 . . . . 10.0 110.004 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.3 127.95 32.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.23 53.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.43 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.94 85.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.692 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -71.07 -44.42 65.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.822 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -63.68 -40.19 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.42 -49.05 73.12 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.261 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -62.69 -34.68 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.4 -26.45 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.934 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 103' ' ' LEU . 25.6 pt -110.14 8.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.796 0.295 . . . . 10.0 111.796 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 20.34 71.77 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.252 -0.499 . . . . 10.0 113.097 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -118.56 -164.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.309 -0.256 . . . . 10.0 110.309 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.3 p -115.05 176.07 5.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.562 0.22 . . . . 10.0 110.589 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.04 89.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 10.0 109.998 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.9 76.12 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.563 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.3 m -62.06 -46.29 89.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 10.0 110.345 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 t -66.17 -43.47 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.071 -0.513 . . . . 10.0 109.91 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.66 -29.54 69.58 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.702 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 m -78.84 -33.77 45.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.898 0.38 . . . . 10.0 111.473 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -65.98 -33.79 76.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.81 -18.27 54.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.821 0.344 . . . . 10.0 111.8 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.432 ' HG2' HG22 ' A' ' 121' ' ' THR . 12.1 ttm180 -71.57 -26.17 62.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.281 0.562 . . . . 10.0 110.51 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.82 12.56 55.37 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.612 -0.722 . . . . 10.0 112.482 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 121' ' ' THR . 8.8 t -153.39 98.68 2.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.715 1.245 . . . . 10.0 109.456 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.06 27.49 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.323 -1.308 . . . . 10.0 109.914 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m 59.37 95.5 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.199 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.48 ' HG3' ' C ' ' A' ' 78' ' ' THR . 74.4 Cg_endo -69.73 99.8 0.77 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.242 2.628 . . . . 10.0 114.646 -176.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.57 117.9 25.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 8.4 mm-40 -48.56 -39.62 24.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.471 0.915 . . . . 10.0 113.471 -174.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.4 t30 -70.55 -34.0 71.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.86 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.79 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.7 mt -68.96 -57.89 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.758 -0.377 . . . . 10.0 111.299 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -39.01 59.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.161 0.505 . . . . 10.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 m -55.02 -49.83 70.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.631 -0.713 . . . . 10.0 111.232 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 35.3 mmtt -75.77 -30.4 59.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.954 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.79 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.7 mtp -56.35 -59.59 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 4.0 mp0 -74.04 -26.49 60.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -53.92 -33.24 56.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.986 0.365 . . . . 10.0 111.986 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.69 -30.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.973 0.416 . . . . 10.0 111.245 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.473 HD12 ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -94.78 -10.73 30.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.565 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.2 t30 62.58 47.11 5.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 10.0 110.749 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.1 m -131.91 158.15 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -130.66 143.69 50.92 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.591 -0.443 . . . . 10.0 110.847 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.996 HD13 HG13 ' A' ' 83' ' ' VAL . 11.6 mt -103.53 40.2 1.46 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.728 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 141' ' ' ARG . 14.8 mmm180 -128.26 139.88 52.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.534 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.08 -146.25 23.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.371 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.33 -21.68 14.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.89 0.376 . . . . 10.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -88.06 52.96 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 110.696 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 140' ' ' LEU . 54.5 mt -76.53 141.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.518 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 1.16 88.16 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.877 -0.678 . . . . 10.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.0 156.37 76.28 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 110.046 -0.353 . . . . 10.0 110.046 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.96 122.3 11.38 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.957 1.772 . . . . 10.0 109.294 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.483 . . . . 10.0 109.829 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 110.23 -0.285 . . . . 10.0 110.23 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.32 136.73 19.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.508 -0.314 . . . . 10.0 111.061 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.03 142.02 45.66 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.993 2.462 . . . . 10.0 112.104 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.12 143.66 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.911 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -136.2 132.13 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 10.0 109.652 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.55 155.56 37.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.832 0.348 . . . . 10.0 111.125 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.69 -155.07 29.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.121 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -162.72 11.79 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.542 -0.623 . . . . 10.0 111.542 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 m -154.52 108.09 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.082 0.441 . . . . 10.0 110.939 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.28 173.85 6.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.6 173.2 34.36 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.348 -0.93 . . . . 10.0 112.692 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -158.25 151.52 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.664 0.268 . . . . 10.0 110.477 179.218 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 120.783 0.325 . . . . 10.0 110.629 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.408 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -76.41 -32.03 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.61 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.34 138.4 5.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.374 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -70.14 -42.65 72.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.987 0.422 . . . . 10.0 110.682 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -75.39 -25.35 57.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.655 0.74 . . . . 10.0 109.234 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 87' ' ' ILE . 37.2 t -69.28 -45.3 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 114.507 -1.224 . . . . 10.0 110.249 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.79 98.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.87 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -62.76 -40.3 96.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 10.0 110.434 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.81 66.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.064 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 83' ' ' VAL . 23.4 mt -59.93 -46.81 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.96 0.41 . . . . 10.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -71.46 -52.95 15.68 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.582 -0.447 . . . . 10.0 110.538 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.45 ' O ' ' HD3' ' A' ' 93' ' ' LYS . 46.8 mt-30 -60.61 -35.05 75.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.239 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.69 -31.9 52.28 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.636 -1.269 . . . . 10.0 112.365 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.647 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 1.3 mpt_? -81.72 -34.43 30.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.924 0.392 . . . . 10.0 111.383 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.522 ' HA ' HG23 ' A' ' 97' ' ' THR . 33.5 mt-30 -75.19 -2.12 26.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.995 0.426 . . . . 10.0 110.451 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 89' ' ' GLN . 1.5 tptm -84.9 0.11 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.023 0.44 . . . . 10.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -171.98 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 10.0 111.185 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.46 112.1 23.2 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.54 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -78.84 -31.19 5.17 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.358 -1.518 . . . . 10.0 112.558 -0.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 92' ' ' GLN . 99.0 m -168.3 130.29 1.4 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.82 -1.536 . . . . 10.0 108.724 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 tpp -73.24 110.36 7.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.521 -0.472 . . . . 10.0 109.958 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -69.53 156.78 38.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.147 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.08 -35.22 76.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.582 -0.735 . . . . 10.0 109.911 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.059 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.68 -49.87 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.701 -0.227 . . . . 10.0 110.794 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.574 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.34 -46.66 85.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.48 0.488 . . . . 10.0 109.887 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.08 -47.18 92.29 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.119 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -64.26 -38.57 91.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.904 0.335 . . . . 10.0 111.904 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.3 -15.18 61.41 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 103' ' ' LEU . 43.4 pt -107.05 3.69 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 10.0 111.006 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.86 25.72 55.31 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.079 -0.582 . . . . 10.0 113.034 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -125.24 -157.47 0.78 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.668 0.271 . . . . 10.0 110.356 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 p -124.92 176.68 6.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.48 91.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.617 0.246 . . . . 10.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.88 76.35 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.76 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 m -60.68 -47.18 87.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.15 -45.16 97.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.246 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.07 -32.35 73.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.806 0.812 . . . . 10.0 109.834 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 11.6 m -74.66 -24.89 58.88 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.201 -0.909 . . . . 10.0 111.275 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -77.61 -34.36 53.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -66.09 -20.36 66.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.9 ptm180 -70.88 -23.05 62.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.665 0.745 . . . . 10.0 110.738 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.51 28.43 7.54 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.012 -0.995 . . . . 10.0 112.063 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 121' ' ' THR . 8.8 t -173.8 107.69 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.167 0.984 . . . . 10.0 110.201 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.04 25.95 0.26 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.843 -1.071 . . . . 10.0 109.616 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 m 62.33 99.99 0.04 OUTLIER Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.806 -0.813 . . . . 10.0 108.806 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.76 99.29 0.95 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.855 2.37 . . . . 10.0 114.042 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.643 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 4.5 t0 -87.5 120.41 28.78 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.443 -2.058 . . . . 10.0 105.443 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.6 mm-40 -52.07 -42.33 63.1 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.22 -30.88 70.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.718 ' O ' ' HG3' ' A' ' 132' ' ' MET . 73.2 mt -72.07 -56.2 10.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.0 mt -48.85 -42.78 37.53 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.615 0.572 . . . . 10.0 110.361 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 74.4 m -57.02 -47.3 81.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.152 -0.931 . . . . 10.0 111.765 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 135' ' ' VAL . 2.6 mppt? -74.66 -38.01 62.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.718 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 32.9 mtp -50.42 -55.83 14.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.832 0.825 . . . . 10.0 111.161 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.633 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 53.8 mt-10 -73.24 -27.24 61.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.801 -1.09 . . . . 10.0 113.315 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -68.74 -27.39 65.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.963 1.098 . . . . 10.0 113.963 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 131' ' ' LYS . 6.0 t -71.0 -22.79 23.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.158 0.429 . . . . 10.0 112.158 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -127.32 -23.85 3.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.816 1.043 . . . . 10.0 113.816 -176.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 2.8 m120 77.91 63.68 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.082 0.944 . . . . 10.0 110.099 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 2.8 t -135.96 139.86 45.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.127 -1.397 . . . . 10.0 108.178 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 12.1 mmtm -112.45 133.14 54.69 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.338 -0.545 . . . . 10.0 112.145 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.633 ' HG ' ' OE2' ' A' ' 133' ' ' GLU . 1.1 mt -93.24 -20.25 20.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.163 -0.926 . . . . 10.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -120.15 152.04 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 10.0 111.06 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.85 -156.78 15.37 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.184 -0.766 . . . . 10.0 111.184 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.8 -37.1 10.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.821 0.343 . . . . 10.0 110.628 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -89.92 55.65 3.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.646 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.84 137.63 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 10.0 110.913 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.66 90.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.093 -0.803 . . . . 10.0 111.093 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.31 147.77 58.68 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.301 -0.449 . . . . 10.0 110.914 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.7 123.65 13.09 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.474 2.116 . . . . 10.0 110.718 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 109.225 -0.658 . . . . 10.0 109.225 -178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 44.6 mtm . . . . . 0 C--O 1.234 0.251 0 N-CA-C 110.03 -0.359 . . . . 10.0 110.03 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -158.57 130.03 3.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.78 46.03 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.069 2.513 . . . . 10.0 114.209 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.89 130.92 55.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -126.5 123.24 37.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 10.0 111.163 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.76 -174.07 2.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.58 -146.95 8.83 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.678 -0.569 . . . . 10.0 111.678 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.27 91.76 1.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.633 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -123.55 124.35 42.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.612 0.244 . . . . 10.0 110.373 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.86 149.83 50.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.25 -166.76 20.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.086 -0.578 . . . . 10.0 111.94 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -139.92 174.08 10.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.815 0.34 . . . . 10.0 110.777 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 . . . . . 0 C--N 1.327 -0.396 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.699 -179.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 109.957 -0.386 . . . . 10.0 109.957 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.9 m -83.17 -23.67 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 10.0 111.663 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.45 139.14 7.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.49 -0.862 . . . . 10.0 112.526 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -68.53 -47.64 66.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.724 0.297 . . . . 10.0 111.426 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -66.32 -33.47 75.79 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.38 0.61 . . . . 10.0 109.512 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.1 -44.52 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.021 -0.991 . . . . 10.0 109.998 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.47 -41.71 98.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.929 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.44 -41.25 98.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 10.0 110.199 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.78 -30.84 65.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.114 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.699 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.3 mt -60.71 -47.38 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.267 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.48 -53.19 46.1 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.434 0.459 . . . . 10.0 110.46 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.74 -33.44 72.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.573 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.04 -31.9 82.28 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.788 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -80.05 -32.34 39.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.483 0.658 . . . . 10.0 109.28 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.442 ' HA ' HG23 ' A' ' 97' ' ' THR . 84.4 mt-30 -74.2 -24.99 59.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.334 -0.848 . . . . 10.0 110.764 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -84.58 54.03 2.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.978 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.94 0.68 8.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.836 0.31 . . . . 10.0 111.836 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 1.6 tt0 56.11 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 124.159 0.912 . . . . 10.0 112.016 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 75.6 Cg_endo -81.81 -37.94 1.43 Allowed 'Cis proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.545 -1.44 . . . . 10.0 113.451 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 92' ' ' GLN . 2.3 m -173.88 124.88 0.36 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.395 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 ttm -83.57 142.36 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.286 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 75.5 p -74.52 163.55 27.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 10.0 111.142 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.27 -32.59 71.87 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.256 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.07 82.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.548 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.435 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 14.0 mm-40 -60.72 -54.45 45.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.594 -0.276 . . . . 10.0 110.445 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HG ' HH11 ' A' ' 91' ' ' ARG . 0.2 OUTLIER -64.76 -36.91 85.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.632 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.63 -47.5 86.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.816 -0.707 . . . . 10.0 111.742 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.96 -40.48 91.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.259 -0.275 . . . . 10.0 110.259 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.4 -31.74 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.352 0.501 . . . . 10.0 112.352 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 103' ' ' LEU . 46.8 pt -90.86 1.8 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 10.0 111.42 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.36 15.24 74.55 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.96 -0.638 . . . . 10.0 113.311 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -116.63 -149.4 0.44 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.65 172.07 9.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.602 0.239 . . . . 10.0 110.988 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.91 78.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.933 0.397 . . . . 10.0 110.505 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.65 77.55 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.637 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 4.0 m -59.64 -47.5 85.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.36 -44.13 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.25 -34.95 78.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.219 0.533 . . . . 10.0 110.893 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 36.5 m -76.83 -32.51 57.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.426 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.402 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.9 m-85 -67.57 -37.37 82.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.511 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.59 -18.78 65.21 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.721 0.296 . . . . 10.0 111.514 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 121' ' ' THR . 42.8 ttt180 -70.48 -20.39 62.86 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.402 0.62 . . . . 10.0 110.105 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.446 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.27 23.14 25.29 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 119' ' ' ARG . 4.1 t -170.21 105.18 0.3 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.888 0.851 . . . . 10.0 110.35 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.47 33.59 0.11 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.98 -1.009 . . . . 10.0 109.824 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 m 64.26 104.04 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.774 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.1 83.74 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.508 2.138 . . . . 10.0 113.353 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.713 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -84.44 120.33 26.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -50.09 -47.36 53.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.74 0.644 . . . . 10.0 112.74 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 26.8 p-10 -61.36 -39.28 90.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.892 -0.14 . . . . 10.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.572 ' O ' ' HG3' ' A' ' 132' ' ' MET . 77.4 mt -69.45 -50.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 12.7 mt -54.4 -41.85 69.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.901 0.381 . . . . 10.0 110.006 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -55.83 -42.47 75.78 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.463 -0.79 . . . . 10.0 111.288 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.575 ' O ' HG23 ' A' ' 135' ' ' VAL . 70.4 mmtt -73.66 -43.34 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 10.0 110.518 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.673 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 4.0 mtt -52.61 -56.13 17.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.161 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.94 -29.61 70.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.544 -0.753 . . . . 10.0 112.45 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.9 mmt180 -75.59 -45.16 39.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.931 0.715 . . . . 10.0 112.931 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 131' ' ' LYS . 17.7 t -65.39 -41.19 90.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 111.898 0.332 . . . . 10.0 111.898 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 132' ' ' MET . 0.0 OUTLIER -89.91 -10.16 46.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.87 -0.332 . . . . 10.0 111.869 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.9 t30 57.51 52.9 7.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.549 0.69 . . . . 10.0 110.481 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 136' ' ' LEU . 27.5 m -142.59 140.66 28.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.762 -1.108 . . . . 10.0 108.19 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 1.5 mtpp -96.67 133.46 41.16 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.028 -0.669 . . . . 10.0 110.251 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.525 ' HA ' HG23 ' A' ' 145' ' ' ILE . 36.6 mt -101.58 14.74 31.05 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.525 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -129.37 145.86 51.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.192 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.52 -155.85 21.86 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.469 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.98 -22.79 14.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.023 0.439 . . . . 10.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.88 51.68 1.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.056 0.455 . . . . 10.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 58.7 mt -71.9 142.65 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.705 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.84 4.29 88.83 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.455 -0.658 . . . . 10.0 111.455 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.55 143.49 48.55 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.568 -0.316 . . . . 10.0 110.548 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 124.0 10.68 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.683 1.589 . . . . 10.0 108.061 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.5 ttp85 . . . . . 0 C--N 1.319 -0.74 0 CA-C-O 121.268 0.556 . . . . 10.0 110.058 -178.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.2 ptp . . . . . 0 N--CA 1.452 -0.338 0 CA-C-O 120.864 0.364 . . . . 10.0 110.223 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -150.63 130.37 6.67 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.448 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.76 122.6 7.42 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.776 2.317 . . . . 10.0 112.86 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.87 145.06 34.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.19 167.37 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 10.0 110.77 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.63 158.74 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.099 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.67 31.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.722 -0.752 . . . . 10.0 112.267 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.07 -20.02 10.79 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.704 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -96.9 112.19 24.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.291 -0.263 . . . . 10.0 110.291 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -153.12 179.47 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.807 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.8 20.02 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.378 -0.689 . . . . 10.0 111.378 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -90.51 151.16 21.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.42 . . . . 10.0 111.533 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.787 179.784 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.637 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 3.5 p . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.76 -0.459 . . . . 10.0 109.76 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.583 HG12 HG21 ' A' ' 83' ' ' VAL . 3.4 t -70.75 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.239 0.542 . . . . 10.0 110.87 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.77 153.35 5.91 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -76.48 -52.28 10.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.581 0.691 . . . . 10.0 112.543 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -30.5 69.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.605 -0.438 . . . . 10.0 111.568 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.583 HG21 HG12 ' A' ' 79' ' ' VAL . 25.9 m -68.01 -35.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 120.735 -0.386 . . . . 10.0 110.39 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.75 -48.66 82.69 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.277 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -63.62 -36.77 84.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 10.0 110.756 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -69.7 -30.75 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.963 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.834 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.7 mt -61.27 -47.88 91.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 109.381 -0.599 . . . . 10.0 109.381 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.81 -53.34 57.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.872 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.6 -35.09 79.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.676 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.26 80.34 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.925 -0.655 . . . . 10.0 113.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.834 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.8 mmt180 -75.84 -35.56 59.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.233 0.539 . . . . 10.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.47 ' HA ' HG23 ' A' ' 97' ' ' THR . 77.6 mt-30 -78.67 -12.91 60.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.776 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -77.94 -0.79 28.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.676 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -168.56 0.47 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.145 0.498 . . . . 10.0 111.466 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 12.7 tp10 -131.05 109.95 15.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.472 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.0 Cg_endo -79.06 -29.2 6.79 Favored 'Cis proline' 0 CA--C 1.515 -0.45 0 C-N-CA 123.188 -1.588 . . . . 10.0 112.157 -0.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 92' ' ' GLN . 38.0 m -168.47 136.21 2.11 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.55 -1.659 . . . . 10.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.9 tpp -87.01 127.57 35.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.3 p -77.25 156.82 31.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.361 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -68.13 -33.68 74.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.192 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.75 71.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.385 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.48 -42.26 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.454 -0.339 . . . . 10.0 111.461 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.551 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tm? -65.46 -44.52 86.93 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.06 96.58 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.769 -0.729 . . . . 10.0 111.394 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.72 -43.92 97.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.987 0.115 . . . . 10.0 111.297 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.91 -16.83 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 103' ' ' LEU . 33.6 pt -103.47 -3.19 9.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.255 -0.578 . . . . 10.0 110.779 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.44 50.09 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.291 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -120.32 -160.17 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.683 0.278 . . . . 10.0 110.481 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 175.09 5.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.453 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.64 -41.65 99.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.758 0.313 . . . . 10.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.82 73.62 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.07 -0.514 . . . . 10.0 110.873 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 m -59.6 -49.54 77.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.878 0.37 . . . . 10.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.36 -42.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.93 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.16 70.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.571 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 67.8 m -78.52 -31.96 47.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.141 0.423 . . . . 10.0 112.141 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -18.77 36.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.373 0.509 . . . . 10.0 112.373 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.444 ' HG3' HG22 ' A' ' 121' ' ' THR . 5.6 tpp180 -69.18 -23.39 63.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.309 0.576 . . . . 10.0 110.339 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.62 13.91 54.23 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.677 -0.773 . . . . 10.0 112.296 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 121' ' ' THR . 9.9 t -158.94 107.32 1.87 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.233 1.016 . . . . 10.0 109.37 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.78 29.17 0.37 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.443 -1.253 . . . . 10.0 110.017 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m 58.58 87.77 0.13 Allowed Pre-proline 0 N--CA 1.463 0.214 0 N-CA-C 108.378 -0.971 . . . . 10.0 108.378 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.637 ' HG3' ' C ' ' A' ' 78' ' ' THR . 87.9 Cg_endo -78.96 110.89 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.717 2.278 . . . . 10.0 115.454 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 128' ' ' ILE . 6.6 t70 -85.95 124.91 32.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.93 -2.989 . . . . 10.0 102.93 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 5.0 mm-40 -50.97 -32.04 19.8 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.14 0.793 . . . . 10.0 113.14 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.531 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.5 t30 -75.9 -31.88 59.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.449 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.756 ' O ' ' HG3' ' A' ' 132' ' ' MET . 97.9 mt -64.85 -55.96 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.955 -0.298 . . . . 10.0 110.499 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -47.94 -38.85 17.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.737 0.779 . . . . 10.0 110.116 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.3 m -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.463 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 67.3 mmtt -75.57 -40.16 57.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.3 mtp -53.47 -57.73 9.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.227 0.537 . . . . 10.0 111.552 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mt-10 -72.27 -27.3 62.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.461 -0.79 . . . . 10.0 112.777 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -56.06 -30.22 61.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 10.0 111.362 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.7 -30.85 19.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.443 . . . . 10.0 111.814 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.713 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -96.18 -10.57 27.8 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 67.24 19.15 10.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.746 0.418 . . . . 10.0 111.772 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.776 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.9 m -114.03 140.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.1 mmtp -121.11 140.6 51.75 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.801 -0.76 . . . . 10.0 111.204 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.684 ' HA ' HG23 ' A' ' 145' ' ' ILE . 1.8 mt -102.46 41.26 1.25 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.192 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -131.3 141.21 49.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 10.0 111.092 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.52 -152.49 30.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.291 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.55 15.09 30.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.195 0.522 . . . . 10.0 110.698 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.08 45.25 2.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.251 0.548 . . . . 10.0 110.173 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.684 HG23 ' HA ' ' A' ' 140' ' ' LEU . 49.1 mt -68.8 138.98 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.72 7.03 87.93 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.367 -1.093 . . . . 10.0 110.367 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -131.62 157.63 77.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 114.833 -0.684 . . . . 10.0 109.799 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.33 122.4 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.751 . . . . 10.0 110.23 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.589 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 3.2 tpp180 . . . . . 0 C--N 1.318 -0.776 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.5 mtm . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.647 0.261 . . . . 10.0 110.419 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -111.71 151.16 43.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.175 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.66 133.88 44.6 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.584 2.19 . . . . 10.0 112.318 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -76.64 152.99 35.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.365 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.37 151.37 29.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.804 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.3 153.64 27.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.402 -0.363 . . . . 10.0 110.594 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.0 -166.71 11.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.329 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.92 158.78 25.85 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.967 -0.635 . . . . 10.0 111.862 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 m -152.64 131.09 12.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.837 0.351 . . . . 10.0 110.58 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -145.01 -178.37 6.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.437 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.88 119.43 1.51 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.022 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -127.26 162.09 27.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 63' ' ' ARG . 11.6 ptm180 . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 120.815 0.34 . . . . 10.0 110.71 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.232 0.177 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.3 m -77.21 -31.48 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 10.0 110.789 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.5 132.05 3.88 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.576 -0.821 . . . . 10.0 112.401 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.53 -45.19 88.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.856 0.36 . . . . 10.0 110.819 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -29.7 65.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 87' ' ' ILE . 41.2 t -65.2 -46.2 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.078 -0.965 . . . . 10.0 109.773 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.58 -45.74 95.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.538 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -61.48 -38.59 87.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.005 0.431 . . . . 10.0 110.347 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.491 ' CB ' HD22 ' A' ' 140' ' ' LEU . . . -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.399 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.812 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.9 mt -59.8 -49.17 84.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.65 -51.45 65.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.538 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.42 -32.23 73.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.744 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 93' ' ' LYS . . . -73.65 -29.78 62.98 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.796 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.812 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.6 mmt180 -82.76 -36.29 25.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 10.0 109.812 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HA ' HG23 ' A' ' 97' ' ' THR . 37.2 mt-30 -72.92 -15.3 61.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 13.5 ptmt -84.86 6.69 23.69 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.703 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.88 -20.96 55.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.718 0.294 . . . . 10.0 111.777 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 56.98 102.44 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.052 -0.977 . . . . 10.0 111.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.46 -62.04 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.524 -1.448 . . . . 10.0 113.234 -0.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 92' ' ' GLN . 47.0 m -161.38 135.44 6.86 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.139 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 132.59 46.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.45 145.73 54.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -69.14 -36.59 77.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 10.0 109.879 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.49 76.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.254 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -64.19 -39.26 93.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 10.0 110.958 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -64.77 -43.89 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.35 -43.98 96.07 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.321 -0.712 . . . . 10.0 111.321 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.63 -38.63 81.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.794 0.331 . . . . 10.0 110.56 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.71 -18.78 65.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.114 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 103' ' ' LEU . 4.4 pt -117.0 5.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.676 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.42 26.72 60.82 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.306 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.41 -171.14 2.11 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 p -107.42 173.61 6.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.635 0.255 . . . . 10.0 110.958 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.04 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 10.0 110.069 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.73 84.99 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.637 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -60.78 -46.49 90.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.729 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.71 -37.2 77.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.993 0.425 . . . . 10.0 110.757 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.22 77.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.09 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.4 p -75.99 -29.83 58.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.023 0.439 . . . . 10.0 110.539 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.449 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 1.0 OUTLIER -63.35 -41.78 98.88 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.881 -0.599 . . . . 10.0 112.356 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -63.54 -18.22 63.62 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.528 ' HG2' HG22 ' A' ' 121' ' ' THR . 17.7 ttt180 -74.08 -22.68 59.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.356 0.598 . . . . 10.0 109.864 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.482 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 101.14 21.58 11.62 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.781 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.528 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -170.09 113.19 0.47 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 122.108 0.956 . . . . 10.0 110.611 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.29 27.73 0.09 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.422 -1.263 . . . . 10.0 108.86 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m 65.4 106.33 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.789 -1.096 . . . . 10.0 108.708 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 85.9 Cg_endo -78.15 89.63 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.763 2.309 . . . . 10.0 115.419 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -83.28 116.49 22.45 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.566 -2.012 . . . . 10.0 105.566 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.421 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 16.3 mm-40 -50.73 -40.13 53.6 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.647 0.61 . . . . 10.0 112.647 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.71 -32.83 73.74 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.258 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.448 HG23 HD12 ' A' ' 107' ' ' ILE . 62.7 mt -69.76 -55.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 121.026 -0.27 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -51.58 -40.11 59.17 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.582 0.706 . . . . 10.0 110.46 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.0 m -60.11 -52.96 63.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.513 -0.767 . . . . 10.0 112.032 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 -33.68 48.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.521 0.934 . . . . 10.0 113.521 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 ptm -63.11 -45.32 92.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.701 0.286 . . . . 10.0 111.564 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.871 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 21.8 mt-10 -75.66 -27.71 58.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.305 0.574 . . . . 10.0 111.801 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -25.22 67.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.411 -0.813 . . . . 10.0 112.514 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.65 -25.34 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.17 0.51 . . . . 10.0 110.995 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.645 HD21 ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -111.95 -12.74 13.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.302 -178.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 70.7 43.38 0.74 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.217 1.008 . . . . 10.0 108.657 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.871 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.9 t -128.31 141.58 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 113.545 -1.662 . . . . 10.0 107.319 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.6 mmmt -128.55 136.05 50.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.583 0.706 . . . . 10.0 111.259 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.521 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -106.76 30.35 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.794 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -131.22 139.13 49.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.524 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.23 -149.47 18.7 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.429 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.7 -24.16 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 10.0 110.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.66 50.58 1.84 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 10.0 110.555 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.521 HG23 ' HA ' ' A' ' 140' ' ' LEU . 4.3 mm -65.28 138.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.987 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.24 3.48 87.17 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.345 -0.702 . . . . 10.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -136.04 163.06 52.97 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.938 -0.631 . . . . 10.0 109.846 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 20.6 Cg_endo -63.67 123.0 11.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.217 1.945 . . . . 10.0 111.328 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.606 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 22.7 tpt180 . . . . . 0 C--N 1.321 -0.639 0 CA-C-O 120.954 0.406 . . . . 10.0 109.973 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.8 ttt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.389 0.614 . . . . 10.0 110.255 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -136.88 85.43 23.42 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.101 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.41 153.91 12.22 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.467 2.111 . . . . 10.0 112.577 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.68 154.07 18.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.025 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -122.99 93.6 4.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.035 0.445 . . . . 10.0 110.223 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.96 137.54 46.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.105 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.46 -176.16 38.57 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.394 -0.908 . . . . 10.0 112.184 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.72 113.61 2.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.114 -0.565 . . . . 10.0 111.99 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.3 t -159.3 149.36 19.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.684 0.278 . . . . 10.0 110.341 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -125.0 -176.41 3.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.317 -0.402 . . . . 10.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.39 102.66 0.66 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.206 -0.997 . . . . 10.0 112.792 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -142.93 143.8 32.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.835 -0.432 . . . . 10.0 109.835 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.688 179.765 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 CA-C-O 120.569 0.223 . . . . 10.0 110.545 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.475 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.7 m -78.88 -30.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 121.033 -0.267 . . . . 10.0 111.199 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.28 137.6 5.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.65 -52.91 39.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.637 0.256 . . . . 10.0 111.533 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.58 -31.03 71.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.902 HG13 HD13 ' A' ' 140' ' ' LEU . 6.0 t -62.36 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.365 -1.289 . . . . 10.0 109.856 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -59.4 -47.86 88.81 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.784 -0.644 . . . . 10.0 112.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -61.12 -38.17 85.41 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.25 0.548 . . . . 10.0 110.065 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.32 68.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.357 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.784 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.5 mt -60.55 -45.81 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.763 -0.458 . . . . 10.0 109.763 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HG2' HE21 ' A' ' 89' ' ' GLN . 0.6 OUTLIER -69.04 -48.05 63.85 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.698 -0.482 . . . . 10.0 109.698 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 4.3 mm-40 -62.31 -34.7 77.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.33 -36.82 93.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.626 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.96 -36.25 31.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.211 0.529 . . . . 10.0 110.004 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.625 ' HA ' HG23 ' A' ' 97' ' ' THR . 86.6 mt-30 -74.49 -24.13 58.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.39 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 12.4 mptt -87.52 23.45 1.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 10.0 111.28 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -16.12 56.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.018 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 58.65 104.23 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.759 -1.11 . . . . 10.0 111.41 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.09 -60.92 0.06 OUTLIER 'Cis proline' 0 CA--C 1.516 -0.392 0 C-N-CA 123.78 -1.342 . . . . 10.0 113.037 0.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 92' ' ' GLN . 74.8 m -158.77 125.15 4.61 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.206 -0.907 . . . . 10.0 110.799 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.3 tpp -78.31 135.55 37.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.16 144.97 50.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.775 0.321 . . . . 10.0 111.09 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.35 -36.55 77.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.989 0.423 . . . . 10.0 110.215 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -65.14 -45.35 85.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 10.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -66.72 -39.95 88.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -63.6 -38.03 89.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -47.7 69.15 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.418 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 33.6 mmtp -59.2 -40.82 86.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.749 0.309 . . . . 10.0 110.663 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -33.87 73.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.066 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 103' ' ' LEU . 31.1 pt -95.54 -0.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 10.0 111.293 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.62 14.93 69.4 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.185 -0.531 . . . . 10.0 113.29 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -111.56 -157.97 0.63 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.6 p -119.3 174.7 6.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.493 0.187 . . . . 10.0 110.63 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.51 81.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.036 0.445 . . . . 10.0 109.804 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.54 72.29 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.447 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.0 m -64.78 -48.01 76.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.728 0.299 . . . . 10.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.8 -45.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 10.0 110.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.18 -31.69 72.68 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.061 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 m -76.64 -34.71 58.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.975 0.417 . . . . 10.0 111.768 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.32 -34.2 77.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.618 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.46 -17.6 59.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.819 0.342 . . . . 10.0 111.551 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 121' ' ' THR . 25.3 ttm180 -69.43 -28.09 65.83 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.226 0.536 . . . . 10.0 111.262 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.475 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.1 21.91 16.7 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.593 -0.813 . . . . 10.0 111.956 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 121' ' ' THR . 8.5 t -169.79 105.56 0.34 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.316 1.055 . . . . 10.0 109.438 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.88 25.13 0.09 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.497 -1.229 . . . . 10.0 109.636 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.7 m 67.56 106.7 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.111 -0.95 . . . . 10.0 110.737 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 129' ' ' LEU . 65.3 Cg_endo -73.99 88.66 1.07 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.572 2.181 . . . . 10.0 113.989 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.73 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.7 t70 -81.88 116.74 21.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.411 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 11.5 mm-40 -49.7 -46.77 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -62.09 -43.4 98.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.544 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.705 ' O ' ' HG3' ' A' ' 132' ' ' MET . 55.7 mt -63.55 -56.84 14.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 13.3 mt -47.44 -45.92 26.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.349 0.595 . . . . 10.0 110.744 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 71.4 m -56.58 -51.18 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.986 -1.006 . . . . 10.0 112.191 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -75.17 -30.66 60.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.705 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 31.4 mtp -56.36 -61.4 2.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 10.0 111.929 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.5 mp0 -76.37 -26.37 55.59 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HB3' ' O ' ' A' ' 130' ' ' SER . 12.3 ptt85 -58.61 -29.66 66.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.924 0.329 . . . . 10.0 111.364 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 131' ' ' LYS . 66.7 t -71.48 -33.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.0 0.429 . . . . 10.0 110.969 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.597 HD12 HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -95.16 -17.45 21.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.488 -178.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.9 t30 62.27 56.03 2.26 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.531 0.682 . . . . 10.0 109.536 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.597 HG22 HD12 ' A' ' 136' ' ' LEU . 11.9 m -137.19 159.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.44 -1.254 . . . . 10.0 108.715 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.5 mmpt? -127.25 139.77 52.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.905 ' HA ' HG23 ' A' ' 145' ' ' ILE . 11.2 mt -95.13 36.11 1.24 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.39 0.614 . . . . 10.0 110.282 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -135.62 155.72 50.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.627 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.02 -163.23 43.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.057 -0.592 . . . . 10.0 112.571 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.86 -12.49 36.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 10.0 110.854 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -104.86 49.89 0.8 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.11 0.481 . . . . 10.0 110.36 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 140' ' ' LEU . 22.7 mt -70.81 137.63 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.96 1.89 67.05 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.77 -0.932 . . . . 10.0 110.77 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -135.24 159.19 72.79 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -0.738 . . . . 10.0 109.217 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.17 120.99 9.29 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.029 1.819 . . . . 10.0 109.905 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 139' ' ' LYS . 7.3 tpp85 . . . . . 0 C--N 1.321 -0.666 0 O-C-N 121.899 -0.5 . . . . 10.0 110.629 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 120.747 0.308 . . . . 10.0 110.318 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.11 136.49 26.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.87 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.94 116.68 3.3 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.171 2.581 . . . . 10.0 112.685 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -83.31 115.11 21.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.156 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.93 141.53 35.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.665 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.85 149.78 22.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.852 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.13 -162.19 37.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.458 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.02 -166.64 23.24 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -154.35 148.94 26.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.907 0.384 . . . . 10.0 110.542 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -157.96 138.73 13.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.259 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.15 174.49 16.16 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.964 -0.636 . . . . 10.0 111.709 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -165.96 135.24 3.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 10.0 110.513 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.212 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 3.1 p . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 109.874 -0.417 . . . . 10.0 109.874 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.456 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.4 m -84.31 -30.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.968 -0.293 . . . . 10.0 111.444 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.1 140.27 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.253 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.71 -51.94 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.791 0.329 . . . . 10.0 111.092 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.21 -33.93 76.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 140' ' ' LEU . 13.1 t -61.88 -47.12 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.154 -0.93 . . . . 10.0 110.478 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -39.47 95.94 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.699 -0.762 . . . . 10.0 111.827 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.77 -40.32 91.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.38 83.18 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.822 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.465 HG23 ' CZ ' ' A' ' 91' ' ' ARG . 3.4 mt -54.25 -45.28 67.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.054 0.454 . . . . 10.0 110.503 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.87 -48.05 60.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.348 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.2 mt-30 -62.54 -37.65 86.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.147 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.98 -38.76 94.44 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.978 -0.556 . . . . 10.0 113.287 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.651 HH22 ' HB3' ' A' ' 132' ' ' MET . 0.5 OUTLIER -78.98 -38.62 36.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.808 0.337 . . . . 10.0 111.425 -178.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.678 ' HA ' HG23 ' A' ' 97' ' ' THR . 2.2 pt20 -72.49 -13.63 61.47 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.492 -0.483 . . . . 10.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 2.0 tttm -81.54 12.12 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -158.42 0.22 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 10.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.66 105.39 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.909 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.08 -30.41 5.33 Favored 'Cis proline' 0 C--N 1.348 0.504 0 C-N-CA 123.523 -1.449 . . . . 10.0 112.725 -0.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 92' ' ' GLN . 15.2 m -161.33 135.76 7.11 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.862 -1.517 . . . . 10.0 109.445 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.18 127.72 35.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.109 -0.33 . . . . 10.0 110.109 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.592 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 59.0 p -79.99 163.69 24.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 10.0 110.641 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.88 -28.91 67.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.87 -32.59 69.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.281 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.592 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 21.4 mm-40 -66.59 -54.97 17.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.547 0.213 . . . . 10.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.559 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -63.91 -40.4 96.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.212 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.38 -46.07 93.48 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 111.352 -0.699 . . . . 10.0 111.352 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -65.48 -44.34 87.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.95 -36.54 77.3 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.634 HD13 ' SD ' ' A' ' 132' ' ' MET . 36.4 pt -87.61 -12.46 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.777 -0.369 . . . . 10.0 111.74 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.86 22.45 30.68 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.888 -0.672 . . . . 10.0 113.476 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -119.89 -154.92 0.6 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 p -115.14 176.96 4.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.568 0.223 . . . . 10.0 110.719 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -34.19 75.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.817 0.342 . . . . 10.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.98 84.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.435 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -58.33 -48.2 81.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.164 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.98 -46.66 90.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.48 -37.84 87.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.274 0.559 . . . . 10.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 58.2 m -74.23 -26.28 60.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.092 -0.503 . . . . 10.0 110.652 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -43.27 69.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.464 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.72 -18.89 57.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.957 0.408 . . . . 10.0 111.035 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 116' ' ' SER . 45.3 ttp180 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.265 0.555 . . . . 10.0 110.411 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.456 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.06 21.49 22.86 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.868 -0.606 . . . . 10.0 111.783 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 121' ' ' THR . 8.0 t -174.62 114.35 0.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.026 0.917 . . . . 10.0 109.712 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.92 29.83 0.15 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.827 -1.079 . . . . 10.0 109.863 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m 58.88 93.1 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HG3' ' O ' ' A' ' 78' ' ' THR . 73.3 Cg_endo -71.45 104.67 1.61 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.926 2.418 . . . . 10.0 115.977 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.585 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 18.3 t70 -90.2 119.57 30.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 104.85 -2.278 . . . . 10.0 104.85 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -49.01 -46.65 44.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -63.3 -36.52 83.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.305 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.37 -55.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.852 -0.158 . . . . 10.0 110.914 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -54.42 -38.76 66.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.979 0.418 . . . . 10.0 110.616 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.6 m -58.69 -50.37 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.605 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -34.51 61.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.719 0.266 . . . . 10.0 111.719 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.651 ' HB3' HH22 ' A' ' 91' ' ' ARG . 5.3 mmm -52.52 -61.06 2.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.355 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HG3' ' HG ' ' A' ' 140' ' ' LEU . 49.4 mm-40 -76.49 -24.04 53.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.487 -0.779 . . . . 10.0 112.17 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 130' ' ' SER . 20.9 ttp180 -52.58 -40.73 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 10.0 111.805 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.98 -24.95 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 10.0 111.197 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -99.57 -16.39 18.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.974 -178.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 6.3 m-20 78.79 52.46 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.57 0.7 . . . . 10.0 109.908 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -133.17 159.49 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.886 -1.052 . . . . 10.0 108.248 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -130.15 -2.19 4.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.566 -0.854 . . . . 10.0 113.103 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.678 ' HB3' HG22 ' A' ' 83' ' ' VAL . 22.4 mt 54.61 10.51 0.35 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.792 -1.095 . . . . 10.0 113.699 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.573 HH21 HG21 ' A' ' 83' ' ' VAL . 4.3 mmt85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.297 -0.252 . . . . 10.0 110.47 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.74 -179.78 26.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.769 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.74 -25.05 48.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 10.0 109.9 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -89.37 56.48 3.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.571 -0.74 . . . . 10.0 110.845 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.68 139.28 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.054 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.54 61.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.088 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -150.46 162.0 28.82 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.577 . . . . 10.0 109.462 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 14.2 Cg_endo -61.83 122.73 11.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.618 1.545 . . . . 10.0 110.149 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 149' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.252 0 N-CA-C 110.315 -0.254 . . . . 10.0 110.315 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -100.71 147.17 33.27 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.539 -0.3 . . . . 10.0 110.723 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.41 151.79 83.23 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.216 2.61 . . . . 10.0 112.507 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -117.28 156.36 27.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -151.59 154.17 35.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -177.81 6.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.763 0.316 . . . . 10.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.37 -133.96 1.86 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.19 -0.529 . . . . 10.0 111.861 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.99 158.01 7.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.148 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -141.45 170.24 16.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.13 179.65 4.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 10.0 110.71 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -125.66 1.21 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.753 -0.737 . . . . 10.0 111.922 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.02 145.22 53.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.902 0.382 . . . . 10.0 110.687 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.991 179.845 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.659 0.266 . . . . 10.0 110.478 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 3.1 p -71.63 -33.89 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.116 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.06 130.18 3.1 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.438 -0.887 . . . . 10.0 112.192 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.99 -53.02 61.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.313 . . . . 10.0 111.089 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -65.34 -33.02 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.51 -0.552 . . . . 10.0 109.51 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 87' ' ' ILE . 92.9 t -62.69 -46.09 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.096 -0.956 . . . . 10.0 110.18 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -60.14 -42.77 98.7 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.973 -0.558 . . . . 10.0 113.176 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -69.24 -34.16 74.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 10.0 110.447 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.22 -29.68 66.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.707 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 83' ' ' VAL . 39.5 mt -59.27 -44.09 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 10.0 109.99 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.38 -54.63 11.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.245 0.545 . . . . 10.0 110.028 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 47.8 mt-30 -55.2 -38.19 68.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.975 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.46 -34.38 40.39 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.158 -1.02 . . . . 10.0 113.12 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.666 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -81.7 -26.03 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.053 0.454 . . . . 10.0 111.375 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG2' HG23 ' A' ' 97' ' ' THR . 71.5 mt-30 -75.21 -8.8 57.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.187 0.517 . . . . 10.0 109.905 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 8.4 mtpm? -76.63 8.13 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.973 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.62 -13.9 55.7 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.873 -0.331 . . . . 10.0 111.689 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER 61.04 111.1 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 O-C-N 124.32 1.013 . . . . 10.0 112.096 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.1 Cg_endo -76.0 -37.86 1.99 Allowed 'Cis proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.205 -1.581 . . . . 10.0 112.373 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 92' ' ' GLN . 3.0 m -170.98 135.85 1.06 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.973 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 33.9 tpp -70.79 127.02 31.21 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -63.18 146.64 52.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.572 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -64.74 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.979 0.419 . . . . 10.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.72 -47.22 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.23 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -68.31 -37.04 80.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.707 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -61.83 -44.24 97.24 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.72 97.97 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.346 -0.843 . . . . 10.0 111.513 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -62.9 -36.05 82.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.168 0.509 . . . . 10.0 110.331 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -71.94 -40.87 68.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.193 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.8 pt -82.53 -5.9 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 111.992 0.367 . . . . 10.0 111.992 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.9 28.45 37.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.837 -0.697 . . . . 10.0 112.907 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -130.14 -146.84 0.32 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.216 -0.661 . . . . 10.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.35 175.73 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.615 0.245 . . . . 10.0 111.097 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.24 91.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.726 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.75 76.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.671 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -60.27 -46.45 89.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.398 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 103' ' ' LEU . 39.2 t -65.49 -45.91 91.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.354 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.92 -32.87 74.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.86 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -77.2 -28.18 53.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.471 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -70.33 -39.71 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.125 0.417 . . . . 10.0 112.125 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.56 -19.51 57.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.091 0.472 . . . . 10.0 111.469 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.57 ' HG2' HG22 ' A' ' 121' ' ' THR . 12.1 ttm180 -72.89 -29.34 63.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.738 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.99 12.21 47.07 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.998 -0.62 . . . . 10.0 113.633 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.1 t -149.38 59.33 1.02 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.795 0.807 . . . . 10.0 111.022 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.2 27.53 9.42 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.613 -0.721 . . . . 10.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.4 m 64.97 109.38 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 123.627 0.58 . . . . 10.0 110.506 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 44.0 Cg_endo -70.37 88.37 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.171 1.914 . . . . 10.0 113.642 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.718 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.0 t70 -87.35 114.43 23.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.7 -1.222 . . . . 10.0 107.7 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.8 mm-40 -49.75 -45.64 49.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.472 0.483 . . . . 10.0 111.933 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 22.6 t30 -61.25 -44.97 96.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.822 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.594 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.5 mt -63.02 -55.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.181 -0.207 . . . . 10.0 110.648 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 6.3 mt -50.12 -41.38 48.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.356 0.598 . . . . 10.0 110.321 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 73.9 m -58.97 -43.55 91.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.124 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 135' ' ' VAL . 74.2 mmtt -72.98 -43.28 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.909 0.337 . . . . 10.0 111.909 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.594 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 14.3 mtp -49.28 -56.97 7.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.752 0.786 . . . . 10.0 111.841 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.442 ' CG ' HH12 ' A' ' 91' ' ' ARG . 11.8 mt-10 -73.93 -27.28 60.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -1.112 . . . . 10.0 113.083 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.604 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -68.72 -22.65 64.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.261 0.467 . . . . 10.0 112.261 -178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.6 t -66.9 -24.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 10.0 109.957 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.55 HD11 HH11 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -123.53 -96.54 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.151 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 19.0 p-10 173.42 31.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.2 m -111.55 147.62 15.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 2.9 mmpt? -115.6 132.92 56.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 10.0 110.711 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.503 HD13 HG13 ' A' ' 83' ' ' VAL . 40.8 mt -97.42 40.58 1.15 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -139.33 139.35 37.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.794 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.58 -157.8 19.83 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.651 -0.785 . . . . 10.0 112.802 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.29 -19.24 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.128 0.49 . . . . 10.0 111.16 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -97.75 54.07 1.14 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 14.1 mm -63.17 136.54 25.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.389 -0.823 . . . . 10.0 112.127 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.2 4.01 90.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.023 -0.608 . . . . 10.0 112.144 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.76 54.66 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.942 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 12.0 Cg_endo -58.5 121.86 10.68 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.803 2.335 . . . . 10.0 110.594 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.645 0 CA-C-O 121.556 0.693 . . . . 10.0 109.169 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.1 mtt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.583 0.23 . . . . 10.0 110.81 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.97 90.34 49.75 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.567 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -86.49 154.7 9.15 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.025 2.483 . . . . 10.0 112.994 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.49 141.34 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.209 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -159.89 151.68 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.712 0.291 . . . . 10.0 110.661 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.38 150.26 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.038 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.76 166.16 34.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.61 -0.805 . . . . 10.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.08 170.4 20.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.187 -0.53 . . . . 10.0 112.307 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 162.39 12.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.844 0.354 . . . . 10.0 111.274 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.91 -175.17 4.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.45 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.78 158.83 31.45 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.601 -0.6 . . . . 10.0 111.601 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.26 176.95 7.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.992 0.396 . . . . 10.0 110.975 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.095 179.749 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.1 m -88.24 -34.12 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.42 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.41 143.03 7.62 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.581 -0.818 . . . . 10.0 112.489 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -67.28 -55.67 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.641 0.237 . . . . 10.0 111.641 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.15 -35.39 80.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.543 0.687 . . . . 10.0 109.221 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.533 HG13 HD13 ' A' ' 140' ' ' LEU . 38.9 t -59.51 -45.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.681 -1.145 . . . . 10.0 110.411 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.11 97.76 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.117 -0.564 . . . . 10.0 112.476 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -65.04 -37.0 86.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 10.0 110.561 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.04 -30.63 67.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.176 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.468 HG12 ' NH2' ' A' ' 91' ' ' ARG . 17.8 mt -60.95 -46.28 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.403 0.621 . . . . 10.0 109.643 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.77 -50.88 31.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.048 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.69 -35.78 75.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.565 . . . . 10.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.71 -34.92 37.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.492 -1.337 . . . . 10.0 113.203 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HD2' HD21 ' A' ' 136' ' ' LEU . 1.3 mpt_? -81.24 -44.22 18.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 10.0 111.582 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' THR . 71.9 mt-30 -67.01 -18.33 65.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.656 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -81.16 29.58 0.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.715 0.293 . . . . 10.0 111.55 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.67 -3.84 51.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.835 0.309 . . . . 10.0 111.835 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 44.0 mt-10 60.13 109.14 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.021 0.826 . . . . 10.0 112.418 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 11.9 Cg_exo -73.62 -54.39 0.15 OUTLIER 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.816 -1.327 . . . . 10.0 112.788 -0.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 13.1 m -161.62 123.14 2.83 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.134 -0.939 . . . . 10.0 110.582 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.5 ttm -64.59 128.84 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.828 0.346 . . . . 10.0 110.438 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.6 p -76.81 157.3 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -66.97 -28.78 68.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.413 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.66 80.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.194 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 46.7 mm-40 -64.51 -53.88 41.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.747 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 114' ' ' VAL . 22.5 tp -60.47 -40.13 90.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.31 -45.68 95.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.684 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -64.36 -44.18 92.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 10.0 110.402 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 58.0 mm-40 -61.47 -41.0 96.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 10.0 112.113 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 131' ' ' LYS . 43.9 pt -84.59 -14.91 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 111.931 0.345 . . . . 10.0 111.931 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.16 41.34 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.969 -0.634 . . . . 10.0 113.225 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -121.95 -176.13 3.27 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.03 163.59 14.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.655 0.264 . . . . 10.0 110.767 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.81 -35.29 76.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 10.0 110.842 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.31 71.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -66.91 -47.4 71.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.599 HG13 HD23 ' A' ' 103' ' ' LEU . 61.2 t -62.46 -43.5 98.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.637 -0.71 . . . . 10.0 110.503 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.31 80.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.403 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 7.2 t -74.29 -30.77 62.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.183 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.09 -44.71 94.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.171 -0.468 . . . . 10.0 111.536 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.59 -19.08 65.69 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.985 -0.286 . . . . 10.0 111.148 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 116' ' ' SER . 20.7 ttp180 -71.92 -22.78 61.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.417 0.627 . . . . 10.0 109.534 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.422 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 100.45 25.49 8.71 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.522 -0.763 . . . . 10.0 112.132 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 121' ' ' THR . 10.3 t -174.2 111.97 0.17 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.975 0.893 . . . . 10.0 110.467 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.35 33.42 0.09 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.99 -1.005 . . . . 10.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m 60.76 99.99 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.312 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.19 88.82 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.878 2.386 . . . . 10.0 115.06 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.5 t70 -86.01 117.07 24.62 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 105.856 -1.905 . . . . 10.0 105.856 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -51.51 -41.28 60.88 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.613 0.571 . . . . 10.0 112.178 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.495 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 53.4 t30 -65.63 -44.15 87.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.62 ' O ' ' HG3' ' A' ' 132' ' ' MET . 79.4 mt -59.87 -53.93 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.7 mt -48.75 -48.02 41.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.478 0.656 . . . . 10.0 109.736 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.9 m -55.12 -39.84 69.84 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.803 -1.09 . . . . 10.0 111.189 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HB2' HG22 ' A' ' 107' ' ' ILE . 66.8 mmtt -71.72 -48.07 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.62 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 10.1 mtp -52.33 -52.29 54.01 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.86 0.838 . . . . 10.0 111.213 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 32.4 mt-10 -72.56 -29.28 63.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.553 -1.203 . . . . 10.0 113.17 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.2 ttp85 -64.43 -28.92 70.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.8 t -64.0 -31.97 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.917 HD23 HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.16 2.77 9.25 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.539 0.94 . . . . 10.0 113.539 -178.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.51 43.38 16.19 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.917 HG22 HD23 ' A' ' 136' ' ' LEU . 31.4 m -131.96 138.47 52.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.501 ' CG ' ' H ' ' A' ' 149' ' ' ARG . 30.4 mmmt -114.06 149.98 34.68 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.466 -0.494 . . . . 10.0 111.364 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.765 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -110.6 15.34 22.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.191 -0.913 . . . . 10.0 109.866 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -115.65 140.68 48.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.434 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.46 -162.81 29.59 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.21 -26.58 21.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.978 0.418 . . . . 10.0 111.117 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -87.74 54.91 3.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.004 0.431 . . . . 10.0 111.726 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.765 HG23 ' HA ' ' A' ' 140' ' ' LEU . 73.6 mt -74.41 142.33 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.1 73.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.688 -0.965 . . . . 10.0 110.688 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.0 156.78 76.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.639 -0.78 . . . . 10.0 109.398 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -61.94 123.72 13.13 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.826 1.684 . . . . 10.0 109.667 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.501 ' H ' ' CG ' ' A' ' 139' ' ' LYS . 23.3 tpt180 . . . . . 0 C--N 1.324 -0.533 0 CA-C-O 121.21 0.528 . . . . 10.0 110.931 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mtp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 110.147 -0.316 . . . . 10.0 110.147 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -151.15 145.42 18.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.124 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.06 147.79 34.19 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.71 2.274 . . . . 10.0 112.619 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.77 143.29 57.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.742 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -72.03 150.36 44.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.423 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.68 30.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.1 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.88 157.19 15.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.241 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.36 169.54 32.17 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.828 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -147.49 97.04 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.062 0.458 . . . . 10.0 110.995 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.06 149.71 24.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.623 -0.51 . . . . 10.0 109.623 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.96 -170.34 12.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.585 -0.817 . . . . 10.0 112.779 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -157.81 167.27 30.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.113 -0.328 . . . . 10.0 110.113 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.981 -179.51 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 109.976 -0.379 . . . . 10.0 109.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.4 m -83.4 -27.61 7.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.759 -0.376 . . . . 10.0 110.69 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.9 139.19 6.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 10.0 111.719 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -65.23 -56.29 13.63 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.709 0.29 . . . . 10.0 111.294 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.56 -32.94 74.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' ILE . 38.5 t -62.15 -43.71 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.224 -0.898 . . . . 10.0 109.857 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.28 99.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.405 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -63.28 -37.81 88.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.622 . . . . 10.0 109.777 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.5 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . . . -73.92 -29.78 62.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.617 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.729 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 12.4 mt -58.39 -52.3 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.99 -48.98 66.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.552 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -60.6 -29.27 69.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.354 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.56 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -76.28 -37.84 35.66 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.422 -0.894 . . . . 10.0 113.051 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.5 mmt180 -79.65 -43.75 22.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.28 0.54 . . . . 10.0 110.747 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.2 -5.44 27.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.04 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 38.8 tttt -78.91 -10.9 59.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.835 0.35 . . . . 10.0 110.643 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.61 172.35 4.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.38 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -120.31 125.12 27.38 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.507 -0.315 . . . . 10.0 110.387 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.52 -39.51 1.3 Allowed 'Cis proline' 0 CA--C 1.519 -0.258 0 C-N-CA 123.617 -1.409 . . . . 10.0 112.544 -0.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.5 m -170.61 120.95 0.58 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.608 -1.178 . . . . 10.0 109.333 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 35.3 tpp -65.28 122.5 17.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.8 p -74.47 159.27 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.033 0.444 . . . . 10.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -68.91 -37.66 79.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.178 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.1 -41.67 90.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.02 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -66.19 -46.15 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.144 -0.222 . . . . 10.0 110.808 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tp -65.45 -39.56 92.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.15 -47.55 90.24 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.147 -0.933 . . . . 10.0 111.384 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.82 -43.41 98.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -60.65 -41.74 95.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.899 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 103' ' ' LEU . 38.9 pt -82.84 -7.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.895 0.332 . . . . 10.0 111.895 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.22 29.99 29.3 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.648 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.51 -154.0 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.51 172.36 7.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.535 -0.172 . . . . 10.0 110.535 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.42 89.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.02 0.438 . . . . 10.0 110.336 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.77 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.639 -0.71 . . . . 10.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -62.22 -46.64 87.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 10.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.0 t -65.67 -43.76 93.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.451 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -65.96 -35.09 79.64 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.208 0.527 . . . . 10.0 111.085 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 68.9 m -77.3 -27.71 53.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.459 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -37.92 89.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.5 -17.83 56.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.575 ' HG2' HG22 ' A' ' 121' ' ' THR . 5.1 ttm180 -64.9 -23.84 67.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.305 0.574 . . . . 10.0 110.405 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.422 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.42 24.28 14.53 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.678 -0.772 . . . . 10.0 111.647 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.575 HG22 ' HG2' ' A' ' 119' ' ' ARG . 8.4 t -175.0 115.02 0.15 Allowed 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.829 0.823 . . . . 10.0 109.549 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.58 30.56 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.898 -1.046 . . . . 10.0 109.585 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.7 m 62.32 97.6 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.08 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.97 90.95 0.94 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.85 2.367 . . . . 10.0 114.515 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.611 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -80.87 124.75 29.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.189 -2.152 . . . . 10.0 105.189 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.3 mm-40 -51.63 -42.69 62.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -176.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -63.99 -39.13 93.42 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.678 0.611 . . . . 10.0 110.84 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.768 ' O ' ' HG3' ' A' ' 132' ' ' MET . 96.9 mt -64.3 -57.08 12.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 120.751 -0.379 . . . . 10.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.3 mt -50.47 -45.65 56.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.505 0.503 . . . . 10.0 110.592 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.2 m -55.32 -46.44 76.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.449 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 135' ' ' VAL . 19.1 mtmt -73.55 -40.35 64.03 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.768 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 29.6 mtp -52.06 -55.22 22.02 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.857 0.837 . . . . 10.0 111.011 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.669 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 27.1 mt-10 -72.98 -31.81 64.78 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.463 -1.244 . . . . 10.0 113.361 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -69.88 -23.43 63.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 131' ' ' LYS . 57.4 t -61.51 -38.17 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 10.0 111.805 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.909 HD22 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -114.53 -5.91 12.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.92 46.41 0.48 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.226 1.013 . . . . 10.0 109.412 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.669 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 47.7 t -122.68 138.91 51.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.648 -1.614 . . . . 10.0 106.943 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 13.4 mmmm -122.79 140.29 53.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 118.842 0.747 . . . . 10.0 111.792 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.726 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -111.57 18.26 19.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -113.98 140.53 48.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.494 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.39 -156.61 25.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.749 -0.738 . . . . 10.0 111.92 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.04 0.74 41.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.089 0.471 . . . . 10.0 110.96 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -110.36 51.1 0.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.799 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.726 HG23 ' HA ' ' A' ' 140' ' ' LEU . 49.0 mt -72.54 136.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.519 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.54 4.4 62.28 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.996 -0.841 . . . . 10.0 110.996 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.28 156.87 73.47 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.278 -0.461 . . . . 10.0 110.245 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -64.55 122.31 10.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.897 1.731 . . . . 10.0 109.387 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.635 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 15.7 tpt180 . . . . . 0 C--N 1.319 -0.735 0 CA-C-O 121.094 0.473 . . . . 10.0 110.052 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.8 tpt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.875 0.369 . . . . 10.0 110.909 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.84 143.5 48.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 166.65 28.42 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.638 2.225 . . . . 10.0 113.245 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.63 162.64 16.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.847 -0.615 . . . . 10.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -145.18 157.78 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.2 144.66 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.21 175.51 42.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.247 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.62 148.85 18.68 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.751 -0.738 . . . . 10.0 112.453 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.6 m -91.64 127.88 37.26 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.039 -0.356 . . . . 10.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.73 167.17 15.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.997 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.04 166.77 28.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.714 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -123.06 165.17 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.813 0.306 . . . . 10.0 111.026 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.331 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 110.196 -0.298 . . . . 10.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.5 m -82.88 -29.94 8.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.831 0.308 . . . . 10.0 111.831 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.31 140.7 8.04 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.111 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.46 -49.84 67.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.882 0.341 . . . . 10.0 111.682 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -59.35 -38.45 80.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.375 0.607 . . . . 10.0 109.742 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.03 -42.93 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.1 -0.955 . . . . 10.0 110.134 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -64.29 -43.61 96.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.14 -0.552 . . . . 10.0 112.538 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -61.34 -43.06 99.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.188 0.518 . . . . 10.0 109.902 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -69.83 -29.69 67.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.33 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.799 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.2 mt -58.1 -48.54 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.981 -0.378 . . . . 10.0 109.981 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.69 -48.57 63.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.248 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.26 -33.39 73.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.67 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.73 -30.15 68.72 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.793 -0.639 . . . . 10.0 113.264 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.799 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 13.0 mmt85 -77.37 -29.41 53.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -79.1 -8.06 58.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 10.0 109.717 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -75.14 -8.5 56.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.929 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -168.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 40.8 mt-10 -133.21 110.35 12.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.469 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.7 Cg_endo -78.13 -30.64 5.69 Favored 'Cis proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.225 -1.573 . . . . 10.0 112.522 -0.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.6 m -170.45 134.37 1.13 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.802 -1.544 . . . . 10.0 109.65 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 122.13 22.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.5 p -69.89 158.15 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 10.0 111.102 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -67.41 -36.08 80.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.845 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.58 78.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.358 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.47 -47.17 86.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.362 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -64.94 -40.71 95.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.574 -0.528 . . . . 10.0 109.574 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -48.38 81.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.214 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -64.02 -38.04 89.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.966 0.412 . . . . 10.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -39.39 92.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.635 -0.711 . . . . 10.0 111.296 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 103' ' ' LEU . 32.6 pt -89.07 -28.63 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.85 6.1 21.35 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.59 -0.814 . . . . 10.0 112.818 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -106.33 -164.39 1.0 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 171.07 7.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.103 -0.239 . . . . 10.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.85 -38.05 80.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 10.0 110.402 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.42 75.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.526 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 9.7 m -66.98 -40.28 87.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.283 0.563 . . . . 10.0 110.271 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.75 -37.23 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.82 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -72.44 -33.03 66.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.38 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 52.3 p -76.58 -29.1 56.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.924 0.392 . . . . 10.0 111.6 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.3 m-85 -63.18 -36.7 84.49 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -63.61 -18.57 64.05 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' A' ' 121' ' ' THR . 61.5 ttt180 -68.13 -18.76 64.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.229 0.538 . . . . 10.0 110.657 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.417 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 91.3 28.84 13.6 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.247 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.527 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.2 t -175.96 111.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.917 0.865 . . . . 10.0 109.793 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.94 34.34 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.946 -1.025 . . . . 10.0 110.057 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m 63.28 99.23 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.454 -0.793 . . . . 10.0 109.137 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' HD21 ' A' ' 129' ' ' LEU . 92.2 Cg_endo -77.16 88.55 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.996 2.464 . . . . 10.0 115.727 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.592 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 5.9 t70 -81.68 116.07 21.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 17.6 mm-40 -48.65 -41.11 30.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.6 t30 -68.78 -42.24 77.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.783 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.583 ' O ' ' HG3' ' A' ' 132' ' ' MET . 66.7 mt -60.46 -55.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 121.186 -0.206 . . . . 10.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 7.5 mt -47.65 -47.23 29.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.659 0.599 . . . . 10.0 110.325 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.0 m -57.95 -38.65 76.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.211 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 74.6 mmtt -73.66 -36.78 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 10.0 111.464 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.583 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 18.9 mtp -54.22 -57.15 12.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.481 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.604 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -73.36 -26.69 61.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.871 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.58 -38.54 60.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.43 -26.7 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.881 -0.327 . . . . 10.0 111.234 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -92.33 -21.18 20.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.252 0.464 . . . . 10.0 112.252 -178.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 57.5 m-20 70.45 48.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.601 0.715 . . . . 10.0 110.184 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.06 169.41 21.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.852 -1.067 . . . . 10.0 108.557 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -137.64 133.21 34.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.938 0.399 . . . . 10.0 110.45 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.695 ' HA ' HG23 ' A' ' 145' ' ' ILE . 8.2 mt -100.86 12.0 38.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.583 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -125.4 139.86 53.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.94 -153.72 17.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.342 -0.703 . . . . 10.0 111.342 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.99 -33.57 10.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.968 0.413 . . . . 10.0 111.16 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -87.43 55.65 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.263 0.554 . . . . 10.0 110.576 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.695 HG23 ' HA ' ' A' ' 140' ' ' LEU . 71.0 mt -69.0 141.17 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.658 . . . . 10.0 111.323 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.94 -5.54 84.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.152 -0.546 . . . . 10.0 111.831 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.64 158.21 62.92 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.304 -0.448 . . . . 10.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.01 122.47 10.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.167 1.912 . . . . 10.0 110.849 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 121.546 0.689 . . . . 10.0 110.046 -179.711 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.5 mtm . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.835 -0.431 . . . . 10.0 109.835 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.18 121.85 6.7 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.612 -0.267 . . . . 10.0 110.366 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.85 122.03 10.39 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.661 2.24 . . . . 10.0 112.425 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.35 137.87 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.596 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -138.44 140.21 39.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.806 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -104.28 -44.64 4.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.032 0.444 . . . . 10.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.61 -119.8 5.06 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.416 -0.674 . . . . 10.0 111.416 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 141.36 117.37 1.34 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.9 m -103.62 142.15 34.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.749 0.309 . . . . 10.0 110.648 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.12 -150.51 0.43 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.267 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.09 -168.05 40.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.013 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -154.17 176.94 11.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 10.0 110.998 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.108 179.738 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.449 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 23.6 p . . . . . 0 CA--C 1.531 0.228 0 CA-C-O 120.702 0.287 . . . . 10.0 110.764 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.676 HG12 HG21 ' A' ' 83' ' ' VAL . 3.0 t -82.26 -68.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.628 -0.26 . . . . 10.0 111.299 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.438 ' C ' HG22 ' A' ' 83' ' ' VAL . . . 146.64 161.6 9.4 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 111.574 -0.611 . . . . 10.0 111.574 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.5 ' HG2' ' H ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -78.87 -55.02 5.47 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 -178.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.1 tp10 -71.97 -28.61 63.54 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.511 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.676 HG21 HG12 ' A' ' 79' ' ' VAL . 6.6 m -64.27 -36.4 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.252 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.16 -47.22 90.08 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.496 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.33 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 10.0 110.816 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.78 68.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.414 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.757 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.3 mt -61.23 -49.76 83.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.95 -53.06 60.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.622 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.4 mt-30 -59.22 -39.8 83.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.043 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.47 -35.34 91.59 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.855 -0.688 . . . . 10.0 113.544 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.4 -39.63 28.01 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.042 0.449 . . . . 10.0 110.509 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -69.91 -25.1 63.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.733 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 39.2 tttm -80.0 54.42 1.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.712 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -126.1 3.38 7.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 38.7 mt-10 54.99 101.24 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.915 0.759 . . . . 10.0 112.817 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.5 Cg_endo -82.79 -30.56 4.63 Favored 'Cis proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.176 -1.593 . . . . 10.0 112.61 -0.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -174.81 129.78 0.32 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.837 -1.529 . . . . 10.0 110.007 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.6 tpp -76.69 143.1 40.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.929 -0.397 . . . . 10.0 109.929 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 145.39 50.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.631 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.69 -41.89 74.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.062 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.68 83.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.953 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -70.93 -32.01 68.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.492 -0.322 . . . . 10.0 110.339 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 103' ' ' LEU . 1.1 tm? -63.81 -43.38 96.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.02 -37.4 91.99 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.157 -0.929 . . . . 10.0 111.357 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -65.47 -35.4 80.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 10.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.71 -40.49 84.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.844 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 29.6 pt -87.81 -22.54 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 34.38 5.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.478 -0.868 . . . . 10.0 112.382 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -129.64 -171.79 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.859 0.362 . . . . 10.0 110.444 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 166.96 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.567 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.4 91.01 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.523 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.71 -32.86 70.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.55 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -60.43 -47.09 87.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.096 -0.502 . . . . 10.0 109.998 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.48 -46.47 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.8 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.59 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.32 -35.86 80.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.322 0.582 . . . . 10.0 111.069 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.3 m -75.26 -27.96 59.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.635 ' OH ' ' HA ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -63.74 -38.91 92.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.801 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -65.09 -18.42 65.29 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.053 0.39 . . . . 10.0 112.053 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.621 ' HG2' HG22 ' A' ' 121' ' ' THR . 19.4 ttt180 -78.39 -18.67 54.71 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.62 14.54 46.7 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.431 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.621 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -160.04 106.1 1.58 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.173 0.987 . . . . 10.0 109.802 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.89 24.6 0.5 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.714 -1.13 . . . . 10.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m 59.67 80.63 0.27 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.288 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.635 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 72.9 Cg_endo -75.21 158.8 41.18 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.785 2.323 . . . . 10.0 114.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.6 t70 -137.48 140.17 41.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.257 -1.338 . . . . 10.0 107.86 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.4 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 6.2 mm-40 -54.73 -40.2 69.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.586 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.97 -35.45 72.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.548 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.738 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.1 mt -66.78 -57.33 10.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 120.581 -0.448 . . . . 10.0 110.234 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.3 mt -50.13 -39.64 43.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.744 0.783 . . . . 10.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 72.1 m -62.56 -50.32 71.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 10.0 111.488 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.586 ' HD3' ' O ' ' A' ' 127' ' ' ASN . 1.5 mptp? -74.91 -31.33 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 10.0 112.449 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.738 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 52.9 mtp -60.32 -59.38 5.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.577 0.703 . . . . 10.0 111.403 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.695 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 2.9 mp0 -74.56 -25.49 59.33 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 19.6 ptt180 -56.87 -26.9 59.63 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.358 0.526 . . . . 10.0 111.395 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.09 -25.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.148 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.637 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -100.29 -19.23 16.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.795 0.294 . . . . 10.0 111.795 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 68.34 43.16 1.52 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.606 0.717 . . . . 10.0 111.312 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.695 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.8 m -136.68 140.1 43.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.342 -1.355 . . . . 10.0 107.342 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 3.4 mmpt? -116.65 135.49 53.75 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.806 -0.758 . . . . 10.0 111.058 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.416 HD13 ' HB ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -102.29 36.05 2.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.125 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -138.21 139.21 39.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.235 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.14 -163.07 21.99 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.309 -0.716 . . . . 10.0 111.309 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.92 23.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.968 0.413 . . . . 10.0 110.399 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -85.93 55.27 3.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.752 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.57 138.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.91 2.5 90.67 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.464 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.32 160.68 56.46 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.815 -0.192 . . . . 10.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -62.52 120.37 7.87 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.451 1.434 . . . . 10.0 109.506 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? . . . . . 0 C--N 1.318 -0.787 0 CA-C-O 120.771 0.32 . . . . 10.0 110.178 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.1 mtm . . . . . 0 CA--C 1.521 -0.157 0 N-CA-C 110.239 -0.282 . . . . 10.0 110.239 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 t70 62.0 99.19 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 123.818 0.699 . . . . 10.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -88.9 164.61 5.98 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.995 2.463 . . . . 10.0 111.797 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.01 139.89 50.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.224 -0.287 . . . . 10.0 110.224 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -121.41 169.91 10.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.364 . . . . 10.0 110.868 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.81 172.5 17.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.901 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.94 121.0 2.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.518 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.5 124.24 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.025 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 t -144.54 139.08 27.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.006 0.432 . . . . 10.0 110.429 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -106.83 -65.79 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.66 175.27 29.63 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.771 -0.65 . . . . 10.0 111.82 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -155.3 138.89 15.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.774 -0.454 . . . . 10.0 109.774 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 63' ' ' ARG . 14.9 tpt180 . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 121' ' ' THR . 4.9 m -79.87 -35.14 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.822 -0.351 . . . . 10.0 111.063 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.95 147.9 6.85 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.97 -53.05 35.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.068 0.434 . . . . 10.0 111.626 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -69.15 -33.45 73.43 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.759 HG13 HD22 ' A' ' 140' ' ' LEU . 38.3 t -58.72 -41.28 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.69 -1.141 . . . . 10.0 109.951 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.8 -41.47 97.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.131 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -64.56 -45.11 88.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.946 0.403 . . . . 10.0 109.958 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.05 77.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.733 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.678 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.6 mt -58.73 -46.01 90.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.733 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.12 -49.15 59.65 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.042 0.448 . . . . 10.0 110.401 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -61.4 -36.55 80.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.7 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.56 98.01 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.039 -0.528 . . . . 10.0 114.013 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 17.7 mmt-85 -69.84 -36.58 75.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.383 0.591 . . . . 10.0 110.254 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 97' ' ' THR . 70.3 mt-30 -82.42 -5.89 58.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.781 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -89.03 14.58 10.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.846 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.87 -17.7 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.876 0.325 . . . . 10.0 111.876 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 60.55 106.95 0.03 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.937 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.98 -59.03 0.14 OUTLIER 'Cis proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.534 -1.444 . . . . 10.0 112.347 0.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 92' ' ' GLN . 72.0 m -157.51 124.07 4.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.878 -1.055 . . . . 10.0 110.732 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.6 tpp -72.49 141.66 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 142.75 55.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.995 0.426 . . . . 10.0 111.037 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -70.5 -37.37 74.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.473 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.23 76.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.195 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.06 -41.93 40.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.817 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.453 ' HG ' ' HD2' ' A' ' 91' ' ' ARG . 1.2 tm? -64.11 -38.33 90.67 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.1 -46.24 59.19 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.391 -0.822 . . . . 10.0 111.555 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -58.09 -39.06 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 10.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.08 -39.29 89.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.301 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.453 HD12 HG23 ' A' ' 128' ' ' ILE . 17.6 pt -92.91 4.01 7.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.15 71.88 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.959 -0.638 . . . . 10.0 113.926 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.414 ' OE1' HG21 ' A' ' 113' ' ' THR . 32.0 mm-40 -109.46 -162.8 0.82 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.0 p -125.24 174.7 7.92 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.252 -0.28 . . . . 10.0 111.048 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.84 87.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.321 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.31 77.62 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.347 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.414 HG21 ' OE1' ' A' ' 109' ' ' GLU . 2.6 m -62.4 -50.32 72.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.43 -42.68 91.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 10.0 110.232 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.44 -37.04 82.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.925 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 m -74.84 -27.44 60.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.17 -0.468 . . . . 10.0 111.967 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.33 -32.75 70.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.153 0.427 . . . . 10.0 112.153 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -18.14 41.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 121' ' ' THR . 1.6 ttt85 -61.89 -24.01 66.67 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.02 0.438 . . . . 10.0 111.093 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.13 23.8 11.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.348 -0.93 . . . . 10.0 113.933 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -154.73 -88.46 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.824 0.312 . . . . 10.0 110.651 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.684 ' H ' HG23 ' A' ' 121' ' ' THR . . . 58.78 11.79 1.98 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.527 0.936 . . . . 10.0 113.527 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.8 m 45.64 76.59 0.53 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.608 ' HB2' HD21 ' A' ' 129' ' ' LEU . 42.6 Cg_endo -89.01 147.46 5.58 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.308 2.672 . . . . 10.0 116.962 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.31 129.33 42.48 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 103.994 -2.595 . . . . 10.0 103.994 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -55.84 -29.55 60.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 107' ' ' ILE . 68.8 mt -68.41 -48.4 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 110.431 -0.211 . . . . 10.0 110.431 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' A' ' 124' ' ' PRO . 5.4 mt -57.76 -36.47 72.15 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.404 0.621 . . . . 10.0 109.883 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -66.04 -49.52 67.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.142 -0.935 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -74.48 -38.62 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.751 1.019 . . . . 10.0 113.751 -178.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.418 ' HG3' ' HG2' ' A' ' 133' ' ' GLU . 7.1 ptm -61.2 -50.25 73.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.009 0.368 . . . . 10.0 111.543 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.627 ' CD ' HH22 ' A' ' 91' ' ' ARG . 15.5 mm-40 -76.91 -29.03 55.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.253 0.834 . . . . 10.0 113.253 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -62.61 -23.38 67.02 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.133 -0.354 . . . . 10.0 111.478 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 131' ' ' LYS . 59.1 t -63.1 -34.18 65.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.189 0.519 . . . . 10.0 110.311 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.516 HD11 ' OE1' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.12 3.65 28.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.881 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.6 t30 70.18 51.79 0.39 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.579 0.704 . . . . 10.0 110.27 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.484 ' CG2' HD12 ' A' ' 136' ' ' LEU . 22.2 t -132.59 152.32 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.129 -0.941 . . . . 10.0 109.606 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 26.0 mmmt -131.04 145.15 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 10.0 110.512 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.759 HD22 HG13 ' A' ' 83' ' ' VAL . 27.6 mt -106.86 20.16 19.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.118 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -134.21 139.28 45.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.841 0.353 . . . . 10.0 110.948 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.33 -157.37 15.15 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.543 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.41 -30.59 14.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.075 0.464 . . . . 10.0 110.007 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.83 59.04 5.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.645 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.5 mm -66.9 137.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 10.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.45 10.32 85.46 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.23 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -133.81 157.14 78.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.372 -0.414 . . . . 10.0 110.381 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.12 123.82 13.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.557 2.171 . . . . 10.0 111.235 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 5.2 tmm_? . . . . . 0 C--N 1.321 -0.647 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.2 ttm . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.861 0.363 . . . . 10.0 110.916 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.08 146.04 31.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.945 -0.57 . . . . 10.0 109.903 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.9 168.46 24.15 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.402 . . . . 10.0 112.699 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -107.6 160.01 16.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.799 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.89 136.89 25.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.725 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.72 168.32 26.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 10.0 111.122 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.58 170.04 29.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.9 -178.69 25.08 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.398 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -147.72 138.42 23.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.118 -0.327 . . . . 10.0 110.118 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -94.55 -64.66 1.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.988 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.65 -166.89 13.76 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.896 -0.669 . . . . 10.0 111.475 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.54 145.76 9.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.074 0.437 . . . . 10.0 110.802 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.294 179.525 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.1 p . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.449 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.5 m -88.35 -25.37 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.567 -0.453 . . . . 10.0 111.541 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.32 138.57 5.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.906 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -67.65 -39.56 84.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 10.0 111.861 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.99 -31.49 50.7 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 140' ' ' LEU . 42.7 t -66.02 -40.22 86.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.184 -0.916 . . . . 10.0 110.056 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.39 -41.74 95.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.891 -0.671 . . . . 10.0 112.12 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -39.5 74.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.163 0.506 . . . . 10.0 110.051 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.32 70.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.817 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 83' ' ' VAL . 7.9 mt -59.47 -45.53 93.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.081 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.93 -53.87 13.44 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.754 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 35.0 mt-30 -54.05 -34.91 61.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.351 -0.84 . . . . 10.0 111.267 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.4 -34.87 39.04 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.754 -0.736 . . . . 10.0 112.766 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.651 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -80.13 -33.61 38.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.019 0.438 . . . . 10.0 110.357 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -73.33 -2.62 22.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.1 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 48.4 mttm -83.25 -2.68 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.015 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -78.0 177.06 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.584 -0.735 . . . . 10.0 110.589 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -120.69 121.27 29.13 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.319 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.98 -29.32 6.82 Favored 'Cis proline' 0 CA--C 1.515 -0.445 0 C-N-CA 123.723 -1.365 . . . . 10.0 112.693 -0.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 m -179.05 122.43 0.08 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 113.754 -1.566 . . . . 10.0 109.324 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.8 ttm -70.46 110.87 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.211 -0.292 . . . . 10.0 110.211 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.577 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.9 p -78.51 172.37 13.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.869 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -62.84 -35.7 80.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.769 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.73 -42.42 81.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.005 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.577 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 16.8 mm-40 -68.52 -48.82 63.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.917 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -61.06 -42.22 98.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.34 98.16 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.575 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -65.99 -36.03 82.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.792 0.33 . . . . 10.0 110.659 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.26 -40.99 77.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.792 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.52 HG22 ' HB3' ' A' ' 131' ' ' LYS . 35.9 pt -83.48 -17.71 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.884 -0.326 . . . . 10.0 111.689 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.91 27.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 10.0 112.77 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -119.89 -169.71 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.769 0.318 . . . . 10.0 110.225 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.7 p -98.98 168.2 10.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.535 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.05 78.6 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.863 0.364 . . . . 10.0 110.623 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.244 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.221 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.77 -43.2 90.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -64.02 -35.23 80.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.443 0.64 . . . . 10.0 110.463 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 48.9 m -76.13 -27.03 56.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.18 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -43.16 77.39 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.676 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.24 -18.69 59.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.975 0.417 . . . . 10.0 111.729 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 116' ' ' SER . 48.3 ttp180 -67.25 -21.63 65.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.312 0.577 . . . . 10.0 110.636 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 95.22 20.34 28.02 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.728 -0.749 . . . . 10.0 111.692 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.416 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.3 t -172.62 108.36 0.19 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.01 0.91 . . . . 10.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.28 30.29 0.2 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.544 -1.207 . . . . 10.0 109.547 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.8 m 60.63 96.4 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.126 -0.943 . . . . 10.0 110.032 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 123' ' ' THR . 47.2 Cg_endo -65.42 94.84 0.26 Allowed 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 123.173 2.582 . . . . 10.0 113.952 -177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.715 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.0 t70 -85.97 120.0 26.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.616 -1.253 . . . . 10.0 107.616 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.2 mm-40 -52.98 -37.97 61.79 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.466 0.479 . . . . 10.0 111.89 -177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -68.49 -44.36 74.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.047 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.639 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.9 mt -64.13 -54.11 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.185 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 17.6 mt -50.61 -41.83 55.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.269 0.557 . . . . 10.0 110.189 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.3 m -59.61 -49.72 76.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.274 -0.875 . . . . 10.0 111.096 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.8 mptp? -67.48 -40.26 85.27 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.377 0.51 . . . . 10.0 112.377 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.639 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -49.01 -58.31 5.12 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.441 0.638 . . . . 10.0 111.765 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 24.9 mt-10 -75.38 -28.63 59.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.413 -0.812 . . . . 10.0 112.805 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -64.88 -22.97 67.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.926 0.713 . . . . 10.0 112.926 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 131' ' ' LYS . 21.2 t -67.9 -25.0 31.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.631 . . . . 10.0 110.006 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -122.17 -100.44 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.198 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.593 ' H ' HD12 ' A' ' 136' ' ' LEU . 63.5 t30 174.29 64.02 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.407 -0.815 . . . . 10.0 109.251 -177.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.3 OUTLIER -136.23 155.83 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.274 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.489 ' HA ' ' OE1' ' A' ' 133' ' ' GLU . 4.6 mmtm -130.82 132.36 45.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.044 0.45 . . . . 10.0 110.969 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.772 ' HA ' HG23 ' A' ' 145' ' ' ILE . 13.5 mt -104.64 17.97 23.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.196 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 141' ' ' ARG . 40.0 mtp-105 -127.96 144.42 51.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.751 -0.658 . . . . 10.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.16 -155.38 19.54 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.443 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.73 15.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.653 0.263 . . . . 10.0 111.523 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.45 52.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.035 0.445 . . . . 10.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.772 HG23 ' HA ' ' A' ' 140' ' ' LEU . 54.7 mt -68.69 139.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.737 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.95 12.01 77.86 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.176 -0.77 . . . . 10.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.01 152.37 64.96 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.925 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.1 120.09 7.42 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.779 1.652 . . . . 10.0 108.737 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 . . . . . 0 C--N 1.322 -0.607 0 CA-C-O 121.126 0.489 . . . . 10.0 110.088 -178.338 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.012 0.434 . . . . 10.0 110.328 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.57 84.12 23.63 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.96 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.27 133.66 23.28 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.273 1.982 . . . . 10.0 111.331 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.23 120.98 25.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.729 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -87.61 159.63 18.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.269 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.28 155.18 17.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.614 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.06 -135.65 8.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.919 -0.657 . . . . 10.0 111.809 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.68 171.05 34.21 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.665 -0.778 . . . . 10.0 112.424 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -137.37 136.21 37.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.743 -0.466 . . . . 10.0 109.743 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -135.43 150.54 49.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.566 0.222 . . . . 10.0 110.62 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.96 173.2 22.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 10.0 111.962 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -113.44 -172.26 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.679 0.276 . . . . 10.0 110.811 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.74 0.305 . . . . 10.0 110.832 -179.837 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 117' ' ' TYR . 1.4 m -84.93 -28.76 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 121.073 -0.251 . . . . 10.0 111.301 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.19 135.63 5.16 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.593 -0.813 . . . . 10.0 112.28 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -65.26 -48.1 74.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.615 0.245 . . . . 10.0 111.364 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.33 -34.91 79.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 140' ' ' LEU . 25.0 t -59.28 -46.99 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.546 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.16 95.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.044 -0.598 . . . . 10.0 112.19 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -64.52 -43.86 92.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 10.0 110.378 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.3 82.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.794 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.786 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.8 mt -56.34 -47.67 80.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -66.16 -49.22 68.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.62 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.16 -37.16 84.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.215 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.96 -34.29 89.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.927 -0.654 . . . . 10.0 112.916 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.809 ' HD2' HD22 ' A' ' 103' ' ' LEU . 5.8 mmt180 -76.27 -34.71 59.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.287 0.565 . . . . 10.0 109.689 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.468 ' HA ' HG23 ' A' ' 97' ' ' THR . 96.8 mt-30 -75.36 -14.38 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -98.55 21.69 10.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.438 -0.346 . . . . 10.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -7.08 59.7 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.817 0.302 . . . . 10.0 111.817 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 37.7 mt-10 54.41 101.17 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.662 0 O-C-N 123.984 0.803 . . . . 10.0 112.228 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 55.4 Cg_endo -74.4 -50.93 0.17 OUTLIER 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.218 -1.576 . . . . 10.0 113.18 0.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 92' ' ' GLN . 21.5 m -163.49 137.15 5.72 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.891 . . . . 10.0 110.169 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.99 132.21 37.29 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.88 -0.415 . . . . 10.0 109.88 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.2 p -75.55 163.46 27.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 10.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.21 -29.69 67.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.679 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.14 84.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.127 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.5 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 55.8 mm-40 -62.8 -49.33 75.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.475 -0.329 . . . . 10.0 111.004 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.809 HD22 ' HD2' ' A' ' 91' ' ' ARG . 24.5 tp -62.03 -47.08 86.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.04 -46.19 91.69 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.076 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -64.82 -42.16 95.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.754 0.279 . . . . 10.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 15.5 pt-20 -69.65 -23.99 63.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 103' ' ' LEU . 27.6 pt -97.3 -7.04 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.769 -0.582 . . . . 10.0 111.127 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.54 16.34 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.745 -0.74 . . . . 10.0 112.664 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 110' ' ' THR . 54.5 mm-40 -130.04 -156.64 0.77 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.74 -0.467 . . . . 10.0 109.74 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 109' ' ' GLU . 3.2 p -126.11 176.35 7.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.521 0.201 . . . . 10.0 110.818 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.43 95.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.785 0.326 . . . . 10.0 111.208 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 116' ' ' SER . . . -61.11 -30.45 70.37 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.922 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.7 m -68.54 -43.79 75.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.135 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.674 HG13 HD23 ' A' ' 103' ' ' LEU . 92.8 t -64.44 -46.17 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.372 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.13 73.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.442 0.639 . . . . 10.0 110.064 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -74.69 -31.89 62.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 10.0 110.667 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.413 ' CE1' HG11 ' A' ' 79' ' ' VAL . 1.9 m-85 -72.41 -41.18 66.53 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.616 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.53 -18.35 64.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.165 0.507 . . . . 10.0 110.439 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 116' ' ' SER . 19.7 tpt180 -73.97 -19.31 60.7 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.18 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.23 26.56 25.58 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.054 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 121' ' ' THR . 5.3 t -175.23 102.6 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.957 0.884 . . . . 10.0 110.507 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 116' ' ' SER . . . -152.5 33.24 0.51 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.376 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 m 63.42 98.96 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.226 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 96.54 0.59 Allowed 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 123.348 2.698 . . . . 10.0 115.169 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.92 112.39 24.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.562 -2.384 . . . . 10.0 104.562 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.5 mm-40 -46.56 -38.98 10.23 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.549 1.314 . . . . 10.0 114.549 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.26 -33.09 65.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 111.683 0.253 . . . . 10.0 111.683 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 132' ' ' MET . 68.6 mt -70.09 -58.91 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.706 -0.398 . . . . 10.0 111.484 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -35.35 71.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.798 0.332 . . . . 10.0 111.558 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 22.7 m -63.31 -44.09 95.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 135' ' ' VAL . 25.2 mtmt -75.14 -34.58 61.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.011 0.375 . . . . 10.0 112.011 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.813 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 44.2 mtp -51.0 -61.34 2.29 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.325 0.584 . . . . 10.0 112.251 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.67 ' HB3' HG23 ' A' ' 138' ' ' VAL . 9.2 mm-40 -74.33 -26.57 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.684 . . . . 10.0 112.074 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 130' ' ' SER . 9.0 ttp85 -55.99 -37.48 69.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.061 0.458 . . . . 10.0 110.719 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 131' ' ' LYS . 29.8 t -63.92 -31.76 54.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.545 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.622 HD21 ' NH1' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -95.51 -2.11 49.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.306 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.5 t30 65.74 45.3 2.65 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.273 0.559 . . . . 10.0 110.136 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' A' ' 133' ' ' GLU . 15.4 m -134.85 155.75 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.651 ' HD2' ' O ' ' A' ' 149' ' ' ARG . 32.0 mttp -133.18 136.62 45.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.255 0.55 . . . . 10.0 110.715 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.642 HD13 HG13 ' A' ' 83' ' ' VAL . 3.1 mt -89.38 39.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.291 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -131.32 136.96 48.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.811 -0.356 . . . . 10.0 110.176 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.14 -161.18 24.28 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.867 -0.682 . . . . 10.0 112.24 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.71 -24.73 17.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 10.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -81.37 50.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.336 0.589 . . . . 10.0 110.286 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.7 mm -70.1 139.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.551 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.49 6.15 74.2 Favored Glycine 0 CA--C 1.509 -0.33 0 C-N-CA 120.761 -0.733 . . . . 10.0 111.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.31 156.76 78.69 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.274 -0.269 . . . . 10.0 110.274 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.75 124.83 16.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.186 1.924 . . . . 10.0 110.171 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.651 ' O ' ' HD2' ' A' ' 139' ' ' LYS . 4.7 ttt180 . . . . . 0 C--N 1.322 -0.599 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 111.793 -0.523 . . . . 10.0 111.793 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.2 160.22 42.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.631 0.253 . . . . 10.0 110.659 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.7 tpt -148.61 128.78 13.69 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.155 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -129.05 87.59 53.95 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.326 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.44 165.77 31.42 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.697 2.265 . . . . 10.0 111.844 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -88.88 -179.84 6.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.073 0.464 . . . . 10.0 110.927 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -125.09 147.23 49.09 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.185 -0.672 . . . . 10.0 109.185 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -145.32 165.66 27.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.829 0.347 . . . . 10.0 111.16 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -150.63 148.65 20.06 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.514 -0.635 . . . . 10.0 111.514 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.82 162.16 30.67 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.541 -0.838 . . . . 10.0 112.002 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -144.31 94.23 2.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 10.0 110.347 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -112.81 148.54 34.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.633 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.85 -137.26 2.24 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.699 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 61.51 85.62 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.279 0.561 . . . . 10.0 111.268 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.74 140.24 41.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.245 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -127.2 135.99 51.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.469 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.17 148.46 25.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.05 -0.352 . . . . 10.0 110.05 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -132.34 148.04 52.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.851 0.358 . . . . 10.0 110.847 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.3 t -102.71 143.69 14.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.075 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.92 157.25 28.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.924 0.392 . . . . 10.0 110.403 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -125.61 93.14 3.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.946 0.403 . . . . 10.0 110.454 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.8 m -122.62 97.88 5.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.588 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -147.07 74.11 1.33 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.251 0.548 . . . . 10.0 109.707 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -132.33 55.22 1.89 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.641 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.0 mt -88.88 90.39 3.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.4 -0.818 . . . . 10.0 109.902 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.6 mm -87.63 95.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.035 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -126.45 111.49 23.26 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.011 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -77.42 85.39 1.79 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.743 2.295 . . . . 10.0 111.856 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 tttm -140.91 137.74 33.37 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.955 -0.566 . . . . 10.0 109.837 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.4 p -56.69 165.88 1.07 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.855 -0.611 . . . . 10.0 111.073 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.481 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -59.35 -42.16 86.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.693 0.257 . . . . 10.0 111.693 -178.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 120.74 148.84 8.1 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.563 -0.827 . . . . 10.0 112.441 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -67.4 -55.05 15.3 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.599 0.199 . . . . 10.0 111.52 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.17 -36.22 81.19 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.314 -0.625 . . . . 10.0 109.314 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.569 ' O ' HG13 ' A' ' 87' ' ' ILE . 43.2 t -58.57 -50.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.189 -0.914 . . . . 10.0 110.553 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.02 -42.37 99.73 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.712 -0.756 . . . . 10.0 112.235 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -64.88 -43.36 93.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.114 0.483 . . . . 10.0 109.983 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.7 68.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.861 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 83' ' ' VAL . 10.0 mt -60.32 -46.32 95.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.926 0.394 . . . . 10.0 110.26 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.93 -52.12 18.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.235 0.54 . . . . 10.0 110.196 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 11.9 mt-30 -60.69 -34.09 73.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.511 -0.768 . . . . 10.0 112.131 -178.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.5 -28.19 57.99 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.582 -0.818 . . . . 10.0 112.459 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.646 HH12 ' HG3' ' A' ' 133' ' ' GLU . 2.5 mpt_? -80.36 -27.28 38.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.481 0.657 . . . . 10.0 109.807 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.435 ' HA ' HG23 ' A' ' 97' ' ' THR . 99.1 mt-30 -76.53 -9.32 58.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.594 -0.73 . . . . 10.0 110.239 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 89' ' ' GLN . 10.0 mmtp -85.73 9.06 17.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.413 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.44 -162.58 0.52 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.556 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 77.9 mm-40 -122.48 104.64 36.93 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.946 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.2 Cg_endo -87.99 -26.71 5.55 Favored 'Cis proline' 0 C--N 1.348 0.503 0 C-N-CA 123.941 -1.275 . . . . 10.0 112.523 -0.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 92' ' ' GLN . 11.4 m -165.22 122.37 1.51 Allowed 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 113.706 -1.588 . . . . 10.0 109.762 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.9 tpp -82.76 112.86 19.98 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.794 -0.447 . . . . 10.0 109.794 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 t -80.82 177.16 9.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.683 0.754 . . . . 10.0 111.971 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.419 ' HA ' HG11 ' A' ' 114' ' ' VAL . 89.4 mt-30 -64.72 -48.84 73.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.241 -1.345 . . . . 10.0 111.352 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.63 -44.61 96.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.512 -0.313 . . . . 10.0 111.808 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -65.78 -50.01 66.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 10.0 111.838 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.585 ' O ' HG12 ' A' ' 107' ' ' ILE . 14.3 tp -62.43 -42.02 99.14 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.381 -0.6 . . . . 10.0 109.381 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.47 -43.62 98.58 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.067 -0.813 . . . . 10.0 111.067 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -49.23 78.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.412 0.149 . . . . 10.0 111.297 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.4 ' OE1' HG21 ' A' ' 135' ' ' VAL . 12.0 pt-20 -67.58 -34.13 76.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 103' ' ' LEU . 36.7 pt -85.05 -8.32 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.536 -0.465 . . . . 10.0 111.807 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.15 26.18 31.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 10.0 113.363 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -123.71 -177.64 3.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.883 0.373 . . . . 10.0 110.662 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.4 170.51 9.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.889 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.8 97.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.759 0.314 . . . . 10.0 110.783 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.68 72.01 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.14 -0.482 . . . . 10.0 110.782 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -61.07 -49.91 75.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.111 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 100' ' ' GLN . 58.9 t -65.46 -44.01 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.295 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.03 -37.28 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.788 -0.642 . . . . 10.0 110.698 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 16.6 m -75.33 -29.42 59.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.829 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -70.02 -42.62 72.72 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.542 -0.299 . . . . 10.0 111.702 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -65.11 -17.79 64.76 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.765 0.316 . . . . 10.0 111.057 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.538 ' HG2' HG22 ' A' ' 121' ' ' THR . 13.2 ttp85 -69.75 -21.74 63.42 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 121.401 0.619 . . . . 10.0 109.855 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.481 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 97.41 20.53 22.35 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.922 -0.656 . . . . 10.0 111.537 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.538 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -175.14 110.17 0.12 Allowed 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 121.939 0.876 . . . . 10.0 110.468 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.19 23.13 0.42 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.18 -0.918 . . . . 10.0 110.083 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.6 m 61.19 91.72 0.07 OUTLIER Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 108.251 -1.018 . . . . 10.0 108.251 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HB3' HG12 ' A' ' 79' ' ' VAL . 74.5 Cg_endo -72.4 104.25 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.688 2.259 . . . . 10.0 115.623 -175.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.75 117.84 25.76 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.056 -2.572 . . . . 10.0 104.056 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.438 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 17.1 mm-40 -46.63 -38.67 10.0 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -175.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 22.1 t30 -64.75 -33.29 75.62 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.909 -0.587 . . . . 10.0 111.813 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.769 ' O ' ' HG3' ' A' ' 132' ' ' MET . 91.7 mt -69.88 -58.73 4.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.29 -0.256 . . . . 10.0 110.54 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 0.2 OUTLIER -52.17 -36.99 53.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.318 0.58 . . . . 10.0 110.955 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.0 m -54.06 -49.94 67.88 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.552 -0.749 . . . . 10.0 111.252 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.5 mppt? -75.9 -38.5 57.74 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.146 0.424 . . . . 10.0 112.146 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.769 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 38.9 mtp -50.04 -58.27 5.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.315 0.579 . . . . 10.0 111.491 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mp0 -78.65 -29.92 46.05 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 115.165 1.543 . . . . 10.0 115.165 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -68.77 -34.52 75.71 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.43 0.53 . . . . 10.0 112.43 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 131' ' ' LYS . 87.1 t -60.89 -25.39 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.654 0.264 . . . . 10.0 111.117 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.605 HD21 ' HD2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -115.13 2.54 14.16 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.283 0.475 . . . . 10.0 112.283 -179.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 60.13 60.74 2.01 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.731 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 1.9 m -143.06 155.94 17.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 30.3 mmmt -129.98 144.57 51.4 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.871 -0.418 . . . . 10.0 109.871 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.556 ' CD1' HG13 ' A' ' 83' ' ' VAL . 10.3 mt -106.49 40.06 1.7 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.462 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -141.03 135.95 31.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.806 -0.634 . . . . 10.0 109.759 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.88 -149.34 16.68 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.016 -0.612 . . . . 10.0 112.384 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.58 -32.21 10.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.005 0.431 . . . . 10.0 110.789 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -87.42 57.89 4.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.506 0.67 . . . . 10.0 109.986 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.2 mm -65.1 132.68 30.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.018 -0.992 . . . . 10.0 111.573 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.18 -1.82 84.86 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.691 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -116.31 160.32 36.34 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.555 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -65.17 115.05 3.09 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.268 1.312 . . . . 10.0 109.231 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? -137.5 93.91 2.86 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 154' ' ' LYS . 29.5 mt 63.57 24.57 14.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.837 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.93 -84.02 0.86 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.417 -0.81 . . . . 10.0 111.673 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.38 -36.44 66.78 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.099 1.866 . . . . 10.0 110.403 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -136.92 121.21 18.02 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.3 -0.864 . . . . 10.0 109.293 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 150' ' ' LEU . 19.9 pttp -88.51 50.45 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.486 0.66 . . . . 10.0 110.852 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt . . . . . 0 C--O 1.246 0.918 0 CA-C-N 115.489 -0.778 . . . . 10.0 109.818 179.699 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.002 -0.439 . . . . 10.0 112.002 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.58 164.66 34.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.353 -0.24 . . . . 10.0 110.353 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 ptt? -148.58 162.26 40.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.007 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -132.57 146.64 62.31 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.679 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.16 163.99 33.92 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.734 2.289 . . . . 10.0 112.08 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.08 174.01 6.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.824 0.345 . . . . 10.0 111.112 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -153.53 111.55 3.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.856 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.67 155.77 47.03 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.943 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.91 138.38 10.11 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.082 -0.58 . . . . 10.0 112.164 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.95 126.53 2.8 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 10.0 112.153 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -157.18 131.78 8.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.927 0.394 . . . . 10.0 110.28 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -144.16 143.41 31.08 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.046 -0.524 . . . . 10.0 109.639 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.32 -159.3 9.24 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.724 -0.75 . . . . 10.0 111.726 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.39 169.1 17.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.615 0.245 . . . . 10.0 110.357 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -117.93 120.69 38.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.362 -0.381 . . . . 10.0 109.982 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.9 mt -83.73 84.29 7.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.815 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.7 m -76.58 76.45 3.27 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.44 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -106.97 118.95 38.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.142 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 p -155.48 119.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.362 0.601 . . . . 10.0 110.506 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -140.42 102.35 4.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.388 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.428 ' HB2' ' OD1' ' A' ' 71' ' ' ASP . 11.5 ptm180 -161.03 152.86 19.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.4 -0.818 . . . . 10.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.33 -3.43 22.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.206 0.527 . . . . 10.0 110.115 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.428 ' OD1' ' HB2' ' A' ' 69' ' ' ARG . 13.8 p-10 -101.96 35.7 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.782 -0.645 . . . . 10.0 110.452 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -84.06 52.28 2.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.256 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.4 mt -73.84 -44.96 50.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.289 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.2 pt -96.78 15.13 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.458 0.647 . . . . 10.0 110.814 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -126.28 97.34 34.62 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.575 -0.739 . . . . 10.0 110.458 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.38 80.42 3.04 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.54 2.16 . . . . 10.0 111.992 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -114.44 21.94 14.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.921 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 p -116.77 147.32 42.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.268 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.521 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.3 m -83.1 -33.18 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 112.454 0.539 . . . . 10.0 112.454 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.4 145.84 8.7 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.321 -0.942 . . . . 10.0 112.302 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 mmtm -71.59 -28.82 64.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.892 0.33 . . . . 10.0 111.892 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.16 -38.88 72.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.663 HG13 HD13 ' A' ' 140' ' ' LEU . 54.2 t -61.44 -44.7 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.461 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.18 -41.04 98.03 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.944 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -62.95 -43.95 97.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.331 . . . . 10.0 110.753 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . . . -70.48 -37.95 74.31 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.649 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.777 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.7 mt -55.35 -48.48 76.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.655 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -70.08 -42.45 72.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.45 -0.341 . . . . 10.0 111.046 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.448 ' NE2' ' HA ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -66.35 -30.7 71.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.255 -0.429 . . . . 10.0 109.926 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.676 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -71.06 -39.98 62.55 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.844 -0.693 . . . . 10.0 113.0 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.777 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 12.8 mmt85 -66.08 -38.32 87.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.141 0.496 . . . . 10.0 110.606 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -83.7 -0.93 52.83 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.61 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -80.1 -11.7 59.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.259 0.552 . . . . 10.0 110.367 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.68 -171.97 1.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 10.0 111.803 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 29.5 mt-10 -131.55 110.87 14.94 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.797 -0.638 . . . . 10.0 110.658 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 72.7 Cg_endo -79.77 -32.84 3.79 Favored 'Cis proline' 0 C--N 1.346 0.422 0 C-N-CA 123.325 -1.531 . . . . 10.0 112.543 -0.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.6 m -163.95 131.19 3.32 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.413 -1.267 . . . . 10.0 110.204 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.452 ' HG2' HD23 ' A' ' 103' ' ' LEU . 26.1 tpp -82.48 136.31 34.93 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.707 -0.224 . . . . 10.0 110.422 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.0 p -83.56 156.33 22.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.887 0.375 . . . . 10.0 110.941 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -69.7 -33.94 73.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.041 -0.527 . . . . 10.0 109.83 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.11 73.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.819 -0.628 . . . . 10.0 111.313 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -66.89 -33.77 76.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.545 -0.298 . . . . 10.0 110.701 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 103' ' ' LEU . 0.3 OUTLIER -70.13 -37.61 75.33 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.278 -0.638 . . . . 10.0 109.278 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.637 ' CA ' HG21 ' A' ' 114' ' ' VAL . . . -68.49 -46.84 60.67 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.498 -0.774 . . . . 10.0 112.605 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -58.67 -39.86 81.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.862 0.363 . . . . 10.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -64.03 -29.19 70.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.954 -0.566 . . . . 10.0 112.512 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.571 HG22 ' HB3' ' A' ' 131' ' ' LYS . 16.5 pt -106.76 3.8 10.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.13 0.418 . . . . 10.0 112.13 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.0 32.96 69.65 Favored Glycine 0 C--N 1.329 0.186 0 C-N-CA 121.296 -0.478 . . . . 10.0 113.402 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -120.18 163.09 18.25 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.849 0.357 . . . . 10.0 110.815 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -78.88 150.3 32.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.757 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.4 -44.15 68.46 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.33 -0.395 . . . . 10.0 111.467 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -45.36 93.15 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.741 -0.209 . . . . 10.0 110.579 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.9 m -59.18 -44.23 92.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.678 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.637 HG21 ' CA ' ' A' ' 104' ' ' GLY . 46.7 t -63.79 -43.21 97.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.121 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.62 -29.47 63.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.222 0.534 . . . . 10.0 110.312 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 63.0 m -76.55 -25.8 54.44 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.553 -0.749 . . . . 10.0 111.311 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -57.5 -37.76 73.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.998 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.443 ' HB3' HG22 ' A' ' 87' ' ' ILE . 6.8 pt-20 -66.61 -17.74 64.99 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.695 0.283 . . . . 10.0 111.693 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.6 ' HB3' ' O ' ' A' ' 116' ' ' SER . 37.3 ttm180 -67.8 -20.52 65.2 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.391 0.615 . . . . 10.0 110.462 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.521 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.88 23.66 22.38 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.339 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.448 ' O ' HG23 ' A' ' 121' ' ' THR . 7.3 t -170.25 107.61 0.34 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.282 1.039 . . . . 10.0 110.447 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.94 28.91 0.08 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.496 -1.229 . . . . 10.0 109.339 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.2 m 64.63 103.04 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.416 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.514 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 84.1 Cg_endo -75.91 92.9 1.02 Allowed 'Trans proline' 0 CA--C 1.505 -0.946 0 C-N-CA 123.058 2.505 . . . . 10.0 116.054 -176.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.667 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.7 t70 -87.92 111.92 21.98 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 105.319 -2.104 . . . . 10.0 105.319 175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -49.08 -38.22 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.132 0.895 . . . . 10.0 112.573 -176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.401 ' O ' ' HD2' ' A' ' 131' ' ' LYS . 60.9 t30 -71.51 -45.31 62.76 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.588 -0.733 . . . . 10.0 110.113 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 125' ' ' ASP . 59.2 mt -60.53 -50.8 78.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 110.481 -0.192 . . . . 10.0 110.481 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 11.7 mt -52.75 -45.27 66.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.562 0.696 . . . . 10.0 109.66 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 74.4 m -62.63 -43.03 99.83 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.018 -0.992 . . . . 10.0 110.992 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HB3' HG22 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -71.36 -42.95 67.84 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -178.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.556 ' SD ' ' HA ' ' A' ' 129' ' ' LEU . 3.7 ptm -61.59 -49.76 75.34 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.778 0.323 . . . . 10.0 111.867 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.604 ' O ' HD22 ' A' ' 136' ' ' LEU . 27.9 mm-40 -73.77 -25.78 60.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.938 0.399 . . . . 10.0 111.464 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.0 OUTLIER -56.35 -23.39 37.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.884 0.373 . . . . 10.0 111.289 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 t -71.92 -33.67 48.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.19 -0.459 . . . . 10.0 111.996 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -113.97 7.71 16.94 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.517 -0.473 . . . . 10.0 112.241 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.443 ' ND2' ' HB3' ' A' ' 148' ' ' PRO . 56.4 t30 67.31 59.06 0.52 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.644 0.735 . . . . 10.0 111.068 177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.426 ' CG2' HD23 ' A' ' 136' ' ' LEU . 3.0 t -129.53 144.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 114.849 -1.068 . . . . 10.0 109.292 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -119.16 132.09 55.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.244 0.545 . . . . 10.0 110.574 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 83' ' ' VAL . 19.4 mt -96.44 21.54 9.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.166 -0.925 . . . . 10.0 111.034 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -143.89 158.3 43.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.784 0.325 . . . . 10.0 110.918 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.38 -163.48 20.92 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 121.095 -0.574 . . . . 10.0 112.022 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.95 -31.82 14.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.02 0.438 . . . . 10.0 110.627 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -94.22 56.64 2.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.073 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.8 mt -62.03 137.75 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.421 -0.809 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.49 -8.51 79.69 Favored Glycine 0 CA--C 1.509 -0.328 0 C-N-CA 121.15 -0.548 . . . . 10.0 111.775 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.96 156.27 39.38 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.113 -0.544 . . . . 10.0 110.523 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.443 ' HB3' ' ND2' ' A' ' 137' ' ' ASN . 17.9 Cg_endo -63.12 124.1 13.35 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.276 1.984 . . . . 10.0 110.018 177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -149.69 -159.59 1.05 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.879 0.371 . . . . 10.0 110.349 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.507 ' O ' ' HD3' ' A' ' 152' ' ' PRO . 31.1 mt -129.31 151.16 50.26 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.376 -0.602 . . . . 10.0 109.376 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -112.52 89.24 0.52 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.62 -0.8 . . . . 10.0 111.717 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 150' ' ' LEU . 1.6 Cg_endo -84.39 97.34 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.028 2.486 . . . . 10.0 111.376 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -141.49 102.02 4.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.308 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -74.26 119.05 17.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.044 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.9 mttp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.278 -0.868 . . . . 10.0 110.495 -179.373 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.963 -0.455 . . . . 10.0 111.963 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.87 110.4 5.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.13 -0.322 . . . . 10.0 110.13 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -120.29 150.31 40.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.792 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -132.13 95.87 20.85 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.185 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.25 112.39 2.97 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.434 2.09 . . . . 10.0 112.088 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -102.66 95.57 6.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.048 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -127.11 155.84 42.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.395 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -161.05 128.64 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.814 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.91 162.12 12.49 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.104 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.84 74.65 0.22 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.975 -0.631 . . . . 10.0 112.403 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -119.88 103.43 9.33 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 122.788 -0.242 . . . . 10.0 110.728 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -90.3 158.2 17.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.419 -0.355 . . . . 10.0 110.544 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.57 124.44 2.85 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.065 -0.588 . . . . 10.0 112.22 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -158.25 150.96 22.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.651 0.226 . . . . 10.0 110.477 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -130.73 137.99 49.77 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.2 mt -84.96 149.39 25.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.538 -0.301 . . . . 10.0 110.867 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.8 m 57.91 41.62 24.3 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.736 0.779 . . . . 10.0 110.204 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -95.65 2.54 54.14 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.206 -0.907 . . . . 10.0 110.987 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.1 p -140.0 131.76 32.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.885 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -162.45 135.61 5.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.018 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -178.29 130.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.96 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -132.65 21.11 4.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.84 0.352 . . . . 10.0 111.247 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -138.99 116.17 11.05 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.462 0.649 . . . . 10.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.91 -19.87 13.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.535 -0.757 . . . . 10.0 109.973 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.3 mt -114.82 138.59 44.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.7 -0.682 . . . . 10.0 109.652 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 82.1 mt -75.24 106.58 5.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.946 0.403 . . . . 10.0 110.675 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -124.0 89.59 51.52 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.395 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -62.74 126.4 18.13 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.892 2.395 . . . . 10.0 111.872 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -138.55 -177.31 4.8 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.092 0.472 . . . . 10.0 109.81 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -107.68 -179.76 4.0 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.374 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 83' ' ' VAL . 2.2 t -85.12 -71.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.815 -0.354 . . . . 10.0 110.511 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.78 157.08 7.58 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -74.89 -53.77 8.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.401 0.601 . . . . 10.0 112.144 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.81 -38.42 88.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.668 -0.242 . . . . 10.0 111.508 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.609 ' HB ' HD23 ' A' ' 140' ' ' LEU . 33.2 m -67.13 -35.91 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 120.74 -0.384 . . . . 10.0 110.391 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.81 -41.68 98.76 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.004 -0.617 . . . . 10.0 111.692 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -41.5 98.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.895 0.379 . . . . 10.0 110.136 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.69 -30.99 70.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.695 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.497 HG23 HH21 ' A' ' 91' ' ' ARG . 7.2 mt -62.84 -42.39 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 10.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -70.45 -50.33 39.39 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.0 109.93 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -61.64 -40.9 96.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.826 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -67.55 -30.38 74.9 Favored Glycine 0 C--N 1.328 0.12 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.833 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.588 HH11 HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -80.35 -42.05 23.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.846 0.355 . . . . 10.0 110.67 -179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.14 -21.15 63.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.236 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -87.73 19.12 3.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.455 0.539 . . . . 10.0 112.455 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.23 -0.12 56.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.439 0.533 . . . . 10.0 112.439 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 62.6 mt-10 53.14 100.07 0.04 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 O-C-N 123.917 0.761 . . . . 10.0 112.831 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.6 Cg_endo -78.44 -41.85 0.83 Allowed 'Cis proline' 0 CA--C 1.517 -0.349 0 C-N-CA 123.292 -1.545 . . . . 10.0 112.524 -0.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.7 m -168.41 128.69 1.25 Allowed 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 114.88 -1.054 . . . . 10.0 110.233 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ttm -58.65 137.53 57.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.51 -0.314 . . . . 10.0 110.834 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.7 144.08 39.59 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.631 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -70.09 -41.03 74.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.162 0.506 . . . . 10.0 110.465 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.98 -39.37 90.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.825 -0.625 . . . . 10.0 111.941 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -71.8 -43.61 65.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.698 -0.228 . . . . 10.0 110.978 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.486 HD23 HG13 ' A' ' 114' ' ' VAL . 56.6 tp -64.49 -39.47 93.85 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.14 -45.41 96.06 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.865 -0.894 . . . . 10.0 110.865 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -39.64 91.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.809 0.338 . . . . 10.0 110.213 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -61.91 -41.54 98.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.161 -0.472 . . . . 10.0 112.049 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 103' ' ' LEU . 29.3 pt -93.24 -7.83 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 112.615 0.598 . . . . 10.0 112.615 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.77 34.12 22.74 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.813 -0.708 . . . . 10.0 112.549 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -125.99 176.67 6.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.93 0.395 . . . . 10.0 110.576 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.35 161.16 15.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.789 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.19 94.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 10.0 110.742 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.79 76.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.464 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.3 m -63.39 -46.34 86.89 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.157 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.486 HG13 HD23 ' A' ' 103' ' ' LEU . 90.0 t -62.28 -43.08 97.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.194 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -66.47 -35.23 79.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.728 -0.669 . . . . 10.0 111.598 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 25.8 p -77.76 -26.27 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.77 0.319 . . . . 10.0 111.496 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -55.07 -40.48 70.39 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.143 0.423 . . . . 10.0 112.143 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 8.2 pt-20 -63.11 -20.48 65.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.785 0.291 . . . . 10.0 111.785 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 116' ' ' SER . 72.9 ttt180 -71.54 -20.34 62.04 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.611 0.719 . . . . 10.0 109.828 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.86 15.91 43.86 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.422 -0.808 . . . . 10.0 112.352 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 121' ' ' THR . 12.9 t -164.15 108.56 0.98 Allowed 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 122.285 1.04 . . . . 10.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.09 19.06 0.5 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.724 -1.125 . . . . 10.0 110.999 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 5.0 m 58.51 83.71 0.21 Allowed Pre-proline 0 C--O 1.235 0.294 0 CA-C-O 121.622 0.725 . . . . 10.0 110.031 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.495 ' HB2' HD21 ' A' ' 129' ' ' LEU . 27.6 Cg_endo -96.13 178.44 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.409 2.739 . . . . 10.0 114.868 -177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.607 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.2 t70 -139.94 150.68 44.83 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -58.32 -37.51 75.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.244 0.545 . . . . 10.0 110.707 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.64 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 9.9 t30 -63.72 -41.66 98.05 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.268 -0.878 . . . . 10.0 110.466 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.9 mt -63.75 -55.87 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 110.362 -0.236 . . . . 10.0 110.362 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.1 mt -48.84 -45.88 41.32 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.312 0.577 . . . . 10.0 110.348 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.9 m -55.01 -47.0 75.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.953 -1.021 . . . . 10.0 111.604 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 49.7 mmtt -74.12 -36.28 64.18 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.74 0.305 . . . . 10.0 111.014 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.495 ' HB3' HH22 ' A' ' 91' ' ' ARG . 3.5 mtp -51.28 -56.41 13.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.762 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.635 ' HG2' HD13 ' A' ' 140' ' ' LEU . 16.0 mt-10 -72.45 -29.56 63.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.144 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -62.07 -43.96 97.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.099 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 131' ' ' LYS . 48.3 t -62.32 -25.54 37.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.322 -0.399 . . . . 10.0 112.006 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.588 HD21 HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -107.14 -3.61 19.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.904 0.705 . . . . 10.0 112.904 -177.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.1 t30 56.57 55.32 6.54 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.524 0.678 . . . . 10.0 109.706 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.495 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 35.5 m -140.99 164.21 20.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 114.736 -1.12 . . . . 10.0 108.754 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -124.19 129.0 50.05 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.151 0.501 . . . . 10.0 110.261 178.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.635 HD13 ' HG2' ' A' ' 133' ' ' GLU . 5.4 mp -92.66 13.01 21.31 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.272 -0.876 . . . . 10.0 110.751 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -128.31 139.4 52.43 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.565 -0.743 . . . . 10.0 110.211 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 104.36 -159.03 16.39 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.131 -0.557 . . . . 10.0 112.095 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.66 -33.29 13.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.926 0.393 . . . . 10.0 110.606 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -86.57 53.14 2.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.095 0.474 . . . . 10.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.581 HG23 ' HA ' ' A' ' 140' ' ' LEU . 61.1 mt -75.03 137.55 22.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.634 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 93.13 -1.27 70.0 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.124 -0.79 . . . . 10.0 111.124 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -130.09 155.41 80.77 Favored Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 115.035 -0.583 . . . . 10.0 109.857 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.38 120.05 7.51 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 121.617 1.545 . . . . 10.0 110.177 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -137.11 65.96 1.48 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.228 0.537 . . . . 10.0 109.606 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.3 mt -90.23 87.46 6.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.535 -0.757 . . . . 10.0 110.588 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -118.61 150.9 17.95 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.42 -0.809 . . . . 10.0 111.622 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.36 -5.44 17.13 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.698 2.265 . . . . 10.0 112.861 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -78.15 115.51 17.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.039 0.447 . . . . 10.0 111.014 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -133.02 -169.46 2.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.675 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.879 -0.582 . . . . 10.0 110.203 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.439 ' HA3' ' OD2' ' A' ' 52' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 112.08 -0.408 . . . . 10.0 112.08 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.43 -37.79 74.46 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.105 0.409 . . . . 10.0 112.105 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 36.9 ttm -147.06 102.53 3.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.971 0.415 . . . . 10.0 111.442 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.439 ' OD2' ' HA3' ' A' ' 49' ' ' GLY . 0.3 OUTLIER -148.28 85.94 6.16 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.764 -0.653 . . . . 10.0 110.102 179.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.93 177.83 8.39 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.689 2.259 . . . . 10.0 112.219 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.55 131.56 36.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.928 0.394 . . . . 10.0 110.833 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -152.94 126.33 8.68 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.808 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.79 150.96 38.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.707 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.31 171.08 13.57 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 111.269 -0.732 . . . . 10.0 111.269 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.55 145.65 13.23 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.385 -0.912 . . . . 10.0 112.427 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.3 m -142.15 127.16 18.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.767 -0.456 . . . . 10.0 109.767 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -118.23 148.78 42.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 10.0 111.504 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 144.78 132.46 2.52 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.16 -0.776 . . . . 10.0 111.16 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -156.94 156.85 33.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.247 0.523 . . . . 10.0 111.743 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -113.26 141.37 47.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.674 -0.693 . . . . 10.0 109.154 179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.436 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -145.56 167.88 21.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.068 0.461 . . . . 10.0 111.814 -179.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.3 m -153.65 137.92 16.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.076 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.1 159.23 19.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.301 . . . . 10.0 110.354 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 p -158.28 117.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.134 -0.485 . . . . 10.0 110.239 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -69.62 151.57 45.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.51 . . . . 10.0 110.473 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HB3' ' H ' ' A' ' 70' ' ' SER . 78.9 mtt180 -147.45 -159.19 0.99 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.468 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.417 ' H ' ' HB3' ' A' ' 69' ' ' ARG . 0.7 OUTLIER -80.86 178.27 8.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.873 0.368 . . . . 10.0 110.848 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -103.56 8.94 37.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.025 0.44 . . . . 10.0 111.192 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -86.91 53.58 2.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.433 0.635 . . . . 10.0 110.375 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.4 pt -134.62 160.87 41.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.732 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.454 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 43.3 pt -80.93 174.7 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.264 -0.426 . . . . 10.0 110.466 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.57 87.57 17.66 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.296 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 74' ' ' ILE . 16.4 Cg_endo -90.93 -143.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.713 2.942 . . . . 10.0 111.71 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -88.69 33.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.018 0.437 . . . . 10.0 110.766 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.419 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 19.2 p -110.76 158.78 18.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.894 -0.41 . . . . 10.0 109.894 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.563 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -91.57 -30.74 4.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.736 -0.386 . . . . 10.0 111.751 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.65 141.95 5.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.542 -0.837 . . . . 10.0 112.333 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -66.58 -52.35 46.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 10.0 111.123 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.04 -32.91 74.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.376 0.608 . . . . 10.0 109.624 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 140' ' ' LEU . 55.3 t -61.87 -50.39 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 114.88 -1.055 . . . . 10.0 110.269 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.14 -40.39 98.89 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.715 -0.755 . . . . 10.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -60.14 -51.14 70.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.845 0.355 . . . . 10.0 110.493 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -66.15 -30.77 71.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.999 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.836 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.6 mt -57.88 -47.33 86.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.481 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -70.9 -47.05 61.29 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.941 0.4 . . . . 10.0 110.4 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -62.18 -34.14 75.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.428 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.64 -30.29 68.76 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.21 -0.995 . . . . 10.0 112.927 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.836 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.6 mmt180 -81.47 -33.81 31.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 10.0 111.373 -178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -77.33 -16.56 58.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.097 0.475 . . . . 10.0 110.536 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -80.44 12.61 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.0 -19.86 23.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 10.0 111.561 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 4.5 tp10 59.89 110.1 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 114.904 -1.044 . . . . 10.0 111.777 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 45.2 Cg_endo -72.05 -59.11 0.13 OUTLIER 'Cis proline' 0 C--N 1.344 0.3 0 C-N-CA 123.279 -1.551 . . . . 10.0 113.026 -0.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 22.2 m -163.97 135.8 4.79 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.492 -0.776 . . . . 10.0 110.903 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 36.4 tpp -74.57 136.85 42.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.539 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 64.7 p -84.03 160.41 20.99 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.359 -0.537 . . . . 10.0 111.251 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -69.56 -26.94 64.73 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.668 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.02 -57.98 5.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.438 -0.801 . . . . 10.0 111.408 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.539 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 13.7 pt-20 -62.52 -36.85 83.88 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.914 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 2.4 tt -61.91 -42.48 99.13 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.296 -0.866 . . . . 10.0 109.682 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.76 -39.74 90.0 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.671 -0.776 . . . . 10.0 111.463 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -62.3 -39.53 93.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.705 0.288 . . . . 10.0 111.574 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 17.3 pt-20 -73.62 -16.59 61.23 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 103' ' ' LEU . 40.6 pt -113.43 0.08 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 120.623 -0.431 . . . . 10.0 111.738 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.42 37.61 53.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.593 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -133.19 -168.92 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.732 0.301 . . . . 10.0 110.52 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -111.95 177.25 4.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.738 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.12 79.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.743 0.306 . . . . 10.0 110.656 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.89 -47.07 87.25 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.657 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.9 m -55.74 -45.3 78.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.55 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -61.82 -50.54 79.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.803 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 118' ' ' GLU . . . -64.92 -32.12 73.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.331 0.586 . . . . 10.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.0 m -73.6 -28.19 61.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.424 ' CE1' HG11 ' A' ' 79' ' ' VAL . 2.4 m-85 -75.34 -35.62 61.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.543 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 12.5 pt-20 -67.42 -17.8 64.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.94 0.4 . . . . 10.0 110.799 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.732 ' HG2' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -74.61 -20.93 59.72 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.21 0.529 . . . . 10.0 109.79 178.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.563 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.52 21.49 29.05 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.43 -0.891 . . . . 10.0 112.053 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 119' ' ' ARG . 9.9 t -170.07 104.22 0.3 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.437 1.113 . . . . 10.0 110.113 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.33 27.7 0.51 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.747 -1.115 . . . . 10.0 109.212 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 10.0 m 61.61 96.98 0.04 OUTLIER Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 114.8 -1.091 . . . . 10.0 108.594 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' A' ' 78' ' ' THR . 70.8 Cg_endo -68.18 99.84 0.61 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.655 2.236 . . . . 10.0 115.256 -175.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.57 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -85.72 116.12 23.8 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 104.92 -2.252 . . . . 10.0 104.92 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.411 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 21.9 mm-40 -48.91 -40.17 28.91 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.142 -0.481 . . . . 10.0 112.147 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.482 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.2 t30 -66.93 -44.06 81.66 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.675 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.673 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.8 mt -58.62 -55.17 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 119.585 -0.245 . . . . 10.0 110.651 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.0 mt -50.24 -42.24 51.47 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.571 0.7 . . . . 10.0 110.235 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 66.7 m -59.86 -45.72 91.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.983 -1.008 . . . . 10.0 111.497 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 29.2 mmtt -73.75 -40.86 63.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.757 0.313 . . . . 10.0 111.234 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.673 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -50.65 -59.46 4.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.53 -0.759 . . . . 10.0 112.207 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.745 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 5.8 mt-10 -74.12 -26.84 60.57 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.045 -0.98 . . . . 10.0 112.997 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -54.63 -27.25 38.22 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.91 -25.64 8.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.81 0.338 . . . . 10.0 111.796 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.833 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -99.0 -16.32 18.76 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.207 0.817 . . . . 10.0 113.207 -177.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-20 67.84 25.99 7.74 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.262 0.553 . . . . 10.0 110.527 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.833 HG22 ' HB2' ' A' ' 136' ' ' LEU . 26.8 m -121.94 142.9 36.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 23.9 mmmt -119.19 142.97 47.51 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.115 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.665 ' HA ' HG23 ' A' ' 145' ' ' ILE . 8.9 mt -102.71 39.44 1.53 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.658 0.742 . . . . 10.0 109.783 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 141' ' ' ARG . 49.2 mtt180 -129.54 141.32 51.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.089 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.22 -162.19 43.93 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.761 -0.733 . . . . 10.0 112.233 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.34 3.24 55.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.885 0.374 . . . . 10.0 111.399 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -110.31 40.95 1.84 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.076 0.465 . . . . 10.0 110.672 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 140' ' ' LEU . 44.9 mt -67.17 136.71 26.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.847 -0.615 . . . . 10.0 110.727 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 91.9 0.3 71.91 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.937 -0.865 . . . . 10.0 110.937 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.56 158.45 75.65 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.546 . . . . 10.0 110.658 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -59.29 121.68 10.3 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.284 1.989 . . . . 10.0 109.914 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -146.64 100.84 3.39 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.964 -0.384 . . . . 10.0 109.964 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 14.3 tp -77.68 72.44 4.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.274 0.559 . . . . 10.0 110.712 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -126.63 72.96 0.45 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.454 -0.793 . . . . 10.0 111.338 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.66 152.68 29.55 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.772 2.315 . . . . 10.0 112.784 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 39.0 tttm -103.83 -31.99 9.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.684 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -143.78 145.62 32.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.189 -0.459 . . . . 10.0 110.363 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 18.1 tptp . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.224 -0.894 . . . . 10.0 109.894 179.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.769 0 N-CA-C 111.745 -0.542 . . . . 10.0 111.745 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.63 -49.26 9.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.555 0.177 . . . . 10.0 111.459 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.8 ptp 43.27 48.67 5.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.741 0.816 . . . . 10.0 111.456 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -121.96 88.44 47.73 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.625 -0.716 . . . . 10.0 110.438 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -91.81 145.9 3.12 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.348 2.699 . . . . 10.0 111.897 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -104.03 154.0 20.2 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.812 0.339 . . . . 10.0 110.671 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -144.68 132.27 21.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.24 166.55 23.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.016 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.61 -177.91 36.01 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.486 -0.864 . . . . 10.0 112.394 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 175.2 147.88 6.46 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.41 -0.676 . . . . 10.0 111.41 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 t -137.31 128.17 27.3 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.105 0.479 . . . . 10.0 110.902 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -90.81 -42.91 10.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.248 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.22 104.31 2.39 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.569 -0.612 . . . . 10.0 111.569 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -107.32 -16.49 14.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.822 0.344 . . . . 10.0 111.387 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -156.93 145.45 19.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.503 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 15.9 tp -120.53 142.49 49.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.858 -0.423 . . . . 10.0 109.858 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -79.56 138.31 37.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.944 -0.571 . . . . 10.0 110.956 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -124.31 168.3 13.17 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.536 -0.542 . . . . 10.0 109.536 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 m -55.39 129.29 16.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.051 0.453 . . . . 10.0 111.476 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -163.08 150.67 13.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.645 -0.707 . . . . 10.0 109.617 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.67 143.45 38.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.571 0.224 . . . . 10.0 110.484 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.5 m -72.21 -77.84 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.61 -0.268 . . . . 10.0 110.469 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.0 t0 53.33 52.47 13.45 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.121 -0.49 . . . . 10.0 111.151 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -165.98 125.19 1.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.636 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.8 mm -77.92 -21.64 13.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.646 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.5 mt -84.46 115.78 27.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.269 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -89.89 117.36 68.04 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.18 0.514 . . . . 10.0 111.168 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 77' ' ' LYS . 61.8 Cg_endo -86.53 -141.03 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.256 2.637 . . . . 10.0 110.49 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.436 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -78.6 72.22 5.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.176 0.512 . . . . 10.0 109.77 178.213 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.551 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 2.8 p -109.91 166.85 10.61 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.623 -0.717 . . . . 10.0 109.904 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.523 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.9 OUTLIER -84.48 -34.65 9.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.651 -0.419 . . . . 10.0 111.157 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.04 136.98 4.33 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.013 -0.613 . . . . 10.0 111.596 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -63.45 -57.04 11.54 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.036 0.384 . . . . 10.0 112.036 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -25.63 65.46 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.702 HG13 HD13 ' A' ' 140' ' ' LEU . 46.0 t -63.36 -46.97 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.497 -1.229 . . . . 10.0 110.052 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.32 -38.42 95.83 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.737 -0.744 . . . . 10.0 111.353 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.592 ' O ' ' HG2' ' A' ' 89' ' ' GLN . 40.1 ttmt -59.32 -49.25 78.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.071 0.462 . . . . 10.0 109.786 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -65.85 -30.51 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.558 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.753 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.3 mt -59.85 -48.5 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 92' ' ' GLN . 4.3 tt0 -67.06 -50.38 62.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.022 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 62.4 mm-40 -59.97 -36.41 77.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.767 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.93 -33.23 85.03 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.967 -0.635 . . . . 10.0 113.281 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.753 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.9 mmt180 -79.22 -29.88 43.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.173 0.511 . . . . 10.0 109.64 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 82.0 mt-30 -78.66 -16.76 56.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.704 . . . . 10.0 110.645 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 55.9 mtpt -85.79 22.13 1.72 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.955 0.407 . . . . 10.0 111.261 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.65 -8.88 36.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.883 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 6.1 mm-40 53.4 104.05 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 114.902 -1.045 . . . . 10.0 112.618 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 56.0 Cg_endo -73.64 -50.12 0.2 Allowed 'Cis proline' 0 C--N 1.347 0.483 0 C-N-CA 123.486 -1.464 . . . . 10.0 113.367 0.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.9 m -168.93 132.62 1.4 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.403 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 35.7 tpp -73.58 134.89 43.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.291 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.17 145.38 51.53 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 120.902 0.382 . . . . 10.0 111.679 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -69.41 -37.49 77.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.022 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.07 -36.39 83.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.75 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -75.79 -39.19 57.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.094 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.552 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -61.19 -43.62 98.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.739 -0.837 . . . . 10.0 108.739 178.444 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -65.74 -39.39 95.23 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.504 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -64.32 -38.27 90.45 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.651 0.262 . . . . 10.0 111.133 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.545 ' OE2' HD22 ' A' ' 103' ' ' LEU . 15.3 pt-20 -78.02 -13.9 59.7 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.119 0.785 . . . . 10.0 113.119 -179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 103' ' ' LEU . 41.2 pt -109.68 -7.45 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.623 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.83 30.89 19.62 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.815 -0.707 . . . . 10.0 112.807 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.94 -168.88 1.96 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 122.278 0.231 . . . . 10.0 110.428 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -109.91 177.25 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.528 -0.305 . . . . 10.0 110.254 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -40.73 95.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.616 -0.265 . . . . 10.0 111.351 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.29 81.34 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.27 -0.423 . . . . 10.0 111.039 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -57.45 -50.3 73.48 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.779 0.323 . . . . 10.0 110.723 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.12 -45.04 97.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.935 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.79 -36.08 82.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.149 0.499 . . . . 10.0 111.115 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 74.3 m -76.77 -27.46 55.32 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.356 -0.384 . . . . 10.0 111.943 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.31 -39.27 94.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.871 0.693 . . . . 10.0 112.871 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -61.53 -18.66 60.13 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.195 0.442 . . . . 10.0 112.195 -179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 119' ' ' ARG . 0.8 OUTLIER -69.53 -22.93 63.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.197 0.522 . . . . 10.0 110.088 179.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.99 21.7 15.08 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 120.607 -0.806 . . . . 10.0 112.086 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.439 ' OG1' HG22 ' A' ' 78' ' ' THR . 6.7 t -171.87 111.9 0.3 Allowed 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 122.24 1.019 . . . . 10.0 110.396 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.57 34.58 0.27 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.561 -1.2 . . . . 10.0 109.277 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 m 55.77 85.16 0.2 Allowed Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 115.266 -0.879 . . . . 10.0 108.839 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.551 ' HG3' ' O ' ' A' ' 78' ' ' THR . 72.8 Cg_endo -72.47 98.04 0.92 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 123.543 2.828 . . . . 10.0 115.544 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.9 t70 -82.18 128.04 33.76 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 104.638 -2.356 . . . . 10.0 104.638 174.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -54.17 -31.31 52.34 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.427 0.528 . . . . 10.0 112.427 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -72.12 -32.89 67.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.848 -0.614 . . . . 10.0 111.355 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.796 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.0 mt -71.3 -57.94 6.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.691 -0.403 . . . . 10.0 110.099 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 129' ' ' LEU . 1.0 OUTLIER -49.6 -43.31 46.33 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.489 0.662 . . . . 10.0 110.777 -179.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.59 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 45.0 m -54.51 -48.95 71.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.033 -0.985 . . . . 10.0 111.828 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 135' ' ' VAL . 13.0 mttt -76.79 -37.68 55.36 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.833 0.309 . . . . 10.0 111.833 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.796 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 75.0 mtp -53.97 -58.56 6.85 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.182 0.515 . . . . 10.0 111.863 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.575 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.0 mp0 -72.52 -26.18 61.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.787 -0.642 . . . . 10.0 112.266 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.4 ttm-85 -59.3 -27.42 65.84 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.036 0.446 . . . . 10.0 110.034 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 131' ' ' LYS . 61.1 t -63.82 -41.34 92.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.689 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.571 HD22 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -94.98 -6.35 42.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 121.152 -0.219 . . . . 10.0 110.437 -179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 49.3 t30 64.36 49.65 2.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.494 0.664 . . . . 10.0 109.736 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 34.4 m -132.12 162.88 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.355 -0.839 . . . . 10.0 109.627 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 15.9 mmtt -131.96 140.89 49.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.342 -0.614 . . . . 10.0 109.342 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.702 HD13 HG13 ' A' ' 83' ' ' VAL . 12.2 mt -108.5 17.71 21.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.26 0.552 . . . . 10.0 110.873 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 75.3 mtp180 -124.25 139.63 53.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.63 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.9 -146.65 17.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.729 -0.748 . . . . 10.0 112.336 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -104.24 -34.99 8.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.985 0.421 . . . . 10.0 110.857 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -82.33 54.82 2.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.929 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.602 HG23 ' HA ' ' A' ' 140' ' ' LEU . 52.6 mt -72.9 137.79 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.207 -0.451 . . . . 10.0 110.474 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.36 -0.48 87.12 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.978 -0.849 . . . . 10.0 110.978 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.71 156.87 70.38 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.476 . . . . 10.0 109.796 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.79 122.5 11.09 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 121.897 1.731 . . . . 10.0 110.382 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.74 68.68 1.38 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.375 0.607 . . . . 10.0 110.146 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.89 143.67 19.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.143 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.27 -78.4 0.92 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 110.81 -0.916 . . . . 10.0 110.81 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.86 144.44 38.74 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.572 2.182 . . . . 10.0 111.436 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 13.8 pttm -74.82 -16.86 60.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.969 0.414 . . . . 10.0 110.715 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -139.53 136.91 35.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.889 -0.596 . . . . 10.0 109.606 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.343 -0.836 . . . . 10.0 110.261 -179.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.849 -0.501 . . . . 10.0 111.849 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.45 64.87 1.47 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.082 0.468 . . . . 10.0 111.525 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -99.63 151.45 21.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.164 -0.471 . . . . 10.0 110.031 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -116.97 150.8 46.56 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.374 -0.375 . . . . 10.0 110.371 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.29 170.38 20.33 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.626 2.217 . . . . 10.0 112.379 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -123.78 152.5 42.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.247 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.14 151.37 49.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.394 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.05 138.05 15.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.466 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.78 -160.78 11.78 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.718 -0.753 . . . . 10.0 112.401 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.22 154.22 25.06 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.225 -0.75 . . . . 10.0 111.225 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.86 132.37 52.21 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.662 0.268 . . . . 10.0 110.846 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -140.14 167.6 21.76 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.897 -0.409 . . . . 10.0 109.897 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.25 117.92 0.8 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.455 -0.879 . . . . 10.0 112.742 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -102.8 173.43 6.33 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.19 -0.3 . . . . 10.0 110.19 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ttp85 -125.52 130.68 52.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.656 0.265 . . . . 10.0 110.901 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.72 149.58 50.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.739 0.304 . . . . 10.0 111.069 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.8 t -167.17 151.78 7.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.069 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -158.29 159.19 35.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.542 -0.17 . . . . 10.0 110.542 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.0 162.3 36.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.594 -0.275 . . . . 10.0 110.863 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.63 140.23 45.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.894 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -154.19 158.96 41.11 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.351 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m -94.41 -173.77 3.15 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.119 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.51 119.29 19.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -97.31 7.6 46.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.738 -0.664 . . . . 10.0 112.634 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.15 106.64 9.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.977 0.417 . . . . 10.0 110.861 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.4 pt -91.01 160.49 2.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.943 -0.571 . . . . 10.0 111.529 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -140.55 98.8 7.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.641 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.71 41.09 1.07 Allowed 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 122.729 2.286 . . . . 10.0 112.73 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -110.11 -154.77 0.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.025 -0.534 . . . . 10.0 109.602 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.48 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 5.0 p -100.07 -171.39 2.03 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.937 HG12 HG11 ' A' ' 83' ' ' VAL . 1.8 t -82.55 -60.15 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 10.0 110.537 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.07 137.23 4.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.33 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.7 -42.85 99.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.663 0.268 . . . . 10.0 111.269 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.72 -29.0 64.06 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.425 -0.583 . . . . 10.0 109.425 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.996 HG13 HD13 ' A' ' 140' ' ' LEU . 3.8 t -68.47 -49.28 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 115.338 -0.846 . . . . 10.0 109.864 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.36 -39.39 97.19 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -64.03 -39.41 94.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 10.0 110.486 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.23 -30.43 64.89 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.685 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.79 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.9 mt -59.89 -49.95 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.134 -0.691 . . . . 10.0 109.134 177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.01 -53.23 58.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.956 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -63.39 -31.47 72.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.773 -0.649 . . . . 10.0 110.901 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.09 -30.73 69.6 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.731 -0.747 . . . . 10.0 113.258 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.79 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -81.6 -41.94 20.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.302 0.573 . . . . 10.0 109.57 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.81 ' HA ' HG23 ' A' ' 97' ' ' THR . 53.2 mt-30 -61.4 -36.89 81.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.535 -0.757 . . . . 10.0 111.31 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -81.75 51.21 1.66 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 10.0 112.067 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.47 -3.54 16.93 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.69 0.281 . . . . 10.0 111.257 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 22.2 mm-40 57.94 100.56 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.102 -0.954 . . . . 10.0 111.926 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 2.8 Cg_exo -76.65 -45.1 0.46 Allowed 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.592 -1.42 . . . . 10.0 112.205 -0.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.81 HG23 ' HA ' ' A' ' 92' ' ' GLN . 38.2 m -161.71 133.56 5.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.541 -1.209 . . . . 10.0 110.004 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.3 127.95 32.97 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.73 -0.47 . . . . 10.0 109.73 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 146.23 53.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.43 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -66.93 -41.17 87.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.884 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.94 85.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 10.0 111.692 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -71.07 -44.42 65.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.822 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -63.68 -40.19 96.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.561 -0.533 . . . . 10.0 109.561 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.42 -49.05 73.12 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.67 -0.776 . . . . 10.0 112.261 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -62.69 -34.68 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.4 -26.45 67.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.934 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 103' ' ' LEU . 25.6 pt -110.14 8.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 111.796 0.295 . . . . 10.0 111.796 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.56 20.34 71.77 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 121.252 -0.499 . . . . 10.0 113.097 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -118.56 -164.53 1.04 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.309 -0.256 . . . . 10.0 110.309 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.3 p -115.05 176.07 5.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.562 0.22 . . . . 10.0 110.589 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.67 -38.04 89.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.011 0.434 . . . . 10.0 109.998 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -33.9 76.12 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.628 -0.714 . . . . 10.0 110.563 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.3 m -62.06 -46.29 89.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 10.0 110.345 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 t -66.17 -43.47 91.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.071 -0.513 . . . . 10.0 109.91 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.66 -29.54 69.58 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.702 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 m -78.84 -33.77 45.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.898 0.38 . . . . 10.0 111.473 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -65.98 -33.79 76.63 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.598 0.592 . . . . 10.0 112.598 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.81 -18.27 54.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.821 0.344 . . . . 10.0 111.8 179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.432 ' HG2' HG22 ' A' ' 121' ' ' THR . 12.1 ttm180 -71.57 -26.17 62.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.281 0.562 . . . . 10.0 110.51 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 94.82 12.56 55.37 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.612 -0.722 . . . . 10.0 112.482 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 121' ' ' THR . 8.8 t -153.39 98.68 2.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.715 1.245 . . . . 10.0 109.456 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -150.06 27.49 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.323 -1.308 . . . . 10.0 109.914 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m 59.37 95.5 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.345 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.199 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.48 ' HG3' ' C ' ' A' ' 78' ' ' THR . 74.4 Cg_endo -69.73 99.8 0.77 Allowed 'Trans proline' 0 C--O 1.241 0.642 0 C-N-CA 123.242 2.628 . . . . 10.0 114.646 -176.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.57 117.9 25.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 175.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 8.4 mm-40 -48.56 -39.62 24.24 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 113.471 0.915 . . . . 10.0 113.471 -174.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.4 t30 -70.55 -34.0 71.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.86 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.79 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.7 mt -68.96 -57.89 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.758 -0.377 . . . . 10.0 111.299 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.2 -39.01 59.57 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.161 0.505 . . . . 10.0 110.592 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 48.6 m -55.02 -49.83 70.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.631 -0.713 . . . . 10.0 111.232 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 35.3 mmtt -75.77 -30.4 59.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.954 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.79 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.7 mtp -56.35 -59.59 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.066 0.395 . . . . 10.0 112.066 -178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 4.0 mp0 -74.04 -26.49 60.43 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 -178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -53.92 -33.24 56.15 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.986 0.365 . . . . 10.0 111.986 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.69 -30.02 28.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.973 0.416 . . . . 10.0 111.245 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.473 HD12 ' CG2' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -94.78 -10.73 30.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.565 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.2 t30 62.58 47.11 5.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.263 0.554 . . . . 10.0 110.749 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.1 m -131.91 158.15 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -130.66 143.69 50.92 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 120.591 -0.443 . . . . 10.0 110.847 179.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.996 HD13 HG13 ' A' ' 83' ' ' VAL . 11.6 mt -103.53 40.2 1.46 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.693 -0.685 . . . . 10.0 109.728 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 141' ' ' ARG . 14.8 mmm180 -128.26 139.88 52.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.534 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 83.08 -146.25 23.87 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.371 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.33 -21.68 14.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.89 0.376 . . . . 10.0 111.068 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -88.06 52.96 2.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 10.0 110.696 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.565 HG23 ' HA ' ' A' ' 140' ' ' LEU . 54.5 mt -76.53 141.95 15.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.518 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.38 1.16 88.16 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.877 -0.678 . . . . 10.0 112.145 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.0 156.37 76.28 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 110.046 -0.353 . . . . 10.0 110.046 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.96 122.3 11.38 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.957 1.772 . . . . 10.0 109.294 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.89 76.03 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.115 0.483 . . . . 10.0 109.829 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.2 mp -77.45 126.18 30.5 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.911 -0.586 . . . . 10.0 109.949 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.33 155.78 53.15 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.273 -0.965 . . . . 10.0 111.412 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.65 149.64 39.26 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.942 2.428 . . . . 10.0 112.434 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.58 171.71 10.93 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.21 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -56.61 -37.56 70.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.347 -0.388 . . . . 10.0 111.002 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.177 -0.916 . . . . 10.0 109.629 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 112.074 -0.41 . . . . 10.0 112.074 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.88 157.11 38.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.148 -0.316 . . . . 10.0 110.148 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -136.71 152.27 50.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.482 -0.327 . . . . 10.0 110.23 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.32 136.73 19.35 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.508 -0.314 . . . . 10.0 111.061 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.03 142.02 45.66 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.993 2.462 . . . . 10.0 112.104 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -83.12 143.66 30.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.471 -0.332 . . . . 10.0 110.911 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -136.2 132.13 35.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.082 -0.508 . . . . 10.0 109.652 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.55 155.56 37.37 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.832 0.348 . . . . 10.0 111.125 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.69 -155.07 29.11 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.965 -0.636 . . . . 10.0 112.121 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.96 -162.72 11.79 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.542 -0.623 . . . . 10.0 111.542 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.0 m -154.52 108.09 2.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.082 0.441 . . . . 10.0 110.939 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -102.28 173.85 6.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.873 -0.417 . . . . 10.0 109.873 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -156.6 173.2 34.36 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.348 -0.93 . . . . 10.0 112.692 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -158.25 151.52 23.06 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.732 -0.47 . . . . 10.0 109.732 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -142.2 151.03 41.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.664 0.268 . . . . 10.0 110.477 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -126.11 133.22 51.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.44 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.4 m -107.59 114.05 27.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.03 0.443 . . . . 10.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -131.85 163.99 27.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.399 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.8 141.61 46.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.22 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -130.3 159.59 36.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.908 -0.404 . . . . 10.0 109.908 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -157.01 123.47 4.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.714 0.293 . . . . 10.0 110.433 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -156.79 103.44 2.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.012 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -104.33 96.5 6.67 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.647 -0.501 . . . . 10.0 109.647 178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -172.47 132.48 0.6 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.715 -0.675 . . . . 10.0 109.884 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 mm -71.33 98.26 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.998 -0.547 . . . . 10.0 109.931 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.9 pt -108.76 -176.44 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.891 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -60.54 146.66 84.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.023 -0.535 . . . . 10.0 111.075 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -62.19 108.91 0.74 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.738 2.292 . . . . 10.0 111.474 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -119.78 -132.03 0.3 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.816 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.5 p -80.4 -176.4 5.65 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.629 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.408 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.8 m -76.41 -32.03 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.349 . . . . 10.0 110.61 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.34 138.4 5.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.864 -0.684 . . . . 10.0 112.374 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -70.14 -42.65 72.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.987 0.422 . . . . 10.0 110.682 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -75.39 -25.35 57.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.655 0.74 . . . . 10.0 109.234 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 87' ' ' ILE . 37.2 t -69.28 -45.3 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 114.507 -1.224 . . . . 10.0 110.249 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.88 -42.79 98.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.87 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -62.76 -40.3 96.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 10.0 110.434 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.35 -30.81 66.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.854 -0.612 . . . . 10.0 111.064 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 83' ' ' VAL . 23.4 mt -59.93 -46.81 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 120.96 0.41 . . . . 10.0 110.635 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -71.46 -52.95 15.68 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.582 -0.447 . . . . 10.0 110.538 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.45 ' O ' ' HD3' ' A' ' 93' ' ' LYS . 46.8 mt-30 -60.61 -35.05 75.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.907 -0.588 . . . . 10.0 112.239 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.69 -31.9 52.28 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 119.636 -1.269 . . . . 10.0 112.365 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.647 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 1.3 mpt_? -81.72 -34.43 30.56 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.924 0.392 . . . . 10.0 111.383 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.522 ' HA ' HG23 ' A' ' 97' ' ' THR . 33.5 mt-30 -75.19 -2.12 26.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.995 0.426 . . . . 10.0 110.451 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 89' ' ' GLN . 1.5 tptm -84.9 0.11 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.023 0.44 . . . . 10.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.8 -171.98 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 10.0 111.185 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -126.46 112.1 23.2 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.54 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -78.84 -31.19 5.17 Favored 'Cis proline' 0 C--N 1.344 0.324 0 C-N-CA 123.358 -1.518 . . . . 10.0 112.558 -0.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 92' ' ' GLN . 99.0 m -168.3 130.29 1.4 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 113.82 -1.536 . . . . 10.0 108.724 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 29.5 tpp -73.24 110.36 7.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.521 -0.472 . . . . 10.0 109.958 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -69.53 156.78 38.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.147 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.08 -35.22 76.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.582 -0.735 . . . . 10.0 109.911 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.51 95.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.059 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -71.68 -49.87 35.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.701 -0.227 . . . . 10.0 110.794 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.574 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -58.34 -46.66 85.79 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.48 0.488 . . . . 10.0 109.887 179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.08 -47.18 92.29 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.119 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -64.26 -38.57 91.53 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.904 0.335 . . . . 10.0 111.904 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -73.3 -15.18 61.41 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 103' ' ' LEU . 43.4 pt -107.05 3.69 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.808 0.337 . . . . 10.0 111.006 178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.86 25.72 55.31 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 121.079 -0.582 . . . . 10.0 113.034 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -125.24 -157.47 0.78 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.668 0.271 . . . . 10.0 110.356 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.3 p -124.92 176.68 6.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 10.0 110.406 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.48 91.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.617 0.246 . . . . 10.0 111.145 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.18 -35.88 76.35 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.257 -0.428 . . . . 10.0 110.76 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.1 m -60.68 -47.18 87.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.923 -0.58 . . . . 10.0 110.883 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.2 t -64.15 -45.16 97.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.246 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.07 -32.35 73.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.806 0.812 . . . . 10.0 109.834 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 11.6 m -74.66 -24.89 58.88 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.201 -0.909 . . . . 10.0 111.275 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -77.61 -34.36 53.45 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.528 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -66.09 -20.36 66.14 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 -178.07 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.647 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.9 ptm180 -70.88 -23.05 62.22 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.665 0.745 . . . . 10.0 110.738 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.408 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.51 28.43 7.54 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.012 -0.995 . . . . 10.0 112.063 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 121' ' ' THR . 8.8 t -173.8 107.69 0.14 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 122.167 0.984 . . . . 10.0 110.201 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -158.04 25.95 0.26 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.843 -1.071 . . . . 10.0 109.616 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.3 m 62.33 99.99 0.04 OUTLIER Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 108.806 -0.813 . . . . 10.0 108.806 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -71.76 99.29 0.95 Allowed 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 122.855 2.37 . . . . 10.0 114.042 -176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.643 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 4.5 t0 -87.5 120.41 28.78 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.443 -2.058 . . . . 10.0 105.443 176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.429 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.6 mm-40 -52.07 -42.33 63.1 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.949 0.722 . . . . 10.0 112.949 -176.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -68.22 -30.88 70.05 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.879 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.718 ' O ' ' HG3' ' A' ' 132' ' ' MET . 73.2 mt -72.07 -56.2 10.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.0 mt -48.85 -42.78 37.53 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.615 0.572 . . . . 10.0 110.361 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 74.4 m -57.02 -47.3 81.21 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.152 -0.931 . . . . 10.0 111.765 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.572 ' O ' HG23 ' A' ' 135' ' ' VAL . 2.6 mppt? -74.66 -38.01 62.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.519 0.562 . . . . 10.0 112.519 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.718 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 32.9 mtp -50.42 -55.83 14.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.832 0.825 . . . . 10.0 111.161 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.633 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 53.8 mt-10 -73.24 -27.24 61.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.801 -1.09 . . . . 10.0 113.315 -178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -68.74 -27.39 65.88 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.963 1.098 . . . . 10.0 113.963 -175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 131' ' ' LYS . 6.0 t -71.0 -22.79 23.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 112.158 0.429 . . . . 10.0 112.158 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -127.32 -23.85 3.46 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 113.816 1.043 . . . . 10.0 113.816 -176.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 2.8 m120 77.91 63.68 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.082 0.944 . . . . 10.0 110.099 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.567 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 2.8 t -135.96 139.86 45.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.127 -1.397 . . . . 10.0 108.178 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 12.1 mmtm -112.45 133.14 54.69 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.338 -0.545 . . . . 10.0 112.145 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.633 ' HG ' ' OE2' ' A' ' 133' ' ' GLU . 1.1 mt -93.24 -20.25 20.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.163 -0.926 . . . . 10.0 110.979 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -120.15 152.04 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 10.0 111.06 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 112.85 -156.78 15.37 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.184 -0.766 . . . . 10.0 111.184 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -96.8 -37.1 10.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.821 0.343 . . . . 10.0 110.628 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -89.92 55.65 3.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.646 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.84 137.63 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.185 0.517 . . . . 10.0 110.913 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.66 90.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.093 -0.803 . . . . 10.0 111.093 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.31 147.77 58.68 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.301 -0.449 . . . . 10.0 110.914 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -61.7 123.65 13.09 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.474 2.116 . . . . 10.0 110.718 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.9 OUTLIER -169.13 98.11 0.36 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.225 -0.658 . . . . 10.0 109.225 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 150' ' ' LEU . 0.6 OUTLIER -53.73 -46.13 70.72 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.273 0.358 . . . . 10.0 111.135 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.447 ' N ' ' HG ' ' A' ' 150' ' ' LEU . . . 58.45 -119.85 19.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.435 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.34 107.56 2.43 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.185 1.924 . . . . 10.0 111.193 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 38.0 pttt -89.89 105.88 18.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.221 0.534 . . . . 10.0 110.809 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.8 tmmt? -152.41 135.06 15.36 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.491 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.57 -0.728 . . . . 10.0 110.209 179.728 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.709 -0.556 . . . . 10.0 111.709 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.55 136.25 52.33 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 122.629 -0.336 . . . . 10.0 110.701 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 44.6 mtm -141.23 144.78 34.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.141 -0.482 . . . . 10.0 110.03 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -158.57 130.03 3.92 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.175 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.78 46.03 1.61 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.069 2.513 . . . . 10.0 114.209 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.89 130.92 55.44 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.08 -0.711 . . . . 10.0 109.08 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -126.5 123.24 37.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 10.0 111.163 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.76 -174.07 2.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.22 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.58 -146.95 8.83 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.678 -0.569 . . . . 10.0 111.678 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.27 91.76 1.73 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.633 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -123.55 124.35 42.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.612 0.244 . . . . 10.0 110.373 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.86 149.83 50.38 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.065 -0.346 . . . . 10.0 110.065 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.25 -166.76 20.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.086 -0.578 . . . . 10.0 111.94 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -139.92 174.08 10.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.815 0.34 . . . . 10.0 110.777 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -141.09 155.56 46.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.699 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.4 mt -132.49 166.81 21.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.305 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.4 m -110.02 133.22 53.42 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.522 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -89.97 93.71 9.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.856 0.36 . . . . 10.0 110.56 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.87 130.27 18.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.861 -0.609 . . . . 10.0 110.145 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -150.14 172.15 15.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.55 -0.295 . . . . 10.0 110.473 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 69' ' ' ARG . 29.9 mtm180 -92.72 151.73 19.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.797 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -98.35 62.91 1.5 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.102 0.477 . . . . 10.0 111.577 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -104.88 90.06 3.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.52 0.676 . . . . 10.0 109.861 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.29 54.74 8.28 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.709 0.766 . . . . 10.0 109.071 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.5 pt -81.77 172.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.87 -1.059 . . . . 10.0 111.824 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.0 pt -75.87 172.72 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.842 -1.072 . . . . 10.0 110.943 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -77.36 146.11 73.54 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.944 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.63 178.44 5.11 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.405 2.07 . . . . 10.0 111.705 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -97.23 -160.09 0.78 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.701 -0.481 . . . . 10.0 109.701 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.93 168.05 12.8 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.072 -0.513 . . . . 10.0 109.957 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.9 m -83.17 -23.67 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.796 -0.362 . . . . 10.0 111.663 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.45 139.14 7.8 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.49 -0.862 . . . . 10.0 112.526 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -68.53 -47.64 66.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.724 0.297 . . . . 10.0 111.426 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -66.32 -33.47 75.79 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.38 0.61 . . . . 10.0 109.512 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.7 t -64.1 -44.52 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.021 -0.991 . . . . 10.0 109.998 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.47 -41.71 98.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.795 -0.717 . . . . 10.0 111.929 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -62.44 -41.25 98.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 10.0 110.199 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -71.78 -30.84 65.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.114 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.699 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 2.3 mt -60.71 -47.38 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 116.418 -0.356 . . . . 10.0 110.267 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.48 -53.19 46.1 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.434 0.459 . . . . 10.0 110.46 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -60.74 -33.44 72.91 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.573 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.04 -31.9 82.28 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.917 -0.583 . . . . 10.0 112.788 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.699 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.2 mmt180 -80.05 -32.34 39.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.483 0.658 . . . . 10.0 109.28 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.442 ' HA ' HG23 ' A' ' 97' ' ' THR . 84.4 mt-30 -74.2 -24.99 59.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.334 -0.848 . . . . 10.0 110.764 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -84.58 54.03 2.88 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.978 -178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -123.94 0.68 8.59 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.836 0.31 . . . . 10.0 111.836 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 1.6 tt0 56.11 98.64 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 O-C-N 124.159 0.912 . . . . 10.0 112.016 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 75.6 Cg_endo -81.81 -37.94 1.43 Allowed 'Cis proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.545 -1.44 . . . . 10.0 113.451 0.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 92' ' ' GLN . 2.3 m -173.88 124.88 0.36 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.395 -178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.7 ttm -83.57 142.36 30.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.447 -0.342 . . . . 10.0 110.286 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 75.5 p -74.52 163.55 27.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.202 0.525 . . . . 10.0 111.142 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -69.27 -32.59 71.87 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.256 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.07 82.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.548 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.435 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 14.0 mm-40 -60.72 -54.45 45.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.594 -0.276 . . . . 10.0 110.445 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HG ' HH11 ' A' ' 91' ' ' ARG . 0.2 OUTLIER -64.76 -36.91 85.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.632 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.63 -47.5 86.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.816 -0.707 . . . . 10.0 111.742 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.96 -40.48 91.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.259 -0.275 . . . . 10.0 110.259 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -62.4 -31.74 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.352 0.501 . . . . 10.0 112.352 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 103' ' ' LEU . 46.8 pt -90.86 1.8 7.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.812 0.339 . . . . 10.0 111.42 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.36 15.24 74.55 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.96 -0.638 . . . . 10.0 113.311 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -116.63 -149.4 0.44 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.851 -0.426 . . . . 10.0 109.851 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.65 172.07 9.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.602 0.239 . . . . 10.0 110.988 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.16 -35.91 78.38 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.933 0.397 . . . . 10.0 110.505 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.08 -35.65 77.55 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.637 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 4.0 m -59.64 -47.5 85.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.476 -0.329 . . . . 10.0 110.462 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.36 -44.13 87.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.654 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.25 -34.95 78.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.219 0.533 . . . . 10.0 110.893 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 36.5 m -76.83 -32.51 57.62 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.426 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.402 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.9 m-85 -67.57 -37.37 82.55 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.475 -0.33 . . . . 10.0 111.511 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -64.59 -18.78 65.21 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.721 0.296 . . . . 10.0 111.514 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.529 ' HG2' HG22 ' A' ' 121' ' ' THR . 42.8 ttt180 -70.48 -20.39 62.86 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.402 0.62 . . . . 10.0 110.105 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.446 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 93.27 23.14 25.29 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.25 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 119' ' ' ARG . 4.1 t -170.21 105.18 0.3 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.888 0.851 . . . . 10.0 110.35 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.47 33.59 0.11 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.98 -1.009 . . . . 10.0 109.824 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.0 m 64.26 104.04 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.348 -0.842 . . . . 10.0 110.774 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.1 83.74 1.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.508 2.138 . . . . 10.0 113.353 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.713 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -84.44 120.33 26.17 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.18 -1.044 . . . . 10.0 108.18 178.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -50.09 -47.36 53.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.74 0.644 . . . . 10.0 112.74 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 26.8 p-10 -61.36 -39.28 90.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.892 -0.14 . . . . 10.0 111.214 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.572 ' O ' ' HG3' ' A' ' 132' ' ' MET . 77.4 mt -69.45 -50.47 50.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 12.7 mt -54.4 -41.85 69.75 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.901 0.381 . . . . 10.0 110.006 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -55.83 -42.47 75.78 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.463 -0.79 . . . . 10.0 111.288 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.575 ' O ' HG23 ' A' ' 135' ' ' VAL . 70.4 mmtt -73.66 -43.34 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.934 0.397 . . . . 10.0 110.518 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.673 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 4.0 mtt -52.61 -56.13 17.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.59 -0.732 . . . . 10.0 111.161 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -62.94 -29.61 70.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.544 -0.753 . . . . 10.0 112.45 -178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 134' ' ' ARG . 8.9 mmt180 -75.59 -45.16 39.25 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.931 0.715 . . . . 10.0 112.931 -177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 131' ' ' LYS . 17.7 t -65.39 -41.19 90.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 111.898 0.332 . . . . 10.0 111.898 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 132' ' ' MET . 0.0 OUTLIER -89.91 -10.16 46.21 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.87 -0.332 . . . . 10.0 111.869 -178.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.9 t30 57.51 52.9 7.93 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.549 0.69 . . . . 10.0 110.481 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 136' ' ' LEU . 27.5 m -142.59 140.66 28.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.762 -1.108 . . . . 10.0 108.19 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 1.5 mtpp -96.67 133.46 41.16 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.028 -0.669 . . . . 10.0 110.251 179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.525 ' HA ' HG23 ' A' ' 145' ' ' ILE . 36.6 mt -101.58 14.74 31.05 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.525 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -129.37 145.86 51.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.228 -0.897 . . . . 10.0 110.192 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.52 -155.85 21.86 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.795 -0.717 . . . . 10.0 112.469 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.98 -22.79 14.67 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.023 0.439 . . . . 10.0 110.752 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -91.88 51.68 1.87 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.056 0.455 . . . . 10.0 110.822 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 58.7 mt -71.9 142.65 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.705 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.84 4.29 88.83 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.455 -0.658 . . . . 10.0 111.455 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.55 143.49 48.55 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.568 -0.316 . . . . 10.0 110.548 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.7 124.0 10.68 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.683 1.589 . . . . 10.0 108.061 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.5 ttp85 -168.47 80.67 0.15 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.268 0.556 . . . . 10.0 110.058 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 150' ' ' LEU . 12.5 tp -85.5 87.88 7.45 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.055 -0.658 . . . . 10.0 110.919 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.78 70.05 0.07 OUTLIER Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.789 -0.719 . . . . 10.0 113.202 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.98 107.98 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.244 1.963 . . . . 10.0 112.202 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.24 148.99 52.0 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.881 -0.414 . . . . 10.0 109.881 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -85.79 -33.75 21.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.675 0.274 . . . . 10.0 111.18 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.1 pttt . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.475 -0.774 . . . . 10.0 110.4 -179.732 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 111.903 -0.479 . . . . 10.0 111.903 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.04 143.09 32.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.723 0.297 . . . . 10.0 110.858 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.2 ptp -147.48 139.27 24.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.223 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -150.63 130.37 6.67 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.448 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.76 122.6 7.42 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.776 2.317 . . . . 10.0 112.86 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.87 145.06 34.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.312 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -156.19 167.37 30.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.858 0.361 . . . . 10.0 110.77 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.63 158.74 43.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.154 -0.475 . . . . 10.0 110.099 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 175.05 165.67 31.68 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.722 -0.752 . . . . 10.0 112.267 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 118.07 -20.02 10.79 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.704 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.8 m -96.9 112.19 24.06 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.291 -0.263 . . . . 10.0 110.291 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -153.12 179.47 8.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.807 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.45 144.8 20.02 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 111.378 -0.689 . . . . 10.0 111.378 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -90.51 151.16 21.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.981 0.42 . . . . 10.0 111.533 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -96.32 149.11 22.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.787 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.509 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -127.96 7.49 6.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.026 0.441 . . . . 10.0 110.806 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.5 m -96.76 125.88 41.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.7 162.31 19.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.049 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 32.8 m -103.84 167.54 2.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.833 0.349 . . . . 10.0 111.097 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -119.77 4.44 11.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.34 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.2 mtm-85 -96.59 133.83 40.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.285 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.2 m -149.48 101.92 3.14 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.286 -0.415 . . . . 10.0 110.44 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -134.49 114.29 12.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.228 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -128.88 98.32 4.92 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.133 0.492 . . . . 10.0 111.334 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.46 129.59 72.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.153 -0.684 . . . . 10.0 109.153 178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.0 pt -85.12 149.09 4.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.808 0.337 . . . . 10.0 110.961 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.08 133.95 23.73 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.427 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.05 117.63 5.23 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.48 2.12 . . . . 10.0 111.897 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -118.35 -160.44 0.79 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.906 0.384 . . . . 10.0 110.312 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.637 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 3.5 p -95.67 -177.94 4.23 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.76 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.583 HG12 HG21 ' A' ' 83' ' ' VAL . 3.4 t -70.75 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.239 0.542 . . . . 10.0 110.87 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.77 153.35 5.91 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -76.48 -52.28 10.13 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 117.581 0.691 . . . . 10.0 112.543 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.49 -30.5 69.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.605 -0.438 . . . . 10.0 111.568 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.583 HG21 HG12 ' A' ' 79' ' ' VAL . 25.9 m -68.01 -35.42 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 120.735 -0.386 . . . . 10.0 110.39 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -61.75 -48.66 82.69 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.277 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -63.62 -36.77 84.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.916 0.389 . . . . 10.0 110.756 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -69.7 -30.75 68.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.963 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.834 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.7 mt -61.27 -47.88 91.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.321 0 N-CA-C 109.381 -0.599 . . . . 10.0 109.381 177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.81 -53.34 57.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.872 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.6 -35.09 79.86 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.676 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.26 80.34 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.925 -0.655 . . . . 10.0 113.375 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.834 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.8 mmt180 -75.84 -35.56 59.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.233 0.539 . . . . 10.0 109.926 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.47 ' HA ' HG23 ' A' ' 97' ' ' THR . 77.6 mt-30 -78.67 -12.91 60.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.583 -0.735 . . . . 10.0 110.776 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -77.94 -0.79 28.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.676 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.73 -168.56 0.47 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.145 0.498 . . . . 10.0 111.466 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 12.7 tp10 -131.05 109.95 15.42 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.974 -0.557 . . . . 10.0 110.472 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.0 Cg_endo -79.06 -29.2 6.79 Favored 'Cis proline' 0 CA--C 1.515 -0.45 0 C-N-CA 123.188 -1.588 . . . . 10.0 112.157 -0.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 92' ' ' GLN . 38.0 m -168.47 136.21 2.11 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 113.55 -1.659 . . . . 10.0 109.198 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.9 tpp -87.01 127.57 35.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.245 -0.28 . . . . 10.0 110.245 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.3 p -77.25 156.82 31.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.361 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -68.13 -33.68 74.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.197 -0.456 . . . . 10.0 110.192 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.75 71.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.385 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -66.48 -42.26 87.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.454 -0.339 . . . . 10.0 111.461 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.551 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tm? -65.46 -44.52 86.93 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.326 -0.62 . . . . 10.0 109.326 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.06 96.58 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.769 -0.729 . . . . 10.0 111.394 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -60.72 -43.92 97.26 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.987 0.115 . . . . 10.0 111.297 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -70.91 -16.83 62.7 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 103' ' ' LEU . 33.6 pt -103.47 -3.19 9.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 120.255 -0.578 . . . . 10.0 110.779 178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.94 20.44 50.09 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 121.056 -0.592 . . . . 10.0 113.291 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -120.32 -160.17 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.683 0.278 . . . . 10.0 110.481 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -119.0 175.09 5.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.485 -0.325 . . . . 10.0 110.453 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.64 -41.65 99.16 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.758 0.313 . . . . 10.0 110.725 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.82 73.62 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 116.07 -0.514 . . . . 10.0 110.873 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.7 m -59.6 -49.54 77.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.878 0.37 . . . . 10.0 110.886 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.36 -42.75 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.93 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.74 -32.16 70.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.21 -0.45 . . . . 10.0 111.571 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 67.8 m -78.52 -31.96 47.81 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.141 0.423 . . . . 10.0 112.141 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -33.93 72.63 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -18.77 36.69 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.373 0.509 . . . . 10.0 112.373 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.444 ' HG3' HG22 ' A' ' 121' ' ' THR . 5.6 tpp180 -69.18 -23.39 63.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.309 0.576 . . . . 10.0 110.339 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.62 13.91 54.23 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.677 -0.773 . . . . 10.0 112.296 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 121' ' ' THR . 9.9 t -158.94 107.32 1.87 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.233 1.016 . . . . 10.0 109.37 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -155.78 29.17 0.37 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.443 -1.253 . . . . 10.0 110.017 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.4 m 58.58 87.77 0.13 Allowed Pre-proline 0 N--CA 1.463 0.214 0 N-CA-C 108.378 -0.971 . . . . 10.0 108.378 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.637 ' HG3' ' C ' ' A' ' 78' ' ' THR . 87.9 Cg_endo -78.96 110.89 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.717 2.278 . . . . 10.0 115.454 -175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 128' ' ' ILE . 6.6 t70 -85.95 124.91 32.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.93 -2.989 . . . . 10.0 102.93 174.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.429 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 5.0 mm-40 -50.97 -32.04 19.8 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.14 0.793 . . . . 10.0 113.14 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.531 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 62.5 t30 -75.9 -31.88 59.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.97 -0.559 . . . . 10.0 111.449 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.756 ' O ' ' HG3' ' A' ' 132' ' ' MET . 97.9 mt -64.85 -55.96 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.175 0 C-N-CA 120.955 -0.298 . . . . 10.0 110.499 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 129' ' ' LEU . 0.9 OUTLIER -47.94 -38.85 17.57 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.737 0.779 . . . . 10.0 110.116 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.3 m -62.34 -44.24 96.94 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.463 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 67.3 mmtt -75.57 -40.16 57.08 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.357 0.503 . . . . 10.0 112.357 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.756 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 49.3 mtp -53.47 -57.73 9.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.227 0.537 . . . . 10.0 111.552 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.776 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 1.5 mt-10 -72.27 -27.3 62.39 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.461 -0.79 . . . . 10.0 112.777 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -56.06 -30.22 61.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.876 0.369 . . . . 10.0 111.362 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.7 -30.85 19.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.224 -0.443 . . . . 10.0 111.814 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.713 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -96.18 -10.57 27.8 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 67.24 19.15 10.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.746 0.418 . . . . 10.0 111.772 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.776 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 19.9 m -114.03 140.89 32.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.1 mmtp -121.11 140.6 51.75 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 119.801 -0.76 . . . . 10.0 111.204 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.684 ' HA ' HG23 ' A' ' 145' ' ' ILE . 1.8 mt -102.46 41.26 1.25 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.192 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -131.3 141.21 49.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.528 . . . . 10.0 111.092 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.52 -152.49 30.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.291 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -102.55 15.09 30.25 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.195 0.522 . . . . 10.0 110.698 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.08 45.25 2.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.251 0.548 . . . . 10.0 110.173 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.684 HG23 ' HA ' ' A' ' 140' ' ' LEU . 49.1 mt -68.8 138.98 21.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.314 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.72 7.03 87.93 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 110.367 -1.093 . . . . 10.0 110.367 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -131.62 157.63 77.62 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 114.833 -0.684 . . . . 10.0 109.799 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -65.33 122.4 10.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 121.927 1.751 . . . . 10.0 110.23 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.589 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 3.2 tpp180 -147.18 94.64 2.43 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.47 143.62 54.94 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.145 -0.48 . . . . 10.0 111.084 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.06 65.98 0.62 Allowed Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.518 -0.765 . . . . 10.0 112.944 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.86 -17.74 13.68 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.361 2.041 . . . . 10.0 111.964 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -137.79 139.73 40.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.077 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -83.34 99.96 10.35 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.141 -0.933 . . . . 10.0 110.084 -179.476 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.078 -0.409 . . . . 10.0 112.078 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -155.81 152.34 28.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.39 -0.226 . . . . 10.0 110.39 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.5 mtm -100.72 144.51 29.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.647 0.261 . . . . 10.0 110.419 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -111.71 151.16 43.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.283 -0.417 . . . . 10.0 110.175 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.66 133.88 44.6 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.584 2.19 . . . . 10.0 112.318 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -76.64 152.99 35.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.365 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.37 151.37 29.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.586 -0.279 . . . . 10.0 110.804 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -157.3 153.64 27.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.402 -0.363 . . . . 10.0 110.594 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.0 -166.71 11.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.329 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -175.92 158.78 25.85 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.967 -0.635 . . . . 10.0 111.862 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.6 m -152.64 131.09 12.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.837 0.351 . . . . 10.0 110.58 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -145.01 -178.37 6.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.437 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 141.88 119.43 1.51 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.022 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -127.26 162.09 27.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.287 -0.264 . . . . 10.0 110.287 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 63' ' ' ARG . 11.6 ptm180 -160.43 149.39 17.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.815 0.34 . . . . 10.0 110.71 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 64' ' ' LEU . 1.3 tm? -151.57 118.43 5.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.802 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 85.7 m -149.71 107.77 3.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.049 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -113.33 133.98 54.86 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.475 -0.565 . . . . 10.0 109.475 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 m -120.68 144.59 29.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.038 0.447 . . . . 10.0 111.501 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.23 161.88 20.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.229 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -159.47 152.41 21.87 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.575 -0.528 . . . . 10.0 109.575 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -63.21 151.39 40.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.612 0.244 . . . . 10.0 110.492 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.75 98.94 7.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.801 0.334 . . . . 10.0 111.099 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -146.77 106.12 3.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.847 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.6 pt -121.39 161.76 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.054 0.454 . . . . 10.0 111.329 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.3 pt -85.46 -179.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.54 -0.754 . . . . 10.0 110.332 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -72.21 135.79 82.07 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.425 -0.352 . . . . 10.0 110.606 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.3 -176.9 3.32 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.863 2.375 . . . . 10.0 112.596 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -118.48 -139.62 0.35 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.905 -0.589 . . . . 10.0 109.484 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.2 p -79.47 -171.89 2.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.917 -0.401 . . . . 10.0 109.917 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.596 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.3 m -77.21 -31.48 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.536 -0.466 . . . . 10.0 110.789 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.5 132.05 3.88 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.576 -0.821 . . . . 10.0 112.401 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -64.53 -45.19 88.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.856 0.36 . . . . 10.0 110.819 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -29.7 65.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.488 -0.56 . . . . 10.0 109.488 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 87' ' ' ILE . 41.2 t -65.2 -46.2 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.078 -0.965 . . . . 10.0 109.773 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.58 -45.74 95.74 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.061 -0.59 . . . . 10.0 112.538 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -61.48 -38.59 87.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.005 0.431 . . . . 10.0 110.347 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.491 ' CB ' HD22 ' A' ' 140' ' ' LEU . . . -71.64 -30.18 65.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.399 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.812 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.9 mt -59.8 -49.17 84.86 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.65 -51.45 65.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.538 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.42 -32.23 73.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.856 -0.611 . . . . 10.0 110.744 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 93' ' ' LYS . . . -73.65 -29.78 62.98 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.796 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.812 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 4.6 mmt180 -82.76 -36.29 25.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 10.0 109.812 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HA ' HG23 ' A' ' 97' ' ' THR . 37.2 mt-30 -72.92 -15.3 61.58 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.862 -0.608 . . . . 10.0 111.445 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 13.5 ptmt -84.86 6.69 23.69 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.812 -0.355 . . . . 10.0 111.703 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.88 -20.96 55.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.718 0.294 . . . . 10.0 111.777 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 56.98 102.44 0.04 OUTLIER Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.052 -0.977 . . . . 10.0 111.865 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.46 -62.04 0.04 OUTLIER 'Cis proline' 0 C--N 1.345 0.393 0 C-N-CA 123.524 -1.448 . . . . 10.0 113.234 -0.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 92' ' ' GLN . 47.0 m -161.38 135.44 6.86 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.329 -0.85 . . . . 10.0 110.139 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.38 132.59 46.61 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.45 145.73 54.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.268 -0.423 . . . . 10.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -69.14 -36.59 77.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.019 0.438 . . . . 10.0 109.879 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.15 -47.49 76.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.254 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -64.19 -39.26 93.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.319 -0.401 . . . . 10.0 110.958 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.454 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.6 OUTLIER -64.77 -43.89 91.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.389 -0.597 . . . . 10.0 109.389 179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.35 -43.98 96.07 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.321 -0.712 . . . . 10.0 111.321 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -59.63 -38.63 81.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.794 0.331 . . . . 10.0 110.56 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -64.71 -18.78 65.31 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.232 -0.44 . . . . 10.0 112.114 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 103' ' ' LEU . 4.4 pt -117.0 5.12 7.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.891 -0.324 . . . . 10.0 111.676 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.42 26.72 60.82 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 120.94 -0.648 . . . . 10.0 113.306 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.41 -171.14 2.11 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.152 -0.314 . . . . 10.0 110.152 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.5 p -107.42 173.61 6.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.635 0.255 . . . . 10.0 110.958 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.04 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.933 0.397 . . . . 10.0 110.069 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.42 -38.73 84.99 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.637 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.4 m -60.78 -46.49 90.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.729 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.71 -37.2 77.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.993 0.425 . . . . 10.0 110.757 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.22 77.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.09 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.4 p -75.99 -29.83 58.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.023 0.439 . . . . 10.0 110.539 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.449 ' HB3' ' CD1' ' A' ' 87' ' ' ILE . 1.0 OUTLIER -63.35 -41.78 98.88 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.881 -0.599 . . . . 10.0 112.356 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -63.54 -18.22 63.62 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.528 ' HG2' HG22 ' A' ' 121' ' ' THR . 17.7 ttt180 -74.08 -22.68 59.41 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.356 0.598 . . . . 10.0 109.864 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.482 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 101.14 21.58 11.62 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.679 -0.691 . . . . 10.0 111.781 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.528 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -170.09 113.19 0.47 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 122.108 0.956 . . . . 10.0 110.611 -178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.29 27.73 0.09 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.422 -1.263 . . . . 10.0 108.86 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 m 65.4 106.33 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.789 -1.096 . . . . 10.0 108.708 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 85.9 Cg_endo -78.15 89.63 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.763 2.309 . . . . 10.0 115.419 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -83.28 116.49 22.45 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.566 -2.012 . . . . 10.0 105.566 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.421 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 16.3 mm-40 -50.73 -40.13 53.6 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.647 0.61 . . . . 10.0 112.647 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -67.71 -32.83 73.74 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.258 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.448 HG23 HD12 ' A' ' 107' ' ' ILE . 62.7 mt -69.76 -55.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 121.026 -0.27 . . . . 10.0 110.348 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -51.58 -40.11 59.17 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.582 0.706 . . . . 10.0 110.46 179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.0 m -60.11 -52.96 63.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.513 -0.767 . . . . 10.0 112.032 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.34 -33.68 48.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.521 0.934 . . . . 10.0 113.521 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 4.5 ptm -63.11 -45.32 92.58 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.701 0.286 . . . . 10.0 111.564 -178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.871 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 21.8 mt-10 -75.66 -27.71 58.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.305 0.574 . . . . 10.0 111.801 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.29 -25.22 67.74 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.411 -0.813 . . . . 10.0 112.514 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.65 -25.34 32.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.17 0.51 . . . . 10.0 110.995 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.645 HD21 ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -111.95 -12.74 13.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.302 -178.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 70.7 43.38 0.74 Allowed 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.217 1.008 . . . . 10.0 108.657 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.871 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.9 t -128.31 141.58 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 113.545 -1.662 . . . . 10.0 107.319 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 21.6 mmmt -128.55 136.05 50.23 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.583 0.706 . . . . 10.0 111.259 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.521 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -106.76 30.35 6.17 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.794 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -131.22 139.13 49.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.514 -0.766 . . . . 10.0 109.524 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.23 -149.47 18.7 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.429 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.7 -24.16 14.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 10.0 110.615 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.66 50.58 1.84 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 10.0 110.555 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.521 HG23 ' HA ' ' A' ' 140' ' ' LEU . 4.3 mm -65.28 138.55 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.987 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.24 3.48 87.17 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 111.345 -0.702 . . . . 10.0 111.345 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -136.04 163.06 52.97 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 114.938 -0.631 . . . . 10.0 109.846 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 20.6 Cg_endo -63.67 123.0 11.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.217 1.945 . . . . 10.0 111.328 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.606 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 22.7 tpt180 -149.14 101.14 3.12 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.954 0.406 . . . . 10.0 109.973 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.07 102.41 9.31 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.542 0.687 . . . . 10.0 110.43 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.405 ' N ' ' HD3' ' A' ' 152' ' ' PRO . . . 178.64 65.07 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 114.797 -1.092 . . . . 10.0 111.646 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 151' ' ' GLY . 16.9 Cg_exo -67.71 -23.38 42.35 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.15 2.567 . . . . 10.0 112.602 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.1 ttpp -120.45 146.72 45.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.52 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -63.94 -55.78 20.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.382 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.258 -0.877 . . . . 10.0 110.358 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 112.578 -0.209 . . . . 10.0 112.578 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.2 120.32 20.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.659 0.266 . . . . 10.0 110.371 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 13.8 ttt -95.86 72.1 3.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.389 0.614 . . . . 10.0 110.255 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -136.88 85.43 23.42 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.527 -0.761 . . . . 10.0 110.101 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -84.41 153.91 12.22 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.467 2.111 . . . . 10.0 112.577 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.68 154.07 18.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.025 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -122.99 93.6 4.01 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.035 0.445 . . . . 10.0 110.223 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.96 137.54 46.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.0 -0.545 . . . . 10.0 110.105 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -168.46 -176.16 38.57 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.394 -0.908 . . . . 10.0 112.184 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.72 113.61 2.86 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.114 -0.565 . . . . 10.0 111.99 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.3 t -159.3 149.36 19.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.684 0.278 . . . . 10.0 110.341 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -125.0 -176.41 3.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.317 -0.402 . . . . 10.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.39 102.66 0.66 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.206 -0.997 . . . . 10.0 112.792 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -142.93 143.8 32.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.835 -0.432 . . . . 10.0 109.835 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -171.37 142.17 1.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.688 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 87.4 mt -141.94 119.42 11.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.509 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.06 79.82 1.81 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.794 0.33 . . . . 10.0 111.4 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -160.62 100.79 1.31 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.407 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.85 170.56 19.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.147 -0.478 . . . . 10.0 110.431 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.57 114.94 4.8 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.023 -0.535 . . . . 10.0 109.769 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -127.27 94.42 3.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.965 0.412 . . . . 10.0 110.615 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m -75.59 -35.64 60.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.141 -0.481 . . . . 10.0 110.802 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -135.77 113.84 11.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.894 -0.594 . . . . 10.0 109.871 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.24 105.91 3.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.549 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 23.4 pt -85.01 -21.9 7.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.47 -0.332 . . . . 10.0 111.194 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.486 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 35.5 mt -65.42 138.22 23.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.875 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -105.3 94.45 8.15 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.17 0.51 . . . . 10.0 110.005 178.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 74' ' ' ILE . 83.9 Cg_endo -85.34 -143.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.804 2.336 . . . . 10.0 111.842 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 6.4 mtpm? -82.1 64.23 6.68 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.195 0.521 . . . . 10.0 109.658 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.06 155.73 27.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.545 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.475 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.7 m -78.88 -30.98 14.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 121.033 -0.267 . . . . 10.0 111.199 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.28 137.6 5.17 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.784 -0.722 . . . . 10.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -66.65 -52.91 39.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.637 0.256 . . . . 10.0 111.533 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -66.58 -31.03 71.47 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.902 HG13 HD13 ' A' ' 140' ' ' LEU . 6.0 t -62.36 -46.42 96.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.365 -1.289 . . . . 10.0 109.856 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -59.4 -47.86 88.81 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.784 -0.644 . . . . 10.0 112.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -61.12 -38.17 85.41 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.25 0.548 . . . . 10.0 110.065 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.29 -30.32 68.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.357 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.784 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 3.5 mt -60.55 -45.81 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.763 -0.458 . . . . 10.0 109.763 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HG2' HE21 ' A' ' 89' ' ' GLN . 0.6 OUTLIER -69.04 -48.05 63.85 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.698 -0.482 . . . . 10.0 109.698 -179.056 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.575 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 4.3 mm-40 -62.31 -34.7 77.11 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.33 -36.82 93.68 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.817 -0.706 . . . . 10.0 112.626 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.784 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.96 -36.25 31.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.211 0.529 . . . . 10.0 110.004 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.625 ' HA ' HG23 ' A' ' 97' ' ' THR . 86.6 mt-30 -74.49 -24.13 58.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.39 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 12.4 mptt -87.52 23.45 1.92 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.89 0.376 . . . . 10.0 111.28 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.86 -16.12 56.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 10.0 111.018 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 58.65 104.23 0.03 OUTLIER Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 114.759 -1.11 . . . . 10.0 111.41 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.09 -60.92 0.06 OUTLIER 'Cis proline' 0 CA--C 1.516 -0.392 0 C-N-CA 123.78 -1.342 . . . . 10.0 113.037 0.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 92' ' ' GLN . 74.8 m -158.77 125.15 4.61 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.206 -0.907 . . . . 10.0 110.799 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.3 tpp -78.31 135.55 37.54 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.16 144.97 50.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.775 0.321 . . . . 10.0 111.09 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.35 -36.55 77.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.989 0.423 . . . . 10.0 110.215 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 105' ' ' LYS . . . -65.14 -45.35 85.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 10.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -66.72 -39.95 88.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 10.0 110.938 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -63.6 -38.03 89.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.34 -47.7 69.15 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.418 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 101' ' ' ALA . 33.6 mmtp -59.2 -40.82 86.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 120.749 0.309 . . . . 10.0 110.663 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.03 -33.87 73.97 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.066 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.433 HG12 ' O ' ' A' ' 103' ' ' LEU . 31.1 pt -95.54 -0.2 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 10.0 111.293 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.62 14.93 69.4 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 121.185 -0.531 . . . . 10.0 113.29 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -111.56 -157.97 0.63 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.164 -0.31 . . . . 10.0 110.164 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 61.6 p -119.3 174.7 6.2 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.493 0.187 . . . . 10.0 110.63 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.7 -35.51 81.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.036 0.445 . . . . 10.0 109.804 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.54 72.29 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.447 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.0 m -64.78 -48.01 76.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.728 0.299 . . . . 10.0 110.683 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.8 t -63.8 -45.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.98 0.419 . . . . 10.0 110.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.618 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -66.18 -31.69 72.68 Favored 'General case' 0 C--O 1.222 -0.359 0 CA-C-N 115.864 -0.607 . . . . 10.0 111.061 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 48.2 m -76.64 -34.71 58.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.975 0.417 . . . . 10.0 111.768 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.32 -34.2 77.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.599 -0.273 . . . . 10.0 111.613 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.618 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -62.46 -17.6 59.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.819 0.342 . . . . 10.0 111.551 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 121' ' ' THR . 25.3 ttm180 -69.43 -28.09 65.83 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.226 0.536 . . . . 10.0 111.262 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.475 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 98.1 21.91 16.7 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.593 -0.813 . . . . 10.0 111.956 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 121' ' ' THR . 8.5 t -169.79 105.56 0.34 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.316 1.055 . . . . 10.0 109.438 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.88 25.13 0.09 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.497 -1.229 . . . . 10.0 109.636 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.7 m 67.56 106.7 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 115.111 -0.95 . . . . 10.0 110.737 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 129' ' ' LEU . 65.3 Cg_endo -73.99 88.66 1.07 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.572 2.181 . . . . 10.0 113.989 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.73 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 11.7 t70 -81.88 116.74 21.68 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.411 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 11.5 mm-40 -49.7 -46.77 50.4 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 -176.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -62.09 -43.4 98.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.544 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.705 ' O ' ' HG3' ' A' ' 132' ' ' MET . 55.7 mt -63.55 -56.84 14.63 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.129 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.73 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 13.3 mt -47.44 -45.92 26.11 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.349 0.595 . . . . 10.0 110.744 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 71.4 m -56.58 -51.18 69.61 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.986 -1.006 . . . . 10.0 112.191 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.1 OUTLIER -75.17 -30.66 60.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.705 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 31.4 mtp -56.36 -61.4 2.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.991 0.424 . . . . 10.0 111.929 -179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 3.5 mp0 -76.37 -26.37 55.59 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.556 ' HB3' ' O ' ' A' ' 130' ' ' SER . 12.3 ptt85 -58.61 -29.66 66.64 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 117.924 0.329 . . . . 10.0 111.364 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 131' ' ' LYS . 66.7 t -71.48 -33.7 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.0 0.429 . . . . 10.0 110.969 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.597 HD12 HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -95.16 -17.45 21.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.488 -178.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 61.9 t30 62.27 56.03 2.26 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.531 0.682 . . . . 10.0 109.536 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.597 HG22 HD12 ' A' ' 136' ' ' LEU . 11.9 m -137.19 159.72 36.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.44 -1.254 . . . . 10.0 108.715 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 149' ' ' ARG . 6.5 mmpt? -127.25 139.77 52.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.905 ' HA ' HG23 ' A' ' 145' ' ' ILE . 11.2 mt -95.13 36.11 1.24 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.39 0.614 . . . . 10.0 110.282 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -135.62 155.72 50.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.627 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.02 -163.23 43.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.057 -0.592 . . . . 10.0 112.571 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.86 -12.49 36.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.955 0.407 . . . . 10.0 110.854 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -104.86 49.89 0.8 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.11 0.481 . . . . 10.0 110.36 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 140' ' ' LEU . 22.7 mt -70.81 137.63 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-N 115.753 -0.658 . . . . 10.0 109.985 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.96 1.89 67.05 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.77 -0.932 . . . . 10.0 110.77 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -135.24 159.19 72.79 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.725 -0.738 . . . . 10.0 109.217 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.17 120.99 9.29 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.029 1.819 . . . . 10.0 109.905 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.524 ' HB3' ' HB2' ' A' ' 139' ' ' LYS . 7.3 tpp85 -140.17 105.69 5.1 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.899 -0.5 . . . . 10.0 110.629 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 80.6 mt -89.44 104.9 17.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.91 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -107.83 156.08 15.99 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.243 -0.98 . . . . 10.0 112.107 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -89.69 144.02 4.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.774 2.316 . . . . 10.0 112.047 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -96.42 4.23 52.3 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.286 0.565 . . . . 10.0 109.903 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 0.2 OUTLIER -96.07 107.23 19.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.673 -0.694 . . . . 10.0 110.177 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.55 -0.738 . . . . 10.0 110.305 179.516 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.686 0 N-CA-C 112.017 -0.433 . . . . 10.0 112.017 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.28 132.48 8.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.375 -0.232 . . . . 10.0 110.375 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -153.58 156.46 38.05 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.458 -0.337 . . . . 10.0 110.318 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -122.11 136.49 26.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.87 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.94 116.68 3.3 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.171 2.581 . . . . 10.0 112.685 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -83.31 115.11 21.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.156 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -102.93 141.53 35.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.343 -0.389 . . . . 10.0 110.665 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.85 149.78 22.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.195 -0.457 . . . . 10.0 110.852 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -91.13 -162.19 37.89 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.834 -0.698 . . . . 10.0 112.458 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -164.02 -166.64 23.24 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.617 -0.593 . . . . 10.0 111.617 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -154.35 148.94 26.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.907 0.384 . . . . 10.0 110.542 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -157.96 138.73 13.03 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.259 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.15 174.49 16.16 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.964 -0.636 . . . . 10.0 111.709 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -165.96 135.24 3.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.802 0.334 . . . . 10.0 110.513 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 141.13 30.84 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.212 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 26.0 tp -148.98 118.89 7.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.991 -0.55 . . . . 10.0 110.239 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -105.49 141.42 37.01 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.396 -0.366 . . . . 10.0 110.335 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -122.44 108.85 13.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.413 -0.358 . . . . 10.0 110.337 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.92 116.45 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.173 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -163.27 -170.82 2.39 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.372 -0.603 . . . . 10.0 109.372 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -92.58 -178.84 5.0 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.242 -0.281 . . . . 10.0 110.242 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.2 m -93.62 70.87 4.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.267 0.556 . . . . 10.0 111.029 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -132.11 41.02 3.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.832 0.825 . . . . 10.0 109.359 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -165.3 125.59 1.87 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.783 -1.099 . . . . 10.0 108.783 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.0 mt -76.47 86.3 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.317 0.58 . . . . 10.0 110.95 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 pt -134.52 -173.38 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.612 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -73.93 143.21 80.74 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.71 80.83 0.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.326 2.017 . . . . 10.0 112.124 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -83.53 46.11 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.285 0.564 . . . . 10.0 110.374 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.412 ' O ' ' HG3' ' A' ' 124' ' ' PRO . 3.1 p -126.18 157.09 39.05 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.874 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.456 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.4 m -84.31 -30.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.968 -0.293 . . . . 10.0 111.444 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.1 140.27 5.65 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.556 -0.83 . . . . 10.0 112.253 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -66.71 -51.94 50.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.791 0.329 . . . . 10.0 111.092 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -66.21 -33.93 76.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.17 -0.678 . . . . 10.0 109.17 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.678 HG22 ' HB3' ' A' ' 140' ' ' LEU . 13.1 t -61.88 -47.12 94.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.154 -0.93 . . . . 10.0 110.478 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.17 -39.47 95.94 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.699 -0.762 . . . . 10.0 111.827 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -65.77 -40.32 91.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.38 83.18 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.822 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.465 HG23 ' CZ ' ' A' ' 91' ' ' ARG . 3.4 mt -54.25 -45.28 67.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.054 0.454 . . . . 10.0 110.503 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -69.87 -48.05 60.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.348 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.2 mt-30 -62.54 -37.65 86.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.747 -0.66 . . . . 10.0 111.147 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -65.98 -38.76 94.44 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.978 -0.556 . . . . 10.0 113.287 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.651 HH22 ' HB3' ' A' ' 132' ' ' MET . 0.5 OUTLIER -78.98 -38.62 36.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.808 0.337 . . . . 10.0 111.425 -178.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.678 ' HA ' HG23 ' A' ' 97' ' ' THR . 2.2 pt20 -72.49 -13.63 61.47 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.492 -0.483 . . . . 10.0 110.078 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 2.0 tttm -81.54 12.12 4.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.874 -0.603 . . . . 10.0 111.346 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.56 -158.42 0.22 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.955 0.407 . . . . 10.0 110.781 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.66 105.39 14.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.909 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.08 -30.41 5.33 Favored 'Cis proline' 0 C--N 1.348 0.504 0 C-N-CA 123.523 -1.449 . . . . 10.0 112.725 -0.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 92' ' ' GLN . 15.2 m -161.33 135.76 7.11 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.862 -1.517 . . . . 10.0 109.445 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.18 127.72 35.76 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.109 -0.33 . . . . 10.0 110.109 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.592 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 59.0 p -79.99 163.69 24.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.969 0.414 . . . . 10.0 110.641 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.88 -28.91 67.12 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.87 -32.59 69.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.281 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.592 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 21.4 mm-40 -66.59 -54.97 17.7 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.547 0.213 . . . . 10.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.559 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -63.91 -40.4 96.4 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.212 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.38 -46.07 93.48 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 111.352 -0.699 . . . . 10.0 111.352 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -65.48 -44.34 87.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -59.95 -36.54 77.3 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.693 0.627 . . . . 10.0 112.693 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.634 HD13 ' SD ' ' A' ' 132' ' ' MET . 36.4 pt -87.61 -12.46 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.777 -0.369 . . . . 10.0 111.74 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 91.86 22.45 30.68 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.888 -0.672 . . . . 10.0 113.476 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -119.89 -154.92 0.6 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.052 -0.351 . . . . 10.0 110.052 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 p -115.14 176.96 4.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.568 0.223 . . . . 10.0 110.719 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -34.19 75.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.817 0.342 . . . . 10.0 110.263 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.98 84.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.435 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -58.33 -48.2 81.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.208 -0.451 . . . . 10.0 110.164 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.98 -46.66 90.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.884 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.48 -37.84 87.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.274 0.559 . . . . 10.0 111.098 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 58.2 m -74.23 -26.28 60.15 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.092 -0.503 . . . . 10.0 110.652 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -43.27 69.65 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.464 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.72 -18.89 57.06 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.957 0.408 . . . . 10.0 111.035 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.545 ' HB3' ' O ' ' A' ' 116' ' ' SER . 45.3 ttp180 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.265 0.555 . . . . 10.0 110.411 178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.456 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.06 21.49 22.86 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.868 -0.606 . . . . 10.0 111.783 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 121' ' ' THR . 8.0 t -174.62 114.35 0.17 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.026 0.917 . . . . 10.0 109.712 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.92 29.83 0.15 Allowed 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.827 -1.079 . . . . 10.0 109.863 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m 58.88 93.1 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.412 ' HG3' ' O ' ' A' ' 78' ' ' THR . 73.3 Cg_endo -71.45 104.67 1.61 Allowed 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.926 2.418 . . . . 10.0 115.977 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.585 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 18.3 t70 -90.2 119.57 30.63 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 104.85 -2.278 . . . . 10.0 104.85 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -49.01 -46.65 44.35 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -63.3 -36.52 83.95 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.305 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.37 -55.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 CA-C-N 116.852 -0.158 . . . . 10.0 110.914 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -54.42 -38.76 66.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.979 0.418 . . . . 10.0 110.616 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.6 m -58.69 -50.37 74.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.605 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -34.51 61.46 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.719 0.266 . . . . 10.0 111.719 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.651 ' HB3' HH22 ' A' ' 91' ' ' ARG . 5.3 mmm -52.52 -61.06 2.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.792 -0.64 . . . . 10.0 112.355 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.547 ' HG3' ' HG ' ' A' ' 140' ' ' LEU . 49.4 mm-40 -76.49 -24.04 53.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.487 -0.779 . . . . 10.0 112.17 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.669 ' HB2' ' O ' ' A' ' 130' ' ' SER . 20.9 ttp180 -52.58 -40.73 62.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 10.0 111.805 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.98 -24.95 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 10.0 111.197 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.573 ' HB2' HG23 ' A' ' 138' ' ' VAL . 0.2 OUTLIER -99.57 -16.39 18.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.974 -178.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 6.3 m-20 78.79 52.46 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.57 0.7 . . . . 10.0 109.908 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 136' ' ' LEU . 0.7 OUTLIER -133.17 159.49 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.886 -1.052 . . . . 10.0 108.248 178.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -130.15 -2.19 4.54 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.566 -0.854 . . . . 10.0 113.103 -179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.678 ' HB3' HG22 ' A' ' 83' ' ' VAL . 22.4 mt 54.61 10.51 0.35 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.792 -1.095 . . . . 10.0 113.699 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.573 HH21 HG21 ' A' ' 83' ' ' VAL . 4.3 mmt85 -132.98 151.68 52.04 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.297 -0.252 . . . . 10.0 110.47 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 102.74 -179.78 26.54 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.769 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.74 -25.05 48.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.176 0.512 . . . . 10.0 109.9 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -89.37 56.48 3.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.571 -0.74 . . . . 10.0 110.845 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.2 mm -65.68 139.28 21.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.054 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.64 19.54 61.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.582 -0.818 . . . . 10.0 111.088 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.406 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -150.46 162.0 28.82 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.046 -0.577 . . . . 10.0 109.462 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.406 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 14.2 Cg_endo -61.83 122.73 11.41 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 121.618 1.545 . . . . 10.0 110.149 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 149' ' ' ARG . 0.9 OUTLIER -140.58 81.74 1.82 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 -178.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 34.2 mt -67.91 104.33 1.69 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.812 -0.631 . . . . 10.0 111.632 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -113.11 -179.9 19.26 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.895 -0.882 . . . . 10.0 110.895 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.57 113.67 2.21 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.539 2.159 . . . . 10.0 111.774 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.28 169.45 17.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.515 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -104.53 165.5 11.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.93 0.395 . . . . 10.0 111.072 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.378 -0.82 . . . . 10.0 109.862 179.636 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.69 -0.564 . . . . 10.0 111.69 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.37 157.91 45.56 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.841 0.353 . . . . 10.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -118.09 155.14 30.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.986 -0.552 . . . . 10.0 110.315 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -100.71 147.17 33.27 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.539 -0.3 . . . . 10.0 110.723 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -63.41 151.79 83.23 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.216 2.61 . . . . 10.0 112.507 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -117.28 156.36 27.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -151.59 154.17 35.93 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.878 -0.416 . . . . 10.0 109.878 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.23 -177.81 6.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.763 0.316 . . . . 10.0 111.017 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.37 -133.96 1.86 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.19 -0.529 . . . . 10.0 111.861 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.99 158.01 7.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.148 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 t -141.45 170.24 16.1 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.265 -0.272 . . . . 10.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -75.13 179.65 4.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.951 0.405 . . . . 10.0 110.71 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -151.57 -125.66 1.21 Allowed Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.753 -0.737 . . . . 10.0 111.922 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -69.02 145.22 53.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.902 0.382 . . . . 10.0 110.687 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -94.59 -48.69 5.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.991 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 pp -97.33 132.48 43.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.167 -0.47 . . . . 10.0 109.806 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.2 p -107.24 -66.02 1.06 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.516 -0.311 . . . . 10.0 111.062 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 143' ' ' ALA . 17.8 ptpt -142.89 147.48 35.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.151 -0.477 . . . . 10.0 110.498 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.8 m -78.67 165.15 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.352 -0.385 . . . . 10.0 110.696 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -114.56 132.03 56.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.901 0.382 . . . . 10.0 110.596 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -135.77 155.5 50.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.002 -0.545 . . . . 10.0 109.551 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.15 159.02 35.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.343 -0.39 . . . . 10.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -150.8 117.82 5.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.477 -0.329 . . . . 10.0 110.125 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.62 31.84 0.47 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.222 0.535 . . . . 10.0 110.908 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.6 tt -83.32 -13.2 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.441 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.7 mt 60.03 77.11 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.59 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -67.59 154.73 92.73 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.746 -0.661 . . . . 10.0 110.951 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.46 -160.41 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.56 2.173 . . . . 10.0 111.638 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -83.15 47.65 1.27 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.111 0.481 . . . . 10.0 110.779 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 13.1 p -100.36 137.35 38.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.478 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 3.1 p -71.63 -33.89 50.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.526 -0.306 . . . . 10.0 111.116 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.06 130.18 3.1 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.438 -0.887 . . . . 10.0 112.192 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.99 -53.02 61.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.756 0.313 . . . . 10.0 111.089 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -65.34 -33.02 74.99 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.51 -0.552 . . . . 10.0 109.51 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 87' ' ' ILE . 92.9 t -62.69 -46.09 97.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.096 -0.956 . . . . 10.0 110.18 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -60.14 -42.77 98.7 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.973 -0.558 . . . . 10.0 113.176 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -69.24 -34.16 74.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.022 0.439 . . . . 10.0 110.447 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.22 -29.68 66.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.707 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.603 HG13 ' O ' ' A' ' 83' ' ' VAL . 39.5 mt -59.27 -44.09 91.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.843 -0.617 . . . . 10.0 109.99 178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -70.38 -54.63 11.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.245 0.545 . . . . 10.0 110.028 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 47.8 mt-30 -55.2 -38.19 68.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.975 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.46 -34.38 40.39 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.158 -1.02 . . . . 10.0 113.12 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.666 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -81.7 -26.03 34.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.053 0.454 . . . . 10.0 111.375 -178.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' HG2' HG23 ' A' ' 97' ' ' THR . 71.5 mt-30 -75.21 -8.8 57.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.187 0.517 . . . . 10.0 109.905 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 8.4 mtpm? -76.63 8.13 3.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.633 -0.712 . . . . 10.0 111.973 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.62 -13.9 55.7 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.873 -0.331 . . . . 10.0 111.689 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 0.6 OUTLIER 61.04 111.1 0.02 OUTLIER Pre-proline 0 C--N 1.322 -0.6 0 O-C-N 124.32 1.013 . . . . 10.0 112.096 -179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.1 Cg_endo -76.0 -37.86 1.99 Allowed 'Cis proline' 0 N--CA 1.463 -0.27 0 C-N-CA 123.205 -1.581 . . . . 10.0 112.373 -0.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 92' ' ' GLN . 3.0 m -170.98 135.85 1.06 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.457 -1.247 . . . . 10.0 109.973 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 33.9 tpp -70.79 127.02 31.21 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -63.18 146.64 52.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.572 -179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -64.74 -40.58 95.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.979 0.419 . . . . 10.0 110.364 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.72 -47.22 81.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 10.0 111.23 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -68.31 -37.04 80.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.707 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 114' ' ' VAL . 0.5 OUTLIER -61.83 -44.24 97.24 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.11 -42.72 97.97 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.346 -0.843 . . . . 10.0 111.513 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -62.9 -36.05 82.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.168 0.509 . . . . 10.0 110.331 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -71.94 -40.87 68.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.193 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 31.8 pt -82.53 -5.9 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 111.992 0.367 . . . . 10.0 111.992 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.9 28.45 37.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.837 -0.697 . . . . 10.0 112.907 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -130.14 -146.84 0.32 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.216 -0.661 . . . . 10.0 109.216 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.35 175.73 7.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.615 0.245 . . . . 10.0 111.097 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.05 -39.24 91.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.726 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.75 76.32 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.671 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.9 m -60.27 -46.45 89.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.398 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 103' ' ' LEU . 39.2 t -65.49 -45.91 91.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 10.0 110.354 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.479 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -63.92 -32.87 74.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.86 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.5 m -77.2 -28.18 53.78 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.194 -0.457 . . . . 10.0 111.471 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -70.33 -39.71 74.58 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.125 0.417 . . . . 10.0 112.125 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -60.56 -19.51 57.61 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.091 0.472 . . . . 10.0 111.469 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.57 ' HG2' HG22 ' A' ' 121' ' ' THR . 12.1 ttm180 -72.89 -29.34 63.08 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.738 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.99 12.21 47.07 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.998 -0.62 . . . . 10.0 113.633 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.57 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.1 t -149.38 59.33 1.02 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.795 0.807 . . . . 10.0 111.022 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -114.2 27.53 9.42 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.613 -0.721 . . . . 10.0 111.13 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.4 m 64.97 109.38 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 123.627 0.58 . . . . 10.0 110.506 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 44.0 Cg_endo -70.37 88.37 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.171 1.914 . . . . 10.0 113.642 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.718 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 9.0 t70 -87.35 114.43 23.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.7 -1.222 . . . . 10.0 107.7 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.431 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.8 mm-40 -49.75 -45.64 49.67 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.472 0.483 . . . . 10.0 111.933 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 22.6 t30 -61.25 -44.97 96.38 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.822 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.594 ' O ' ' HG3' ' A' ' 132' ' ' MET . 76.5 mt -63.02 -55.39 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 121.181 -0.207 . . . . 10.0 110.648 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 6.3 mt -50.12 -41.38 48.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.356 0.598 . . . . 10.0 110.321 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 73.9 m -58.97 -43.55 91.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.124 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.566 ' O ' HG23 ' A' ' 135' ' ' VAL . 74.2 mmtt -72.98 -43.28 62.42 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.909 0.337 . . . . 10.0 111.909 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.594 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 14.3 mtp -49.28 -56.97 7.69 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.752 0.786 . . . . 10.0 111.841 -178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.442 ' CG ' HH12 ' A' ' 91' ' ' ARG . 11.8 mt-10 -73.93 -27.28 60.94 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.753 -1.112 . . . . 10.0 113.083 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.604 ' HB2' ' O ' ' A' ' 130' ' ' SER . 0.1 OUTLIER -68.72 -22.65 64.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.261 0.467 . . . . 10.0 112.261 -178.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.6 t -66.9 -24.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.142 0.496 . . . . 10.0 109.957 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.55 HD11 HH11 ' A' ' 91' ' ' ARG . 0.0 OUTLIER -123.53 -96.54 0.46 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.151 -177.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' PRO . 19.0 p-10 173.42 31.56 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.249 0.463 . . . . 10.0 112.249 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.427 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 3.2 m -111.55 147.62 15.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 2.9 mmpt? -115.6 132.92 56.48 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.171 0.51 . . . . 10.0 110.711 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.503 HD13 HG13 ' A' ' 83' ' ' VAL . 40.8 mt -97.42 40.58 1.15 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.189 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -139.33 139.35 37.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 10.0 109.794 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.58 -157.8 19.83 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.651 -0.785 . . . . 10.0 112.802 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' LYS . . . -96.29 -19.24 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.128 0.49 . . . . 10.0 111.16 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -97.75 54.07 1.14 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.334 -0.617 . . . . 10.0 109.334 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 14.1 mm -63.17 136.54 25.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.389 -0.823 . . . . 10.0 112.127 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.2 4.01 90.36 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.023 -0.608 . . . . 10.0 112.144 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.76 54.66 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.566 -0.317 . . . . 10.0 110.942 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 137' ' ' ASN . 12.0 Cg_endo -58.5 121.86 10.68 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.803 2.335 . . . . 10.0 110.594 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.515 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -164.24 68.05 0.17 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.556 0.693 . . . . 10.0 109.169 179.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 5.0 mt -75.69 83.58 2.69 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.216 -0.902 . . . . 10.0 111.227 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 152.87 76.16 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.82 -1.082 . . . . 10.0 111.198 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.51 170.32 18.78 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.426 2.084 . . . . 10.0 112.259 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -92.91 147.49 22.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.866 0.365 . . . . 10.0 110.346 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -107.84 149.78 27.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.921 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.676 -0.678 . . . . 10.0 109.962 179.729 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 112.321 -0.312 . . . . 10.0 112.321 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.73 104.27 16.18 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.805 0.336 . . . . 10.0 110.409 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.1 mtt -103.61 143.74 32.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.81 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.97 90.34 49.75 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.567 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -86.49 154.7 9.15 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 123.025 2.483 . . . . 10.0 112.994 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.49 141.34 19.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.311 -0.404 . . . . 10.0 110.209 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -159.89 151.68 20.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.712 0.291 . . . . 10.0 110.661 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.38 150.26 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.038 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.76 166.16 34.32 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.61 -0.805 . . . . 10.0 112.583 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -130.08 170.4 20.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.187 -0.53 . . . . 10.0 112.307 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 162.39 12.96 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.844 0.354 . . . . 10.0 111.274 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.91 -175.17 4.4 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.45 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.78 158.83 31.45 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.601 -0.6 . . . . 10.0 111.601 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.26 176.95 7.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.992 0.396 . . . . 10.0 110.975 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -118.51 179.22 4.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.095 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 84.3 mt -109.97 168.58 9.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.528 -0.305 . . . . 10.0 110.673 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.63 150.54 49.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.461 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 tttm -110.34 134.23 52.49 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.091 -0.337 . . . . 10.0 110.091 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.54 177.96 2.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.587 -0.278 . . . . 10.0 110.54 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.21 131.27 34.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.036 0.446 . . . . 10.0 110.333 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.4 mtt180 -147.73 -164.57 2.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.046 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.3 m -62.65 131.91 50.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.938 0.399 . . . . 10.0 111.052 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.4 91.5 2.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.679 -0.691 . . . . 10.0 110.533 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -86.05 86.14 7.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.315 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.3 pt -61.3 118.97 4.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.196 -0.911 . . . . 10.0 111.818 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.3 pt -118.09 176.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.911 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.5 pttt 38.3 77.8 0.39 Allowed Pre-proline 0 N--CA 1.473 0.719 0 O-C-N 124.262 0.976 . . . . 10.0 112.265 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.5 -166.12 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.734 2.289 . . . . 10.0 111.811 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.37 76.95 0.55 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 121.252 0.549 . . . . 10.0 110.51 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 p -138.93 168.3 20.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.254 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.1 m -88.24 -34.12 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.33 -0.548 . . . . 10.0 111.42 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.41 143.03 7.62 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.581 -0.818 . . . . 10.0 112.489 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -67.28 -55.67 12.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.641 0.237 . . . . 10.0 111.641 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.15 -35.39 80.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.543 0.687 . . . . 10.0 109.221 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.533 HG13 HD13 ' A' ' 140' ' ' LEU . 38.9 t -59.51 -45.99 93.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.681 -1.145 . . . . 10.0 110.411 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -60.21 -44.11 97.76 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.117 -0.564 . . . . 10.0 112.476 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -65.04 -37.0 86.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 10.0 110.561 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -70.04 -30.63 67.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.176 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.468 HG12 ' NH2' ' A' ' 91' ' ' ARG . 17.8 mt -60.95 -46.28 96.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.403 0.621 . . . . 10.0 109.643 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -70.77 -50.88 31.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.592 -0.731 . . . . 10.0 110.048 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -59.69 -35.78 75.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.956 -0.565 . . . . 10.0 112.27 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.71 -34.92 37.6 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.492 -1.337 . . . . 10.0 113.203 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HD2' HD21 ' A' ' 136' ' ' LEU . 1.3 mpt_? -81.24 -44.22 18.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.787 0.327 . . . . 10.0 111.582 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 97' ' ' THR . 71.9 mt-30 -67.01 -18.33 65.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.656 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -81.16 29.58 0.34 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.715 0.293 . . . . 10.0 111.55 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.67 -3.84 51.7 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.835 0.309 . . . . 10.0 111.835 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 44.0 mt-10 60.13 109.14 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.021 0.826 . . . . 10.0 112.418 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 11.9 Cg_exo -73.62 -54.39 0.15 OUTLIER 'Cis proline' 0 C--N 1.344 0.328 0 C-N-CA 123.816 -1.327 . . . . 10.0 112.788 -0.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 13.1 m -161.62 123.14 2.83 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.134 -0.939 . . . . 10.0 110.582 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.5 ttm -64.59 128.84 37.51 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.828 0.346 . . . . 10.0 110.438 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.6 p -76.81 157.3 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -66.97 -28.78 68.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.773 -0.649 . . . . 10.0 109.413 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.66 80.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.53 -0.759 . . . . 10.0 111.194 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.527 ' O ' ' HG2' ' A' ' 106' ' ' GLU . 46.7 mm-40 -64.51 -53.88 41.16 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.747 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.599 HD23 HG13 ' A' ' 114' ' ' VAL . 22.5 tp -60.47 -40.13 90.14 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.31 -45.68 95.05 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.684 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -64.36 -44.18 92.2 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.679 0.276 . . . . 10.0 110.402 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 58.0 mm-40 -61.47 -41.0 96.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 10.0 112.113 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 131' ' ' LYS . 43.9 pt -84.59 -14.91 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 111.931 0.345 . . . . 10.0 111.931 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.33 23.16 41.34 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.969 -0.634 . . . . 10.0 113.225 178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -121.95 -176.13 3.27 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.827 -0.434 . . . . 10.0 109.827 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.03 163.59 14.26 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.655 0.264 . . . . 10.0 110.767 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.81 -35.29 76.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 10.0 110.842 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.89 -31.31 71.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.818 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -66.91 -47.4 71.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.599 HG13 HD23 ' A' ' 103' ' ' LEU . 61.2 t -62.46 -43.5 98.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.637 -0.71 . . . . 10.0 110.503 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.31 80.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.403 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 7.2 t -74.29 -30.77 62.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.183 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -63.09 -44.71 94.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.171 -0.468 . . . . 10.0 111.536 -179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -66.59 -19.08 65.69 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.985 -0.286 . . . . 10.0 111.148 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 116' ' ' SER . 20.7 ttp180 -71.92 -22.78 61.43 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.417 0.627 . . . . 10.0 109.534 178.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.422 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 100.45 25.49 8.71 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.522 -0.763 . . . . 10.0 112.132 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 121' ' ' THR . 10.3 t -174.2 111.97 0.17 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.975 0.893 . . . . 10.0 110.467 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.35 33.42 0.09 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.99 -1.005 . . . . 10.0 110.424 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.3 m 60.76 99.99 0.04 OUTLIER Pre-proline 0 C--O 1.232 0.136 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.312 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.19 88.82 0.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.878 2.386 . . . . 10.0 115.06 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.5 t70 -86.01 117.07 24.62 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 105.856 -1.905 . . . . 10.0 105.856 176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -51.51 -41.28 60.88 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 123.613 0.571 . . . . 10.0 112.178 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.495 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 53.4 t30 -65.63 -44.15 87.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.88 -0.6 . . . . 10.0 110.176 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.62 ' O ' ' HG3' ' A' ' 132' ' ' MET . 79.4 mt -59.87 -53.93 41.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 9.7 mt -48.75 -48.02 41.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.478 0.656 . . . . 10.0 109.736 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 62.9 m -55.12 -39.84 69.84 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 114.803 -1.09 . . . . 10.0 111.189 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HB2' HG22 ' A' ' 107' ' ' ILE . 66.8 mmtt -71.72 -48.07 49.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.924 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.62 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 10.1 mtp -52.33 -52.29 54.01 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.86 0.838 . . . . 10.0 111.213 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 32.4 mt-10 -72.56 -29.28 63.42 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.553 -1.203 . . . . 10.0 113.17 -178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.2 ttp85 -64.43 -28.92 70.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.991 0.367 . . . . 10.0 111.991 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 131' ' ' LYS . 22.8 t -64.0 -31.97 55.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.029 0.752 . . . . 10.0 113.029 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.917 HD23 HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.16 2.77 9.25 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.539 0.94 . . . . 10.0 113.539 -178.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 m120 59.51 43.38 16.19 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.735 0.643 . . . . 10.0 112.735 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.917 HG22 HD23 ' A' ' 136' ' ' LEU . 31.4 m -131.96 138.47 52.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.501 ' CG ' ' H ' ' A' ' 149' ' ' ARG . 30.4 mmmt -114.06 149.98 34.68 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.466 -0.494 . . . . 10.0 111.364 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.765 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -110.6 15.34 22.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.191 -0.913 . . . . 10.0 109.866 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -115.65 140.68 48.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.434 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.46 -162.81 29.59 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.796 -0.716 . . . . 10.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -89.21 -26.58 21.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.978 0.418 . . . . 10.0 111.117 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -87.74 54.91 3.27 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.004 0.431 . . . . 10.0 111.726 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.765 HG23 ' HA ' ' A' ' 140' ' ' LEU . 73.6 mt -74.41 142.33 14.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.652 -0.499 . . . . 10.0 109.652 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 92.34 -2.1 73.96 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.688 -0.965 . . . . 10.0 110.688 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -136.0 156.78 76.86 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 114.639 -0.78 . . . . 10.0 109.398 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -61.94 123.72 13.13 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 121.826 1.684 . . . . 10.0 109.667 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.501 ' H ' ' CG ' ' A' ' 139' ' ' LYS . 23.3 tpt180 -151.41 99.31 2.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.21 0.528 . . . . 10.0 110.931 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -154.56 170.91 20.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.389 -0.823 . . . . 10.0 109.107 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.59 173.46 51.69 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.455 -0.879 . . . . 10.0 111.286 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -20.28 60.8 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.507 2.138 . . . . 10.0 112.119 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -99.63 118.49 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.073 -0.512 . . . . 10.0 109.933 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.65 167.96 12.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.204 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.254 -0.879 . . . . 10.0 110.001 179.353 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.947 0 N-CA-C 111.697 -0.561 . . . . 10.0 111.697 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -141.59 138.13 32.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.825 0.345 . . . . 10.0 110.873 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 88.6 mtp -98.48 139.18 34.6 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.047 -0.524 . . . . 10.0 110.147 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -151.15 145.42 18.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.124 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.06 147.79 34.19 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.71 2.274 . . . . 10.0 112.619 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.77 143.29 57.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.742 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -72.03 150.36 44.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.053 -0.521 . . . . 10.0 111.423 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.9 162.68 30.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.1 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.88 157.19 15.13 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.808 -0.71 . . . . 10.0 112.241 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.36 169.54 32.17 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.871 -0.68 . . . . 10.0 111.828 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.5 m -147.49 97.04 2.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.062 0.458 . . . . 10.0 110.995 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -104.06 149.71 24.95 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.623 -0.51 . . . . 10.0 109.623 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.96 -170.34 12.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.585 -0.817 . . . . 10.0 112.779 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -157.81 167.27 30.49 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.113 -0.328 . . . . 10.0 110.113 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -118.9 15.88 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.981 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 81.0 mt -79.95 124.6 28.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.008 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -140.7 115.42 9.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.659 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -128.21 132.59 48.8 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.473 -0.566 . . . . 10.0 109.473 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.24 132.43 71.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.912 0.387 . . . . 10.0 110.987 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -114.67 151.55 33.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.708 -0.478 . . . . 10.0 109.708 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.3 mmm180 -135.75 166.6 22.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.899 0.38 . . . . 10.0 110.66 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m -128.67 138.39 52.14 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -137.52 138.88 40.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 121.454 0.645 . . . . 10.0 110.515 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -155.13 -107.4 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.637 -1.165 . . . . 10.0 109.03 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.0 pt -92.57 -177.36 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.0 mt -63.19 108.45 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.818 0.342 . . . . 10.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -83.14 154.87 67.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.158 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.57 -176.47 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.796 2.331 . . . . 10.0 111.591 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt 64.53 104.45 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.561 0.538 . . . . 10.0 110.739 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 60.9 p -90.22 -168.73 2.2 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.976 -0.379 . . . . 10.0 109.976 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.422 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.4 m -83.4 -27.61 7.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.759 -0.376 . . . . 10.0 110.69 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.9 139.19 6.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.753 . . . . 10.0 111.719 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -65.23 -56.29 13.63 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.709 0.29 . . . . 10.0 111.294 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -66.56 -32.94 74.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.309 -0.626 . . . . 10.0 109.309 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 87' ' ' ILE . 38.5 t -62.15 -43.71 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.224 -0.898 . . . . 10.0 109.857 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -62.57 -42.28 99.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.405 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -63.28 -37.81 88.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.405 0.622 . . . . 10.0 109.777 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.5 ' HA ' ' NE2' ' A' ' 89' ' ' GLN . . . -73.92 -29.78 62.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.323 -0.853 . . . . 10.0 110.617 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.729 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 12.4 mt -58.39 -52.3 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.99 -48.98 66.81 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.552 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.513 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -60.6 -29.27 69.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.354 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.56 ' O ' ' HG ' ' A' ' 136' ' ' LEU . . . -76.28 -37.84 35.66 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.422 -0.894 . . . . 10.0 113.051 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 5.5 mmt180 -79.65 -43.75 22.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.28 0.54 . . . . 10.0 110.747 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -70.2 -5.44 27.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.04 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 38.8 tttt -78.91 -10.9 59.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.835 0.35 . . . . 10.0 110.643 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.61 172.35 4.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.38 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -120.31 125.12 27.38 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.507 -0.315 . . . . 10.0 110.387 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.52 -39.51 1.3 Allowed 'Cis proline' 0 CA--C 1.519 -0.258 0 C-N-CA 123.617 -1.409 . . . . 10.0 112.544 -0.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 88.5 m -170.61 120.95 0.58 Allowed 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.608 -1.178 . . . . 10.0 109.333 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 35.3 tpp -65.28 122.5 17.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.844 -0.428 . . . . 10.0 109.844 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 75.8 p -74.47 159.27 32.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.033 0.444 . . . . 10.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -68.91 -37.66 79.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 10.0 110.178 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.1 -41.67 90.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.911 -0.586 . . . . 10.0 112.02 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -66.19 -46.15 78.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.144 -0.222 . . . . 10.0 110.808 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' HG12 ' A' ' 107' ' ' ILE . 2.2 tp -65.45 -39.56 92.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.055 -0.72 . . . . 10.0 109.055 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.15 -47.55 90.24 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.147 -0.933 . . . . 10.0 111.384 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -61.82 -43.41 98.91 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -60.65 -41.74 95.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.939 -0.573 . . . . 10.0 111.899 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 103' ' ' LEU . 38.9 pt -82.84 -7.78 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.895 0.332 . . . . 10.0 111.895 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 84.22 29.99 29.3 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.993 -0.623 . . . . 10.0 112.648 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -130.51 -154.0 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -120.51 172.36 7.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.535 -0.172 . . . . 10.0 110.535 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.97 -39.42 89.51 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.02 0.438 . . . . 10.0 110.336 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -34.2 73.77 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.639 -0.71 . . . . 10.0 110.462 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.4 m -62.22 -46.64 87.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.873 0.368 . . . . 10.0 110.113 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 52.0 t -65.67 -43.76 93.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.451 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -65.96 -35.09 79.64 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.208 0.527 . . . . 10.0 111.085 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 68.9 m -77.3 -27.71 53.07 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.459 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -37.92 89.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.576 0.584 . . . . 10.0 112.576 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.5 -17.83 56.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.946 0.35 . . . . 10.0 111.946 -179.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.575 ' HG2' HG22 ' A' ' 121' ' ' THR . 5.1 ttm180 -64.9 -23.84 67.35 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 121.305 0.574 . . . . 10.0 110.405 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.422 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 96.42 24.28 14.53 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.678 -0.772 . . . . 10.0 111.647 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.575 HG22 ' HG2' ' A' ' 119' ' ' ARG . 8.4 t -175.0 115.02 0.15 Allowed 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.829 0.823 . . . . 10.0 109.549 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.58 30.56 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.898 -1.046 . . . . 10.0 109.585 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.7 m 62.32 97.6 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 115.361 -0.836 . . . . 10.0 109.08 -177.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.97 90.95 0.94 Allowed 'Trans proline' 0 C--O 1.239 0.55 0 C-N-CA 122.85 2.367 . . . . 10.0 114.515 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.611 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 7.0 t70 -80.87 124.75 29.35 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.189 -2.152 . . . . 10.0 105.189 176.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.432 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.3 mm-40 -51.63 -42.69 62.2 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.668 0.618 . . . . 10.0 112.668 -176.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -63.99 -39.13 93.42 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.678 0.611 . . . . 10.0 110.84 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.768 ' O ' ' HG3' ' A' ' 132' ' ' MET . 96.9 mt -64.3 -57.08 12.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 120.751 -0.379 . . . . 10.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 3.3 mt -50.47 -45.65 56.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.505 0.503 . . . . 10.0 110.592 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 68.2 m -55.32 -46.44 76.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.423 -0.808 . . . . 10.0 111.449 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 135' ' ' VAL . 19.1 mtmt -73.55 -40.35 64.03 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.982 0.364 . . . . 10.0 111.982 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.768 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 29.6 mtp -52.06 -55.22 22.02 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.857 0.837 . . . . 10.0 111.011 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.669 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 27.1 mt-10 -72.98 -31.81 64.78 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.463 -1.244 . . . . 10.0 113.361 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -69.88 -23.43 63.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 131' ' ' LYS . 57.4 t -61.51 -38.17 79.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 10.0 111.805 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.909 HD22 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -114.53 -5.91 12.82 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.505 0.557 . . . . 10.0 112.505 -179.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.92 46.41 0.48 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.226 1.013 . . . . 10.0 109.412 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.669 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 47.7 t -122.68 138.91 51.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 113.648 -1.614 . . . . 10.0 106.943 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.635 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 13.4 mmmm -122.79 140.29 53.07 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 118.842 0.747 . . . . 10.0 111.792 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.726 ' HA ' HG23 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -111.57 18.26 19.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.944 -1.025 . . . . 10.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -113.98 140.53 48.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.494 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.39 -156.61 25.1 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.749 -0.738 . . . . 10.0 111.92 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.04 0.74 41.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.089 0.471 . . . . 10.0 110.96 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -110.36 51.1 0.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.799 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.726 HG23 ' HA ' ' A' ' 140' ' ' LEU . 49.0 mt -72.54 136.24 26.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.519 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 94.54 4.4 62.28 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.996 -0.841 . . . . 10.0 110.996 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -138.28 156.87 73.47 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.278 -0.461 . . . . 10.0 110.245 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -64.55 122.31 10.17 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.897 1.731 . . . . 10.0 109.387 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.635 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 15.7 tpt180 -155.05 102.59 2.33 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.094 0.473 . . . . 10.0 110.052 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.87 133.7 30.64 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.08 0.467 . . . . 10.0 111.208 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -120.21 -169.36 14.0 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.403 -1.079 . . . . 10.0 110.403 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.46 102.6 0.23 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.46 2.106 . . . . 10.0 112.068 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -148.2 96.09 2.57 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.875 -0.602 . . . . 10.0 109.672 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -147.67 166.36 27.67 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.202 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.0 tttm . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.135 -0.936 . . . . 10.0 109.073 179.593 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 112.386 -0.285 . . . . 10.0 112.386 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.58 157.27 41.71 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.8 tpt -149.29 120.65 7.88 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.875 0.369 . . . . 10.0 110.909 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -132.84 143.5 48.91 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.203 -0.453 . . . . 10.0 110.291 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 166.65 28.42 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.638 2.225 . . . . 10.0 113.245 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.63 162.64 16.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.847 -0.615 . . . . 10.0 111.143 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -145.18 157.78 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.973 -0.558 . . . . 10.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.2 144.66 47.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.999 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -89.21 175.51 42.96 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.247 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.62 148.85 18.68 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.751 -0.738 . . . . 10.0 112.453 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.6 m -91.64 127.88 37.26 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.039 -0.356 . . . . 10.0 110.039 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.73 167.17 15.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.426 -0.352 . . . . 10.0 110.997 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.04 166.77 28.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.714 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -123.06 165.17 17.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.813 0.306 . . . . 10.0 111.026 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.74 158.61 6.12 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.331 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.64 165.25 26.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.737 0.303 . . . . 10.0 110.523 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.3 m -112.95 138.14 50.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.449 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -131.33 115.54 16.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.438 -0.346 . . . . 10.0 110.458 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.98 126.72 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.893 0.377 . . . . 10.0 111.228 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -159.34 163.79 35.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.062 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -149.7 118.96 6.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.673 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.3 m -154.28 125.32 7.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.401 . . . . 10.0 110.277 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.06 119.43 10.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.069 0.461 . . . . 10.0 110.573 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -120.05 26.6 9.16 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.561 -0.745 . . . . 10.0 109.698 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 73' ' ' ILE . 18.7 mm 65.15 34.75 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.425 -0.807 . . . . 10.0 110.156 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.5 pt -133.77 136.07 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.357 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -132.88 76.02 71.44 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.034 -0.53 . . . . 10.0 109.644 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.73 85.56 1.13 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.016 2.477 . . . . 10.0 111.653 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 1.8 mptp? 52.74 41.66 31.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.75 -0.659 . . . . 10.0 111.217 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 p -131.17 161.33 32.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.196 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 120' ' ' GLY . 1.5 m -82.88 -29.94 8.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 111.831 0.308 . . . . 10.0 111.831 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.31 140.7 8.04 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.775 -0.726 . . . . 10.0 112.111 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -65.46 -49.84 67.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.882 0.341 . . . . 10.0 111.682 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -59.35 -38.45 80.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.375 0.607 . . . . 10.0 109.742 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.9 t -64.03 -42.93 97.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.1 -0.955 . . . . 10.0 110.134 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 87' ' ' ILE . . . -64.29 -43.61 96.7 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.14 -0.552 . . . . 10.0 112.538 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.7 tptp -61.34 -43.06 99.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.188 0.518 . . . . 10.0 109.902 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB3' HD22 ' A' ' 140' ' ' LEU . . . -69.83 -29.69 67.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.33 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.799 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 1.2 mt -58.1 -48.54 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.981 -0.378 . . . . 10.0 109.981 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -68.69 -48.57 63.57 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.248 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.26 -33.39 73.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.956 -0.566 . . . . 10.0 110.67 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.73 -30.15 68.72 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.793 -0.639 . . . . 10.0 113.264 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.799 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 13.0 mmt85 -77.37 -29.41 53.25 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.292 -0.633 . . . . 10.0 109.292 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -79.1 -8.06 58.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.605 -0.725 . . . . 10.0 109.717 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -75.14 -8.5 56.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.929 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -168.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.731 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 40.8 mt-10 -133.21 110.35 12.77 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.213 -0.449 . . . . 10.0 110.469 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 60.7 Cg_endo -78.13 -30.64 5.69 Favored 'Cis proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.225 -1.573 . . . . 10.0 112.522 -0.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.6 m -170.45 134.37 1.13 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.802 -1.544 . . . . 10.0 109.65 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 122.13 22.44 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.5 p -69.89 158.15 36.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.119 0.485 . . . . 10.0 111.102 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -67.41 -36.08 80.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.845 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.58 78.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.358 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -61.47 -47.17 86.87 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.362 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 107' ' ' ILE . 0.8 OUTLIER -64.94 -40.71 95.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.574 -0.528 . . . . 10.0 109.574 179.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -48.38 81.92 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.214 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.4 tptt -64.02 -38.04 89.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.966 0.412 . . . . 10.0 110.468 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -39.39 92.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.635 -0.711 . . . . 10.0 111.296 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 103' ' ' LEU . 32.6 pt -89.07 -28.63 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.756 0.28 . . . . 10.0 111.756 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.85 6.1 21.35 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.59 -0.814 . . . . 10.0 112.818 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -106.33 -164.39 1.0 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -111.69 171.07 7.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 121.103 -0.239 . . . . 10.0 110.872 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.85 -38.05 80.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.957 0.408 . . . . 10.0 110.402 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.84 -33.42 75.65 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.852 -0.613 . . . . 10.0 110.526 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.406 ' O ' ' HD2' ' A' ' 117' ' ' TYR . 9.7 m -66.98 -40.28 87.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.283 0.563 . . . . 10.0 110.271 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.75 -37.23 77.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.82 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -72.44 -33.03 66.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.38 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 52.3 p -76.58 -29.1 56.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.924 0.392 . . . . 10.0 111.6 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 113' ' ' THR . 1.3 m-85 -63.18 -36.7 84.49 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.856 0.687 . . . . 10.0 112.856 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -63.61 -18.57 64.05 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.527 ' HG2' HG22 ' A' ' 121' ' ' THR . 61.5 ttt180 -68.13 -18.76 64.72 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 121.229 0.538 . . . . 10.0 110.657 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.417 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 91.3 28.84 13.6 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.782 -0.723 . . . . 10.0 112.247 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.527 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.2 t -175.96 111.91 0.11 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.917 0.865 . . . . 10.0 109.793 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.94 34.34 0.04 OUTLIER 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.946 -1.025 . . . . 10.0 110.057 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 24.8 m 63.28 99.23 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 115.454 -0.793 . . . . 10.0 109.137 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' HD21 ' A' ' 129' ' ' LEU . 92.2 Cg_endo -77.16 88.55 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.996 2.464 . . . . 10.0 115.727 -176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.592 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 5.9 t70 -81.68 116.07 21.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.798 -2.297 . . . . 10.0 104.798 174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.444 ' HG2' ' H ' ' A' ' 126' ' ' GLN . 17.6 mm-40 -48.65 -41.11 30.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 -176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.517 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 61.6 t30 -68.78 -42.24 77.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.783 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.583 ' O ' ' HG3' ' A' ' 132' ' ' MET . 66.7 mt -60.46 -55.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 121.186 -0.206 . . . . 10.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 7.5 mt -47.65 -47.23 29.34 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.659 0.599 . . . . 10.0 110.325 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.0 m -57.95 -38.65 76.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.211 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 127' ' ' ASN . 74.6 mmtt -73.66 -36.78 65.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.567 0.222 . . . . 10.0 111.464 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.583 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 18.9 mtp -54.22 -57.15 12.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.481 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.604 ' OE2' ' HG ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -73.36 -26.69 61.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.562 -0.744 . . . . 10.0 111.871 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.58 -38.54 60.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 -177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.43 -26.7 20.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 120.881 -0.327 . . . . 10.0 111.234 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -92.33 -21.18 20.41 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.252 0.464 . . . . 10.0 112.252 -178.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 136' ' ' LEU . 57.5 m-20 70.45 48.05 0.48 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.601 0.715 . . . . 10.0 110.184 -178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.06 169.41 21.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.852 -1.067 . . . . 10.0 108.557 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -137.64 133.21 34.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.938 0.399 . . . . 10.0 110.45 178.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.695 ' HA ' HG23 ' A' ' 145' ' ' ILE . 8.2 mt -100.86 12.0 38.47 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.583 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -125.4 139.86 53.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 105.94 -153.72 17.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.342 -0.703 . . . . 10.0 111.342 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.99 -33.57 10.12 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.968 0.413 . . . . 10.0 111.16 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -87.43 55.65 3.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.263 0.554 . . . . 10.0 110.576 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.695 HG23 ' HA ' ' A' ' 140' ' ' LEU . 71.0 mt -69.0 141.17 17.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.751 -0.658 . . . . 10.0 111.323 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.94 -5.54 84.91 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.152 -0.546 . . . . 10.0 111.831 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.64 158.21 62.92 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.304 -0.448 . . . . 10.0 110.212 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.01 122.47 10.98 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.167 1.912 . . . . 10.0 110.849 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -151.33 81.23 1.3 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.546 0.689 . . . . 10.0 110.046 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.638 ' HB3' ' CB ' ' A' ' 154' ' ' LYS . 4.1 mm? -106.65 -26.71 11.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.356 -0.838 . . . . 10.0 110.329 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.34 -171.31 46.65 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.762 -0.653 . . . . 10.0 112.301 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.71 141.47 41.44 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.595 2.197 . . . . 10.0 111.802 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt 57.18 53.56 7.68 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.34 0.59 . . . . 10.0 110.319 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.638 ' CB ' ' HB3' ' A' ' 150' ' ' LEU . 55.3 pttt -63.7 139.62 58.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.482 -0.781 . . . . 10.0 111.467 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 42.8 tttm . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.192 -0.908 . . . . 10.0 109.888 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.81 -0.516 . . . . 10.0 111.81 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.83 134.11 21.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.928 0.394 . . . . 10.0 110.97 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 75.5 mtm -129.59 132.79 46.88 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.872 -0.604 . . . . 10.0 109.835 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -144.18 121.85 6.7 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.612 -0.267 . . . . 10.0 110.366 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.85 122.03 10.39 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.661 2.24 . . . . 10.0 112.425 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -102.35 137.87 40.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.596 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -138.44 140.21 39.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.806 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -104.28 -44.64 4.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.032 0.444 . . . . 10.0 111.04 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.61 -119.8 5.06 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 111.416 -0.674 . . . . 10.0 111.416 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 141.36 117.37 1.34 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.9 m -103.62 142.15 34.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.749 0.309 . . . . 10.0 110.648 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -105.12 -150.51 0.43 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.267 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.09 -168.05 40.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.013 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -154.17 176.94 11.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 10.0 110.998 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.9 mtt180 -131.36 -173.31 3.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.108 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 pp -144.67 162.08 37.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.562 -0.29 . . . . 10.0 110.344 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 87.8 m -150.5 124.89 9.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.961 0.41 . . . . 10.0 110.925 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 144.48 30.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.915 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.61 153.34 2.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.703 0.287 . . . . 10.0 110.531 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.97 177.02 11.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.397 -0.365 . . . . 10.0 110.03 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 69' ' ' ARG . 10.6 ptt-85 -141.07 21.43 2.27 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.489 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.9 m -133.66 47.55 2.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.564 0.697 . . . . 10.0 109.393 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -97.9 97.14 8.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.306 -0.861 . . . . 10.0 111.132 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.51 -27.49 15.94 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.491 -0.777 . . . . 10.0 110.645 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.0 tt -84.15 138.99 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 115.898 -0.592 . . . . 10.0 111.004 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.657 HD13 ' H ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -70.41 154.35 8.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.535 179.479 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.477 ' HB2' HG23 ' A' ' 123' ' ' THR . 39.9 mttm -104.35 147.56 34.57 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.54 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.63 170.33 20.54 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.565 2.177 . . . . 10.0 111.683 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt 66.47 96.72 0.05 Allowed 'General case' 0 C--O 1.234 0.269 0 O-C-N 123.764 0.665 . . . . 10.0 110.661 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.449 ' C ' ' HG3' ' A' ' 124' ' ' PRO . 23.6 p -83.72 -173.57 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.629 -0.714 . . . . 10.0 110.764 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.676 HG12 HG21 ' A' ' 83' ' ' VAL . 3.0 t -82.26 -68.82 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.628 -0.26 . . . . 10.0 111.299 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.438 ' C ' HG22 ' A' ' 83' ' ' VAL . . . 146.64 161.6 9.4 Favored Glycine 0 C--O 1.222 -0.652 0 N-CA-C 111.574 -0.611 . . . . 10.0 111.574 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.5 ' HG2' ' H ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -78.87 -55.02 5.47 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 -178.363 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.1 tp10 -71.97 -28.61 63.54 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.511 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.676 HG21 HG12 ' A' ' 79' ' ' VAL . 6.6 m -64.27 -36.4 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.252 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.16 -47.22 90.08 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.918 -0.658 . . . . 10.0 112.496 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -64.33 -38.02 89.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.824 0.345 . . . . 10.0 110.816 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -69.86 -30.78 68.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.414 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.757 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.3 mt -61.23 -49.76 83.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.803 -0.443 . . . . 10.0 109.803 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -61.95 -53.06 60.91 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.622 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 43.4 mt-30 -59.22 -39.8 83.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.043 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.47 -35.34 91.59 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.855 -0.688 . . . . 10.0 113.544 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 3.5 mmt180 -80.4 -39.63 28.01 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.042 0.449 . . . . 10.0 110.509 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -69.91 -25.1 63.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.733 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 89' ' ' GLN . 39.2 tttm -80.0 54.42 1.9 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 10.0 110.712 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -126.1 3.38 7.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.536 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 38.7 mt-10 54.99 101.24 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.915 0.759 . . . . 10.0 112.817 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 61.5 Cg_endo -82.79 -30.56 4.63 Favored 'Cis proline' 0 N--CA 1.461 -0.428 0 C-N-CA 123.176 -1.593 . . . . 10.0 112.61 -0.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -174.81 129.78 0.32 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.837 -1.529 . . . . 10.0 110.007 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.6 tpp -76.69 143.1 40.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.929 -0.397 . . . . 10.0 109.929 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 145.39 50.08 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.631 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -69.69 -41.89 74.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.062 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.5 -36.68 83.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.953 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -70.93 -32.01 68.78 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.492 -0.322 . . . . 10.0 110.339 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 103' ' ' LEU . 1.1 tm? -63.81 -43.38 96.45 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.02 -37.4 91.99 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.157 -0.929 . . . . 10.0 111.357 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -65.47 -35.4 80.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.865 0.364 . . . . 10.0 110.567 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.71 -40.49 84.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.032 -0.531 . . . . 10.0 111.844 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 29.6 pt -87.81 -22.54 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 34.38 5.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.478 -0.868 . . . . 10.0 112.382 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -129.64 -171.79 2.6 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.859 0.362 . . . . 10.0 110.444 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 166.96 11.39 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.567 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.74 -42.4 91.01 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.341 -0.39 . . . . 10.0 111.523 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.71 -32.86 70.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.55 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -60.43 -47.09 87.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.096 -0.502 . . . . 10.0 109.998 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 34.5 t -66.48 -46.47 86.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.8 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.59 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -62.32 -35.86 80.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.322 0.582 . . . . 10.0 111.069 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.3 m -75.26 -27.96 59.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.982 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.635 ' OH ' ' HA ' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -63.74 -38.91 92.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.284 -0.416 . . . . 10.0 111.801 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -65.09 -18.42 65.29 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.053 0.39 . . . . 10.0 112.053 -179.436 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.621 ' HG2' HG22 ' A' ' 121' ' ' THR . 19.4 ttt180 -78.39 -18.67 54.71 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.918 -0.771 . . . . 10.0 108.918 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.62 14.54 46.7 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.416 -0.811 . . . . 10.0 112.431 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.621 HG22 ' HG2' ' A' ' 119' ' ' ARG . 7.5 t -160.04 106.1 1.58 Allowed 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 122.173 0.987 . . . . 10.0 109.802 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.89 24.6 0.5 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.714 -1.13 . . . . 10.0 110.385 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.477 HG23 ' HB2' ' A' ' 75' ' ' LYS . 3.8 m 59.67 80.63 0.27 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.288 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.635 ' HA ' ' OH ' ' A' ' 117' ' ' TYR . 72.9 Cg_endo -75.21 158.8 41.18 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.785 2.323 . . . . 10.0 114.189 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 13.6 t70 -137.48 140.17 41.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.257 -1.338 . . . . 10.0 107.86 178.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.4 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 6.2 mm-40 -54.73 -40.2 69.04 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.586 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.97 -35.45 72.15 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.548 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.738 ' O ' ' HG3' ' A' ' 132' ' ' MET . 75.1 mt -66.78 -57.33 10.53 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 C-N-CA 120.581 -0.448 . . . . 10.0 110.234 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 5.3 mt -50.13 -39.64 43.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.744 0.783 . . . . 10.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 72.1 m -62.56 -50.32 71.78 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.835 . . . . 10.0 111.488 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.586 ' HD3' ' O ' ' A' ' 127' ' ' ASN . 1.5 mptp? -74.91 -31.33 61.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.449 0.537 . . . . 10.0 112.449 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.738 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 52.9 mtp -60.32 -59.38 5.5 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.577 0.703 . . . . 10.0 111.403 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.695 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 2.9 mp0 -74.56 -25.49 59.33 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.968 1.099 . . . . 10.0 113.968 -178.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 131' ' ' LYS . 19.6 ptt180 -56.87 -26.9 59.63 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.358 0.526 . . . . 10.0 111.395 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.09 -25.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.148 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.637 ' HB2' HG22 ' A' ' 138' ' ' VAL . 0.0 OUTLIER -100.29 -19.23 16.45 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.795 0.294 . . . . 10.0 111.795 -178.596 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 68.34 43.16 1.52 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.606 0.717 . . . . 10.0 111.312 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.695 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 10.8 m -136.68 140.1 43.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 107.342 -1.355 . . . . 10.0 107.342 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 3.4 mmpt? -116.65 135.49 53.75 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.806 -0.758 . . . . 10.0 111.058 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.416 HD13 ' HB ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -102.29 36.05 2.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.125 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 43.7 mmt-85 -138.21 139.21 39.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.235 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.14 -163.07 21.99 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.309 -0.716 . . . . 10.0 111.309 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -86.6 -27.92 23.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.968 0.413 . . . . 10.0 110.399 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -85.93 55.27 3.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.752 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.2 mm -68.57 138.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.477 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.91 2.5 90.67 Favored Glycine 0 CA--C 1.505 -0.553 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.464 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -126.32 160.68 56.46 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 115.815 -0.192 . . . . 10.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -62.52 120.37 7.87 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.451 1.434 . . . . 10.0 109.506 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 1.7 tmt_? -149.5 89.77 1.66 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.771 0.32 . . . . 10.0 110.178 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.63 82.38 6.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.799 0.809 . . . . 10.0 110.841 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -136.46 76.52 0.37 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.729 -1.123 . . . . 10.0 110.663 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.24 -178.77 2.29 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.514 2.142 . . . . 10.0 112.861 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -89.3 -172.76 3.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.977 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.87 161.01 31.24 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.579 -0.724 . . . . 10.0 110.473 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.872 0 N-CA-C 111.828 -0.509 . . . . 10.0 111.828 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.59 115.75 19.39 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.834 0.35 . . . . 10.0 110.714 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.1 mtm -127.72 146.13 50.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.239 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 t70 62.0 99.19 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.456 0 O-C-N 123.818 0.699 . . . . 10.0 111.962 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -88.9 164.61 5.98 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.995 2.463 . . . . 10.0 111.797 179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -117.01 139.89 50.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.224 -0.287 . . . . 10.0 110.224 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -121.41 169.91 10.16 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.863 0.364 . . . . 10.0 110.868 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.81 172.5 17.88 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.901 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 126.94 121.0 2.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.518 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.5 124.24 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.025 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.2 t -144.54 139.08 27.97 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.006 0.432 . . . . 10.0 110.429 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -106.83 -65.79 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.869 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.66 175.27 29.63 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.771 -0.65 . . . . 10.0 111.82 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -155.3 138.89 15.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.774 -0.454 . . . . 10.0 109.774 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 63' ' ' ARG . 14.9 tpt180 -125.65 136.53 53.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.034 -0.358 . . . . 10.0 110.034 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.58 148.65 24.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.477 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.0 m -96.76 148.87 22.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.733 -0.667 . . . . 10.0 109.775 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.422 ' HG3' ' HB ' ' A' ' 123' ' ' THR . 24.8 tttp -83.5 114.88 21.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.616 0.245 . . . . 10.0 110.712 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 p -167.39 141.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.423 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -132.61 158.45 42.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.195 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -131.02 157.43 43.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.53 -0.305 . . . . 10.0 110.302 179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.5 m -91.93 85.26 5.51 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.581 -0.526 . . . . 10.0 109.581 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -123.42 -173.72 2.8 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.759 -0.655 . . . . 10.0 109.647 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -116.34 -22.08 8.98 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.714 -0.676 . . . . 10.0 111.005 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 11.4 tt -66.73 126.1 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.152 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 pt -76.26 126.88 37.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.672 -0.695 . . . . 10.0 110.081 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -133.57 153.69 80.4 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.423 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.93 36.64 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.919 2.413 . . . . 10.0 112.31 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -107.5 13.63 26.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.902 -0.59 . . . . 10.0 110.372 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.5 p -133.02 163.45 29.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.537 -0.756 . . . . 10.0 109.796 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 121' ' ' THR . 4.9 m -79.87 -35.14 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.822 -0.351 . . . . 10.0 111.063 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.95 147.9 6.85 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.892 -0.883 . . . . 10.0 110.892 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -66.97 -53.05 35.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.068 0.434 . . . . 10.0 111.626 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -69.15 -33.45 73.43 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.967 -0.753 . . . . 10.0 108.967 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.759 HG13 HD22 ' A' ' 140' ' ' LEU . 38.3 t -58.72 -41.28 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 114.69 -1.141 . . . . 10.0 109.951 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -59.8 -41.47 97.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.741 -0.742 . . . . 10.0 112.131 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -64.56 -45.11 88.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.946 0.403 . . . . 10.0 109.958 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.05 77.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.733 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.678 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 5.6 mt -58.73 -46.01 90.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.733 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.12 -49.15 59.65 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.042 0.448 . . . . 10.0 110.401 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -61.4 -36.55 80.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.7 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.27 -39.56 98.01 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 116.039 -0.528 . . . . 10.0 114.013 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 87' ' ' ILE . 17.7 mmt-85 -69.84 -36.58 75.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.383 0.591 . . . . 10.0 110.254 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.412 ' HA ' HG23 ' A' ' 97' ' ' THR . 70.3 mt-30 -82.42 -5.89 58.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.781 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -89.03 14.58 10.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.197 -0.456 . . . . 10.0 111.846 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.87 -17.7 34.86 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.876 0.325 . . . . 10.0 111.876 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 60.55 106.95 0.03 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.071 -0.968 . . . . 10.0 111.937 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.98 -59.03 0.14 OUTLIER 'Cis proline' 0 CA--C 1.517 -0.371 0 C-N-CA 123.534 -1.444 . . . . 10.0 112.347 0.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 92' ' ' GLN . 72.0 m -157.51 124.07 4.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.878 -1.055 . . . . 10.0 110.732 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 30.6 tpp -72.49 141.66 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.043 -0.725 . . . . 10.0 109.043 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.41 142.75 55.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.995 0.426 . . . . 10.0 111.037 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -70.5 -37.37 74.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.473 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.23 76.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.195 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.06 -41.93 40.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.399 -0.364 . . . . 10.0 110.817 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.453 ' HG ' ' HD2' ' A' ' 91' ' ' ARG . 1.2 tm? -64.11 -38.33 90.67 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.017 -0.734 . . . . 10.0 109.017 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.1 -46.24 59.19 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.391 -0.822 . . . . 10.0 111.555 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -58.09 -39.06 77.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.552 0.215 . . . . 10.0 111.321 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.08 -39.29 89.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 10.0 111.301 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.453 HD12 HG23 ' A' ' 128' ' ' ILE . 17.6 pt -92.91 4.01 7.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 112.496 0.554 . . . . 10.0 112.496 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 86.6 11.15 71.88 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 120.959 -0.638 . . . . 10.0 113.926 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.414 ' OE1' HG21 ' A' ' 113' ' ' THR . 32.0 mm-40 -109.46 -162.8 0.82 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.765 -0.457 . . . . 10.0 109.765 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.0 p -125.24 174.7 7.92 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.252 -0.28 . . . . 10.0 111.048 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.84 87.43 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.52 -0.309 . . . . 10.0 111.321 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.31 77.62 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.347 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.414 HG21 ' OE1' ' A' ' 109' ' ' GLU . 2.6 m -62.4 -50.32 72.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.005 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.43 -42.68 91.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.047 0.451 . . . . 10.0 110.232 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.44 -37.04 82.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.925 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 m -74.84 -27.44 60.27 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.17 -0.468 . . . . 10.0 111.967 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.33 -32.75 70.37 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.153 0.427 . . . . 10.0 112.153 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.8 -18.14 41.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.031 0.382 . . . . 10.0 112.031 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.578 ' HG2' HG22 ' A' ' 121' ' ' THR . 1.6 ttt85 -61.89 -24.01 66.67 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.02 0.438 . . . . 10.0 111.093 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.44 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 99.13 23.8 11.04 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.348 -0.93 . . . . 10.0 113.933 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.684 HG23 ' H ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -154.73 -88.46 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.824 0.312 . . . . 10.0 110.651 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.684 ' H ' HG23 ' A' ' 121' ' ' THR . . . 58.78 11.79 1.98 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.527 0.936 . . . . 10.0 113.527 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.422 ' HB ' ' HG3' ' A' ' 66' ' ' LYS . 2.8 m 45.64 76.59 0.53 Allowed Pre-proline 0 CA--C 1.518 -0.283 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 -177.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.608 ' HB2' HD21 ' A' ' 129' ' ' LEU . 42.6 Cg_endo -89.01 147.46 5.58 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.308 2.672 . . . . 10.0 116.962 -173.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.31 129.33 42.48 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 103.994 -2.595 . . . . 10.0 103.994 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -55.84 -29.55 60.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -72.33 -29.86 64.21 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 107' ' ' ILE . 68.8 mt -68.41 -48.4 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 110.431 -0.211 . . . . 10.0 110.431 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' A' ' 124' ' ' PRO . 5.4 mt -57.76 -36.47 72.15 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.404 0.621 . . . . 10.0 109.883 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -66.04 -49.52 67.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.142 -0.935 . . . . 10.0 110.862 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -74.48 -38.62 62.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.751 1.019 . . . . 10.0 113.751 -178.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.418 ' HG3' ' HG2' ' A' ' 133' ' ' GLU . 7.1 ptm -61.2 -50.25 73.87 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.009 0.368 . . . . 10.0 111.543 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.627 ' CD ' HH22 ' A' ' 91' ' ' ARG . 15.5 mm-40 -76.91 -29.03 55.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.253 0.834 . . . . 10.0 113.253 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -62.61 -23.38 67.02 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.133 -0.354 . . . . 10.0 111.478 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 131' ' ' LYS . 59.1 t -63.1 -34.18 65.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.189 0.519 . . . . 10.0 110.311 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.516 HD11 ' OE1' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.12 3.65 28.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.881 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.6 t30 70.18 51.79 0.39 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.579 0.704 . . . . 10.0 110.27 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.484 ' CG2' HD12 ' A' ' 136' ' ' LEU . 22.2 t -132.59 152.32 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.129 -0.941 . . . . 10.0 109.606 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.617 ' HG3' ' O ' ' A' ' 149' ' ' ARG . 26.0 mmmt -131.04 145.15 51.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.938 0.399 . . . . 10.0 110.512 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.759 HD22 HG13 ' A' ' 83' ' ' VAL . 27.6 mt -106.86 20.16 19.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.94 -0.573 . . . . 10.0 111.118 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -134.21 139.28 45.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.841 0.353 . . . . 10.0 110.948 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 109.33 -157.37 15.15 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.816 -0.629 . . . . 10.0 111.543 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.41 -30.59 14.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.075 0.464 . . . . 10.0 110.007 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.83 59.04 5.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.645 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 15.5 mm -66.9 137.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 10.0 110.652 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.45 10.32 85.46 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.722 -0.751 . . . . 10.0 111.23 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -133.81 157.14 78.53 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.372 -0.414 . . . . 10.0 110.381 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.12 123.82 13.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.557 2.171 . . . . 10.0 111.235 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.617 ' O ' ' HG3' ' A' ' 139' ' ' LYS . 5.2 tmm_? -142.42 125.21 16.0 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.047 -0.353 . . . . 10.0 110.047 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 91.5 mt -73.85 113.69 11.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.235 0.541 . . . . 10.0 110.327 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.518 ' HA3' ' NH1' ' A' ' 149' ' ' ARG . . . 178.0 73.8 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.43 -0.804 . . . . 10.0 111.361 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.96 125.86 13.1 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.713 2.275 . . . . 10.0 112.63 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -129.35 152.55 48.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.506 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -138.94 -52.28 0.56 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.064 -0.516 . . . . 10.0 109.928 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.529 -0.748 . . . . 10.0 110.487 179.892 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 112.01 -0.436 . . . . 10.0 112.01 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.27 170.71 15.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.468 -0.197 . . . . 10.0 110.468 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 34.2 ttm -133.59 125.25 28.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.861 0.363 . . . . 10.0 110.916 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -101.08 146.04 31.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.945 -0.57 . . . . 10.0 109.903 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.9 168.46 24.15 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.902 2.402 . . . . 10.0 112.699 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -107.6 160.01 16.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.799 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.89 136.89 25.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.725 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.72 168.32 26.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.858 0.361 . . . . 10.0 111.122 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.58 170.04 29.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.9 -178.69 25.08 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.86 -0.686 . . . . 10.0 112.398 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -147.72 138.42 23.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.118 -0.327 . . . . 10.0 110.118 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -94.55 -64.66 1.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.988 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.65 -166.89 13.76 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.896 -0.669 . . . . 10.0 111.475 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.54 145.76 9.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.074 0.437 . . . . 10.0 110.802 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -153.5 141.32 20.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.294 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -148.87 110.52 4.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.141 179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.38 150.75 43.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.189 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.54 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 51.1 mttp -117.57 178.8 4.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.379 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.73 150.19 26.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.791 0.329 . . . . 10.0 111.241 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -100.87 151.11 22.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.83 -0.433 . . . . 10.0 109.83 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -147.76 138.14 23.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.378 -0.374 . . . . 10.0 110.679 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -55.81 4.15 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.238 -0.652 . . . . 10.0 109.238 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 50.17 56.95 7.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.088 -0.96 . . . . 10.0 112.04 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.45 12.52 33.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.688 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.6 pt -72.84 179.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.112 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.2 mt -80.25 108.58 13.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.841 -0.618 . . . . 10.0 110.004 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.9 pttt -76.1 113.17 25.35 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 10.0 110.542 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.71 -147.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.999 2.466 . . . . 10.0 112.064 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -89.21 33.55 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.148 0.499 . . . . 10.0 111.082 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.1 p -120.05 161.06 21.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG22 ' C ' ' A' ' 120' ' ' GLY . 2.5 m -88.35 -25.37 5.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.567 -0.453 . . . . 10.0 111.541 -178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.32 138.57 5.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.906 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -67.65 -39.56 84.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.861 0.319 . . . . 10.0 111.861 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.99 -31.49 50.7 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 140' ' ' LEU . 42.7 t -66.02 -40.22 86.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.184 -0.916 . . . . 10.0 110.056 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.39 -41.74 95.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.891 -0.671 . . . . 10.0 112.12 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.43 -39.5 74.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.163 0.506 . . . . 10.0 110.051 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.32 70.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.646 -0.706 . . . . 10.0 110.817 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 83' ' ' VAL . 7.9 mt -59.47 -45.53 93.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.081 178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.93 -53.87 13.44 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 116.124 -0.489 . . . . 10.0 109.754 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 35.0 mt-30 -54.05 -34.91 61.31 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.351 -0.84 . . . . 10.0 111.267 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.4 -34.87 39.04 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.754 -0.736 . . . . 10.0 112.766 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.651 ' HD3' ' N ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -80.13 -33.61 38.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.019 0.438 . . . . 10.0 110.357 -178.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -73.33 -2.62 22.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.1 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 89' ' ' GLN . 48.4 mttm -83.25 -2.68 56.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 10.0 110.015 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -78.0 177.06 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.584 -0.735 . . . . 10.0 110.589 179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -120.69 121.27 29.13 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.319 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.98 -29.32 6.82 Favored 'Cis proline' 0 CA--C 1.515 -0.445 0 C-N-CA 123.723 -1.365 . . . . 10.0 112.693 -0.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.2 m -179.05 122.43 0.08 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 113.754 -1.566 . . . . 10.0 109.324 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.8 ttm -70.46 110.87 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.211 -0.292 . . . . 10.0 110.211 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.577 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.9 p -78.51 172.37 13.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.869 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -62.84 -35.7 80.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.769 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.73 -42.42 81.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.005 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.577 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 16.8 mm-40 -68.52 -48.82 63.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.369 -0.378 . . . . 10.0 110.917 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 107' ' ' ILE . 1.4 tm? -61.06 -42.22 98.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.41 -44.34 98.16 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.575 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -65.99 -36.03 82.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.792 0.33 . . . . 10.0 110.659 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -69.26 -40.99 77.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 10.0 111.792 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.52 HG22 ' HB3' ' A' ' 131' ' ' LYS . 35.9 pt -83.48 -17.71 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 120.884 -0.326 . . . . 10.0 111.689 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.57 22.91 27.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.755 -0.736 . . . . 10.0 112.77 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -119.89 -169.71 1.83 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.769 0.318 . . . . 10.0 110.225 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.7 p -98.98 168.2 10.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.535 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.05 78.6 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.863 0.364 . . . . 10.0 110.623 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.33 79.46 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.886 -0.597 . . . . 10.0 110.244 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.8 m -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.221 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.7 t -66.77 -43.2 90.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.064 -0.516 . . . . 10.0 110.349 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.53 ' O ' ' HG3' ' A' ' 118' ' ' GLU . . . -64.02 -35.23 80.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.443 0.64 . . . . 10.0 110.463 179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 48.9 m -76.13 -27.03 56.91 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.774 -0.648 . . . . 10.0 111.18 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.51 -43.16 77.39 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.676 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -61.24 -18.69 59.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.975 0.417 . . . . 10.0 111.729 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 116' ' ' SER . 48.3 ttp180 -67.25 -21.63 65.72 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.312 0.577 . . . . 10.0 110.636 179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 79' ' ' VAL . . . 95.22 20.34 28.02 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.728 -0.749 . . . . 10.0 111.692 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.416 HG22 ' HG2' ' A' ' 119' ' ' ARG . 5.3 t -172.62 108.36 0.19 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 122.01 0.91 . . . . 10.0 109.968 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -159.28 30.29 0.2 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.544 -1.207 . . . . 10.0 109.547 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 124' ' ' PRO . 11.8 m 60.63 96.4 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.126 -0.943 . . . . 10.0 110.032 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 123' ' ' THR . 47.2 Cg_endo -65.42 94.84 0.26 Allowed 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 123.173 2.582 . . . . 10.0 113.952 -177.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.715 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 10.0 t70 -85.97 120.0 26.89 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.616 -1.253 . . . . 10.0 107.616 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 10.2 mm-40 -52.98 -37.97 61.79 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.466 0.479 . . . . 10.0 111.89 -177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -68.49 -44.36 74.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.047 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.639 ' O ' ' HG3' ' A' ' 132' ' ' MET . 78.9 mt -64.13 -54.11 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.185 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 125' ' ' ASP . 17.6 mt -50.61 -41.83 55.29 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.269 0.557 . . . . 10.0 110.189 179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.3 m -59.61 -49.72 76.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.274 -0.875 . . . . 10.0 111.096 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 135' ' ' VAL . 1.8 mptp? -67.48 -40.26 85.27 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.377 0.51 . . . . 10.0 112.377 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.639 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 17.1 mtp -49.01 -58.31 5.12 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.441 0.638 . . . . 10.0 111.765 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HB3' ' O ' ' A' ' 138' ' ' VAL . 24.9 mt-10 -75.38 -28.63 59.58 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.413 -0.812 . . . . 10.0 112.805 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -64.88 -22.97 67.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.926 0.713 . . . . 10.0 112.926 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 131' ' ' LYS . 21.2 t -67.9 -25.0 31.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.426 0.631 . . . . 10.0 110.006 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.593 HD12 ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -122.17 -100.44 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.494 -0.776 . . . . 10.0 112.198 -178.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.593 ' H ' HD12 ' A' ' 136' ' ' LEU . 63.5 t30 174.29 64.02 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.407 -0.815 . . . . 10.0 109.251 -177.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.527 ' O ' ' HB3' ' A' ' 133' ' ' GLU . 0.3 OUTLIER -136.23 155.83 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.274 179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.489 ' HA ' ' OE1' ' A' ' 133' ' ' GLU . 4.6 mmtm -130.82 132.36 45.17 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.044 0.45 . . . . 10.0 110.969 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.772 ' HA ' HG23 ' A' ' 145' ' ' ILE . 13.5 mt -104.64 17.97 23.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.196 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 141' ' ' ARG . 40.0 mtp-105 -127.96 144.42 51.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.751 -0.658 . . . . 10.0 109.942 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.16 -155.38 19.54 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.714 -0.755 . . . . 10.0 112.443 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.29 -25.73 15.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.653 0.263 . . . . 10.0 111.523 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.45 52.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.035 0.445 . . . . 10.0 110.466 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.772 HG23 ' HA ' ' A' ' 140' ' ' LEU . 54.7 mt -68.69 139.98 19.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.737 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 83.95 12.01 77.86 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.176 -0.77 . . . . 10.0 111.176 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.54 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . . . -141.01 152.37 64.96 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.572 -0.314 . . . . 10.0 110.925 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -63.1 120.09 7.42 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 121.779 1.652 . . . . 10.0 108.737 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 43.1 tpt85 -176.73 89.49 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.126 0.489 . . . . 10.0 110.088 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.04 167.07 12.12 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.841 -0.618 . . . . 10.0 109.952 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -166.65 -162.37 18.05 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.836 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.64 156.36 61.2 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.892 2.395 . . . . 10.0 112.613 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -123.59 108.74 12.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.616 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -89.89 161.01 16.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.366 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.526 -0.75 . . . . 10.0 110.477 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.666 -0.574 . . . . 10.0 111.666 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.0 87.95 3.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.856 0.36 . . . . 10.0 110.293 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.6 mmt -61.42 -46.21 91.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.328 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -137.57 84.12 23.63 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.96 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.27 133.66 23.28 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.273 1.982 . . . . 10.0 111.331 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -81.23 120.98 25.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.377 -0.374 . . . . 10.0 110.729 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -87.61 159.63 18.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.269 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.28 155.18 17.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.528 -0.306 . . . . 10.0 110.614 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.06 -135.65 8.9 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.919 -0.657 . . . . 10.0 111.809 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.68 171.05 34.21 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.665 -0.778 . . . . 10.0 112.424 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.6 m -137.37 136.21 37.68 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.743 -0.466 . . . . 10.0 109.743 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -135.43 150.54 49.89 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.566 0.222 . . . . 10.0 110.62 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -138.96 173.2 22.76 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 10.0 111.962 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -113.44 -172.26 2.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.679 0.276 . . . . 10.0 110.811 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -119.97 -179.75 4.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.74 0.305 . . . . 10.0 110.832 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.5 mt -101.9 -173.99 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.428 . . . . 10.0 111.329 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.44 135.94 57.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.016 -0.538 . . . . 10.0 111.817 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -81.38 134.91 35.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.237 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.89 136.05 18.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.716 -0.675 . . . . 10.0 109.921 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.436 ' HA ' ' HE3' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -149.12 138.18 21.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 10.0 110.986 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 80.2 mtt180 -145.84 157.54 43.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.577 -0.738 . . . . 10.0 109.93 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.8 m -69.44 118.74 12.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.896 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -160.35 131.82 5.86 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.558 -0.534 . . . . 10.0 109.558 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -94.57 8.97 40.46 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.157 -0.474 . . . . 10.0 111.31 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.3 tt -60.38 140.41 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.064 0.459 . . . . 10.0 111.085 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.6 pt -69.9 142.33 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.826 -0.625 . . . . 10.0 110.9 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -125.64 155.22 72.67 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.67 -0.695 . . . . 10.0 109.185 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -65.6 -163.64 0.06 OUTLIER 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.424 2.083 . . . . 10.0 111.6 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -66.48 89.88 0.15 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.44 0.638 . . . . 10.0 110.188 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 p -135.59 168.52 19.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.144 -0.934 . . . . 10.0 109.865 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 117' ' ' TYR . 1.4 m -84.93 -28.76 6.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 121.073 -0.251 . . . . 10.0 111.301 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.19 135.63 5.16 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.593 -0.813 . . . . 10.0 112.28 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' HE3' ' HA ' ' A' ' 68' ' ' ASP . 28.9 mtpp -65.26 -48.1 74.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.615 0.245 . . . . 10.0 111.364 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -66.33 -34.91 79.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 140' ' ' LEU . 25.0 t -59.28 -46.99 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.964 -1.016 . . . . 10.0 110.546 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -58.86 -41.16 95.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.044 -0.598 . . . . 10.0 112.19 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -64.52 -43.86 92.68 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.311 . . . . 10.0 110.378 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.3 82.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.125 -0.489 . . . . 10.0 110.794 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.786 ' O ' ' HG2' ' A' ' 91' ' ' ARG . 4.8 mt -56.34 -47.67 80.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -66.16 -49.22 68.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.62 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -62.16 -37.16 84.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.215 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.96 -34.29 89.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.927 -0.654 . . . . 10.0 112.916 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.809 ' HD2' HD22 ' A' ' 103' ' ' LEU . 5.8 mmt180 -76.27 -34.71 59.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.287 0.565 . . . . 10.0 109.689 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.468 ' HA ' HG23 ' A' ' 97' ' ' THR . 96.8 mt-30 -75.36 -14.38 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.85 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -98.55 21.69 10.89 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.438 -0.346 . . . . 10.0 111.424 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -82.96 -7.08 59.7 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.817 0.302 . . . . 10.0 111.817 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 96' ' ' PRO . 37.7 mt-10 54.41 101.17 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.662 0 O-C-N 123.984 0.803 . . . . 10.0 112.228 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 55.4 Cg_endo -74.4 -50.93 0.17 OUTLIER 'Cis proline' 0 C--N 1.345 0.378 0 C-N-CA 123.218 -1.576 . . . . 10.0 113.18 0.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.468 HG23 ' HA ' ' A' ' 92' ' ' GLN . 21.5 m -163.49 137.15 5.72 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.891 . . . . 10.0 110.169 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.99 132.21 37.29 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.88 -0.415 . . . . 10.0 109.88 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.5 ' OG1' ' HG2' ' A' ' 102' ' ' GLU . 72.2 p -75.55 163.46 27.34 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.178 0.513 . . . . 10.0 111.149 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.21 -29.69 67.7 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.679 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.34 -42.14 84.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.127 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.5 ' HG2' ' OG1' ' A' ' 99' ' ' THR . 55.8 mm-40 -62.8 -49.33 75.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.475 -0.329 . . . . 10.0 111.004 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.809 HD22 ' HD2' ' A' ' 91' ' ' ARG . 24.5 tp -62.03 -47.08 86.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.996 -0.372 . . . . 10.0 109.996 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -57.04 -46.19 91.69 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.857 -0.687 . . . . 10.0 112.076 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 tptp -64.82 -42.16 95.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 111.754 0.279 . . . . 10.0 111.754 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 103' ' ' LEU . 15.5 pt-20 -69.65 -23.99 63.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 103' ' ' LEU . 27.6 pt -97.3 -7.04 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 121.769 -0.582 . . . . 10.0 111.127 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.5 33.54 16.34 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.745 -0.74 . . . . 10.0 112.664 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 110' ' ' THR . 54.5 mm-40 -130.04 -156.64 0.77 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.74 -0.467 . . . . 10.0 109.74 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 109' ' ' GLU . 3.2 p -126.11 176.35 7.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.521 0.201 . . . . 10.0 110.818 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.43 95.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.785 0.326 . . . . 10.0 111.208 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 116' ' ' SER . . . -61.11 -30.45 70.37 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.922 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 11.7 m -68.54 -43.79 75.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.321 -0.399 . . . . 10.0 110.135 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.674 HG13 HD23 ' A' ' 103' ' ' LEU . 92.8 t -64.44 -46.17 93.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.372 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.76 -33.13 73.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.442 0.639 . . . . 10.0 110.064 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 119' ' ' ARG . 0.4 OUTLIER -74.69 -31.89 62.03 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.399 -0.818 . . . . 10.0 110.667 178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.413 ' CE1' HG11 ' A' ' 79' ' ' VAL . 1.9 m-85 -72.41 -41.18 66.53 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.354 -0.385 . . . . 10.0 111.616 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.53 -18.35 64.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.165 0.507 . . . . 10.0 110.439 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 116' ' ' SER . 19.7 tpt180 -73.97 -19.31 60.7 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.18 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.23 26.56 25.58 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.054 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 121' ' ' THR . 5.3 t -175.23 102.6 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.957 0.884 . . . . 10.0 110.507 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 116' ' ' SER . . . -152.5 33.24 0.51 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.376 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.4 m 63.42 98.96 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.226 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.64 96.54 0.59 Allowed 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 123.348 2.698 . . . . 10.0 115.169 -176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -90.92 112.39 24.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 104.562 -2.384 . . . . 10.0 104.562 175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.443 ' H ' ' HG2' ' A' ' 126' ' ' GLN . 7.5 mm-40 -46.56 -38.98 10.23 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.549 1.314 . . . . 10.0 114.549 -174.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.26 -33.09 65.07 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 111.683 0.253 . . . . 10.0 111.683 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.813 ' O ' ' HG3' ' A' ' 132' ' ' MET . 68.6 mt -70.09 -58.91 4.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.706 -0.398 . . . . 10.0 111.484 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -35.35 71.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.798 0.332 . . . . 10.0 111.558 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 22.7 m -63.31 -44.09 95.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.611 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 135' ' ' VAL . 25.2 mtmt -75.14 -34.58 61.66 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.011 0.375 . . . . 10.0 112.011 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.813 ' HG3' ' O ' ' A' ' 128' ' ' ILE . 44.2 mtp -51.0 -61.34 2.29 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.325 0.584 . . . . 10.0 112.251 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.67 ' HB3' HG23 ' A' ' 138' ' ' VAL . 9.2 mm-40 -74.33 -26.57 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.684 . . . . 10.0 112.074 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 130' ' ' SER . 9.0 ttp85 -55.99 -37.48 69.16 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.061 0.458 . . . . 10.0 110.719 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 131' ' ' LYS . 29.8 t -63.92 -31.76 54.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.545 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.622 HD21 ' NH1' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -95.51 -2.11 49.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.306 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 62.5 t30 65.74 45.3 2.65 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.273 0.559 . . . . 10.0 110.136 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.67 HG23 ' HB3' ' A' ' 133' ' ' GLU . 15.4 m -134.85 155.75 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.651 ' HD2' ' O ' ' A' ' 149' ' ' ARG . 32.0 mttp -133.18 136.62 45.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.255 0.55 . . . . 10.0 110.715 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.642 HD13 HG13 ' A' ' 83' ' ' VAL . 3.1 mt -89.38 39.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.341 -0.845 . . . . 10.0 111.291 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -131.32 136.96 48.56 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.811 -0.356 . . . . 10.0 110.176 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.14 -161.18 24.28 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.867 -0.682 . . . . 10.0 112.24 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -94.71 -24.73 17.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 10.0 110.147 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -81.37 50.45 1.45 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.336 0.589 . . . . 10.0 110.286 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.7 mm -70.1 139.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.642 -0.708 . . . . 10.0 110.551 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.49 6.15 74.2 Favored Glycine 0 CA--C 1.509 -0.33 0 C-N-CA 120.761 -0.733 . . . . 10.0 111.762 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.31 156.76 78.69 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.274 -0.269 . . . . 10.0 110.274 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.75 124.83 16.21 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.186 1.924 . . . . 10.0 110.171 177.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.651 ' O ' ' HD2' ' A' ' 139' ' ' LYS . 4.7 ttt180 -145.95 106.61 4.1 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.1 mp -63.07 125.5 24.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.737 0.303 . . . . 10.0 110.642 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -165.5 -172.22 32.65 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.744 -0.543 . . . . 10.0 111.744 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.63 121.72 7.29 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.947 2.432 . . . . 10.0 112.566 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -109.1 168.02 9.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 126' ' ' GLN . 52.4 tptt -118.76 117.38 28.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.04 0.448 . . . . 10.0 110.458 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 47.9 tttm . . . . . 0 C--O 1.249 1.032 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.911 -179.538 . . . . . . . . 0 0 . 1 stop_ save_